data_2mem_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mem _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 -173.4 2.03 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.413 0.685 . . . . 0.0 111.337 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 23.8 p -140.65 144.45 35.72 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.031 0.932 . . . . 0.0 110.569 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 19.3 m -145.03 174.22 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 125.257 1.423 . . . . 0.0 110.339 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.486 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 29.0 p -147.21 109.11 4.41 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.488 0.715 . . . . 0.0 109.82 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' A' ' 464' ' ' SER . 33.8 m -98.21 149.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.192 0.597 . . . . 0.0 109.581 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -112.9 98.82 7.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 379' ' ' LEU . 66.5 t -65.39 103.3 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 124.244 0.965 . . . . 0.0 110.706 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -98.63 99.87 11.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.669 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.87 54.64 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.974 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -81.58 -21.83 38.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.392 0.677 . . . . 0.0 111.067 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.79 0.03 OUTLIER Glycine 0 C--N 1.353 1.516 0 O-C-N 123.35 0.406 . . . . 0.0 113.101 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 55.9 t-20 -131.91 150.75 52.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -91.38 -63.31 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -143.6 -93.49 0.18 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.317 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.06 18.98 31.82 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 120.469 2.135 . . . . 0.0 114.319 9.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.24 0.85 52.81 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.686 0.794 . . . . 0.0 110.783 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.484 HD21 HD11 ' A' ' 456' ' ' LEU . 48.7 mt -116.21 145.93 42.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.65 1.18 . . . . 0.0 109.011 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.96 118.21 63.37 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 123.586 0.554 . . . . 0.0 109.675 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.51 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 36.1 Cg_endo -61.39 -29.82 86.16 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.779 2.319 . . . . 0.0 113.248 -173.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -72.78 -43.43 62.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.554 . . . . 0.0 110.581 -178.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -69.9 -30.27 67.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.153 0.581 . . . . 0.0 111.05 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.86 -31.11 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.492 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 77.7 mm-40 -82.81 -19.36 37.81 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 122.376 0.27 . . . . 0.0 111.324 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 83.3 mm-40 -80.1 -41.54 25.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.015 0.526 . . . . 0.0 112.061 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . 2.7 pp -65.18 163.94 27.2 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 123.828 0.851 . . . . 0.0 111.293 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 379' ' ' LEU . 74.0 Cg_endo -68.51 169.75 16.53 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 122.381 2.054 . . . . 0.0 114.565 -169.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.2 -20.91 54.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.832 1.253 . . . . 0.0 112.031 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.469 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 29.6 p80 -161.0 159.16 29.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.062 0.458 . . . . 0.0 111.224 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -125.11 102.04 7.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 141.14 167.51 11.13 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.454 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.65 129.89 19.63 Favored 'Cis proline' 0 C--N 1.381 2.249 0 CA-C-N 118.902 1.351 . . . . 0.0 112.498 -1.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.73 -178.83 37.67 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.192 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.531 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 42.3 Cg_endo -64.27 134.72 43.4 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.053 2.502 . . . . 0.0 114.434 -171.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -38.55 -48.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.337 2.255 . . . . 0.0 113.782 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -76.09 -33.7 59.51 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.63 1.172 . . . . 0.0 112.158 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 94.2 t -81.87 -35.39 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.513 0.325 . . . . 0.0 110.601 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.64 -42.67 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 122.174 0.19 . . . . 0.0 110.803 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 445' ' ' ALA . 4.3 pp -67.0 -43.91 81.71 Favored 'General case' 0 C--N 1.359 0.988 0 O-C-N 123.189 0.306 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 397' ' ' GLN . 12.9 ptm180 -68.54 -33.9 74.92 Favored 'General case' 0 C--N 1.363 1.17 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -75.58 -20.18 58.78 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 359' ' ' VAL . 32.4 mm -75.21 -52.58 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 167.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.6 t -58.5 -57.08 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.949 -172.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.4 pt20 -70.47 -23.83 62.76 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.797 0.439 . . . . 0.0 112.062 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.54 92.57 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 75.0 m -66.88 -47.66 71.16 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.946 0.779 . . . . 0.0 111.026 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 396' ' ' VAL . 12.3 t -65.35 -35.97 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.727 0.411 . . . . 0.0 110.344 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.51 -39.81 77.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.957 0.503 . . . . 0.0 110.222 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 75.0 m -78.01 -14.69 59.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.159 0.584 . . . . 0.0 111.894 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 409' ' ' VAL . . . -60.36 130.82 48.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -167.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 81.4 mt -72.13 120.66 18.04 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 65.36 59.25 0.81 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.115 0.96 . . . . 0.0 109.199 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.3 m -54.58 -34.77 62.47 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.63 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.35 -38.71 43.65 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.764 1.226 . . . . 0.0 113.272 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.437 HG22 ' HE1' ' A' ' 412' ' ' TYR . 58.0 m -89.14 -40.51 12.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.334 0.654 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 403' ' ' ALA . 70.9 t -61.55 -30.24 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.006 0.922 . . . . 0.0 111.869 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.71 -15.44 60.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.353 1.061 . . . . 0.0 110.302 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -77.38 -25.49 63.36 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.699 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.437 ' HE1' HG22 ' A' ' 408' ' ' THR . 96.0 m-85 -76.47 2.92 12.37 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.41 0.684 . . . . 0.0 111.965 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 113.0 8.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.552 0.741 . . . . 0.0 109.815 165.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -76.7 159.15 79.79 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.911 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 57.4 Cg_endo -70.65 123.29 9.68 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.127 1.218 . . . . 0.0 109.83 163.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -109.86 111.74 23.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -85.37 29.27 0.68 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.356 0.663 . . . . 0.0 112.035 -162.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -78.89 -25.49 43.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.358 0.663 . . . . 0.0 110.602 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.19 40.95 5.02 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.127 0.267 . . . . 0.0 113.359 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.24 -119.29 2.54 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.599 ' HB2' HD12 ' A' ' 436' ' ' LEU . 14.8 mm-40 -85.51 -178.63 6.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.58 . . . . 0.0 111.198 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.14 125.54 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.662 0.785 . . . . 0.0 109.067 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 397' ' ' GLN . 41.6 mm -104.03 126.2 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.498 0.719 . . . . 0.0 109.085 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 24.5 p -105.95 149.74 26.33 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.768 0.827 . . . . 0.0 109.649 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -161.12 175.59 12.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.485 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 64.7 m -120.47 117.43 27.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.965 0.906 . . . . 0.0 109.708 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.64 112.68 12.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.977 0.911 . . . . 0.0 109.285 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.7 t70 71.05 23.2 4.26 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.441 1.497 . . . . 0.0 110.983 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 -12.67 69.37 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.722 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.97 164.73 15.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.695 0.798 . . . . 0.0 109.91 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.5 t -108.92 114.76 28.8 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -119.09 140.99 49.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.774 0.321 . . . . 0.0 110.227 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 55.7 p -125.12 149.28 48.02 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 110.327 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 26.8 pt -120.38 179.88 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 0.0 110.096 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.29 154.39 22.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.655 0.782 . . . . 0.0 109.81 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' A' ' 421' ' ' GLU . 80.8 mt -115.61 167.91 9.27 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.381 1.073 . . . . 0.0 109.379 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.11 142.42 30.86 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.844 1.696 . . . . 0.0 111.877 165.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.08 138.55 18.31 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.559 2.172 . . . . 0.0 111.507 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.13 160.93 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.479 0.712 . . . . 0.0 110.605 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -142.56 -3.22 1.04 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.436 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -115.3 140.06 49.44 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.07 72.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.086 0.955 . . . . 0.0 111.643 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.7 m -63.4 -35.05 79.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.204 0.601 . . . . 0.0 111.227 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -23.22 59.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.709 0.404 . . . . 0.0 110.106 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.615 ' HB2' HG22 ' A' ' 388' ' ' VAL . . . -55.55 -59.0 5.46 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.3 -41.72 89.32 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.571 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -26.66 61.08 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.567 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -63.71 -55.4 23.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.801 0.441 . . . . 0.0 110.574 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.436 HD23 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -80.04 -14.99 58.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.138 -175.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -40.86 98.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 109.612 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -69.14 -43.08 75.09 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.162 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.48 -46.34 63.97 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.144 0.578 . . . . 0.0 111.509 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 71.3 m -63.68 -27.91 69.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.698 0.799 . . . . 0.0 111.108 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -66.93 -40.53 87.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.342 0.657 . . . . 0.0 111.175 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 72.6 p -75.36 -15.22 60.49 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.605 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.484 HD11 HD21 ' A' ' 371' ' ' LEU . 47.5 mt -97.7 -6.34 33.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.536 0.734 . . . . 0.0 111.35 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 70.23 9.17 6.93 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.644 1.577 . . . . 0.0 112.129 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.509 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -87.62 133.57 33.79 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.409 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 20.9 t70 -155.37 151.69 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 65.99 18.09 10.96 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.653 0.781 . . . . 0.0 110.495 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.3 tp -83.81 -7.66 59.4 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.314 1.046 . . . . 0.0 110.251 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.436 HD23 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.86 163.12 32.26 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.584 1.153 . . . . 0.0 108.683 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 27.9 m -151.49 109.83 3.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.538 ' HG ' HG11 ' A' ' 359' ' ' VAL . 14.5 m . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 124.286 1.035 . . . . 0.0 112.201 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 120.487 0.184 . . . . 0.0 110.567 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.4 t -81.82 -179.39 7.37 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.819 0.847 . . . . 0.0 111.067 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.8 p -139.34 134.67 32.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.387 1.075 . . . . 0.0 109.6 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.52 159.52 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.558 0.743 . . . . 0.0 110.799 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 13.2 p -131.11 106.03 8.09 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.839 0.855 . . . . 0.0 109.602 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.426 HG13 HD21 ' A' ' 462' ' ' LEU . 46.2 t -93.56 158.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.378 1.071 . . . . 0.0 109.743 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.32 107.36 9.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.53 105.92 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.152 0.581 . . . . 0.0 110.463 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 48.3 t30 -94.33 88.02 5.4 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -14.12 62.85 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.559 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -83.97 -16.45 44.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.518 0.727 . . . . 0.0 111.136 174.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -71.6 -65.34 2.44 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 123.015 0.197 . . . . 0.0 112.626 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -154.93 165.54 36.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.411 ' O ' HD11 ' A' ' 371' ' ' LEU . 1.2 m-85 -109.22 -65.02 1.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.49 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -144.07 -95.2 0.2 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.774 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.9 22.09 29.43 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.54 2.17 . . . . 0.0 114.098 7.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -79.16 -8.21 58.82 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.753 0.421 . . . . 0.0 110.292 166.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.7 mt -110.85 142.61 42.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.99 1.316 . . . . 0.0 108.962 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.11 129.29 87.99 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.494 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.8 Cg_endo -59.78 -41.26 56.38 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.296 2.664 . . . . 0.0 113.549 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.494 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -69.92 -41.77 74.21 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.604 0.361 . . . . 0.0 110.725 -175.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -72.22 -28.48 63.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.207 0.603 . . . . 0.0 110.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.478 HD11 HD23 ' A' ' 379' ' ' LEU . 18.4 mm -65.42 -29.54 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.876 0.87 . . . . 0.0 110.52 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 81.8 mm-40 -80.04 -25.63 40.07 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.467 0.307 . . . . 0.0 110.92 174.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 89.5 mm-40 -74.03 -34.56 64.15 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.102 0.561 . . . . 0.0 112.004 -176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.478 HD23 HD11 ' A' ' 376' ' ' ILE . 3.3 pp -73.55 154.94 89.66 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.776 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.39 155.51 2.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 0.0 115.705 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.74 -7.59 59.64 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.228 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.4 147.06 7.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.735 0.814 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.66 126.97 50.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.967 0.907 . . . . 0.0 109.306 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 109.68 -173.91 17.35 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.973 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.79 127.47 14.41 Favored 'Cis proline' 0 C--N 1.381 2.247 0 CA-C-N 119.664 1.732 . . . . 0.0 112.33 -2.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.95 -174.13 25.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.0 138.72 58.28 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.567 2.178 . . . . 0.0 112.686 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.709 HG23 ' HB3' ' A' ' 445' ' ' ALA . 6.8 p -46.67 -40.82 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.363 1.865 . . . . 0.0 112.442 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.59 -51.82 65.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 0.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 91.7 t -71.54 -45.21 68.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.723 -174.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.4 -29.62 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.76 -40.2 55.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.055 0.389 . . . . 0.0 110.442 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -70.12 -33.33 71.71 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 16.2 mmm-85 -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.444 0.698 . . . . 0.0 111.503 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.16 -55.12 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.444 ' O ' HG21 ' A' ' 400' ' ' VAL . 61.0 t -66.13 -52.77 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.758 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.409 ' HA ' HG22 ' A' ' 423' ' ' ILE . 7.9 pt20 -63.58 -23.86 67.56 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.208 0.603 . . . . 0.0 112.25 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -70.73 -49.52 46.0 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 77.8 m -63.18 -52.47 62.25 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.054 0.942 . . . . 0.0 112.688 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.456 HG13 HG21 ' A' ' 406' ' ' THR . 11.0 t -64.59 -41.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.353 0.661 . . . . 0.0 110.215 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -72.13 -31.92 66.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 379' ' ' LEU . 85.1 m -88.38 8.96 25.1 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.381 0.672 . . . . 0.0 111.819 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -82.32 161.14 22.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.3 119.79 26.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.601 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 59.49 72.6 0.52 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.192 0.997 . . . . 0.0 109.763 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 400' ' ' VAL . 93.7 m -62.25 -34.89 77.39 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.978 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -55.87 -37.37 68.7 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.1 m -76.53 -43.41 39.39 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.239 0.616 . . . . 0.0 109.546 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.502 HG22 ' HB1' ' A' ' 403' ' ' ALA . 74.7 t -66.01 -28.05 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.54 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . 0.42 ' HD2' HG11 ' A' ' 400' ' ' VAL . 19.0 t80 -78.92 -17.65 55.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.476 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -74.94 -10.5 83.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.598 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -77.49 -10.15 59.31 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.517 0.727 . . . . 0.0 111.376 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.606 HD13 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -141.1 141.46 34.21 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.018 0.927 . . . . 0.0 109.561 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -115.89 159.55 38.68 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.215 0.606 . . . . 0.0 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.49 151.52 75.56 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.87 1.713 . . . . 0.0 111.766 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.92 122.32 17.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.136 1.374 . . . . 0.0 107.99 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -80.46 14.46 2.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.817 0.847 . . . . 0.0 112.425 -168.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.09 -45.76 92.1 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.379 1.072 . . . . 0.0 111.403 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 95.09 43.55 3.5 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.712 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -99.85 -109.91 3.11 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.811 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.4 mp0 -78.5 171.36 15.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.41 0.684 . . . . 0.0 110.915 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.3 135.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.812 0.845 . . . . 0.0 109.354 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.51 HG12 HD12 ' A' ' 436' ' ' LEU . 36.0 mm -113.18 123.9 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.8 p -107.36 146.25 31.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.939 0.896 . . . . 0.0 109.646 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.83 159.89 14.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.869 0.868 . . . . 0.0 110.077 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.4 m -81.61 116.97 21.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.857 0.463 . . . . 0.0 110.456 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -143.12 120.69 11.76 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.163 0.985 . . . . 0.0 110.499 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.85 22.58 7.15 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.835 1.254 . . . . 0.0 113.264 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.8 58.07 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 113.895 0.318 . . . . 0.0 113.895 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.64 172.38 13.09 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.0 t -86.1 126.99 34.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -106.43 139.75 40.42 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.505 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.3 p -123.69 149.12 45.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.344 1.058 . . . . 0.0 109.861 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 413' ' ' LEU . 25.9 pt -124.8 176.35 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 0.0 110.247 173.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -112.94 144.07 43.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.996 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 423' ' ' ILE . 7.8 mp -114.35 160.71 31.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.858 1.263 . . . . 0.0 108.373 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.465 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 67.8 Cg_endo -75.48 134.97 17.65 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.083 1.855 . . . . 0.0 112.167 169.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.24 136.71 29.72 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 122.716 2.277 . . . . 0.0 112.918 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.75 174.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.424 1.09 . . . . 0.0 110.92 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.8 0.44 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.164 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 19.0 m -119.77 142.01 48.96 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.262 0.483 . . . . 0.0 110.511 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.62 80.6 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.019 0.928 . . . . 0.0 112.904 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.0 m -65.23 -26.64 68.2 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.447 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.431 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 1.8 t80 -85.19 -22.05 28.91 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.709 ' HB3' HG23 ' A' ' 388' ' ' VAL . . . -53.44 -60.41 3.33 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 121.544 0.688 . . . . 0.0 109.224 170.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.39 -36.49 74.13 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.518 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . 0.481 HH11 ' HA ' ' A' ' 448' ' ' PHE . 0.0 OUTLIER -63.86 -31.96 73.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.688 0.795 . . . . 0.0 111.569 177.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . 0.481 ' HA ' HH11 ' A' ' 447' ' ' ARG . 2.5 t80 -67.19 -46.17 74.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.459 0.304 . . . . 0.0 111.358 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -13.53 44.76 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.199 -0.313 . . . . 0.0 111.057 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.62 -55.28 33.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.879 1.272 . . . . 0.0 111.864 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.09 -34.86 78.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.458 0.703 . . . . 0.0 111.277 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 40.8 t80 -65.87 -56.48 11.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.573 0.749 . . . . 0.0 110.635 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.3 m -60.9 -30.68 70.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.781 0.832 . . . . 0.0 110.979 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.84 -44.53 85.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.914 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 52.4 p -75.47 -21.16 58.32 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 79.9 mt -78.06 -11.11 59.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.99 0.516 . . . . 0.0 111.491 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 74.03 9.4 4.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.525 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 456' ' ' LEU . 22.6 p -95.05 133.37 38.92 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.39 0.676 . . . . 0.0 109.742 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -149.38 150.75 32.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 14.1 m-80 67.47 17.15 10.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.881 1.273 . . . . 0.0 109.884 -167.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.3 tp -78.99 -26.73 43.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.765 0.826 . . . . 0.0 110.263 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.426 HD21 HG13 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -163.24 150.4 12.77 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.959 0.504 . . . . 0.0 110.873 178.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 67.1 m -166.07 138.54 3.97 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.501 1.12 . . . . 0.0 108.987 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.483 1.208 0 C-N-CA 123.303 0.641 . . . . 0.0 110.77 170.309 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 121.015 0.436 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.2 t -77.2 172.78 12.71 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -137.51 142.69 41.45 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.908 0.883 . . . . 0.0 110.193 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.64 166.02 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.468 1.107 . . . . 0.0 111.149 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.497 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 22.8 p -136.26 108.85 7.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.229 1.012 . . . . 0.0 109.631 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 25.0 t -93.99 149.76 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.535 0.734 . . . . 0.0 109.795 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -119.66 99.63 6.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.441 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -68.72 103.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.541 0.736 . . . . 0.0 110.018 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -94.9 94.58 8.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.857 0.863 . . . . 0.0 109.55 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -11.57 59.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.764 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -76.61 -13.97 60.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.239 0.615 . . . . 0.0 110.339 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -83.69 -159.3 28.3 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 169.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 40.3 t30 -73.41 144.5 46.33 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.416 0.608 . . . . 0.0 110.516 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -61.15 1.79 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.484 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.07 -91.27 0.11 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.025 -0.875 . . . . 0.0 112.472 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -86.01 13.28 46.46 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.849 2.325 . . . . 0.0 113.906 7.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.99 -2.0 38.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.21 0.604 . . . . 0.0 111.351 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 456' ' ' LEU . 30.3 mt -112.28 141.54 45.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.839 1.255 . . . . 0.0 108.321 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.472 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 16.3 t70 -70.74 117.93 60.28 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 110.009 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.4 Cg_endo -57.13 -34.61 98.06 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 123.597 2.864 . . . . 0.0 113.519 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -68.09 -51.42 46.61 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.577 0.548 . . . . 0.0 109.871 -177.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.472 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 19.7 mtp180 -62.31 -33.37 74.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.863 0.865 . . . . 0.0 111.398 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.431 HD13 HD23 ' A' ' 379' ' ' LEU . 24.0 mm -61.64 -33.32 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.872 0.869 . . . . 0.0 111.04 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 73.9 mm-40 -80.55 -21.33 41.87 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.2 -0.313 . . . . 0.0 111.289 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 61.8 mm-40 -85.34 -37.22 20.18 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.726 0.41 . . . . 0.0 112.105 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.431 HD23 HD13 ' A' ' 376' ' ' ILE . 2.8 pp -64.84 156.01 80.92 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.828 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.13 154.32 28.74 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.848 2.365 . . . . 0.0 113.667 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.25 -14.0 60.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.818 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.441 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 9.7 p-80 -166.91 146.99 5.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.94 0.496 . . . . 0.0 111.552 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.92 104.43 10.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.744 1.218 . . . . 0.0 109.052 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 145.02 168.47 12.85 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.825 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.09 140.47 64.79 Favored 'Cis proline' 0 C--N 1.379 2.149 0 CA-C-N 119.713 1.757 . . . . 0.0 112.828 -1.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -164.4 -168.83 27.1 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.092 -0.838 . . . . 0.0 111.607 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.07 143.0 48.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 123.156 2.571 . . . . 0.0 111.949 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.703 HG22 ' HB1' ' A' ' 445' ' ' ALA . 7.7 p -52.85 -39.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.955 1.302 . . . . 0.0 111.638 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.412 ' HB3' HH21 ' A' ' 393' ' ' ARG . 14.3 m120 -68.89 -48.19 63.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 72.9 t -76.75 -44.31 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.5 -41.08 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.862 0.465 . . . . 0.0 111.487 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.82 -40.99 79.2 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 9.7 ptp180 -69.76 -25.78 63.99 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.135 0.272 . . . . 0.0 110.569 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 53.2 mmm-85 -70.8 -37.13 73.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.999 0.52 . . . . 0.0 111.258 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.79 -52.58 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.721 0.638 . . . . 0.0 109.489 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.452 ' O ' HG21 ' A' ' 400' ' ' VAL . 72.4 t -61.05 -47.74 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.998 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -65.01 -31.13 72.21 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.184 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.44 84.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.097 0.559 . . . . 0.0 110.231 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.34 -48.42 61.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.642 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 396' ' ' VAL . 36.4 t -62.9 -42.18 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.399 0.68 . . . . 0.0 110.468 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.88 -51.84 67.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 79.4 m -77.13 -8.0 56.76 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.726 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.613 ' HB2' HG23 ' A' ' 409' ' ' VAL . . . -65.5 123.05 18.63 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.908 0.883 . . . . 0.0 112.335 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.54 115.34 5.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 166.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 68.61 66.68 0.31 Allowed 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.543 1.164 . . . . 0.0 109.258 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 84.6 m -55.43 -33.32 63.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.14 1.776 . . . . 0.0 112.428 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.91 1.284 . . . . 0.0 112.753 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.7 m -79.27 -34.29 42.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.898 0.879 . . . . 0.0 109.787 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 403' ' ' ALA . 55.2 t -69.09 -30.36 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.51 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -69.24 -23.61 63.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.018 0.927 . . . . 0.0 110.196 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.04 71.07 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -79.98 -21.32 43.84 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.009 0.524 . . . . 0.0 112.163 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.26 115.08 20.46 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.688 0.756 . . . . 0.0 111.486 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.05 158.93 32.53 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.556 1.143 . . . . 0.0 110.045 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.21 126.84 10.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.244 1.963 . . . . 0.0 113.045 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.58 ' HB3' ' HE ' ' A' ' 418' ' ' ARG . 2.5 m-20 -123.77 104.96 9.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.09 58.77 5.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.768 0.827 . . . . 0.0 111.403 -164.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.58 ' HE ' ' HB3' ' A' ' 416' ' ' ASP . 0.9 OUTLIER -106.0 14.26 28.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.635 0.774 . . . . 0.0 111.073 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.58 26.19 72.85 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.33 -115.06 1.44 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.125 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.8 mp0 -86.1 170.39 12.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.112 0.565 . . . . 0.0 110.625 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.3 t -136.97 128.58 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.432 HG12 HD11 ' A' ' 436' ' ' LEU . 41.4 mm -116.48 138.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.4 p -106.51 142.7 35.74 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.817 0.847 . . . . 0.0 109.628 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.29 120.99 12.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.491 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.3 m -77.32 101.13 6.16 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . 0.543 ' HB3' ' HD1' ' A' ' 432' ' ' HIS . 81.0 t80 -123.2 134.32 54.15 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.015 1.326 . . . . 0.0 108.213 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.3 t70 65.37 16.08 10.35 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.956 1.302 . . . . 0.0 110.29 -175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 89.0 -13.35 63.39 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.936 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -96.85 153.65 17.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.483 0.713 . . . . 0.0 110.143 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -84.26 123.05 29.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.543 ' HD1' ' HB3' ' A' ' 427' ' ' PHE . 32.3 m170 -123.9 124.12 41.92 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 47.7 p -107.05 151.35 25.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.717 0.807 . . . . 0.0 111.057 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.02 -178.08 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.931 . . . . 0.0 110.217 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -118.06 150.64 38.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.811 0.844 . . . . 0.0 109.523 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.9 mp -116.56 160.26 37.02 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.726 1.21 . . . . 0.0 108.185 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.99 139.88 19.7 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.157 1.905 . . . . 0.0 110.818 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.52 145.48 37.71 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.507 2.138 . . . . 0.0 112.939 -173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.5 156.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.989 0.915 . . . . 0.0 110.332 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.44 9.4 2.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.215 0.606 . . . . 0.0 111.525 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 42.4 t -115.21 139.92 49.53 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.26 68.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.612 0.765 . . . . 0.0 112.187 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.4 m -69.87 -16.97 63.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.058 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.83 -27.79 23.3 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.703 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -50.26 -65.8 0.5 Allowed 'General case' 0 C--N 1.366 1.3 0 O-C-N 124.201 0.938 . . . . 0.0 109.914 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.77 -43.12 99.62 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.473 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -60.55 -36.39 78.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.58 0.752 . . . . 0.0 111.641 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -61.43 -52.68 63.54 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 123.579 0.549 . . . . 0.0 110.14 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -19.14 60.78 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.938 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.68 -34.44 46.19 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.205 0.457 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -62.42 -35.77 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.997 171.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -76.85 -36.6 56.69 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.126 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 92.4 m -65.72 -26.98 68.0 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.208 0.603 . . . . 0.0 110.74 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.34 -39.36 93.73 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.818 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.3 m -70.38 -18.12 63.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.252 1.021 . . . . 0.0 111.813 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 371' ' ' LEU . 38.7 mt -98.35 -13.3 20.75 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.853 0.861 . . . . 0.0 111.612 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 70.41 8.61 6.68 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.32 1.448 . . . . 0.0 111.958 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.495 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 26.4 p -86.8 135.24 33.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.34 146.57 25.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 65.66 15.58 10.11 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.126 0.97 . . . . 0.0 110.067 -168.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 35.6 tp -79.77 -12.02 59.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.574 0.75 . . . . 0.0 110.519 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.04 164.75 36.41 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 108.829 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 72.3 m -158.62 108.9 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 13.6 m . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 122.964 0.506 . . . . 0.0 110.34 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 43.3 t -79.21 171.75 14.76 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.4 p -138.86 134.41 33.27 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.572 0.749 . . . . 0.0 109.861 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 388' ' ' VAL . 17.4 m -137.68 169.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.579 1.151 . . . . 0.0 110.218 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.5 106.86 4.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.635 0.774 . . . . 0.0 109.278 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 395' ' ' ILE . 32.6 m -90.7 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.182 0.515 . . . . 0.0 110.133 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -118.34 100.63 7.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.55 105.92 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.031 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 30.8 t30 -87.34 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 381' ' ' ASP . 6.7 mmmm -69.38 -31.02 69.14 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.094 -172.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.89 0.8 57.4 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.638 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.11 -80.9 0.23 Allowed Glycine 0 C--N 1.354 1.529 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -147.75 155.45 41.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.462 ' HA ' HG23 ' A' ' 376' ' ' ILE . 0.8 OUTLIER -97.54 -64.51 1.03 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.18 -91.4 0.1 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.367 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -86.88 12.12 53.11 Favored 'Cis proline' 0 C--N 1.374 1.879 0 CA-C-N 120.384 2.092 . . . . 0.0 114.325 11.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -76.64 -8.87 58.09 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.271 0.557 . . . . 0.0 110.335 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 456' ' ' LEU . 45.6 mt -107.59 144.26 34.86 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -69.32 122.83 86.82 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.647 0.779 . . . . 0.0 110.302 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.515 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 57.0 Cg_endo -67.61 -21.16 46.16 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.969 2.446 . . . . 0.0 113.899 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.515 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -82.91 -45.47 14.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.546 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 4.5 mtt-85 -66.09 -32.49 73.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.913 . . . . 0.0 111.541 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 367' ' ' PHE . 22.2 mm -62.31 -27.85 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.187 172.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -83.84 -23.96 31.12 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.637 0.375 . . . . 0.0 110.667 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.6 mm-40 -77.6 -37.51 50.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.92 0.488 . . . . 0.0 112.103 -175.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.7 153.34 83.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.086 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.9 169.36 10.45 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.609 2.206 . . . . 0.0 114.284 -172.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 363' ' ' LYS . 21.1 t70 -84.36 -3.34 58.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.419 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.17 151.78 18.04 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.255 0.622 . . . . 0.0 110.127 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -126.2 103.46 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 146.58 171.88 16.34 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.057 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -77.9 136.1 41.03 Favored 'Cis proline' 0 C--N 1.377 2.027 0 CA-C-N 118.65 1.225 . . . . 0.0 111.408 -1.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -160.92 -168.67 23.12 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.299 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.413 ' HB3' ' HE2' ' A' ' 354' ' ' MET . 9.2 Cg_exo -68.46 148.49 73.27 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.339 2.693 . . . . 0.0 112.383 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.4 p -55.32 -43.74 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.266 1.027 . . . . 0.0 111.634 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -72.01 -39.61 69.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.536 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 69.4 t -73.2 -48.93 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 119.559 -0.258 . . . . 0.0 110.847 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.8 t -58.74 -39.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.717 0.407 . . . . 0.0 111.775 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.475 HD12 ' HG2' ' A' ' 421' ' ' GLU . 1.9 pp -68.67 -43.95 75.08 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.9 ptt180 -70.25 -27.99 64.88 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.155 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.3 mmt180 -63.78 -38.21 90.25 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.506 0.722 . . . . 0.0 110.91 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 359' ' ' VAL . 34.4 mm -66.17 -54.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.738 0.649 . . . . 0.0 109.279 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 400' ' ' VAL . 57.9 t -57.66 -63.63 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.427 1.08 . . . . 0.0 110.462 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -55.75 -36.27 67.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.7 0.8 . . . . 0.0 112.21 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.41 -44.86 81.8 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 122.746 0.418 . . . . 0.0 109.938 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 88.0 m -64.87 -38.84 92.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.575 0.75 . . . . 0.0 111.516 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 396' ' ' VAL . 11.8 t -69.5 -43.54 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.016 0.527 . . . . 0.0 110.275 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.55 -33.83 75.85 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.277 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.546 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 72.1 m -86.23 -4.83 59.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.509 0.724 . . . . 0.0 111.465 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.561 ' HB3' HG23 ' A' ' 409' ' ' VAL . . . -73.77 136.39 43.62 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.955 0.502 . . . . 0.0 111.429 -176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 70.5 mt -83.43 129.5 34.99 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 164.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 66.48 54.0 0.92 Allowed 'General case' 0 CA--C 1.562 1.425 0 O-C-N 124.196 0.935 . . . . 0.0 108.874 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 400' ' ' VAL . 89.8 m -55.03 -38.47 67.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.491 1.516 . . . . 0.0 111.961 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -57.5 -38.45 74.64 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.796 1.238 . . . . 0.0 113.762 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -83.84 -29.58 27.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.167 0.508 . . . . 0.0 110.148 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.561 HG23 ' HB3' ' A' ' 403' ' ' ALA . 69.4 t -65.79 -31.78 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.82 0.848 . . . . 0.0 110.369 171.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.91 -15.63 60.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.382 1.073 . . . . 0.0 110.712 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.02 62.95 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 116.506 -0.315 . . . . 0.0 113.264 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -92.74 -1.46 56.8 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 110.821 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.45 HD11 HG22 ' A' ' 423' ' ' ILE . 53.8 mt -121.66 100.16 6.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.027 0.931 . . . . 0.0 110.231 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -103.25 135.98 19.3 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 122.818 0.447 . . . . 0.0 110.12 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.74 162.35 42.39 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.555 2.837 . . . . 0.0 112.623 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.96 152.18 26.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -89.77 60.41 5.01 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.959 0.885 . . . . 0.0 109.185 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -109.87 -62.21 1.54 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.64 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.57 41.37 5.11 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.509 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.86 -72.63 1.14 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 19.2 mp0 -108.59 167.72 9.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.559 0.744 . . . . 0.0 109.267 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 83.5 t -138.79 127.86 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.109 0.964 . . . . 0.0 108.515 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 413' ' ' LEU . 36.6 mm -118.25 135.22 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 0.0 109.887 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 5.4 p -108.04 140.31 41.4 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.685 0.794 . . . . 0.0 109.563 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.02 118.51 10.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.429 1.092 . . . . 0.0 109.513 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.6 m -76.01 100.1 4.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.551 0.691 . . . . 0.0 109.47 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' A' ' 432' ' ' HIS . 65.0 t80 -117.93 117.09 28.31 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.879 1.272 . . . . 0.0 108.815 -174.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 62.78 25.17 14.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.942 1.297 . . . . 0.0 111.89 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.76 61.23 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.174 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.86 160.28 14.62 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.853 0.827 . . . . 0.0 109.247 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 14.0 t -96.71 127.65 42.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 427' ' ' PHE . 26.3 m-70 -119.46 123.29 43.69 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.2 p -105.22 137.58 42.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.382 0.673 . . . . 0.0 110.06 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.9 pt -122.64 172.27 10.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 123.805 0.842 . . . . 0.0 109.445 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -123.17 140.61 52.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.55 0.69 . . . . 0.0 109.743 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 4.8 mp -114.47 156.78 44.11 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.025 1.33 . . . . 0.0 108.646 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.31 130.48 14.07 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.154 1.903 . . . . 0.0 112.429 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -60.27 144.22 99.5 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.275 2.65 . . . . 0.0 113.16 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 24.8 m -111.64 158.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.844 0.857 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -137.46 7.23 2.81 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.3 t -121.65 141.78 50.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.64 0.376 . . . . 0.0 110.125 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.1 72.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.245 1.018 . . . . 0.0 112.604 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.3 m -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.957 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.72 -23.8 36.51 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.49 -61.94 1.89 Allowed 'General case' 0 C--N 1.365 1.243 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.06 -48.11 66.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.458 -169.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -58.17 -34.21 70.07 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.884 0.74 . . . . 0.0 112.753 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . 0.402 ' CE1' HD22 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -61.15 -43.93 98.11 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.938 0.774 . . . . 0.0 109.864 -176.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.649 HD21 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.06 -16.0 34.76 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.479 175.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.71 -42.17 82.38 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.408 1.004 . . . . 0.0 110.752 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -66.56 -37.7 85.52 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.838 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.0 -45.91 76.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.028 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 74.5 m -70.04 -25.96 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.132 0.973 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -66.58 -35.88 81.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.49 0.716 . . . . 0.0 109.926 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.4 m -71.13 -20.3 62.33 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.0 0.92 . . . . 0.0 111.538 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.501 HD12 HD21 ' A' ' 371' ' ' LEU . 44.9 mt -99.76 -11.3 20.94 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.977 0.911 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 74.34 7.89 4.58 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 0.0 112.113 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.517 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 10.9 p -87.88 133.34 33.93 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.809 0.444 . . . . 0.0 110.232 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -149.53 149.61 30.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.545 0.738 . . . . 0.0 109.7 -175.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 23.4 m-80 67.42 15.85 9.93 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.7 1.2 . . . . 0.0 111.003 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.01 -21.91 53.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -152.78 163.81 39.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.313 0.645 . . . . 0.0 110.111 175.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.6 p -165.16 115.47 1.1 Allowed 'General case' 0 C--O 1.239 0.52 0 O-C-N 123.963 0.789 . . . . 0.0 109.402 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 10.1 t . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.802 0.334 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.4 t -76.69 -179.7 5.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.347 0.659 . . . . 0.0 110.97 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.91 143.12 44.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.826 0.85 . . . . 0.0 110.314 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.36 169.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.677 1.191 . . . . 0.0 109.581 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.98 105.94 3.59 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.551 HG23 HD12 ' A' ' 395' ' ' ILE . 30.4 m -92.08 152.63 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.048 0.539 . . . . 0.0 109.962 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 76.2 m-85 -110.76 101.36 9.99 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.62 HG12 ' HZ2' ' A' ' 363' ' ' LYS . 58.1 t -70.62 92.84 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 124.15 0.98 . . . . 0.0 110.344 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -87.77 99.11 11.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.718 0.807 . . . . 0.0 108.969 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.758 ' HZ1' ' HB2' ' A' ' 379' ' ' LEU . 0.0 OUTLIER -80.65 -10.04 59.76 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.252 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -77.27 -14.36 59.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.681 0.392 . . . . 0.0 110.103 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.23 -166.93 29.97 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.362 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -71.11 131.53 43.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.019 0.437 . . . . 0.0 110.155 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -78.04 -62.83 1.55 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.408 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.495 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -142.36 -94.96 0.22 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.824 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.86 9.67 56.82 Favored 'Cis proline' 0 C--N 1.373 1.847 0 CA-C-N 120.385 2.092 . . . . 0.0 114.96 10.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -73.8 -7.94 54.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.766 0.426 . . . . 0.0 111.33 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.495 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.9 mt -114.16 130.04 56.61 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.573 1.549 . . . . 0.0 107.557 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.13 125.32 89.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 123.583 0.552 . . . . 0.0 110.827 -176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 12.2 Cg_endo -53.78 -38.14 85.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.786 2.991 . . . . 0.0 114.377 -175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.82 -42.83 48.72 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.397 0.436 . . . . 0.0 110.209 -173.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -68.36 -30.42 69.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.555 0.742 . . . . 0.0 110.764 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.4 mm -63.84 -31.1 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.239 1.016 . . . . 0.0 111.198 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 64.5 mm-40 -74.98 -27.58 60.21 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 56.0 mm-40 -81.84 -3.38 53.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.384 0.674 . . . . 0.0 111.749 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.758 ' HB2' ' HZ1' ' A' ' 363' ' ' LYS . 18.6 mt -70.46 172.23 6.47 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.104 0.562 . . . . 0.0 110.187 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 379' ' ' LEU . 75.9 Cg_endo -73.34 163.65 37.26 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.114 1.209 . . . . 0.0 110.479 166.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.86 -23.22 60.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.199 0.6 . . . . 0.0 111.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -158.76 147.04 18.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.617 0.367 . . . . 0.0 110.938 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.05 104.79 13.72 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 143.92 172.7 14.85 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.248 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.3 139.97 58.28 Favored 'Cis proline' 0 C--N 1.379 2.168 0 CA-C-N 119.134 1.467 . . . . 0.0 112.191 1.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.59 -170.23 27.13 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.473 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 390' ' ' VAL . 6.0 Cg_exo -69.98 145.72 56.71 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.312 2.675 . . . . 0.0 111.722 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 445' ' ' ALA . 7.3 p -54.51 -39.4 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.501 1.12 . . . . 0.0 111.478 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.43 -47.01 74.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.613 1.165 . . . . 0.0 110.541 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' A' ' 387' ' ' PRO . 94.2 t -72.08 -51.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.84 -39.32 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.79 -42.34 73.9 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.613 HH11 ' HA ' ' A' ' 421' ' ' GLU . 34.8 ptt180 -74.44 -24.76 59.11 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.885 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 15.2 mmt85 -63.75 -36.7 84.74 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.707 0.629 . . . . 0.0 110.515 174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.551 HD12 HG23 ' A' ' 359' ' ' VAL . 48.5 mm -66.84 -54.25 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 109.694 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 400' ' ' VAL . 81.8 t -56.56 -50.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 124.336 1.022 . . . . 0.0 111.354 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.85 -34.16 73.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.95 0.5 . . . . 0.0 111.613 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.61 88.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -67.2 -55.23 14.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.035 0.834 . . . . 0.0 110.93 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 396' ' ' VAL . 61.1 t -57.5 -40.68 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.702 0.801 . . . . 0.0 111.446 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.54 -48.25 67.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' A' ' 379' ' ' LEU . 74.0 m -73.61 -10.15 59.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.109 0.564 . . . . 0.0 111.908 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.54 ' HB1' HG23 ' A' ' 409' ' ' VAL . . . -68.63 148.36 50.56 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.071 0.949 . . . . 0.0 112.649 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.28 130.16 34.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 60.41 61.48 1.76 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.153 0.977 . . . . 0.0 109.33 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -50.78 -37.13 40.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 112.848 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -53.34 -41.12 65.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.914 1.286 . . . . 0.0 112.755 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 -41.94 20.48 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.632 0.773 . . . . 0.0 109.531 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.54 HG23 ' HB1' ' A' ' 403' ' ' ALA . 76.7 t -60.35 -33.18 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.129 0.972 . . . . 0.0 111.767 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -81.82 -13.35 57.79 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.426 0.691 . . . . 0.0 110.903 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -78.94 -3.14 87.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.461 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.92 -5.21 58.15 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.279 0.632 . . . . 0.0 111.411 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -139.8 113.39 8.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.53 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 414' ' ' LYS . 0.5 OUTLIER -95.88 156.61 37.05 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.86 0.864 . . . . 0.0 110.886 -177.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.71 129.38 17.55 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.26 1.973 . . . . 0.0 113.24 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.629 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 59.1 m-20 -122.28 111.77 17.33 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.749 174.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -88.94 45.6 1.31 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.865 0.84 . . . . 0.0 109.44 -171.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.629 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 12.2 mpt_? -78.58 -15.66 58.3 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 110.151 173.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 84.84 42.16 7.33 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.329 0.393 . . . . 0.0 113.399 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.88 -112.18 3.59 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 120.169 -0.24 . . . . 0.0 113.014 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 22.5 mp0 -79.53 167.24 21.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.309 0.644 . . . . 0.0 110.642 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.8 t -134.54 129.23 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.419 HG12 HD13 ' A' ' 436' ' ' LEU . 41.1 mm -115.18 130.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 433' ' ' SER . 22.8 p -106.09 154.54 20.51 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 124.03 0.831 . . . . 0.0 109.403 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -154.91 158.66 39.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.963 0.905 . . . . 0.0 109.914 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 45.6 m -105.06 119.49 39.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.463 0.705 . . . . 0.0 109.435 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -132.29 109.99 10.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.406 0.682 . . . . 0.0 109.945 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.41 41.03 16.63 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.684 1.194 . . . . 0.0 111.114 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.6 -0.65 85.18 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.314 -0.857 . . . . 0.0 114.064 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -103.7 171.73 7.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 109.303 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -116.13 119.59 36.31 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -107.07 137.57 44.88 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.423 ' HB3' HG23 ' A' ' 424' ' ' THR . 54.4 p -127.98 148.67 50.53 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 109.876 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.437 HD13 HD12 ' A' ' 413' ' ' LEU . 36.0 pt -130.55 174.12 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.811 0.845 . . . . 0.0 110.054 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -113.87 149.88 34.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.661 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.5 mp -116.64 158.94 42.25 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.862 1.265 . . . . 0.0 108.664 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.463 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 71.2 Cg_endo -74.93 131.47 14.41 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 C-N-CA 122.362 2.041 . . . . 0.0 112.456 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.55 146.71 74.9 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.858 2.372 . . . . 0.0 113.422 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.35 161.25 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.89 0.876 . . . . 0.0 110.544 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -141.17 5.44 1.89 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.504 0.721 . . . . 0.0 111.767 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.7 m -124.26 140.49 52.91 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.52 0.6 . . . . 0.0 110.995 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.39 79.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.201 1.0 . . . . 0.0 112.542 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 m -69.1 -24.18 64.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.96 -22.16 25.75 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.681 ' HB3' HG21 ' A' ' 388' ' ' VAL . . . -48.14 -58.59 4.3 Favored 'General case' 0 C--N 1.365 1.271 0 CA-C-O 121.629 0.728 . . . . 0.0 109.239 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.79 -44.57 80.96 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.859 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -56.71 -38.65 72.61 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.443 1.089 . . . . 0.0 112.197 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . 0.463 ' HZ ' ' HD2' ' A' ' 437' ' ' PRO . 4.3 t80 -65.63 -45.09 84.38 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.536 -171.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.694 HD23 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -85.82 -13.16 48.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.792 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.484 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 0.8 OUTLIER -63.82 -43.74 95.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.009 0.368 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.26 93.36 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.449 ' CE2' HD12 ' A' ' 456' ' ' LEU . 43.8 t80 -69.7 -45.43 68.27 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.448 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 450' ' ' GLU . 29.4 p -72.59 -21.65 61.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.351 0.661 . . . . 0.0 110.073 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -70.58 -36.07 73.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.869 0.868 . . . . 0.0 109.844 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 -31.49 68.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.569 0.747 . . . . 0.0 110.99 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.449 HD12 ' CE2' ' A' ' 452' ' ' PHE . 45.5 mt -80.87 -17.62 50.07 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.171 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 72.06 8.91 6.01 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.714 1.606 . . . . 0.0 111.518 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.483 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 21.9 p -82.73 137.26 34.46 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.227 0.611 . . . . 0.0 109.947 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.52 148.89 28.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 109.563 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 64.01 14.42 8.45 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.214 1.005 . . . . 0.0 111.436 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.46 -20.74 43.07 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.405 0.682 . . . . 0.0 112.006 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.694 HD21 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.83 159.53 36.8 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.072 0.549 . . . . 0.0 110.624 176.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 35.5 p -165.88 121.78 1.31 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.916 0.486 . . . . 0.0 111.026 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 122.99 0.516 . . . . 0.0 111.273 175.812 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.2 t -86.58 -177.66 6.21 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.627 0.771 . . . . 0.0 110.303 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.9 p -141.04 142.21 34.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.147 0.979 . . . . 0.0 109.913 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.06 147.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 123.908 0.883 . . . . 0.0 110.782 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.479 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 19.0 p -114.36 105.1 12.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.639 0.776 . . . . 0.0 108.972 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 462' ' ' LEU . 48.4 t -98.34 154.44 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -130.18 107.5 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.461 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 36.6 t -78.01 106.48 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.476 0.71 . . . . 0.0 110.023 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -94.58 90.17 6.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.152 0.981 . . . . 0.0 109.257 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -12.12 60.49 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.955 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.35 -19.67 60.96 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.752 0.821 . . . . 0.0 111.034 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -72.47 -135.72 0.2 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 38.2 t30 -101.69 137.23 40.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.038 0.919 . . . . 0.0 109.295 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.02 -57.61 3.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -150.45 -87.98 0.07 OUTLIER Glycine 0 C--N 1.343 0.942 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.784 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.7 19.21 23.87 Favored 'Cis proline' 0 C--N 1.374 1.896 0 CA-C-N 120.705 2.252 . . . . 0.0 113.868 5.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.44 -7.27 46.33 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.627 0.771 . . . . 0.0 111.537 166.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.483 HD11 HD12 ' A' ' 456' ' ' LEU . 40.2 mt -116.84 140.05 49.89 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.2 1.0 . . . . 0.0 109.445 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.54 119.14 54.45 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.367 1.067 . . . . 0.0 110.619 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 24.5 Cg_endo -58.68 -24.64 71.83 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.478 2.785 . . . . 0.0 114.528 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -83.8 -44.64 14.15 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.746 0.419 . . . . 0.0 110.108 -176.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 32.7 mtt180 -67.23 -34.74 78.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.132 0.973 . . . . 0.0 111.723 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.48 -27.77 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.728 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 65.2 mm-40 -84.92 -27.76 26.37 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 122.058 -0.401 . . . . 0.0 110.469 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.9 mm-40 -71.96 -35.03 69.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.247 0.619 . . . . 0.0 112.253 -176.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.96 158.76 87.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.036 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.18 157.26 45.72 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.581 2.188 . . . . 0.0 113.042 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.25 0.27 29.31 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.504 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.461 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.1 p80 -166.4 149.97 7.31 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -122.9 107.91 12.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 168.87 12.56 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.19 -0.783 . . . . 0.0 112.141 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 130.22 19.33 Favored 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 120.058 1.929 . . . . 0.0 113.609 -0.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.03 -165.41 14.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.99 140.62 38.45 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.533 2.155 . . . . 0.0 111.205 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.735 HG22 ' HB1' ' A' ' 445' ' ' ALA . 6.1 p -47.87 -42.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.697 1.199 . . . . 0.0 112.214 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.01 -55.27 27.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.048 1.339 . . . . 0.0 110.697 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 393' ' ' ARG . 58.0 t -67.9 -43.72 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.144 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.68 -47.49 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.728 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 117.861 0.3 . . . . 0.0 110.777 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.3 ptt180 -73.22 -32.78 64.97 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -65.55 -30.61 71.38 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.377 0.671 . . . . 0.0 111.289 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.509 HG21 ' HG ' ' A' ' 449' ' ' LEU . 20.7 mm -67.6 -59.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.487 ' O ' HG22 ' A' ' 400' ' ' VAL . 80.7 t -61.44 -50.77 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.401 -171.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -65.32 -31.86 73.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.244 0.618 . . . . 0.0 111.785 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.23 94.71 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 452' ' ' PHE . 84.5 m -70.06 -41.64 73.89 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.184 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.504 HG23 ' CZ ' ' A' ' 452' ' ' PHE . 3.6 t -67.02 -42.6 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.18 -37.07 83.08 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 71.1 m -87.24 1.68 52.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 111.856 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.474 ' HB1' HG23 ' A' ' 409' ' ' VAL . . . -72.14 143.82 48.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 89.6 mt -82.27 125.11 30.58 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 67.74 53.17 0.7 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.502 1.121 . . . . 0.0 109.639 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.1 m -58.52 -27.24 64.32 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.068 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -36.7 69.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.242 0.617 . . . . 0.0 111.669 177.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.2 m -88.95 -37.43 15.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.474 HG23 ' HB1' ' A' ' 403' ' ' ALA . 98.3 t -64.05 -35.33 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.885 0.874 . . . . 0.0 111.722 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -72.27 -22.06 61.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.161 0.984 . . . . 0.0 110.28 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.81 -19.59 78.79 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.729 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.47 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 82.9 m-85 -75.68 -15.34 60.32 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.272 0.536 . . . . 0.0 111.726 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 104.46 6.5 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.685 0.755 . . . . 0.0 111.134 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 163.43 38.18 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.177 0.991 . . . . 0.0 110.181 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 167.54 26.73 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.284 1.989 . . . . 0.0 113.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.655 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 12.8 m-20 -145.3 130.37 18.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.941 1.296 . . . . 0.0 109.506 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -89.97 45.78 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.033 0.921 . . . . 0.0 109.708 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.655 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -93.15 -31.26 14.86 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.43 171.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.76 30.06 33.46 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.47 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.98 -122.54 1.55 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.54 166.67 18.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.368 0.667 . . . . 0.0 110.818 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 85.2 t -132.93 132.67 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 436' ' ' LEU . 28.1 mm -114.85 126.49 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.317 0.647 . . . . 0.0 109.883 175.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 9.2 p -107.64 151.0 26.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 110.716 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.91 140.56 12.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.221 1.008 . . . . 0.0 110.007 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 48.9 m -87.15 118.88 26.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.913 0.485 . . . . 0.0 110.443 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -140.36 134.5 30.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.747 0.819 . . . . 0.0 109.448 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.2 t70 64.51 25.99 13.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.702 1.201 . . . . 0.0 110.988 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.33 88.7 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.554 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -109.44 168.82 9.11 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.626 1.171 . . . . 0.0 110.331 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.8 t -100.12 135.05 42.14 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -132.1 133.63 44.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.179 0.592 . . . . 0.0 110.283 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 64.7 p -126.42 140.24 52.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.741 0.816 . . . . 0.0 110.524 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 20.2 pt -119.85 161.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.315 0.646 . . . . 0.0 109.857 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -103.32 147.41 27.11 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.103 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 423' ' ' ILE . 7.6 mp -115.01 165.56 13.77 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.464 1.505 . . . . 0.0 108.809 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.31 142.0 23.59 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 121.92 1.747 . . . . 0.0 111.585 163.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.42 128.86 10.67 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.381 2.054 . . . . 0.0 112.87 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.07 172.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.556 0.742 . . . . 0.0 110.38 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -151.48 5.63 0.46 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.7 t -125.23 141.14 52.27 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.341 0.519 . . . . 0.0 110.53 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.47 -26.91 67.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.172 0.989 . . . . 0.0 111.919 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 33.2 t -70.34 -31.14 68.3 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.126 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -23.09 39.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -53.99 -62.05 1.91 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.242 0.544 . . . . 0.0 110.034 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.27 -35.67 68.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.812 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -62.75 -32.27 73.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.942 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.23 -56.4 11.45 Favored 'General case' 0 C--O 1.246 0.873 0 O-C-N 123.157 0.286 . . . . 0.0 110.608 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.509 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -73.67 -13.66 61.02 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.967 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 2.4 mm-40 -63.35 -47.06 83.72 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.351 0.66 . . . . 0.0 111.487 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -59.51 -43.86 93.28 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.615 0.766 . . . . 0.0 110.738 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.504 ' CZ ' HG23 ' A' ' 400' ' ' VAL . 44.6 t80 -69.98 -48.36 58.55 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.4 p -70.67 -21.32 62.61 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.574 0.749 . . . . 0.0 111.145 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -71.94 -37.55 69.99 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.634 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 77.0 p -76.58 -24.67 53.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.618 0.367 . . . . 0.0 110.582 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 371' ' ' LEU . 72.6 mt -77.67 -17.94 57.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 111.313 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.26 7.59 6.15 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.817 1.647 . . . . 0.0 111.745 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.59 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 17.7 p -81.11 134.8 35.71 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.368 0.604 . . . . 0.0 110.419 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 6.5 p-10 -145.38 147.09 31.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.997 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 59.75 19.08 7.85 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.811 0.844 . . . . 0.0 110.907 -171.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 38.3 tp -81.02 -27.15 35.94 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.16 0.584 . . . . 0.0 111.228 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.455 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -164.41 150.08 10.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.023 0.529 . . . . 0.0 110.727 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 70.2 m -166.3 149.13 7.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.328 1.051 . . . . 0.0 109.197 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 121.871 0.843 . . . . 0.0 111.553 176.513 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 120.903 0.382 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.6 t -83.25 179.09 7.8 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.695 0.798 . . . . 0.0 110.647 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.2 p -139.74 136.83 34.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.575 1.15 . . . . 0.0 109.112 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.44 157.67 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.826 0.85 . . . . 0.0 110.834 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 385' ' ' PRO . 24.1 p -124.16 116.88 23.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.356 1.062 . . . . 0.0 109.188 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.6 t -113.16 151.24 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.096 0.558 . . . . 0.0 110.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -126.72 103.26 7.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.105 1.362 . . . . 0.0 108.065 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.04 110.77 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.628 0.771 . . . . 0.0 110.862 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -99.05 92.91 5.71 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.583 0.753 . . . . 0.0 110.12 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -12.22 60.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.233 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -74.39 -19.59 60.37 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.774 0.83 . . . . 0.0 111.185 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.79 -111.11 0.03 OUTLIER Glycine 0 C--N 1.353 1.493 0 C-N-CA 122.985 0.326 . . . . 0.0 112.941 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 42.9 t30 -125.43 143.94 50.76 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.27 -62.28 1.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.03 -94.74 0.14 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.397 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -89.06 26.29 17.32 Favored 'Cis proline' 0 C--N 1.371 1.73 0 CA-C-N 120.116 1.958 . . . . 0.0 113.427 7.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.95 -10.25 59.49 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.214 0.606 . . . . 0.0 109.95 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.496 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 36.1 mt -114.74 140.86 48.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 125.454 1.501 . . . . 0.0 108.301 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.43 124.35 89.71 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.13 0.572 . . . . 0.0 110.414 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 30.5 Cg_endo -59.47 -32.97 97.21 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.244 2.63 . . . . 0.0 114.163 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.87 -42.55 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.468 0.307 . . . . 0.0 110.958 -176.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -70.96 -28.88 64.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 110.593 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.447 HD11 HD22 ' A' ' 379' ' ' LEU . 20.7 mm -63.0 -30.48 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.825 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 68.0 mm-40 -81.67 -22.36 37.53 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.462 0.305 . . . . 0.0 111.043 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 81.8 mm-40 -81.93 -35.29 29.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.447 HD22 HD11 ' A' ' 376' ' ' ILE . 3.0 pp -66.48 153.81 92.28 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.911 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.72 161.33 21.71 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.675 2.25 . . . . 0.0 114.327 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.77 -8.92 58.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.678 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -161.95 153.16 18.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.937 0.495 . . . . 0.0 110.967 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.402 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.6 m-85 -132.23 109.01 9.62 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.415 1.086 . . . . 0.0 108.078 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.27 -179.53 16.14 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 358' ' ' CYS . 59.7 Cg_endo -72.88 130.21 19.36 Favored 'Cis proline' 0 C--N 1.383 2.394 0 CA-C-N 119.889 1.845 . . . . 0.0 113.1 -4.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.71 -163.56 12.53 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.982 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -65.87 139.88 58.76 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.993 2.462 . . . . 0.0 111.926 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.757 HG22 ' HB1' ' A' ' 445' ' ' ALA . 5.3 p -49.26 -41.35 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.352 1.061 . . . . 0.0 111.579 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.09 -52.18 63.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.942 1.297 . . . . 0.0 110.675 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 81.4 t -69.07 -50.87 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.941 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.49 -40.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 122.999 0.52 . . . . 0.0 112.203 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.99 -41.48 74.33 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 117.859 0.299 . . . . 0.0 110.624 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -73.27 -24.47 60.44 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.542 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 48.6 mmm-85 -68.44 -38.77 81.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.819 0.448 . . . . 0.0 111.073 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.509 HG21 ' HG ' ' A' ' 449' ' ' LEU . 8.4 mm -65.63 -53.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 400' ' ' VAL . 91.3 t -61.78 -47.16 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.135 -174.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.407 ' HA ' HG22 ' A' ' 423' ' ' ILE . 2.6 pt20 -64.0 -30.03 71.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.582 0.353 . . . . 0.0 111.285 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -72.26 -40.97 67.25 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.256 0.622 . . . . 0.0 110.532 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.7 m -69.58 -46.47 66.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.341 0.657 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 396' ' ' VAL . 38.8 t -65.7 -39.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.199 0.6 . . . . 0.0 110.084 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.34 -53.46 57.02 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.232 0.613 . . . . 0.0 110.581 173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' A' ' 379' ' ' LEU . 73.9 m -79.92 0.99 28.97 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.553 -172.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -71.73 135.32 46.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.71 118.36 17.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 160.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.16 60.01 0.66 Allowed 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.077 0.942 . . . . 0.0 109.431 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 96.9 m -51.41 -40.62 59.67 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.075 1.75 . . . . 0.0 112.416 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -50.44 -41.09 52.18 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.176 1.39 . . . . 0.0 114.04 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 98.4 m -78.96 -39.39 34.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.645 0.778 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -60.69 -41.57 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.71 -14.07 59.98 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.073 0.949 . . . . 0.0 110.774 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.45 -23.24 77.56 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.507 -0.315 . . . . 0.0 113.401 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -71.27 -24.77 62.23 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.072 0.549 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 434' ' ' ILE . 0.7 OUTLIER -119.43 112.72 19.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.026 0.931 . . . . 0.0 108.677 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -96.21 158.61 33.7 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.28 0.632 . . . . 0.0 110.738 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.69 144.9 45.27 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.168 1.912 . . . . 0.0 112.496 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.549 ' HB3' ' HG2' ' A' ' 418' ' ' ARG . 3.6 m-20 -150.13 136.1 18.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.977 1.311 . . . . 0.0 108.132 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.68 68.67 10.47 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.52 1.152 . . . . 0.0 108.33 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.549 ' HG2' ' HB3' ' A' ' 416' ' ' ASP . 78.7 mmt-85 -106.93 -22.49 12.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.611 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.27 65.64 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.614 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -97.71 -127.22 5.65 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.958 -0.356 . . . . 0.0 112.387 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.0 OUTLIER -72.88 169.32 17.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.887 0.875 . . . . 0.0 110.841 -176.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 54.4 t -140.32 133.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.825 . . . . 0.0 109.102 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 436' ' ' LEU . 47.8 mm -116.02 134.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 122.607 0.363 . . . . 0.0 110.219 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.0 p -107.25 143.09 35.98 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.93 15.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.527 0.731 . . . . 0.0 111.041 -169.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.4 m -86.53 104.2 15.76 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.89 0.476 . . . . 0.0 110.312 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -116.23 106.57 13.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.29 1.036 . . . . 0.0 109.569 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.18 54.1 9.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.232 1.413 . . . . 0.0 111.56 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 83.2 -15.89 31.49 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.85 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.15 170.53 9.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.181 0.592 . . . . 0.0 111.37 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.9 t -111.46 102.02 10.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -94.92 142.26 27.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.397 0.679 . . . . 0.0 109.904 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 41.7 p -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.912 . . . . 0.0 109.771 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 413' ' ' LEU . 41.3 pt -123.99 -176.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.846 0.858 . . . . 0.0 111.047 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.28 143.31 51.26 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 121.462 0.648 . . . . 0.0 110.012 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.0 mp -111.0 159.2 33.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.901 1.68 . . . . 0.0 108.124 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.69 132.65 19.05 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.094 1.863 . . . . 0.0 111.706 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.19 129.7 19.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.279 1.986 . . . . 0.0 112.112 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.0 173.39 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.011 0.925 . . . . 0.0 110.87 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -153.46 -0.21 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.517 0.727 . . . . 0.0 111.243 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.6 m -118.21 138.29 52.43 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.07 -31.83 68.34 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.855 0.862 . . . . 0.0 111.281 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 22.0 m -59.57 -31.82 69.8 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.757 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -86.2 -22.79 26.76 Favored 'General case' 0 C--N 1.362 1.151 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.757 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -52.18 -66.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.598 0.759 . . . . 0.0 111.182 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.41 ' O ' HD21 ' A' ' 449' ' ' LEU . 0.4 OUTLIER -72.13 -34.62 68.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.68 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' A' ' 451' ' ' ASN . 0.0 OUTLIER -53.33 -36.33 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.285 0.634 . . . . 0.0 111.514 178.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -60.07 -56.48 21.07 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.139 0.899 . . . . 0.0 110.34 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.509 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -80.7 -13.92 58.59 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.706 -176.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.412 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 55.7 mt-10 -70.28 -46.63 63.95 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.673 0.669 . . . . 0.0 109.988 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.467 ' HB2' ' NH1' ' A' ' 447' ' ' ARG . 0.2 OUTLIER -67.52 -35.25 78.74 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 449' ' ' LEU . 36.9 t80 -68.6 -48.83 63.14 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.444 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.5 p -70.09 -22.88 62.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.068 0.547 . . . . 0.0 111.021 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -57.17 -46.4 82.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 93.7 p -73.07 -23.28 60.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.046 0.539 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.498 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 47.7 mt -83.7 -8.37 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.651 0.781 . . . . 0.0 111.077 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.82 9.16 7.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.35 1.46 . . . . 0.0 111.275 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.694 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.8 p -94.94 144.58 25.56 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.553 0.741 . . . . 0.0 110.044 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -163.04 164.21 25.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 65.53 14.58 9.57 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.159 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.08 -8.63 59.06 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.373 1.069 . . . . 0.0 111.533 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 169.22 22.66 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.347 0.659 . . . . 0.0 109.916 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 46.6 m -158.38 114.18 2.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.629 0.772 . . . . 0.0 109.79 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 26.5 t . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.769 0.827 . . . . 0.0 111.237 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.78 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.9 m -72.99 178.05 4.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.027 0.531 . . . . 0.0 111.852 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.7 p -139.61 133.45 30.71 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.527 1.131 . . . . 0.0 109.131 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.57 157.49 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.285 1.034 . . . . 0.0 111.148 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.57 108.05 10.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.313 1.045 . . . . 0.0 108.72 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.451 HG22 HD13 ' A' ' 395' ' ' ILE . 30.4 m -92.59 120.95 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -88.54 97.94 11.37 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.491 HG12 HD11 ' A' ' 379' ' ' LEU . 44.9 t -72.63 98.28 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.622 -171.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -91.08 86.44 6.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.757 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.591 ' HB3' ' HZ2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -72.5 -12.93 61.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.786 175.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.793 0.837 . . . . 0.0 110.299 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -76.9 -149.83 3.37 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.11 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 41.3 t30 -82.85 142.32 31.59 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.301 0.551 . . . . 0.0 110.132 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -85.42 -56.11 3.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.99 -88.95 0.07 OUTLIER Glycine 0 C--N 1.349 1.256 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.127 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.73 4.06 65.3 Favored 'Cis proline' 0 C--N 1.371 1.712 0 CA-C-N 120.879 2.34 . . . . 0.0 113.744 10.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -70.46 -13.01 61.95 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.953 0.901 . . . . 0.0 110.37 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.514 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 28.5 mt -99.1 143.96 28.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.0 109.116 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.31 121.82 84.45 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 123.99 0.806 . . . . 0.0 110.455 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.534 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 50.9 Cg_endo -64.35 -22.28 66.3 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.187 2.591 . . . . 0.0 114.646 -172.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.534 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -83.94 -43.63 15.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.121 0.418 . . . . 0.0 110.076 -176.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 57.9 mtt180 -67.22 -37.49 83.69 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.085 0.954 . . . . 0.0 111.923 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.456 ' HA ' HD23 ' A' ' 379' ' ' LEU . 15.7 mm -53.64 -28.85 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.433 0 C-N-CA 124.076 0.951 . . . . 0.0 112.347 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 71.0 mm-40 -83.59 -17.85 40.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.257 0.623 . . . . 0.0 111.737 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -80.33 -43.08 21.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.424 0.69 . . . . 0.0 111.728 -171.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.491 HD11 HG12 ' A' ' 361' ' ' VAL . 0.4 OUTLIER -64.03 153.27 85.48 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.564 175.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -62.95 165.78 15.72 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.678 2.252 . . . . 0.0 113.233 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.66 -6.86 59.42 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.307 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.411 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.1 p80 -162.58 137.62 6.86 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.33 0.652 . . . . 0.0 110.605 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.97 103.81 14.47 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.38 -174.14 17.44 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.3 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 128.19 15.21 Favored 'Cis proline' 0 C--N 1.382 2.333 0 CA-C-N 119.291 1.545 . . . . 0.0 112.817 0.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.72 30.34 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.977 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.55 129.95 28.27 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.125 2.55 . . . . 0.0 113.279 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.739 HG21 ' HB1' ' A' ' 445' ' ' ALA . 3.1 p -45.42 -50.16 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.274 1.829 . . . . 0.0 112.688 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.446 ' OD1' HG12 ' A' ' 388' ' ' VAL . 2.4 m120 -57.64 -43.96 85.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.395 . . . . 0.0 112.009 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 93.7 t -76.41 -51.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.134 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.01 -42.27 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 123.386 0.674 . . . . 0.0 112.404 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 122.856 0.097 . . . . 0.0 110.984 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.452 ' N ' HD13 ' A' ' 392' ' ' LEU . 7.8 ptt180 -73.09 -25.54 60.92 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.141 0.276 . . . . 0.0 110.388 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 11.5 mmm180 -68.23 -35.21 77.6 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 122.846 0.458 . . . . 0.0 110.124 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.548 HG13 HD23 ' A' ' 449' ' ' LEU . 25.9 mm -63.62 -47.67 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.875 0.734 . . . . 0.0 109.405 173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 452' ' ' PHE . 38.9 t -63.96 -60.62 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.733 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 423' ' ' ILE . 3.5 pt20 -60.86 -29.47 69.54 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.58 -59.63 2.72 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.25 -32.77 74.39 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 396' ' ' VAL . 38.5 t -68.17 -47.51 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.92 -19.92 58.4 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.348 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 93.5 m -100.02 10.11 41.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.114 0.965 . . . . 0.0 110.352 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -86.07 151.29 23.82 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.47 122.78 27.95 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 162.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 66.65 57.67 0.67 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.48 1.112 . . . . 0.0 109.934 -174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.43 HG23 HG13 ' A' ' 400' ' ' VAL . 89.6 m -54.12 -34.0 59.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.592 1.557 . . . . 0.0 112.415 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -55.64 -39.55 71.0 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.855 1.262 . . . . 0.0 113.466 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.3 m -81.47 -36.05 29.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 110.171 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.423 HG11 ' HA ' ' A' ' 400' ' ' VAL . 67.7 t -62.44 -38.07 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.867 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -68.44 -19.31 64.57 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.95 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.81 -23.57 77.78 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.927 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -77.01 -10.73 59.56 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 117.276 0.538 . . . . 0.0 111.641 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.551 HD12 HD11 ' A' ' 434' ' ' ILE . 0.3 OUTLIER -129.04 117.8 21.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.729 0.812 . . . . 0.0 109.614 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -95.18 157.91 35.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.789 0.836 . . . . 0.0 110.916 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.87 153.14 76.28 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.144 1.896 . . . . 0.0 111.434 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -151.15 136.54 17.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.689 0.28 . . . . 0.0 110.527 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.52 10.11 26.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.807 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.477 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 5.9 mpt_? -59.59 -35.0 73.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.527 1.131 . . . . 0.0 111.417 171.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.444 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 85.49 28.23 30.52 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.36 0.413 . . . . 0.0 113.378 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.93 -110.03 0.31 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 120.023 -0.321 . . . . 0.0 113.39 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.98 172.0 8.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.802 0.441 . . . . 0.0 110.348 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 75.8 t -132.08 130.2 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 397' ' ' GLN . 36.9 mm -115.11 131.66 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.43 ' HB ' ' OG1' ' A' ' 431' ' ' THR . 19.2 p -108.86 137.64 46.46 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.417 1.087 . . . . 0.0 108.743 172.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -158.63 128.95 5.99 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.67 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.5 m -66.87 102.47 0.96 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.462 0.705 . . . . 0.0 112.149 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -135.68 136.2 40.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.936 1.294 . . . . 0.0 108.813 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.7 t70 66.63 16.35 10.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.391 1.076 . . . . 0.0 111.163 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.02 61.79 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 122.012 -0.43 . . . . 0.0 113.849 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -116.91 166.99 11.53 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.43 ' OG1' ' HB ' ' A' ' 424' ' ' THR . 12.9 t -89.86 102.87 15.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.914 0.864 . . . . 0.0 109.248 175.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.73 131.41 40.82 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.046 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 34.8 p -111.01 131.46 55.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.328 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 413' ' ' LEU . 16.4 pt -132.41 174.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 124.298 1.039 . . . . 0.0 109.762 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.444 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 21.0 mt-30 -113.11 147.88 36.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.273 0.629 . . . . 0.0 110.842 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.416 HD22 ' HE1' ' A' ' 448' ' ' PHE . 9.8 mp -115.48 166.6 11.69 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.156 1.382 . . . . 0.0 108.636 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.11 145.48 44.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 121.998 1.799 . . . . 0.0 111.939 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 418' ' ' ARG . 64.3 Cg_endo -83.54 159.95 14.62 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.453 2.102 . . . . 0.0 112.015 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.94 173.51 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.712 0.805 . . . . 0.0 109.695 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -150.43 18.26 0.83 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.807 0.443 . . . . 0.0 111.169 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.2 t -124.82 140.21 53.13 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.03 63.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.211 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.9 m -69.85 -25.01 63.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.104 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.7 -21.74 25.04 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.739 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -53.29 -65.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.7 0.8 . . . . 0.0 111.17 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 1.4 pp -62.68 -37.84 88.04 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.119 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.38 71.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.415 1.086 . . . . 0.0 112.019 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . 0.416 ' HE1' HD22 ' A' ' 436' ' ' LEU . 31.1 t80 -71.74 -43.27 66.12 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.12 0.962 . . . . 0.0 108.562 -173.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.557 HD13 HD22 ' A' ' 462' ' ' LEU . 3.9 pp -89.19 -14.3 36.36 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.418 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.1 tm-20 -69.21 -50.3 48.61 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.826 1.251 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.9 -38.01 77.91 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.728 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.499 ' CE2' ' HA ' ' A' ' 396' ' ' VAL . 34.8 t80 -66.84 -50.85 61.26 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.385 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 31.2 p -71.57 -22.0 61.8 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.408 0.683 . . . . 0.0 110.687 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -66.3 -39.92 89.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.087 0.955 . . . . 0.0 110.127 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.1 m -65.81 -29.74 70.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.803 0.841 . . . . 0.0 111.321 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 371' ' ' LEU . 41.0 mt -84.25 -13.5 52.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.008 0.923 . . . . 0.0 111.311 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 71.38 7.91 6.17 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.826 1.651 . . . . 0.0 111.668 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 21.1 p -83.27 133.64 34.98 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -148.55 147.42 29.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.935 -173.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 59.86 21.85 10.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.583 0.753 . . . . 0.0 110.425 -168.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 18.3 tp -83.12 -15.76 49.45 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.449 0.7 . . . . 0.0 109.893 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.28 171.44 19.15 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.365 1.066 . . . . 0.0 108.757 174.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.0 m -165.79 115.54 1.01 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.1 t . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.809 0.338 . . . . 0.0 111.398 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 11.0 t -79.72 -177.9 6.12 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.845 0.458 . . . . 0.0 110.516 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 28.1 p -138.99 136.58 35.51 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.564 0.746 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.75 161.51 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.41 1.084 . . . . 0.0 110.851 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 30.5 p -132.76 132.36 42.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.51 HG23 HD13 ' A' ' 395' ' ' ILE . 26.3 m -117.34 154.58 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.119 0.568 . . . . 0.0 110.022 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 47.8 m-85 -111.78 100.32 8.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.48 88.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 0.0 109.501 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -81.78 93.21 6.78 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.909 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.563 ' HZ2' HD11 ' A' ' 379' ' ' LEU . 0.0 OUTLIER -76.67 -5.22 47.02 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.114 178.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -84.31 -13.22 53.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.268 0.627 . . . . 0.0 111.006 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -73.3 -112.14 0.07 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.405 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -121.62 138.42 54.34 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.68 3.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.54 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -156.22 -86.98 0.06 OUTLIER Glycine 0 C--O 1.216 -0.974 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.485 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.04 12.9 44.41 Favored 'Cis proline' 0 C--N 1.368 1.582 0 CA-C-N 120.931 2.366 . . . . 0.0 114.084 8.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -72.75 -7.82 52.44 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.001 0.52 . . . . 0.0 111.478 172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.1 mt -110.41 143.78 40.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.495 1.118 . . . . 0.0 109.227 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.15 118.92 60.52 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.631 0.772 . . . . 0.0 110.532 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 12.4 Cg_endo -52.84 -36.61 74.72 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.887 3.058 . . . . 0.0 114.337 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -80.28 -45.48 17.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -170.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -64.39 -36.06 82.91 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 111.58 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.4 HD13 HD23 ' A' ' 379' ' ' LEU . 17.6 mm -55.82 -31.96 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 124.392 1.058 . . . . 0.0 111.427 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 54.3 mm-40 -78.4 -35.92 46.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.7 0.4 . . . . 0.0 110.696 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 69.9 mm-40 -71.54 -33.84 69.5 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.524 0.73 . . . . 0.0 112.092 -171.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.563 HD11 ' HZ2' ' A' ' 363' ' ' LYS . 2.5 pp -71.11 155.64 92.94 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.53 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.44 148.62 33.23 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.19 2.594 . . . . 0.0 113.903 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.27 -10.54 59.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.034 1.333 . . . . 0.0 111.825 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -164.52 145.5 8.05 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -114.57 159.44 20.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.79 1.236 . . . . 0.0 108.766 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.88 -179.68 51.0 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.111 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -79.87 128.82 16.75 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 119.441 1.621 . . . . 0.0 111.831 2.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.14 25.02 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 133.57 38.73 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 123.051 2.501 . . . . 0.0 113.629 -169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' ' 445' ' ' ALA . 7.2 p -47.3 -39.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.511 1.924 . . . . 0.0 111.985 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.29 -54.14 49.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.467 1.507 . . . . 0.0 111.014 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 393' ' ' ARG . 97.0 t -74.11 -47.64 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.121 -173.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.67 -38.54 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.15 -43.43 61.55 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 390' ' ' VAL . 39.6 ptt180 -72.1 -25.63 61.82 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.661 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.54 -36.15 82.96 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.81 0.694 . . . . 0.0 110.698 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.51 HD13 HG23 ' A' ' 359' ' ' VAL . 35.3 mm -66.66 -56.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 400' ' ' VAL . 95.5 t -57.57 -52.72 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 124.113 0.883 . . . . 0.0 111.045 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 423' ' ' ILE . 2.8 pt20 -64.34 -35.89 82.35 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.7 0.4 . . . . 0.0 111.914 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -68.29 -36.44 79.37 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 123.381 0.426 . . . . 0.0 110.046 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 84.1 m -68.87 -49.82 55.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.025 0.53 . . . . 0.0 111.205 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.0 t -63.59 -48.23 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 122.921 0.488 . . . . 0.0 110.068 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.96 -36.4 77.86 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.59 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 72.6 m -83.99 -1.27 54.36 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.452 0.301 . . . . 0.0 111.286 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -71.33 137.47 48.5 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.37 117.15 8.96 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 166.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 64.46 66.26 0.61 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.135 0.969 . . . . 0.0 109.625 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.515 HG22 HG13 ' A' ' 400' ' ' VAL . 78.0 m -54.75 -35.62 63.94 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.771 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -59.41 -35.36 73.85 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.56 1.144 . . . . 0.0 113.131 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 85.7 m -80.4 -37.89 31.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.69 0.796 . . . . 0.0 109.775 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 403' ' ' ALA . 40.3 t -69.43 -30.41 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.082 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -73.24 -20.01 60.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.444 1.098 . . . . 0.0 110.209 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -63.74 -15.05 57.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.584 -0.735 . . . . 0.0 114.692 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.07 3.03 55.88 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.598 0.699 . . . . 0.0 111.719 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -148.07 106.53 3.78 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.416 0.626 . . . . 0.0 110.476 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 160.8 31.0 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.133 0.973 . . . . 0.0 109.779 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.03 163.79 24.41 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.488 2.125 . . . . 0.0 113.655 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.08 163.18 23.65 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 0.0 108.857 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -130.26 35.95 4.03 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.235 0.614 . . . . 0.0 110.867 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.52 -39.75 4.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.868 170.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 100.65 42.59 2.47 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.23 -106.57 0.28 Allowed Glycine 0 C--N 1.343 0.947 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.736 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 5.2 mp0 -83.33 172.74 12.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.994 0.397 . . . . 0.0 110.266 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.96 131.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.887 0.875 . . . . 0.0 108.791 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 433' ' ' SER . 35.8 mm -117.81 133.53 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.152 0.581 . . . . 0.0 110.02 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.4 p -108.85 137.18 47.2 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.932 0.893 . . . . 0.0 109.931 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.09 134.71 11.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 13.6 p -77.2 115.89 17.37 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.203 0.601 . . . . 0.0 109.851 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -153.98 140.7 19.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 108.945 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . 0.414 ' HB3' ' HE1' ' A' ' 432' ' ' HIS . 17.3 t70 63.01 16.9 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.728 1.211 . . . . 0.0 112.162 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.94 -18.44 57.18 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.11 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -109.23 166.38 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.5 t -89.69 104.72 17.26 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 167.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.414 ' HE1' ' HB3' ' A' ' 428' ' ' ASP . 51.0 m80 -95.53 129.07 42.83 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.312 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 57.8 p -118.07 132.88 56.32 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.586 0.755 . . . . 0.0 109.99 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 413' ' ' LEU . 30.7 pt -118.43 179.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.275 0.63 . . . . 0.0 109.843 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -111.36 151.73 28.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 82.4 mt -117.31 151.44 47.95 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.48 1.112 . . . . 0.0 108.557 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.26 131.22 35.42 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.392 2.062 . . . . 0.0 111.757 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.28 137.78 77.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.06 2.506 . . . . 0.0 114.533 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.2 m -109.82 167.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.917 0.887 . . . . 0.0 109.603 171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.67 15.69 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.557 0.343 . . . . 0.0 111.254 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 26.0 t -123.48 141.43 52.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.804 0.442 . . . . 0.0 109.927 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.07 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.113 0.965 . . . . 0.0 112.322 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.5 m -70.3 -19.47 63.09 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.999 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -51.61 -60.98 2.54 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.65 -54.38 46.07 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.682 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -49.06 -40.66 32.34 Favored 'General case' 0 C--O 1.247 0.935 0 O-C-N 125.023 1.452 . . . . 0.0 112.281 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.18 -48.64 79.15 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.151 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -83.22 -17.1 43.92 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.133 178.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.59 -42.71 74.09 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 119.325 0.966 . . . . 0.0 110.047 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -62.42 -38.48 89.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.826 0.704 . . . . 0.0 110.629 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 456' ' ' LEU . 36.5 t80 -68.91 -49.8 54.98 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.033 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 89.5 m -67.39 -22.41 65.55 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.25 1.02 . . . . 0.0 111.514 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -65.97 -36.44 83.33 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.8 t -77.23 -28.58 53.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.876 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.491 HD13 HD22 ' A' ' 371' ' ' LEU . 64.9 mt -77.23 -16.75 58.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.256 0.623 . . . . 0.0 111.397 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 71.0 6.55 5.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.012 1.725 . . . . 0.0 111.471 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.565 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -78.0 132.34 37.77 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 34.5 t70 -147.35 142.34 27.0 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.065 -165.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 60.28 18.8 8.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.17 0.988 . . . . 0.0 110.276 -167.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 32.5 tp -80.81 -24.09 38.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 122.933 0.493 . . . . 0.0 111.019 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.612 HD21 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -155.58 160.35 40.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.668 0.387 . . . . 0.0 111.018 174.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 33.5 p -164.3 133.54 3.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.801 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 123.069 0.548 . . . . 0.0 111.831 -177.256 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 387' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 120.803 0.335 . . . . 0.0 110.448 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.1 t -72.48 -178.94 2.76 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.468 0.307 . . . . 0.0 110.178 168.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.29 138.3 43.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.23 0.612 . . . . 0.0 110.25 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.03 158.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.311 1.044 . . . . 0.0 110.485 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 21.0 p -134.36 107.5 7.65 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.65 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 395' ' ' ILE . 34.4 m -94.77 154.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -117.63 99.95 7.3 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.421 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 48.6 t -69.9 98.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.743 0.817 . . . . 0.0 110.015 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.29 83.73 7.88 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.583 ' HB3' ' HZ2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -72.59 -6.24 42.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.31 176.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -78.0 -21.26 51.09 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.467 0.707 . . . . 0.0 110.51 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.63 -148.08 6.28 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.885 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.5 t30 -74.46 140.37 44.56 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.283 0.564 . . . . 0.0 109.973 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -54.06 4.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.558 1.143 . . . . 0.0 108.253 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.695 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -155.22 -86.53 0.06 OUTLIER Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.75 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -88.61 15.99 44.42 Favored 'Cis proline' 0 C--N 1.365 1.422 0 CA-C-N 120.194 1.997 . . . . 0.0 114.022 8.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -70.75 -12.21 61.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.705 0.402 . . . . 0.0 110.847 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 22.5 mt -107.44 131.93 53.75 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 109.035 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.18 126.87 93.18 Favored Pre-proline 0 N--CA 1.481 1.099 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.498 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.1 Cg_endo -60.07 -41.49 51.92 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.349 2.699 . . . . 0.0 113.294 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.517 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -66.57 -39.7 88.61 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.879 0.471 . . . . 0.0 110.74 -175.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -74.11 -30.93 62.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.754 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.503 ' HA ' HD22 ' A' ' 379' ' ' LEU . 10.0 mm -62.75 -24.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.047 0.939 . . . . 0.0 111.466 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 55.1 mm-40 -83.31 -17.05 43.84 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.675 0.39 . . . . 0.0 111.15 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -79.2 -30.46 43.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.162 0.585 . . . . 0.0 111.626 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 376' ' ' ILE . 0.3 OUTLIER -74.82 157.43 85.74 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 169.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.25 166.5 21.06 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.56 2.174 . . . . 0.0 112.972 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.39 1.49 21.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.13 0.972 . . . . 0.0 111.179 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.421 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.8 p80 -158.84 155.57 28.05 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.725 0.81 . . . . 0.0 110.34 173.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -125.07 113.29 17.55 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 167.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 114.53 176.75 18.97 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.357 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.65 128.98 16.81 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 119.71 1.755 . . . . 0.0 112.655 1.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.51 -164.29 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.051 -0.861 . . . . 0.0 111.594 -174.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.509 ' HB3' ' HG3' ' A' ' 354' ' ' MET . 7.8 Cg_exo -66.36 139.21 53.63 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.955 2.437 . . . . 0.0 112.072 -170.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.75 HG21 ' HB1' ' A' ' 445' ' ' ALA . 4.1 p -53.75 -45.71 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.133 0.973 . . . . 0.0 111.341 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.517 ' HB3' HH21 ' A' ' 393' ' ' ARG . 12.7 m120 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.277 . . . . 0.0 110.74 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 71.1 t -70.63 -57.67 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.632 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.75 -44.19 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.397 0.679 . . . . 0.0 112.457 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -41.68 76.25 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-N 117.571 0.169 . . . . 0.0 110.564 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.517 HH21 ' HB3' ' A' ' 389' ' ' ASN . 11.4 ptp180 -70.48 -28.63 65.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 29.9 mmt180 -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 123.688 0.617 . . . . 0.0 110.989 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 359' ' ' VAL . 24.6 mm -65.62 -57.18 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.506 ' O ' HG21 ' A' ' 400' ' ' VAL . 85.4 t -58.69 -49.31 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.737 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.543 ' HA ' HG22 ' A' ' 423' ' ' ILE . 3.3 pt20 -68.27 -37.36 80.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.631 0.372 . . . . 0.0 111.398 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 379' ' ' LEU . . . -66.37 -35.35 80.11 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.395 0.435 . . . . 0.0 110.064 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 93.0 m -67.68 -53.33 28.62 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.597 0.561 . . . . 0.0 110.978 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 396' ' ' VAL . 20.3 t -61.26 -47.27 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 122.748 0.419 . . . . 0.0 110.527 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.98 -46.8 76.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 89.3 m -73.61 -5.68 41.89 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.895 0.478 . . . . 0.0 112.264 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.67 143.78 55.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.414 0.625 . . . . 0.0 112.635 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.94 126.79 30.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.959 163.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 56.5 2.72 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-O 122.085 0.945 . . . . 0.0 109.694 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 92.2 m -53.75 -32.16 51.23 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.037 1.335 . . . . 0.0 111.77 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -57.48 -32.23 66.78 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.815 1.246 . . . . 0.0 112.666 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 80.7 m -89.3 -42.73 11.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.716 0.806 . . . . 0.0 110.48 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 403' ' ' ALA . 69.7 t -60.66 -32.91 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.832 0.853 . . . . 0.0 111.66 -177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -72.48 -26.83 61.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.771 1.228 . . . . 0.0 110.557 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.29 -15.36 72.44 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.966 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -79.73 -2.66 44.03 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.492 0.646 . . . . 0.0 111.845 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -145.81 105.26 3.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.489 0.661 . . . . 0.0 110.148 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -83.9 157.42 63.41 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.146 0.978 . . . . 0.0 110.375 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.91 163.39 37.66 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.007 1.805 . . . . 0.0 112.873 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.15 137.5 29.12 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.464 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -96.34 38.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.265 0.626 . . . . 0.0 111.423 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -95.01 -16.98 22.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.402 0.681 . . . . 0.0 110.638 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.41 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 74.97 39.42 38.15 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.29 -122.63 3.91 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.153 -0.248 . . . . 0.0 113.09 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.4 OUTLIER -70.07 162.63 27.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.788 0.835 . . . . 0.0 110.642 -177.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.1 128.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 397' ' ' GLN . 36.6 mm -111.4 121.92 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.452 0.701 . . . . 0.0 110.215 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.2 p -107.51 142.9 36.67 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.442 1.097 . . . . 0.0 110.221 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -163.41 136.33 5.45 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.891 0.744 . . . . 0.0 110.986 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 67.4 m -74.88 119.6 19.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.48 0.712 . . . . 0.0 111.875 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -148.51 137.7 21.81 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.468 1.107 . . . . 0.0 109.73 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 58.83 33.47 23.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.945 1.298 . . . . 0.0 112.117 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.04 87.15 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.386 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.82 171.68 13.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.06 0.944 . . . . 0.0 109.572 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -94.77 130.18 41.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -119.37 142.45 48.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.651 0.781 . . . . 0.0 109.716 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 42.2 p -129.08 143.07 50.74 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 110.483 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.479 HD11 HD11 ' A' ' 413' ' ' LEU . 26.8 pt -119.61 173.65 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.216 0.606 . . . . 0.0 109.42 171.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.41 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 28.5 mt-30 -113.8 151.72 31.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.351 0.661 . . . . 0.0 110.342 171.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 78.9 mt -116.56 168.49 8.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.287 1.435 . . . . 0.0 108.962 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.24 136.77 20.36 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.601 1.534 . . . . 0.0 111.256 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -73.07 133.04 19.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.469 2.112 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.5 m -99.99 174.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.977 0.911 . . . . 0.0 110.997 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.32 12.11 0.41 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.959 0.504 . . . . 0.0 110.966 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.6 t -119.21 138.32 53.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.722 0.409 . . . . 0.0 110.635 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.89 -29.21 62.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.978 0.911 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 18.6 m -71.87 -22.25 61.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.187 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.6 -32.98 20.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.75 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -47.38 -63.73 0.97 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.708 1.203 . . . . 0.0 111.478 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.25 -47.77 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.994 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -32.34 64.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.122 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -62.98 -56.6 15.67 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 122.884 0.474 . . . . 0.0 110.121 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.54 -14.97 59.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.556 -178.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.564 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 50.0 mt-10 -72.74 -40.3 66.19 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.586 0.63 . . . . 0.0 109.853 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.73 -32.3 72.82 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.511 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.501 ' CE2' HD13 ' A' ' 456' ' ' LEU . 48.4 t80 -81.02 -42.14 21.59 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.405 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 21.7 p -68.28 -23.85 64.8 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.199 0.599 . . . . 0.0 110.411 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -62.17 -32.81 73.47 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.07 1.348 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -78.34 -32.86 49.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.539 0.736 . . . . 0.0 110.794 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.513 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 39.0 mt -83.8 -10.29 58.18 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.641 0.776 . . . . 0.0 112.204 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 71.26 7.29 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.741 1.616 . . . . 0.0 111.373 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.695 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -84.67 135.42 34.17 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 122.894 0.478 . . . . 0.0 110.04 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 28.1 t70 -147.12 158.66 44.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.602 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.2 p30 48.64 26.11 1.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.643 1.177 . . . . 0.0 112.654 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.55 -15.66 30.24 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.905 1.282 . . . . 0.0 110.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.74 164.56 33.75 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.354 0.661 . . . . 0.0 110.273 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 42.0 p -168.06 129.0 1.37 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 108.459 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.2 t . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.103 0.561 . . . . 0.0 111.72 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.772 0.32 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.7 t -90.34 178.2 6.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.396 1.078 . . . . 0.0 110.841 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.2 p -136.39 135.32 38.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.729 1.212 . . . . 0.0 109.624 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.96 167.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.922 0.889 . . . . 0.0 110.738 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.44 121.24 18.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.068 0.947 . . . . 0.0 108.809 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 395' ' ' ILE . 35.5 m -105.19 146.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 170.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -111.94 98.46 7.38 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 42.4 t -68.66 101.53 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 124.323 1.014 . . . . 0.0 109.897 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 51.2 t30 -92.21 90.39 7.28 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.156 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -5.69 49.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.761 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . 0.414 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 66.5 t60 -76.87 -19.36 57.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.673 0.789 . . . . 0.0 110.174 167.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -74.0 -125.74 0.12 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.677 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -106.8 156.05 19.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.496 0.648 . . . . 0.0 109.374 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.14 -64.41 1.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.52 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.94 -87.9 0.07 OUTLIER Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.275 -173.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -85.91 17.2 33.85 Favored 'Cis proline' 0 C--N 1.374 1.907 0 CA-C-N 120.51 2.155 . . . . 0.0 113.998 4.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -70.81 -22.69 62.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.117 0.567 . . . . 0.0 110.284 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.52 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.7 mt -96.34 136.74 36.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.33 1.052 . . . . 0.0 109.56 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 375' ' ' ARG . 12.8 t70 -65.35 126.16 90.89 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.827 0.851 . . . . 0.0 110.653 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.487 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 60.5 Cg_endo -68.0 -19.49 45.71 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.814 2.343 . . . . 0.0 113.872 -170.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -84.74 -47.41 10.45 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 372' ' ' ASP . 38.4 mtt180 -62.32 -35.53 79.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 0.0 112.064 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.9 mm -58.47 -29.64 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.505 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.6 mm-40 -85.76 -19.12 31.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.568 0.347 . . . . 0.0 110.996 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 79.3 mm-40 -87.4 -29.11 21.73 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.345 0.658 . . . . 0.0 112.556 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 361' ' ' VAL . 2.7 pp -69.84 159.61 83.36 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.741 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.2 152.13 74.15 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.512 2.142 . . . . 0.0 113.279 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.34 -4.07 37.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.41 1.084 . . . . 0.0 111.808 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 38.7 p-80 -161.55 148.76 14.61 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.339 0.656 . . . . 0.0 110.815 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -116.85 104.17 11.04 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 133.03 -173.92 20.79 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.376 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.99 128.36 14.48 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.097 -5.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -152.27 -162.3 10.78 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.21 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -68.69 139.39 44.03 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.067 2.511 . . . . 0.0 112.072 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.697 HG23 ' HB1' ' A' ' 445' ' ' ALA . 6.8 p -50.51 -39.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.46 1.104 . . . . 0.0 111.754 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.61 -48.28 67.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.65 -47.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.23 -43.58 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.23 0.612 . . . . 0.0 111.98 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.21 -44.29 76.11 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 120.68 0.276 . . . . 0.0 110.563 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.485 HH11 ' HA ' ' A' ' 421' ' ' GLU . 29.4 ptt180 -74.56 -24.51 58.93 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.54 -38.63 91.7 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.921 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.515 HD13 HG23 ' A' ' 359' ' ' VAL . 27.6 mm -65.42 -55.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 400' ' ' VAL . 68.2 t -61.66 -47.02 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.706 -172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.98 -32.14 71.5 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.645 0.378 . . . . 0.0 110.88 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.551 0.532 . . . . 0.0 110.068 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.37 -56.17 12.36 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.152 0.908 . . . . 0.0 110.949 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 396' ' ' VAL . 3.0 t -62.55 -37.38 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.75 -43.73 95.56 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.593 0.757 . . . . 0.0 111.19 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 19.9 p -83.44 -8.03 59.45 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.166 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 409' ' ' VAL . . . -72.04 134.02 45.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 53.2 mt -75.76 124.6 27.56 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.655 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 64.55 68.49 0.53 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.624 1.17 . . . . 0.0 109.319 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.469 HG21 HG12 ' A' ' 400' ' ' VAL . 55.3 m -61.18 -37.83 84.33 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.533 -173.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -43.13 60.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.864 0.866 . . . . 0.0 113.035 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.3 m -74.71 -38.64 62.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.472 0.654 . . . . 0.0 109.874 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 403' ' ' ALA . 78.0 t -68.94 -31.4 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.638 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.06 -10.28 59.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.334 1.054 . . . . 0.0 110.034 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.67 -7.74 83.89 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.908 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -83.34 -9.72 58.9 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 117.621 0.711 . . . . 0.0 111.869 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.98 142.74 49.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.636 0.775 . . . . 0.0 109.713 174.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -117.06 149.71 44.74 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.443 0.697 . . . . 0.0 111.091 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 59.7 Cg_endo -68.67 128.07 16.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.832 2.355 . . . . 0.0 112.603 174.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.06 169.64 8.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.843 1.257 . . . . 0.0 108.801 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -118.99 22.58 11.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.71 . . . . 0.0 112.391 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.9 -25.12 14.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.085 0.554 . . . . 0.0 111.623 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.2 45.89 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.191 1.237 . . . . 0.0 116.191 162.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -85.69 -85.0 1.03 Allowed Glycine 0 C--O 1.239 0.436 0 CA-C-N 116.779 0.29 . . . . 0.0 112.694 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 3.1 mp0 -85.17 162.79 19.08 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.84 0.456 . . . . 0.0 110.346 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 67.5 t -136.08 124.21 36.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.063 0.945 . . . . 0.0 108.633 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 436' ' ' LEU . 32.3 mm -104.39 122.82 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.2 p -106.76 145.75 31.69 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.257 1.023 . . . . 0.0 109.498 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.37 142.85 4.9 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.539 0.736 . . . . 0.0 110.879 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 103.38 6.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 110.024 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -114.92 124.64 52.22 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.706 0.802 . . . . 0.0 109.098 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 32.0 t70 61.19 28.59 18.19 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-O 122.245 1.022 . . . . 0.0 111.124 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.87 -17.8 58.22 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.863 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.29 162.01 15.45 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 117.441 0.621 . . . . 0.0 110.651 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.1 t -81.98 121.88 27.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -126.42 149.96 48.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.54 0.736 . . . . 0.0 109.871 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.0 p -140.29 146.08 38.08 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.354 0.662 . . . . 0.0 110.252 -173.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 29.0 pt -120.11 178.84 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.558 0.743 . . . . 0.0 110.361 175.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -118.51 147.88 43.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.578 0.751 . . . . 0.0 109.863 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.0 mp -116.26 156.04 47.61 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.863 1.265 . . . . 0.0 108.188 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.16 131.06 21.25 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 121.877 1.718 . . . . 0.0 111.061 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 128.79 20.04 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.954 2.436 . . . . 0.0 113.167 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.08 168.8 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.249 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -153.22 0.07 0.25 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.386 0.674 . . . . 0.0 110.772 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.6 t -120.61 142.63 49.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.274 0.63 . . . . 0.0 109.997 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.16 67.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.835 0.854 . . . . 0.0 112.462 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.4 m -70.39 -28.2 64.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.444 0.698 . . . . 0.0 111.321 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -24.03 29.87 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' A' ' 388' ' ' VAL . . . -48.16 -59.68 3.22 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 123.907 0.754 . . . . 0.0 109.668 171.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.89 -51.03 62.22 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -48.76 -41.94 33.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.319 1.047 . . . . 0.0 112.878 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -41.11 99.11 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.955 0.784 . . . . 0.0 110.951 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.46 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -87.44 -18.92 28.83 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.318 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.29 -42.38 59.65 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.861 0.755 . . . . 0.0 110.416 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.63 -40.8 92.95 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.444 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -65.57 -47.11 76.91 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.257 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 86.7 m -66.66 -31.43 72.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 110.771 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.59 -32.4 71.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.249 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 45.9 m -67.28 -33.81 76.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.136 0.574 . . . . 0.0 110.511 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.502 HD12 HD21 ' A' ' 371' ' ' LEU . 56.7 mt -84.31 -8.93 58.86 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.635 0.774 . . . . 0.0 111.702 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 79.02 5.23 2.3 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.502 1.921 . . . . 0.0 111.779 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.448 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 7.4 p -87.4 146.44 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.059 0.544 . . . . 0.0 110.896 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -162.64 154.45 18.32 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 32.3 m-80 64.54 18.84 11.58 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.268 1.027 . . . . 0.0 111.115 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 23.7 tp -83.32 -9.42 59.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.574 0.749 . . . . 0.0 110.606 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.46 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.6 171.85 19.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.935 0.894 . . . . 0.0 109.908 176.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 29.1 p -162.16 126.22 3.17 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.473 0.709 . . . . 0.0 109.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.629 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.7 m -75.27 -177.39 3.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.596 0.358 . . . . 0.0 111.801 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.0 p -141.6 134.37 28.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.119 0.968 . . . . 0.0 109.622 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 388' ' ' VAL . 13.0 m -137.29 171.4 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.344 1.058 . . . . 0.0 110.509 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 25.9 p -145.83 108.12 4.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.383 0.673 . . . . 0.0 109.751 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.541 HG23 HD13 ' A' ' 395' ' ' ILE . 30.8 m -98.34 143.91 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -109.89 100.69 9.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 78.0 t -73.42 102.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.411 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 36.3 t30 -97.11 96.13 8.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.828 0.851 . . . . 0.0 109.624 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -5.93 53.18 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.023 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -85.8 -8.93 57.8 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.524 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.61 -137.04 2.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -92.13 142.78 27.13 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 117.817 0.808 . . . . 0.0 109.369 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.428 ' HB3' HG13 ' A' ' 376' ' ' ILE . 1.8 m-85 -84.03 -56.23 3.79 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.501 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -147.38 -74.48 0.02 OUTLIER Glycine 0 C--N 1.349 1.268 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.912 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.8 -15.26 17.65 Favored 'Cis proline' 0 C--N 1.371 1.729 0 CA-C-N 121.118 2.459 . . . . 0.0 115.308 4.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 456' ' ' LEU . 14.2 p80 -73.09 0.94 10.1 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.907 0.776 . . . . 0.0 113.079 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 12.7 mt -91.39 127.86 37.0 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.01 118.38 17.35 Favored Pre-proline 0 N--CA 1.478 0.974 0 O-C-N 124.165 0.916 . . . . 0.0 110.763 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.507 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 58.7 Cg_endo -65.61 -19.36 60.17 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.92 2.413 . . . . 0.0 113.664 -169.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 3.1 mppt? -84.5 -42.7 15.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.86 0.362 . . . . 0.0 110.04 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 24.1 mtt-85 -68.01 -33.08 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.216 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.434 HD12 HD23 ' A' ' 379' ' ' LEU . 24.6 mm -60.68 -27.02 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.159 171.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 69.7 mm-40 -84.47 -22.3 30.33 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 174.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 85.7 mm-40 -79.73 -30.19 40.79 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.318 0.647 . . . . 0.0 112.367 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 376' ' ' ILE . 3.1 pp -73.2 154.6 90.39 Favored Pre-proline 0 N--CA 1.482 1.137 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.29 164.78 24.36 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.233 1.955 . . . . 0.0 114.773 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.27 -18.28 61.82 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.461 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.446 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 47.5 p-80 -166.32 149.93 7.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.54 0.736 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -116.49 101.94 9.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 144.68 165.85 11.28 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.444 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.23 130.36 20.59 Favored 'Cis proline' 0 C--N 1.379 2.171 0 CA-C-N 118.984 1.392 . . . . 0.0 112.237 -3.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.67 -173.22 24.06 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.875 -0.958 . . . . 0.0 111.074 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.44 143.11 34.22 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.804 HG21 ' HB1' ' A' ' 445' ' ' ALA . 3.3 p -45.47 -50.95 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 112.775 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.49 -34.58 72.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.617 1.167 . . . . 0.0 111.817 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 99.4 t -76.57 -47.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.17 -38.82 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 122.883 0.473 . . . . 0.0 111.658 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 445' ' ' ALA . 4.2 pp -70.77 -41.61 71.5 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.146 0.179 . . . . 0.0 111.428 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 392' ' ' LEU . 28.8 ptt180 -71.9 -30.74 65.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -68.84 -29.39 67.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.614 0.765 . . . . 0.0 111.51 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.541 HD13 HG23 ' A' ' 359' ' ' VAL . 35.4 mm -69.6 -54.85 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 400' ' ' VAL . 98.3 t -58.76 -50.07 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 O-C-N 124.193 0.933 . . . . 0.0 111.572 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 423' ' ' ILE . 2.7 pt20 -68.44 -31.35 70.61 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.929 0.491 . . . . 0.0 111.91 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.22 83.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.01 -32.45 72.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.45 0.7 . . . . 0.0 112.629 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.7 t -80.24 -52.38 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.55 -38.98 89.43 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.734 0.414 . . . . 0.0 111.055 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 50.5 m -89.28 12.94 14.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.297 0.639 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -89.51 144.91 25.66 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.212 0.605 . . . . 0.0 111.732 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.87 122.23 18.2 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.839 166.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.32 62.28 0.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.445 1.09 . . . . 0.0 109.192 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.5 m -55.96 -41.13 74.25 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.64 1.576 . . . . 0.0 111.483 -173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . 0.425 ' HA ' ' HD1' ' A' ' 427' ' ' PHE . 17.5 ptmt -54.2 -34.67 61.11 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.116 1.366 . . . . 0.0 114.497 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.2 m -79.14 -39.4 33.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.469 0.652 . . . . 0.0 109.653 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 403' ' ' ALA . 59.8 t -67.11 -26.17 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.013 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.3 -17.54 63.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.314 1.446 . . . . 0.0 110.146 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -81.9 -8.21 86.97 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.4 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.16 -2.31 55.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.213 0.605 . . . . 0.0 111.3 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.46 HD12 HD13 ' A' ' 434' ' ' ILE . 1.5 pt? -149.31 139.17 21.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.611 0.764 . . . . 0.0 110.052 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -105.87 152.7 40.29 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.101 0.961 . . . . 0.0 111.474 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.03 151.68 62.01 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.046 166.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -148.24 107.78 3.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -91.06 44.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.019 0.914 . . . . 0.0 110.979 -167.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.63 5.94 50.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.407 169.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.81 66.2 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.51 0.506 . . . . 0.0 113.178 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.52 -126.86 2.38 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.737 0.316 . . . . 0.0 112.727 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.439 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.5 mp0 -85.12 174.56 9.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.415 0.686 . . . . 0.0 110.755 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.64 135.31 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.34 0.656 . . . . 0.0 109.432 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 397' ' ' GLN . 31.2 mm -109.74 124.19 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.897 0.879 . . . . 0.0 108.998 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.8 p -106.87 133.83 50.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.224 0.61 . . . . 0.0 109.613 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.47 134.04 10.86 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.605 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 62.7 m -77.03 104.64 7.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 122.951 0.5 . . . . 0.0 111.023 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 407' ' ' LYS . 45.8 t80 -111.05 110.63 21.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.985 0.914 . . . . 0.0 110.598 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 39.0 t70 58.09 57.6 3.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.745 1.218 . . . . 0.0 111.76 169.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 78.32 -6.94 49.2 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.131 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.98 170.84 7.83 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.708 0.754 . . . . 0.0 110.309 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 5.1 t -114.22 109.39 18.32 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -120.66 168.75 11.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.608 0.763 . . . . 0.0 110.686 -173.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 51.0 p -147.94 154.86 40.9 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.331 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.46 HD13 HD12 ' A' ' 413' ' ' LEU . 25.5 pt -122.49 -179.75 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.957 0.903 . . . . 0.0 109.173 172.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -116.17 153.32 32.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.404 0.681 . . . . 0.0 110.211 170.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 421' ' ' GLU . 85.0 mt -114.96 164.68 15.96 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 0.0 109.374 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.34 134.47 17.3 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.814 1.676 . . . . 0.0 111.008 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.43 128.02 14.84 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.002 1.801 . . . . 0.0 112.248 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.51 172.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 0.0 110.369 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.18 -12.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.421 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.9 m -108.78 138.89 44.38 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.4 0.545 . . . . 0.0 111.044 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.81 -30.37 68.91 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.265 1.026 . . . . 0.0 111.622 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.6 m -62.85 -33.53 75.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.837 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -82.56 -25.32 33.43 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.804 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -48.2 -65.97 0.48 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.865 0.866 . . . . 0.0 111.473 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 3.1 pp -65.98 -37.43 85.93 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.609 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.65 71.69 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.263 1.025 . . . . 0.0 111.686 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -62.73 -49.71 73.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.529 0.732 . . . . 0.0 110.245 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.535 HD22 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -89.05 -14.5 36.25 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.519 -175.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.0 OUTLIER -59.69 -48.86 79.98 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.047 0.939 . . . . 0.0 110.807 -176.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.92 -32.89 71.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.075 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.419 ' HZ ' HG21 ' A' ' 400' ' ' VAL . 60.4 t80 -68.23 -52.83 29.74 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.136 0.575 . . . . 0.0 110.87 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.08 -28.01 69.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.824 1.249 . . . . 0.0 111.31 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.72 -36.53 80.77 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.624 0.769 . . . . 0.0 110.273 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.1 m -71.41 -28.13 63.79 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.723 0.809 . . . . 0.0 110.923 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.495 ' HA ' ' HE2' ' A' ' 370' ' ' HIS . 23.9 mt -82.91 -17.81 42.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.128 0.571 . . . . 0.0 111.157 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 73.8 6.82 4.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 111.777 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.476 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 22.4 p -79.22 131.53 36.21 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -151.68 145.43 25.05 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.358 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 18.1 m-80 62.72 20.67 12.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 -167.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -86.27 -19.95 29.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.51 0.724 . . . . 0.0 110.476 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.535 HD23 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.09 169.55 24.23 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.537 0.735 . . . . 0.0 110.059 173.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.9 p -157.22 109.43 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 123.518 0.727 . . . . 0.0 111.626 -177.523 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.55 0.973 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.2 p -86.47 -173.58 4.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.941 0.496 . . . . 0.0 110.899 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -139.62 142.44 37.04 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.611 0.764 . . . . 0.0 110.667 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.22 152.7 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.459 1.103 . . . . 0.0 110.584 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.475 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 42.2 t -121.07 105.72 10.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 0.0 109.102 171.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.1 t -94.95 149.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.66 0.784 . . . . 0.0 109.734 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.5 103.46 9.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.572 1.149 . . . . 0.0 108.585 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.78 106.53 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.033 0.533 . . . . 0.0 110.749 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -91.64 87.93 6.53 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.439 0.696 . . . . 0.0 109.271 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.638 ' HB3' ' HZ2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -72.56 -15.61 61.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.257 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -73.98 -19.22 60.72 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.397 0.679 . . . . 0.0 110.833 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -80.52 -153.95 9.66 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.201 0.429 . . . . 0.0 112.89 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 52.5 t30 -72.69 141.5 48.23 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.828 0.347 . . . . 0.0 110.169 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.414 ' O ' HD11 ' A' ' 371' ' ' LEU . 2.0 m-85 -97.32 -64.63 1.02 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.446 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -138.32 -100.89 0.53 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.029 -0.873 . . . . 0.0 112.259 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -88.75 15.94 44.84 Favored 'Cis proline' 0 C--N 1.373 1.862 0 CA-C-N 120.312 2.056 . . . . 0.0 114.238 12.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -83.58 -1.79 54.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.641 0.777 . . . . 0.0 111.196 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 42.4 mt -114.78 146.79 40.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.361 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.19 122.37 86.1 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.611 0.764 . . . . 0.0 110.701 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.465 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 37.6 Cg_endo -61.34 -23.76 77.47 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.229 2.619 . . . . 0.0 114.871 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -84.7 -48.2 9.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.149 0.432 . . . . 0.0 110.457 -176.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 64.7 mtt180 -68.5 -34.68 76.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.077 0.951 . . . . 0.0 111.949 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.43 ' HA ' HD22 ' A' ' 379' ' ' LEU . 15.8 mm -52.55 -31.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.909 0.883 . . . . 0.0 111.884 170.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -80.28 -28.2 38.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.115 0.566 . . . . 0.0 111.385 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -78.45 -31.33 47.93 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.623 0.769 . . . . 0.0 112.346 -169.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 376' ' ' ILE . 0.8 OUTLIER -71.54 154.0 93.45 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.106 172.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.2 165.44 8.9 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.977 2.451 . . . . 0.0 114.812 -171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.91 -13.62 60.93 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.522 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -159.7 150.47 19.27 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.2 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -119.46 104.22 10.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 178.09 15.17 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.963 -0.91 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.67 136.53 36.72 Favored 'Cis proline' 0 C--N 1.386 2.54 0 CA-C-N 119.875 1.838 . . . . 0.0 113.23 -2.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -170.46 -172.89 37.28 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.03 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.546 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 58.5 Cg_endo -68.26 138.78 44.04 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.841 2.361 . . . . 0.0 112.366 -174.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 445' ' ' ALA . 11.4 p -51.05 -43.02 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.333 1.453 . . . . 0.0 111.724 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -50.77 -59.33 4.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 111.035 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.546 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 57.6 t -71.74 -42.37 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.867 -172.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.27 -45.26 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.844 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.66 -40.65 84.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 390' ' ' VAL . 10.9 ptm180 -72.71 -30.05 63.89 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -72.23 -23.06 61.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.086 0.554 . . . . 0.0 111.929 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.511 HG21 ' HG ' ' A' ' 449' ' ' LEU . 22.0 mm -73.42 -55.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 400' ' ' VAL . 85.9 t -62.29 -55.79 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.587 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.0 pt20 -64.07 -29.63 70.75 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.795 0.438 . . . . 0.0 111.9 -176.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.418 ' HB1' HD21 ' A' ' 379' ' ' LEU . . . -64.09 -48.9 74.38 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.24 -47.86 78.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.856 0.723 . . . . 0.0 112.318 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 406' ' ' THR . 10.2 t -65.13 -48.12 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.958 0.409 . . . . 0.0 110.154 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.95 -33.55 74.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.686 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 73.5 m -93.01 17.22 11.11 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.429 0.692 . . . . 0.0 110.958 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -91.13 155.46 18.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.611 0.719 . . . . 0.0 112.318 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.47 121.94 26.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.689 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 57.32 61.91 2.36 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.333 1.02 . . . . 0.0 109.712 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.485 HG21 HG13 ' A' ' 400' ' ' VAL . 97.1 m -48.67 -35.81 14.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.094 1.758 . . . . 0.0 112.742 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -56.93 -39.51 74.62 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.492 1.117 . . . . 0.0 113.036 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 92.9 m -79.6 -40.48 29.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.816 0.847 . . . . 0.0 109.772 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 403' ' ' ALA . 94.5 t -61.08 -33.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.429 1.092 . . . . 0.0 111.46 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.12 -10.54 59.49 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.368 1.067 . . . . 0.0 110.908 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -82.38 -6.94 88.24 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.574 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.14 10.1 28.32 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.414 0.685 . . . . 0.0 111.464 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -152.14 141.05 21.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.295 1.038 . . . . 0.0 108.964 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -117.15 154.99 50.1 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 123.688 0.795 . . . . 0.0 111.53 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.09 157.8 56.73 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.692 2.261 . . . . 0.0 112.037 167.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -155.15 139.23 16.47 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -90.12 27.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.44 -33.42 23.67 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 111.024 175.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.77 41.82 8.63 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.723 0.249 . . . . 0.0 113.723 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -94.18 -110.25 2.19 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.761 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 23.5 mp0 -74.28 162.74 28.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.438 ' HB ' ' NH2' ' A' ' 393' ' ' ARG . 90.1 t -135.64 130.07 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.476 HG12 HD12 ' A' ' 436' ' ' LEU . 37.3 mm -110.4 127.55 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.418 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.7 p -106.04 150.7 25.5 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.673 0.789 . . . . 0.0 108.999 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -165.87 135.96 3.47 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.583 0.753 . . . . 0.0 109.678 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 69.0 m -67.48 101.06 0.92 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.585 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -139.21 136.75 35.33 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 109.502 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.7 t70 62.71 31.64 16.53 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.97 1.308 . . . . 0.0 111.514 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 81.34 1.87 90.24 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.893 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.81 172.96 10.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.586 1.155 . . . . 0.0 109.308 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.8 t -87.75 102.24 14.47 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 164.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -85.94 133.08 33.96 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 424' ' ' THR . 25.2 p -114.56 143.3 45.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.017 0.927 . . . . 0.0 110.445 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 413' ' ' LEU . 16.5 pt -128.46 168.44 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.046 0.938 . . . . 0.0 109.761 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -112.28 146.93 37.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.536 0.734 . . . . 0.0 110.766 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.7 mp -115.86 155.48 47.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.233 1.413 . . . . 0.0 108.355 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.17 128.66 14.11 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.79 1.66 . . . . 0.0 111.462 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.09 135.36 27.14 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.927 2.418 . . . . 0.0 111.617 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.16 160.78 4.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.285 0.564 . . . . 0.0 110.751 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.62 12.43 3.19 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.316 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 39.5 t -118.36 139.13 51.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.896 0.478 . . . . 0.0 109.97 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.25 45.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.462 1.105 . . . . 0.0 111.365 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 27.2 m -72.89 -22.4 60.76 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.03 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.41 -21.39 25.63 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.707 ' HB3' HG22 ' A' ' 388' ' ' VAL . . . -47.81 -60.73 2.36 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 121.701 0.762 . . . . 0.0 109.918 170.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 464' ' ' SER . 20.6 mt -69.69 -39.77 76.75 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.952 -174.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 0.0 OUTLIER -61.15 -30.8 70.61 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.879 0.872 . . . . 0.0 111.442 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -45.51 72.88 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.903 0.481 . . . . 0.0 110.492 -177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.511 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.51 -13.1 43.98 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.074 -0.488 . . . . 0.0 111.846 176.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 1.4 mm-40 -57.17 -56.98 14.71 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.725 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.39 -35.72 81.05 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.931 0.769 . . . . 0.0 111.147 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.416 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 38.8 t80 -60.31 -61.06 2.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.522 0.729 . . . . 0.0 110.818 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.85 -30.54 69.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.435 1.094 . . . . 0.0 111.81 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -66.04 -40.26 90.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.224 0.61 . . . . 0.0 110.582 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 49.9 m -67.91 -35.86 79.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.536 0.734 . . . . 0.0 110.486 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.511 HD11 HD23 ' A' ' 371' ' ' LEU . 50.3 mt -72.59 -12.91 61.25 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.542 0.737 . . . . 0.0 111.5 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 73.74 14.61 4.12 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.807 1.643 . . . . 0.0 111.61 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.525 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 15.3 p -93.88 139.59 30.71 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 123.379 0.672 . . . . 0.0 109.982 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -155.31 144.82 21.18 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 3.2 t30 66.84 12.62 9.0 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 124.191 0.932 . . . . 0.0 110.342 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 34.8 tp -74.57 -17.94 60.65 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.866 0.866 . . . . 0.0 110.24 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.01 161.66 31.56 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.344 0.658 . . . . 0.0 110.775 177.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 80.8 p -167.81 129.06 1.45 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.698 0.799 . . . . 0.0 109.001 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 35.4 t . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.839 0.352 . . . . 0.0 111.432 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 387' ' ' PRO . 20.1 ptp . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.883 0.373 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.5 t -76.74 172.49 13.0 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.8 p -136.68 137.02 39.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.392 0.677 . . . . 0.0 109.411 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 388' ' ' VAL . 17.2 m -138.25 165.9 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.024 0.93 . . . . 0.0 110.969 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 24.6 p -142.65 108.89 5.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 108.548 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 395' ' ' ILE . 26.3 m -94.92 159.32 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.27 99.89 6.74 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.84 107.61 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 123.869 0.731 . . . . 0.0 110.313 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.55 89.6 5.05 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.368 1.067 . . . . 0.0 109.117 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.6 42.54 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.509 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.95 -11.46 58.86 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.223 0.609 . . . . 0.0 110.414 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.56 -151.05 5.32 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.453 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 51.2 t-20 -77.52 139.26 39.56 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.41 -52.69 6.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.46 -76.22 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 114.738 -1.119 . . . . 0.0 114.32 -176.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.03 -10.06 13.83 Favored 'Cis proline' 0 C--N 1.371 1.759 0 CA-C-N 121.102 2.451 . . . . 0.0 114.095 -2.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 14.8 p-80 -61.29 -12.33 13.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.188 0.995 . . . . 0.0 113.029 175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.59 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.4 mt -98.69 143.07 29.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.152 0.981 . . . . 0.0 109.408 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 127.49 91.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 123.864 0.727 . . . . 0.0 110.068 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.571 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 29.7 Cg_endo -59.63 -41.25 57.83 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.992 2.461 . . . . 0.0 112.875 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -65.64 -45.2 83.93 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.398 0.436 . . . . 0.0 110.675 -175.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -66.88 -31.2 71.65 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.687 0.795 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 18.5 mm -66.63 -28.83 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.068 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 62.2 mm-40 -82.93 -23.04 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.961 -0.462 . . . . 0.0 110.906 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 70.9 mm-40 -74.6 -38.67 62.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.953 0.501 . . . . 0.0 111.716 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.6 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.1 pp -67.51 156.77 87.87 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.926 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.29 150.69 83.6 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.539 2.159 . . . . 0.0 113.122 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.55 -1.8 26.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.879 1.272 . . . . 0.0 111.442 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -157.33 151.33 24.57 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 109.965 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -118.1 104.25 10.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 166.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 148.27 176.69 21.96 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.248 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -82.23 128.74 15.07 Favored 'Cis proline' 0 C--N 1.376 2.004 0 CA-C-N 118.751 1.276 . . . . 0.0 111.326 -2.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -153.49 -165.45 13.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.099 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.427 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 3.1 Cg_exo -70.97 146.31 52.4 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.951 2.434 . . . . 0.0 112.265 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 445' ' ' ALA . 4.0 p -54.64 -45.32 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 124.28 1.032 . . . . 0.0 111.15 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -62.44 -49.74 74.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.064 1.346 . . . . 0.0 110.948 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 83.4 t -70.63 -48.9 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.508 -174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.12 -40.61 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.87 0.468 . . . . 0.0 111.897 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.7 pp -66.87 -41.84 86.6 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 392' ' ' LEU . 17.4 ptt180 -74.49 -25.4 59.35 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 123.32 0.388 . . . . 0.0 110.033 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 36.7 mmm-85 -64.09 -40.33 95.99 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.422 0.451 . . . . 0.0 110.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 359' ' ' VAL . 43.6 mm -63.55 -51.33 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.953 0.783 . . . . 0.0 109.735 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.79 -44.87 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.298 -174.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.58 -28.03 41.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.857 -0.592 . . . . 0.0 111.834 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -73.53 -31.88 63.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.274 0.488 . . . . 0.0 110.508 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.96 -56.12 19.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.085 0.554 . . . . 0.0 109.56 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.73 -30.13 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.729 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.06 -33.97 70.77 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.484 0.714 . . . . 0.0 111.566 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.6 ' SG ' HD23 ' A' ' 379' ' ' LEU . 78.4 m -91.23 0.1 57.59 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.989 0.516 . . . . 0.0 111.637 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 409' ' ' VAL . . . -68.93 138.84 54.95 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.4 mt -82.6 115.98 21.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.53 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 64.54 61.39 0.85 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.444 1.116 . . . . 0.0 109.286 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.0 m -51.8 -34.8 41.59 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.217 1.807 . . . . 0.0 112.806 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -54.93 -42.24 72.0 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.532 1.133 . . . . 0.0 112.315 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 49.6 m -80.53 -37.25 31.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 403' ' ' ALA . 90.8 t -65.37 -34.92 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.235 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.37 -16.64 60.36 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.832 0.853 . . . . 0.0 110.84 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -68.72 -13.55 66.18 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 116.257 -0.429 . . . . 0.0 114.14 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.88 -13.32 60.01 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.738 . . . . 0.0 111.444 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.6 HD23 ' HE1' ' A' ' 452' ' ' PHE . 1.0 OUTLIER -141.52 112.71 7.43 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.376 0.671 . . . . 0.0 110.267 -173.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 415' ' ' PRO . 47.0 mtpt -112.56 160.67 29.61 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 124.163 0.985 . . . . 0.0 109.637 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 414' ' ' LYS . 67.3 Cg_endo -67.75 155.52 69.62 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.288 1.992 . . . . 0.0 114.698 -170.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.87 124.34 26.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.062 1.345 . . . . 0.0 108.601 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.82 33.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.193 0.597 . . . . 0.0 112.212 -164.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -92.01 -10.62 38.56 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 111.42 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.65 41.33 64.96 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.53 -116.8 2.37 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 120.113 -0.27 . . . . 0.0 112.961 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.9 OUTLIER -77.4 168.73 19.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 110.592 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 81.2 t -132.92 125.29 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.631 0.772 . . . . 0.0 109.217 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.511 HG12 HD12 ' A' ' 436' ' ' LEU . 37.6 mm -103.37 128.06 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.5 p -106.63 140.9 38.77 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.941 0.896 . . . . 0.0 109.809 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.05 141.8 24.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.037 0.935 . . . . 0.0 110.151 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.2 p -83.65 112.7 20.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -144.24 137.48 27.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.031 0.932 . . . . 0.0 109.428 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.17 18.32 11.38 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.494 1.117 . . . . 0.0 112.434 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.38 70.89 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 121.792 -0.567 . . . . 0.0 112.776 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -131.74 170.99 14.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.661 1.184 . . . . 0.0 109.71 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -92.09 126.08 37.03 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.8 126.9 53.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.728 0.811 . . . . 0.0 109.297 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.8 p -117.76 140.63 49.42 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 0.0 110.336 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.14 162.3 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.396 0.678 . . . . 0.0 109.947 172.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -99.27 146.69 25.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.816 0.847 . . . . 0.0 110.111 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.511 HD12 HG12 ' A' ' 423' ' ' ILE . 8.5 mp -115.18 171.43 4.51 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.64 141.73 25.2 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 121.957 1.771 . . . . 0.0 111.735 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.32 128.47 8.91 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.148 1.898 . . . . 0.0 112.257 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.45 172.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.617 0.767 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -149.04 -0.93 0.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.008 0.523 . . . . 0.0 111.979 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -126.5 139.93 52.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.005 0.522 . . . . 0.0 110.751 -172.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.19 70.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.226 1.01 . . . . 0.0 111.517 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 t -63.49 -27.69 69.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.565 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -86.9 -27.87 23.13 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.734 0.414 . . . . 0.0 110.395 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.766 ' HB3' HG22 ' A' ' 388' ' ' VAL . . . -48.9 -66.94 0.31 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.974 0.91 . . . . 0.0 111.954 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 450' ' ' GLU . 0.9 OUTLIER -61.79 -43.75 98.23 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.179 178.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -31.59 58.47 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.364 1.066 . . . . 0.0 111.917 -175.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -62.65 -55.28 28.38 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.687 0.617 . . . . 0.0 110.046 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.76 -14.84 59.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.24 -178.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 446' ' ' LEU . 10.5 mm-40 -64.54 -45.92 85.1 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.292 0.496 . . . . 0.0 110.143 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.15 -39.59 65.55 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.169 0.588 . . . . 0.0 110.599 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.6 ' HE1' HD23 ' A' ' 413' ' ' LEU . 67.9 t80 -57.88 -59.14 5.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.657 0.783 . . . . 0.0 110.952 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.62 -27.16 69.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.118 0.967 . . . . 0.0 112.149 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -65.1 -41.53 94.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.03 0.532 . . . . 0.0 110.505 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 51.1 m -67.62 -21.84 65.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.708 0.803 . . . . 0.0 111.65 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 71.1 mt -100.05 -14.02 18.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.056 0.942 . . . . 0.0 112.963 -173.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.07 7.23 1.65 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.687 1.595 . . . . 0.0 112.19 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . . . . . . . . . 6.1 p -89.44 134.22 34.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.453 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.3 t70 -152.2 152.18 31.92 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 59.74 18.27 7.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.243 1.017 . . . . 0.0 111.259 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.23 -18.52 49.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.77 0.428 . . . . 0.0 110.966 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -163.74 172.5 14.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.23 0.612 . . . . 0.0 110.47 171.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 18.9 p -163.28 126.48 2.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.779 0.831 . . . . 0.0 108.839 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 29.2 t . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 122.66 0.384 . . . . 0.0 111.553 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.9 t -82.37 179.19 7.88 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.144 0.578 . . . . 0.0 110.864 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.5 p -137.89 134.69 35.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.18 0.992 . . . . 0.0 109.864 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 388' ' ' VAL . 15.9 m -140.41 162.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.959 0.903 . . . . 0.0 110.771 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 20.4 p -137.45 115.57 11.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.431 1.092 . . . . 0.0 108.815 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 395' ' ' ILE . 34.9 m -104.01 141.91 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.837 0.455 . . . . 0.0 109.801 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.48 98.24 7.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.434 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 67.5 t -70.68 99.59 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.463 1.102 . . . . 0.0 110.713 -173.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 33.6 t30 -94.47 97.11 9.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.62 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -11.33 59.83 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.334 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -83.32 -15.74 48.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.546 0.738 . . . . 0.0 110.783 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -70.95 -88.32 0.11 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -141.13 152.0 44.37 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.0 -62.19 1.32 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -149.23 -91.75 0.09 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.609 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -85.5 10.48 53.13 Favored 'Cis proline' 0 C--N 1.371 1.763 0 CA-C-N 120.496 2.148 . . . . 0.0 114.832 11.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -74.16 -8.23 55.46 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 26.0 mt -107.89 136.06 48.24 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.415 1.086 . . . . 0.0 108.743 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.16 125.19 86.42 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.481 0.712 . . . . 0.0 110.318 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.517 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 35.0 Cg_endo -62.95 -31.03 77.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.717 2.278 . . . . 0.0 113.137 -172.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.32 -45.97 36.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.148 0.579 . . . . 0.0 110.119 -176.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -61.94 -34.59 76.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.356 1.062 . . . . 0.0 111.598 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.464 HD12 HD23 ' A' ' 379' ' ' LEU . 24.2 mm -64.04 -29.93 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.777 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 76.9 mm-40 -83.18 -21.91 33.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.325 0.25 . . . . 0.0 110.859 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 82.9 mm-40 -79.58 -32.56 42.02 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.03 0.532 . . . . 0.0 112.148 -176.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 376' ' ' ILE . 3.0 pp -72.06 156.98 90.23 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.018 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.85 161.34 18.8 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.854 2.37 . . . . 0.0 114.33 -173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.36 -21.37 61.31 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.952 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.434 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 20.5 p-80 -167.05 154.04 8.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.086 0.955 . . . . 0.0 110.67 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -117.9 146.38 43.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.072 0.949 . . . . 0.0 108.969 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.18 -174.85 39.09 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.271 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.56 128.58 16.82 Favored 'Cis proline' 0 C--N 1.377 2.049 0 CA-C-N 119.187 1.493 . . . . 0.0 112.329 1.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.66 -154.69 7.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.201 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.31 137.2 25.44 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.655 2.237 . . . . 0.0 112.122 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.76 -42.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.606 1.562 . . . . 0.0 112.073 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.23 -55.5 27.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.395 1.478 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -70.13 -46.08 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.888 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.21 -36.63 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 122.566 0.346 . . . . 0.0 111.672 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 393' ' ' ARG . 3.3 pp -73.89 -40.68 63.02 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.744 0.247 . . . . 0.0 111.02 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.409 ' N ' HD13 ' A' ' 392' ' ' LEU . 24.5 ptt180 -67.98 -29.18 68.14 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 22.0 mmm-85 -65.37 -43.32 91.16 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 123.864 0.727 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 359' ' ' VAL . 29.4 mm -65.26 -53.59 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.455 0.472 . . . . 0.0 109.838 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 400' ' ' VAL . 66.7 t -62.05 -44.81 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.027 0.829 . . . . 0.0 110.896 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.503 ' HA ' HG21 ' A' ' 423' ' ' ILE . 2.6 pt20 -67.5 -33.99 76.22 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.63 0.195 . . . . 0.0 110.838 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.1 84.67 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 122.879 0.472 . . . . 0.0 110.147 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 82.3 m -68.61 -51.35 43.3 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.591 0.756 . . . . 0.0 111.1 -175.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 406' ' ' THR . 21.0 t -62.06 -43.9 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.7 -33.35 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.002 0.521 . . . . 0.0 111.524 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 19.2 p -84.34 -10.07 57.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.696 0.398 . . . . 0.0 111.023 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.38 150.03 49.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 112.987 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.55 121.27 26.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.408 169.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 62.77 61.3 1.18 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 122.249 1.023 . . . . 0.0 109.148 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.502 HG21 HG12 ' A' ' 400' ' ' VAL . 52.2 m -54.63 -34.35 61.99 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.437 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -57.66 -37.23 73.02 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 113.175 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.8 m -84.42 -35.34 23.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.055 0.542 . . . . 0.0 110.281 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 403' ' ' ALA . 88.6 t -64.58 -31.22 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.864 0.866 . . . . 0.0 110.837 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.56 -21.6 62.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.944 1.298 . . . . 0.0 110.436 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.59 76.07 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.198 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -77.38 -18.13 57.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.209 0.604 . . . . 0.0 111.689 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -133.26 125.56 29.59 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.501 0.721 . . . . 0.0 110.088 -175.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -103.45 159.03 30.59 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.931 0.892 . . . . 0.0 109.963 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.17 122.64 8.2 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.768 1.645 . . . . 0.0 112.64 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.588 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 4.3 m-20 -110.16 107.67 17.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.328 1.451 . . . . 0.0 107.342 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -83.83 67.62 9.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.095 0.95 . . . . 0.0 108.566 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.588 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -107.53 4.1 25.7 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.97 40.13 93.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.44 0.462 . . . . 0.0 113.053 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -106.61 -132.34 7.05 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 120.125 -0.264 . . . . 0.0 112.633 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.5 OUTLIER -73.21 172.78 10.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.972 0.909 . . . . 0.0 111.389 -175.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 131.22 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 109.32 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.503 HG21 ' HA ' ' A' ' 397' ' ' GLN . 42.1 mm -111.77 123.73 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 433' ' ' SER . 17.0 p -106.51 144.95 32.45 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.831 0.852 . . . . 0.0 109.051 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -160.63 133.03 6.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.662 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.4 m -70.9 109.03 4.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.326 0.651 . . . . 0.0 111.91 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -131.21 126.85 36.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.684 1.194 . . . . 0.0 109.033 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.26 14.35 7.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.036 1.335 . . . . 0.0 112.355 169.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 7.2 62.5 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.721 -0.612 . . . . 0.0 113.015 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -120.6 166.08 14.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.256 1.022 . . . . 0.0 109.46 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.2 t -97.9 101.23 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -88.6 126.95 35.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.446 ' HB3' HG22 ' A' ' 424' ' ' THR . 55.2 p -116.88 148.68 41.09 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.458 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.408 HD13 HD11 ' A' ' 413' ' ' LEU . 46.4 pt -125.56 179.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.086 0.954 . . . . 0.0 109.215 173.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -115.66 153.21 31.71 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 86.1 mt -115.58 166.07 12.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.488 1.115 . . . . 0.0 108.933 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.92 135.07 12.26 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 121.814 1.676 . . . . 0.0 111.105 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.42 134.01 25.64 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.809 2.339 . . . . 0.0 112.494 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.29 173.64 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.787 0.835 . . . . 0.0 111.647 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -152.06 -4.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.43 0.692 . . . . 0.0 112.312 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.5 t -113.96 139.16 49.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.727 0.411 . . . . 0.0 109.999 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.12 67.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.541 0.736 . . . . 0.0 111.308 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 48.3 m -63.87 -32.94 74.62 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.441 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -83.21 -27.28 30.09 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.712 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.65 -62.27 1.7 Allowed 'General case' 0 C--N 1.366 1.3 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.427 ' O ' HD21 ' A' ' 449' ' ' LEU . 17.7 mt -66.31 -52.18 49.88 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.31 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -51.46 -36.14 42.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -59.06 -49.09 79.22 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.847 0.717 . . . . 0.0 109.964 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.592 HD22 HD22 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.58 -14.13 38.34 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.729 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.428 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 49.9 mt-10 -78.02 -36.57 48.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.348 0.976 . . . . 0.0 110.153 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.25 -42.28 96.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.088 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 58.8 t80 -72.42 -43.42 63.88 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.48 -174.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 20.7 p -70.84 -26.66 63.38 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.557 0.743 . . . . 0.0 109.963 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -65.74 -35.06 79.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.031 0.932 . . . . 0.0 110.271 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 17.2 m -75.94 -29.11 58.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.643 0.777 . . . . 0.0 110.598 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 371' ' ' LEU . 51.3 mt -80.27 -14.75 58.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.43 0.692 . . . . 0.0 110.951 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 75.69 9.74 3.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 0.0 112.07 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 11.8 p -91.5 138.42 31.59 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.34 0.656 . . . . 0.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -133.82 156.83 47.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 109.501 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 29.8 m-80 59.01 22.21 10.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.754 0.821 . . . . 0.0 111.634 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.95 -17.29 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.177 0.591 . . . . 0.0 110.255 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.592 HD22 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.05 172.55 17.96 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.982 0.913 . . . . 0.0 109.805 173.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 24.0 p -165.88 134.79 3.17 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.736 0.648 . . . . 0.0 109.882 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.123 0.487 . . . . 0.0 111.668 179.579 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.4 m -73.39 171.98 12.1 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.771 0.428 . . . . 0.0 110.87 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.3 p -133.6 137.99 45.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.169 0.588 . . . . 0.0 110.087 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.3 m -143.15 162.36 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.466 1.106 . . . . 0.0 109.819 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.426 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 46.9 t -135.27 107.94 7.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.56 0.744 . . . . 0.0 109.299 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 42.5 t -96.46 151.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.299 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.17 106.33 8.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.578 1.151 . . . . 0.0 108.669 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.439 HG13 ' CD1' ' A' ' 379' ' ' LEU . 62.1 t -71.7 112.3 6.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.306 0.642 . . . . 0.0 110.31 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 51.5 t30 -93.51 81.22 4.34 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -13.64 62.41 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.312 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -74.29 -23.04 59.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.481 0.713 . . . . 0.0 110.876 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.33 -140.8 2.1 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.094 0.246 . . . . 0.0 112.924 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 59.3 t-20 -74.62 143.55 44.3 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.92 -53.55 3.64 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -155.52 -70.88 0.01 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.447 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.21 5.12 58.47 Favored 'Cis proline' 0 C--N 1.373 1.842 0 CA-C-N 120.382 2.091 . . . . 0.0 114.702 2.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 456' ' ' LEU . 2.3 p80 -76.35 -9.08 58.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 117.914 0.325 . . . . 0.0 111.275 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.481 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 25.4 mt -87.18 123.99 32.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.489 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 9.8 t70 -55.09 122.53 42.86 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 124.502 1.126 . . . . 0.0 110.374 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.536 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 37.1 Cg_endo -60.93 -31.11 91.16 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.015 2.477 . . . . 0.0 113.406 -172.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.95 -46.77 33.28 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.617 0.367 . . . . 0.0 110.489 -176.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . 0.489 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 23.8 mtp180 -65.03 -30.92 71.93 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 110.719 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.7 mm -63.78 -28.78 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.123 0.969 . . . . 0.0 110.988 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.1 mm-40 -85.57 -25.37 26.76 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.492 0.317 . . . . 0.0 110.79 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 78.9 mm-40 -75.39 -31.68 60.54 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.756 0.422 . . . . 0.0 112.134 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.591 HD22 ' SG ' ' A' ' 402' ' ' CYS . 3.2 pp -71.2 155.28 93.26 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.167 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.05 158.09 40.84 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.451 2.101 . . . . 0.0 113.311 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.54 -3.58 25.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.697 1.199 . . . . 0.0 111.855 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 5.4 p80 -159.25 156.77 29.4 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.223 0.609 . . . . 0.0 110.513 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.29 103.76 7.35 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 133.81 176.8 14.55 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.511 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.82 129.86 19.65 Favored 'Cis proline' 0 C--N 1.376 2.009 0 CA-C-N 120.008 1.904 . . . . 0.0 112.645 -4.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -154.24 -161.62 10.58 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.806 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -74.02 130.76 14.71 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.756 2.304 . . . . 0.0 111.176 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.734 HG23 ' HB1' ' A' ' 445' ' ' ALA . 4.2 p -38.01 -48.41 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.661 1.984 . . . . 0.0 113.63 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -72.97 -39.95 65.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.797 1.639 . . . . 0.0 112.134 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.33 -43.18 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.451 0.301 . . . . 0.0 110.718 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.35 -40.18 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.369 0.668 . . . . 0.0 111.892 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -67.95 -40.22 83.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.467 ' N ' HD11 ' A' ' 392' ' ' LEU . 5.5 ptt180 -70.69 -24.81 62.74 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.989 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -65.26 -42.05 93.65 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.816 0.846 . . . . 0.0 110.907 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.81 -50.68 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 400' ' ' VAL . 99.2 t -59.27 -52.72 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.539 -1.209 . . . . 0.0 111.689 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.436 ' HA ' HG21 ' A' ' 423' ' ' ILE . 3.2 pt20 -65.54 -34.33 78.0 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.292 0.637 . . . . 0.0 110.793 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.47 ' HB2' HD23 ' A' ' 379' ' ' LEU . . . -69.12 -36.88 77.96 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 123.856 0.723 . . . . 0.0 110.586 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 89.2 m -68.56 -42.75 77.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.196 0.598 . . . . 0.0 111.462 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 396' ' ' VAL . 21.5 t -70.51 -41.66 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.774 0.43 . . . . 0.0 109.858 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.74 -40.93 96.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.922 0.889 . . . . 0.0 111.024 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.591 ' SG ' HD22 ' A' ' 379' ' ' LEU . 71.5 m -93.1 10.78 30.16 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.469 0.708 . . . . 0.0 111.975 -176.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.585 ' HB1' HG22 ' A' ' 409' ' ' VAL . . . -87.4 143.39 27.26 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.21 131.71 39.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 61.11 57.21 2.55 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 122.134 0.968 . . . . 0.0 109.741 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 32.1 m -50.37 -32.48 17.53 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.956 1.702 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -61.19 -34.65 75.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 112.949 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -81.8 -34.53 30.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.509 0.724 . . . . 0.0 109.953 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.585 HG22 ' HB1' ' A' ' 403' ' ' ALA . 45.7 t -71.4 -26.5 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.33 -23.2 61.89 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.064 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -80.82 -9.16 86.67 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.19 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 409' ' ' VAL . 31.2 m-85 -72.12 -21.89 61.41 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 117.787 0.793 . . . . 0.0 111.138 176.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.08 146.39 45.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.746 0.818 . . . . 0.0 110.624 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -116.75 155.75 48.65 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.071 0.948 . . . . 0.0 110.247 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 55.7 Cg_endo -66.53 131.11 25.27 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.173 1.915 . . . . 0.0 112.065 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -102.57 167.77 9.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.725 1.21 . . . . 0.0 108.965 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -131.95 43.7 3.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.695 0.76 . . . . 0.0 111.96 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -104.8 2.49 30.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.482 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.25 32.01 75.43 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.229 0.331 . . . . 0.0 113.301 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.03 -117.04 1.5 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 113.711 0.244 . . . . 0.0 113.711 -172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 18.7 mm-40 -89.94 170.37 10.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.089 0.556 . . . . 0.0 111.457 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 434' ' ' ILE . 60.3 t -131.51 128.72 61.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 122.749 0.419 . . . . 0.0 109.96 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 433' ' ' SER . 43.4 mm -114.23 128.57 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.9 p -105.57 144.49 32.26 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.024 0.929 . . . . 0.0 109.862 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -157.05 127.67 6.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.05 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 60.4 p -72.49 124.63 25.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.243 0.617 . . . . 0.0 109.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -147.14 115.74 6.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.625 0.77 . . . . 0.0 109.918 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.3 t70 64.46 23.97 13.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.762 1.225 . . . . 0.0 111.504 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.63 -16.03 60.23 Favored Glycine 0 N--CA 1.471 0.97 0 O-C-N 121.89 -0.506 . . . . 0.0 113.138 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -97.88 168.69 10.15 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.592 0.757 . . . . 0.0 109.796 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.2 t -113.22 104.8 12.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -97.79 125.42 42.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.02 0.928 . . . . 0.0 110.378 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.5 p -118.19 138.78 52.08 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.748 0.819 . . . . 0.0 109.784 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 23.8 pt -117.31 171.63 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.024 0.53 . . . . 0.0 109.863 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 27.7 mt-30 -102.62 150.45 23.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 170.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 80.1 mt -115.94 164.41 17.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.229 1.412 . . . . 0.0 108.278 169.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.82 139.03 32.73 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.898 1.732 . . . . 0.0 111.153 168.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.76 127.86 6.49 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.107 1.871 . . . . 0.0 110.994 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.67 164.35 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.09 0.471 . . . . 0.0 109.845 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -151.22 23.31 0.73 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.901 0.88 . . . . 0.0 110.163 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 47.7 t -124.69 137.28 54.36 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.73 65.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.9 t -69.88 -21.27 63.34 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.033 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.4 -29.72 24.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.734 ' HB1' HG23 ' A' ' 388' ' ' VAL . . . -47.42 -67.51 0.27 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.995 0.918 . . . . 0.0 111.895 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 450' ' ' GLU . 0.1 OUTLIER -62.79 -45.06 94.42 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.651 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -59.48 -29.47 67.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.922 0.889 . . . . 0.0 112.399 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -61.84 -60.91 2.94 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.51 0.724 . . . . 0.0 109.609 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.571 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -76.97 -13.91 59.91 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 112.32 -177.008 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 446' ' ' LEU . 38.2 mt-10 -58.16 -41.66 84.29 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.883 0.765 . . . . 0.0 110.921 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -68.61 -44.57 74.0 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.398 0.437 . . . . 0.0 110.584 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.443 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 62.9 t80 -60.85 -52.62 64.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.622 0.769 . . . . 0.0 110.749 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.5 -34.29 76.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.699 1.2 . . . . 0.0 111.583 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -69.32 -32.98 72.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.842 0.457 . . . . 0.0 110.261 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.1 m -72.21 -28.44 63.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.52 0.728 . . . . 0.0 110.409 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.47 ' HB3' ' HE2' ' A' ' 370' ' ' HIS . 22.7 mt -80.9 -12.9 59.33 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.315 0.646 . . . . 0.0 111.292 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 76.27 5.39 3.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 126.562 1.945 . . . . 0.0 111.933 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.459 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.9 p -89.99 140.25 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.818 0.447 . . . . 0.0 110.102 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 23.3 t70 -148.6 151.92 35.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -174.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 9.6 p30 47.62 27.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.788 1.235 . . . . 0.0 112.539 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.41 -10.49 59.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.08 0.952 . . . . 0.0 109.443 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.571 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.85 158.01 35.97 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.629 0.772 . . . . 0.0 109.921 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 25.0 p -145.56 109.81 4.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.287 0.635 . . . . 0.0 109.937 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 16.5 t . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.306 0.643 . . . . 0.0 111.159 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.3 t -79.14 -172.91 3.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.686 0.794 . . . . 0.0 110.613 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.1 p -140.08 135.62 32.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 110.028 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 388' ' ' VAL . 25.8 m -136.7 156.61 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 124.208 1.003 . . . . 0.0 110.88 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.543 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 26.3 p -119.54 107.15 12.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.521 0.728 . . . . 0.0 109.263 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 56.1 t -96.67 150.54 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -129.21 104.33 7.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.434 1.094 . . . . 0.0 108.564 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . 0.423 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 64.8 t -74.28 105.17 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 110.31 -176.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 41.2 t30 -88.31 87.82 7.43 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -17.43 63.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.306 175.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -71.69 -17.99 62.2 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.592 . . . . 0.0 110.547 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -82.14 -167.63 40.12 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.832 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -68.03 129.28 39.45 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.964 0.506 . . . . 0.0 110.479 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.459 ' HB3' HG13 ' A' ' 376' ' ' ILE . 0.9 OUTLIER -75.95 -58.85 3.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.639 -173.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.428 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.42 -91.13 0.08 OUTLIER Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.341 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.5 19.86 33.93 Favored 'Cis proline' 0 C--N 1.37 1.702 0 CA-C-N 120.502 2.151 . . . . 0.0 114.31 11.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -77.15 -6.19 51.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.525 0.33 . . . . 0.0 111.359 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 456' ' ' LEU . 31.1 mt -111.28 142.91 42.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.397 1.079 . . . . 0.0 108.832 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.81 122.32 87.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.069 0.548 . . . . 0.0 110.159 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 26.1 Cg_endo -59.08 -28.21 87.19 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.283 2.655 . . . . 0.0 114.247 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.79 -48.08 23.15 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.384 0.427 . . . . 0.0 109.937 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -67.83 -28.78 67.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.559 0.744 . . . . 0.0 111.661 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 379' ' ' LEU . 12.7 mm -60.35 -29.66 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.933 172.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 57.0 mm-40 -85.15 -25.38 27.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.612 0.365 . . . . 0.0 110.602 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 65.9 mm-40 -82.26 -24.06 34.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.016 0.527 . . . . 0.0 112.116 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.5 HD21 HD12 ' A' ' 376' ' ' ILE . 3.0 pp -74.59 158.71 84.67 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.25 153.39 74.53 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.153 1.902 . . . . 0.0 112.718 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.99 -18.2 65.08 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.114 1.365 . . . . 0.0 112.386 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . 0.423 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.6 p80 -161.97 160.14 27.39 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.197 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.407 ' HD2' HD11 ' A' ' 395' ' ' ILE . 57.3 m-85 -124.76 104.66 8.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 135.09 161.51 9.41 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.631 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -79.15 129.87 19.26 Favored 'Cis proline' 0 C--N 1.373 1.857 0 CA-C-N 120.147 1.973 . . . . 0.0 112.123 4.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.99 -176.04 34.64 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.667 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.4 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 39.3 Cg_endo -66.46 133.91 33.98 Favored 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 112.838 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.732 HG21 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -38.27 -46.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 127.038 2.135 . . . . 0.0 113.621 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -76.81 -37.4 55.81 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.168 0.987 . . . . 0.0 111.684 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.0 t -74.41 -41.23 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.36 -42.28 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.46 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 393' ' ' ARG . 4.4 pp -70.42 -40.1 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.481 ' N ' HD13 ' A' ' 392' ' ' LEU . 16.2 ptm180 -68.52 -31.85 71.39 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 27.7 mmm-85 -72.35 -32.69 66.7 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.469 HG23 ' HG ' ' A' ' 449' ' ' LEU . 18.2 mm -65.4 -53.43 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 400' ' ' VAL . 93.9 t -55.76 -53.84 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 124.34 1.025 . . . . 0.0 110.749 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.36 -37.55 77.66 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . 0.6 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 83.3 m -71.75 -40.42 69.36 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.023 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 396' ' ' VAL . 74.8 t -68.56 -32.99 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.093 0.557 . . . . 0.0 110.42 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.77 -51.01 68.8 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.182 0.593 . . . . 0.0 109.973 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 29.6 p -79.36 -10.57 59.84 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.447 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 409' ' ' VAL . . . -57.62 119.07 5.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.581 1.152 . . . . 0.0 113.459 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.24 116.94 7.1 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.852 167.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 63.58 68.73 0.58 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.026 0.917 . . . . 0.0 108.7 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.9 m -54.73 -40.93 69.78 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.466 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -50.86 -40.12 55.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.778 1.231 . . . . 0.0 113.878 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -84.98 -35.17 22.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.379 0.672 . . . . 0.0 110.207 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 403' ' ' ALA . 55.5 t -66.15 -33.61 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.52 0.728 . . . . 0.0 111.063 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.45 -11.37 59.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.988 0.915 . . . . 0.0 110.083 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.75 -9.75 84.93 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.268 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.65 0.73 55.27 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.613 0.765 . . . . 0.0 111.597 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -142.7 133.74 25.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.274 0.63 . . . . 0.0 110.482 176.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -114.2 159.43 36.47 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 124.025 0.93 . . . . 0.0 109.764 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.45 143.07 30.55 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.029 1.819 . . . . 0.0 111.022 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -139.25 132.87 30.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -87.89 25.7 1.49 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -164.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -9.07 58.3 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.363 0.665 . . . . 0.0 110.871 171.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 67.28 31.91 78.43 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.556 0.535 . . . . 0.0 114.006 172.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.11 -121.07 1.2 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 123.598 0.234 . . . . 0.0 112.936 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.519 ' HB2' HD13 ' A' ' 436' ' ' LEU . 3.8 mp0 -82.26 172.71 12.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.842 0.857 . . . . 0.0 110.603 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 94.3 t -134.11 131.65 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.419 0.688 . . . . 0.0 109.837 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 433' ' ' SER . 46.5 mm -104.37 127.64 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 0.0 109.358 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.7 p -106.72 148.29 28.59 Favored 'General case' 0 C--O 1.241 0.635 0 O-C-N 123.906 0.754 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.01 170.97 20.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.849 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 52.3 m -103.2 115.87 31.39 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -142.87 125.46 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.359 0.663 . . . . 0.0 109.927 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 37.9 t70 67.08 16.45 10.29 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.916 1.286 . . . . 0.0 111.641 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 96.78 -15.41 62.72 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.95 -0.469 . . . . 0.0 112.937 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.77 171.21 8.92 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.174 0.99 . . . . 0.0 110.12 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.0 t -97.04 102.81 14.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -91.11 133.89 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 36.5 p -132.64 126.98 33.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 109.352 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 413' ' ' LEU . 2.2 pp -117.07 163.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.838 0.855 . . . . 0.0 109.525 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.75 150.81 22.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.516 0.674 . . . . 0.0 111.206 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 421' ' ' GLU . 81.7 mt -114.59 160.75 31.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.296 1.438 . . . . 0.0 109.013 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.46 136.44 19.49 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 121.84 1.693 . . . . 0.0 111.519 164.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.81 144.53 31.09 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.92 2.414 . . . . 0.0 112.055 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.7 172.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.036 0.534 . . . . 0.0 110.846 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -154.91 4.19 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.367 0.667 . . . . 0.0 112.114 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.1 t -122.6 141.56 51.58 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.041 0.536 . . . . 0.0 110.212 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.77 -36.19 70.3 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.292 1.037 . . . . 0.0 112.499 -170.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 39.8 m -66.54 -22.15 66.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.313 0.645 . . . . 0.0 111.075 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 3.6 t80 -86.84 -22.52 25.76 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.725 0.41 . . . . 0.0 109.973 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 388' ' ' VAL . . . -51.39 -66.24 0.42 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -29.38 68.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.587 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 444' ' ' PHE . 0.5 OUTLIER -65.3 -33.12 75.22 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.813 0.445 . . . . 0.0 110.864 176.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.66 -45.52 82.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.066 0.546 . . . . 0.0 110.749 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.469 ' HG ' HG23 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.35 -13.86 42.33 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.555 -179.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.6 -50.48 73.0 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.868 0.867 . . . . 0.0 111.375 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -67.41 -29.65 69.2 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.989 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.442 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 54.9 t80 -73.29 -42.63 62.19 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.216 0.606 . . . . 0.0 110.985 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.01 -26.83 66.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.918 0.887 . . . . 0.0 110.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -67.62 -38.8 84.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.19 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 18.7 m -67.51 -30.68 70.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.924 0.89 . . . . 0.0 111.132 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 371' ' ' LEU . 33.3 mt -82.28 -17.43 45.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 0.0 111.425 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 71.41 7.83 6.14 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.987 1.715 . . . . 0.0 111.758 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.408 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 24.7 p -75.82 135.77 40.22 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.103 0.478 . . . . 0.0 110.359 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.37 141.37 51.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.642 0.777 . . . . 0.0 110.605 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 8.0 p30 46.35 25.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.163 1.785 . . . . 0.0 113.286 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 52.9 tp -76.82 -15.61 59.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.339 1.055 . . . . 0.0 111.279 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -158.98 159.28 34.66 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.016 0.526 . . . . 0.0 110.184 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 61.7 p -160.63 129.71 4.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.247 0.619 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 21.6 t . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 123.243 0.617 . . . . 0.0 111.462 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.681 0.277 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -79.36 -179.04 6.56 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.162 0.585 . . . . 0.0 110.171 175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.1 p -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 0.0 110.972 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 388' ' ' VAL . 3.1 m -137.76 157.47 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.567 1.147 . . . . 0.0 109.525 173.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 7.7 p -137.57 101.59 4.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.566 HG21 HD13 ' A' ' 395' ' ' ILE . 29.0 m -94.34 151.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.23 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 53.6 m-85 -110.05 100.49 9.42 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 23.2 t -70.65 88.38 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.8 0.688 . . . . 0.0 109.735 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -85.04 88.23 7.44 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.865 -174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.608 ' HZ1' HD12 ' A' ' 379' ' ' LEU . 0.0 OUTLIER -70.62 -12.45 61.57 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.731 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -76.26 -28.56 57.13 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.745 0.818 . . . . 0.0 111.134 173.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -61.22 -76.23 0.25 Allowed Glycine 0 C--N 1.353 1.523 0 O-C-N 123.429 0.456 . . . . 0.0 112.838 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.4 t30 -152.92 143.2 22.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.472 ' HA ' HG22 ' A' ' 376' ' ' ILE . 1.0 OUTLIER -86.06 -62.64 1.47 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -146.19 -94.81 0.17 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.271 0.982 . . . . 0.0 112.763 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -90.13 15.89 46.11 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.326 2.063 . . . . 0.0 113.804 10.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -82.69 -2.26 53.63 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 110.063 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.6 mt -109.83 142.91 40.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.126 1.37 . . . . 0.0 108.034 172.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.408 ' OD1' ' HE3' ' A' ' 374' ' ' LYS . 16.2 t70 -70.27 120.16 76.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.161 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.409 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 31.8 Cg_endo -60.71 -28.38 86.42 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.205 2.603 . . . . 0.0 114.192 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.06 -47.9 26.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.808 0.443 . . . . 0.0 110.706 -178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -67.49 -29.99 69.56 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.632 0.582 . . . . 0.0 111.146 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . 0.518 HD12 HD23 ' A' ' 379' ' ' LEU . 22.4 mm -62.01 -31.79 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.92 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.31 -24.68 42.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.211 0.604 . . . . 0.0 111.159 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.8 mm-40 -81.9 -34.76 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.033 0.533 . . . . 0.0 112.258 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.608 HD12 ' HZ1' ' A' ' 363' ' ' LYS . 2.4 pp -70.24 153.99 94.84 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.543 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -41.69 152.94 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 124.519 3.479 . . . . 0.0 116.052 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -86.41 -11.15 52.74 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.817 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -160.86 144.97 13.65 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.43 1.092 . . . . 0.0 110.013 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -120.61 128.9 53.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.98 179.57 33.0 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.958 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.79 137.42 46.15 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 120.341 2.07 . . . . 0.0 113.437 2.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 175.92 -166.05 37.03 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.768 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . 0.433 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 17.9 Cg_endo -59.27 129.58 32.14 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.379 2.72 . . . . 0.0 113.369 -169.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.73 HG21 ' HB1' ' A' ' 445' ' ' ALA . 4.7 p -47.24 -44.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.796 1.638 . . . . 0.0 111.81 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.99 -45.3 93.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.081 1.352 . . . . 0.0 111.465 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.433 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 97.7 t -74.08 -51.72 22.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.74 -40.03 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.507 HD11 ' HD2' ' A' ' 448' ' ' PHE . 3.7 pp -68.14 -42.55 79.95 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.485 ' N ' HD12 ' A' ' 392' ' ' LEU . 14.0 ptt180 -74.91 -25.5 58.97 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -66.97 -34.37 77.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.911 0.884 . . . . 0.0 110.494 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.566 HD13 HG21 ' A' ' 359' ' ' VAL . 42.8 mm -64.58 -56.65 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.525 ' O ' HG21 ' A' ' 400' ' ' VAL . 58.5 t -60.81 -47.57 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 124.875 1.36 . . . . 0.0 111.817 -171.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . 0.492 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.3 pt20 -71.12 -34.98 71.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.826 0.45 . . . . 0.0 111.548 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.71 77.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.758 0.423 . . . . 0.0 109.925 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 371' ' ' LEU . 48.4 t -71.71 -43.29 66.18 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.161 0.984 . . . . 0.0 111.586 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 406' ' ' THR . 11.1 t -66.81 -45.87 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.93 -37.91 87.28 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.4 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 379' ' ' LEU . 93.1 m -83.24 -10.24 58.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.005 0.522 . . . . 0.0 111.773 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -68.61 141.88 55.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.2 122.6 23.04 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.801 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . 0.402 ' O ' HG21 ' A' ' 409' ' ' VAL . 41.3 tt0 65.34 59.85 0.79 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 400' ' ' VAL . 98.0 m -53.88 -31.06 48.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.899 1.68 . . . . 0.0 112.636 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -58.31 -39.83 80.43 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.676 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 64.9 m -82.13 -28.91 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.238 0.615 . . . . 0.0 110.431 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.482 HG23 ' HB1' ' A' ' 403' ' ' ALA . 60.0 t -72.03 -31.47 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.089 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -64.23 -21.87 66.74 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.636 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -69.45 -27.13 73.86 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.947 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . 0.424 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 89.3 m-85 -75.7 -4.81 42.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.036 0.534 . . . . 0.0 112.313 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.05 136.42 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.189 0.595 . . . . 0.0 111.247 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -119.83 151.03 51.77 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.268 1.027 . . . . 0.0 111.013 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.69 156.57 63.16 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.651 2.234 . . . . 0.0 114.199 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.25 154.03 39.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.085 1.754 . . . . 0.0 109.119 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.12 30.52 4.78 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.199 0.523 . . . . 0.0 111.241 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -28.48 14.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 0.0 110.469 167.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.98 44.0 1.98 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.663 -0.244 . . . . 0.0 112.955 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.25 -132.22 5.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.7 OUTLIER -66.84 168.61 9.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.514 1.126 . . . . 0.0 111.454 -178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.4 t -136.15 130.1 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.493 HG12 HD11 ' A' ' 436' ' ' LEU . 29.1 mm -114.9 134.03 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.251 0.62 . . . . 0.0 109.368 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 22.4 p -105.96 139.93 39.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.75 0.82 . . . . 0.0 109.602 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.69 125.56 5.91 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.918 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.6 m -82.66 108.66 16.2 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 122.982 0.513 . . . . 0.0 110.752 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . 0.586 ' HB3' ' HD1' ' A' ' 432' ' ' HIS . 62.6 t80 -131.92 143.0 49.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.209 1.004 . . . . 0.0 109.078 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 66.06 16.56 10.5 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.711 1.204 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.44 0.15 86.28 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.94 -172.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -107.92 159.04 16.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.197 0.999 . . . . 0.0 109.669 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.3 t -91.84 122.92 34.82 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . 0.586 ' HD1' ' HB3' ' A' ' 427' ' ' PHE . 32.9 m170 -122.84 152.2 40.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.731 0.812 . . . . 0.0 109.72 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 62.2 p -143.69 144.4 31.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.015 0.526 . . . . 0.0 110.725 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.1 pt -125.86 -177.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.285 1.034 . . . . 0.0 109.059 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 26.4 mt-30 -115.27 148.49 39.11 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.103 0.561 . . . . 0.0 110.425 171.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 10.5 mp -116.56 147.48 39.83 Favored Pre-proline 0 N--CA 1.485 1.296 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.79 132.7 43.88 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.501 2.134 . . . . 0.0 112.61 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.77 129.8 20.57 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.805 2.337 . . . . 0.0 114.027 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.8 m -92.08 175.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.556 1.143 . . . . 0.0 110.602 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -155.12 11.04 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.8 t -126.9 141.35 51.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.23 0.468 . . . . 0.0 110.503 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.72 64.5 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.939 0.896 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.8 m -74.74 -28.16 60.66 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.263 0.625 . . . . 0.0 110.427 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -84.24 -21.56 31.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.73 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -51.18 -63.18 1.21 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 124.428 1.091 . . . . 0.0 111.048 174.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.08 -41.08 71.12 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.272 -167.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . 0.437 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 36.0 ttm180 -61.19 -33.82 74.07 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 124.68 1.237 . . . . 0.0 111.735 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . 0.507 ' HD2' HD11 ' A' ' 392' ' ' LEU . 4.3 t80 -68.74 -37.71 79.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 -173.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.696 HD21 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.39 -16.27 33.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.817 171.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 0.9 OUTLIER -64.4 -40.07 95.08 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.706 0.403 . . . . 0.0 110.522 -173.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.29 -45.95 90.97 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.556 0.742 . . . . 0.0 110.604 175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.35 -53.51 47.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.751 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 82.6 m -63.35 -29.78 71.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.555 1.142 . . . . 0.0 111.823 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -69.72 -33.61 72.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.042 0.537 . . . . 0.0 110.797 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 42.7 m -71.0 -24.05 62.3 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.084 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.486 HD13 HD22 ' A' ' 371' ' ' LEU . 35.0 mt -100.18 -1.21 37.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.785 0.834 . . . . 0.0 111.048 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 71.71 7.33 5.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.115 1.766 . . . . 0.0 112.585 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.551 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 9.5 p -83.08 133.03 35.08 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 31.8 t70 -151.1 151.7 32.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.935 0.494 . . . . 0.0 109.779 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 59.59 14.97 4.27 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.585 0.754 . . . . 0.0 111.272 -170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.48 -18.26 45.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.616 0.767 . . . . 0.0 111.013 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.696 HD23 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -164.21 151.71 12.11 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.639 0.775 . . . . 0.0 109.751 174.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 68.0 m -158.07 133.67 8.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 108.433 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 12.8 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.468 0.651 . . . . 0.0 112.066 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.0 m -80.31 176.27 9.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.79 0.436 . . . . 0.0 110.232 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 76.2 p -133.9 138.63 45.66 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.617 0.767 . . . . 0.0 109.293 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 388' ' ' VAL . 22.1 m -139.07 163.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.527 0.731 . . . . 0.0 110.788 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 26.6 p -136.81 127.42 27.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.477 1.111 . . . . 0.0 108.068 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.519 HG23 HD11 ' A' ' 395' ' ' ILE . 28.9 m -112.91 161.71 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.104 0.561 . . . . 0.0 110.656 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -120.14 102.78 8.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.14 103.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.733 0.813 . . . . 0.0 110.899 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 53.7 t30 -96.16 85.54 4.03 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.881 0.848 . . . . 0.0 109.267 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . 0.419 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.69 -23.97 65.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.473 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -73.45 -17.99 61.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.785 0.834 . . . . 0.0 111.471 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -67.8 -89.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.517 0 C-N-CA 123.101 0.381 . . . . 0.0 112.867 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 49.6 t-20 -141.72 148.31 38.82 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . 0.41 ' O ' HD11 ' A' ' 371' ' ' LEU . 0.5 OUTLIER -90.48 -64.64 1.1 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.265 1.026 . . . . 0.0 108.264 -173.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.508 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.22 -94.91 0.18 Allowed Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.358 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -88.52 18.04 38.01 Favored 'Cis proline' 0 C--N 1.373 1.866 0 CA-C-N 120.374 2.087 . . . . 0.0 114.293 9.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . 0.418 ' HB3' HG22 ' A' ' 409' ' ' VAL . 76.8 m-70 -72.3 -18.42 61.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.201 0.6 . . . . 0.0 110.733 168.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.3 mt -104.74 140.01 38.7 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.939 1.295 . . . . 0.0 108.962 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.62 122.47 86.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.46 0.475 . . . . 0.0 110.385 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.3 Cg_endo -56.89 -34.0 96.12 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.659 2.906 . . . . 0.0 114.58 -173.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.44 -45.0 49.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.808 0.443 . . . . 0.0 110.702 -176.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.95 -29.78 68.92 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.706 0.629 . . . . 0.0 111.205 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.85 -30.67 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.977 0.911 . . . . 0.0 111.245 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 75.5 mm-40 -79.95 -17.48 52.89 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 122.093 -0.379 . . . . 0.0 110.8 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.5 mm-40 -86.97 -5.8 58.97 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.757 0.423 . . . . 0.0 111.094 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 167.67 11.44 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.156 0.582 . . . . 0.0 111.542 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 158.22 58.05 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 121.761 1.64 . . . . 0.0 111.383 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.0 -18.08 59.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.545 0.738 . . . . 0.0 111.673 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -163.84 160.81 22.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 111.193 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -126.36 157.79 37.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.69 1.196 . . . . 0.0 108.878 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 81.95 -177.19 53.9 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.51 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 128.99 17.56 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.591 1.695 . . . . 0.0 112.302 -1.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.25 -172.91 30.28 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.42 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.36 129.95 35.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.219 2.613 . . . . 0.0 112.574 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 445' ' ' ALA . 4.6 p -42.48 -46.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.656 1.983 . . . . 0.0 112.891 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.76 -36.95 81.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.908 1.283 . . . . 0.0 112.379 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 69.0 t -79.01 -47.19 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.195 -0.316 . . . . 0.0 110.646 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.46 -31.68 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 122.656 0.382 . . . . 0.0 111.715 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 393' ' ' ARG . 4.0 pp -74.17 -41.13 61.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.111 0.164 . . . . 0.0 110.766 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.445 ' N ' HD13 ' A' ' 392' ' ' LEU . 6.2 ptt180 -69.49 -26.55 64.61 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -66.17 -31.78 72.83 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.806 0.842 . . . . 0.0 111.282 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 359' ' ' VAL . 32.1 mm -74.71 -49.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 400' ' ' VAL . 94.5 t -59.62 -48.87 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 124.148 0.905 . . . . 0.0 111.424 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.8 -27.8 63.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.505 0.322 . . . . 0.0 111.29 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.85 90.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.82 -60.7 2.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 110.806 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 396' ' ' VAL . 43.1 t -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.039 0.936 . . . . 0.0 111.797 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.28 -46.67 66.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.723 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 71.9 m -80.08 3.22 21.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.137 0.575 . . . . 0.0 112.219 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -72.58 137.9 46.48 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.854 0.861 . . . . 0.0 112.411 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 404' ' ' LEU . 2.5 pp -84.86 132.57 34.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 57.82 61.72 2.31 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.371 1.082 . . . . 0.0 109.618 -172.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.1 m -57.27 -26.98 61.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.489 1.515 . . . . 0.0 112.614 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -60.46 -31.44 70.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.99 0.916 . . . . 0.0 112.438 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -75.41 -44.9 42.15 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.853 0.861 . . . . 0.0 109.576 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 403' ' ' ALA . 97.9 t -68.78 -27.66 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-N 114.194 -1.367 . . . . 0.0 111.338 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.51 -30.05 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.361 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.11 -16.26 40.18 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -85.02 -17.35 37.8 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.393 0.677 . . . . 0.0 111.866 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.04 135.52 31.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.277 0.56 . . . . 0.0 112.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -113.4 168.68 7.42 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.609 0.764 . . . . 0.0 109.176 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 58.3 Cg_endo -69.0 136.65 35.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 121.785 1.657 . . . . 0.0 112.742 171.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -141.7 99.51 3.56 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.012 1.725 . . . . 0.0 107.446 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -85.09 72.44 10.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.539 1.161 . . . . 0.0 108.814 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -97.39 -2.84 41.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.754 -1.567 . . . . 0.0 109.869 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 79.2 27.62 55.28 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -103.99 -120.79 4.82 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.507 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 14.6 mm-40 -84.88 178.91 7.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.116 0.567 . . . . 0.0 111.507 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.91 126.1 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 122.868 0.467 . . . . 0.0 110.426 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.24 143.05 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.423 1.089 . . . . 0.0 108.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 2.9 p -107.06 142.07 37.28 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.209 0.603 . . . . 0.0 109.824 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -132.16 115.95 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.279 1.031 . . . . 0.0 109.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 102.17 4.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.039 0.536 . . . . 0.0 110.275 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -123.34 120.62 33.58 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.289 1.036 . . . . 0.0 109.193 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.9 t70 57.23 50.13 12.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.212 1.405 . . . . 0.0 112.198 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 79.66 -3.91 66.93 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.372 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -118.56 171.71 7.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.085 0.954 . . . . 0.0 108.832 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.3 t -127.73 111.43 13.67 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.586 0.708 . . . . 0.0 109.955 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -94.57 127.0 40.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.573 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.0 p -95.35 138.78 32.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.071 0.949 . . . . 0.0 109.775 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 25.9 pt -125.73 171.28 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.778 1.231 . . . . 0.0 109.263 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -115.38 143.77 44.78 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.235 0.541 . . . . 0.0 110.6 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 8.0 mp -113.88 155.8 44.72 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.072 1.349 . . . . 0.0 108.16 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.52 143.92 64.83 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.189 1.926 . . . . 0.0 111.762 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.34 155.22 25.04 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.295 1.997 . . . . 0.0 111.796 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.89 169.35 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 122.862 0.465 . . . . 0.0 109.864 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -147.47 8.36 0.9 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.108 0.563 . . . . 0.0 111.869 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.3 t -115.9 138.67 50.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.631 0.372 . . . . 0.0 110.131 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -73.16 -26.54 61.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.031 0.932 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 31.4 m -72.03 -29.4 64.13 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.535 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.94 -21.09 29.75 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.724 ' HB3' HG23 ' A' ' 388' ' ' VAL . . . -47.43 -63.29 1.09 Allowed 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.098 0.873 . . . . 0.0 110.153 171.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 16.9 mt -65.1 -50.12 67.33 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 113.175 -1.829 . . . . 0.0 109.319 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -32.74 57.78 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 125.146 1.529 . . . . 0.0 112.706 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . 0.423 ' HE1' HD23 ' A' ' 436' ' ' LEU . 4.4 t80 -65.12 -49.19 70.9 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.651 0.381 . . . . 0.0 110.564 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.11 -15.83 35.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 0.8 OUTLIER -65.15 -46.64 80.05 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 109.699 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -37.84 85.14 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.033 0.833 . . . . 0.0 110.06 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -65.5 -50.66 64.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.57 0.748 . . . . 0.0 111.217 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.28 -28.54 67.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.089 0.956 . . . . 0.0 110.823 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.63 -34.16 75.26 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.993 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.9 m -75.05 -25.08 58.39 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.682 0.793 . . . . 0.0 110.962 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 371' ' ' LEU . 67.3 mt -82.91 -12.0 57.72 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.013 0.525 . . . . 0.0 110.977 173.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 74.67 8.14 4.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.782 1.633 . . . . 0.0 111.562 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 11.2 p -86.9 134.3 33.53 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . 0.436 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.7 t70 -146.36 157.08 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.036 . . . . 0.0 108.379 -173.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 15.4 m-80 63.2 15.92 8.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.24 1.016 . . . . 0.0 111.109 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -83.34 -18.58 38.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.725 0.81 . . . . 0.0 111.366 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.78 166.15 26.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.365 0.666 . . . . 0.0 110.662 175.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 47.8 t -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.021 0.928 . . . . 0.0 108.769 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.453 ' HB2' HD23 ' A' ' 446' ' ' LEU . 39.9 t . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.425 0.69 . . . . 0.0 111.592 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 C--O 1.243 0.712 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 20.8 t -79.97 178.66 8.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.165 0.586 . . . . 0.0 110.241 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.0 p -131.9 134.17 45.39 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.772 0.829 . . . . 0.0 109.541 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.05 171.23 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.598 1.159 . . . . 0.0 109.565 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.503 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 52.6 t -146.85 105.97 3.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.659 0.784 . . . . 0.0 109.152 178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' VAL . . . . . 0.553 HG23 HD13 ' A' ' 395' ' ' ILE . 34.3 m -91.99 153.61 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.87 99.78 6.56 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 45.2 t -63.96 98.85 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.537 1.148 . . . . 0.0 109.86 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -91.87 89.24 6.95 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.753 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -9.26 58.47 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.166 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -74.25 -20.01 60.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.231 0.613 . . . . 0.0 109.804 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.29 -169.66 37.93 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.752 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -69.57 141.1 53.84 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.583 0.691 . . . . 0.0 110.497 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.58 -56.48 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.57 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.1 -83.84 0.06 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.494 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.17 1.42 23.95 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 120.53 2.165 . . . . 0.0 114.381 -0.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' HIS . . . . . 0.525 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 16.3 p-80 -65.66 -16.11 63.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.966 0.906 . . . . 0.0 112.228 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 42.2 mt -95.46 136.55 35.69 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.855 0.862 . . . . 0.0 108.923 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.09 113.23 8.68 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 124.33 1.019 . . . . 0.0 110.119 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.409 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 34.7 Cg_endo -62.17 -16.89 53.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.182 2.588 . . . . 0.0 114.243 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -82.25 -49.18 10.37 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -62.48 -35.64 79.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.435 1.094 . . . . 0.0 111.95 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.55 -30.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.711 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 84.4 mm-40 -85.39 -19.27 31.64 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.977 -0.452 . . . . 0.0 111.236 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 66.8 mm-40 -81.64 -35.85 29.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.732 0.413 . . . . 0.0 111.277 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.417 HD21 ' HB1' ' A' ' 398' ' ' ALA . 3.1 pp -68.17 157.14 88.25 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.89 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.63 161.73 23.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.928 2.419 . . . . 0.0 114.078 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.8 -17.15 59.96 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.159 -173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -162.49 160.55 26.3 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.09 102.95 6.47 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 140.56 169.37 11.7 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.848 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.46 129.78 19.61 Favored 'Cis proline' 0 C--N 1.381 2.241 0 CA-C-N 119.512 1.656 . . . . 0.0 112.636 0.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.04 -165.55 15.71 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.306 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.28 141.65 16.29 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.834 2.356 . . . . 0.0 112.314 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.636 HG22 ' HB1' ' A' ' 445' ' ' ALA . 7.5 p -46.55 -45.05 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.993 1.717 . . . . 0.0 113.329 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -75.74 -35.29 60.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.098 0.959 . . . . 0.0 111.888 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 80.1 t -76.92 -46.15 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.44 -38.69 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.19 0.596 . . . . 0.0 112.116 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.3 -41.22 70.2 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 122.945 0.153 . . . . 0.0 111.204 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 12.0 ptp180 -67.57 -33.84 75.84 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 46.4 mmm-85 -63.07 -34.91 78.6 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.745 0.653 . . . . 0.0 111.711 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.553 HD13 HG23 ' A' ' 359' ' ' VAL . 36.4 mm -68.09 -52.54 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 123.628 0.58 . . . . 0.0 109.797 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.19 -43.48 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.775 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.39 -21.97 59.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.84 0.456 . . . . 0.0 111.457 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.417 ' HB1' HD21 ' A' ' 379' ' ' LEU . . . -83.7 -16.73 43.86 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.359 0.664 . . . . 0.0 110.771 173.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.5 m -81.52 -61.88 1.81 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 122.876 0.471 . . . . 0.0 109.949 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.67 -50.65 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 0.0 111.071 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.22 -37.8 88.41 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.64 19.74 9.5 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.39 0.676 . . . . 0.0 111.522 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -85.13 150.65 24.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.334 0.654 . . . . 0.0 112.435 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 76.1 mt -66.45 114.12 5.21 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 162.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 61.96 73.43 0.47 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.284 0.99 . . . . 0.0 109.914 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.4 m -55.2 -41.18 71.66 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -54.59 -38.49 66.79 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 65.3 m -77.5 -38.57 48.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' VAL . . . . . 0.5 HG21 ' HB1' ' A' ' 403' ' ' ALA . 84.2 t -67.55 -26.65 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.367 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -75.03 -18.87 60.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.039 1.336 . . . . 0.0 110.147 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.08 -14.98 70.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 114.157 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -69.2 -37.46 78.1 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 117.871 0.836 . . . . 0.0 111.1 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.58 152.21 25.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.252 0.621 . . . . 0.0 109.818 175.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -117.19 157.54 46.68 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.844 0.858 . . . . 0.0 110.119 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 60.2 Cg_endo -71.07 124.51 10.6 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 121.722 1.614 . . . . 0.0 111.54 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -113.9 123.06 48.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.884 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -88.17 55.22 3.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.021 0.929 . . . . 0.0 110.007 -167.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -97.08 -32.24 12.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.09 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.22 33.09 8.32 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.127 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.78 -112.56 2.71 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.635 0.217 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.5 mp0 -79.08 165.26 23.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.854 0.862 . . . . 0.0 110.312 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.29 126.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.589 0.756 . . . . 0.0 109.155 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ILE . . . . . 0.443 HG12 HD12 ' A' ' 436' ' ' LEU . 28.3 mm -106.26 122.96 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.238 0.615 . . . . 0.0 109.513 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.3 p -105.51 141.25 37.31 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.662 0.785 . . . . 0.0 109.816 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.56 130.82 6.04 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.497 -172.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 21.0 p -74.95 104.44 5.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.447 0.699 . . . . 0.0 109.882 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -114.61 107.34 15.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 0.0 109.359 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 36.1 t70 56.97 53.92 7.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.762 1.225 . . . . 0.0 111.502 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 86.18 -25.38 7.02 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.625 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.14 171.54 8.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.953 0.901 . . . . 0.0 109.569 -174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.1 t -115.63 104.17 11.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -110.73 160.54 16.62 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.862 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.6 p -148.76 153.62 38.42 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.819 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 18.7 pt -123.08 166.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.624 0.77 . . . . 0.0 109.987 176.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.86 149.08 26.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.399 0.68 . . . . 0.0 109.813 172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.7 mp -115.86 159.48 38.9 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.941 1.296 . . . . 0.0 109.545 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.17 130.87 18.27 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.324 2.016 . . . . 0.0 111.765 164.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.07 151.83 56.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.909 2.406 . . . . 0.0 112.508 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.38 167.97 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.451 0.701 . . . . 0.0 110.733 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.78 2.68 0.94 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.987 0.515 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.4 m -119.15 140.08 50.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.958 0.503 . . . . 0.0 110.102 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.06 90.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.074 0.949 . . . . 0.0 112.373 -169.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.1 m -59.43 -28.51 67.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.608 0.763 . . . . 0.0 111.328 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -21.51 42.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.867 0.467 . . . . 0.0 110.147 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.636 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -55.26 -66.02 0.48 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 446' ' ' LEU . 0.2 OUTLIER -63.75 -43.87 95.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.797 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -33.58 70.28 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.531 0.732 . . . . 0.0 112.189 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.18 -51.55 67.36 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.55 0.531 . . . . 0.0 110.307 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' LEU . . . . . 0.738 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -86.64 -15.3 40.14 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.667 -178.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 454' ' ' HIS . 1.7 tm-20 -61.77 -53.26 58.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.819 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -62.95 -40.91 99.1 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.975 0.797 . . . . 0.0 110.84 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.474 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 61.6 t80 -56.09 -64.31 0.9 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.558 1.143 . . . . 0.0 110.637 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' CYS . . . . . 0.507 ' HB3' ' HG ' ' A' ' 458' ' ' CYS . 81.9 m -64.94 -27.17 68.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.728 1.211 . . . . 0.0 112.582 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 450' ' ' GLU . 51.2 t-80 -69.1 -41.63 77.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.644 0.777 . . . . 0.0 109.997 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.0 t -73.72 -7.95 54.09 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.416 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 92.0 mt -103.32 -6.41 22.02 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.71 0.804 . . . . 0.0 112.324 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 80.46 5.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.268 1.827 . . . . 0.0 112.682 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' CYS . . . . . 0.507 ' HG ' ' HB3' ' A' ' 453' ' ' CYS . 16.3 p -90.38 132.37 35.64 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -156.86 148.26 22.28 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 66.29 13.74 9.33 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.568 1.147 . . . . 0.0 110.736 -168.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.83 -20.31 35.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.129 0.571 . . . . 0.0 111.543 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' LEU . . . . . 0.738 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.91 166.22 30.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.781 0.432 . . . . 0.0 110.506 175.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 37.2 p -162.79 121.69 2.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.704 0.802 . . . . 0.0 109.47 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 22.3 t . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 123.408 0.683 . . . . 0.0 111.816 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 p -146.16 136.1 23.48 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.999 0.92 . . . . 0.0 109.331 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -77.81 171.69 14.58 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.382 0.611 . . . . 0.0 110.71 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -75.23 -175.93 2.88 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.662 175.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 164.72 4.24 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.283 1.033 . . . . 0.0 111.964 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 -173.4 2.03 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.413 0.685 . . . . 0.0 111.337 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 23.8 p -140.65 144.45 35.72 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.031 0.932 . . . . 0.0 110.569 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 19.3 m -145.03 174.22 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 125.257 1.423 . . . . 0.0 110.339 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 466' ' ' PRO . 29.0 p -147.21 109.11 4.41 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.488 0.715 . . . . 0.0 109.82 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.538 HG11 ' HG ' ' A' ' 464' ' ' SER . 33.8 m -98.21 149.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.192 0.597 . . . . 0.0 109.581 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.488 ' CE1' ' HA ' ' A' ' 466' ' ' PRO . 9.1 m-85 -112.9 98.82 7.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 379' ' ' LEU . 66.5 t -65.39 103.3 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 124.244 0.965 . . . . 0.0 110.706 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -98.63 99.87 11.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.669 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.87 54.64 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.974 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -81.58 -21.83 38.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.392 0.677 . . . . 0.0 111.067 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.79 0.03 OUTLIER Glycine 0 C--N 1.353 1.516 0 O-C-N 123.35 0.406 . . . . 0.0 113.101 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 55.9 t-20 -131.91 150.75 52.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -91.38 -63.31 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -143.6 -93.49 0.18 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.317 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.06 18.98 31.82 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 120.469 2.135 . . . . 0.0 114.319 9.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.24 0.85 52.81 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.686 0.794 . . . . 0.0 110.783 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.484 HD21 HD11 ' A' ' 456' ' ' LEU . 48.7 mt -116.21 145.93 42.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.65 1.18 . . . . 0.0 109.011 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.96 118.21 63.37 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 123.586 0.554 . . . . 0.0 109.675 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.51 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 36.1 Cg_endo -61.39 -29.82 86.16 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.779 2.319 . . . . 0.0 113.248 -173.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -72.78 -43.43 62.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.554 . . . . 0.0 110.581 -178.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -69.9 -30.27 67.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.153 0.581 . . . . 0.0 111.05 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.86 -31.11 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.492 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 77.7 mm-40 -82.81 -19.36 37.81 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 122.376 0.27 . . . . 0.0 111.324 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 83.3 mm-40 -80.1 -41.54 25.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.015 0.526 . . . . 0.0 112.061 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.49 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . 2.7 pp -65.18 163.94 27.2 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 123.828 0.851 . . . . 0.0 111.293 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 379' ' ' LEU . 74.0 Cg_endo -68.51 169.75 16.53 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 122.381 2.054 . . . . 0.0 114.565 -169.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.2 -20.91 54.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.832 1.253 . . . . 0.0 112.031 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.469 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 29.6 p80 -161.0 159.16 29.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.062 0.458 . . . . 0.0 111.224 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -125.11 102.04 7.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 141.14 167.51 11.13 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.454 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.65 129.89 19.63 Favored 'Cis proline' 0 C--N 1.381 2.249 0 CA-C-N 118.902 1.351 . . . . 0.0 112.498 -1.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.73 -178.83 37.67 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.192 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.531 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 42.3 Cg_endo -64.27 134.72 43.4 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.053 2.502 . . . . 0.0 114.434 -171.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -38.55 -48.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.337 2.255 . . . . 0.0 113.782 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -76.09 -33.7 59.51 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.63 1.172 . . . . 0.0 112.158 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 94.2 t -81.87 -35.39 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.513 0.325 . . . . 0.0 110.601 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.64 -42.67 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 122.174 0.19 . . . . 0.0 110.803 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 445' ' ' ALA . 4.3 pp -67.0 -43.91 81.71 Favored 'General case' 0 C--N 1.359 0.988 0 O-C-N 123.189 0.306 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.504 ' O ' ' HG2' ' A' ' 397' ' ' GLN . 12.9 ptm180 -68.54 -33.9 74.92 Favored 'General case' 0 C--N 1.363 1.17 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -75.58 -20.18 58.78 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 359' ' ' VAL . 32.4 mm -75.21 -52.58 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 167.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.6 t -58.5 -57.08 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.949 -172.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.4 pt20 -70.47 -23.83 62.76 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.797 0.439 . . . . 0.0 112.062 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.54 92.57 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 75.0 m -66.88 -47.66 71.16 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.946 0.779 . . . . 0.0 111.026 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 396' ' ' VAL . 12.3 t -65.35 -35.97 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.727 0.411 . . . . 0.0 110.344 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.51 -39.81 77.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.957 0.503 . . . . 0.0 110.222 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 75.0 m -78.01 -14.69 59.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.159 0.584 . . . . 0.0 111.894 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 409' ' ' VAL . . . -60.36 130.82 48.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -167.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 81.4 mt -72.13 120.66 18.04 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 65.36 59.25 0.81 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.115 0.96 . . . . 0.0 109.199 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.3 m -54.58 -34.77 62.47 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.63 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.35 -38.71 43.65 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.764 1.226 . . . . 0.0 113.272 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.437 HG22 ' HE1' ' A' ' 412' ' ' TYR . 58.0 m -89.14 -40.51 12.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.334 0.654 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 403' ' ' ALA . 70.9 t -61.55 -30.24 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.006 0.922 . . . . 0.0 111.869 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.71 -15.44 60.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.353 1.061 . . . . 0.0 110.302 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -77.38 -25.49 63.36 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.699 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.437 ' HE1' HG22 ' A' ' 408' ' ' THR . 96.0 m-85 -76.47 2.92 12.37 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.41 0.684 . . . . 0.0 111.965 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.38 113.0 8.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.552 0.741 . . . . 0.0 109.815 165.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -76.7 159.15 79.79 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.911 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 57.4 Cg_endo -70.65 123.29 9.68 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.127 1.218 . . . . 0.0 109.83 163.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -109.86 111.74 23.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -85.37 29.27 0.68 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.356 0.663 . . . . 0.0 112.035 -162.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -78.89 -25.49 43.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.358 0.663 . . . . 0.0 110.602 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.19 40.95 5.02 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.127 0.267 . . . . 0.0 113.359 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.24 -119.29 2.54 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.599 ' HB2' HD12 ' A' ' 436' ' ' LEU . 14.8 mm-40 -85.51 -178.63 6.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.58 . . . . 0.0 111.198 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.14 125.54 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.662 0.785 . . . . 0.0 109.067 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 397' ' ' GLN . 41.6 mm -104.03 126.2 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.498 0.719 . . . . 0.0 109.085 173.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 24.5 p -105.95 149.74 26.33 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.768 0.827 . . . . 0.0 109.649 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -161.12 175.59 12.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.485 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 64.7 m -120.47 117.43 27.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.965 0.906 . . . . 0.0 109.708 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.64 112.68 12.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.977 0.911 . . . . 0.0 109.285 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.7 t70 71.05 23.2 4.26 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.441 1.497 . . . . 0.0 110.983 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 -12.67 69.37 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.722 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.97 164.73 15.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.695 0.798 . . . . 0.0 109.91 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.5 t -108.92 114.76 28.8 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -119.09 140.99 49.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.774 0.321 . . . . 0.0 110.227 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 55.7 p -125.12 149.28 48.02 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 110.327 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 26.8 pt -120.38 179.88 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 0.0 110.096 174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.29 154.39 22.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.655 0.782 . . . . 0.0 109.81 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' A' ' 421' ' ' GLU . 80.8 mt -115.61 167.91 9.27 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.381 1.073 . . . . 0.0 109.379 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.11 142.42 30.86 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.844 1.696 . . . . 0.0 111.877 165.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.08 138.55 18.31 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.559 2.172 . . . . 0.0 111.507 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.13 160.93 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.479 0.712 . . . . 0.0 110.605 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -142.56 -3.22 1.04 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.436 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -115.3 140.06 49.44 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.07 72.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.086 0.955 . . . . 0.0 111.643 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.7 m -63.4 -35.05 79.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.204 0.601 . . . . 0.0 111.227 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -23.22 59.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.709 0.404 . . . . 0.0 110.106 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.615 ' HB2' HG22 ' A' ' 388' ' ' VAL . . . -55.55 -59.0 5.46 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.3 -41.72 89.32 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.571 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -26.66 61.08 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.567 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -63.71 -55.4 23.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.801 0.441 . . . . 0.0 110.574 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.436 HD23 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -80.04 -14.99 58.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.138 -175.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -40.86 98.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 109.612 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -69.14 -43.08 75.09 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.162 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.48 -46.34 63.97 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.144 0.578 . . . . 0.0 111.509 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 71.3 m -63.68 -27.91 69.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.698 0.799 . . . . 0.0 111.108 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -66.93 -40.53 87.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.342 0.657 . . . . 0.0 111.175 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 72.6 p -75.36 -15.22 60.49 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.605 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.484 HD11 HD21 ' A' ' 371' ' ' LEU . 47.5 mt -97.7 -6.34 33.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.536 0.734 . . . . 0.0 111.35 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 70.23 9.17 6.93 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.644 1.577 . . . . 0.0 112.129 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.509 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -87.62 133.57 33.79 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.409 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 20.9 t70 -155.37 151.69 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 65.99 18.09 10.96 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.653 0.781 . . . . 0.0 110.495 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.3 tp -83.81 -7.66 59.4 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.314 1.046 . . . . 0.0 110.251 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.436 HD23 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.86 163.12 32.26 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.584 1.153 . . . . 0.0 108.683 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 27.9 m -151.49 109.83 3.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.538 ' HG ' HG11 ' A' ' 359' ' ' VAL . 14.5 m -69.22 -15.26 63.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.286 1.035 . . . . 0.0 112.201 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.31 111.48 12.93 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.029 0.931 . . . . 0.0 109.382 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.55 ' HB3' ' SG ' ' A' ' 358' ' ' CYS . 90.8 Cg_endo -79.03 153.5 25.14 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.492 2.128 . . . . 0.0 113.21 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -81.7 1.56 33.72 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.459 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 CA--C 1.559 1.302 0 C-N-CA 124.792 1.237 . . . . 0.0 110.582 170.701 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -86.86 -36.47 18.44 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.564 0.746 . . . . 0.0 110.729 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.6 119.36 21.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.466 0.706 . . . . 0.0 110.681 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -89.8 6.47 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.304 0.641 . . . . 0.0 110.621 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -153.28 173.61 15.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.238 1.015 . . . . 0.0 110.567 -168.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.4 t -81.82 -179.39 7.37 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.819 0.847 . . . . 0.0 111.067 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.8 p -139.34 134.67 32.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.387 1.075 . . . . 0.0 109.6 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.52 159.52 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.558 0.743 . . . . 0.0 110.799 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 13.2 p -131.11 106.03 8.09 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.839 0.855 . . . . 0.0 109.602 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.426 HG13 HD21 ' A' ' 462' ' ' LEU . 46.2 t -93.56 158.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.378 1.071 . . . . 0.0 109.743 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.32 107.36 9.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.53 105.92 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.152 0.581 . . . . 0.0 110.463 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 48.3 t30 -94.33 88.02 5.4 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -14.12 62.85 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.559 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -83.97 -16.45 44.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.518 0.727 . . . . 0.0 111.136 174.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -71.6 -65.34 2.44 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 123.015 0.197 . . . . 0.0 112.626 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -154.93 165.54 36.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.411 ' O ' HD11 ' A' ' 371' ' ' LEU . 1.2 m-85 -109.22 -65.02 1.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.49 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -144.07 -95.2 0.2 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.774 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.9 22.09 29.43 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.54 2.17 . . . . 0.0 114.098 7.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -79.16 -8.21 58.82 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.753 0.421 . . . . 0.0 110.292 166.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.7 mt -110.85 142.61 42.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.99 1.316 . . . . 0.0 108.962 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.11 129.29 87.99 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.494 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.8 Cg_endo -59.78 -41.26 56.38 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.296 2.664 . . . . 0.0 113.549 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.494 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -69.92 -41.77 74.21 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.604 0.361 . . . . 0.0 110.725 -175.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -72.22 -28.48 63.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.207 0.603 . . . . 0.0 110.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.478 HD11 HD23 ' A' ' 379' ' ' LEU . 18.4 mm -65.42 -29.54 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.876 0.87 . . . . 0.0 110.52 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 81.8 mm-40 -80.04 -25.63 40.07 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.467 0.307 . . . . 0.0 110.92 174.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 89.5 mm-40 -74.03 -34.56 64.15 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.102 0.561 . . . . 0.0 112.004 -176.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.478 HD23 HD11 ' A' ' 376' ' ' ILE . 3.3 pp -73.55 154.94 89.66 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.776 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.39 155.51 2.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 0.0 115.705 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.74 -7.59 59.64 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.228 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.4 147.06 7.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.735 0.814 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.66 126.97 50.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.967 0.907 . . . . 0.0 109.306 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 109.68 -173.91 17.35 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.973 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.79 127.47 14.41 Favored 'Cis proline' 0 C--N 1.381 2.247 0 CA-C-N 119.664 1.732 . . . . 0.0 112.33 -2.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.95 -174.13 25.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.0 138.72 58.28 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.567 2.178 . . . . 0.0 112.686 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.709 HG23 ' HB3' ' A' ' 445' ' ' ALA . 6.8 p -46.67 -40.82 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.363 1.865 . . . . 0.0 112.442 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.59 -51.82 65.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 0.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 91.7 t -71.54 -45.21 68.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.723 -174.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.4 -29.62 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.76 -40.2 55.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.055 0.389 . . . . 0.0 110.442 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -70.12 -33.33 71.71 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 16.2 mmm-85 -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.444 0.698 . . . . 0.0 111.503 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 35.6 mm -73.16 -55.12 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.444 ' O ' HG21 ' A' ' 400' ' ' VAL . 61.0 t -66.13 -52.77 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.758 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.409 ' HA ' HG22 ' A' ' 423' ' ' ILE . 7.9 pt20 -63.58 -23.86 67.56 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.208 0.603 . . . . 0.0 112.25 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -70.73 -49.52 46.0 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 77.8 m -63.18 -52.47 62.25 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.054 0.942 . . . . 0.0 112.688 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.456 HG13 HG21 ' A' ' 406' ' ' THR . 11.0 t -64.59 -41.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.353 0.661 . . . . 0.0 110.215 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -72.13 -31.92 66.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 379' ' ' LEU . 85.1 m -88.38 8.96 25.1 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.381 0.672 . . . . 0.0 111.819 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -82.32 161.14 22.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.3 119.79 26.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.601 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 59.49 72.6 0.52 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.192 0.997 . . . . 0.0 109.763 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 400' ' ' VAL . 93.7 m -62.25 -34.89 77.39 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.978 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -55.87 -37.37 68.7 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.1 m -76.53 -43.41 39.39 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.239 0.616 . . . . 0.0 109.546 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.502 HG22 ' HB1' ' A' ' 403' ' ' ALA . 74.7 t -66.01 -28.05 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.54 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . 0.42 ' HD2' HG11 ' A' ' 400' ' ' VAL . 19.0 t80 -78.92 -17.65 55.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.476 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -74.94 -10.5 83.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.598 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -77.49 -10.15 59.31 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.517 0.727 . . . . 0.0 111.376 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.606 HD13 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -141.1 141.46 34.21 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.018 0.927 . . . . 0.0 109.561 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -115.89 159.55 38.68 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.215 0.606 . . . . 0.0 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.49 151.52 75.56 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.87 1.713 . . . . 0.0 111.766 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.92 122.32 17.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.136 1.374 . . . . 0.0 107.99 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -80.46 14.46 2.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.817 0.847 . . . . 0.0 112.425 -168.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.09 -45.76 92.1 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.379 1.072 . . . . 0.0 111.403 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 95.09 43.55 3.5 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.712 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -99.85 -109.91 3.11 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.811 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.4 mp0 -78.5 171.36 15.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.41 0.684 . . . . 0.0 110.915 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.3 135.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.812 0.845 . . . . 0.0 109.354 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.51 HG12 HD12 ' A' ' 436' ' ' LEU . 36.0 mm -113.18 123.9 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.8 p -107.36 146.25 31.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.939 0.896 . . . . 0.0 109.646 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.83 159.89 14.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.869 0.868 . . . . 0.0 110.077 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.4 m -81.61 116.97 21.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.857 0.463 . . . . 0.0 110.456 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -143.12 120.69 11.76 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.163 0.985 . . . . 0.0 110.499 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.85 22.58 7.15 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.835 1.254 . . . . 0.0 113.264 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.8 58.07 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 113.895 0.318 . . . . 0.0 113.895 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.64 172.38 13.09 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.0 t -86.1 126.99 34.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -106.43 139.75 40.42 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.505 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.3 p -123.69 149.12 45.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.344 1.058 . . . . 0.0 109.861 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 413' ' ' LEU . 25.9 pt -124.8 176.35 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 0.0 110.247 173.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -112.94 144.07 43.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.996 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 423' ' ' ILE . 7.8 mp -114.35 160.71 31.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.858 1.263 . . . . 0.0 108.373 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.465 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 67.8 Cg_endo -75.48 134.97 17.65 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.083 1.855 . . . . 0.0 112.167 169.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.24 136.71 29.72 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 122.716 2.277 . . . . 0.0 112.918 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.75 174.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.424 1.09 . . . . 0.0 110.92 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.8 0.44 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.164 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 19.0 m -119.77 142.01 48.96 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.262 0.483 . . . . 0.0 110.511 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.62 80.6 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.019 0.928 . . . . 0.0 112.904 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.0 m -65.23 -26.64 68.2 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.447 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.431 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 1.8 t80 -85.19 -22.05 28.91 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.709 ' HB3' HG23 ' A' ' 388' ' ' VAL . . . -53.44 -60.41 3.33 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 121.544 0.688 . . . . 0.0 109.224 170.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.39 -36.49 74.13 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.518 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . 0.481 HH11 ' HA ' ' A' ' 448' ' ' PHE . 0.0 OUTLIER -63.86 -31.96 73.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.688 0.795 . . . . 0.0 111.569 177.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . 0.481 ' HA ' HH11 ' A' ' 447' ' ' ARG . 2.5 t80 -67.19 -46.17 74.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.459 0.304 . . . . 0.0 111.358 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -13.53 44.76 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.199 -0.313 . . . . 0.0 111.057 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.62 -55.28 33.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.879 1.272 . . . . 0.0 111.864 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.09 -34.86 78.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.458 0.703 . . . . 0.0 111.277 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 40.8 t80 -65.87 -56.48 11.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.573 0.749 . . . . 0.0 110.635 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.3 m -60.9 -30.68 70.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.781 0.832 . . . . 0.0 110.979 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.84 -44.53 85.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.914 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 52.4 p -75.47 -21.16 58.32 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 79.9 mt -78.06 -11.11 59.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.99 0.516 . . . . 0.0 111.491 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 74.03 9.4 4.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.525 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 456' ' ' LEU . 22.6 p -95.05 133.37 38.92 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.39 0.676 . . . . 0.0 109.742 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -149.38 150.75 32.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 14.1 m-80 67.47 17.15 10.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.881 1.273 . . . . 0.0 109.884 -167.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.3 tp -78.99 -26.73 43.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.765 0.826 . . . . 0.0 110.263 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.426 HD21 HG13 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -163.24 150.4 12.77 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.959 0.504 . . . . 0.0 110.873 178.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 67.1 m -166.07 138.54 3.97 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.501 1.12 . . . . 0.0 108.987 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 30.2 t -72.71 -11.29 60.57 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.303 0.641 . . . . 0.0 110.77 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -73.73 141.51 79.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.384 1.073 . . . . 0.0 110.467 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.27 135.55 18.74 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.459 2.106 . . . . 0.0 111.011 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -82.65 -5.91 59.09 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.543 0.737 . . . . 0.0 111.204 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.606 1.162 . . . . 0.0 107.99 178.004 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.335 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 35.8 m -85.54 129.51 34.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -133.23 8.67 4.02 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.371 0.668 . . . . 0.0 110.113 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -85.15 -173.17 4.56 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.018 0.527 . . . . 0.0 110.984 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 172.51 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.983 0.913 . . . . 0.0 111.201 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.2 t -77.2 172.78 12.71 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -137.51 142.69 41.45 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.908 0.883 . . . . 0.0 110.193 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.64 166.02 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.468 1.107 . . . . 0.0 111.149 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.497 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 22.8 p -136.26 108.85 7.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.229 1.012 . . . . 0.0 109.631 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 25.0 t -93.99 149.76 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.535 0.734 . . . . 0.0 109.795 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -119.66 99.63 6.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.441 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -68.72 103.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.541 0.736 . . . . 0.0 110.018 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -94.9 94.58 8.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.857 0.863 . . . . 0.0 109.55 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -11.57 59.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.764 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -76.61 -13.97 60.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.239 0.615 . . . . 0.0 110.339 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -83.69 -159.3 28.3 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 169.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 40.3 t30 -73.41 144.5 46.33 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.416 0.608 . . . . 0.0 110.516 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -61.15 1.79 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.484 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.07 -91.27 0.11 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.025 -0.875 . . . . 0.0 112.472 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -86.01 13.28 46.46 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.849 2.325 . . . . 0.0 113.906 7.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.99 -2.0 38.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.21 0.604 . . . . 0.0 111.351 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 456' ' ' LEU . 30.3 mt -112.28 141.54 45.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.839 1.255 . . . . 0.0 108.321 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.472 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 16.3 t70 -70.74 117.93 60.28 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 110.009 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.472 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.4 Cg_endo -57.13 -34.61 98.06 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 123.597 2.864 . . . . 0.0 113.519 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -68.09 -51.42 46.61 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.577 0.548 . . . . 0.0 109.871 -177.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.472 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 19.7 mtp180 -62.31 -33.37 74.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.863 0.865 . . . . 0.0 111.398 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.431 HD13 HD23 ' A' ' 379' ' ' LEU . 24.0 mm -61.64 -33.32 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.872 0.869 . . . . 0.0 111.04 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 73.9 mm-40 -80.55 -21.33 41.87 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.2 -0.313 . . . . 0.0 111.289 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 61.8 mm-40 -85.34 -37.22 20.18 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.726 0.41 . . . . 0.0 112.105 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.431 HD23 HD13 ' A' ' 376' ' ' ILE . 2.8 pp -64.84 156.01 80.92 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.828 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.13 154.32 28.74 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.848 2.365 . . . . 0.0 113.667 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.25 -14.0 60.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.818 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.441 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 9.7 p-80 -166.91 146.99 5.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.94 0.496 . . . . 0.0 111.552 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.92 104.43 10.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.744 1.218 . . . . 0.0 109.052 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 145.02 168.47 12.85 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.825 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.09 140.47 64.79 Favored 'Cis proline' 0 C--N 1.379 2.149 0 CA-C-N 119.713 1.757 . . . . 0.0 112.828 -1.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -164.4 -168.83 27.1 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.092 -0.838 . . . . 0.0 111.607 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.07 143.0 48.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 123.156 2.571 . . . . 0.0 111.949 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.703 HG22 ' HB1' ' A' ' 445' ' ' ALA . 7.7 p -52.85 -39.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.955 1.302 . . . . 0.0 111.638 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.412 ' HB3' HH21 ' A' ' 393' ' ' ARG . 14.3 m120 -68.89 -48.19 63.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 72.9 t -76.75 -44.31 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.5 -41.08 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.862 0.465 . . . . 0.0 111.487 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.82 -40.99 79.2 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 9.7 ptp180 -69.76 -25.78 63.99 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.135 0.272 . . . . 0.0 110.569 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 53.2 mmm-85 -70.8 -37.13 73.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.999 0.52 . . . . 0.0 111.258 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.79 -52.58 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.721 0.638 . . . . 0.0 109.489 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.452 ' O ' HG21 ' A' ' 400' ' ' VAL . 72.4 t -61.05 -47.74 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.998 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -65.01 -31.13 72.21 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.184 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.44 84.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.097 0.559 . . . . 0.0 110.231 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.34 -48.42 61.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.642 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 396' ' ' VAL . 36.4 t -62.9 -42.18 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.399 0.68 . . . . 0.0 110.468 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.88 -51.84 67.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 79.4 m -77.13 -8.0 56.76 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.726 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.613 ' HB2' HG23 ' A' ' 409' ' ' VAL . . . -65.5 123.05 18.63 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.908 0.883 . . . . 0.0 112.335 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.54 115.34 5.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 166.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 68.61 66.68 0.31 Allowed 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.543 1.164 . . . . 0.0 109.258 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 84.6 m -55.43 -33.32 63.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.14 1.776 . . . . 0.0 112.428 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.91 1.284 . . . . 0.0 112.753 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.7 m -79.27 -34.29 42.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.898 0.879 . . . . 0.0 109.787 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 403' ' ' ALA . 55.2 t -69.09 -30.36 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.51 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -69.24 -23.61 63.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.018 0.927 . . . . 0.0 110.196 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.04 71.07 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -79.98 -21.32 43.84 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.009 0.524 . . . . 0.0 112.163 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.26 115.08 20.46 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.688 0.756 . . . . 0.0 111.486 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.05 158.93 32.53 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.556 1.143 . . . . 0.0 110.045 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.21 126.84 10.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.244 1.963 . . . . 0.0 113.045 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.58 ' HB3' ' HE ' ' A' ' 418' ' ' ARG . 2.5 m-20 -123.77 104.96 9.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.09 58.77 5.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.768 0.827 . . . . 0.0 111.403 -164.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.58 ' HE ' ' HB3' ' A' ' 416' ' ' ASP . 0.9 OUTLIER -106.0 14.26 28.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.635 0.774 . . . . 0.0 111.073 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.58 26.19 72.85 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.33 -115.06 1.44 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.125 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.8 mp0 -86.1 170.39 12.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.112 0.565 . . . . 0.0 110.625 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.3 t -136.97 128.58 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.432 HG12 HD11 ' A' ' 436' ' ' LEU . 41.4 mm -116.48 138.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.4 p -106.51 142.7 35.74 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.817 0.847 . . . . 0.0 109.628 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.29 120.99 12.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.491 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.3 m -77.32 101.13 6.16 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . 0.543 ' HB3' ' HD1' ' A' ' 432' ' ' HIS . 81.0 t80 -123.2 134.32 54.15 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.015 1.326 . . . . 0.0 108.213 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.3 t70 65.37 16.08 10.35 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.956 1.302 . . . . 0.0 110.29 -175.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 89.0 -13.35 63.39 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.936 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -96.85 153.65 17.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.483 0.713 . . . . 0.0 110.143 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -84.26 123.05 29.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.543 ' HD1' ' HB3' ' A' ' 427' ' ' PHE . 32.3 m170 -123.9 124.12 41.92 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 47.7 p -107.05 151.35 25.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.717 0.807 . . . . 0.0 111.057 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.02 -178.08 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.931 . . . . 0.0 110.217 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -118.06 150.64 38.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.811 0.844 . . . . 0.0 109.523 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.682 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.9 mp -116.56 160.26 37.02 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.726 1.21 . . . . 0.0 108.185 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.99 139.88 19.7 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.157 1.905 . . . . 0.0 110.818 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.52 145.48 37.71 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.507 2.138 . . . . 0.0 112.939 -173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.5 156.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.989 0.915 . . . . 0.0 110.332 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.44 9.4 2.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.215 0.606 . . . . 0.0 111.525 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 42.4 t -115.21 139.92 49.53 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.26 68.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.612 0.765 . . . . 0.0 112.187 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.4 m -69.87 -16.97 63.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.058 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.83 -27.79 23.3 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.703 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -50.26 -65.8 0.5 Allowed 'General case' 0 C--N 1.366 1.3 0 O-C-N 124.201 0.938 . . . . 0.0 109.914 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.77 -43.12 99.62 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.473 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -60.55 -36.39 78.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.58 0.752 . . . . 0.0 111.641 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -61.43 -52.68 63.54 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 123.579 0.549 . . . . 0.0 110.14 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -19.14 60.78 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.938 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.68 -34.44 46.19 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.205 0.457 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -62.42 -35.77 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.997 171.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -76.85 -36.6 56.69 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.126 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 92.4 m -65.72 -26.98 68.0 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.208 0.603 . . . . 0.0 110.74 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.34 -39.36 93.73 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.818 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.3 m -70.38 -18.12 63.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.252 1.021 . . . . 0.0 111.813 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.486 HD12 HD13 ' A' ' 371' ' ' LEU . 38.7 mt -98.35 -13.3 20.75 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.853 0.861 . . . . 0.0 111.612 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 70.41 8.61 6.68 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.32 1.448 . . . . 0.0 111.958 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.495 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 26.4 p -86.8 135.24 33.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.34 146.57 25.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 65.66 15.58 10.11 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.126 0.97 . . . . 0.0 110.067 -168.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 35.6 tp -79.77 -12.02 59.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.574 0.75 . . . . 0.0 110.519 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.04 164.75 36.41 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 108.829 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 72.3 m -158.62 108.9 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 13.6 m -79.9 -7.32 58.67 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.964 0.506 . . . . 0.0 110.34 173.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -81.93 105.96 5.4 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.09 173.82 12.93 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.376 2.051 . . . . 0.0 112.256 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -74.7 -19.08 60.4 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 110.336 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.501 0.72 . . . . 0.0 109.378 170.555 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 29.5 p -158.49 -179.36 8.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.983 0.913 . . . . 0.0 109.852 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -74.86 80.66 2.13 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.247 0.546 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.27 15.32 21.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.443 1.097 . . . . 0.0 108.975 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -159.56 177.63 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.242 1.817 . . . . 0.0 107.532 -178.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 43.3 t -79.21 171.75 14.76 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.4 p -138.86 134.41 33.27 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.572 0.749 . . . . 0.0 109.861 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 388' ' ' VAL . 17.4 m -137.68 169.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.579 1.151 . . . . 0.0 110.218 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.5 106.86 4.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.635 0.774 . . . . 0.0 109.278 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 395' ' ' ILE . 32.6 m -90.7 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.182 0.515 . . . . 0.0 110.133 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -118.34 100.63 7.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.55 105.92 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.031 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 30.8 t30 -87.34 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 381' ' ' ASP . 6.7 mmmm -69.38 -31.02 69.14 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.094 -172.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.89 0.8 57.4 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.638 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.11 -80.9 0.23 Allowed Glycine 0 C--N 1.354 1.529 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -147.75 155.45 41.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.462 ' HA ' HG23 ' A' ' 376' ' ' ILE . 0.8 OUTLIER -97.54 -64.51 1.03 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.517 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.18 -91.4 0.1 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.367 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -86.88 12.12 53.11 Favored 'Cis proline' 0 C--N 1.374 1.879 0 CA-C-N 120.384 2.092 . . . . 0.0 114.325 11.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -76.64 -8.87 58.09 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.271 0.557 . . . . 0.0 110.335 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 456' ' ' LEU . 45.6 mt -107.59 144.26 34.86 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -69.32 122.83 86.82 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.647 0.779 . . . . 0.0 110.302 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.515 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 57.0 Cg_endo -67.61 -21.16 46.16 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.969 2.446 . . . . 0.0 113.899 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.515 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -82.91 -45.47 14.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.546 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 4.5 mtt-85 -66.09 -32.49 73.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.913 . . . . 0.0 111.541 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.462 HG23 ' HA ' ' A' ' 367' ' ' PHE . 22.2 mm -62.31 -27.85 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.187 172.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -83.84 -23.96 31.12 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.637 0.375 . . . . 0.0 110.667 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.6 mm-40 -77.6 -37.51 50.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.92 0.488 . . . . 0.0 112.103 -175.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.7 153.34 83.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.086 171.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.9 169.36 10.45 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.609 2.206 . . . . 0.0 114.284 -172.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 363' ' ' LYS . 21.1 t70 -84.36 -3.34 58.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.419 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.17 151.78 18.04 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.255 0.622 . . . . 0.0 110.127 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -126.2 103.46 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 146.58 171.88 16.34 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.057 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -77.9 136.1 41.03 Favored 'Cis proline' 0 C--N 1.377 2.027 0 CA-C-N 118.65 1.225 . . . . 0.0 111.408 -1.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -160.92 -168.67 23.12 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.299 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.413 ' HB3' ' HE2' ' A' ' 354' ' ' MET . 9.2 Cg_exo -68.46 148.49 73.27 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.339 2.693 . . . . 0.0 112.383 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.629 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.4 p -55.32 -43.74 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.266 1.027 . . . . 0.0 111.634 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -72.01 -39.61 69.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.536 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 69.4 t -73.2 -48.93 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 119.559 -0.258 . . . . 0.0 110.847 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.8 t -58.74 -39.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.717 0.407 . . . . 0.0 111.775 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.475 HD12 ' HG2' ' A' ' 421' ' ' GLU . 1.9 pp -68.67 -43.95 75.08 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.9 ptt180 -70.25 -27.99 64.88 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.155 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.3 mmt180 -63.78 -38.21 90.25 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.506 0.722 . . . . 0.0 110.91 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 359' ' ' VAL . 34.4 mm -66.17 -54.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.738 0.649 . . . . 0.0 109.279 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 400' ' ' VAL . 57.9 t -57.66 -63.63 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.427 1.08 . . . . 0.0 110.462 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -55.75 -36.27 67.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.7 0.8 . . . . 0.0 112.21 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.41 -44.86 81.8 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 122.746 0.418 . . . . 0.0 109.938 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 88.0 m -64.87 -38.84 92.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.575 0.75 . . . . 0.0 111.516 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 396' ' ' VAL . 11.8 t -69.5 -43.54 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.016 0.527 . . . . 0.0 110.275 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.55 -33.83 75.85 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.277 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.546 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 72.1 m -86.23 -4.83 59.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.509 0.724 . . . . 0.0 111.465 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.561 ' HB3' HG23 ' A' ' 409' ' ' VAL . . . -73.77 136.39 43.62 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.955 0.502 . . . . 0.0 111.429 -176.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 70.5 mt -83.43 129.5 34.99 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 164.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 66.48 54.0 0.92 Allowed 'General case' 0 CA--C 1.562 1.425 0 O-C-N 124.196 0.935 . . . . 0.0 108.874 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.462 HG22 HG12 ' A' ' 400' ' ' VAL . 89.8 m -55.03 -38.47 67.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.491 1.516 . . . . 0.0 111.961 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -57.5 -38.45 74.64 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.796 1.238 . . . . 0.0 113.762 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -83.84 -29.58 27.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.167 0.508 . . . . 0.0 110.148 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.561 HG23 ' HB3' ' A' ' 403' ' ' ALA . 69.4 t -65.79 -31.78 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.82 0.848 . . . . 0.0 110.369 171.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.91 -15.63 60.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.382 1.073 . . . . 0.0 110.712 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.02 62.95 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 116.506 -0.315 . . . . 0.0 113.264 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -92.74 -1.46 56.8 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 110.821 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.45 HD11 HG22 ' A' ' 423' ' ' ILE . 53.8 mt -121.66 100.16 6.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.027 0.931 . . . . 0.0 110.231 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -103.25 135.98 19.3 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 122.818 0.447 . . . . 0.0 110.12 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.74 162.35 42.39 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.555 2.837 . . . . 0.0 112.623 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.96 152.18 26.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -89.77 60.41 5.01 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.959 0.885 . . . . 0.0 109.185 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -109.87 -62.21 1.54 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.64 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.57 41.37 5.11 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.509 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.86 -72.63 1.14 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 19.2 mp0 -108.59 167.72 9.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.559 0.744 . . . . 0.0 109.267 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 83.5 t -138.79 127.86 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.109 0.964 . . . . 0.0 108.515 177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 413' ' ' LEU . 36.6 mm -118.25 135.22 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 0.0 109.887 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 5.4 p -108.04 140.31 41.4 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.685 0.794 . . . . 0.0 109.563 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.02 118.51 10.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.429 1.092 . . . . 0.0 109.513 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.6 m -76.01 100.1 4.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.551 0.691 . . . . 0.0 109.47 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' A' ' 432' ' ' HIS . 65.0 t80 -117.93 117.09 28.31 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.879 1.272 . . . . 0.0 108.815 -174.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 62.78 25.17 14.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.942 1.297 . . . . 0.0 111.89 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.76 61.23 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.174 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.86 160.28 14.62 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.853 0.827 . . . . 0.0 109.247 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 14.0 t -96.71 127.65 42.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 427' ' ' PHE . 26.3 m-70 -119.46 123.29 43.69 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.2 p -105.22 137.58 42.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.382 0.673 . . . . 0.0 110.06 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.9 pt -122.64 172.27 10.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 123.805 0.842 . . . . 0.0 109.445 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -123.17 140.61 52.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.55 0.69 . . . . 0.0 109.743 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 4.8 mp -114.47 156.78 44.11 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.025 1.33 . . . . 0.0 108.646 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.31 130.48 14.07 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.154 1.903 . . . . 0.0 112.429 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -60.27 144.22 99.5 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.275 2.65 . . . . 0.0 113.16 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 24.8 m -111.64 158.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.844 0.857 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -137.46 7.23 2.81 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.3 t -121.65 141.78 50.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.64 0.376 . . . . 0.0 110.125 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.1 72.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.245 1.018 . . . . 0.0 112.604 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.3 m -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.957 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.72 -23.8 36.51 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.49 -61.94 1.89 Allowed 'General case' 0 C--N 1.365 1.243 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.06 -48.11 66.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.458 -169.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -58.17 -34.21 70.07 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.884 0.74 . . . . 0.0 112.753 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . 0.402 ' CE1' HD22 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -61.15 -43.93 98.11 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.938 0.774 . . . . 0.0 109.864 -176.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.649 HD21 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.06 -16.0 34.76 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.479 175.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.71 -42.17 82.38 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.408 1.004 . . . . 0.0 110.752 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -66.56 -37.7 85.52 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.838 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.0 -45.91 76.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.028 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 74.5 m -70.04 -25.96 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.132 0.973 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -66.58 -35.88 81.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.49 0.716 . . . . 0.0 109.926 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.4 m -71.13 -20.3 62.33 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.0 0.92 . . . . 0.0 111.538 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.501 HD12 HD21 ' A' ' 371' ' ' LEU . 44.9 mt -99.76 -11.3 20.94 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.977 0.911 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 74.34 7.89 4.58 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 0.0 112.113 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.517 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 10.9 p -87.88 133.34 33.93 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.809 0.444 . . . . 0.0 110.232 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -149.53 149.61 30.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.545 0.738 . . . . 0.0 109.7 -175.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 23.4 m-80 67.42 15.85 9.93 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.7 1.2 . . . . 0.0 111.003 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.01 -21.91 53.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -152.78 163.81 39.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.313 0.645 . . . . 0.0 110.111 175.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.6 p -165.16 115.47 1.1 Allowed 'General case' 0 C--O 1.239 0.52 0 O-C-N 123.963 0.789 . . . . 0.0 109.402 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 10.1 t -85.19 0.3 52.25 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -78.73 110.08 12.98 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.36 158.93 44.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.09 1.86 . . . . 0.0 111.98 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.12 -23.96 67.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.822 0.849 . . . . 0.0 111.021 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.247 0.966 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 22.9 t -86.0 158.09 19.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 0.0 110.102 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -86.99 68.56 10.1 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.705 0.764 . . . . 0.0 109.916 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 24.8 ttt -145.22 132.8 20.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.173 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -75.57 172.27 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.886 0.874 . . . . 0.0 110.945 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.4 t -76.69 -179.7 5.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.347 0.659 . . . . 0.0 110.97 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.91 143.12 44.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.826 0.85 . . . . 0.0 110.314 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.36 169.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.677 1.191 . . . . 0.0 109.581 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.98 105.94 3.59 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.551 HG23 HD12 ' A' ' 395' ' ' ILE . 30.4 m -92.08 152.63 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.048 0.539 . . . . 0.0 109.962 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 76.2 m-85 -110.76 101.36 9.99 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.62 HG12 ' HZ2' ' A' ' 363' ' ' LYS . 58.1 t -70.62 92.84 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 124.15 0.98 . . . . 0.0 110.344 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -87.77 99.11 11.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.718 0.807 . . . . 0.0 108.969 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.758 ' HZ1' ' HB2' ' A' ' 379' ' ' LEU . 0.0 OUTLIER -80.65 -10.04 59.76 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.252 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -77.27 -14.36 59.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.681 0.392 . . . . 0.0 110.103 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.23 -166.93 29.97 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.362 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -71.11 131.53 43.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.019 0.437 . . . . 0.0 110.155 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -78.04 -62.83 1.55 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.408 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.495 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -142.36 -94.96 0.22 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.824 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.86 9.67 56.82 Favored 'Cis proline' 0 C--N 1.373 1.847 0 CA-C-N 120.385 2.092 . . . . 0.0 114.96 10.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -73.8 -7.94 54.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.766 0.426 . . . . 0.0 111.33 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.495 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.9 mt -114.16 130.04 56.61 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.573 1.549 . . . . 0.0 107.557 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.13 125.32 89.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 123.583 0.552 . . . . 0.0 110.827 -176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 12.2 Cg_endo -53.78 -38.14 85.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.786 2.991 . . . . 0.0 114.377 -175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.82 -42.83 48.72 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.397 0.436 . . . . 0.0 110.209 -173.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -68.36 -30.42 69.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.555 0.742 . . . . 0.0 110.764 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.4 mm -63.84 -31.1 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.239 1.016 . . . . 0.0 111.198 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 64.5 mm-40 -74.98 -27.58 60.21 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 56.0 mm-40 -81.84 -3.38 53.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.384 0.674 . . . . 0.0 111.749 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.758 ' HB2' ' HZ1' ' A' ' 363' ' ' LYS . 18.6 mt -70.46 172.23 6.47 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.104 0.562 . . . . 0.0 110.187 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 379' ' ' LEU . 75.9 Cg_endo -73.34 163.65 37.26 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.114 1.209 . . . . 0.0 110.479 166.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.86 -23.22 60.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.199 0.6 . . . . 0.0 111.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -158.76 147.04 18.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.617 0.367 . . . . 0.0 110.938 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.05 104.79 13.72 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 143.92 172.7 14.85 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.248 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.3 139.97 58.28 Favored 'Cis proline' 0 C--N 1.379 2.168 0 CA-C-N 119.134 1.467 . . . . 0.0 112.191 1.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.59 -170.23 27.13 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.473 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 390' ' ' VAL . 6.0 Cg_exo -69.98 145.72 56.71 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.312 2.675 . . . . 0.0 111.722 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 445' ' ' ALA . 7.3 p -54.51 -39.4 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.501 1.12 . . . . 0.0 111.478 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.43 -47.01 74.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.613 1.165 . . . . 0.0 110.541 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' A' ' 387' ' ' PRO . 94.2 t -72.08 -51.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.84 -39.32 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.79 -42.34 73.9 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.613 HH11 ' HA ' ' A' ' 421' ' ' GLU . 34.8 ptt180 -74.44 -24.76 59.11 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.885 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 15.2 mmt85 -63.75 -36.7 84.74 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.707 0.629 . . . . 0.0 110.515 174.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.551 HD12 HG23 ' A' ' 359' ' ' VAL . 48.5 mm -66.84 -54.25 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 109.694 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.464 ' O ' HG22 ' A' ' 400' ' ' VAL . 81.8 t -56.56 -50.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 124.336 1.022 . . . . 0.0 111.354 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.85 -34.16 73.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.95 0.5 . . . . 0.0 111.613 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.61 88.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -67.2 -55.23 14.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.035 0.834 . . . . 0.0 110.93 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 396' ' ' VAL . 61.1 t -57.5 -40.68 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.702 0.801 . . . . 0.0 111.446 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.54 -48.25 67.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.477 ' SG ' HD23 ' A' ' 379' ' ' LEU . 74.0 m -73.61 -10.15 59.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.109 0.564 . . . . 0.0 111.908 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.54 ' HB1' HG23 ' A' ' 409' ' ' VAL . . . -68.63 148.36 50.56 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.071 0.949 . . . . 0.0 112.649 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.28 130.16 34.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 60.41 61.48 1.76 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.153 0.977 . . . . 0.0 109.33 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -50.78 -37.13 40.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 112.848 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -53.34 -41.12 65.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.914 1.286 . . . . 0.0 112.755 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 -41.94 20.48 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.632 0.773 . . . . 0.0 109.531 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.54 HG23 ' HB1' ' A' ' 403' ' ' ALA . 76.7 t -60.35 -33.18 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.129 0.972 . . . . 0.0 111.767 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -81.82 -13.35 57.79 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.426 0.691 . . . . 0.0 110.903 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -78.94 -3.14 87.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.461 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.92 -5.21 58.15 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.279 0.632 . . . . 0.0 111.411 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.437 HD12 HD13 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -139.8 113.39 8.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.53 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 414' ' ' LYS . 0.5 OUTLIER -95.88 156.61 37.05 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.86 0.864 . . . . 0.0 110.886 -177.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.71 129.38 17.55 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.26 1.973 . . . . 0.0 113.24 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.629 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 59.1 m-20 -122.28 111.77 17.33 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.749 174.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -88.94 45.6 1.31 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.865 0.84 . . . . 0.0 109.44 -171.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.629 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 12.2 mpt_? -78.58 -15.66 58.3 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 110.151 173.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 84.84 42.16 7.33 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.329 0.393 . . . . 0.0 113.399 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.88 -112.18 3.59 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 120.169 -0.24 . . . . 0.0 113.014 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 22.5 mp0 -79.53 167.24 21.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.309 0.644 . . . . 0.0 110.642 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.8 t -134.54 129.23 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.419 HG12 HD13 ' A' ' 436' ' ' LEU . 41.1 mm -115.18 130.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 433' ' ' SER . 22.8 p -106.09 154.54 20.51 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 124.03 0.831 . . . . 0.0 109.403 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -154.91 158.66 39.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.963 0.905 . . . . 0.0 109.914 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 45.6 m -105.06 119.49 39.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.463 0.705 . . . . 0.0 109.435 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -132.29 109.99 10.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.406 0.682 . . . . 0.0 109.945 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.41 41.03 16.63 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.684 1.194 . . . . 0.0 111.114 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.6 -0.65 85.18 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.314 -0.857 . . . . 0.0 114.064 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -103.7 171.73 7.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 109.303 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -116.13 119.59 36.31 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -107.07 137.57 44.88 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.423 ' HB3' HG23 ' A' ' 424' ' ' THR . 54.4 p -127.98 148.67 50.53 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 109.876 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.437 HD13 HD12 ' A' ' 413' ' ' LEU . 36.0 pt -130.55 174.12 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.811 0.845 . . . . 0.0 110.054 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -113.87 149.88 34.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.661 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.5 mp -116.64 158.94 42.25 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.862 1.265 . . . . 0.0 108.664 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.463 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 71.2 Cg_endo -74.93 131.47 14.41 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 C-N-CA 122.362 2.041 . . . . 0.0 112.456 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.55 146.71 74.9 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.858 2.372 . . . . 0.0 113.422 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.35 161.25 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.89 0.876 . . . . 0.0 110.544 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -141.17 5.44 1.89 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.504 0.721 . . . . 0.0 111.767 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.7 m -124.26 140.49 52.91 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.52 0.6 . . . . 0.0 110.995 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.39 79.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.201 1.0 . . . . 0.0 112.542 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 m -69.1 -24.18 64.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.96 -22.16 25.75 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.681 ' HB3' HG21 ' A' ' 388' ' ' VAL . . . -48.14 -58.59 4.3 Favored 'General case' 0 C--N 1.365 1.271 0 CA-C-O 121.629 0.728 . . . . 0.0 109.239 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.79 -44.57 80.96 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.859 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -56.71 -38.65 72.61 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.443 1.089 . . . . 0.0 112.197 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . 0.463 ' HZ ' ' HD2' ' A' ' 437' ' ' PRO . 4.3 t80 -65.63 -45.09 84.38 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.536 -171.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.694 HD23 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -85.82 -13.16 48.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.792 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.484 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 0.8 OUTLIER -63.82 -43.74 95.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.009 0.368 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.26 93.36 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.449 ' CE2' HD12 ' A' ' 456' ' ' LEU . 43.8 t80 -69.7 -45.43 68.27 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.448 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 450' ' ' GLU . 29.4 p -72.59 -21.65 61.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.351 0.661 . . . . 0.0 110.073 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -70.58 -36.07 73.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.869 0.868 . . . . 0.0 109.844 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 -31.49 68.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.569 0.747 . . . . 0.0 110.99 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.449 HD12 ' CE2' ' A' ' 452' ' ' PHE . 45.5 mt -80.87 -17.62 50.07 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.171 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 72.06 8.91 6.01 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.714 1.606 . . . . 0.0 111.518 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.483 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 21.9 p -82.73 137.26 34.46 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.227 0.611 . . . . 0.0 109.947 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.52 148.89 28.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 109.563 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 64.01 14.42 8.45 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.214 1.005 . . . . 0.0 111.436 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.46 -20.74 43.07 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.405 0.682 . . . . 0.0 112.006 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.694 HD21 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.83 159.53 36.8 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.072 0.549 . . . . 0.0 110.624 176.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 35.5 p -165.88 121.78 1.31 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.916 0.486 . . . . 0.0 111.026 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 11.1 t -86.3 5.64 33.58 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.99 0.516 . . . . 0.0 111.273 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -102.7 103.43 32.55 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.912 0.885 . . . . 0.0 109.622 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.47 176.28 10.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.338 2.692 . . . . 0.0 112.836 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -56.45 -44.96 80.99 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.106 0.562 . . . . 0.0 110.766 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 123.701 0.801 . . . . 0.0 109.266 175.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.769 -0.132 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 44.3 m -65.47 -33.52 76.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.076 0.95 . . . . 0.0 111.956 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 48.9 m80 66.08 5.81 3.77 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.762 1.225 . . . . 0.0 113.416 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.5 ptm -89.61 -0.43 57.51 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.324 0.649 . . . . 0.0 111.137 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -125.58 172.26 9.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.512 1.125 . . . . 0.0 109.392 174.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.2 t -86.58 -177.66 6.21 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.627 0.771 . . . . 0.0 110.303 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.9 p -141.04 142.21 34.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.147 0.979 . . . . 0.0 109.913 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.06 147.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 123.908 0.883 . . . . 0.0 110.782 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.479 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 19.0 p -114.36 105.1 12.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.639 0.776 . . . . 0.0 108.972 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 462' ' ' LEU . 48.4 t -98.34 154.44 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -130.18 107.5 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.461 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 36.6 t -78.01 106.48 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.476 0.71 . . . . 0.0 110.023 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -94.58 90.17 6.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.152 0.981 . . . . 0.0 109.257 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -12.12 60.49 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.955 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.35 -19.67 60.96 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.752 0.821 . . . . 0.0 111.034 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -72.47 -135.72 0.2 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 38.2 t30 -101.69 137.23 40.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.038 0.919 . . . . 0.0 109.295 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.02 -57.61 3.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -150.45 -87.98 0.07 OUTLIER Glycine 0 C--N 1.343 0.942 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.784 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.7 19.21 23.87 Favored 'Cis proline' 0 C--N 1.374 1.896 0 CA-C-N 120.705 2.252 . . . . 0.0 113.868 5.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.44 -7.27 46.33 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.627 0.771 . . . . 0.0 111.537 166.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.483 HD11 HD12 ' A' ' 456' ' ' LEU . 40.2 mt -116.84 140.05 49.89 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.2 1.0 . . . . 0.0 109.445 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.54 119.14 54.45 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.367 1.067 . . . . 0.0 110.619 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 24.5 Cg_endo -58.68 -24.64 71.83 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.478 2.785 . . . . 0.0 114.528 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -83.8 -44.64 14.15 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.746 0.419 . . . . 0.0 110.108 -176.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 32.7 mtt180 -67.23 -34.74 78.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.132 0.973 . . . . 0.0 111.723 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.48 -27.77 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.728 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 65.2 mm-40 -84.92 -27.76 26.37 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 122.058 -0.401 . . . . 0.0 110.469 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.9 mm-40 -71.96 -35.03 69.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.247 0.619 . . . . 0.0 112.253 -176.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.96 158.76 87.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.036 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.18 157.26 45.72 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.581 2.188 . . . . 0.0 113.042 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.25 0.27 29.31 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.504 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.461 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.1 p80 -166.4 149.97 7.31 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -122.9 107.91 12.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 168.87 12.56 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.19 -0.783 . . . . 0.0 112.141 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 130.22 19.33 Favored 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 120.058 1.929 . . . . 0.0 113.609 -0.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.03 -165.41 14.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.99 140.62 38.45 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.533 2.155 . . . . 0.0 111.205 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.735 HG22 ' HB1' ' A' ' 445' ' ' ALA . 6.1 p -47.87 -42.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.697 1.199 . . . . 0.0 112.214 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.01 -55.27 27.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.048 1.339 . . . . 0.0 110.697 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 393' ' ' ARG . 58.0 t -67.9 -43.72 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.144 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.68 -47.49 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.728 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 117.861 0.3 . . . . 0.0 110.777 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.3 ptt180 -73.22 -32.78 64.97 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -65.55 -30.61 71.38 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.377 0.671 . . . . 0.0 111.289 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.509 HG21 ' HG ' ' A' ' 449' ' ' LEU . 20.7 mm -67.6 -59.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.487 ' O ' HG22 ' A' ' 400' ' ' VAL . 80.7 t -61.44 -50.77 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.401 -171.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -65.32 -31.86 73.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.244 0.618 . . . . 0.0 111.785 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.23 94.71 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . 0.444 ' HB2' ' HE2' ' A' ' 452' ' ' PHE . 84.5 m -70.06 -41.64 73.89 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.184 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.504 HG23 ' CZ ' ' A' ' 452' ' ' PHE . 3.6 t -67.02 -42.6 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.18 -37.07 83.08 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 71.1 m -87.24 1.68 52.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 111.856 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.474 ' HB1' HG23 ' A' ' 409' ' ' VAL . . . -72.14 143.82 48.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 89.6 mt -82.27 125.11 30.58 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 67.74 53.17 0.7 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.502 1.121 . . . . 0.0 109.639 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.1 m -58.52 -27.24 64.32 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.068 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -36.7 69.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.242 0.617 . . . . 0.0 111.669 177.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.2 m -88.95 -37.43 15.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.474 HG23 ' HB1' ' A' ' 403' ' ' ALA . 98.3 t -64.05 -35.33 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.885 0.874 . . . . 0.0 111.722 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -72.27 -22.06 61.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.161 0.984 . . . . 0.0 110.28 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.81 -19.59 78.79 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.729 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.47 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 82.9 m-85 -75.68 -15.34 60.32 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.272 0.536 . . . . 0.0 111.726 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 104.46 6.5 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.685 0.755 . . . . 0.0 111.134 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 163.43 38.18 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.177 0.991 . . . . 0.0 110.181 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 167.54 26.73 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.284 1.989 . . . . 0.0 113.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.655 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 12.8 m-20 -145.3 130.37 18.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.941 1.296 . . . . 0.0 109.506 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -89.97 45.78 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.033 0.921 . . . . 0.0 109.708 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.655 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -93.15 -31.26 14.86 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.43 171.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.76 30.06 33.46 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.47 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.98 -122.54 1.55 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.54 166.67 18.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.368 0.667 . . . . 0.0 110.818 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 85.2 t -132.93 132.67 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.486 HG12 HD12 ' A' ' 436' ' ' LEU . 28.1 mm -114.85 126.49 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.317 0.647 . . . . 0.0 109.883 175.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 9.2 p -107.64 151.0 26.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 110.716 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.91 140.56 12.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.221 1.008 . . . . 0.0 110.007 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 48.9 m -87.15 118.88 26.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.913 0.485 . . . . 0.0 110.443 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -140.36 134.5 30.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.747 0.819 . . . . 0.0 109.448 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.2 t70 64.51 25.99 13.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.702 1.201 . . . . 0.0 110.988 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.33 88.7 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.554 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -109.44 168.82 9.11 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.626 1.171 . . . . 0.0 110.331 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.8 t -100.12 135.05 42.14 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -132.1 133.63 44.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.179 0.592 . . . . 0.0 110.283 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 64.7 p -126.42 140.24 52.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.741 0.816 . . . . 0.0 110.524 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 20.2 pt -119.85 161.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.315 0.646 . . . . 0.0 109.857 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -103.32 147.41 27.11 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.103 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 423' ' ' ILE . 7.6 mp -115.01 165.56 13.77 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.464 1.505 . . . . 0.0 108.809 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.31 142.0 23.59 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 121.92 1.747 . . . . 0.0 111.585 163.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.42 128.86 10.67 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.381 2.054 . . . . 0.0 112.87 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.07 172.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.556 0.742 . . . . 0.0 110.38 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -151.48 5.63 0.46 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.7 t -125.23 141.14 52.27 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.341 0.519 . . . . 0.0 110.53 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.47 -26.91 67.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.172 0.989 . . . . 0.0 111.919 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 33.2 t -70.34 -31.14 68.3 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.126 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -23.09 39.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -53.99 -62.05 1.91 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.242 0.544 . . . . 0.0 110.034 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.27 -35.67 68.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.812 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -62.75 -32.27 73.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.942 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.23 -56.4 11.45 Favored 'General case' 0 C--O 1.246 0.873 0 O-C-N 123.157 0.286 . . . . 0.0 110.608 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.509 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -73.67 -13.66 61.02 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.967 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.466 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 2.4 mm-40 -63.35 -47.06 83.72 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.351 0.66 . . . . 0.0 111.487 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -59.51 -43.86 93.28 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.615 0.766 . . . . 0.0 110.738 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.504 ' CZ ' HG23 ' A' ' 400' ' ' VAL . 44.6 t80 -69.98 -48.36 58.55 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.4 p -70.67 -21.32 62.61 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.574 0.749 . . . . 0.0 111.145 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -71.94 -37.55 69.99 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.634 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 77.0 p -76.58 -24.67 53.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.618 0.367 . . . . 0.0 110.582 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 371' ' ' LEU . 72.6 mt -77.67 -17.94 57.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 111.313 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.26 7.59 6.15 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.817 1.647 . . . . 0.0 111.745 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.59 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 17.7 p -81.11 134.8 35.71 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.368 0.604 . . . . 0.0 110.419 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 6.5 p-10 -145.38 147.09 31.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.997 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 59.75 19.08 7.85 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.811 0.844 . . . . 0.0 110.907 -171.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 38.3 tp -81.02 -27.15 35.94 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.16 0.584 . . . . 0.0 111.228 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.455 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -164.41 150.08 10.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.023 0.529 . . . . 0.0 110.727 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 70.2 m -166.3 149.13 7.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.328 1.051 . . . . 0.0 109.197 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 70.9 m -88.06 47.03 1.44 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.871 0.843 . . . . 0.0 111.553 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.29 143.7 17.8 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.042 1.337 . . . . 0.0 107.626 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.94 166.8 21.53 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.197 1.931 . . . . 0.0 112.921 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -68.83 -32.06 71.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.537 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.033 0.933 . . . . 0.0 109.526 173.719 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 34.6 t -69.32 -34.51 74.76 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 109.889 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . 0.419 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 77.6 m-70 -92.22 156.78 17.07 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.766 0.827 . . . . 0.0 108.847 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -68.14 -21.19 64.93 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.046 0.538 . . . . 0.0 111.54 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 352' ' ' HIS . 1.3 pmm? -102.02 171.13 7.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.6 t -83.25 179.09 7.8 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.695 0.798 . . . . 0.0 110.647 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.2 p -139.74 136.83 34.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.575 1.15 . . . . 0.0 109.112 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.44 157.67 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.826 0.85 . . . . 0.0 110.834 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 385' ' ' PRO . 24.1 p -124.16 116.88 23.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.356 1.062 . . . . 0.0 109.188 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.6 t -113.16 151.24 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.096 0.558 . . . . 0.0 110.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -126.72 103.26 7.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.105 1.362 . . . . 0.0 108.065 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.04 110.77 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.628 0.771 . . . . 0.0 110.862 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -99.05 92.91 5.71 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.583 0.753 . . . . 0.0 110.12 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -12.22 60.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.233 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -74.39 -19.59 60.37 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.774 0.83 . . . . 0.0 111.185 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.79 -111.11 0.03 OUTLIER Glycine 0 C--N 1.353 1.493 0 C-N-CA 122.985 0.326 . . . . 0.0 112.941 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 42.9 t30 -125.43 143.94 50.76 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.27 -62.28 1.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.03 -94.74 0.14 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.397 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -89.06 26.29 17.32 Favored 'Cis proline' 0 C--N 1.371 1.73 0 CA-C-N 120.116 1.958 . . . . 0.0 113.427 7.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.95 -10.25 59.49 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.214 0.606 . . . . 0.0 109.95 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.496 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 36.1 mt -114.74 140.86 48.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 125.454 1.501 . . . . 0.0 108.301 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.43 124.35 89.71 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.13 0.572 . . . . 0.0 110.414 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 30.5 Cg_endo -59.47 -32.97 97.21 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.244 2.63 . . . . 0.0 114.163 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.87 -42.55 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.468 0.307 . . . . 0.0 110.958 -176.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -70.96 -28.88 64.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 110.593 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.447 HD11 HD22 ' A' ' 379' ' ' LEU . 20.7 mm -63.0 -30.48 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.825 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 68.0 mm-40 -81.67 -22.36 37.53 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.462 0.305 . . . . 0.0 111.043 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 81.8 mm-40 -81.93 -35.29 29.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.447 HD22 HD11 ' A' ' 376' ' ' ILE . 3.0 pp -66.48 153.81 92.28 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.911 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.72 161.33 21.71 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.675 2.25 . . . . 0.0 114.327 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.77 -8.92 58.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.678 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -161.95 153.16 18.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.937 0.495 . . . . 0.0 110.967 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.402 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.6 m-85 -132.23 109.01 9.62 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.415 1.086 . . . . 0.0 108.078 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.27 -179.53 16.14 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 358' ' ' CYS . 59.7 Cg_endo -72.88 130.21 19.36 Favored 'Cis proline' 0 C--N 1.383 2.394 0 CA-C-N 119.889 1.845 . . . . 0.0 113.1 -4.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.71 -163.56 12.53 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.982 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -65.87 139.88 58.76 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.993 2.462 . . . . 0.0 111.926 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.757 HG22 ' HB1' ' A' ' 445' ' ' ALA . 5.3 p -49.26 -41.35 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.352 1.061 . . . . 0.0 111.579 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.09 -52.18 63.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.942 1.297 . . . . 0.0 110.675 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 81.4 t -69.07 -50.87 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.941 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.49 -40.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 122.999 0.52 . . . . 0.0 112.203 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.99 -41.48 74.33 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 117.859 0.299 . . . . 0.0 110.624 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -73.27 -24.47 60.44 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.542 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 48.6 mmm-85 -68.44 -38.77 81.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.819 0.448 . . . . 0.0 111.073 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.509 HG21 ' HG ' ' A' ' 449' ' ' LEU . 8.4 mm -65.63 -53.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 400' ' ' VAL . 91.3 t -61.78 -47.16 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.135 -174.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.407 ' HA ' HG22 ' A' ' 423' ' ' ILE . 2.6 pt20 -64.0 -30.03 71.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.582 0.353 . . . . 0.0 111.285 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -72.26 -40.97 67.25 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.256 0.622 . . . . 0.0 110.532 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.7 m -69.58 -46.47 66.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.341 0.657 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 396' ' ' VAL . 38.8 t -65.7 -39.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.199 0.6 . . . . 0.0 110.084 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.34 -53.46 57.02 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.232 0.613 . . . . 0.0 110.581 173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.442 ' SG ' HD23 ' A' ' 379' ' ' LEU . 73.9 m -79.92 0.99 28.97 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.553 -172.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -71.73 135.32 46.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.71 118.36 17.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 160.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.16 60.01 0.66 Allowed 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.077 0.942 . . . . 0.0 109.431 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 96.9 m -51.41 -40.62 59.67 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.075 1.75 . . . . 0.0 112.416 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -50.44 -41.09 52.18 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.176 1.39 . . . . 0.0 114.04 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 98.4 m -78.96 -39.39 34.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.645 0.778 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -60.69 -41.57 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.71 -14.07 59.98 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.073 0.949 . . . . 0.0 110.774 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.45 -23.24 77.56 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.507 -0.315 . . . . 0.0 113.401 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -71.27 -24.77 62.23 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.072 0.549 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.475 HD12 HD13 ' A' ' 434' ' ' ILE . 0.7 OUTLIER -119.43 112.72 19.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.026 0.931 . . . . 0.0 108.677 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -96.21 158.61 33.7 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.28 0.632 . . . . 0.0 110.738 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.69 144.9 45.27 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.168 1.912 . . . . 0.0 112.496 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.549 ' HB3' ' HG2' ' A' ' 418' ' ' ARG . 3.6 m-20 -150.13 136.1 18.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.977 1.311 . . . . 0.0 108.132 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.68 68.67 10.47 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.52 1.152 . . . . 0.0 108.33 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.549 ' HG2' ' HB3' ' A' ' 416' ' ' ASP . 78.7 mmt-85 -106.93 -22.49 12.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.611 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.27 65.64 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.614 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -97.71 -127.22 5.65 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.958 -0.356 . . . . 0.0 112.387 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.0 OUTLIER -72.88 169.32 17.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.887 0.875 . . . . 0.0 110.841 -176.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 54.4 t -140.32 133.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.825 . . . . 0.0 109.102 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 436' ' ' LEU . 47.8 mm -116.02 134.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 122.607 0.363 . . . . 0.0 110.219 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.0 p -107.25 143.09 35.98 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.93 15.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.527 0.731 . . . . 0.0 111.041 -169.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.4 m -86.53 104.2 15.76 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.89 0.476 . . . . 0.0 110.312 178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -116.23 106.57 13.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.29 1.036 . . . . 0.0 109.569 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.18 54.1 9.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.232 1.413 . . . . 0.0 111.56 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 83.2 -15.89 31.49 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.85 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.15 170.53 9.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.181 0.592 . . . . 0.0 111.37 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.9 t -111.46 102.02 10.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -94.92 142.26 27.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.397 0.679 . . . . 0.0 109.904 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 41.7 p -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.912 . . . . 0.0 109.771 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 413' ' ' LEU . 41.3 pt -123.99 -176.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.846 0.858 . . . . 0.0 111.047 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.28 143.31 51.26 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 121.462 0.648 . . . . 0.0 110.012 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.0 mp -111.0 159.2 33.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.901 1.68 . . . . 0.0 108.124 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.69 132.65 19.05 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.094 1.863 . . . . 0.0 111.706 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.19 129.7 19.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.279 1.986 . . . . 0.0 112.112 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.0 173.39 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.011 0.925 . . . . 0.0 110.87 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -153.46 -0.21 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.517 0.727 . . . . 0.0 111.243 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.6 m -118.21 138.29 52.43 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.07 -31.83 68.34 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.855 0.862 . . . . 0.0 111.281 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 22.0 m -59.57 -31.82 69.8 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.757 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -86.2 -22.79 26.76 Favored 'General case' 0 C--N 1.362 1.151 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.757 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -52.18 -66.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.598 0.759 . . . . 0.0 111.182 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.41 ' O ' HD21 ' A' ' 449' ' ' LEU . 0.4 OUTLIER -72.13 -34.62 68.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.68 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' A' ' 451' ' ' ASN . 0.0 OUTLIER -53.33 -36.33 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.285 0.634 . . . . 0.0 111.514 178.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -60.07 -56.48 21.07 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.139 0.899 . . . . 0.0 110.34 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.509 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -80.7 -13.92 58.59 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.706 -176.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.412 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 55.7 mt-10 -70.28 -46.63 63.95 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.673 0.669 . . . . 0.0 109.988 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.467 ' HB2' ' NH1' ' A' ' 447' ' ' ARG . 0.2 OUTLIER -67.52 -35.25 78.74 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.496 ' HB3' ' HA ' ' A' ' 449' ' ' LEU . 36.9 t80 -68.6 -48.83 63.14 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.444 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.5 p -70.09 -22.88 62.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.068 0.547 . . . . 0.0 111.021 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -57.17 -46.4 82.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 93.7 p -73.07 -23.28 60.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.046 0.539 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.498 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 47.7 mt -83.7 -8.37 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.651 0.781 . . . . 0.0 111.077 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.82 9.16 7.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.35 1.46 . . . . 0.0 111.275 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.694 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.8 p -94.94 144.58 25.56 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.553 0.741 . . . . 0.0 110.044 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -163.04 164.21 25.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 65.53 14.58 9.57 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.159 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.08 -8.63 59.06 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.373 1.069 . . . . 0.0 111.533 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 169.22 22.66 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.347 0.659 . . . . 0.0 109.916 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 46.6 m -158.38 114.18 2.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.629 0.772 . . . . 0.0 109.79 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 26.5 t -73.23 -6.66 47.37 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.769 0.827 . . . . 0.0 111.237 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -105.76 149.68 38.25 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.323 1.049 . . . . 0.0 109.698 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.48 171.33 15.47 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.792 2.328 . . . . 0.0 112.645 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.78 -19.87 61.27 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.795 0.838 . . . . 0.0 111.358 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.252 1.19 0 C-N-CA 124.164 0.985 . . . . 0.0 108.367 172.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 46.7 t -151.24 163.79 38.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.975 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -159.06 123.33 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.288 1.035 . . . . 0.0 109.849 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.5 ptm -114.98 11.79 16.59 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.775 0.798 . . . . 0.0 109.548 165.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -148.8 167.66 25.04 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.414 1.485 . . . . 0.0 108.16 -177.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.9 m -72.99 178.05 4.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.027 0.531 . . . . 0.0 111.852 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.7 p -139.61 133.45 30.71 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.527 1.131 . . . . 0.0 109.131 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.57 157.49 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.285 1.034 . . . . 0.0 111.148 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.57 108.05 10.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.313 1.045 . . . . 0.0 108.72 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.451 HG22 HD13 ' A' ' 395' ' ' ILE . 30.4 m -92.59 120.95 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -88.54 97.94 11.37 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.491 HG12 HD11 ' A' ' 379' ' ' LEU . 44.9 t -72.63 98.28 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.622 -171.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.487 ' HB2' ' HZ ' ' A' ' 467' ' ' PHE . 37.9 t30 -91.08 86.44 6.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.757 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.591 ' HB3' ' HZ2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -72.5 -12.93 61.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.786 175.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.793 0.837 . . . . 0.0 110.299 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -76.9 -149.83 3.37 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.11 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 41.3 t30 -82.85 142.32 31.59 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.301 0.551 . . . . 0.0 110.132 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -85.42 -56.11 3.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.514 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.99 -88.95 0.07 OUTLIER Glycine 0 C--N 1.349 1.256 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.127 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.73 4.06 65.3 Favored 'Cis proline' 0 C--N 1.371 1.712 0 CA-C-N 120.879 2.34 . . . . 0.0 113.744 10.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -70.46 -13.01 61.95 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.953 0.901 . . . . 0.0 110.37 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.514 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 28.5 mt -99.1 143.96 28.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.0 109.116 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.31 121.82 84.45 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 123.99 0.806 . . . . 0.0 110.455 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.534 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 50.9 Cg_endo -64.35 -22.28 66.3 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.187 2.591 . . . . 0.0 114.646 -172.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.534 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -83.94 -43.63 15.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.121 0.418 . . . . 0.0 110.076 -176.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 57.9 mtt180 -67.22 -37.49 83.69 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.085 0.954 . . . . 0.0 111.923 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.456 ' HA ' HD23 ' A' ' 379' ' ' LEU . 15.7 mm -53.64 -28.85 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.433 0 C-N-CA 124.076 0.951 . . . . 0.0 112.347 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 71.0 mm-40 -83.59 -17.85 40.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.257 0.623 . . . . 0.0 111.737 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -80.33 -43.08 21.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.424 0.69 . . . . 0.0 111.728 -171.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.491 HD11 HG12 ' A' ' 361' ' ' VAL . 0.4 OUTLIER -64.03 153.27 85.48 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.564 175.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -62.95 165.78 15.72 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.678 2.252 . . . . 0.0 113.233 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.66 -6.86 59.42 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.307 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.411 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.1 p80 -162.58 137.62 6.86 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.33 0.652 . . . . 0.0 110.605 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.97 103.81 14.47 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.38 -174.14 17.44 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.3 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 128.19 15.21 Favored 'Cis proline' 0 C--N 1.382 2.333 0 CA-C-N 119.291 1.545 . . . . 0.0 112.817 0.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.72 30.34 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.977 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.55 129.95 28.27 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.125 2.55 . . . . 0.0 113.279 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.739 HG21 ' HB1' ' A' ' 445' ' ' ALA . 3.1 p -45.42 -50.16 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.274 1.829 . . . . 0.0 112.688 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.446 ' OD1' HG12 ' A' ' 388' ' ' VAL . 2.4 m120 -57.64 -43.96 85.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.395 . . . . 0.0 112.009 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 93.7 t -76.41 -51.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.134 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.01 -42.27 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 123.386 0.674 . . . . 0.0 112.404 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 122.856 0.097 . . . . 0.0 110.984 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.452 ' N ' HD13 ' A' ' 392' ' ' LEU . 7.8 ptt180 -73.09 -25.54 60.92 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.141 0.276 . . . . 0.0 110.388 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 11.5 mmm180 -68.23 -35.21 77.6 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 122.846 0.458 . . . . 0.0 110.124 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.548 HG13 HD23 ' A' ' 449' ' ' LEU . 25.9 mm -63.62 -47.67 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.875 0.734 . . . . 0.0 109.405 173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 452' ' ' PHE . 38.9 t -63.96 -60.62 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.733 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 423' ' ' ILE . 3.5 pt20 -60.86 -29.47 69.54 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.58 -59.63 2.72 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.25 -32.77 74.39 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 396' ' ' VAL . 38.5 t -68.17 -47.51 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.92 -19.92 58.4 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.348 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 93.5 m -100.02 10.11 41.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.114 0.965 . . . . 0.0 110.352 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -86.07 151.29 23.82 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.47 122.78 27.95 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 162.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 66.65 57.67 0.67 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.48 1.112 . . . . 0.0 109.934 -174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.43 HG23 HG13 ' A' ' 400' ' ' VAL . 89.6 m -54.12 -34.0 59.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.592 1.557 . . . . 0.0 112.415 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -55.64 -39.55 71.0 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.855 1.262 . . . . 0.0 113.466 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.3 m -81.47 -36.05 29.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 110.171 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.423 HG11 ' HA ' ' A' ' 400' ' ' VAL . 67.7 t -62.44 -38.07 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.867 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -68.44 -19.31 64.57 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.95 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.81 -23.57 77.78 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.927 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -77.01 -10.73 59.56 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 117.276 0.538 . . . . 0.0 111.641 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.551 HD12 HD11 ' A' ' 434' ' ' ILE . 0.3 OUTLIER -129.04 117.8 21.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.729 0.812 . . . . 0.0 109.614 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -95.18 157.91 35.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.789 0.836 . . . . 0.0 110.916 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.87 153.14 76.28 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.144 1.896 . . . . 0.0 111.434 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -151.15 136.54 17.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.689 0.28 . . . . 0.0 110.527 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.52 10.11 26.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.807 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.477 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 5.9 mpt_? -59.59 -35.0 73.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.527 1.131 . . . . 0.0 111.417 171.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.444 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 85.49 28.23 30.52 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.36 0.413 . . . . 0.0 113.378 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.93 -110.03 0.31 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 120.023 -0.321 . . . . 0.0 113.39 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.98 172.0 8.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.802 0.441 . . . . 0.0 110.348 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 75.8 t -132.08 130.2 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 397' ' ' GLN . 36.9 mm -115.11 131.66 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.43 ' HB ' ' OG1' ' A' ' 431' ' ' THR . 19.2 p -108.86 137.64 46.46 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.417 1.087 . . . . 0.0 108.743 172.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -158.63 128.95 5.99 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.67 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.5 m -66.87 102.47 0.96 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.462 0.705 . . . . 0.0 112.149 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -135.68 136.2 40.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.936 1.294 . . . . 0.0 108.813 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.7 t70 66.63 16.35 10.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.391 1.076 . . . . 0.0 111.163 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.02 61.79 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 122.012 -0.43 . . . . 0.0 113.849 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -116.91 166.99 11.53 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.43 ' OG1' ' HB ' ' A' ' 424' ' ' THR . 12.9 t -89.86 102.87 15.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.914 0.864 . . . . 0.0 109.248 175.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.73 131.41 40.82 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.046 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 34.8 p -111.01 131.46 55.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.328 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.551 HD11 HD12 ' A' ' 413' ' ' LEU . 16.4 pt -132.41 174.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 124.298 1.039 . . . . 0.0 109.762 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.444 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 21.0 mt-30 -113.11 147.88 36.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.273 0.629 . . . . 0.0 110.842 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.416 HD22 ' HE1' ' A' ' 448' ' ' PHE . 9.8 mp -115.48 166.6 11.69 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.156 1.382 . . . . 0.0 108.636 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.11 145.48 44.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 121.998 1.799 . . . . 0.0 111.939 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 418' ' ' ARG . 64.3 Cg_endo -83.54 159.95 14.62 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.453 2.102 . . . . 0.0 112.015 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.94 173.51 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.712 0.805 . . . . 0.0 109.695 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -150.43 18.26 0.83 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.807 0.443 . . . . 0.0 111.169 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.2 t -124.82 140.21 53.13 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.03 63.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.211 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.9 m -69.85 -25.01 63.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.104 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.7 -21.74 25.04 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.739 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -53.29 -65.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.7 0.8 . . . . 0.0 111.17 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 1.4 pp -62.68 -37.84 88.04 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.119 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.38 71.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.415 1.086 . . . . 0.0 112.019 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . 0.416 ' HE1' HD22 ' A' ' 436' ' ' LEU . 31.1 t80 -71.74 -43.27 66.12 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.12 0.962 . . . . 0.0 108.562 -173.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.557 HD13 HD22 ' A' ' 462' ' ' LEU . 3.9 pp -89.19 -14.3 36.36 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.418 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.1 tm-20 -69.21 -50.3 48.61 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.826 1.251 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.9 -38.01 77.91 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.728 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.499 ' CE2' ' HA ' ' A' ' 396' ' ' VAL . 34.8 t80 -66.84 -50.85 61.26 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.385 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.501 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 31.2 p -71.57 -22.0 61.8 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.408 0.683 . . . . 0.0 110.687 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -66.3 -39.92 89.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.087 0.955 . . . . 0.0 110.127 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.1 m -65.81 -29.74 70.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.803 0.841 . . . . 0.0 111.321 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.443 HD11 HD11 ' A' ' 371' ' ' LEU . 41.0 mt -84.25 -13.5 52.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.008 0.923 . . . . 0.0 111.311 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 71.38 7.91 6.17 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.826 1.651 . . . . 0.0 111.668 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 21.1 p -83.27 133.64 34.98 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -148.55 147.42 29.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.935 -173.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 59.86 21.85 10.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.583 0.753 . . . . 0.0 110.425 -168.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 18.3 tp -83.12 -15.76 49.45 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.449 0.7 . . . . 0.0 109.893 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.557 HD22 HD13 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.28 171.44 19.15 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.365 1.066 . . . . 0.0 108.757 174.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.0 m -165.79 115.54 1.01 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.1 t -64.74 -17.42 64.13 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.809 0.338 . . . . 0.0 111.398 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.85 151.26 38.26 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.274 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.12 168.53 23.86 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.565 2.176 . . . . 0.0 112.768 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . 0.487 ' HZ ' ' HB2' ' A' ' 362' ' ' ASN . 19.4 m-85 -74.13 -26.6 60.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.763 0.825 . . . . 0.0 110.301 178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.406 1.083 . . . . 0.0 108.243 169.263 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.964 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 m -80.97 175.92 10.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.785 0.834 . . . . 0.0 111.025 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -80.64 66.11 6.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.203 0.525 . . . . 0.0 109.82 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.1 ptm -75.0 -18.74 60.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.217 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -99.89 158.51 15.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 108.73 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 11.0 t -79.72 -177.9 6.12 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.845 0.458 . . . . 0.0 110.516 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 28.1 p -138.99 136.58 35.51 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.564 0.746 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.75 161.51 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.41 1.084 . . . . 0.0 110.851 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 30.5 p -132.76 132.36 42.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.51 HG23 HD13 ' A' ' 395' ' ' ILE . 26.3 m -117.34 154.58 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.119 0.568 . . . . 0.0 110.022 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 47.8 m-85 -111.78 100.32 8.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.48 88.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 0.0 109.501 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -81.78 93.21 6.78 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.909 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.563 ' HZ2' HD11 ' A' ' 379' ' ' LEU . 0.0 OUTLIER -76.67 -5.22 47.02 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.114 178.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -84.31 -13.22 53.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.268 0.627 . . . . 0.0 111.006 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -73.3 -112.14 0.07 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.405 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -121.62 138.42 54.34 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.68 3.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.54 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -156.22 -86.98 0.06 OUTLIER Glycine 0 C--O 1.216 -0.974 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.485 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.04 12.9 44.41 Favored 'Cis proline' 0 C--N 1.368 1.582 0 CA-C-N 120.931 2.366 . . . . 0.0 114.084 8.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -72.75 -7.82 52.44 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.001 0.52 . . . . 0.0 111.478 172.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.1 mt -110.41 143.78 40.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.495 1.118 . . . . 0.0 109.227 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.15 118.92 60.52 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.631 0.772 . . . . 0.0 110.532 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 12.4 Cg_endo -52.84 -36.61 74.72 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.887 3.058 . . . . 0.0 114.337 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -80.28 -45.48 17.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -170.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -64.39 -36.06 82.91 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 111.58 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.4 HD13 HD23 ' A' ' 379' ' ' LEU . 17.6 mm -55.82 -31.96 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 124.392 1.058 . . . . 0.0 111.427 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 54.3 mm-40 -78.4 -35.92 46.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.7 0.4 . . . . 0.0 110.696 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 69.9 mm-40 -71.54 -33.84 69.5 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.524 0.73 . . . . 0.0 112.092 -171.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.563 HD11 ' HZ2' ' A' ' 363' ' ' LYS . 2.5 pp -71.11 155.64 92.94 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.53 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.44 148.62 33.23 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.19 2.594 . . . . 0.0 113.903 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.27 -10.54 59.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.034 1.333 . . . . 0.0 111.825 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -164.52 145.5 8.05 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -114.57 159.44 20.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.79 1.236 . . . . 0.0 108.766 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.88 -179.68 51.0 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.111 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -79.87 128.82 16.75 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 119.441 1.621 . . . . 0.0 111.831 2.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.14 25.02 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 133.57 38.73 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 123.051 2.501 . . . . 0.0 113.629 -169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.699 HG21 ' HB1' ' A' ' 445' ' ' ALA . 7.2 p -47.3 -39.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.511 1.924 . . . . 0.0 111.985 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.29 -54.14 49.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.467 1.507 . . . . 0.0 111.014 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 393' ' ' ARG . 97.0 t -74.11 -47.64 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.121 -173.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.67 -38.54 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.15 -43.43 61.55 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 390' ' ' VAL . 39.6 ptt180 -72.1 -25.63 61.82 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.661 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.54 -36.15 82.96 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.81 0.694 . . . . 0.0 110.698 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.51 HD13 HG23 ' A' ' 359' ' ' VAL . 35.3 mm -66.66 -56.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 400' ' ' VAL . 95.5 t -57.57 -52.72 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 124.113 0.883 . . . . 0.0 111.045 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 423' ' ' ILE . 2.8 pt20 -64.34 -35.89 82.35 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.7 0.4 . . . . 0.0 111.914 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -68.29 -36.44 79.37 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 123.381 0.426 . . . . 0.0 110.046 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 84.1 m -68.87 -49.82 55.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.025 0.53 . . . . 0.0 111.205 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.0 t -63.59 -48.23 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 122.921 0.488 . . . . 0.0 110.068 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.96 -36.4 77.86 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.59 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 72.6 m -83.99 -1.27 54.36 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.452 0.301 . . . . 0.0 111.286 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -71.33 137.47 48.5 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.37 117.15 8.96 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 166.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 64.46 66.26 0.61 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.135 0.969 . . . . 0.0 109.625 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.515 HG22 HG13 ' A' ' 400' ' ' VAL . 78.0 m -54.75 -35.62 63.94 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.771 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -59.41 -35.36 73.85 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.56 1.144 . . . . 0.0 113.131 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 85.7 m -80.4 -37.89 31.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.69 0.796 . . . . 0.0 109.775 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 403' ' ' ALA . 40.3 t -69.43 -30.41 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.082 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -73.24 -20.01 60.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.444 1.098 . . . . 0.0 110.209 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -63.74 -15.05 57.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.584 -0.735 . . . . 0.0 114.692 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.07 3.03 55.88 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.598 0.699 . . . . 0.0 111.719 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.441 HD11 HD13 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -148.07 106.53 3.78 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.416 0.626 . . . . 0.0 110.476 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 160.8 31.0 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.133 0.973 . . . . 0.0 109.779 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.03 163.79 24.41 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.488 2.125 . . . . 0.0 113.655 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.08 163.18 23.65 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 0.0 108.857 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -130.26 35.95 4.03 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.235 0.614 . . . . 0.0 110.867 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.52 -39.75 4.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.868 170.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 100.65 42.59 2.47 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.23 -106.57 0.28 Allowed Glycine 0 C--N 1.343 0.947 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.736 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 5.2 mp0 -83.33 172.74 12.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.994 0.397 . . . . 0.0 110.266 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.96 131.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.887 0.875 . . . . 0.0 108.791 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 433' ' ' SER . 35.8 mm -117.81 133.53 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.152 0.581 . . . . 0.0 110.02 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.4 p -108.85 137.18 47.2 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.932 0.893 . . . . 0.0 109.931 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.09 134.71 11.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 13.6 p -77.2 115.89 17.37 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.203 0.601 . . . . 0.0 109.851 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -153.98 140.7 19.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 108.945 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . 0.414 ' HB3' ' HE1' ' A' ' 432' ' ' HIS . 17.3 t70 63.01 16.9 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.728 1.211 . . . . 0.0 112.162 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.94 -18.44 57.18 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.11 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -109.23 166.38 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.5 t -89.69 104.72 17.26 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 167.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.414 ' HE1' ' HB3' ' A' ' 428' ' ' ASP . 51.0 m80 -95.53 129.07 42.83 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.312 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 57.8 p -118.07 132.88 56.32 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.586 0.755 . . . . 0.0 109.99 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.441 HD13 HD11 ' A' ' 413' ' ' LEU . 30.7 pt -118.43 179.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.275 0.63 . . . . 0.0 109.843 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -111.36 151.73 28.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 82.4 mt -117.31 151.44 47.95 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.48 1.112 . . . . 0.0 108.557 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.26 131.22 35.42 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.392 2.062 . . . . 0.0 111.757 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.28 137.78 77.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.06 2.506 . . . . 0.0 114.533 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.2 m -109.82 167.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.917 0.887 . . . . 0.0 109.603 171.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.67 15.69 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.557 0.343 . . . . 0.0 111.254 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 26.0 t -123.48 141.43 52.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.804 0.442 . . . . 0.0 109.927 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.07 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.113 0.965 . . . . 0.0 112.322 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.5 m -70.3 -19.47 63.09 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.999 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.699 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -51.61 -60.98 2.54 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.65 -54.38 46.07 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.682 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -49.06 -40.66 32.34 Favored 'General case' 0 C--O 1.247 0.935 0 O-C-N 125.023 1.452 . . . . 0.0 112.281 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.18 -48.64 79.15 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.151 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -83.22 -17.1 43.92 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.133 178.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.59 -42.71 74.09 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 119.325 0.966 . . . . 0.0 110.047 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -62.42 -38.48 89.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.826 0.704 . . . . 0.0 110.629 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 456' ' ' LEU . 36.5 t80 -68.91 -49.8 54.98 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.033 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.474 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 89.5 m -67.39 -22.41 65.55 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.25 1.02 . . . . 0.0 111.514 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -65.97 -36.44 83.33 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.8 t -77.23 -28.58 53.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.876 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.491 HD13 HD22 ' A' ' 371' ' ' LEU . 64.9 mt -77.23 -16.75 58.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.256 0.623 . . . . 0.0 111.397 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 71.0 6.55 5.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.012 1.725 . . . . 0.0 111.471 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.565 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -78.0 132.34 37.77 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 34.5 t70 -147.35 142.34 27.0 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.065 -165.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 60.28 18.8 8.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.17 0.988 . . . . 0.0 110.276 -167.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 32.5 tp -80.81 -24.09 38.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 122.933 0.493 . . . . 0.0 111.019 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.612 HD21 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -155.58 160.35 40.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.668 0.387 . . . . 0.0 111.018 174.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 33.5 p -164.3 133.54 3.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.801 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 8.4 t -81.67 -2.2 49.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.069 0.548 . . . . 0.0 111.831 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -72.09 109.36 5.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.679 1.192 . . . . 0.0 110.17 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.68 174.58 4.0 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.809 2.339 . . . . 0.0 112.234 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -78.28 -21.83 49.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.108 0.563 . . . . 0.0 110.139 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.392 0 C-N-CA 123.821 0.848 . . . . 0.0 109.707 177.183 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 m -80.6 -35.3 34.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.264 0.626 . . . . 0.0 110.383 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -75.92 126.07 30.3 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.75 -165.5 0.45 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 123.696 0.622 . . . . 0.0 110.71 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.509 ' HG3' ' HB3' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -65.93 150.15 49.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.813 0.445 . . . . 0.0 110.448 171.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.1 t -72.48 -178.94 2.76 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.468 0.307 . . . . 0.0 110.178 168.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.29 138.3 43.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.23 0.612 . . . . 0.0 110.25 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.03 158.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.311 1.044 . . . . 0.0 110.485 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 21.0 p -134.36 107.5 7.65 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.65 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.524 HG22 HD11 ' A' ' 395' ' ' ILE . 34.4 m -94.77 154.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -117.63 99.95 7.3 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.421 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 48.6 t -69.9 98.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.743 0.817 . . . . 0.0 110.015 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.29 83.73 7.88 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.583 ' HB3' ' HZ2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -72.59 -6.24 42.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.31 176.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -78.0 -21.26 51.09 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.467 0.707 . . . . 0.0 110.51 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.63 -148.08 6.28 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.885 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.5 t30 -74.46 140.37 44.56 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.283 0.564 . . . . 0.0 109.973 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -54.06 4.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.558 1.143 . . . . 0.0 108.253 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.695 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -155.22 -86.53 0.06 OUTLIER Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.75 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -88.61 15.99 44.42 Favored 'Cis proline' 0 C--N 1.365 1.422 0 CA-C-N 120.194 1.997 . . . . 0.0 114.022 8.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -70.75 -12.21 61.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.705 0.402 . . . . 0.0 110.847 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 22.5 mt -107.44 131.93 53.75 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 109.035 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.18 126.87 93.18 Favored Pre-proline 0 N--CA 1.481 1.099 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.498 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.517 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.1 Cg_endo -60.07 -41.49 51.92 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.349 2.699 . . . . 0.0 113.294 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.517 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -66.57 -39.7 88.61 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.879 0.471 . . . . 0.0 110.74 -175.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -74.11 -30.93 62.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.754 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.503 ' HA ' HD22 ' A' ' 379' ' ' LEU . 10.0 mm -62.75 -24.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.047 0.939 . . . . 0.0 111.466 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 55.1 mm-40 -83.31 -17.05 43.84 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.675 0.39 . . . . 0.0 111.15 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -79.2 -30.46 43.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.162 0.585 . . . . 0.0 111.626 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 376' ' ' ILE . 0.3 OUTLIER -74.82 157.43 85.74 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 169.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.25 166.5 21.06 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.56 2.174 . . . . 0.0 112.972 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.39 1.49 21.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.13 0.972 . . . . 0.0 111.179 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.421 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.8 p80 -158.84 155.57 28.05 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.725 0.81 . . . . 0.0 110.34 173.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -125.07 113.29 17.55 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 167.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 114.53 176.75 18.97 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.357 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.65 128.98 16.81 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 119.71 1.755 . . . . 0.0 112.655 1.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.51 -164.29 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.051 -0.861 . . . . 0.0 111.594 -174.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.509 ' HB3' ' HG3' ' A' ' 354' ' ' MET . 7.8 Cg_exo -66.36 139.21 53.63 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.955 2.437 . . . . 0.0 112.072 -170.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.75 HG21 ' HB1' ' A' ' 445' ' ' ALA . 4.1 p -53.75 -45.71 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.133 0.973 . . . . 0.0 111.341 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.517 ' HB3' HH21 ' A' ' 393' ' ' ARG . 12.7 m120 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.277 . . . . 0.0 110.74 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 71.1 t -70.63 -57.67 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.632 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.75 -44.19 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.397 0.679 . . . . 0.0 112.457 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.36 -41.68 76.25 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-N 117.571 0.169 . . . . 0.0 110.564 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.517 HH21 ' HB3' ' A' ' 389' ' ' ASN . 11.4 ptp180 -70.48 -28.63 65.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 29.9 mmt180 -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 123.688 0.617 . . . . 0.0 110.989 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.524 HD11 HG22 ' A' ' 359' ' ' VAL . 24.6 mm -65.62 -57.18 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.506 ' O ' HG21 ' A' ' 400' ' ' VAL . 85.4 t -58.69 -49.31 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.737 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.543 ' HA ' HG22 ' A' ' 423' ' ' ILE . 3.3 pt20 -68.27 -37.36 80.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.631 0.372 . . . . 0.0 111.398 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 379' ' ' LEU . . . -66.37 -35.35 80.11 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.395 0.435 . . . . 0.0 110.064 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 93.0 m -67.68 -53.33 28.62 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.597 0.561 . . . . 0.0 110.978 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 396' ' ' VAL . 20.3 t -61.26 -47.27 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 122.748 0.419 . . . . 0.0 110.527 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.98 -46.8 76.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 89.3 m -73.61 -5.68 41.89 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.895 0.478 . . . . 0.0 112.264 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.67 143.78 55.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.414 0.625 . . . . 0.0 112.635 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.94 126.79 30.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.959 163.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 56.5 2.72 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-O 122.085 0.945 . . . . 0.0 109.694 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 92.2 m -53.75 -32.16 51.23 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.037 1.335 . . . . 0.0 111.77 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -57.48 -32.23 66.78 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.815 1.246 . . . . 0.0 112.666 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 80.7 m -89.3 -42.73 11.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.716 0.806 . . . . 0.0 110.48 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 403' ' ' ALA . 69.7 t -60.66 -32.91 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.832 0.853 . . . . 0.0 111.66 -177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -72.48 -26.83 61.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.771 1.228 . . . . 0.0 110.557 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.29 -15.36 72.44 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.966 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -79.73 -2.66 44.03 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.492 0.646 . . . . 0.0 111.845 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -145.81 105.26 3.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.489 0.661 . . . . 0.0 110.148 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -83.9 157.42 63.41 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.146 0.978 . . . . 0.0 110.375 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.91 163.39 37.66 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.007 1.805 . . . . 0.0 112.873 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.15 137.5 29.12 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.464 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -96.34 38.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.265 0.626 . . . . 0.0 111.423 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -95.01 -16.98 22.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.402 0.681 . . . . 0.0 110.638 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.41 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 74.97 39.42 38.15 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.29 -122.63 3.91 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.153 -0.248 . . . . 0.0 113.09 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.4 OUTLIER -70.07 162.63 27.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.788 0.835 . . . . 0.0 110.642 -177.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.1 128.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.543 HG22 ' HA ' ' A' ' 397' ' ' GLN . 36.6 mm -111.4 121.92 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.452 0.701 . . . . 0.0 110.215 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.2 p -107.51 142.9 36.67 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.442 1.097 . . . . 0.0 110.221 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -163.41 136.33 5.45 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.891 0.744 . . . . 0.0 110.986 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 67.4 m -74.88 119.6 19.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.48 0.712 . . . . 0.0 111.875 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -148.51 137.7 21.81 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.468 1.107 . . . . 0.0 109.73 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 58.83 33.47 23.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.945 1.298 . . . . 0.0 112.117 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.04 87.15 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.386 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.82 171.68 13.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.06 0.944 . . . . 0.0 109.572 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -94.77 130.18 41.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -119.37 142.45 48.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.651 0.781 . . . . 0.0 109.716 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 42.2 p -129.08 143.07 50.74 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 110.483 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.479 HD11 HD11 ' A' ' 413' ' ' LEU . 26.8 pt -119.61 173.65 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.216 0.606 . . . . 0.0 109.42 171.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.41 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 28.5 mt-30 -113.8 151.72 31.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.351 0.661 . . . . 0.0 110.342 171.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 78.9 mt -116.56 168.49 8.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.287 1.435 . . . . 0.0 108.962 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.24 136.77 20.36 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.601 1.534 . . . . 0.0 111.256 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -73.07 133.04 19.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.469 2.112 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.5 m -99.99 174.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.977 0.911 . . . . 0.0 110.997 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.32 12.11 0.41 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.959 0.504 . . . . 0.0 110.966 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.6 t -119.21 138.32 53.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.722 0.409 . . . . 0.0 110.635 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.89 -29.21 62.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.978 0.911 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 18.6 m -71.87 -22.25 61.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.187 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.6 -32.98 20.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.75 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -47.38 -63.73 0.97 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.708 1.203 . . . . 0.0 111.478 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.25 -47.77 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.994 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -32.34 64.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.122 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -62.98 -56.6 15.67 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 122.884 0.474 . . . . 0.0 110.121 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.54 -14.97 59.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.556 -178.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.564 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 50.0 mt-10 -72.74 -40.3 66.19 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.586 0.63 . . . . 0.0 109.853 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.73 -32.3 72.82 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.511 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.501 ' CE2' HD13 ' A' ' 456' ' ' LEU . 48.4 t80 -81.02 -42.14 21.59 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.405 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 21.7 p -68.28 -23.85 64.8 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.199 0.599 . . . . 0.0 110.411 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -62.17 -32.81 73.47 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.07 1.348 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -78.34 -32.86 49.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.539 0.736 . . . . 0.0 110.794 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.513 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 39.0 mt -83.8 -10.29 58.18 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.641 0.776 . . . . 0.0 112.204 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 71.26 7.29 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.741 1.616 . . . . 0.0 111.373 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.695 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -84.67 135.42 34.17 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 122.894 0.478 . . . . 0.0 110.04 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.517 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 28.1 t70 -147.12 158.66 44.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.602 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.2 p30 48.64 26.11 1.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.643 1.177 . . . . 0.0 112.654 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.55 -15.66 30.24 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.905 1.282 . . . . 0.0 110.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.449 HD23 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.74 164.56 33.75 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.354 0.661 . . . . 0.0 110.273 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 42.0 p -168.06 129.0 1.37 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 108.459 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.2 t -67.85 -20.64 65.16 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.103 0.561 . . . . 0.0 111.72 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 146.95 34.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.984 0.914 . . . . 0.0 109.096 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.44 174.88 11.81 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.301 2.0 . . . . 0.0 111.621 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -75.27 -8.94 57.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.919 0.488 . . . . 0.0 112.184 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 CA--C 1.556 1.211 0 C-N-CA 123.569 0.748 . . . . 0.0 109.394 175.73 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 52.6 p -67.36 -39.93 85.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.197 0.599 . . . . 0.0 111.048 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -80.71 1.87 28.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.671 0.788 . . . . 0.0 112.641 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 43.0 ttm -80.0 -41.54 25.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.596 0.758 . . . . 0.0 110.834 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.66 -175.51 5.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.263 0.625 . . . . 0.0 111.071 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.7 t -90.34 178.2 6.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.396 1.078 . . . . 0.0 110.841 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.2 p -136.39 135.32 38.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.729 1.212 . . . . 0.0 109.624 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.96 167.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.922 0.889 . . . . 0.0 110.738 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.44 121.24 18.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.068 0.947 . . . . 0.0 108.809 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 395' ' ' ILE . 35.5 m -105.19 146.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 170.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -111.94 98.46 7.38 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.478 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 42.4 t -68.66 101.53 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 124.323 1.014 . . . . 0.0 109.897 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 51.2 t30 -92.21 90.39 7.28 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.156 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -5.69 49.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.761 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . 0.414 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 66.5 t60 -76.87 -19.36 57.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.673 0.789 . . . . 0.0 110.174 167.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -74.0 -125.74 0.12 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.677 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -106.8 156.05 19.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.496 0.648 . . . . 0.0 109.374 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.14 -64.41 1.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.52 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.94 -87.9 0.07 OUTLIER Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.275 -173.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -85.91 17.2 33.85 Favored 'Cis proline' 0 C--N 1.374 1.907 0 CA-C-N 120.51 2.155 . . . . 0.0 113.998 4.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -70.81 -22.69 62.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.117 0.567 . . . . 0.0 110.284 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.52 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.7 mt -96.34 136.74 36.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.33 1.052 . . . . 0.0 109.56 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 375' ' ' ARG . 12.8 t70 -65.35 126.16 90.89 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.827 0.851 . . . . 0.0 110.653 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.487 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 60.5 Cg_endo -68.0 -19.49 45.71 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.814 2.343 . . . . 0.0 113.872 -170.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -84.74 -47.41 10.45 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 372' ' ' ASP . 38.4 mtt180 -62.32 -35.53 79.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 0.0 112.064 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.9 mm -58.47 -29.64 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.505 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.6 mm-40 -85.76 -19.12 31.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.568 0.347 . . . . 0.0 110.996 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 79.3 mm-40 -87.4 -29.11 21.73 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.345 0.658 . . . . 0.0 112.556 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 361' ' ' VAL . 2.7 pp -69.84 159.61 83.36 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.741 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.2 152.13 74.15 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.512 2.142 . . . . 0.0 113.279 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.34 -4.07 37.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.41 1.084 . . . . 0.0 111.808 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 38.7 p-80 -161.55 148.76 14.61 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.339 0.656 . . . . 0.0 110.815 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -116.85 104.17 11.04 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 133.03 -173.92 20.79 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.376 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.99 128.36 14.48 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.097 -5.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -152.27 -162.3 10.78 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.21 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -68.69 139.39 44.03 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.067 2.511 . . . . 0.0 112.072 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.697 HG23 ' HB1' ' A' ' 445' ' ' ALA . 6.8 p -50.51 -39.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.46 1.104 . . . . 0.0 111.754 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.61 -48.28 67.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.65 -47.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.23 -43.58 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.23 0.612 . . . . 0.0 111.98 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.7 pp -68.21 -44.29 76.11 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 120.68 0.276 . . . . 0.0 110.563 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.485 HH11 ' HA ' ' A' ' 421' ' ' GLU . 29.4 ptt180 -74.56 -24.51 58.93 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.54 -38.63 91.7 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.921 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.515 HD13 HG23 ' A' ' 359' ' ' VAL . 27.6 mm -65.42 -55.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 400' ' ' VAL . 68.2 t -61.66 -47.02 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.706 -172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.98 -32.14 71.5 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.645 0.378 . . . . 0.0 110.88 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.551 0.532 . . . . 0.0 110.068 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.37 -56.17 12.36 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.152 0.908 . . . . 0.0 110.949 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 396' ' ' VAL . 3.0 t -62.55 -37.38 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.75 -43.73 95.56 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.593 0.757 . . . . 0.0 111.19 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 19.9 p -83.44 -8.03 59.45 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.166 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 409' ' ' VAL . . . -72.04 134.02 45.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 53.2 mt -75.76 124.6 27.56 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.655 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 64.55 68.49 0.53 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.624 1.17 . . . . 0.0 109.319 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.469 HG21 HG12 ' A' ' 400' ' ' VAL . 55.3 m -61.18 -37.83 84.33 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.533 -173.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -43.13 60.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.864 0.866 . . . . 0.0 113.035 178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.3 m -74.71 -38.64 62.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.472 0.654 . . . . 0.0 109.874 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.586 HG21 ' HB2' ' A' ' 403' ' ' ALA . 78.0 t -68.94 -31.4 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.638 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.06 -10.28 59.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.334 1.054 . . . . 0.0 110.034 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.67 -7.74 83.89 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.908 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -83.34 -9.72 58.9 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 117.621 0.711 . . . . 0.0 111.869 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.98 142.74 49.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.636 0.775 . . . . 0.0 109.713 174.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -117.06 149.71 44.74 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.443 0.697 . . . . 0.0 111.091 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 59.7 Cg_endo -68.67 128.07 16.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.832 2.355 . . . . 0.0 112.603 174.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.06 169.64 8.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.843 1.257 . . . . 0.0 108.801 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -118.99 22.58 11.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.71 . . . . 0.0 112.391 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.9 -25.12 14.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.085 0.554 . . . . 0.0 111.623 175.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.2 45.89 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.191 1.237 . . . . 0.0 116.191 162.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -85.69 -85.0 1.03 Allowed Glycine 0 C--O 1.239 0.436 0 CA-C-N 116.779 0.29 . . . . 0.0 112.694 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 3.1 mp0 -85.17 162.79 19.08 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.84 0.456 . . . . 0.0 110.346 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 67.5 t -136.08 124.21 36.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.063 0.945 . . . . 0.0 108.633 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 436' ' ' LEU . 32.3 mm -104.39 122.82 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.2 p -106.76 145.75 31.69 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.257 1.023 . . . . 0.0 109.498 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.37 142.85 4.9 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.539 0.736 . . . . 0.0 110.879 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 103.38 6.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 110.024 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -114.92 124.64 52.22 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.706 0.802 . . . . 0.0 109.098 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 32.0 t70 61.19 28.59 18.19 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-O 122.245 1.022 . . . . 0.0 111.124 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.87 -17.8 58.22 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.863 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.29 162.01 15.45 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 117.441 0.621 . . . . 0.0 110.651 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.1 t -81.98 121.88 27.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -126.42 149.96 48.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.54 0.736 . . . . 0.0 109.871 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.0 p -140.29 146.08 38.08 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.354 0.662 . . . . 0.0 110.252 -173.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 29.0 pt -120.11 178.84 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.558 0.743 . . . . 0.0 110.361 175.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -118.51 147.88 43.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.578 0.751 . . . . 0.0 109.863 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.0 mp -116.26 156.04 47.61 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.863 1.265 . . . . 0.0 108.188 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.16 131.06 21.25 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 121.877 1.718 . . . . 0.0 111.061 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 128.79 20.04 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.954 2.436 . . . . 0.0 113.167 -175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.08 168.8 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.249 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -153.22 0.07 0.25 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.386 0.674 . . . . 0.0 110.772 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.6 t -120.61 142.63 49.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.274 0.63 . . . . 0.0 109.997 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.16 67.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.835 0.854 . . . . 0.0 112.462 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.4 m -70.39 -28.2 64.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.444 0.698 . . . . 0.0 111.321 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -24.03 29.87 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' A' ' 388' ' ' VAL . . . -48.16 -59.68 3.22 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 123.907 0.754 . . . . 0.0 109.668 171.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.89 -51.03 62.22 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -48.76 -41.94 33.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.319 1.047 . . . . 0.0 112.878 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -41.11 99.11 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.955 0.784 . . . . 0.0 110.951 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.46 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -87.44 -18.92 28.83 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.318 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.29 -42.38 59.65 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.861 0.755 . . . . 0.0 110.416 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.63 -40.8 92.95 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.444 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -65.57 -47.11 76.91 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.257 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 86.7 m -66.66 -31.43 72.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 110.771 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.59 -32.4 71.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.249 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 45.9 m -67.28 -33.81 76.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.136 0.574 . . . . 0.0 110.511 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.502 HD12 HD21 ' A' ' 371' ' ' LEU . 56.7 mt -84.31 -8.93 58.86 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.635 0.774 . . . . 0.0 111.702 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 79.02 5.23 2.3 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.502 1.921 . . . . 0.0 111.779 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.448 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 7.4 p -87.4 146.44 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.059 0.544 . . . . 0.0 110.896 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -162.64 154.45 18.32 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 32.3 m-80 64.54 18.84 11.58 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.268 1.027 . . . . 0.0 111.115 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 23.7 tp -83.32 -9.42 59.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.574 0.749 . . . . 0.0 110.606 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.46 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.6 171.85 19.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.935 0.894 . . . . 0.0 109.908 176.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 29.1 p -162.16 126.22 3.17 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.473 0.709 . . . . 0.0 109.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 21.5 t -72.27 -6.32 42.21 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.83 146.91 52.12 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.499 1.12 . . . . 0.0 109.381 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.52 163.21 38.94 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.394 2.063 . . . . 0.0 112.568 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -77.27 -16.6 58.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 0.0 111.542 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.667 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 76.0 p -161.68 156.44 23.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.39 0.676 . . . . 0.0 111.058 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -125.61 -172.41 2.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.654 1.182 . . . . 0.0 109.459 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 50.3 tpp -74.7 130.37 39.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.586 0.354 . . . . 0.0 110.593 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.39 164.75 13.1 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.011 0.924 . . . . 0.0 110.509 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.7 m -75.27 -177.39 3.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.596 0.358 . . . . 0.0 111.801 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.0 p -141.6 134.37 28.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.119 0.968 . . . . 0.0 109.622 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 388' ' ' VAL . 13.0 m -137.29 171.4 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.344 1.058 . . . . 0.0 110.509 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.484 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 25.9 p -145.83 108.12 4.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.383 0.673 . . . . 0.0 109.751 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.541 HG23 HD13 ' A' ' 395' ' ' ILE . 30.8 m -98.34 143.91 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -109.89 100.69 9.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.446 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 78.0 t -73.42 102.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.411 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 36.3 t30 -97.11 96.13 8.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.828 0.851 . . . . 0.0 109.624 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -5.93 53.18 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.023 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -85.8 -8.93 57.8 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.524 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.61 -137.04 2.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -92.13 142.78 27.13 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 117.817 0.808 . . . . 0.0 109.369 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.428 ' HB3' HG13 ' A' ' 376' ' ' ILE . 1.8 m-85 -84.03 -56.23 3.79 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.501 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -147.38 -74.48 0.02 OUTLIER Glycine 0 C--N 1.349 1.268 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.912 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.8 -15.26 17.65 Favored 'Cis proline' 0 C--N 1.371 1.729 0 CA-C-N 121.118 2.459 . . . . 0.0 115.308 4.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 456' ' ' LEU . 14.2 p80 -73.09 0.94 10.1 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.907 0.776 . . . . 0.0 113.079 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 12.7 mt -91.39 127.86 37.0 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.01 118.38 17.35 Favored Pre-proline 0 N--CA 1.478 0.974 0 O-C-N 124.165 0.916 . . . . 0.0 110.763 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.507 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 58.7 Cg_endo -65.61 -19.36 60.17 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.92 2.413 . . . . 0.0 113.664 -169.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 3.1 mppt? -84.5 -42.7 15.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.86 0.362 . . . . 0.0 110.04 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 24.1 mtt-85 -68.01 -33.08 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.216 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.434 HD12 HD23 ' A' ' 379' ' ' LEU . 24.6 mm -60.68 -27.02 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.159 171.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 69.7 mm-40 -84.47 -22.3 30.33 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 174.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 85.7 mm-40 -79.73 -30.19 40.79 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.318 0.647 . . . . 0.0 112.367 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.434 HD23 HD12 ' A' ' 376' ' ' ILE . 3.1 pp -73.2 154.6 90.39 Favored Pre-proline 0 N--CA 1.482 1.137 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.29 164.78 24.36 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.233 1.955 . . . . 0.0 114.773 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.27 -18.28 61.82 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.461 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.446 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 47.5 p-80 -166.32 149.93 7.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.54 0.736 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -116.49 101.94 9.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 144.68 165.85 11.28 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.444 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.23 130.36 20.59 Favored 'Cis proline' 0 C--N 1.379 2.171 0 CA-C-N 118.984 1.392 . . . . 0.0 112.237 -3.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.67 -173.22 24.06 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.875 -0.958 . . . . 0.0 111.074 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.44 143.11 34.22 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.804 HG21 ' HB1' ' A' ' 445' ' ' ALA . 3.3 p -45.47 -50.95 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 112.775 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.49 -34.58 72.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.617 1.167 . . . . 0.0 111.817 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 99.4 t -76.57 -47.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.17 -38.82 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 122.883 0.473 . . . . 0.0 111.658 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 445' ' ' ALA . 4.2 pp -70.77 -41.61 71.5 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.146 0.179 . . . . 0.0 111.428 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 392' ' ' LEU . 28.8 ptt180 -71.9 -30.74 65.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -68.84 -29.39 67.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.614 0.765 . . . . 0.0 111.51 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.541 HD13 HG23 ' A' ' 359' ' ' VAL . 35.4 mm -69.6 -54.85 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 400' ' ' VAL . 98.3 t -58.76 -50.07 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 O-C-N 124.193 0.933 . . . . 0.0 111.572 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 423' ' ' ILE . 2.7 pt20 -68.44 -31.35 70.61 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.929 0.491 . . . . 0.0 111.91 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.22 83.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.01 -32.45 72.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.45 0.7 . . . . 0.0 112.629 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.7 t -80.24 -52.38 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.55 -38.98 89.43 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.734 0.414 . . . . 0.0 111.055 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 50.5 m -89.28 12.94 14.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.297 0.639 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -89.51 144.91 25.66 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.212 0.605 . . . . 0.0 111.732 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.87 122.23 18.2 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.839 166.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.32 62.28 0.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.445 1.09 . . . . 0.0 109.192 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 89.5 m -55.96 -41.13 74.25 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.64 1.576 . . . . 0.0 111.483 -173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . 0.425 ' HA ' ' HD1' ' A' ' 427' ' ' PHE . 17.5 ptmt -54.2 -34.67 61.11 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.116 1.366 . . . . 0.0 114.497 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.2 m -79.14 -39.4 33.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.469 0.652 . . . . 0.0 109.653 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 403' ' ' ALA . 59.8 t -67.11 -26.17 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.013 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.3 -17.54 63.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.314 1.446 . . . . 0.0 110.146 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -81.9 -8.21 86.97 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.4 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.16 -2.31 55.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.213 0.605 . . . . 0.0 111.3 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.46 HD12 HD13 ' A' ' 434' ' ' ILE . 1.5 pt? -149.31 139.17 21.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.611 0.764 . . . . 0.0 110.052 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -105.87 152.7 40.29 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.101 0.961 . . . . 0.0 111.474 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.03 151.68 62.01 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.046 166.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -148.24 107.78 3.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -91.06 44.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.019 0.914 . . . . 0.0 110.979 -167.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.63 5.94 50.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.407 169.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.81 66.2 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.51 0.506 . . . . 0.0 113.178 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.52 -126.86 2.38 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.737 0.316 . . . . 0.0 112.727 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.439 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.5 mp0 -85.12 174.56 9.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.415 0.686 . . . . 0.0 110.755 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.64 135.31 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.34 0.656 . . . . 0.0 109.432 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 397' ' ' GLN . 31.2 mm -109.74 124.19 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.897 0.879 . . . . 0.0 108.998 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.8 p -106.87 133.83 50.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.224 0.61 . . . . 0.0 109.613 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.47 134.04 10.86 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.605 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 62.7 m -77.03 104.64 7.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 122.951 0.5 . . . . 0.0 111.023 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 407' ' ' LYS . 45.8 t80 -111.05 110.63 21.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.985 0.914 . . . . 0.0 110.598 -173.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 39.0 t70 58.09 57.6 3.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.745 1.218 . . . . 0.0 111.76 169.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 78.32 -6.94 49.2 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.131 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.98 170.84 7.83 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.708 0.754 . . . . 0.0 110.309 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 5.1 t -114.22 109.39 18.32 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -120.66 168.75 11.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.608 0.763 . . . . 0.0 110.686 -173.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 51.0 p -147.94 154.86 40.9 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.331 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.46 HD13 HD12 ' A' ' 413' ' ' LEU . 25.5 pt -122.49 -179.75 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.957 0.903 . . . . 0.0 109.173 172.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -116.17 153.32 32.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.404 0.681 . . . . 0.0 110.211 170.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' A' ' 421' ' ' GLU . 85.0 mt -114.96 164.68 15.96 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 0.0 109.374 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.34 134.47 17.3 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.814 1.676 . . . . 0.0 111.008 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.43 128.02 14.84 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.002 1.801 . . . . 0.0 112.248 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.51 172.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 0.0 110.369 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.18 -12.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.421 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.9 m -108.78 138.89 44.38 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.4 0.545 . . . . 0.0 111.044 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.81 -30.37 68.91 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.265 1.026 . . . . 0.0 111.622 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.6 m -62.85 -33.53 75.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.837 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -82.56 -25.32 33.43 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.804 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -48.2 -65.97 0.48 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.865 0.866 . . . . 0.0 111.473 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 3.1 pp -65.98 -37.43 85.93 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.609 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.65 71.69 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.263 1.025 . . . . 0.0 111.686 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -62.73 -49.71 73.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.529 0.732 . . . . 0.0 110.245 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.535 HD22 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -89.05 -14.5 36.25 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.519 -175.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.0 OUTLIER -59.69 -48.86 79.98 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.047 0.939 . . . . 0.0 110.807 -176.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.92 -32.89 71.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.075 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.419 ' HZ ' HG21 ' A' ' 400' ' ' VAL . 60.4 t80 -68.23 -52.83 29.74 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.136 0.575 . . . . 0.0 110.87 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.08 -28.01 69.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.824 1.249 . . . . 0.0 111.31 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.72 -36.53 80.77 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.624 0.769 . . . . 0.0 110.273 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.1 m -71.41 -28.13 63.79 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.723 0.809 . . . . 0.0 110.923 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.495 ' HA ' ' HE2' ' A' ' 370' ' ' HIS . 23.9 mt -82.91 -17.81 42.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.128 0.571 . . . . 0.0 111.157 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 73.8 6.82 4.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 111.777 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.476 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 22.4 p -79.22 131.53 36.21 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -151.68 145.43 25.05 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.358 -170.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 18.1 m-80 62.72 20.67 12.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 -167.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -86.27 -19.95 29.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.51 0.724 . . . . 0.0 110.476 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.535 HD23 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.09 169.55 24.23 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.537 0.735 . . . . 0.0 110.059 173.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.9 p -157.22 109.43 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 37.9 t -71.7 -17.84 62.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.518 0.727 . . . . 0.0 111.626 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -85.97 111.16 36.1 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.62 151.74 64.37 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.159 1.906 . . . . 0.0 112.928 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -67.18 -27.09 66.98 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.837 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.96 0.904 . . . . 0.0 108.936 177.572 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 CA-C-O 120.041 -0.311 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 48.4 p -72.57 78.97 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.463 1.105 . . . . 0.0 111.286 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -81.96 77.96 8.72 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -73.45 -21.81 60.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.929 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -118.02 170.23 9.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 108.755 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.2 p -86.47 -173.58 4.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.941 0.496 . . . . 0.0 110.899 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -139.62 142.44 37.04 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.611 0.764 . . . . 0.0 110.667 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.22 152.7 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.459 1.103 . . . . 0.0 110.584 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.475 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 42.2 t -121.07 105.72 10.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 0.0 109.102 171.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.1 t -94.95 149.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.66 0.784 . . . . 0.0 109.734 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.5 103.46 9.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.572 1.149 . . . . 0.0 108.585 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.78 106.53 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.033 0.533 . . . . 0.0 110.749 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -91.64 87.93 6.53 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.439 0.696 . . . . 0.0 109.271 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.638 ' HB3' ' HZ2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -72.56 -15.61 61.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.257 176.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -73.98 -19.22 60.72 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.397 0.679 . . . . 0.0 110.833 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -80.52 -153.95 9.66 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.201 0.429 . . . . 0.0 112.89 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 52.5 t30 -72.69 141.5 48.23 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.828 0.347 . . . . 0.0 110.169 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.414 ' O ' HD11 ' A' ' 371' ' ' LEU . 2.0 m-85 -97.32 -64.63 1.02 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.446 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -138.32 -100.89 0.53 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.029 -0.873 . . . . 0.0 112.259 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -88.75 15.94 44.84 Favored 'Cis proline' 0 C--N 1.373 1.862 0 CA-C-N 120.312 2.056 . . . . 0.0 114.238 12.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -83.58 -1.79 54.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.641 0.777 . . . . 0.0 111.196 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 42.4 mt -114.78 146.79 40.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.361 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.19 122.37 86.1 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.611 0.764 . . . . 0.0 110.701 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.465 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 37.6 Cg_endo -61.34 -23.76 77.47 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.229 2.619 . . . . 0.0 114.871 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -84.7 -48.2 9.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.149 0.432 . . . . 0.0 110.457 -176.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 64.7 mtt180 -68.5 -34.68 76.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.077 0.951 . . . . 0.0 111.949 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.43 ' HA ' HD22 ' A' ' 379' ' ' LEU . 15.8 mm -52.55 -31.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.909 0.883 . . . . 0.0 111.884 170.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -80.28 -28.2 38.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.115 0.566 . . . . 0.0 111.385 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -78.45 -31.33 47.93 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.623 0.769 . . . . 0.0 112.346 -169.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 376' ' ' ILE . 0.8 OUTLIER -71.54 154.0 93.45 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.106 172.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.2 165.44 8.9 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.977 2.451 . . . . 0.0 114.812 -171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.91 -13.62 60.93 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.522 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -159.7 150.47 19.27 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.2 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -119.46 104.22 10.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 178.09 15.17 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.963 -0.91 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.67 136.53 36.72 Favored 'Cis proline' 0 C--N 1.386 2.54 0 CA-C-N 119.875 1.838 . . . . 0.0 113.23 -2.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -170.46 -172.89 37.28 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.03 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.546 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 58.5 Cg_endo -68.26 138.78 44.04 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.841 2.361 . . . . 0.0 112.366 -174.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.707 HG22 ' HB3' ' A' ' 445' ' ' ALA . 11.4 p -51.05 -43.02 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.333 1.453 . . . . 0.0 111.724 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -50.77 -59.33 4.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 111.035 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.546 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 57.6 t -71.74 -42.37 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.867 -172.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.27 -45.26 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.844 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.66 -40.65 84.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.485 ' HD3' ' HA ' ' A' ' 390' ' ' VAL . 10.9 ptm180 -72.71 -30.05 63.89 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -72.23 -23.06 61.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.086 0.554 . . . . 0.0 111.929 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.511 HG21 ' HG ' ' A' ' 449' ' ' LEU . 22.0 mm -73.42 -55.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 400' ' ' VAL . 85.9 t -62.29 -55.79 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.587 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.0 pt20 -64.07 -29.63 70.75 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.795 0.438 . . . . 0.0 111.9 -176.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.418 ' HB1' HD21 ' A' ' 379' ' ' LEU . . . -64.09 -48.9 74.38 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.24 -47.86 78.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.856 0.723 . . . . 0.0 112.318 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 406' ' ' THR . 10.2 t -65.13 -48.12 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.958 0.409 . . . . 0.0 110.154 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.95 -33.55 74.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.686 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 73.5 m -93.01 17.22 11.11 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.429 0.692 . . . . 0.0 110.958 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -91.13 155.46 18.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.611 0.719 . . . . 0.0 112.318 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.47 121.94 26.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.689 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 57.32 61.91 2.36 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.333 1.02 . . . . 0.0 109.712 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.485 HG21 HG13 ' A' ' 400' ' ' VAL . 97.1 m -48.67 -35.81 14.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.094 1.758 . . . . 0.0 112.742 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -56.93 -39.51 74.62 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.492 1.117 . . . . 0.0 113.036 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 92.9 m -79.6 -40.48 29.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.816 0.847 . . . . 0.0 109.772 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 403' ' ' ALA . 94.5 t -61.08 -33.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.429 1.092 . . . . 0.0 111.46 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.12 -10.54 59.49 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.368 1.067 . . . . 0.0 110.908 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -82.38 -6.94 88.24 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.574 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.14 10.1 28.32 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.414 0.685 . . . . 0.0 111.464 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -152.14 141.05 21.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.295 1.038 . . . . 0.0 108.964 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -117.15 154.99 50.1 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 123.688 0.795 . . . . 0.0 111.53 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.09 157.8 56.73 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.692 2.261 . . . . 0.0 112.037 167.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -155.15 139.23 16.47 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -90.12 27.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.44 -33.42 23.67 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 111.024 175.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.77 41.82 8.63 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.723 0.249 . . . . 0.0 113.723 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -94.18 -110.25 2.19 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.761 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 23.5 mp0 -74.28 162.74 28.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.438 ' HB ' ' NH2' ' A' ' 393' ' ' ARG . 90.1 t -135.64 130.07 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.476 HG12 HD12 ' A' ' 436' ' ' LEU . 37.3 mm -110.4 127.55 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.418 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.7 p -106.04 150.7 25.5 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.673 0.789 . . . . 0.0 108.999 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -165.87 135.96 3.47 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.583 0.753 . . . . 0.0 109.678 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 69.0 m -67.48 101.06 0.92 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.585 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -139.21 136.75 35.33 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 109.502 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.7 t70 62.71 31.64 16.53 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.97 1.308 . . . . 0.0 111.514 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 81.34 1.87 90.24 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.893 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.81 172.96 10.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.586 1.155 . . . . 0.0 109.308 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.8 t -87.75 102.24 14.47 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 164.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -85.94 133.08 33.96 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 424' ' ' THR . 25.2 p -114.56 143.3 45.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.017 0.927 . . . . 0.0 110.445 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.604 HD11 HD11 ' A' ' 413' ' ' LEU . 16.5 pt -128.46 168.44 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.046 0.938 . . . . 0.0 109.761 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -112.28 146.93 37.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.536 0.734 . . . . 0.0 110.766 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.7 mp -115.86 155.48 47.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.233 1.413 . . . . 0.0 108.355 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.17 128.66 14.11 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.79 1.66 . . . . 0.0 111.462 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.09 135.36 27.14 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.927 2.418 . . . . 0.0 111.617 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.16 160.78 4.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.285 0.564 . . . . 0.0 110.751 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.62 12.43 3.19 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.316 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 39.5 t -118.36 139.13 51.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.896 0.478 . . . . 0.0 109.97 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.25 45.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.462 1.105 . . . . 0.0 111.365 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 27.2 m -72.89 -22.4 60.76 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.03 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.41 -21.39 25.63 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.707 ' HB3' HG22 ' A' ' 388' ' ' VAL . . . -47.81 -60.73 2.36 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 121.701 0.762 . . . . 0.0 109.918 170.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 464' ' ' SER . 20.6 mt -69.69 -39.77 76.75 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.952 -174.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . 0.465 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 0.0 OUTLIER -61.15 -30.8 70.61 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.879 0.872 . . . . 0.0 111.442 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -45.51 72.88 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.903 0.481 . . . . 0.0 110.492 -177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.511 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.51 -13.1 43.98 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.074 -0.488 . . . . 0.0 111.846 176.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 1.4 mm-40 -57.17 -56.98 14.71 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.725 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.39 -35.72 81.05 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.931 0.769 . . . . 0.0 111.147 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.416 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 38.8 t80 -60.31 -61.06 2.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.522 0.729 . . . . 0.0 110.818 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.85 -30.54 69.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.435 1.094 . . . . 0.0 111.81 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -66.04 -40.26 90.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.224 0.61 . . . . 0.0 110.582 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 49.9 m -67.91 -35.86 79.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.536 0.734 . . . . 0.0 110.486 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.511 HD11 HD23 ' A' ' 371' ' ' LEU . 50.3 mt -72.59 -12.91 61.25 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.542 0.737 . . . . 0.0 111.5 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 73.74 14.61 4.12 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.807 1.643 . . . . 0.0 111.61 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.525 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 15.3 p -93.88 139.59 30.71 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 123.379 0.672 . . . . 0.0 109.982 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -155.31 144.82 21.18 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 3.2 t30 66.84 12.62 9.0 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 124.191 0.932 . . . . 0.0 110.342 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 34.8 tp -74.57 -17.94 60.65 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.866 0.866 . . . . 0.0 110.24 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.495 HD22 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.01 161.66 31.56 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.344 0.658 . . . . 0.0 110.775 177.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 80.8 p -167.81 129.06 1.45 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.698 0.799 . . . . 0.0 109.001 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 35.4 t -66.47 -25.72 66.85 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.839 0.352 . . . . 0.0 111.432 177.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -93.57 133.31 28.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.1 174.48 9.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.826 2.35 . . . . 0.0 111.653 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -71.28 -11.46 60.93 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.873 0.469 . . . . 0.0 111.775 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.505 1.122 . . . . 0.0 108.27 168.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.924 0 CA-C-O 120.358 -0.135 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.9 m -73.33 -10.01 59.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.812 0.845 . . . . 0.0 112.868 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.29 156.27 20.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.775 0.83 . . . . 0.0 110.117 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.95 133.43 43.04 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.391 0.676 . . . . 0.0 110.078 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 387' ' ' PRO . 20.1 ptp -70.94 170.64 12.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.587 0.755 . . . . 0.0 110.442 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.5 t -76.74 172.49 13.0 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.8 p -136.68 137.02 39.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.392 0.677 . . . . 0.0 109.411 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.436 HG23 ' HA ' ' A' ' 388' ' ' VAL . 17.2 m -138.25 165.9 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.024 0.93 . . . . 0.0 110.969 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 24.6 p -142.65 108.89 5.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 108.548 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 395' ' ' ILE . 26.3 m -94.92 159.32 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.27 99.89 6.74 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.84 107.61 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 123.869 0.731 . . . . 0.0 110.313 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.55 89.6 5.05 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.368 1.067 . . . . 0.0 109.117 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -3.6 42.54 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.509 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.95 -11.46 58.86 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.223 0.609 . . . . 0.0 110.414 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.56 -151.05 5.32 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.453 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 51.2 t-20 -77.52 139.26 39.56 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.41 -52.69 6.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.46 -76.22 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 114.738 -1.119 . . . . 0.0 114.32 -176.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.03 -10.06 13.83 Favored 'Cis proline' 0 C--N 1.371 1.759 0 CA-C-N 121.102 2.451 . . . . 0.0 114.095 -2.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . 0.615 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 14.8 p-80 -61.29 -12.33 13.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.188 0.995 . . . . 0.0 113.029 175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.59 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.4 mt -98.69 143.07 29.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.152 0.981 . . . . 0.0 109.408 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 127.49 91.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 123.864 0.727 . . . . 0.0 110.068 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.571 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 29.7 Cg_endo -59.63 -41.25 57.83 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.992 2.461 . . . . 0.0 112.875 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -65.64 -45.2 83.93 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.398 0.436 . . . . 0.0 110.675 -175.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -66.88 -31.2 71.65 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.687 0.795 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 18.5 mm -66.63 -28.83 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.068 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 62.2 mm-40 -82.93 -23.04 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.961 -0.462 . . . . 0.0 110.906 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 70.9 mm-40 -74.6 -38.67 62.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.953 0.501 . . . . 0.0 111.716 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.6 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.1 pp -67.51 156.77 87.87 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.926 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.29 150.69 83.6 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.539 2.159 . . . . 0.0 113.122 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.55 -1.8 26.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.879 1.272 . . . . 0.0 111.442 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -157.33 151.33 24.57 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 109.965 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -118.1 104.25 10.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 166.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 148.27 176.69 21.96 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.248 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -82.23 128.74 15.07 Favored 'Cis proline' 0 C--N 1.376 2.004 0 CA-C-N 118.751 1.276 . . . . 0.0 111.326 -2.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -153.49 -165.45 13.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.099 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.427 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 3.1 Cg_exo -70.97 146.31 52.4 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.951 2.434 . . . . 0.0 112.265 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 445' ' ' ALA . 4.0 p -54.64 -45.32 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 124.28 1.032 . . . . 0.0 111.15 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -62.44 -49.74 74.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.064 1.346 . . . . 0.0 110.948 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 83.4 t -70.63 -48.9 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.508 -174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.12 -40.61 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.87 0.468 . . . . 0.0 111.897 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.7 pp -66.87 -41.84 86.6 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 392' ' ' LEU . 17.4 ptt180 -74.49 -25.4 59.35 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 123.32 0.388 . . . . 0.0 110.033 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 36.7 mmm-85 -64.09 -40.33 95.99 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.422 0.451 . . . . 0.0 110.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 359' ' ' VAL . 43.6 mm -63.55 -51.33 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.953 0.783 . . . . 0.0 109.735 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.79 -44.87 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.298 -174.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.58 -28.03 41.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.857 -0.592 . . . . 0.0 111.834 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -73.53 -31.88 63.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.274 0.488 . . . . 0.0 110.508 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.96 -56.12 19.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.085 0.554 . . . . 0.0 109.56 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.73 -30.13 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.729 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.06 -33.97 70.77 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.484 0.714 . . . . 0.0 111.566 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.6 ' SG ' HD23 ' A' ' 379' ' ' LEU . 78.4 m -91.23 0.1 57.59 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.989 0.516 . . . . 0.0 111.637 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 409' ' ' VAL . . . -68.93 138.84 54.95 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.4 mt -82.6 115.98 21.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.53 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 64.54 61.39 0.85 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.444 1.116 . . . . 0.0 109.286 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.0 m -51.8 -34.8 41.59 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.217 1.807 . . . . 0.0 112.806 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -54.93 -42.24 72.0 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.532 1.133 . . . . 0.0 112.315 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 49.6 m -80.53 -37.25 31.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 403' ' ' ALA . 90.8 t -65.37 -34.92 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.235 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.37 -16.64 60.36 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.832 0.853 . . . . 0.0 110.84 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -68.72 -13.55 66.18 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 116.257 -0.429 . . . . 0.0 114.14 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.88 -13.32 60.01 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.738 . . . . 0.0 111.444 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.6 HD23 ' HE1' ' A' ' 452' ' ' PHE . 1.0 OUTLIER -141.52 112.71 7.43 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.376 0.671 . . . . 0.0 110.267 -173.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 415' ' ' PRO . 47.0 mtpt -112.56 160.67 29.61 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 124.163 0.985 . . . . 0.0 109.637 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 414' ' ' LYS . 67.3 Cg_endo -67.75 155.52 69.62 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.288 1.992 . . . . 0.0 114.698 -170.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.87 124.34 26.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.062 1.345 . . . . 0.0 108.601 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.82 33.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.193 0.597 . . . . 0.0 112.212 -164.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -92.01 -10.62 38.56 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 111.42 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.65 41.33 64.96 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.53 -116.8 2.37 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 120.113 -0.27 . . . . 0.0 112.961 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.9 OUTLIER -77.4 168.73 19.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 110.592 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 81.2 t -132.92 125.29 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.631 0.772 . . . . 0.0 109.217 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.511 HG12 HD12 ' A' ' 436' ' ' LEU . 37.6 mm -103.37 128.06 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.5 p -106.63 140.9 38.77 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.941 0.896 . . . . 0.0 109.809 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.05 141.8 24.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.037 0.935 . . . . 0.0 110.151 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.2 p -83.65 112.7 20.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -144.24 137.48 27.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.031 0.932 . . . . 0.0 109.428 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.17 18.32 11.38 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.494 1.117 . . . . 0.0 112.434 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.38 70.89 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 121.792 -0.567 . . . . 0.0 112.776 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -131.74 170.99 14.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.661 1.184 . . . . 0.0 109.71 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -92.09 126.08 37.03 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.8 126.9 53.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.728 0.811 . . . . 0.0 109.297 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.8 p -117.76 140.63 49.42 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 0.0 110.336 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.14 162.3 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.396 0.678 . . . . 0.0 109.947 172.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -99.27 146.69 25.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.816 0.847 . . . . 0.0 110.111 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.511 HD12 HG12 ' A' ' 423' ' ' ILE . 8.5 mp -115.18 171.43 4.51 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.64 141.73 25.2 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 121.957 1.771 . . . . 0.0 111.735 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.32 128.47 8.91 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.148 1.898 . . . . 0.0 112.257 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.45 172.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.617 0.767 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -149.04 -0.93 0.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.008 0.523 . . . . 0.0 111.979 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -126.5 139.93 52.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.005 0.522 . . . . 0.0 110.751 -172.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.19 70.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.226 1.01 . . . . 0.0 111.517 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 t -63.49 -27.69 69.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.565 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -86.9 -27.87 23.13 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.734 0.414 . . . . 0.0 110.395 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.766 ' HB3' HG22 ' A' ' 388' ' ' VAL . . . -48.9 -66.94 0.31 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.974 0.91 . . . . 0.0 111.954 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 450' ' ' GLU . 0.9 OUTLIER -61.79 -43.75 98.23 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.179 178.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -31.59 58.47 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.364 1.066 . . . . 0.0 111.917 -175.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -62.65 -55.28 28.38 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.687 0.617 . . . . 0.0 110.046 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.76 -14.84 59.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.24 -178.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 446' ' ' LEU . 10.5 mm-40 -64.54 -45.92 85.1 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.292 0.496 . . . . 0.0 110.143 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.15 -39.59 65.55 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.169 0.588 . . . . 0.0 110.599 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.6 ' HE1' HD23 ' A' ' 413' ' ' LEU . 67.9 t80 -57.88 -59.14 5.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.657 0.783 . . . . 0.0 110.952 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.62 -27.16 69.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.118 0.967 . . . . 0.0 112.149 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -65.1 -41.53 94.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.03 0.532 . . . . 0.0 110.505 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 51.1 m -67.62 -21.84 65.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.708 0.803 . . . . 0.0 111.65 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.615 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 71.1 mt -100.05 -14.02 18.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.056 0.942 . . . . 0.0 112.963 -173.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.07 7.23 1.65 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.687 1.595 . . . . 0.0 112.19 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . . . . . . . . . 6.1 p -89.44 134.22 34.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.453 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.3 t70 -152.2 152.18 31.92 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 59.74 18.27 7.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.243 1.017 . . . . 0.0 111.259 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.23 -18.52 49.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.77 0.428 . . . . 0.0 110.966 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -163.74 172.5 14.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.23 0.612 . . . . 0.0 110.47 171.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 18.9 p -163.28 126.48 2.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.779 0.831 . . . . 0.0 108.839 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 29.2 t -70.27 -17.17 63.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.66 0.384 . . . . 0.0 111.553 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.65 146.84 32.16 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.831 0.852 . . . . 0.0 109.386 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.66 171.25 14.7 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.661 2.24 . . . . 0.0 112.104 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -75.95 -31.6 59.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.949 0.5 . . . . 0.0 111.202 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.547 0.864 0 C-N-CA 123.752 0.821 . . . . 0.0 109.081 174.661 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 CA-C-O 120.26 -0.189 . . . . 0.0 112.775 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 43.7 m -67.37 -35.91 80.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.788 0.835 . . . . 0.0 110.317 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -119.09 129.12 54.9 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 24.3 ptp -99.12 10.01 42.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.869 0.868 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -149.71 168.93 22.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.007 0.923 . . . . 0.0 109.949 -171.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.9 t -82.37 179.19 7.88 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.144 0.578 . . . . 0.0 110.864 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.5 p -137.89 134.69 35.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.18 0.992 . . . . 0.0 109.864 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 388' ' ' VAL . 15.9 m -140.41 162.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.959 0.903 . . . . 0.0 110.771 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 20.4 p -137.45 115.57 11.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.431 1.092 . . . . 0.0 108.815 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 395' ' ' ILE . 34.9 m -104.01 141.91 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.837 0.455 . . . . 0.0 109.801 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.48 98.24 7.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.434 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 67.5 t -70.68 99.59 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.463 1.102 . . . . 0.0 110.713 -173.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.496 ' HB2' ' HZ ' ' A' ' 467' ' ' PHE . 33.6 t30 -94.47 97.11 9.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.62 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.4 -11.33 59.83 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.334 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -83.32 -15.74 48.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.546 0.738 . . . . 0.0 110.783 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -70.95 -88.32 0.11 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -141.13 152.0 44.37 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.0 -62.19 1.32 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -149.23 -91.75 0.09 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.609 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -85.5 10.48 53.13 Favored 'Cis proline' 0 C--N 1.371 1.763 0 CA-C-N 120.496 2.148 . . . . 0.0 114.832 11.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -74.16 -8.23 55.46 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 26.0 mt -107.89 136.06 48.24 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.415 1.086 . . . . 0.0 108.743 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.16 125.19 86.42 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.481 0.712 . . . . 0.0 110.318 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.517 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 35.0 Cg_endo -62.95 -31.03 77.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.717 2.278 . . . . 0.0 113.137 -172.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.32 -45.97 36.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.148 0.579 . . . . 0.0 110.119 -176.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -61.94 -34.59 76.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.356 1.062 . . . . 0.0 111.598 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.464 HD12 HD23 ' A' ' 379' ' ' LEU . 24.2 mm -64.04 -29.93 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.777 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 76.9 mm-40 -83.18 -21.91 33.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.325 0.25 . . . . 0.0 110.859 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 82.9 mm-40 -79.58 -32.56 42.02 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.03 0.532 . . . . 0.0 112.148 -176.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 376' ' ' ILE . 3.0 pp -72.06 156.98 90.23 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.018 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.85 161.34 18.8 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.854 2.37 . . . . 0.0 114.33 -173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.36 -21.37 61.31 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.952 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.434 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 20.5 p-80 -167.05 154.04 8.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.086 0.955 . . . . 0.0 110.67 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -117.9 146.38 43.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.072 0.949 . . . . 0.0 108.969 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.18 -174.85 39.09 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.271 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.56 128.58 16.82 Favored 'Cis proline' 0 C--N 1.377 2.049 0 CA-C-N 119.187 1.493 . . . . 0.0 112.329 1.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.66 -154.69 7.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.201 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.31 137.2 25.44 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.655 2.237 . . . . 0.0 112.122 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.712 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.76 -42.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.606 1.562 . . . . 0.0 112.073 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.23 -55.5 27.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.395 1.478 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.475 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -70.13 -46.08 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.888 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.21 -36.63 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 122.566 0.346 . . . . 0.0 111.672 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 393' ' ' ARG . 3.3 pp -73.89 -40.68 63.02 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.744 0.247 . . . . 0.0 111.02 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.409 ' N ' HD13 ' A' ' 392' ' ' LEU . 24.5 ptt180 -67.98 -29.18 68.14 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 22.0 mmm-85 -65.37 -43.32 91.16 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 123.864 0.727 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 359' ' ' VAL . 29.4 mm -65.26 -53.59 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.455 0.472 . . . . 0.0 109.838 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 400' ' ' VAL . 66.7 t -62.05 -44.81 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.027 0.829 . . . . 0.0 110.896 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.503 ' HA ' HG21 ' A' ' 423' ' ' ILE . 2.6 pt20 -67.5 -33.99 76.22 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.63 0.195 . . . . 0.0 110.838 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.1 84.67 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 122.879 0.472 . . . . 0.0 110.147 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . 0.452 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 82.3 m -68.61 -51.35 43.3 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.591 0.756 . . . . 0.0 111.1 -175.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 406' ' ' THR . 21.0 t -62.06 -43.9 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.7 -33.35 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.002 0.521 . . . . 0.0 111.524 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 19.2 p -84.34 -10.07 57.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.696 0.398 . . . . 0.0 111.023 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.38 150.03 49.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 112.987 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.55 121.27 26.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.408 169.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 62.77 61.3 1.18 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 122.249 1.023 . . . . 0.0 109.148 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.502 HG21 HG12 ' A' ' 400' ' ' VAL . 52.2 m -54.63 -34.35 61.99 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.437 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -57.66 -37.23 73.02 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 113.175 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.8 m -84.42 -35.34 23.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.055 0.542 . . . . 0.0 110.281 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 403' ' ' ALA . 88.6 t -64.58 -31.22 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.864 0.866 . . . . 0.0 110.837 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.56 -21.6 62.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.944 1.298 . . . . 0.0 110.436 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.59 76.07 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.198 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -77.38 -18.13 57.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.209 0.604 . . . . 0.0 111.689 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.408 HD11 HD13 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -133.26 125.56 29.59 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.501 0.721 . . . . 0.0 110.088 -175.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -103.45 159.03 30.59 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.931 0.892 . . . . 0.0 109.963 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.17 122.64 8.2 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.768 1.645 . . . . 0.0 112.64 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.588 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 4.3 m-20 -110.16 107.67 17.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.328 1.451 . . . . 0.0 107.342 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -83.83 67.62 9.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.095 0.95 . . . . 0.0 108.566 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.588 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -107.53 4.1 25.7 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.97 40.13 93.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.44 0.462 . . . . 0.0 113.053 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -106.61 -132.34 7.05 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 120.125 -0.264 . . . . 0.0 112.633 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.5 OUTLIER -73.21 172.78 10.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.972 0.909 . . . . 0.0 111.389 -175.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 131.22 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 109.32 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.503 HG21 ' HA ' ' A' ' 397' ' ' GLN . 42.1 mm -111.77 123.73 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' THR . . . . . 0.446 HG22 ' HB3' ' A' ' 433' ' ' SER . 17.0 p -106.51 144.95 32.45 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.831 0.852 . . . . 0.0 109.051 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -160.63 133.03 6.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.662 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.4 m -70.9 109.03 4.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.326 0.651 . . . . 0.0 111.91 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -131.21 126.85 36.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.684 1.194 . . . . 0.0 109.033 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.26 14.35 7.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.036 1.335 . . . . 0.0 112.355 169.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 7.2 62.5 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.721 -0.612 . . . . 0.0 113.015 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -120.6 166.08 14.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.256 1.022 . . . . 0.0 109.46 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.2 t -97.9 101.23 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -88.6 126.95 35.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.446 ' HB3' HG22 ' A' ' 424' ' ' THR . 55.2 p -116.88 148.68 41.09 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.458 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.408 HD13 HD11 ' A' ' 413' ' ' LEU . 46.4 pt -125.56 179.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.086 0.954 . . . . 0.0 109.215 173.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -115.66 153.21 31.71 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 86.1 mt -115.58 166.07 12.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.488 1.115 . . . . 0.0 108.933 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.92 135.07 12.26 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 121.814 1.676 . . . . 0.0 111.105 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.42 134.01 25.64 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.809 2.339 . . . . 0.0 112.494 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.29 173.64 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.787 0.835 . . . . 0.0 111.647 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -152.06 -4.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.43 0.692 . . . . 0.0 112.312 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.5 t -113.96 139.16 49.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.727 0.411 . . . . 0.0 109.999 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.12 67.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.541 0.736 . . . . 0.0 111.308 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 48.3 m -63.87 -32.94 74.62 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.441 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -83.21 -27.28 30.09 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.712 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.65 -62.27 1.7 Allowed 'General case' 0 C--N 1.366 1.3 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.427 ' O ' HD21 ' A' ' 449' ' ' LEU . 17.7 mt -66.31 -52.18 49.88 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.31 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -51.46 -36.14 42.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -59.06 -49.09 79.22 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.847 0.717 . . . . 0.0 109.964 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.592 HD22 HD22 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.58 -14.13 38.34 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.729 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.428 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 49.9 mt-10 -78.02 -36.57 48.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.348 0.976 . . . . 0.0 110.153 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.25 -42.28 96.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.088 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 58.8 t80 -72.42 -43.42 63.88 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.48 -174.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.48 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 20.7 p -70.84 -26.66 63.38 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.557 0.743 . . . . 0.0 109.963 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -65.74 -35.06 79.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.031 0.932 . . . . 0.0 110.271 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 17.2 m -75.94 -29.11 58.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.643 0.777 . . . . 0.0 110.598 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.454 HD12 HD11 ' A' ' 371' ' ' LEU . 51.3 mt -80.27 -14.75 58.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.43 0.692 . . . . 0.0 110.951 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 75.69 9.74 3.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 0.0 112.07 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 11.8 p -91.5 138.42 31.59 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.34 0.656 . . . . 0.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -133.82 156.83 47.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 109.501 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 29.8 m-80 59.01 22.21 10.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.754 0.821 . . . . 0.0 111.634 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.95 -17.29 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.177 0.591 . . . . 0.0 110.255 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.592 HD22 HD22 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.05 172.55 17.96 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.982 0.913 . . . . 0.0 109.805 173.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 24.0 p -165.88 134.79 3.17 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.736 0.648 . . . . 0.0 109.882 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 23.1 t -68.31 -22.51 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.123 0.487 . . . . 0.0 111.668 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -118.47 147.59 42.24 Favored Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 124.501 1.12 . . . . 0.0 109.076 -174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.97 174.37 6.92 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.641 2.227 . . . . 0.0 112.292 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . 0.496 ' HZ ' ' HB2' ' A' ' 362' ' ' ASN . 26.8 m-85 -78.9 -24.08 44.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.166 0.586 . . . . 0.0 110.103 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.557 1.222 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.024 171.769 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.404 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 31.3 t -112.06 137.08 50.59 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.714 0.806 . . . . 0.0 109.837 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -88.93 -25.49 22.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.103 0.561 . . . . 0.0 110.553 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.1 ttt -85.44 130.54 34.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -75.17 164.4 26.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.999 0.92 . . . . 0.0 109.77 171.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.4 m -73.39 171.98 12.1 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.771 0.428 . . . . 0.0 110.87 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.3 p -133.6 137.99 45.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.169 0.588 . . . . 0.0 110.087 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.3 m -143.15 162.36 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.466 1.106 . . . . 0.0 109.819 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.426 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 46.9 t -135.27 107.94 7.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.56 0.744 . . . . 0.0 109.299 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 42.5 t -96.46 151.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.299 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.17 106.33 8.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.578 1.151 . . . . 0.0 108.669 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.439 HG13 ' CD1' ' A' ' 379' ' ' LEU . 62.1 t -71.7 112.3 6.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.306 0.642 . . . . 0.0 110.31 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 51.5 t30 -93.51 81.22 4.34 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -13.64 62.41 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.312 175.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -74.29 -23.04 59.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.481 0.713 . . . . 0.0 110.876 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.33 -140.8 2.1 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.094 0.246 . . . . 0.0 112.924 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 59.3 t-20 -74.62 143.55 44.3 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.92 -53.55 3.64 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -155.52 -70.88 0.01 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.447 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.21 5.12 58.47 Favored 'Cis proline' 0 C--N 1.373 1.842 0 CA-C-N 120.382 2.091 . . . . 0.0 114.702 2.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 456' ' ' LEU . 2.3 p80 -76.35 -9.08 58.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 117.914 0.325 . . . . 0.0 111.275 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.481 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 25.4 mt -87.18 123.99 32.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.489 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 9.8 t70 -55.09 122.53 42.86 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 124.502 1.126 . . . . 0.0 110.374 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.536 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 37.1 Cg_endo -60.93 -31.11 91.16 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.015 2.477 . . . . 0.0 113.406 -172.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.95 -46.77 33.28 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.617 0.367 . . . . 0.0 110.489 -176.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . 0.489 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 23.8 mtp180 -65.03 -30.92 71.93 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 110.719 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.7 mm -63.78 -28.78 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.123 0.969 . . . . 0.0 110.988 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.1 mm-40 -85.57 -25.37 26.76 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.492 0.317 . . . . 0.0 110.79 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 78.9 mm-40 -75.39 -31.68 60.54 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.756 0.422 . . . . 0.0 112.134 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.591 HD22 ' SG ' ' A' ' 402' ' ' CYS . 3.2 pp -71.2 155.28 93.26 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.167 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.05 158.09 40.84 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.451 2.101 . . . . 0.0 113.311 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.54 -3.58 25.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.697 1.199 . . . . 0.0 111.855 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 5.4 p80 -159.25 156.77 29.4 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.223 0.609 . . . . 0.0 110.513 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.29 103.76 7.35 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 133.81 176.8 14.55 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.511 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.82 129.86 19.65 Favored 'Cis proline' 0 C--N 1.376 2.009 0 CA-C-N 120.008 1.904 . . . . 0.0 112.645 -4.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -154.24 -161.62 10.58 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.806 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -74.02 130.76 14.71 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.756 2.304 . . . . 0.0 111.176 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.734 HG23 ' HB1' ' A' ' 445' ' ' ALA . 4.2 p -38.01 -48.41 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.661 1.984 . . . . 0.0 113.63 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -72.97 -39.95 65.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.797 1.639 . . . . 0.0 112.134 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.33 -43.18 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.451 0.301 . . . . 0.0 110.718 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.35 -40.18 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.369 0.668 . . . . 0.0 111.892 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -67.95 -40.22 83.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.467 ' N ' HD11 ' A' ' 392' ' ' LEU . 5.5 ptt180 -70.69 -24.81 62.74 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.989 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -65.26 -42.05 93.65 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.816 0.846 . . . . 0.0 110.907 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.81 -50.68 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 400' ' ' VAL . 99.2 t -59.27 -52.72 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.539 -1.209 . . . . 0.0 111.689 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.436 ' HA ' HG21 ' A' ' 423' ' ' ILE . 3.2 pt20 -65.54 -34.33 78.0 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.292 0.637 . . . . 0.0 110.793 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.47 ' HB2' HD23 ' A' ' 379' ' ' LEU . . . -69.12 -36.88 77.96 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 123.856 0.723 . . . . 0.0 110.586 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 89.2 m -68.56 -42.75 77.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.196 0.598 . . . . 0.0 111.462 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 396' ' ' VAL . 21.5 t -70.51 -41.66 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.774 0.43 . . . . 0.0 109.858 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.74 -40.93 96.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.922 0.889 . . . . 0.0 111.024 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.591 ' SG ' HD22 ' A' ' 379' ' ' LEU . 71.5 m -93.1 10.78 30.16 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.469 0.708 . . . . 0.0 111.975 -176.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.585 ' HB1' HG22 ' A' ' 409' ' ' VAL . . . -87.4 143.39 27.26 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.21 131.71 39.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 61.11 57.21 2.55 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 122.134 0.968 . . . . 0.0 109.741 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 32.1 m -50.37 -32.48 17.53 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.956 1.702 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -61.19 -34.65 75.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 112.949 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -81.8 -34.53 30.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.509 0.724 . . . . 0.0 109.953 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.585 HG22 ' HB1' ' A' ' 403' ' ' ALA . 45.7 t -71.4 -26.5 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.33 -23.2 61.89 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.064 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -80.82 -9.16 86.67 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.19 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 409' ' ' VAL . 31.2 m-85 -72.12 -21.89 61.41 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 117.787 0.793 . . . . 0.0 111.138 176.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.08 146.39 45.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.746 0.818 . . . . 0.0 110.624 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -116.75 155.75 48.65 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.071 0.948 . . . . 0.0 110.247 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 55.7 Cg_endo -66.53 131.11 25.27 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.173 1.915 . . . . 0.0 112.065 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -102.57 167.77 9.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.725 1.21 . . . . 0.0 108.965 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -131.95 43.7 3.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.695 0.76 . . . . 0.0 111.96 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -104.8 2.49 30.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.482 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.25 32.01 75.43 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.229 0.331 . . . . 0.0 113.301 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.03 -117.04 1.5 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 113.711 0.244 . . . . 0.0 113.711 -172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 18.7 mm-40 -89.94 170.37 10.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.089 0.556 . . . . 0.0 111.457 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 434' ' ' ILE . 60.3 t -131.51 128.72 61.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 122.749 0.419 . . . . 0.0 109.96 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 433' ' ' SER . 43.4 mm -114.23 128.57 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.9 p -105.57 144.49 32.26 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.024 0.929 . . . . 0.0 109.862 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -157.05 127.67 6.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.05 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 60.4 p -72.49 124.63 25.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.243 0.617 . . . . 0.0 109.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -147.14 115.74 6.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.625 0.77 . . . . 0.0 109.918 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.3 t70 64.46 23.97 13.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.762 1.225 . . . . 0.0 111.504 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.63 -16.03 60.23 Favored Glycine 0 N--CA 1.471 0.97 0 O-C-N 121.89 -0.506 . . . . 0.0 113.138 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -97.88 168.69 10.15 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.592 0.757 . . . . 0.0 109.796 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.2 t -113.22 104.8 12.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -97.79 125.42 42.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.02 0.928 . . . . 0.0 110.378 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.5 p -118.19 138.78 52.08 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.748 0.819 . . . . 0.0 109.784 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 23.8 pt -117.31 171.63 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.024 0.53 . . . . 0.0 109.863 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 27.7 mt-30 -102.62 150.45 23.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 170.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.67 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 80.1 mt -115.94 164.41 17.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.229 1.412 . . . . 0.0 108.278 169.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.82 139.03 32.73 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.898 1.732 . . . . 0.0 111.153 168.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.76 127.86 6.49 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.107 1.871 . . . . 0.0 110.994 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.67 164.35 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.09 0.471 . . . . 0.0 109.845 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -151.22 23.31 0.73 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.901 0.88 . . . . 0.0 110.163 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 47.7 t -124.69 137.28 54.36 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.73 65.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.9 t -69.88 -21.27 63.34 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.033 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.4 -29.72 24.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.734 ' HB1' HG23 ' A' ' 388' ' ' VAL . . . -47.42 -67.51 0.27 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.995 0.918 . . . . 0.0 111.895 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 450' ' ' GLU . 0.1 OUTLIER -62.79 -45.06 94.42 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.651 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -59.48 -29.47 67.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.922 0.889 . . . . 0.0 112.399 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -61.84 -60.91 2.94 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.51 0.724 . . . . 0.0 109.609 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.571 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -76.97 -13.91 59.91 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 112.32 -177.008 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 446' ' ' LEU . 38.2 mt-10 -58.16 -41.66 84.29 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.883 0.765 . . . . 0.0 110.921 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -68.61 -44.57 74.0 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.398 0.437 . . . . 0.0 110.584 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.443 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 62.9 t80 -60.85 -52.62 64.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.622 0.769 . . . . 0.0 110.749 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.5 -34.29 76.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.699 1.2 . . . . 0.0 111.583 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -69.32 -32.98 72.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.842 0.457 . . . . 0.0 110.261 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.1 m -72.21 -28.44 63.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.52 0.728 . . . . 0.0 110.409 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.47 ' HB3' ' HE2' ' A' ' 370' ' ' HIS . 22.7 mt -80.9 -12.9 59.33 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.315 0.646 . . . . 0.0 111.292 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 76.27 5.39 3.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 126.562 1.945 . . . . 0.0 111.933 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.459 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.9 p -89.99 140.25 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.818 0.447 . . . . 0.0 110.102 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 23.3 t70 -148.6 151.92 35.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -174.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 9.6 p30 47.62 27.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.788 1.235 . . . . 0.0 112.539 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.41 -10.49 59.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.08 0.952 . . . . 0.0 109.443 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.571 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.85 158.01 35.97 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.629 0.772 . . . . 0.0 109.921 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 25.0 p -145.56 109.81 4.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.287 0.635 . . . . 0.0 109.937 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 16.5 t -76.72 -5.51 48.34 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.306 0.643 . . . . 0.0 111.159 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -114.37 120.07 38.87 Favored Pre-proline 0 C--N 1.351 0.648 0 C-N-CA 123.629 0.771 . . . . 0.0 109.415 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.16 176.78 9.49 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.451 2.767 . . . . 0.0 112.024 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -63.23 -34.99 78.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.386 0.674 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 123.885 0.874 . . . . 0.0 109.03 175.199 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 49.8 m -148.61 156.73 42.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.73 0.812 . . . . 0.0 110.346 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -79.0 81.5 5.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.154 0.582 . . . . 0.0 109.805 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.3 ptp -72.81 -16.14 61.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.98 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -137.96 163.46 31.47 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.008 1.323 . . . . 0.0 109.503 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.3 t -79.14 -172.91 3.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.686 0.794 . . . . 0.0 110.613 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.1 p -140.08 135.62 32.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 110.028 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 388' ' ' VAL . 25.8 m -136.7 156.61 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 124.208 1.003 . . . . 0.0 110.88 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.543 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 26.3 p -119.54 107.15 12.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.521 0.728 . . . . 0.0 109.263 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 56.1 t -96.67 150.54 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -129.21 104.33 7.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.434 1.094 . . . . 0.0 108.564 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . 0.423 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 64.8 t -74.28 105.17 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 110.31 -176.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 41.2 t30 -88.31 87.82 7.43 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -17.43 63.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.306 175.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -71.69 -17.99 62.2 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.592 . . . . 0.0 110.547 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -82.14 -167.63 40.12 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.832 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -68.03 129.28 39.45 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.964 0.506 . . . . 0.0 110.479 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.459 ' HB3' HG13 ' A' ' 376' ' ' ILE . 0.9 OUTLIER -75.95 -58.85 3.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.639 -173.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.428 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.42 -91.13 0.08 OUTLIER Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.341 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.5 19.86 33.93 Favored 'Cis proline' 0 C--N 1.37 1.702 0 CA-C-N 120.502 2.151 . . . . 0.0 114.31 11.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -77.15 -6.19 51.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.525 0.33 . . . . 0.0 111.359 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 456' ' ' LEU . 31.1 mt -111.28 142.91 42.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.397 1.079 . . . . 0.0 108.832 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.81 122.32 87.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.069 0.548 . . . . 0.0 110.159 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 26.1 Cg_endo -59.08 -28.21 87.19 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.283 2.655 . . . . 0.0 114.247 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.79 -48.08 23.15 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.384 0.427 . . . . 0.0 109.937 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -67.83 -28.78 67.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.559 0.744 . . . . 0.0 111.661 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.5 HD12 HD21 ' A' ' 379' ' ' LEU . 12.7 mm -60.35 -29.66 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.933 172.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 57.0 mm-40 -85.15 -25.38 27.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.612 0.365 . . . . 0.0 110.602 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 65.9 mm-40 -82.26 -24.06 34.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.016 0.527 . . . . 0.0 112.116 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.5 HD21 HD12 ' A' ' 376' ' ' ILE . 3.0 pp -74.59 158.71 84.67 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.25 153.39 74.53 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.153 1.902 . . . . 0.0 112.718 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.99 -18.2 65.08 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.114 1.365 . . . . 0.0 112.386 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . 0.423 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.6 p80 -161.97 160.14 27.39 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.197 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.407 ' HD2' HD11 ' A' ' 395' ' ' ILE . 57.3 m-85 -124.76 104.66 8.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 135.09 161.51 9.41 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.631 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -79.15 129.87 19.26 Favored 'Cis proline' 0 C--N 1.373 1.857 0 CA-C-N 120.147 1.973 . . . . 0.0 112.123 4.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.99 -176.04 34.64 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.667 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.4 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 39.3 Cg_endo -66.46 133.91 33.98 Favored 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 112.838 -177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.732 HG21 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -38.27 -46.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 127.038 2.135 . . . . 0.0 113.621 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -76.81 -37.4 55.81 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.168 0.987 . . . . 0.0 111.684 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.0 t -74.41 -41.23 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.2 t -61.36 -42.28 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.46 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 393' ' ' ARG . 4.4 pp -70.42 -40.1 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.481 ' N ' HD13 ' A' ' 392' ' ' LEU . 16.2 ptm180 -68.52 -31.85 71.39 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 27.7 mmm-85 -72.35 -32.69 66.7 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.469 HG23 ' HG ' ' A' ' 449' ' ' LEU . 18.2 mm -65.4 -53.43 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 400' ' ' VAL . 93.9 t -55.76 -53.84 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 124.34 1.025 . . . . 0.0 110.749 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.36 -37.55 77.66 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . 0.6 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 83.3 m -71.75 -40.42 69.36 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.023 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 396' ' ' VAL . 74.8 t -68.56 -32.99 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.093 0.557 . . . . 0.0 110.42 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.77 -51.01 68.8 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.182 0.593 . . . . 0.0 109.973 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 29.6 p -79.36 -10.57 59.84 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.447 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 409' ' ' VAL . . . -57.62 119.07 5.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.581 1.152 . . . . 0.0 113.459 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.24 116.94 7.1 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.852 167.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 63.58 68.73 0.58 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.026 0.917 . . . . 0.0 108.7 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.9 m -54.73 -40.93 69.78 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.466 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -50.86 -40.12 55.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.778 1.231 . . . . 0.0 113.878 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -84.98 -35.17 22.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.379 0.672 . . . . 0.0 110.207 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 403' ' ' ALA . 55.5 t -66.15 -33.61 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.52 0.728 . . . . 0.0 111.063 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.45 -11.37 59.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.988 0.915 . . . . 0.0 110.083 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.75 -9.75 84.93 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.268 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.65 0.73 55.27 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.613 0.765 . . . . 0.0 111.597 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -142.7 133.74 25.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.274 0.63 . . . . 0.0 110.482 176.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -114.2 159.43 36.47 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 124.025 0.93 . . . . 0.0 109.764 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.45 143.07 30.55 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.029 1.819 . . . . 0.0 111.022 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -139.25 132.87 30.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -87.89 25.7 1.49 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -164.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -9.07 58.3 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.363 0.665 . . . . 0.0 110.871 171.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 67.28 31.91 78.43 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.556 0.535 . . . . 0.0 114.006 172.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.11 -121.07 1.2 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 123.598 0.234 . . . . 0.0 112.936 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.519 ' HB2' HD13 ' A' ' 436' ' ' LEU . 3.8 mp0 -82.26 172.71 12.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.842 0.857 . . . . 0.0 110.603 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 94.3 t -134.11 131.65 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.419 0.688 . . . . 0.0 109.837 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 433' ' ' SER . 46.5 mm -104.37 127.64 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 0.0 109.358 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.7 p -106.72 148.29 28.59 Favored 'General case' 0 C--O 1.241 0.635 0 O-C-N 123.906 0.754 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.01 170.97 20.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.849 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 52.3 m -103.2 115.87 31.39 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -142.87 125.46 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.359 0.663 . . . . 0.0 109.927 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 37.9 t70 67.08 16.45 10.29 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.916 1.286 . . . . 0.0 111.641 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 96.78 -15.41 62.72 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.95 -0.469 . . . . 0.0 112.937 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.77 171.21 8.92 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.174 0.99 . . . . 0.0 110.12 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.0 t -97.04 102.81 14.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -91.11 133.89 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 36.5 p -132.64 126.98 33.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 109.352 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.464 HD12 HD11 ' A' ' 413' ' ' LEU . 2.2 pp -117.07 163.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.838 0.855 . . . . 0.0 109.525 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.75 150.81 22.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.516 0.674 . . . . 0.0 111.206 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 421' ' ' GLU . 81.7 mt -114.59 160.75 31.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.296 1.438 . . . . 0.0 109.013 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.46 136.44 19.49 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 121.84 1.693 . . . . 0.0 111.519 164.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.81 144.53 31.09 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.92 2.414 . . . . 0.0 112.055 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.7 172.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.036 0.534 . . . . 0.0 110.846 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -154.91 4.19 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.367 0.667 . . . . 0.0 112.114 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.1 t -122.6 141.56 51.58 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.041 0.536 . . . . 0.0 110.212 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.77 -36.19 70.3 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.292 1.037 . . . . 0.0 112.499 -170.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 39.8 m -66.54 -22.15 66.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.313 0.645 . . . . 0.0 111.075 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 3.6 t80 -86.84 -22.52 25.76 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.725 0.41 . . . . 0.0 109.973 -177.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 388' ' ' VAL . . . -51.39 -66.24 0.42 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -29.38 68.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.587 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 444' ' ' PHE . 0.5 OUTLIER -65.3 -33.12 75.22 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.813 0.445 . . . . 0.0 110.864 176.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.66 -45.52 82.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.066 0.546 . . . . 0.0 110.749 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.469 ' HG ' HG23 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.35 -13.86 42.33 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.555 -179.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.6 -50.48 73.0 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.868 0.867 . . . . 0.0 111.375 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -67.41 -29.65 69.2 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.989 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.442 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 54.9 t80 -73.29 -42.63 62.19 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.216 0.606 . . . . 0.0 110.985 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.01 -26.83 66.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.918 0.887 . . . . 0.0 110.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -67.62 -38.8 84.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.19 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 18.7 m -67.51 -30.68 70.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.924 0.89 . . . . 0.0 111.132 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 371' ' ' LEU . 33.3 mt -82.28 -17.43 45.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 0.0 111.425 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 71.41 7.83 6.14 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.987 1.715 . . . . 0.0 111.758 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.408 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 24.7 p -75.82 135.77 40.22 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.103 0.478 . . . . 0.0 110.359 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -127.37 141.37 51.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.642 0.777 . . . . 0.0 110.605 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 8.0 p30 46.35 25.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.163 1.785 . . . . 0.0 113.286 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 52.9 tp -76.82 -15.61 59.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.339 1.055 . . . . 0.0 111.279 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -158.98 159.28 34.66 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.016 0.526 . . . . 0.0 110.184 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 61.7 p -160.63 129.71 4.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.247 0.619 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 21.6 t -80.55 4.29 18.93 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.243 0.617 . . . . 0.0 111.462 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.47 117.71 68.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.087 0.955 . . . . 0.0 109.209 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.14 174.83 11.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.084 2.523 . . . . 0.0 112.881 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -65.65 -30.91 71.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.157 0.583 . . . . 0.0 110.99 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.557 1.231 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.093 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.87 -0.092 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 60.2 p -87.85 157.38 19.01 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.742 0.817 . . . . 0.0 110.16 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 35.7 t60 62.32 28.46 16.94 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.031 0.933 . . . . 0.0 109.26 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 21.3 ttt -70.15 149.48 47.51 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -97.63 172.55 7.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.404 0.682 . . . . 0.0 110.583 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -79.36 -179.04 6.56 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.162 0.585 . . . . 0.0 110.171 175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.1 p -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 0.0 110.972 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 388' ' ' VAL . 3.1 m -137.76 157.47 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.567 1.147 . . . . 0.0 109.525 173.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 7.7 p -137.57 101.59 4.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.566 HG21 HD13 ' A' ' 395' ' ' ILE . 29.0 m -94.34 151.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.23 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 53.6 m-85 -110.05 100.49 9.42 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 23.2 t -70.65 88.38 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.8 0.688 . . . . 0.0 109.735 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -85.04 88.23 7.44 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.865 -174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.608 ' HZ1' HD12 ' A' ' 379' ' ' LEU . 0.0 OUTLIER -70.62 -12.45 61.57 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.731 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -76.26 -28.56 57.13 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.745 0.818 . . . . 0.0 111.134 173.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -61.22 -76.23 0.25 Allowed Glycine 0 C--N 1.353 1.523 0 O-C-N 123.429 0.456 . . . . 0.0 112.838 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.4 t30 -152.92 143.2 22.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.472 ' HA ' HG22 ' A' ' 376' ' ' ILE . 1.0 OUTLIER -86.06 -62.64 1.47 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.551 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -146.19 -94.81 0.17 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.271 0.982 . . . . 0.0 112.763 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -90.13 15.89 46.11 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.326 2.063 . . . . 0.0 113.804 10.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -82.69 -2.26 53.63 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 110.063 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.6 mt -109.83 142.91 40.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.126 1.37 . . . . 0.0 108.034 172.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.408 ' OD1' ' HE3' ' A' ' 374' ' ' LYS . 16.2 t70 -70.27 120.16 76.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.161 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.409 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 31.8 Cg_endo -60.71 -28.38 86.42 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.205 2.603 . . . . 0.0 114.192 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.06 -47.9 26.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.808 0.443 . . . . 0.0 110.706 -178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -67.49 -29.99 69.56 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.632 0.582 . . . . 0.0 111.146 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . 0.518 HD12 HD23 ' A' ' 379' ' ' LEU . 22.4 mm -62.01 -31.79 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.92 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.31 -24.68 42.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.211 0.604 . . . . 0.0 111.159 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.8 mm-40 -81.9 -34.76 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.033 0.533 . . . . 0.0 112.258 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.608 HD12 ' HZ1' ' A' ' 363' ' ' LYS . 2.4 pp -70.24 153.99 94.84 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.543 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -41.69 152.94 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 124.519 3.479 . . . . 0.0 116.052 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -86.41 -11.15 52.74 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.817 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -160.86 144.97 13.65 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.43 1.092 . . . . 0.0 110.013 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -120.61 128.9 53.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.98 179.57 33.0 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.958 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.79 137.42 46.15 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 120.341 2.07 . . . . 0.0 113.437 2.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 175.92 -166.05 37.03 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.768 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . 0.433 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 17.9 Cg_endo -59.27 129.58 32.14 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.379 2.72 . . . . 0.0 113.369 -169.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.73 HG21 ' HB1' ' A' ' 445' ' ' ALA . 4.7 p -47.24 -44.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.796 1.638 . . . . 0.0 111.81 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.99 -45.3 93.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.081 1.352 . . . . 0.0 111.465 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.433 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 97.7 t -74.08 -51.72 22.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.74 -40.03 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.507 HD11 ' HD2' ' A' ' 448' ' ' PHE . 3.7 pp -68.14 -42.55 79.95 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.485 ' N ' HD12 ' A' ' 392' ' ' LEU . 14.0 ptt180 -74.91 -25.5 58.97 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -66.97 -34.37 77.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.911 0.884 . . . . 0.0 110.494 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.566 HD13 HG21 ' A' ' 359' ' ' VAL . 42.8 mm -64.58 -56.65 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.525 ' O ' HG21 ' A' ' 400' ' ' VAL . 58.5 t -60.81 -47.57 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 124.875 1.36 . . . . 0.0 111.817 -171.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . 0.492 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.3 pt20 -71.12 -34.98 71.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.826 0.45 . . . . 0.0 111.548 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.71 77.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.758 0.423 . . . . 0.0 109.925 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . 0.479 ' SG ' HD12 ' A' ' 371' ' ' LEU . 48.4 t -71.71 -43.29 66.18 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.161 0.984 . . . . 0.0 111.586 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.562 HG13 HG22 ' A' ' 406' ' ' THR . 11.1 t -66.81 -45.87 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.93 -37.91 87.28 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.4 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . 0.466 ' SG ' HD21 ' A' ' 379' ' ' LEU . 93.1 m -83.24 -10.24 58.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.005 0.522 . . . . 0.0 111.773 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -68.61 141.88 55.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.2 122.6 23.04 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.801 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . 0.402 ' O ' HG21 ' A' ' 409' ' ' VAL . 41.3 tt0 65.34 59.85 0.79 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 400' ' ' VAL . 98.0 m -53.88 -31.06 48.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.899 1.68 . . . . 0.0 112.636 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -58.31 -39.83 80.43 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.676 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 64.9 m -82.13 -28.91 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.238 0.615 . . . . 0.0 110.431 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.482 HG23 ' HB1' ' A' ' 403' ' ' ALA . 60.0 t -72.03 -31.47 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.089 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -64.23 -21.87 66.74 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.636 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -69.45 -27.13 73.86 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.947 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . 0.424 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 89.3 m-85 -75.7 -4.81 42.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.036 0.534 . . . . 0.0 112.313 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.05 136.42 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.189 0.595 . . . . 0.0 111.247 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -119.83 151.03 51.77 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.268 1.027 . . . . 0.0 111.013 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.69 156.57 63.16 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.651 2.234 . . . . 0.0 114.199 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.25 154.03 39.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.085 1.754 . . . . 0.0 109.119 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.12 30.52 4.78 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.199 0.523 . . . . 0.0 111.241 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -28.48 14.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 0.0 110.469 167.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.98 44.0 1.98 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.663 -0.244 . . . . 0.0 112.955 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.25 -132.22 5.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.7 OUTLIER -66.84 168.61 9.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.514 1.126 . . . . 0.0 111.454 -178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.4 t -136.15 130.1 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.493 HG12 HD11 ' A' ' 436' ' ' LEU . 29.1 mm -114.9 134.03 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.251 0.62 . . . . 0.0 109.368 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 22.4 p -105.96 139.93 39.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.75 0.82 . . . . 0.0 109.602 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.69 125.56 5.91 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.918 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.6 m -82.66 108.66 16.2 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 122.982 0.513 . . . . 0.0 110.752 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . 0.586 ' HB3' ' HD1' ' A' ' 432' ' ' HIS . 62.6 t80 -131.92 143.0 49.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.209 1.004 . . . . 0.0 109.078 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 66.06 16.56 10.5 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.711 1.204 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.44 0.15 86.28 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.94 -172.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -107.92 159.04 16.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.197 0.999 . . . . 0.0 109.669 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.3 t -91.84 122.92 34.82 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . 0.586 ' HD1' ' HB3' ' A' ' 427' ' ' PHE . 32.9 m170 -122.84 152.2 40.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.731 0.812 . . . . 0.0 109.72 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 62.2 p -143.69 144.4 31.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.015 0.526 . . . . 0.0 110.725 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.1 pt -125.86 -177.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.285 1.034 . . . . 0.0 109.059 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 26.4 mt-30 -115.27 148.49 39.11 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.103 0.561 . . . . 0.0 110.425 171.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 10.5 mp -116.56 147.48 39.83 Favored Pre-proline 0 N--CA 1.485 1.296 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.79 132.7 43.88 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.501 2.134 . . . . 0.0 112.61 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.77 129.8 20.57 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.805 2.337 . . . . 0.0 114.027 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.8 m -92.08 175.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.556 1.143 . . . . 0.0 110.602 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -155.12 11.04 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.8 t -126.9 141.35 51.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.23 0.468 . . . . 0.0 110.503 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.72 64.5 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.939 0.896 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.8 m -74.74 -28.16 60.66 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.263 0.625 . . . . 0.0 110.427 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -84.24 -21.56 31.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.73 ' HB1' HG21 ' A' ' 388' ' ' VAL . . . -51.18 -63.18 1.21 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 124.428 1.091 . . . . 0.0 111.048 174.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.08 -41.08 71.12 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.272 -167.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . 0.437 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 36.0 ttm180 -61.19 -33.82 74.07 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 124.68 1.237 . . . . 0.0 111.735 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . 0.507 ' HD2' HD11 ' A' ' 392' ' ' LEU . 4.3 t80 -68.74 -37.71 79.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 -173.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.696 HD21 HD23 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.39 -16.27 33.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.817 171.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.437 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 0.9 OUTLIER -64.4 -40.07 95.08 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.706 0.403 . . . . 0.0 110.522 -173.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.29 -45.95 90.97 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.556 0.742 . . . . 0.0 110.604 175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.35 -53.51 47.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.751 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.405 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 82.6 m -63.35 -29.78 71.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.555 1.142 . . . . 0.0 111.823 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -69.72 -33.61 72.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.042 0.537 . . . . 0.0 110.797 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 42.7 m -71.0 -24.05 62.3 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.084 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.486 HD13 HD22 ' A' ' 371' ' ' LEU . 35.0 mt -100.18 -1.21 37.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.785 0.834 . . . . 0.0 111.048 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 71.71 7.33 5.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.115 1.766 . . . . 0.0 112.585 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.551 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 9.5 p -83.08 133.03 35.08 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 31.8 t70 -151.1 151.7 32.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.935 0.494 . . . . 0.0 109.779 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 59.59 14.97 4.27 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.585 0.754 . . . . 0.0 111.272 -170.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.48 -18.26 45.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.616 0.767 . . . . 0.0 111.013 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.696 HD23 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -164.21 151.71 12.11 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.639 0.775 . . . . 0.0 109.751 174.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 68.0 m -158.07 133.67 8.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 108.433 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 12.8 t -83.08 19.14 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.468 0.651 . . . . 0.0 112.066 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -147.75 154.11 43.68 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.719 1.608 . . . . 0.0 108.032 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.27 149.33 90.43 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.039 1.826 . . . . 0.0 111.586 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.74 -11.57 60.44 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.656 0.782 . . . . 0.0 111.506 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.015 1.326 . . . . 0.0 108.609 174.547 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 33.5 t -78.08 167.59 21.2 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 111.111 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -149.09 -33.99 0.2 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -52.84 61.99 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.454 0.702 . . . . 0.0 111.789 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -169.82 173.22 6.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.658 0.783 . . . . 0.0 110.11 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.0 m -80.31 176.27 9.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.79 0.436 . . . . 0.0 110.232 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 76.2 p -133.9 138.63 45.66 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.617 0.767 . . . . 0.0 109.293 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 388' ' ' VAL . 22.1 m -139.07 163.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.527 0.731 . . . . 0.0 110.788 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 26.6 p -136.81 127.42 27.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.477 1.111 . . . . 0.0 108.068 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.519 HG23 HD11 ' A' ' 395' ' ' ILE . 28.9 m -112.91 161.71 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.104 0.561 . . . . 0.0 110.656 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -120.14 102.78 8.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.14 103.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.733 0.813 . . . . 0.0 110.899 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 53.7 t30 -96.16 85.54 4.03 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.881 0.848 . . . . 0.0 109.267 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . 0.419 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.69 -23.97 65.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.473 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -73.45 -17.99 61.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.785 0.834 . . . . 0.0 111.471 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -67.8 -89.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.517 0 C-N-CA 123.101 0.381 . . . . 0.0 112.867 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.436 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 49.6 t-20 -141.72 148.31 38.82 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.41 ' O ' HD11 ' A' ' 371' ' ' LEU . 0.5 OUTLIER -90.48 -64.64 1.1 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.265 1.026 . . . . 0.0 108.264 -173.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.508 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.22 -94.91 0.18 Allowed Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.358 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -88.52 18.04 38.01 Favored 'Cis proline' 0 C--N 1.373 1.866 0 CA-C-N 120.374 2.087 . . . . 0.0 114.293 9.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . 0.418 ' HB3' HG22 ' A' ' 409' ' ' VAL . 76.8 m-70 -72.3 -18.42 61.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.201 0.6 . . . . 0.0 110.733 168.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.3 mt -104.74 140.01 38.7 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.939 1.295 . . . . 0.0 108.962 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.62 122.47 86.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.46 0.475 . . . . 0.0 110.385 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.3 Cg_endo -56.89 -34.0 96.12 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.659 2.906 . . . . 0.0 114.58 -173.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.44 -45.0 49.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.808 0.443 . . . . 0.0 110.702 -176.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.95 -29.78 68.92 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.706 0.629 . . . . 0.0 111.205 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 21.6 mm -64.85 -30.67 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.977 0.911 . . . . 0.0 111.245 173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 75.5 mm-40 -79.95 -17.48 52.89 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 122.093 -0.379 . . . . 0.0 110.8 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.5 mm-40 -86.97 -5.8 58.97 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.757 0.423 . . . . 0.0 111.094 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 167.67 11.44 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.156 0.582 . . . . 0.0 111.542 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 158.22 58.05 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 121.761 1.64 . . . . 0.0 111.383 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.0 -18.08 59.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.545 0.738 . . . . 0.0 111.673 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -163.84 160.81 22.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 111.193 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -126.36 157.79 37.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.69 1.196 . . . . 0.0 108.878 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 81.95 -177.19 53.9 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.51 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 128.99 17.56 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.591 1.695 . . . . 0.0 112.302 -1.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.25 -172.91 30.28 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.42 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.36 129.95 35.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.219 2.613 . . . . 0.0 112.574 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.724 HG23 ' HB3' ' A' ' 445' ' ' ALA . 4.6 p -42.48 -46.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.656 1.983 . . . . 0.0 112.891 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.76 -36.95 81.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.908 1.283 . . . . 0.0 112.379 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 69.0 t -79.01 -47.19 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.195 -0.316 . . . . 0.0 110.646 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.46 -31.68 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 122.656 0.382 . . . . 0.0 111.715 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 393' ' ' ARG . 4.0 pp -74.17 -41.13 61.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.111 0.164 . . . . 0.0 110.766 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.445 ' N ' HD13 ' A' ' 392' ' ' LEU . 6.2 ptt180 -69.49 -26.55 64.61 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -66.17 -31.78 72.83 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.806 0.842 . . . . 0.0 111.282 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 359' ' ' VAL . 32.1 mm -74.71 -49.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 400' ' ' VAL . 94.5 t -59.62 -48.87 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 124.148 0.905 . . . . 0.0 111.424 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.8 -27.8 63.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.505 0.322 . . . . 0.0 111.29 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.85 90.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.82 -60.7 2.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 110.806 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 396' ' ' VAL . 43.1 t -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.039 0.936 . . . . 0.0 111.797 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.28 -46.67 66.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.723 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 71.9 m -80.08 3.22 21.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.137 0.575 . . . . 0.0 112.219 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -72.58 137.9 46.48 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.854 0.861 . . . . 0.0 112.411 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 404' ' ' LEU . 2.5 pp -84.86 132.57 34.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 57.82 61.72 2.31 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.371 1.082 . . . . 0.0 109.618 -172.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.1 m -57.27 -26.98 61.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.489 1.515 . . . . 0.0 112.614 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -60.46 -31.44 70.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.99 0.916 . . . . 0.0 112.438 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -75.41 -44.9 42.15 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.853 0.861 . . . . 0.0 109.576 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.524 HG23 ' HB3' ' A' ' 403' ' ' ALA . 97.9 t -68.78 -27.66 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-N 114.194 -1.367 . . . . 0.0 111.338 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.51 -30.05 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.361 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.11 -16.26 40.18 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -85.02 -17.35 37.8 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.393 0.677 . . . . 0.0 111.866 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.04 135.52 31.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.277 0.56 . . . . 0.0 112.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -113.4 168.68 7.42 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.609 0.764 . . . . 0.0 109.176 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 58.3 Cg_endo -69.0 136.65 35.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 121.785 1.657 . . . . 0.0 112.742 171.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -141.7 99.51 3.56 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.012 1.725 . . . . 0.0 107.446 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -85.09 72.44 10.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.539 1.161 . . . . 0.0 108.814 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -97.39 -2.84 41.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.754 -1.567 . . . . 0.0 109.869 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 79.2 27.62 55.28 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -103.99 -120.79 4.82 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.507 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 14.6 mm-40 -84.88 178.91 7.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.116 0.567 . . . . 0.0 111.507 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.91 126.1 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 122.868 0.467 . . . . 0.0 110.426 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.24 143.05 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.423 1.089 . . . . 0.0 108.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 2.9 p -107.06 142.07 37.28 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.209 0.603 . . . . 0.0 109.824 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -132.16 115.95 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.279 1.031 . . . . 0.0 109.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 102.17 4.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.039 0.536 . . . . 0.0 110.275 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -123.34 120.62 33.58 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.289 1.036 . . . . 0.0 109.193 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.9 t70 57.23 50.13 12.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.212 1.405 . . . . 0.0 112.198 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 79.66 -3.91 66.93 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.372 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -118.56 171.71 7.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.085 0.954 . . . . 0.0 108.832 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.3 t -127.73 111.43 13.67 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.586 0.708 . . . . 0.0 109.955 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -94.57 127.0 40.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.573 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.0 p -95.35 138.78 32.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.071 0.949 . . . . 0.0 109.775 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 25.9 pt -125.73 171.28 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.778 1.231 . . . . 0.0 109.263 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -115.38 143.77 44.78 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.235 0.541 . . . . 0.0 110.6 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 8.0 mp -113.88 155.8 44.72 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.072 1.349 . . . . 0.0 108.16 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.52 143.92 64.83 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.189 1.926 . . . . 0.0 111.762 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.34 155.22 25.04 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.295 1.997 . . . . 0.0 111.796 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.89 169.35 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 122.862 0.465 . . . . 0.0 109.864 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -147.47 8.36 0.9 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.108 0.563 . . . . 0.0 111.869 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.3 t -115.9 138.67 50.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.631 0.372 . . . . 0.0 110.131 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -73.16 -26.54 61.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.031 0.932 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 31.4 m -72.03 -29.4 64.13 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.535 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.94 -21.09 29.75 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.724 ' HB3' HG23 ' A' ' 388' ' ' VAL . . . -47.43 -63.29 1.09 Allowed 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.098 0.873 . . . . 0.0 110.153 171.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 16.9 mt -65.1 -50.12 67.33 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 113.175 -1.829 . . . . 0.0 109.319 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -32.74 57.78 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 125.146 1.529 . . . . 0.0 112.706 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . 0.423 ' HE1' HD23 ' A' ' 436' ' ' LEU . 4.4 t80 -65.12 -49.19 70.9 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.651 0.381 . . . . 0.0 110.564 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.11 -15.83 35.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 0.8 OUTLIER -65.15 -46.64 80.05 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 109.699 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -37.84 85.14 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.033 0.833 . . . . 0.0 110.06 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -65.5 -50.66 64.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.57 0.748 . . . . 0.0 111.217 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.28 -28.54 67.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.089 0.956 . . . . 0.0 110.823 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.63 -34.16 75.26 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.993 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.9 m -75.05 -25.08 58.39 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.682 0.793 . . . . 0.0 110.962 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 371' ' ' LEU . 67.3 mt -82.91 -12.0 57.72 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.013 0.525 . . . . 0.0 110.977 173.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 74.67 8.14 4.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.782 1.633 . . . . 0.0 111.562 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 11.2 p -86.9 134.3 33.53 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . 0.436 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.7 t70 -146.36 157.08 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.036 . . . . 0.0 108.379 -173.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 15.4 m-80 63.2 15.92 8.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.24 1.016 . . . . 0.0 111.109 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -83.34 -18.58 38.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.725 0.81 . . . . 0.0 111.366 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.78 166.15 26.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.365 0.666 . . . . 0.0 110.662 175.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 47.8 t -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.021 0.928 . . . . 0.0 108.769 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.453 ' HB2' HD23 ' A' ' 446' ' ' LEU . 39.9 t -69.53 -24.02 63.68 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.425 0.69 . . . . 0.0 111.592 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -102.67 148.77 36.01 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 109.776 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.12 143.42 90.21 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.649 2.233 . . . . 0.0 112.155 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.56 -19.66 62.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.768 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.95 0.9 . . . . 0.0 109.549 177.147 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 48.9 m -69.35 120.95 15.95 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 111.114 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -76.7 80.9 3.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.073 0.549 . . . . 0.0 109.526 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.6 ptm -90.58 -33.62 15.81 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -101.76 152.41 20.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.657 0.783 . . . . 0.0 108.891 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 20.8 t -79.97 178.66 8.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.165 0.586 . . . . 0.0 110.241 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.0 p -131.9 134.17 45.39 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.772 0.829 . . . . 0.0 109.541 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.05 171.23 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.598 1.159 . . . . 0.0 109.565 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.503 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 52.6 t -146.85 105.97 3.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.659 0.784 . . . . 0.0 109.152 178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' VAL . . . . . 0.553 HG23 HD13 ' A' ' 395' ' ' ILE . 34.3 m -91.99 153.61 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.87 99.78 6.56 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 45.2 t -63.96 98.85 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.537 1.148 . . . . 0.0 109.86 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -91.87 89.24 6.95 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.753 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -9.26 58.47 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.166 176.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -74.25 -20.01 60.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.231 0.613 . . . . 0.0 109.804 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.29 -169.66 37.93 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.752 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -69.57 141.1 53.84 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.583 0.691 . . . . 0.0 110.497 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.58 -56.48 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.57 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.1 -83.84 0.06 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.494 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.17 1.42 23.95 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 120.53 2.165 . . . . 0.0 114.381 -0.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' HIS . . . . . 0.525 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 16.3 p-80 -65.66 -16.11 63.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.966 0.906 . . . . 0.0 112.228 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 42.2 mt -95.46 136.55 35.69 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.855 0.862 . . . . 0.0 108.923 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.09 113.23 8.68 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 124.33 1.019 . . . . 0.0 110.119 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.409 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 34.7 Cg_endo -62.17 -16.89 53.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.182 2.588 . . . . 0.0 114.243 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' LYS . . . . . 0.484 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -82.25 -49.18 10.37 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.104 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -62.48 -35.64 79.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.435 1.094 . . . . 0.0 111.95 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.55 -30.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.711 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 84.4 mm-40 -85.39 -19.27 31.64 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.977 -0.452 . . . . 0.0 111.236 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 66.8 mm-40 -81.64 -35.85 29.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.732 0.413 . . . . 0.0 111.277 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.417 HD21 ' HB1' ' A' ' 398' ' ' ALA . 3.1 pp -68.17 157.14 88.25 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.89 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.63 161.73 23.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.928 2.419 . . . . 0.0 114.078 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.8 -17.15 59.96 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.159 -173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -162.49 160.55 26.3 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.09 102.95 6.47 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 140.56 169.37 11.7 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.848 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.46 129.78 19.61 Favored 'Cis proline' 0 C--N 1.381 2.241 0 CA-C-N 119.512 1.656 . . . . 0.0 112.636 0.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.04 -165.55 15.71 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.306 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.28 141.65 16.29 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.834 2.356 . . . . 0.0 112.314 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.636 HG22 ' HB1' ' A' ' 445' ' ' ALA . 7.5 p -46.55 -45.05 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.993 1.717 . . . . 0.0 113.329 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -75.74 -35.29 60.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.098 0.959 . . . . 0.0 111.888 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 80.1 t -76.92 -46.15 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.44 -38.69 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.19 0.596 . . . . 0.0 112.116 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.3 -41.22 70.2 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 122.945 0.153 . . . . 0.0 111.204 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 12.0 ptp180 -67.57 -33.84 75.84 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 46.4 mmm-85 -63.07 -34.91 78.6 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.745 0.653 . . . . 0.0 111.711 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.553 HD13 HG23 ' A' ' 359' ' ' VAL . 36.4 mm -68.09 -52.54 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 123.628 0.58 . . . . 0.0 109.797 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.19 -43.48 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.775 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.39 -21.97 59.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.84 0.456 . . . . 0.0 111.457 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.417 ' HB1' HD21 ' A' ' 379' ' ' LEU . . . -83.7 -16.73 43.86 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.359 0.664 . . . . 0.0 110.771 173.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.5 m -81.52 -61.88 1.81 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 122.876 0.471 . . . . 0.0 109.949 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.67 -50.65 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 0.0 111.071 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.22 -37.8 88.41 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.64 19.74 9.5 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.39 0.676 . . . . 0.0 111.522 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -85.13 150.65 24.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.334 0.654 . . . . 0.0 112.435 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 76.1 mt -66.45 114.12 5.21 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 162.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 61.96 73.43 0.47 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.284 0.99 . . . . 0.0 109.914 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.4 m -55.2 -41.18 71.66 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -54.59 -38.49 66.79 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 65.3 m -77.5 -38.57 48.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' VAL . . . . . 0.5 HG21 ' HB1' ' A' ' 403' ' ' ALA . 84.2 t -67.55 -26.65 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.367 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -75.03 -18.87 60.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.039 1.336 . . . . 0.0 110.147 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.08 -14.98 70.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 114.157 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -69.2 -37.46 78.1 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 117.871 0.836 . . . . 0.0 111.1 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.58 152.21 25.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.252 0.621 . . . . 0.0 109.818 175.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -117.19 157.54 46.68 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.844 0.858 . . . . 0.0 110.119 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 434' ' ' ILE . 60.2 Cg_endo -71.07 124.51 10.6 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 121.722 1.614 . . . . 0.0 111.54 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -113.9 123.06 48.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.884 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -88.17 55.22 3.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.021 0.929 . . . . 0.0 110.007 -167.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -97.08 -32.24 12.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.09 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.22 33.09 8.32 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.127 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.78 -112.56 2.71 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.635 0.217 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.5 mp0 -79.08 165.26 23.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.854 0.862 . . . . 0.0 110.312 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.29 126.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.589 0.756 . . . . 0.0 109.155 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ILE . . . . . 0.443 HG12 HD12 ' A' ' 436' ' ' LEU . 28.3 mm -106.26 122.96 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.238 0.615 . . . . 0.0 109.513 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.3 p -105.51 141.25 37.31 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.662 0.785 . . . . 0.0 109.816 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.56 130.82 6.04 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.497 -172.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 21.0 p -74.95 104.44 5.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.447 0.699 . . . . 0.0 109.882 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -114.61 107.34 15.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 0.0 109.359 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 36.1 t70 56.97 53.92 7.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.762 1.225 . . . . 0.0 111.502 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 86.18 -25.38 7.02 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.625 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.14 171.54 8.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.953 0.901 . . . . 0.0 109.569 -174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.1 t -115.63 104.17 11.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -110.73 160.54 16.62 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.862 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.6 p -148.76 153.62 38.42 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.819 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 415' ' ' PRO . 18.7 pt -123.08 166.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.624 0.77 . . . . 0.0 109.987 176.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.86 149.08 26.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.399 0.68 . . . . 0.0 109.813 172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.7 mp -115.86 159.48 38.9 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.941 1.296 . . . . 0.0 109.545 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.17 130.87 18.27 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.324 2.016 . . . . 0.0 111.765 164.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.07 151.83 56.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.909 2.406 . . . . 0.0 112.508 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.38 167.97 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.451 0.701 . . . . 0.0 110.733 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.78 2.68 0.94 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.987 0.515 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.4 m -119.15 140.08 50.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.958 0.503 . . . . 0.0 110.102 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.06 90.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.074 0.949 . . . . 0.0 112.373 -169.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.1 m -59.43 -28.51 67.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.608 0.763 . . . . 0.0 111.328 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -21.51 42.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.867 0.467 . . . . 0.0 110.147 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.636 ' HB1' HG22 ' A' ' 388' ' ' VAL . . . -55.26 -66.02 0.48 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 446' ' ' LEU . 0.2 OUTLIER -63.75 -43.87 95.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.797 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -33.58 70.28 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.531 0.732 . . . . 0.0 112.189 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.18 -51.55 67.36 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.55 0.531 . . . . 0.0 110.307 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' LEU . . . . . 0.738 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -86.64 -15.3 40.14 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.667 -178.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 454' ' ' HIS . 1.7 tm-20 -61.77 -53.26 58.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.819 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -62.95 -40.91 99.1 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.975 0.797 . . . . 0.0 110.84 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.474 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 61.6 t80 -56.09 -64.31 0.9 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.558 1.143 . . . . 0.0 110.637 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' CYS . . . . . 0.507 ' HB3' ' HG ' ' A' ' 458' ' ' CYS . 81.9 m -64.94 -27.17 68.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.728 1.211 . . . . 0.0 112.582 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 450' ' ' GLU . 51.2 t-80 -69.1 -41.63 77.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.644 0.777 . . . . 0.0 109.997 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.0 t -73.72 -7.95 54.09 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.416 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 92.0 mt -103.32 -6.41 22.02 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.71 0.804 . . . . 0.0 112.324 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 80.46 5.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.268 1.827 . . . . 0.0 112.682 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' CYS . . . . . 0.507 ' HG ' ' HB3' ' A' ' 453' ' ' CYS . 16.3 p -90.38 132.37 35.64 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -156.86 148.26 22.28 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 66.29 13.74 9.33 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.568 1.147 . . . . 0.0 110.736 -168.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.83 -20.31 35.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.129 0.571 . . . . 0.0 111.543 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' LEU . . . . . 0.738 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.91 166.22 30.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.781 0.432 . . . . 0.0 110.506 175.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 37.2 p -162.79 121.69 2.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.704 0.802 . . . . 0.0 109.47 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 22.3 t -80.03 3.91 18.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.408 0.683 . . . . 0.0 111.816 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.6 116.42 59.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.376 1.07 . . . . 0.0 108.191 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.91 174.74 11.8 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.833 2.355 . . . . 0.0 112.752 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -78.0 -32.83 51.39 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.262 0.625 . . . . 0.0 110.561 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 123.489 0.716 . . . . 0.0 109.707 174.864 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 -173.4 2.03 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.413 0.685 . . . . 0.0 111.337 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 23.8 p -140.65 144.45 35.72 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.031 0.932 . . . . 0.0 110.569 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 19.3 m -145.03 174.22 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 125.257 1.423 . . . . 0.0 110.339 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 29.0 p -147.21 109.11 4.41 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.488 0.715 . . . . 0.0 109.82 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 33.8 m -98.21 149.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.192 0.597 . . . . 0.0 109.581 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -112.9 98.82 7.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 66.5 t -65.39 103.3 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 124.244 0.965 . . . . 0.0 110.706 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -98.63 99.87 11.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.669 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.19 -6.87 54.64 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.974 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -81.58 -21.83 38.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.392 0.677 . . . . 0.0 111.067 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.79 0.03 OUTLIER Glycine 0 C--N 1.353 1.516 0 O-C-N 123.35 0.406 . . . . 0.0 113.101 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 55.9 t-20 -131.91 150.75 52.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -91.38 -63.31 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -143.6 -93.49 0.18 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.317 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.06 18.98 31.82 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 120.469 2.135 . . . . 0.0 114.319 9.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.24 0.85 52.81 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.686 0.794 . . . . 0.0 110.783 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 456' ' ' LEU . 48.7 mt -116.21 145.93 42.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.65 1.18 . . . . 0.0 109.011 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.96 118.21 63.37 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 123.586 0.554 . . . . 0.0 109.675 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 36.1 Cg_endo -61.39 -29.82 86.16 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.779 2.319 . . . . 0.0 113.248 -173.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.498 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -72.78 -43.43 62.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.554 . . . . 0.0 110.581 -178.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -69.9 -30.27 67.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.153 0.581 . . . . 0.0 111.05 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.86 -31.11 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.492 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 77.7 mm-40 -82.81 -19.36 37.81 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 122.376 0.27 . . . . 0.0 111.324 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 83.3 mm-40 -80.1 -41.54 25.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.015 0.526 . . . . 0.0 112.061 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.499 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . 2.7 pp -65.18 163.94 27.2 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 123.828 0.851 . . . . 0.0 111.293 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 379' ' ' LEU . 74.0 Cg_endo -68.51 169.75 16.53 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 122.381 2.054 . . . . 0.0 114.565 -169.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.2 -20.91 54.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.832 1.253 . . . . 0.0 112.031 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.512 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 29.6 p80 -161.0 159.16 29.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.062 0.458 . . . . 0.0 111.224 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -125.11 102.04 7.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 141.14 167.51 11.13 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.454 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.65 129.89 19.63 Favored 'Cis proline' 0 C--N 1.381 2.249 0 CA-C-N 118.902 1.351 . . . . 0.0 112.498 -1.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.73 -178.83 37.67 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.192 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 42.3 Cg_endo -64.27 134.72 43.4 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.053 2.502 . . . . 0.0 114.434 -171.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -38.55 -48.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.337 2.255 . . . . 0.0 113.782 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -76.09 -33.7 59.51 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.63 1.172 . . . . 0.0 112.158 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.521 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 94.2 t -81.87 -35.39 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.513 0.325 . . . . 0.0 110.601 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.64 -42.67 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 122.174 0.19 . . . . 0.0 110.803 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.3 pp -67.0 -43.91 81.71 Favored 'General case' 0 C--N 1.359 0.988 0 O-C-N 123.189 0.306 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 397' ' ' GLN . 12.9 ptm180 -68.54 -33.9 74.92 Favored 'General case' 0 C--N 1.363 1.17 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -75.58 -20.18 58.78 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 32.4 mm -75.21 -52.58 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 167.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.6 t -58.5 -57.08 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.949 -172.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.4 pt20 -70.47 -23.83 62.76 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.797 0.439 . . . . 0.0 112.062 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.54 92.57 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 75.0 m -66.88 -47.66 71.16 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.946 0.779 . . . . 0.0 111.026 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 396' ' ' VAL . 12.3 t -65.35 -35.97 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.727 0.411 . . . . 0.0 110.344 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.51 -39.81 77.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.957 0.503 . . . . 0.0 110.222 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 75.0 m -78.01 -14.69 59.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.159 0.584 . . . . 0.0 111.894 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -60.36 130.82 48.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -167.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 81.4 mt -72.13 120.66 18.04 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 65.36 59.25 0.81 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.115 0.96 . . . . 0.0 109.199 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.3 m -54.58 -34.77 62.47 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.63 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.35 -38.71 43.65 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.764 1.226 . . . . 0.0 113.272 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.44 HG22 ' HE1' ' A' ' 412' ' ' TYR . 58.0 m -89.14 -40.51 12.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.334 0.654 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 403' ' ' ALA . 70.9 t -61.55 -30.24 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.006 0.922 . . . . 0.0 111.869 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.71 -15.44 60.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.353 1.061 . . . . 0.0 110.302 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -77.38 -25.49 63.36 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.699 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.44 ' HE1' HG22 ' A' ' 408' ' ' THR . 96.0 m-85 -76.47 2.92 12.37 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.41 0.684 . . . . 0.0 111.965 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 400' ' ' VAL . 0.4 OUTLIER -140.38 113.0 8.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.552 0.741 . . . . 0.0 109.815 165.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -76.7 159.15 79.79 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.911 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.65 123.29 9.68 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.127 1.218 . . . . 0.0 109.83 163.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -109.86 111.74 23.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -85.37 29.27 0.68 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.356 0.663 . . . . 0.0 112.035 -162.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -78.89 -25.49 43.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.358 0.663 . . . . 0.0 110.602 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.19 40.95 5.02 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.127 0.267 . . . . 0.0 113.359 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.24 -119.29 2.54 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.624 ' HB2' HD12 ' A' ' 436' ' ' LEU . 14.8 mm-40 -85.51 -178.63 6.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.58 . . . . 0.0 111.198 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.14 125.54 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.662 0.785 . . . . 0.0 109.067 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 41.6 mm -104.03 126.2 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.498 0.719 . . . . 0.0 109.085 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 24.5 p -105.95 149.74 26.33 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.768 0.827 . . . . 0.0 109.649 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -161.12 175.59 12.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.485 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 64.7 m -120.47 117.43 27.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.965 0.906 . . . . 0.0 109.708 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.64 112.68 12.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.977 0.911 . . . . 0.0 109.285 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.7 t70 71.05 23.2 4.26 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.441 1.497 . . . . 0.0 110.983 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 -12.67 69.37 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.722 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.97 164.73 15.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.695 0.798 . . . . 0.0 109.91 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.5 t -108.92 114.76 28.8 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -119.09 140.99 49.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.774 0.321 . . . . 0.0 110.227 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 55.7 p -125.12 149.28 48.02 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 110.327 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 26.8 pt -120.38 179.88 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 0.0 110.096 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.29 154.39 22.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.655 0.782 . . . . 0.0 109.81 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 421' ' ' GLU . 80.8 mt -115.61 167.91 9.27 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.381 1.073 . . . . 0.0 109.379 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.11 142.42 30.86 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.844 1.696 . . . . 0.0 111.877 165.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.08 138.55 18.31 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.559 2.172 . . . . 0.0 111.507 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.13 160.93 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.479 0.712 . . . . 0.0 110.605 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -142.56 -3.22 1.04 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.436 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -115.3 140.06 49.44 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.07 72.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.086 0.955 . . . . 0.0 111.643 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.7 m -63.4 -35.05 79.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.204 0.601 . . . . 0.0 111.227 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -23.22 59.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.709 0.404 . . . . 0.0 110.106 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.55 -59.0 5.46 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.3 -41.72 89.32 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.571 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -26.66 61.08 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.567 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -63.71 -55.4 23.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.801 0.441 . . . . 0.0 110.574 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.04 -14.99 58.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.138 -175.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -40.86 98.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 109.612 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -69.14 -43.08 75.09 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.162 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.48 -46.34 63.97 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.144 0.578 . . . . 0.0 111.509 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 71.3 m -63.68 -27.91 69.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.698 0.799 . . . . 0.0 111.108 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -66.93 -40.53 87.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.342 0.657 . . . . 0.0 111.175 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 72.6 p -75.36 -15.22 60.49 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.605 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 371' ' ' LEU . 47.5 mt -97.7 -6.34 33.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.536 0.734 . . . . 0.0 111.35 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 70.23 9.17 6.93 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.644 1.577 . . . . 0.0 112.129 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.519 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -87.62 133.57 33.79 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 20.9 t70 -155.37 151.69 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 65.99 18.09 10.96 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.653 0.781 . . . . 0.0 110.495 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.3 tp -83.81 -7.66 59.4 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.314 1.046 . . . . 0.0 110.251 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.86 163.12 32.26 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.584 1.153 . . . . 0.0 108.683 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 27.9 m -151.49 109.83 3.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 124.286 1.035 . . . . 0.0 112.201 -176.783 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 120.487 0.184 . . . . 0.0 110.567 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.4 t -81.82 -179.39 7.37 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.819 0.847 . . . . 0.0 111.067 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.8 p -139.34 134.67 32.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.387 1.075 . . . . 0.0 109.6 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.52 159.52 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.558 0.743 . . . . 0.0 110.799 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 13.2 p -131.11 106.03 8.09 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.839 0.855 . . . . 0.0 109.602 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.427 HG11 HD23 ' A' ' 462' ' ' LEU . 46.2 t -93.56 158.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.378 1.071 . . . . 0.0 109.743 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.32 107.36 9.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 379' ' ' LEU . 46.6 t -77.53 105.92 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.152 0.581 . . . . 0.0 110.463 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 48.3 t30 -94.33 88.02 5.4 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.92 -14.12 62.85 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.559 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -83.97 -16.45 44.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.518 0.727 . . . . 0.0 111.136 174.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -71.6 -65.34 2.44 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 123.015 0.197 . . . . 0.0 112.626 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -154.93 165.54 36.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -109.22 -65.02 1.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.576 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -144.07 -95.2 0.2 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.774 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.9 22.09 29.43 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.54 2.17 . . . . 0.0 114.098 7.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -79.16 -8.21 58.82 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.753 0.421 . . . . 0.0 110.292 166.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.7 mt -110.85 142.61 42.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.99 1.316 . . . . 0.0 108.962 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.11 129.29 87.99 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.499 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.8 Cg_endo -59.78 -41.26 56.38 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.296 2.664 . . . . 0.0 113.549 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.499 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -69.92 -41.77 74.21 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.604 0.361 . . . . 0.0 110.725 -175.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -72.22 -28.48 63.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.207 0.603 . . . . 0.0 110.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.476 HD13 HD21 ' A' ' 379' ' ' LEU . 18.4 mm -65.42 -29.54 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.876 0.87 . . . . 0.0 110.52 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 81.8 mm-40 -80.04 -25.63 40.07 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.467 0.307 . . . . 0.0 110.92 174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 89.5 mm-40 -74.03 -34.56 64.15 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.102 0.561 . . . . 0.0 112.004 -176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.532 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.3 pp -73.55 154.94 89.66 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.776 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.39 155.51 2.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 0.0 115.705 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.74 -7.59 59.64 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.228 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.4 147.06 7.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.735 0.814 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.66 126.97 50.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.967 0.907 . . . . 0.0 109.306 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 109.68 -173.91 17.35 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.973 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.79 127.47 14.41 Favored 'Cis proline' 0 C--N 1.381 2.247 0 CA-C-N 119.664 1.732 . . . . 0.0 112.33 -2.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.95 -174.13 25.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.0 138.72 58.28 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.567 2.178 . . . . 0.0 112.686 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -46.67 -40.82 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.363 1.865 . . . . 0.0 112.442 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.59 -51.82 65.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 0.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 91.7 t -71.54 -45.21 68.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.723 -174.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.4 -29.62 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.8 pp -75.76 -40.2 55.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.055 0.389 . . . . 0.0 110.442 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.409 ' N ' HD12 ' A' ' 392' ' ' LEU . 10.5 ptm180 -70.12 -33.33 71.71 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 16.2 mmm-85 -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.444 0.698 . . . . 0.0 111.503 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.423 HG21 ' HG ' ' A' ' 449' ' ' LEU . 35.6 mm -73.16 -55.12 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.0 t -66.13 -52.77 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.758 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 423' ' ' ILE . 7.9 pt20 -63.58 -23.86 67.56 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.208 0.603 . . . . 0.0 112.25 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.532 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -70.73 -49.52 46.0 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 77.8 m -63.18 -52.47 62.25 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.054 0.942 . . . . 0.0 112.688 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.462 HG12 HG23 ' A' ' 406' ' ' THR . 11.0 t -64.59 -41.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.353 0.661 . . . . 0.0 110.215 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -72.13 -31.92 66.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 379' ' ' LEU . 85.1 m -88.38 8.96 25.1 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.381 0.672 . . . . 0.0 111.819 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -82.32 161.14 22.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.3 119.79 26.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.601 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 59.49 72.6 0.52 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.192 0.997 . . . . 0.0 109.763 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 400' ' ' VAL . 93.7 m -62.25 -34.89 77.39 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.978 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -55.87 -37.37 68.7 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.1 m -76.53 -43.41 39.39 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.239 0.616 . . . . 0.0 109.546 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' A' ' 403' ' ' ALA . 74.7 t -66.01 -28.05 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.54 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.418 ' HD2' HG11 ' A' ' 400' ' ' VAL . 19.0 t80 -78.92 -17.65 55.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.476 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -74.94 -10.5 83.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.598 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -77.49 -10.15 59.31 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.517 0.727 . . . . 0.0 111.376 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -141.1 141.46 34.21 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.018 0.927 . . . . 0.0 109.561 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -115.89 159.55 38.68 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.215 0.606 . . . . 0.0 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.49 151.52 75.56 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.87 1.713 . . . . 0.0 111.766 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.92 122.32 17.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.136 1.374 . . . . 0.0 107.99 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -80.46 14.46 2.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.817 0.847 . . . . 0.0 112.425 -168.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.09 -45.76 92.1 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.379 1.072 . . . . 0.0 111.403 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 95.09 43.55 3.5 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.712 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -99.85 -109.91 3.11 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.811 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.4 mp0 -78.5 171.36 15.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.41 0.684 . . . . 0.0 110.915 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.3 135.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.812 0.845 . . . . 0.0 109.354 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 436' ' ' LEU . 36.0 mm -113.18 123.9 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.8 p -107.36 146.25 31.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.939 0.896 . . . . 0.0 109.646 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.83 159.89 14.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.869 0.868 . . . . 0.0 110.077 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.4 m -81.61 116.97 21.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.857 0.463 . . . . 0.0 110.456 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -143.12 120.69 11.76 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.163 0.985 . . . . 0.0 110.499 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.85 22.58 7.15 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.835 1.254 . . . . 0.0 113.264 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.8 58.07 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 113.895 0.318 . . . . 0.0 113.895 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.64 172.38 13.09 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.0 t -86.1 126.99 34.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -106.43 139.75 40.42 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.3 p -123.69 149.12 45.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.344 1.058 . . . . 0.0 109.861 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 413' ' ' LEU . 25.9 pt -124.8 176.35 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 0.0 110.247 173.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -112.94 144.07 43.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.996 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 423' ' ' ILE . 7.8 mp -114.35 160.71 31.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.858 1.263 . . . . 0.0 108.373 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.46 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 67.8 Cg_endo -75.48 134.97 17.65 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.083 1.855 . . . . 0.0 112.167 169.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.24 136.71 29.72 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 122.716 2.277 . . . . 0.0 112.918 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.75 174.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.424 1.09 . . . . 0.0 110.92 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -155.8 0.44 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.164 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 19.0 m -119.77 142.01 48.96 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.262 0.483 . . . . 0.0 110.511 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.62 80.6 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.019 0.928 . . . . 0.0 112.904 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.0 m -65.23 -26.64 68.2 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.447 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 1.8 t80 -85.19 -22.05 28.91 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.44 -60.41 3.33 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 121.544 0.688 . . . . 0.0 109.224 170.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.39 -36.49 74.13 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.518 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 448' ' ' PHE . 0.0 OUTLIER -63.86 -31.96 73.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.688 0.795 . . . . 0.0 111.569 177.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.491 ' HA ' HH11 ' A' ' 447' ' ' ARG . 2.5 t80 -67.19 -46.17 74.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.459 0.304 . . . . 0.0 111.358 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -86.83 -13.53 44.76 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.199 -0.313 . . . . 0.0 111.057 -178.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.62 -55.28 33.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.879 1.272 . . . . 0.0 111.864 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.09 -34.86 78.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.458 0.703 . . . . 0.0 111.277 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 40.8 t80 -65.87 -56.48 11.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.573 0.749 . . . . 0.0 110.635 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.3 m -60.9 -30.68 70.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.781 0.832 . . . . 0.0 110.979 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.84 -44.53 85.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.914 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 52.4 p -75.47 -21.16 58.32 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 79.9 mt -78.06 -11.11 59.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.99 0.516 . . . . 0.0 111.491 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 74.03 9.4 4.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.525 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 456' ' ' LEU . 22.6 p -95.05 133.37 38.92 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.39 0.676 . . . . 0.0 109.742 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -149.38 150.75 32.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 14.1 m-80 67.47 17.15 10.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.881 1.273 . . . . 0.0 109.884 -167.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.3 tp -78.99 -26.73 43.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.765 0.826 . . . . 0.0 110.263 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.427 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -163.24 150.4 12.77 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.959 0.504 . . . . 0.0 110.873 178.195 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 67.1 m -166.07 138.54 3.97 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.501 1.12 . . . . 0.0 108.987 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.483 1.208 0 C-N-CA 123.303 0.641 . . . . 0.0 110.77 170.309 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 121.015 0.436 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.2 t -77.2 172.78 12.71 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -137.51 142.69 41.45 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.908 0.883 . . . . 0.0 110.193 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.64 166.02 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.468 1.107 . . . . 0.0 111.149 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.508 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 22.8 p -136.26 108.85 7.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.229 1.012 . . . . 0.0 109.631 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 25.0 t -93.99 149.76 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.535 0.734 . . . . 0.0 109.795 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -119.66 99.63 6.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.466 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -68.72 103.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.541 0.736 . . . . 0.0 110.018 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -94.9 94.58 8.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.857 0.863 . . . . 0.0 109.55 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.71 -11.57 59.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.764 177.005 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -76.61 -13.97 60.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.239 0.615 . . . . 0.0 110.339 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -83.69 -159.3 28.3 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 169.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 40.3 t30 -73.41 144.5 46.33 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.416 0.608 . . . . 0.0 110.516 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -61.15 1.79 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.565 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.07 -91.27 0.11 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.025 -0.875 . . . . 0.0 112.472 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -86.01 13.28 46.46 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.849 2.325 . . . . 0.0 113.906 7.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.99 -2.0 38.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.21 0.604 . . . . 0.0 111.351 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.565 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 30.3 mt -112.28 141.54 45.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.839 1.255 . . . . 0.0 108.321 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.491 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 16.3 t70 -70.74 117.93 60.28 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 110.009 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.48 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.4 Cg_endo -57.13 -34.61 98.06 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 123.597 2.864 . . . . 0.0 113.519 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -68.09 -51.42 46.61 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.577 0.548 . . . . 0.0 109.871 -177.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.491 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 19.7 mtp180 -62.31 -33.37 74.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.863 0.865 . . . . 0.0 111.398 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 379' ' ' LEU . 24.0 mm -61.64 -33.32 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.872 0.869 . . . . 0.0 111.04 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 73.9 mm-40 -80.55 -21.33 41.87 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.2 -0.313 . . . . 0.0 111.289 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 61.8 mm-40 -85.34 -37.22 20.18 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.726 0.41 . . . . 0.0 112.105 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.443 HD21 HD13 ' A' ' 376' ' ' ILE . 2.8 pp -64.84 156.01 80.92 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.828 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.13 154.32 28.74 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.848 2.365 . . . . 0.0 113.667 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.25 -14.0 60.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.818 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.466 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 9.7 p-80 -166.91 146.99 5.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.94 0.496 . . . . 0.0 111.552 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.92 104.43 10.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.744 1.218 . . . . 0.0 109.052 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 145.02 168.47 12.85 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.825 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.09 140.47 64.79 Favored 'Cis proline' 0 C--N 1.379 2.149 0 CA-C-N 119.713 1.757 . . . . 0.0 112.828 -1.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -164.4 -168.83 27.1 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.092 -0.838 . . . . 0.0 111.607 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.07 143.0 48.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 123.156 2.571 . . . . 0.0 111.949 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -52.85 -39.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.955 1.302 . . . . 0.0 111.638 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.427 ' HB3' HH21 ' A' ' 393' ' ' ARG . 14.3 m120 -68.89 -48.19 63.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 72.9 t -76.75 -44.31 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.5 -41.08 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.862 0.465 . . . . 0.0 111.487 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.82 -40.99 79.2 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 9.7 ptp180 -69.76 -25.78 63.99 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.135 0.272 . . . . 0.0 110.569 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 53.2 mmm-85 -70.8 -37.13 73.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.999 0.52 . . . . 0.0 111.258 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.79 -52.58 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.721 0.638 . . . . 0.0 109.489 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 400' ' ' VAL . 72.4 t -61.05 -47.74 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.998 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -65.01 -31.13 72.21 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.184 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.44 84.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.097 0.559 . . . . 0.0 110.231 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.34 -48.42 61.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.642 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 396' ' ' VAL . 36.4 t -62.9 -42.18 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.399 0.68 . . . . 0.0 110.468 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.88 -51.84 67.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 79.4 m -77.13 -8.0 56.76 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.726 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -65.5 123.05 18.63 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.908 0.883 . . . . 0.0 112.335 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.54 115.34 5.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 166.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 68.61 66.68 0.31 Allowed 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.543 1.164 . . . . 0.0 109.258 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 400' ' ' VAL . 84.6 m -55.43 -33.32 63.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.14 1.776 . . . . 0.0 112.428 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.91 1.284 . . . . 0.0 112.753 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.7 m -79.27 -34.29 42.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.898 0.879 . . . . 0.0 109.787 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -69.09 -30.36 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.51 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -69.24 -23.61 63.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.018 0.927 . . . . 0.0 110.196 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.04 71.07 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -79.98 -21.32 43.84 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.009 0.524 . . . . 0.0 112.163 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.26 115.08 20.46 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.688 0.756 . . . . 0.0 111.486 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.05 158.93 32.53 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.556 1.143 . . . . 0.0 110.045 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.21 126.84 10.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.244 1.963 . . . . 0.0 113.045 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.619 ' HB3' ' HE ' ' A' ' 418' ' ' ARG . 2.5 m-20 -123.77 104.96 9.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -86.09 58.77 5.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.768 0.827 . . . . 0.0 111.403 -164.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.619 ' HE ' ' HB3' ' A' ' 416' ' ' ASP . 0.9 OUTLIER -106.0 14.26 28.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.635 0.774 . . . . 0.0 111.073 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.58 26.19 72.85 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.33 -115.06 1.44 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.125 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.8 mp0 -86.1 170.39 12.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.112 0.565 . . . . 0.0 110.625 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.3 t -136.97 128.58 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 41.4 mm -116.48 138.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.4 p -106.51 142.7 35.74 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.817 0.847 . . . . 0.0 109.628 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.29 120.99 12.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.491 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.3 m -77.32 101.13 6.16 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -123.2 134.32 54.15 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.015 1.326 . . . . 0.0 108.213 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.3 t70 65.37 16.08 10.35 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.956 1.302 . . . . 0.0 110.29 -175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 89.0 -13.35 63.39 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.936 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -96.85 153.65 17.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.483 0.713 . . . . 0.0 110.143 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -84.26 123.05 29.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -123.9 124.12 41.92 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 47.7 p -107.05 151.35 25.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.717 0.807 . . . . 0.0 111.057 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.02 -178.08 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.931 . . . . 0.0 110.217 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -118.06 150.64 38.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.811 0.844 . . . . 0.0 109.523 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.9 mp -116.56 160.26 37.02 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.726 1.21 . . . . 0.0 108.185 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.99 139.88 19.7 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.157 1.905 . . . . 0.0 110.818 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.52 145.48 37.71 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.507 2.138 . . . . 0.0 112.939 -173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.5 156.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.989 0.915 . . . . 0.0 110.332 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.44 9.4 2.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.215 0.606 . . . . 0.0 111.525 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 42.4 t -115.21 139.92 49.53 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.26 68.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.612 0.765 . . . . 0.0 112.187 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.4 m -69.87 -16.97 63.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.058 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.83 -27.79 23.3 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.26 -65.8 0.5 Allowed 'General case' 0 C--N 1.366 1.3 0 O-C-N 124.201 0.938 . . . . 0.0 109.914 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.77 -43.12 99.62 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.473 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -60.55 -36.39 78.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.58 0.752 . . . . 0.0 111.641 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -61.43 -52.68 63.54 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 123.579 0.549 . . . . 0.0 110.14 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -73.93 -19.14 60.78 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.938 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.68 -34.44 46.19 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.205 0.457 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -62.42 -35.77 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.997 171.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.401 ' CE2' HD11 ' A' ' 456' ' ' LEU . 75.5 t80 -76.85 -36.6 56.69 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.126 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 92.4 m -65.72 -26.98 68.0 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.208 0.603 . . . . 0.0 110.74 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.34 -39.36 93.73 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.818 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.3 m -70.38 -18.12 63.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.252 1.021 . . . . 0.0 111.813 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 371' ' ' LEU . 38.7 mt -98.35 -13.3 20.75 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.853 0.861 . . . . 0.0 111.612 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 70.41 8.61 6.68 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.32 1.448 . . . . 0.0 111.958 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.482 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 26.4 p -86.8 135.24 33.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 32.8 t70 -152.34 146.57 25.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 65.66 15.58 10.11 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.126 0.97 . . . . 0.0 110.067 -168.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 35.6 tp -79.77 -12.02 59.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.574 0.75 . . . . 0.0 110.519 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.04 164.75 36.41 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 108.829 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 72.3 m -158.62 108.9 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 13.6 m . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 122.964 0.506 . . . . 0.0 110.34 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 43.3 t -79.21 171.75 14.76 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.4 p -138.86 134.41 33.27 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.572 0.749 . . . . 0.0 109.861 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.68 169.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.579 1.151 . . . . 0.0 110.218 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.5 106.86 4.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.635 0.774 . . . . 0.0 109.278 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.71 HG21 HD11 ' A' ' 395' ' ' ILE . 32.6 m -90.7 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.182 0.515 . . . . 0.0 110.133 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -118.34 100.63 7.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.55 105.92 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.031 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 30.8 t30 -87.34 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.499 ' HD3' ' HA ' ' A' ' 381' ' ' ASP . 6.7 mmmm -69.38 -31.02 69.14 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.094 -172.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.89 0.8 57.4 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.638 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.11 -80.9 0.23 Allowed Glycine 0 C--N 1.354 1.529 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -147.75 155.45 41.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.5 ' HA ' HG21 ' A' ' 376' ' ' ILE . 0.8 OUTLIER -97.54 -64.51 1.03 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.301 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.566 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.18 -91.4 0.1 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.367 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -86.88 12.12 53.11 Favored 'Cis proline' 0 C--N 1.374 1.879 0 CA-C-N 120.384 2.092 . . . . 0.0 114.325 11.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -76.64 -8.87 58.09 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.271 0.557 . . . . 0.0 110.335 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.566 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 45.6 mt -107.59 144.26 34.86 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -69.32 122.83 86.82 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.647 0.779 . . . . 0.0 110.302 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.519 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 57.0 Cg_endo -67.61 -21.16 46.16 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.969 2.446 . . . . 0.0 113.899 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -82.91 -45.47 14.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 4.5 mtt-85 -66.09 -32.49 73.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.913 . . . . 0.0 111.541 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 367' ' ' PHE . 22.2 mm -62.31 -27.85 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.187 172.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -83.84 -23.96 31.12 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.637 0.375 . . . . 0.0 110.667 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.6 mm-40 -77.6 -37.51 50.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.92 0.488 . . . . 0.0 112.103 -175.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.408 HD12 ' HE3' ' A' ' 363' ' ' LYS . 3.2 pp -63.7 153.34 83.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.086 171.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.9 169.36 10.45 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.609 2.206 . . . . 0.0 114.284 -172.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 363' ' ' LYS . 21.1 t70 -84.36 -3.34 58.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.419 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.17 151.78 18.04 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.255 0.622 . . . . 0.0 110.127 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -126.2 103.46 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 146.58 171.88 16.34 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.057 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -77.9 136.1 41.03 Favored 'Cis proline' 0 C--N 1.377 2.027 0 CA-C-N 118.65 1.225 . . . . 0.0 111.408 -1.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -160.92 -168.67 23.12 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.299 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.46 148.49 73.27 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.339 2.693 . . . . 0.0 112.383 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.4 p -55.32 -43.74 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.266 1.027 . . . . 0.0 111.634 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -72.01 -39.61 69.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.536 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 69.4 t -73.2 -48.93 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 119.559 -0.258 . . . . 0.0 110.847 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.8 t -58.74 -39.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.717 0.407 . . . . 0.0 111.775 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 421' ' ' GLU . 1.9 pp -68.67 -43.95 75.08 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.9 ptt180 -70.25 -27.99 64.88 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.155 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.3 mmt180 -63.78 -38.21 90.25 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.506 0.722 . . . . 0.0 110.91 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 359' ' ' VAL . 34.4 mm -66.17 -54.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.738 0.649 . . . . 0.0 109.279 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 400' ' ' VAL . 57.9 t -57.66 -63.63 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.427 1.08 . . . . 0.0 110.462 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -55.75 -36.27 67.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.7 0.8 . . . . 0.0 112.21 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.41 -44.86 81.8 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 122.746 0.418 . . . . 0.0 109.938 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 88.0 m -64.87 -38.84 92.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.575 0.75 . . . . 0.0 111.516 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 396' ' ' VAL . 11.8 t -69.5 -43.54 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.016 0.527 . . . . 0.0 110.275 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.55 -33.83 75.85 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.277 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 72.1 m -86.23 -4.83 59.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.509 0.724 . . . . 0.0 111.465 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -73.77 136.39 43.62 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.955 0.502 . . . . 0.0 111.429 -176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 70.5 mt -83.43 129.5 34.99 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 164.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 66.48 54.0 0.92 Allowed 'General case' 0 CA--C 1.562 1.425 0 O-C-N 124.196 0.935 . . . . 0.0 108.874 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 89.8 m -55.03 -38.47 67.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.491 1.516 . . . . 0.0 111.961 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -57.5 -38.45 74.64 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.796 1.238 . . . . 0.0 113.762 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -83.84 -29.58 27.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.167 0.508 . . . . 0.0 110.148 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.4 t -65.79 -31.78 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.82 0.848 . . . . 0.0 110.369 171.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' PHE . . . . . 0.419 ' HA ' HD12 ' A' ' 413' ' ' LEU . 65.4 t80 -75.91 -15.63 60.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.382 1.073 . . . . 0.0 110.712 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.02 62.95 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 116.506 -0.315 . . . . 0.0 113.264 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -92.74 -1.46 56.8 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 110.821 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 423' ' ' ILE . 53.8 mt -121.66 100.16 6.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.027 0.931 . . . . 0.0 110.231 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -103.25 135.98 19.3 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 122.818 0.447 . . . . 0.0 110.12 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.74 162.35 42.39 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.555 2.837 . . . . 0.0 112.623 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.96 152.18 26.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -89.77 60.41 5.01 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.959 0.885 . . . . 0.0 109.185 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -109.87 -62.21 1.54 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.64 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.57 41.37 5.11 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.509 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.86 -72.63 1.14 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 19.2 mp0 -108.59 167.72 9.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.559 0.744 . . . . 0.0 109.267 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.46 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 83.5 t -138.79 127.86 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.109 0.964 . . . . 0.0 108.515 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 436' ' ' LEU . 36.6 mm -118.25 135.22 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 0.0 109.887 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 5.4 p -108.04 140.31 41.4 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.685 0.794 . . . . 0.0 109.563 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.02 118.51 10.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.429 1.092 . . . . 0.0 109.513 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.6 m -76.01 100.1 4.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.551 0.691 . . . . 0.0 109.47 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' PHE . . . . . 0.412 ' HB3' ' CD2' ' A' ' 432' ' ' HIS . 65.0 t80 -117.93 117.09 28.31 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.879 1.272 . . . . 0.0 108.815 -174.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 62.78 25.17 14.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.942 1.297 . . . . 0.0 111.89 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.76 61.23 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.174 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.86 160.28 14.62 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.853 0.827 . . . . 0.0 109.247 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 14.0 t -96.71 127.65 42.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 427' ' ' PHE . 26.3 m-70 -119.46 123.29 43.69 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.2 p -105.22 137.58 42.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.382 0.673 . . . . 0.0 110.06 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.9 pt -122.64 172.27 10.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 123.805 0.842 . . . . 0.0 109.445 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -123.17 140.61 52.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.55 0.69 . . . . 0.0 109.743 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 4.8 mp -114.47 156.78 44.11 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.025 1.33 . . . . 0.0 108.646 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.31 130.48 14.07 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.154 1.903 . . . . 0.0 112.429 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -60.27 144.22 99.5 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.275 2.65 . . . . 0.0 113.16 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 24.8 m -111.64 158.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.844 0.857 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -137.46 7.23 2.81 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.3 t -121.65 141.78 50.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.64 0.376 . . . . 0.0 110.125 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.1 72.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.245 1.018 . . . . 0.0 112.604 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.3 m -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.957 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.72 -23.8 36.51 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.49 -61.94 1.89 Allowed 'General case' 0 C--N 1.365 1.243 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.06 -48.11 66.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.458 -169.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -58.17 -34.21 70.07 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.884 0.74 . . . . 0.0 112.753 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.418 ' CE1' HD23 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -61.15 -43.93 98.11 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.938 0.774 . . . . 0.0 109.864 -176.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.06 -16.0 34.76 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.479 175.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.71 -42.17 82.38 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.408 1.004 . . . . 0.0 110.752 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -66.56 -37.7 85.52 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.838 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.427 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 63.3 t80 -67.0 -45.91 76.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.028 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 74.5 m -70.04 -25.96 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.132 0.973 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -66.58 -35.88 81.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.49 0.716 . . . . 0.0 109.926 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.4 m -71.13 -20.3 62.33 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.0 0.92 . . . . 0.0 111.538 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 371' ' ' LEU . 44.9 mt -99.76 -11.3 20.94 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.977 0.911 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 74.34 7.89 4.58 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 0.0 112.113 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 10.9 p -87.88 133.34 33.93 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.809 0.444 . . . . 0.0 110.232 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -149.53 149.61 30.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.545 0.738 . . . . 0.0 109.7 -175.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 23.4 m-80 67.42 15.85 9.93 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.7 1.2 . . . . 0.0 111.003 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.01 -21.91 53.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -152.78 163.81 39.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.313 0.645 . . . . 0.0 110.111 175.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.6 p -165.16 115.47 1.1 Allowed 'General case' 0 C--O 1.239 0.52 0 O-C-N 123.963 0.789 . . . . 0.0 109.402 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 10.1 t . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.802 0.334 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.4 t -76.69 -179.7 5.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.347 0.659 . . . . 0.0 110.97 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.91 143.12 44.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.826 0.85 . . . . 0.0 110.314 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.36 169.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.677 1.191 . . . . 0.0 109.581 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.98 105.94 3.59 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.668 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.08 152.63 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.048 0.539 . . . . 0.0 109.962 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 76.2 m-85 -110.76 101.36 9.99 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.483 HG12 ' NZ ' ' A' ' 363' ' ' LYS . 58.1 t -70.62 92.84 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 124.15 0.98 . . . . 0.0 110.344 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -87.77 99.11 11.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.718 0.807 . . . . 0.0 108.969 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.483 ' NZ ' HG12 ' A' ' 361' ' ' VAL . 0.0 OUTLIER -80.65 -10.04 59.76 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.252 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -77.27 -14.36 59.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.681 0.392 . . . . 0.0 110.103 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.23 -166.93 29.97 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.362 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 2.5 t-20 -71.11 131.53 43.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.019 0.437 . . . . 0.0 110.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -78.04 -62.83 1.55 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.408 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.583 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -142.36 -94.96 0.22 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.824 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.86 9.67 56.82 Favored 'Cis proline' 0 C--N 1.373 1.847 0 CA-C-N 120.385 2.092 . . . . 0.0 114.96 10.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -73.8 -7.94 54.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.766 0.426 . . . . 0.0 111.33 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.583 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.9 mt -114.16 130.04 56.61 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.573 1.549 . . . . 0.0 107.557 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.13 125.32 89.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 123.583 0.552 . . . . 0.0 110.827 -176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 12.2 Cg_endo -53.78 -38.14 85.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.786 2.991 . . . . 0.0 114.377 -175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 374' ' ' LYS . 0.0 OUTLIER -75.82 -42.83 48.72 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.397 0.436 . . . . 0.0 110.209 -173.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -68.36 -30.42 69.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.555 0.742 . . . . 0.0 110.764 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.4 mm -63.84 -31.1 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.239 1.016 . . . . 0.0 111.198 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 64.5 mm-40 -74.98 -27.58 60.21 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 56.0 mm-40 -81.84 -3.38 53.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.384 0.674 . . . . 0.0 111.749 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 402' ' ' CYS . 18.6 mt -70.46 172.23 6.47 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.104 0.562 . . . . 0.0 110.187 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 379' ' ' LEU . 75.9 Cg_endo -73.34 163.65 37.26 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.114 1.209 . . . . 0.0 110.479 166.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.86 -23.22 60.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.199 0.6 . . . . 0.0 111.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 15.6 p-80 -158.76 147.04 18.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.617 0.367 . . . . 0.0 110.938 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.05 104.79 13.72 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 143.92 172.7 14.85 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.248 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.3 139.97 58.28 Favored 'Cis proline' 0 C--N 1.379 2.168 0 CA-C-N 119.134 1.467 . . . . 0.0 112.191 1.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.59 -170.23 27.13 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.473 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 390' ' ' VAL . 6.0 Cg_exo -69.98 145.72 56.71 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.312 2.675 . . . . 0.0 111.722 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.3 p -54.51 -39.4 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.501 1.12 . . . . 0.0 111.478 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.43 -47.01 74.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.613 1.165 . . . . 0.0 110.541 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 94.2 t -72.08 -51.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.84 -39.32 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.79 -42.34 73.9 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 421' ' ' GLU . 34.8 ptt180 -74.44 -24.76 59.11 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.885 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 15.2 mmt85 -63.75 -36.7 84.74 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.707 0.629 . . . . 0.0 110.515 174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.668 HD11 HG21 ' A' ' 359' ' ' VAL . 48.5 mm -66.84 -54.25 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 109.694 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 400' ' ' VAL . 81.8 t -56.56 -50.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 124.336 1.022 . . . . 0.0 111.354 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -69.85 -34.16 73.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.95 0.5 . . . . 0.0 111.613 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.61 88.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -67.2 -55.23 14.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.035 0.834 . . . . 0.0 110.93 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 396' ' ' VAL . 61.1 t -57.5 -40.68 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.702 0.801 . . . . 0.0 111.446 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.54 -48.25 67.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 379' ' ' LEU . 74.0 m -73.61 -10.15 59.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.109 0.564 . . . . 0.0 111.908 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.63 148.36 50.56 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.071 0.949 . . . . 0.0 112.649 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.28 130.16 34.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 60.41 61.48 1.76 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.153 0.977 . . . . 0.0 109.33 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -50.78 -37.13 40.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 112.848 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -53.34 -41.12 65.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.914 1.286 . . . . 0.0 112.755 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 -41.94 20.48 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.632 0.773 . . . . 0.0 109.531 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 403' ' ' ALA . 76.7 t -60.35 -33.18 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.129 0.972 . . . . 0.0 111.767 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -81.82 -13.35 57.79 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.426 0.691 . . . . 0.0 110.903 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -78.94 -3.14 87.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.461 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.92 -5.21 58.15 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.279 0.632 . . . . 0.0 111.411 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -139.8 113.39 8.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.53 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.88 156.61 37.05 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.86 0.864 . . . . 0.0 110.886 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.71 129.38 17.55 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.26 1.973 . . . . 0.0 113.24 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.647 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 59.1 m-20 -122.28 111.77 17.33 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.749 174.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -88.94 45.6 1.31 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.865 0.84 . . . . 0.0 109.44 -171.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.647 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 12.2 mpt_? -78.58 -15.66 58.3 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 110.151 173.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 84.84 42.16 7.33 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.329 0.393 . . . . 0.0 113.399 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.88 -112.18 3.59 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 120.169 -0.24 . . . . 0.0 113.014 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 22.5 mp0 -79.53 167.24 21.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.309 0.644 . . . . 0.0 110.642 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.8 t -134.54 129.23 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 436' ' ' LEU . 41.1 mm -115.18 130.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 433' ' ' SER . 22.8 p -106.09 154.54 20.51 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 124.03 0.831 . . . . 0.0 109.403 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -154.91 158.66 39.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.963 0.905 . . . . 0.0 109.914 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 45.6 m -105.06 119.49 39.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.463 0.705 . . . . 0.0 109.435 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -132.29 109.99 10.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.406 0.682 . . . . 0.0 109.945 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.41 41.03 16.63 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.684 1.194 . . . . 0.0 111.114 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.6 -0.65 85.18 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.314 -0.857 . . . . 0.0 114.064 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -103.7 171.73 7.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 109.303 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -116.13 119.59 36.31 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -107.07 137.57 44.88 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.4 p -127.98 148.67 50.53 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 109.876 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 413' ' ' LEU . 36.0 pt -130.55 174.12 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.811 0.845 . . . . 0.0 110.054 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -113.87 149.88 34.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.5 mp -116.64 158.94 42.25 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.862 1.265 . . . . 0.0 108.664 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.452 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 71.2 Cg_endo -74.93 131.47 14.41 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 C-N-CA 122.362 2.041 . . . . 0.0 112.456 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.55 146.71 74.9 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.858 2.372 . . . . 0.0 113.422 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.35 161.25 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.89 0.876 . . . . 0.0 110.544 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -141.17 5.44 1.89 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.504 0.721 . . . . 0.0 111.767 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.7 m -124.26 140.49 52.91 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.52 0.6 . . . . 0.0 110.995 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.39 79.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.201 1.0 . . . . 0.0 112.542 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 m -69.1 -24.18 64.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.96 -22.16 25.75 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.14 -58.59 4.3 Favored 'General case' 0 C--N 1.365 1.271 0 CA-C-O 121.629 0.728 . . . . 0.0 109.239 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.79 -44.57 80.96 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.859 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -56.71 -38.65 72.61 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.443 1.089 . . . . 0.0 112.197 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.452 ' HZ ' ' HD2' ' A' ' 437' ' ' PRO . 4.3 t80 -65.63 -45.09 84.38 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.536 -171.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -85.82 -13.16 48.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.792 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.473 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 0.8 OUTLIER -63.82 -43.74 95.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.009 0.368 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.26 93.36 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.453 ' CE2' HD11 ' A' ' 456' ' ' LEU . 43.8 t80 -69.7 -45.43 68.27 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.448 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 29.4 p -72.59 -21.65 61.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.351 0.661 . . . . 0.0 110.073 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -70.58 -36.07 73.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.869 0.868 . . . . 0.0 109.844 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 -31.49 68.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.569 0.747 . . . . 0.0 110.99 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.453 HD11 ' CE2' ' A' ' 452' ' ' PHE . 45.5 mt -80.87 -17.62 50.07 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.171 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 72.06 8.91 6.01 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.714 1.606 . . . . 0.0 111.518 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.496 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 21.9 p -82.73 137.26 34.46 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.227 0.611 . . . . 0.0 109.947 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 29.5 t70 -151.52 148.89 28.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 109.563 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 64.01 14.42 8.45 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.214 1.005 . . . . 0.0 111.436 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.46 -20.74 43.07 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.405 0.682 . . . . 0.0 112.006 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.83 159.53 36.8 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.072 0.549 . . . . 0.0 110.624 176.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 35.5 p -165.88 121.78 1.31 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.916 0.486 . . . . 0.0 111.026 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 122.99 0.516 . . . . 0.0 111.273 175.812 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.2 t -86.58 -177.66 6.21 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.627 0.771 . . . . 0.0 110.303 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.9 p -141.04 142.21 34.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.147 0.979 . . . . 0.0 109.913 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.06 147.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 123.908 0.883 . . . . 0.0 110.782 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.476 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 19.0 p -114.36 105.1 12.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.639 0.776 . . . . 0.0 108.972 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.472 HG11 HD23 ' A' ' 462' ' ' LEU . 48.4 t -98.34 154.44 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -130.18 107.5 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 36.6 t -78.01 106.48 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.476 0.71 . . . . 0.0 110.023 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 44.2 t30 -94.58 90.17 6.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.152 0.981 . . . . 0.0 109.257 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.18 -12.12 60.49 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.955 176.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 364' ' ' HIS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 82.3 t60 -73.35 -19.67 60.96 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.752 0.821 . . . . 0.0 111.034 169.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -72.47 -135.72 0.2 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.479 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 38.2 t30 -101.69 137.23 40.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.038 0.919 . . . . 0.0 109.295 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.02 -57.61 3.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -150.45 -87.98 0.07 OUTLIER Glycine 0 C--N 1.343 0.942 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.784 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.7 19.21 23.87 Favored 'Cis proline' 0 C--N 1.374 1.896 0 CA-C-N 120.705 2.252 . . . . 0.0 113.868 5.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.44 -7.27 46.33 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.627 0.771 . . . . 0.0 111.537 166.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.536 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.2 mt -116.84 140.05 49.89 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.2 1.0 . . . . 0.0 109.445 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.54 119.14 54.45 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.367 1.067 . . . . 0.0 110.619 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 24.5 Cg_endo -58.68 -24.64 71.83 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.478 2.785 . . . . 0.0 114.528 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -83.8 -44.64 14.15 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.746 0.419 . . . . 0.0 110.108 -176.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 32.7 mtt180 -67.23 -34.74 78.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.132 0.973 . . . . 0.0 111.723 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.48 -27.77 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.728 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 65.2 mm-40 -84.92 -27.76 26.37 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 122.058 -0.401 . . . . 0.0 110.469 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.9 mm-40 -71.96 -35.03 69.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.247 0.619 . . . . 0.0 112.253 -176.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.96 158.76 87.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.036 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.18 157.26 45.72 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.581 2.188 . . . . 0.0 113.042 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.25 0.27 29.31 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.504 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.496 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.1 p80 -166.4 149.97 7.31 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.442 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.7 m-85 -122.9 107.91 12.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 168.87 12.56 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.19 -0.783 . . . . 0.0 112.141 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 130.22 19.33 Favored 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 120.058 1.929 . . . . 0.0 113.609 -0.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.03 -165.41 14.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.99 140.62 38.45 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.533 2.155 . . . . 0.0 111.205 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.1 p -47.87 -42.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.697 1.199 . . . . 0.0 112.214 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.01 -55.27 27.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.048 1.339 . . . . 0.0 110.697 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 393' ' ' ARG . 58.0 t -67.9 -43.72 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.144 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.68 -47.49 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.728 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 117.861 0.3 . . . . 0.0 110.777 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.3 ptt180 -73.22 -32.78 64.97 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -65.55 -30.61 71.38 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.377 0.671 . . . . 0.0 111.289 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.543 HG21 ' HG ' ' A' ' 449' ' ' LEU . 20.7 mm -67.6 -59.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 80.7 t -61.44 -50.77 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.401 -171.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -65.32 -31.86 73.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.244 0.618 . . . . 0.0 111.785 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.23 94.71 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' CYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 452' ' ' PHE . 84.5 m -70.06 -41.64 73.89 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.184 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.522 HG22 ' CZ ' ' A' ' 452' ' ' PHE . 3.6 t -67.02 -42.6 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.18 -37.07 83.08 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 71.1 m -87.24 1.68 52.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 111.856 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.478 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.14 143.82 48.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 89.6 mt -82.27 125.11 30.58 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 67.74 53.17 0.7 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.502 1.121 . . . . 0.0 109.639 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.1 m -58.52 -27.24 64.32 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.068 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -56.35 -36.7 69.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.242 0.617 . . . . 0.0 111.669 177.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.2 m -88.95 -37.43 15.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 412' ' ' TYR . 98.3 t -64.05 -35.33 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.885 0.874 . . . . 0.0 111.722 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -72.27 -22.06 61.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.161 0.984 . . . . 0.0 110.28 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.81 -19.59 78.79 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.729 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.49 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 82.9 m-85 -75.68 -15.34 60.32 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.272 0.536 . . . . 0.0 111.726 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 104.46 6.5 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.685 0.755 . . . . 0.0 111.134 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 163.43 38.18 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.177 0.991 . . . . 0.0 110.181 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 167.54 26.73 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.284 1.989 . . . . 0.0 113.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 12.8 m-20 -145.3 130.37 18.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.941 1.296 . . . . 0.0 109.506 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -89.97 45.78 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.033 0.921 . . . . 0.0 109.708 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.676 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -93.15 -31.26 14.86 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.43 171.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.76 30.06 33.46 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.47 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.98 -122.54 1.55 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.401 ' HB2' HD22 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -69.54 166.67 18.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.368 0.667 . . . . 0.0 110.818 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 85.2 t -132.93 132.67 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 436' ' ' LEU . 28.1 mm -114.85 126.49 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.317 0.647 . . . . 0.0 109.883 175.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 9.2 p -107.64 151.0 26.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 110.716 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.91 140.56 12.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.221 1.008 . . . . 0.0 110.007 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 48.9 m -87.15 118.88 26.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.913 0.485 . . . . 0.0 110.443 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -140.36 134.5 30.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.747 0.819 . . . . 0.0 109.448 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.2 t70 64.51 25.99 13.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.702 1.201 . . . . 0.0 110.988 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.33 88.7 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.554 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -109.44 168.82 9.11 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.626 1.171 . . . . 0.0 110.331 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.8 t -100.12 135.05 42.14 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -132.1 133.63 44.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.179 0.592 . . . . 0.0 110.283 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 64.7 p -126.42 140.24 52.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.741 0.816 . . . . 0.0 110.524 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 20.2 pt -119.85 161.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.315 0.646 . . . . 0.0 109.857 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -103.32 147.41 27.11 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.103 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.54 HD11 HG12 ' A' ' 423' ' ' ILE . 7.6 mp -115.01 165.56 13.77 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.464 1.505 . . . . 0.0 108.809 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.31 142.0 23.59 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 121.92 1.747 . . . . 0.0 111.585 163.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.42 128.86 10.67 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.381 2.054 . . . . 0.0 112.87 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.07 172.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.556 0.742 . . . . 0.0 110.38 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -151.48 5.63 0.46 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' SER . . . . . 0.421 ' O ' HG21 ' A' ' 388' ' ' VAL . 45.7 t -125.23 141.14 52.27 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.341 0.519 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.47 -26.91 67.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.172 0.989 . . . . 0.0 111.919 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 33.2 t -70.34 -31.14 68.3 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.126 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -23.09 39.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.99 -62.05 1.91 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.242 0.544 . . . . 0.0 110.034 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.27 -35.67 68.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.812 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -62.75 -32.27 73.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.942 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.23 -56.4 11.45 Favored 'General case' 0 C--O 1.246 0.873 0 O-C-N 123.157 0.286 . . . . 0.0 110.608 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.543 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -73.67 -13.66 61.02 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.967 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.467 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 2.4 mm-40 -63.35 -47.06 83.72 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.351 0.66 . . . . 0.0 111.487 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -59.51 -43.86 93.28 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.615 0.766 . . . . 0.0 110.738 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 400' ' ' VAL . 44.6 t80 -69.98 -48.36 58.55 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.4 p -70.67 -21.32 62.61 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.574 0.749 . . . . 0.0 111.145 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -71.94 -37.55 69.99 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.634 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 77.0 p -76.58 -24.67 53.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.618 0.367 . . . . 0.0 110.582 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.502 HD11 ' CE2' ' A' ' 452' ' ' PHE . 72.6 mt -77.67 -17.94 57.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 111.313 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.26 7.59 6.15 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.817 1.647 . . . . 0.0 111.745 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.597 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 17.7 p -81.11 134.8 35.71 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.368 0.604 . . . . 0.0 110.419 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.479 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 6.5 p-10 -145.38 147.09 31.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.997 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 59.75 19.08 7.85 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.811 0.844 . . . . 0.0 110.907 -171.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 38.3 tp -81.02 -27.15 35.94 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.16 0.584 . . . . 0.0 111.228 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.472 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -164.41 150.08 10.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.023 0.529 . . . . 0.0 110.727 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 70.2 m -166.3 149.13 7.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.328 1.051 . . . . 0.0 109.197 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 121.871 0.843 . . . . 0.0 111.553 176.513 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 120.903 0.382 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.6 t -83.25 179.09 7.8 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.695 0.798 . . . . 0.0 110.647 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.2 p -139.74 136.83 34.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.575 1.15 . . . . 0.0 109.112 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.44 157.67 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.826 0.85 . . . . 0.0 110.834 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 385' ' ' PRO . 24.1 p -124.16 116.88 23.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.356 1.062 . . . . 0.0 109.188 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.6 t -113.16 151.24 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.096 0.558 . . . . 0.0 110.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -126.72 103.26 7.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.105 1.362 . . . . 0.0 108.065 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.04 110.77 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.628 0.771 . . . . 0.0 110.862 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -99.05 92.91 5.71 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.583 0.753 . . . . 0.0 110.12 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.42 -12.22 60.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.233 178.04 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -74.39 -19.59 60.37 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.774 0.83 . . . . 0.0 111.185 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.79 -111.11 0.03 OUTLIER Glycine 0 C--N 1.353 1.493 0 C-N-CA 122.985 0.326 . . . . 0.0 112.941 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 42.9 t30 -125.43 143.94 50.76 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.27 -62.28 1.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.03 -94.74 0.14 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.397 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -89.06 26.29 17.32 Favored 'Cis proline' 0 C--N 1.371 1.73 0 CA-C-N 120.116 1.958 . . . . 0.0 113.427 7.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.95 -10.25 59.49 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.214 0.606 . . . . 0.0 109.95 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.574 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 36.1 mt -114.74 140.86 48.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 125.454 1.501 . . . . 0.0 108.301 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.43 124.35 89.71 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.13 0.572 . . . . 0.0 110.414 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 30.5 Cg_endo -59.47 -32.97 97.21 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.244 2.63 . . . . 0.0 114.163 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.87 -42.55 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.468 0.307 . . . . 0.0 110.958 -176.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -70.96 -28.88 64.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 110.593 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 379' ' ' LEU . 20.7 mm -63.0 -30.48 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.825 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 68.0 mm-40 -81.67 -22.36 37.53 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.462 0.305 . . . . 0.0 111.043 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 81.8 mm-40 -81.93 -35.29 29.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.451 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.0 pp -66.48 153.81 92.28 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.911 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.72 161.33 21.71 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.675 2.25 . . . . 0.0 114.327 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.77 -8.92 58.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.678 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -161.95 153.16 18.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.937 0.495 . . . . 0.0 110.967 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 395' ' ' ILE . 52.6 m-85 -132.23 109.01 9.62 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.415 1.086 . . . . 0.0 108.078 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.27 -179.53 16.14 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 358' ' ' CYS . 59.7 Cg_endo -72.88 130.21 19.36 Favored 'Cis proline' 0 C--N 1.383 2.394 0 CA-C-N 119.889 1.845 . . . . 0.0 113.1 -4.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.71 -163.56 12.53 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.982 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -65.87 139.88 58.76 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.993 2.462 . . . . 0.0 111.926 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 445' ' ' ALA . 5.3 p -49.26 -41.35 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.352 1.061 . . . . 0.0 111.579 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.09 -52.18 63.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.942 1.297 . . . . 0.0 110.675 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 81.4 t -69.07 -50.87 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.941 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.49 -40.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 122.999 0.52 . . . . 0.0 112.203 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.99 -41.48 74.33 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 117.859 0.299 . . . . 0.0 110.624 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -73.27 -24.47 60.44 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.542 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 48.6 mmm-85 -68.44 -38.77 81.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.819 0.448 . . . . 0.0 111.073 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.57 HD13 ' HD2' ' A' ' 383' ' ' PHE . 8.4 mm -65.63 -53.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 91.3 t -61.78 -47.16 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.135 -174.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.421 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.6 pt20 -64.0 -30.03 71.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.582 0.353 . . . . 0.0 111.285 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -72.26 -40.97 67.25 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.256 0.622 . . . . 0.0 110.532 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.7 m -69.58 -46.47 66.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.341 0.657 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.8 t -65.7 -39.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.199 0.6 . . . . 0.0 110.084 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.34 -53.46 57.02 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.232 0.613 . . . . 0.0 110.581 173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.451 ' SG ' HD23 ' A' ' 379' ' ' LEU . 73.9 m -79.92 0.99 28.97 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.553 -172.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -71.73 135.32 46.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.71 118.36 17.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 160.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.16 60.01 0.66 Allowed 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.077 0.942 . . . . 0.0 109.431 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 96.9 m -51.41 -40.62 59.67 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.075 1.75 . . . . 0.0 112.416 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -50.44 -41.09 52.18 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.176 1.39 . . . . 0.0 114.04 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 98.4 m -78.96 -39.39 34.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.645 0.778 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.564 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -60.69 -41.57 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.71 -14.07 59.98 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.073 0.949 . . . . 0.0 110.774 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.45 -23.24 77.56 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.507 -0.315 . . . . 0.0 113.401 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -71.27 -24.77 62.23 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.072 0.549 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 434' ' ' ILE . 0.7 OUTLIER -119.43 112.72 19.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.026 0.931 . . . . 0.0 108.677 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -96.21 158.61 33.7 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.28 0.632 . . . . 0.0 110.738 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.69 144.9 45.27 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.168 1.912 . . . . 0.0 112.496 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.572 ' HB3' ' HG2' ' A' ' 418' ' ' ARG . 3.6 m-20 -150.13 136.1 18.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.977 1.311 . . . . 0.0 108.132 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.68 68.67 10.47 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.52 1.152 . . . . 0.0 108.33 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 416' ' ' ASP . 78.7 mmt-85 -106.93 -22.49 12.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.611 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.27 65.64 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.614 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -97.71 -127.22 5.65 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.958 -0.356 . . . . 0.0 112.387 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.0 OUTLIER -72.88 169.32 17.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.887 0.875 . . . . 0.0 110.841 -176.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 54.4 t -140.32 133.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.825 . . . . 0.0 109.102 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 47.8 mm -116.02 134.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 122.607 0.363 . . . . 0.0 110.219 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 433' ' ' SER . 18.0 p -107.25 143.09 35.98 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.93 15.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.527 0.731 . . . . 0.0 111.041 -169.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 430' ' ' GLU . 49.4 m -86.53 104.2 15.76 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.89 0.476 . . . . 0.0 110.312 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -116.23 106.57 13.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.29 1.036 . . . . 0.0 109.569 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.18 54.1 9.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.232 1.413 . . . . 0.0 111.56 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 83.2 -15.89 31.49 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.85 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 426' ' ' SER . 39.9 mt-10 -95.15 170.53 9.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.181 0.592 . . . . 0.0 111.37 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.9 t -111.46 102.02 10.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -94.92 142.26 27.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.397 0.679 . . . . 0.0 109.904 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 424' ' ' THR . 41.7 p -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.912 . . . . 0.0 109.771 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 413' ' ' LEU . 41.3 pt -123.99 -176.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.846 0.858 . . . . 0.0 111.047 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -127.28 143.31 51.26 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 121.462 0.648 . . . . 0.0 110.012 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.0 mp -111.0 159.2 33.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.901 1.68 . . . . 0.0 108.124 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.69 132.65 19.05 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.094 1.863 . . . . 0.0 111.706 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.19 129.7 19.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.279 1.986 . . . . 0.0 112.112 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.0 173.39 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.011 0.925 . . . . 0.0 110.87 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -153.46 -0.21 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.517 0.727 . . . . 0.0 111.243 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.6 m -118.21 138.29 52.43 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.07 -31.83 68.34 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.855 0.862 . . . . 0.0 111.281 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 22.0 m -59.57 -31.82 69.8 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.757 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -86.2 -22.79 26.76 Favored 'General case' 0 C--N 1.362 1.151 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -52.18 -66.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.598 0.759 . . . . 0.0 111.182 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.403 ' O ' HD22 ' A' ' 449' ' ' LEU . 0.4 OUTLIER -72.13 -34.62 68.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.68 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ARG . . . . . 0.465 ' NH1' ' HB2' ' A' ' 451' ' ' ASN . 0.0 OUTLIER -53.33 -36.33 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.285 0.634 . . . . 0.0 111.514 178.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -60.07 -56.48 21.07 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.139 0.899 . . . . 0.0 110.34 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.7 -13.92 58.59 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.706 -176.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.4 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 55.7 mt-10 -70.28 -46.63 63.95 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.673 0.669 . . . . 0.0 109.988 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.465 ' HB2' ' NH1' ' A' ' 447' ' ' ARG . 0.2 OUTLIER -67.52 -35.25 78.74 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 449' ' ' LEU . 36.9 t80 -68.6 -48.83 63.14 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.444 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.5 p -70.09 -22.88 62.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.068 0.547 . . . . 0.0 111.021 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -57.17 -46.4 82.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 93.7 p -73.07 -23.28 60.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.046 0.539 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.507 HD13 HD21 ' A' ' 371' ' ' LEU . 47.7 mt -83.7 -8.37 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.651 0.781 . . . . 0.0 111.077 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.82 9.16 7.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.35 1.46 . . . . 0.0 111.275 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.713 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.8 p -94.94 144.58 25.56 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.553 0.741 . . . . 0.0 110.044 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -163.04 164.21 25.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 65.53 14.58 9.57 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.159 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.08 -8.63 59.06 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.373 1.069 . . . . 0.0 111.533 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 169.22 22.66 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.347 0.659 . . . . 0.0 109.916 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 46.6 m -158.38 114.18 2.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.629 0.772 . . . . 0.0 109.79 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 26.5 t . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.769 0.827 . . . . 0.0 111.237 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.78 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.9 m -72.99 178.05 4.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.027 0.531 . . . . 0.0 111.852 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.7 p -139.61 133.45 30.71 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.527 1.131 . . . . 0.0 109.131 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.57 157.49 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.285 1.034 . . . . 0.0 111.148 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.57 108.05 10.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.313 1.045 . . . . 0.0 108.72 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.59 120.95 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -88.54 97.94 11.37 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 379' ' ' LEU . 44.9 t -72.63 98.28 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.622 -171.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -91.08 86.44 6.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.757 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -12.93 61.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.786 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.793 0.837 . . . . 0.0 110.299 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -76.9 -149.83 3.37 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.11 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 41.3 t30 -82.85 142.32 31.59 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.301 0.551 . . . . 0.0 110.132 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -85.42 -56.11 3.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.99 -88.95 0.07 OUTLIER Glycine 0 C--N 1.349 1.256 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.127 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.73 4.06 65.3 Favored 'Cis proline' 0 C--N 1.371 1.712 0 CA-C-N 120.879 2.34 . . . . 0.0 113.744 10.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -70.46 -13.01 61.95 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.953 0.901 . . . . 0.0 110.37 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.608 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 28.5 mt -99.1 143.96 28.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.0 109.116 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.31 121.82 84.45 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 123.99 0.806 . . . . 0.0 110.455 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.537 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 50.9 Cg_endo -64.35 -22.28 66.3 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.187 2.591 . . . . 0.0 114.646 -172.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.537 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -83.94 -43.63 15.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.121 0.418 . . . . 0.0 110.076 -176.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 57.9 mtt180 -67.22 -37.49 83.69 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.085 0.954 . . . . 0.0 111.923 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.453 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.7 mm -53.64 -28.85 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.433 0 C-N-CA 124.076 0.951 . . . . 0.0 112.347 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 71.0 mm-40 -83.59 -17.85 40.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.257 0.623 . . . . 0.0 111.737 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -80.33 -43.08 21.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.424 0.69 . . . . 0.0 111.728 -171.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 361' ' ' VAL . 0.4 OUTLIER -64.03 153.27 85.48 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.564 175.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -62.95 165.78 15.72 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.678 2.252 . . . . 0.0 113.233 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.66 -6.86 59.42 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.307 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.456 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.1 p80 -162.58 137.62 6.86 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.33 0.652 . . . . 0.0 110.605 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.97 103.81 14.47 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.38 -174.14 17.44 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.3 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 128.19 15.21 Favored 'Cis proline' 0 C--N 1.382 2.333 0 CA-C-N 119.291 1.545 . . . . 0.0 112.817 0.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.72 30.34 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.977 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.55 129.95 28.27 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.125 2.55 . . . . 0.0 113.279 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.1 p -45.42 -50.16 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.274 1.829 . . . . 0.0 112.688 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.455 ' OD1' HG13 ' A' ' 388' ' ' VAL . 2.4 m120 -57.64 -43.96 85.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.395 . . . . 0.0 112.009 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.494 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 93.7 t -76.41 -51.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.134 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.01 -42.27 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 123.386 0.674 . . . . 0.0 112.404 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 122.856 0.097 . . . . 0.0 110.984 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 392' ' ' LEU . 7.8 ptt180 -73.09 -25.54 60.92 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.141 0.276 . . . . 0.0 110.388 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 11.5 mmm180 -68.23 -35.21 77.6 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 122.846 0.458 . . . . 0.0 110.124 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 449' ' ' LEU . 25.9 mm -63.62 -47.67 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.875 0.734 . . . . 0.0 109.405 173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.504 ' HA ' ' CE2' ' A' ' 452' ' ' PHE . 38.9 t -63.96 -60.62 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.733 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.46 ' HA ' HG23 ' A' ' 423' ' ' ILE . 14.1 pt20 -60.86 -29.47 69.54 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.58 -59.63 2.72 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.25 -32.77 74.39 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.5 t -68.17 -47.51 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.92 -19.92 58.4 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.348 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 93.5 m -100.02 10.11 41.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.114 0.965 . . . . 0.0 110.352 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -86.07 151.29 23.82 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.47 122.78 27.95 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 162.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 66.65 57.67 0.67 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.48 1.112 . . . . 0.0 109.934 -174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 400' ' ' VAL . 89.6 m -54.12 -34.0 59.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.592 1.557 . . . . 0.0 112.415 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -55.64 -39.55 71.0 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.855 1.262 . . . . 0.0 113.466 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.3 m -81.47 -36.05 29.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 110.171 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 400' ' ' VAL . 67.7 t -62.44 -38.07 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.867 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -68.44 -19.31 64.57 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.95 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.81 -23.57 77.78 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.927 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -77.01 -10.73 59.56 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 117.276 0.538 . . . . 0.0 111.641 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 434' ' ' ILE . 0.3 OUTLIER -129.04 117.8 21.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.729 0.812 . . . . 0.0 109.614 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -95.18 157.91 35.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.789 0.836 . . . . 0.0 110.916 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.87 153.14 76.28 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.144 1.896 . . . . 0.0 111.434 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -151.15 136.54 17.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.689 0.28 . . . . 0.0 110.527 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.52 10.11 26.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.807 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.502 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 5.9 mpt_? -59.59 -35.0 73.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.527 1.131 . . . . 0.0 111.417 171.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 85.49 28.23 30.52 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.36 0.413 . . . . 0.0 113.378 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.93 -110.03 0.31 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 120.023 -0.321 . . . . 0.0 113.39 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.98 172.0 8.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.802 0.441 . . . . 0.0 110.348 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 75.8 t -132.08 130.2 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.9 mm -115.11 131.66 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.44 ' HB ' ' OG1' ' A' ' 431' ' ' THR . 19.2 p -108.86 137.64 46.46 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.417 1.087 . . . . 0.0 108.743 172.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -158.63 128.95 5.99 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.67 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.5 m -66.87 102.47 0.96 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.462 0.705 . . . . 0.0 112.149 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -135.68 136.2 40.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.936 1.294 . . . . 0.0 108.813 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.7 t70 66.63 16.35 10.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.391 1.076 . . . . 0.0 111.163 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.02 61.79 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 122.012 -0.43 . . . . 0.0 113.849 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -116.91 166.99 11.53 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 424' ' ' THR . 12.9 t -89.86 102.87 15.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.914 0.864 . . . . 0.0 109.248 175.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.73 131.41 40.82 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.046 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 34.8 p -111.01 131.46 55.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.328 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.636 HD11 HD12 ' A' ' 413' ' ' LEU . 16.4 pt -132.41 174.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 124.298 1.039 . . . . 0.0 109.762 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -113.11 147.88 36.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.273 0.629 . . . . 0.0 110.842 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.421 HD23 ' HE1' ' A' ' 448' ' ' PHE . 9.8 mp -115.48 166.6 11.69 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.156 1.382 . . . . 0.0 108.636 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.11 145.48 44.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 121.998 1.799 . . . . 0.0 111.939 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 418' ' ' ARG . 64.3 Cg_endo -83.54 159.95 14.62 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.453 2.102 . . . . 0.0 112.015 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.94 173.51 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.712 0.805 . . . . 0.0 109.695 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -150.43 18.26 0.83 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.807 0.443 . . . . 0.0 111.169 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.2 t -124.82 140.21 53.13 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.03 63.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.211 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.9 m -69.85 -25.01 63.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.104 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.7 -21.74 25.04 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.29 -65.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.7 0.8 . . . . 0.0 111.17 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 1.4 pp -62.68 -37.84 88.04 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.119 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.38 71.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.415 1.086 . . . . 0.0 112.019 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.421 ' HE1' HD23 ' A' ' 436' ' ' LEU . 31.1 t80 -71.74 -43.27 66.12 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.12 0.962 . . . . 0.0 108.562 -173.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 395' ' ' ILE . 3.9 pp -89.19 -14.3 36.36 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.418 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.1 tm-20 -69.21 -50.3 48.61 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.826 1.251 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.9 -38.01 77.91 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.728 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.504 ' CE2' ' HA ' ' A' ' 396' ' ' VAL . 34.8 t80 -66.84 -50.85 61.26 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.385 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 31.2 p -71.57 -22.0 61.8 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.408 0.683 . . . . 0.0 110.687 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -66.3 -39.92 89.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.087 0.955 . . . . 0.0 110.127 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.1 m -65.81 -29.74 70.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.803 0.841 . . . . 0.0 111.321 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 371' ' ' LEU . 41.0 mt -84.25 -13.5 52.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.008 0.923 . . . . 0.0 111.311 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 71.38 7.91 6.17 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.826 1.651 . . . . 0.0 111.668 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 21.1 p -83.27 133.64 34.98 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.4 p-10 -148.55 147.42 29.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.935 -173.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 59.86 21.85 10.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.583 0.753 . . . . 0.0 110.425 -168.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 18.3 tp -83.12 -15.76 49.45 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.449 0.7 . . . . 0.0 109.893 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.28 171.44 19.15 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.365 1.066 . . . . 0.0 108.757 174.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.0 m -165.79 115.54 1.01 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.1 t . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.809 0.338 . . . . 0.0 111.398 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 11.0 t -79.72 -177.9 6.12 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.845 0.458 . . . . 0.0 110.516 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 28.1 p -138.99 136.58 35.51 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.564 0.746 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.75 161.51 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.41 1.084 . . . . 0.0 110.851 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 30.5 p -132.76 132.36 42.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -117.34 154.58 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.119 0.568 . . . . 0.0 110.022 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 47.8 m-85 -111.78 100.32 8.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 379' ' ' LEU . 38.6 t -70.48 88.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 0.0 109.501 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -81.78 93.21 6.78 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.909 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -76.67 -5.22 47.02 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.114 178.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -84.31 -13.22 53.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.268 0.627 . . . . 0.0 111.006 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -73.3 -112.14 0.07 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -121.62 138.42 54.34 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.68 3.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.54 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -156.22 -86.98 0.06 OUTLIER Glycine 0 C--O 1.216 -0.974 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.485 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.04 12.9 44.41 Favored 'Cis proline' 0 C--N 1.368 1.582 0 CA-C-N 120.931 2.366 . . . . 0.0 114.084 8.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -72.75 -7.82 52.44 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.001 0.52 . . . . 0.0 111.478 172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.1 mt -110.41 143.78 40.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.495 1.118 . . . . 0.0 109.227 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.15 118.92 60.52 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.631 0.772 . . . . 0.0 110.532 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 12.4 Cg_endo -52.84 -36.61 74.72 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.887 3.058 . . . . 0.0 114.337 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -80.28 -45.48 17.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -170.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -64.39 -36.06 82.91 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 111.58 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.418 HD13 HD21 ' A' ' 379' ' ' LEU . 17.6 mm -55.82 -31.96 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 124.392 1.058 . . . . 0.0 111.427 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 54.3 mm-40 -78.4 -35.92 46.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.7 0.4 . . . . 0.0 110.696 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 69.9 mm-40 -71.54 -33.84 69.5 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.524 0.73 . . . . 0.0 112.092 -171.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.418 HD21 HD13 ' A' ' 376' ' ' ILE . 2.5 pp -71.11 155.64 92.94 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.53 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.44 148.62 33.23 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.19 2.594 . . . . 0.0 113.903 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.27 -10.54 59.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.034 1.333 . . . . 0.0 111.825 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -164.52 145.5 8.05 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -114.57 159.44 20.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.79 1.236 . . . . 0.0 108.766 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.88 -179.68 51.0 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.111 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -79.87 128.82 16.75 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 119.441 1.621 . . . . 0.0 111.831 2.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.14 25.02 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 133.57 38.73 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 123.051 2.501 . . . . 0.0 113.629 -169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.2 p -47.3 -39.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.511 1.924 . . . . 0.0 111.985 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.29 -54.14 49.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.467 1.507 . . . . 0.0 111.014 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 393' ' ' ARG . 97.0 t -74.11 -47.64 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.121 -173.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.67 -38.54 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.15 -43.43 61.55 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 422' ' ' VAL . 39.6 ptt180 -72.1 -25.63 61.82 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.661 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.54 -36.15 82.96 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.81 0.694 . . . . 0.0 110.698 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 35.3 mm -66.66 -56.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 400' ' ' VAL . 95.5 t -57.57 -52.72 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 124.113 0.883 . . . . 0.0 111.045 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.8 pt20 -64.34 -35.89 82.35 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.7 0.4 . . . . 0.0 111.914 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -68.29 -36.44 79.37 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 123.381 0.426 . . . . 0.0 110.046 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 84.1 m -68.87 -49.82 55.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.025 0.53 . . . . 0.0 111.205 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.0 t -63.59 -48.23 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 122.921 0.488 . . . . 0.0 110.068 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.96 -36.4 77.86 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.59 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 72.6 m -83.99 -1.27 54.36 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.452 0.301 . . . . 0.0 111.286 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -71.33 137.47 48.5 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.37 117.15 8.96 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 166.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 64.46 66.26 0.61 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.135 0.969 . . . . 0.0 109.625 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 400' ' ' VAL . 78.0 m -54.75 -35.62 63.94 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.771 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -59.41 -35.36 73.85 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.56 1.144 . . . . 0.0 113.131 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 85.7 m -80.4 -37.89 31.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.69 0.796 . . . . 0.0 109.775 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 403' ' ' ALA . 40.3 t -69.43 -30.41 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.082 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -73.24 -20.01 60.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.444 1.098 . . . . 0.0 110.209 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -63.74 -15.05 57.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.584 -0.735 . . . . 0.0 114.692 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.07 3.03 55.88 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.598 0.699 . . . . 0.0 111.719 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -148.07 106.53 3.78 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.416 0.626 . . . . 0.0 110.476 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 160.8 31.0 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.133 0.973 . . . . 0.0 109.779 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.03 163.79 24.41 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.488 2.125 . . . . 0.0 113.655 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.08 163.18 23.65 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 0.0 108.857 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -130.26 35.95 4.03 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.235 0.614 . . . . 0.0 110.867 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.52 -39.75 4.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.868 170.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 100.65 42.59 2.47 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.23 -106.57 0.28 Allowed Glycine 0 C--N 1.343 0.947 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.736 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 5.2 mp0 -83.33 172.74 12.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.994 0.397 . . . . 0.0 110.266 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.467 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 90.0 t -138.96 131.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.887 0.875 . . . . 0.0 108.791 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 433' ' ' SER . 35.8 mm -117.81 133.53 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.152 0.581 . . . . 0.0 110.02 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.4 p -108.85 137.18 47.2 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.932 0.893 . . . . 0.0 109.931 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.09 134.71 11.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 13.6 p -77.2 115.89 17.37 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.203 0.601 . . . . 0.0 109.851 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -153.98 140.7 19.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 108.945 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.3 t70 63.01 16.9 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.728 1.211 . . . . 0.0 112.162 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.94 -18.44 57.18 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.11 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -109.23 166.38 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.5 t -89.69 104.72 17.26 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 167.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -95.53 129.07 42.83 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.312 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 57.8 p -118.07 132.88 56.32 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.586 0.755 . . . . 0.0 109.99 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 413' ' ' LEU . 30.7 pt -118.43 179.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.275 0.63 . . . . 0.0 109.843 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -111.36 151.73 28.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 82.4 mt -117.31 151.44 47.95 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.48 1.112 . . . . 0.0 108.557 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.26 131.22 35.42 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.392 2.062 . . . . 0.0 111.757 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.28 137.78 77.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.06 2.506 . . . . 0.0 114.533 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.2 m -109.82 167.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.917 0.887 . . . . 0.0 109.603 171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.67 15.69 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.557 0.343 . . . . 0.0 111.254 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 26.0 t -123.48 141.43 52.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.804 0.442 . . . . 0.0 109.927 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.07 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.113 0.965 . . . . 0.0 112.322 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.5 m -70.3 -19.47 63.09 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.999 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.61 -60.98 2.54 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.65 -54.38 46.07 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.682 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -49.06 -40.66 32.34 Favored 'General case' 0 C--O 1.247 0.935 0 O-C-N 125.023 1.452 . . . . 0.0 112.281 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.18 -48.64 79.15 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.151 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -83.22 -17.1 43.92 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.133 178.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.59 -42.71 74.09 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 119.325 0.966 . . . . 0.0 110.047 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -62.42 -38.48 89.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.826 0.704 . . . . 0.0 110.629 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 456' ' ' LEU . 36.5 t80 -68.91 -49.8 54.98 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.033 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 89.5 m -67.39 -22.41 65.55 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.25 1.02 . . . . 0.0 111.514 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -65.97 -36.44 83.33 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.8 t -77.23 -28.58 53.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.876 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.531 HD13 HD21 ' A' ' 371' ' ' LEU . 64.9 mt -77.23 -16.75 58.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.256 0.623 . . . . 0.0 111.397 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 71.0 6.55 5.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.012 1.725 . . . . 0.0 111.471 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.574 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -78.0 132.34 37.77 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.496 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 34.5 t70 -147.35 142.34 27.0 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.065 -165.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 60.28 18.8 8.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.17 0.988 . . . . 0.0 110.276 -167.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 32.5 tp -80.81 -24.09 38.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 122.933 0.493 . . . . 0.0 111.019 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -155.58 160.35 40.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.668 0.387 . . . . 0.0 111.018 174.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 33.5 p -164.3 133.54 3.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.801 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 123.069 0.548 . . . . 0.0 111.831 -177.256 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 387' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 120.803 0.335 . . . . 0.0 110.448 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.1 t -72.48 -178.94 2.76 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.468 0.307 . . . . 0.0 110.178 168.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.29 138.3 43.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.23 0.612 . . . . 0.0 110.25 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.03 158.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.311 1.044 . . . . 0.0 110.485 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 21.0 p -134.36 107.5 7.65 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.65 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.627 HG21 HD11 ' A' ' 395' ' ' ILE . 34.4 m -94.77 154.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -117.63 99.95 7.3 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.452 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 48.6 t -69.9 98.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.743 0.817 . . . . 0.0 110.015 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.29 83.73 7.88 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.24 42.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.31 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -78.0 -21.26 51.09 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.467 0.707 . . . . 0.0 110.51 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.63 -148.08 6.28 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.885 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.5 t30 -74.46 140.37 44.56 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.283 0.564 . . . . 0.0 109.973 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -54.06 4.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.558 1.143 . . . . 0.0 108.253 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.699 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -155.22 -86.53 0.06 OUTLIER Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.75 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -88.61 15.99 44.42 Favored 'Cis proline' 0 C--N 1.365 1.422 0 CA-C-N 120.194 1.997 . . . . 0.0 114.022 8.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -70.75 -12.21 61.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.705 0.402 . . . . 0.0 110.847 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 22.5 mt -107.44 131.93 53.75 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 109.035 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.18 126.87 93.18 Favored Pre-proline 0 N--CA 1.481 1.099 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.498 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.1 Cg_endo -60.07 -41.49 51.92 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.349 2.699 . . . . 0.0 113.294 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -66.57 -39.7 88.61 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.879 0.471 . . . . 0.0 110.74 -175.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -74.11 -30.93 62.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.754 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 379' ' ' LEU . 10.0 mm -62.75 -24.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.047 0.939 . . . . 0.0 111.466 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 55.1 mm-40 -83.31 -17.05 43.84 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.675 0.39 . . . . 0.0 111.15 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -79.2 -30.46 43.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.162 0.585 . . . . 0.0 111.626 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 376' ' ' ILE . 0.3 OUTLIER -74.82 157.43 85.74 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 169.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.25 166.5 21.06 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.56 2.174 . . . . 0.0 112.972 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.39 1.49 21.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.13 0.972 . . . . 0.0 111.179 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.452 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.8 p80 -158.84 155.57 28.05 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.725 0.81 . . . . 0.0 110.34 173.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -125.07 113.29 17.55 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 167.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 114.53 176.75 18.97 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.357 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.65 128.98 16.81 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 119.71 1.755 . . . . 0.0 112.655 1.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.51 -164.29 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.051 -0.861 . . . . 0.0 111.594 -174.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.525 ' HB3' ' HG3' ' A' ' 354' ' ' MET . 7.8 Cg_exo -66.36 139.21 53.63 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.955 2.437 . . . . 0.0 112.072 -170.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.935 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.1 p -53.75 -45.71 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.133 0.973 . . . . 0.0 111.341 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.533 ' HB3' HH21 ' A' ' 393' ' ' ARG . 12.7 m120 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.277 . . . . 0.0 110.74 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 71.1 t -70.63 -57.67 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.632 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.75 -44.19 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.397 0.679 . . . . 0.0 112.457 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 449' ' ' LEU . 3.3 pp -69.36 -41.68 76.25 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-N 117.571 0.169 . . . . 0.0 110.564 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.533 HH21 ' HB3' ' A' ' 389' ' ' ASN . 11.4 ptp180 -70.48 -28.63 65.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 29.9 mmt180 -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 123.688 0.617 . . . . 0.0 110.989 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 359' ' ' VAL . 24.6 mm -65.62 -57.18 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.4 t -58.69 -49.31 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.737 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.56 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.3 pt20 -68.27 -37.36 80.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.631 0.372 . . . . 0.0 111.398 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -66.37 -35.35 80.11 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.395 0.435 . . . . 0.0 110.064 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 93.0 m -67.68 -53.33 28.62 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.597 0.561 . . . . 0.0 110.978 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 396' ' ' VAL . 20.3 t -61.26 -47.27 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 122.748 0.419 . . . . 0.0 110.527 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.98 -46.8 76.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 89.3 m -73.61 -5.68 41.89 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.895 0.478 . . . . 0.0 112.264 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.67 143.78 55.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.414 0.625 . . . . 0.0 112.635 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.94 126.79 30.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.959 163.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 56.5 2.72 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-O 122.085 0.945 . . . . 0.0 109.694 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 92.2 m -53.75 -32.16 51.23 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.037 1.335 . . . . 0.0 111.77 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -57.48 -32.23 66.78 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.815 1.246 . . . . 0.0 112.666 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 80.7 m -89.3 -42.73 11.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.716 0.806 . . . . 0.0 110.48 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.7 t -60.66 -32.91 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.832 0.853 . . . . 0.0 111.66 -177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -72.48 -26.83 61.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.771 1.228 . . . . 0.0 110.557 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.29 -15.36 72.44 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.966 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -79.73 -2.66 44.03 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.492 0.646 . . . . 0.0 111.845 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -145.81 105.26 3.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.489 0.661 . . . . 0.0 110.148 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -83.9 157.42 63.41 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.146 0.978 . . . . 0.0 110.375 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.91 163.39 37.66 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.007 1.805 . . . . 0.0 112.873 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.15 137.5 29.12 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.464 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -96.34 38.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.265 0.626 . . . . 0.0 111.423 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -95.01 -16.98 22.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.402 0.681 . . . . 0.0 110.638 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 74.97 39.42 38.15 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.29 -122.63 3.91 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.153 -0.248 . . . . 0.0 113.09 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.4 OUTLIER -70.07 162.63 27.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.788 0.835 . . . . 0.0 110.642 -177.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.1 128.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.56 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.6 mm -111.4 121.92 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.452 0.701 . . . . 0.0 110.215 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.2 p -107.51 142.9 36.67 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.442 1.097 . . . . 0.0 110.221 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -163.41 136.33 5.45 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.891 0.744 . . . . 0.0 110.986 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 67.4 m -74.88 119.6 19.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.48 0.712 . . . . 0.0 111.875 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -148.51 137.7 21.81 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.468 1.107 . . . . 0.0 109.73 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 58.83 33.47 23.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.945 1.298 . . . . 0.0 112.117 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.04 87.15 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.386 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.82 171.68 13.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.06 0.944 . . . . 0.0 109.572 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -94.77 130.18 41.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -119.37 142.45 48.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.651 0.781 . . . . 0.0 109.716 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 42.2 p -129.08 143.07 50.74 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 110.483 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 413' ' ' LEU . 26.8 pt -119.61 173.65 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.216 0.606 . . . . 0.0 109.42 171.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -113.8 151.72 31.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.351 0.661 . . . . 0.0 110.342 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 78.9 mt -116.56 168.49 8.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.287 1.435 . . . . 0.0 108.962 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.24 136.77 20.36 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.601 1.534 . . . . 0.0 111.256 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -73.07 133.04 19.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.469 2.112 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.5 m -99.99 174.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.977 0.911 . . . . 0.0 110.997 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.32 12.11 0.41 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.959 0.504 . . . . 0.0 110.966 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.6 t -119.21 138.32 53.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.722 0.409 . . . . 0.0 110.635 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.89 -29.21 62.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.978 0.911 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 18.6 m -71.87 -22.25 61.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.187 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.6 -32.98 20.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.935 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.38 -63.73 0.97 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.708 1.203 . . . . 0.0 111.478 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.25 -47.77 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.994 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -32.34 64.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.122 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' A' ' 436' ' ' LEU . 28.1 t80 -62.98 -56.6 15.67 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 122.884 0.474 . . . . 0.0 110.121 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -78.54 -14.97 59.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.556 -178.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.556 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 50.0 mt-10 -72.74 -40.3 66.19 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.586 0.63 . . . . 0.0 109.853 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.73 -32.3 72.82 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.511 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.516 ' CE2' HD11 ' A' ' 456' ' ' LEU . 48.4 t80 -81.02 -42.14 21.59 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.405 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 21.7 p -68.28 -23.85 64.8 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.199 0.599 . . . . 0.0 110.411 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -62.17 -32.81 73.47 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.07 1.348 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -78.34 -32.86 49.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.539 0.736 . . . . 0.0 110.794 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.519 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 39.0 mt -83.8 -10.29 58.18 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.641 0.776 . . . . 0.0 112.204 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 71.26 7.29 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.741 1.616 . . . . 0.0 111.373 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.699 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -84.67 135.42 34.17 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 122.894 0.478 . . . . 0.0 110.04 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 28.1 t70 -147.12 158.66 44.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.602 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.2 p30 48.64 26.11 1.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.643 1.177 . . . . 0.0 112.654 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.55 -15.66 30.24 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.905 1.282 . . . . 0.0 110.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.406 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.74 164.56 33.75 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.354 0.661 . . . . 0.0 110.273 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 42.0 p -168.06 129.0 1.37 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 108.459 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.2 t . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.103 0.561 . . . . 0.0 111.72 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.772 0.32 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.7 t -90.34 178.2 6.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.396 1.078 . . . . 0.0 110.841 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.2 p -136.39 135.32 38.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.729 1.212 . . . . 0.0 109.624 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.96 167.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.922 0.889 . . . . 0.0 110.738 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.44 121.24 18.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.068 0.947 . . . . 0.0 108.809 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 395' ' ' ILE . 35.5 m -105.19 146.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 170.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -111.94 98.46 7.38 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.519 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 42.4 t -68.66 101.53 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 124.323 1.014 . . . . 0.0 109.897 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.426 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 51.2 t30 -92.21 90.39 7.28 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.156 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.05 -5.69 49.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.761 176.031 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 364' ' ' HIS . . . . . 0.426 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 66.5 t60 -76.87 -19.36 57.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.673 0.789 . . . . 0.0 110.174 167.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -74.0 -125.74 0.12 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.677 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -106.8 156.05 19.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.496 0.648 . . . . 0.0 109.374 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.14 -64.41 1.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.593 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.94 -87.9 0.07 OUTLIER Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.275 -173.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -85.91 17.2 33.85 Favored 'Cis proline' 0 C--N 1.374 1.907 0 CA-C-N 120.51 2.155 . . . . 0.0 113.998 4.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -70.81 -22.69 62.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.117 0.567 . . . . 0.0 110.284 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.593 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.7 mt -96.34 136.74 36.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.33 1.052 . . . . 0.0 109.56 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 375' ' ' ARG . 12.8 t70 -65.35 126.16 90.89 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.827 0.851 . . . . 0.0 110.653 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 60.5 Cg_endo -68.0 -19.49 45.71 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.814 2.343 . . . . 0.0 113.872 -170.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -84.74 -47.41 10.45 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 38.4 mtt180 -62.32 -35.53 79.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 0.0 112.064 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.9 mm -58.47 -29.64 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.505 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.6 mm-40 -85.76 -19.12 31.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.568 0.347 . . . . 0.0 110.996 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 79.3 mm-40 -87.4 -29.11 21.73 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.345 0.658 . . . . 0.0 112.556 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.454 HD13 HG11 ' A' ' 361' ' ' VAL . 2.7 pp -69.84 159.61 83.36 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.741 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.2 152.13 74.15 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.512 2.142 . . . . 0.0 113.279 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.34 -4.07 37.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.41 1.084 . . . . 0.0 111.808 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 38.7 p-80 -161.55 148.76 14.61 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.339 0.656 . . . . 0.0 110.815 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -116.85 104.17 11.04 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 133.03 -173.92 20.79 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.376 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.99 128.36 14.48 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.097 -5.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -152.27 -162.3 10.78 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.21 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -68.69 139.39 44.03 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.067 2.511 . . . . 0.0 112.072 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -50.51 -39.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.46 1.104 . . . . 0.0 111.754 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.61 -48.28 67.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.65 -47.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.23 -43.58 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.23 0.612 . . . . 0.0 111.98 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 449' ' ' LEU . 2.7 pp -68.21 -44.29 76.11 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 120.68 0.276 . . . . 0.0 110.563 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.5 HH11 ' HA ' ' A' ' 421' ' ' GLU . 29.4 ptt180 -74.56 -24.51 58.93 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.54 -38.63 91.7 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.921 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 359' ' ' VAL . 27.6 mm -65.42 -55.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 68.2 t -61.66 -47.02 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.706 -172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.98 -32.14 71.5 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.645 0.378 . . . . 0.0 110.88 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.551 0.532 . . . . 0.0 110.068 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.37 -56.17 12.36 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.152 0.908 . . . . 0.0 110.949 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 3.0 t -62.55 -37.38 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.75 -43.73 95.56 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.593 0.757 . . . . 0.0 111.19 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 19.9 p -83.44 -8.03 59.45 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.166 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.622 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.04 134.02 45.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 53.2 mt -75.76 124.6 27.56 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.655 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 64.55 68.49 0.53 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.624 1.17 . . . . 0.0 109.319 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 55.3 m -61.18 -37.83 84.33 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.533 -173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -51.06 -43.13 60.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.864 0.866 . . . . 0.0 113.035 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.3 m -74.71 -38.64 62.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.472 0.654 . . . . 0.0 109.874 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.622 HG21 ' HB1' ' A' ' 403' ' ' ALA . 78.0 t -68.94 -31.4 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.638 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.06 -10.28 59.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.334 1.054 . . . . 0.0 110.034 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.67 -7.74 83.89 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.908 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -83.34 -9.72 58.9 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 117.621 0.711 . . . . 0.0 111.869 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.98 142.74 49.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.636 0.775 . . . . 0.0 109.713 174.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -117.06 149.71 44.74 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.443 0.697 . . . . 0.0 111.091 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.67 128.07 16.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.832 2.355 . . . . 0.0 112.603 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.06 169.64 8.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.843 1.257 . . . . 0.0 108.801 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -118.99 22.58 11.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.71 . . . . 0.0 112.391 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 438' ' ' PRO . 0.5 OUTLIER -100.9 -25.12 14.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.085 0.554 . . . . 0.0 111.623 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.2 45.89 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.191 1.237 . . . . 0.0 116.191 162.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -85.69 -85.0 1.03 Allowed Glycine 0 C--O 1.239 0.436 0 CA-C-N 116.779 0.29 . . . . 0.0 112.694 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 3.1 mp0 -85.17 162.79 19.08 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.84 0.456 . . . . 0.0 110.346 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 67.5 t -136.08 124.21 36.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.063 0.945 . . . . 0.0 108.633 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.561 HG12 HD11 ' A' ' 436' ' ' LEU . 32.3 mm -104.39 122.82 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.2 p -106.76 145.75 31.69 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.257 1.023 . . . . 0.0 109.498 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.37 142.85 4.9 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.539 0.736 . . . . 0.0 110.879 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 103.38 6.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 110.024 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -114.92 124.64 52.22 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.706 0.802 . . . . 0.0 109.098 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 32.0 t70 61.19 28.59 18.19 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-O 122.245 1.022 . . . . 0.0 111.124 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.87 -17.8 58.22 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.863 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.29 162.01 15.45 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 117.441 0.621 . . . . 0.0 110.651 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.1 t -81.98 121.88 27.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -126.42 149.96 48.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.54 0.736 . . . . 0.0 109.871 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.0 p -140.29 146.08 38.08 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.354 0.662 . . . . 0.0 110.252 -173.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 29.0 pt -120.11 178.84 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.558 0.743 . . . . 0.0 110.361 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -118.51 147.88 43.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.578 0.751 . . . . 0.0 109.863 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.0 mp -116.26 156.04 47.61 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.863 1.265 . . . . 0.0 108.188 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.16 131.06 21.25 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 121.877 1.718 . . . . 0.0 111.061 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 418' ' ' ARG . 41.6 Cg_endo -66.33 128.79 20.04 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.954 2.436 . . . . 0.0 113.167 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.08 168.8 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.249 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -153.22 0.07 0.25 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.386 0.674 . . . . 0.0 110.772 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.6 t -120.61 142.63 49.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.274 0.63 . . . . 0.0 109.997 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.16 67.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.835 0.854 . . . . 0.0 112.462 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.4 m -70.39 -28.2 64.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.444 0.698 . . . . 0.0 111.321 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -24.03 29.87 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.16 -59.68 3.22 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 123.907 0.754 . . . . 0.0 109.668 171.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.89 -51.03 62.22 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -48.76 -41.94 33.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.319 1.047 . . . . 0.0 112.878 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -41.11 99.11 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.955 0.784 . . . . 0.0 110.951 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.44 -18.92 28.83 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.318 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.29 -42.38 59.65 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.861 0.755 . . . . 0.0 110.416 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.63 -40.8 92.95 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.444 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 456' ' ' LEU . 67.7 t80 -65.57 -47.11 76.91 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.257 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 86.7 m -66.66 -31.43 72.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 110.771 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.59 -32.4 71.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.249 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 45.9 m -67.28 -33.81 76.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.136 0.574 . . . . 0.0 110.511 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.56 HD13 HD21 ' A' ' 371' ' ' LEU . 56.7 mt -84.31 -8.93 58.86 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.635 0.774 . . . . 0.0 111.702 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 79.02 5.23 2.3 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.502 1.921 . . . . 0.0 111.779 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.455 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 7.4 p -87.4 146.44 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.059 0.544 . . . . 0.0 110.896 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -162.64 154.45 18.32 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 32.3 m-80 64.54 18.84 11.58 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.268 1.027 . . . . 0.0 111.115 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 23.7 tp -83.32 -9.42 59.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.574 0.749 . . . . 0.0 110.606 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.423 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.6 171.85 19.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.935 0.894 . . . . 0.0 109.908 176.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 29.1 p -162.16 126.22 3.17 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.473 0.709 . . . . 0.0 109.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.629 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.7 m -75.27 -177.39 3.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.596 0.358 . . . . 0.0 111.801 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.0 p -141.6 134.37 28.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.119 0.968 . . . . 0.0 109.622 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 388' ' ' VAL . 13.0 m -137.29 171.4 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.344 1.058 . . . . 0.0 110.509 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 25.9 p -145.83 108.12 4.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.383 0.673 . . . . 0.0 109.751 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.647 HG21 HD11 ' A' ' 395' ' ' ILE . 30.8 m -98.34 143.91 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -109.89 100.69 9.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.493 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 78.0 t -73.42 102.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.411 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 36.3 t30 -97.11 96.13 8.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.828 0.851 . . . . 0.0 109.624 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.13 -5.93 53.18 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.023 177.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -85.8 -8.93 57.8 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.524 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.61 -137.04 2.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.455 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 45.4 t30 -92.13 142.78 27.13 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 117.817 0.808 . . . . 0.0 109.369 174.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 376' ' ' ILE . 1.8 m-85 -84.03 -56.23 3.79 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -147.38 -74.48 0.02 OUTLIER Glycine 0 C--N 1.349 1.268 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.912 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.8 -15.26 17.65 Favored 'Cis proline' 0 C--N 1.371 1.729 0 CA-C-N 121.118 2.459 . . . . 0.0 115.308 4.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -73.09 0.94 10.1 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.907 0.776 . . . . 0.0 113.079 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.581 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 12.7 mt -91.39 127.86 37.0 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.01 118.38 17.35 Favored Pre-proline 0 N--CA 1.478 0.974 0 O-C-N 124.165 0.916 . . . . 0.0 110.763 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 58.7 Cg_endo -65.61 -19.36 60.17 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.92 2.413 . . . . 0.0 113.664 -169.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 3.1 mppt? -84.5 -42.7 15.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.86 0.362 . . . . 0.0 110.04 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 24.1 mtt-85 -68.01 -33.08 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.216 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 367' ' ' PHE . 24.6 mm -60.68 -27.02 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.159 171.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 69.7 mm-40 -84.47 -22.3 30.33 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 174.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 85.7 mm-40 -79.73 -30.19 40.79 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.318 0.647 . . . . 0.0 112.367 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 376' ' ' ILE . 3.1 pp -73.2 154.6 90.39 Favored Pre-proline 0 N--CA 1.482 1.137 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.29 164.78 24.36 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.233 1.955 . . . . 0.0 114.773 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.27 -18.28 61.82 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.461 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.493 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 47.5 p-80 -166.32 149.93 7.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.54 0.736 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -116.49 101.94 9.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 144.68 165.85 11.28 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.444 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.23 130.36 20.59 Favored 'Cis proline' 0 C--N 1.379 2.171 0 CA-C-N 118.984 1.392 . . . . 0.0 112.237 -3.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.67 -173.22 24.06 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.875 -0.958 . . . . 0.0 111.074 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.44 143.11 34.22 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.933 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.3 p -45.47 -50.95 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 112.775 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.49 -34.58 72.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.617 1.167 . . . . 0.0 111.817 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 99.4 t -76.57 -47.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.17 -38.82 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 122.883 0.473 . . . . 0.0 111.658 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -70.77 -41.61 71.5 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.146 0.179 . . . . 0.0 111.428 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.487 ' N ' HD12 ' A' ' 392' ' ' LEU . 28.8 ptt180 -71.9 -30.74 65.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -68.84 -29.39 67.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.614 0.765 . . . . 0.0 111.51 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.647 HD11 HG21 ' A' ' 359' ' ' VAL . 35.4 mm -69.6 -54.85 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 98.3 t -58.76 -50.07 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 O-C-N 124.193 0.933 . . . . 0.0 111.572 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.7 pt20 -68.44 -31.35 70.61 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.929 0.491 . . . . 0.0 111.91 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.22 83.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.01 -32.45 72.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.45 0.7 . . . . 0.0 112.629 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.7 t -80.24 -52.38 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.55 -38.98 89.43 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.734 0.414 . . . . 0.0 111.055 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 50.5 m -89.28 12.94 14.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.297 0.639 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -89.51 144.91 25.66 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.212 0.605 . . . . 0.0 111.732 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.87 122.23 18.2 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.839 166.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.32 62.28 0.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.445 1.09 . . . . 0.0 109.192 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 400' ' ' VAL . 89.5 m -55.96 -41.13 74.25 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.64 1.576 . . . . 0.0 111.483 -173.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -54.2 -34.67 61.11 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.116 1.366 . . . . 0.0 114.497 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.2 m -79.14 -39.4 33.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.469 0.652 . . . . 0.0 109.653 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 403' ' ' ALA . 59.8 t -67.11 -26.17 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.013 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.3 -17.54 63.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.314 1.446 . . . . 0.0 110.146 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -81.9 -8.21 86.97 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.4 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.16 -2.31 55.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.213 0.605 . . . . 0.0 111.3 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 434' ' ' ILE . 1.5 pt? -149.31 139.17 21.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.611 0.764 . . . . 0.0 110.052 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -105.87 152.7 40.29 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.101 0.961 . . . . 0.0 111.474 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.03 151.68 62.01 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.046 166.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -148.24 107.78 3.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -91.06 44.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.019 0.914 . . . . 0.0 110.979 -167.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.63 5.94 50.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.407 169.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.81 66.2 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.51 0.506 . . . . 0.0 113.178 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.52 -126.86 2.38 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.737 0.316 . . . . 0.0 112.727 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.461 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.5 mp0 -85.12 174.56 9.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.415 0.686 . . . . 0.0 110.755 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.64 135.31 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.34 0.656 . . . . 0.0 109.432 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 397' ' ' GLN . 31.2 mm -109.74 124.19 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.897 0.879 . . . . 0.0 108.998 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.8 p -106.87 133.83 50.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.224 0.61 . . . . 0.0 109.613 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.47 134.04 10.86 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.605 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 62.7 m -77.03 104.64 7.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 122.951 0.5 . . . . 0.0 111.023 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -111.05 110.63 21.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.985 0.914 . . . . 0.0 110.598 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 39.0 t70 58.09 57.6 3.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.745 1.218 . . . . 0.0 111.76 169.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 78.32 -6.94 49.2 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.131 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.98 170.84 7.83 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.708 0.754 . . . . 0.0 110.309 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 5.1 t -114.22 109.39 18.32 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -120.66 168.75 11.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.608 0.763 . . . . 0.0 110.686 -173.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 51.0 p -147.94 154.86 40.9 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.331 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 413' ' ' LEU . 25.5 pt -122.49 -179.75 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.957 0.903 . . . . 0.0 109.173 172.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.17 153.32 32.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.404 0.681 . . . . 0.0 110.211 170.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 421' ' ' GLU . 85.0 mt -114.96 164.68 15.96 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 0.0 109.374 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.34 134.47 17.3 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.814 1.676 . . . . 0.0 111.008 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.43 128.02 14.84 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.002 1.801 . . . . 0.0 112.248 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.51 172.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 0.0 110.369 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.18 -12.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.421 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.9 m -108.78 138.89 44.38 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.4 0.545 . . . . 0.0 111.044 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.81 -30.37 68.91 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.265 1.026 . . . . 0.0 111.622 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.6 m -62.85 -33.53 75.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.837 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -82.56 -25.32 33.43 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.933 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.2 -65.97 0.48 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.865 0.866 . . . . 0.0 111.473 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 3.1 pp -65.98 -37.43 85.93 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.609 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.65 71.69 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.263 1.025 . . . . 0.0 111.686 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -62.73 -49.71 73.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.529 0.732 . . . . 0.0 110.245 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -89.05 -14.5 36.25 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.519 -175.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.0 OUTLIER -59.69 -48.86 79.98 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.047 0.939 . . . . 0.0 110.807 -176.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.92 -32.89 71.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.075 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 60.4 t80 -68.23 -52.83 29.74 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.136 0.575 . . . . 0.0 110.87 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.08 -28.01 69.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.824 1.249 . . . . 0.0 111.31 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.72 -36.53 80.77 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.624 0.769 . . . . 0.0 110.273 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.1 m -71.41 -28.13 63.79 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.723 0.809 . . . . 0.0 110.923 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 23.9 mt -82.91 -17.81 42.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.128 0.571 . . . . 0.0 111.157 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 73.8 6.82 4.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 111.777 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 22.4 p -79.22 131.53 36.21 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.9 t70 -151.68 145.43 25.05 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.358 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 18.1 m-80 62.72 20.67 12.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 -167.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -86.27 -19.95 29.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.51 0.724 . . . . 0.0 110.476 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.09 169.55 24.23 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.537 0.735 . . . . 0.0 110.059 173.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.9 p -157.22 109.43 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 123.518 0.727 . . . . 0.0 111.626 -177.523 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.55 0.973 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.2 p -86.47 -173.58 4.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.941 0.496 . . . . 0.0 110.899 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -139.62 142.44 37.04 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.611 0.764 . . . . 0.0 110.667 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.416 HG23 HG11 ' A' ' 391' ' ' VAL . 12.4 m -143.22 152.7 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.459 1.103 . . . . 0.0 110.584 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.479 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 42.2 t -121.07 105.72 10.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 0.0 109.102 171.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.1 t -94.95 149.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.66 0.784 . . . . 0.0 109.734 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.5 103.46 9.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.572 1.149 . . . . 0.0 108.585 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.419 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -75.78 106.53 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.033 0.533 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -91.64 87.93 6.53 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.439 0.696 . . . . 0.0 109.271 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -15.61 61.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.257 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -73.98 -19.22 60.72 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.397 0.679 . . . . 0.0 110.833 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -80.52 -153.95 9.66 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.201 0.429 . . . . 0.0 112.89 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 52.5 t30 -72.69 141.5 48.23 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.828 0.347 . . . . 0.0 110.169 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 371' ' ' LEU . 2.0 m-85 -97.32 -64.63 1.02 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -138.32 -100.89 0.53 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.029 -0.873 . . . . 0.0 112.259 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -88.75 15.94 44.84 Favored 'Cis proline' 0 C--N 1.373 1.862 0 CA-C-N 120.312 2.056 . . . . 0.0 114.238 12.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -83.58 -1.79 54.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.641 0.777 . . . . 0.0 111.196 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 456' ' ' LEU . 42.4 mt -114.78 146.79 40.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.361 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.19 122.37 86.1 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.611 0.764 . . . . 0.0 110.701 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.465 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 37.6 Cg_endo -61.34 -23.76 77.47 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.229 2.619 . . . . 0.0 114.871 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -84.7 -48.2 9.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.149 0.432 . . . . 0.0 110.457 -176.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 64.7 mtt180 -68.5 -34.68 76.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.077 0.951 . . . . 0.0 111.949 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.427 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.8 mm -52.55 -31.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.909 0.883 . . . . 0.0 111.884 170.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -80.28 -28.2 38.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.115 0.566 . . . . 0.0 111.385 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -78.45 -31.33 47.93 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.623 0.769 . . . . 0.0 112.346 -169.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' A' ' 398' ' ' ALA . 0.8 OUTLIER -71.54 154.0 93.45 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.106 172.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.2 165.44 8.9 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.977 2.451 . . . . 0.0 114.812 -171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.91 -13.62 60.93 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.522 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.2 p80 -159.7 150.47 19.27 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.2 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -119.46 104.22 10.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 178.09 15.17 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.963 -0.91 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.67 136.53 36.72 Favored 'Cis proline' 0 C--N 1.386 2.54 0 CA-C-N 119.875 1.838 . . . . 0.0 113.23 -2.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -170.46 -172.89 37.28 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.03 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 58.5 Cg_endo -68.26 138.78 44.04 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.841 2.361 . . . . 0.0 112.366 -174.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 445' ' ' ALA . 11.4 p -51.05 -43.02 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.333 1.453 . . . . 0.0 111.724 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -50.77 -59.33 4.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 111.035 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.523 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 57.6 t -71.74 -42.37 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.867 -172.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 357' ' ' VAL . 97.1 t -63.27 -45.26 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.844 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.66 -40.65 84.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 390' ' ' VAL . 10.9 ptm180 -72.71 -30.05 63.89 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -72.23 -23.06 61.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.086 0.554 . . . . 0.0 111.929 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.564 HG21 ' HG ' ' A' ' 449' ' ' LEU . 22.0 mm -73.42 -55.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.9 t -62.29 -55.79 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.587 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.0 pt20 -64.07 -29.63 70.75 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.795 0.438 . . . . 0.0 111.9 -176.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -64.09 -48.9 74.38 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.24 -47.86 78.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.856 0.723 . . . . 0.0 112.318 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 396' ' ' VAL . 10.2 t -65.13 -48.12 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.958 0.409 . . . . 0.0 110.154 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.95 -33.55 74.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.686 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 73.5 m -93.01 17.22 11.11 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.429 0.692 . . . . 0.0 110.958 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.596 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -91.13 155.46 18.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.611 0.719 . . . . 0.0 112.318 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.47 121.94 26.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.689 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 57.32 61.91 2.36 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.333 1.02 . . . . 0.0 109.712 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 400' ' ' VAL . 97.1 m -48.67 -35.81 14.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.094 1.758 . . . . 0.0 112.742 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -56.93 -39.51 74.62 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.492 1.117 . . . . 0.0 113.036 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 92.9 m -79.6 -40.48 29.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.816 0.847 . . . . 0.0 109.772 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.596 HG21 ' HB1' ' A' ' 403' ' ' ALA . 94.5 t -61.08 -33.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.429 1.092 . . . . 0.0 111.46 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.12 -10.54 59.49 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.368 1.067 . . . . 0.0 110.908 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -82.38 -6.94 88.24 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.574 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.14 10.1 28.32 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.414 0.685 . . . . 0.0 111.464 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -152.14 141.05 21.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.295 1.038 . . . . 0.0 108.964 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -117.15 154.99 50.1 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 123.688 0.795 . . . . 0.0 111.53 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.09 157.8 56.73 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.692 2.261 . . . . 0.0 112.037 167.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.405 ' OD1' ' HD2' ' A' ' 418' ' ' ARG . 5.3 t0 -155.15 139.23 16.47 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -90.12 27.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.405 ' HD2' ' OD1' ' A' ' 416' ' ' ASP . 0.0 OUTLIER -84.44 -33.42 23.67 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 111.024 175.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.77 41.82 8.63 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.723 0.249 . . . . 0.0 113.723 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -94.18 -110.25 2.19 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.761 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 23.5 mp0 -74.28 162.74 28.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.446 ' HB ' ' NH2' ' A' ' 393' ' ' ARG . 90.1 t -135.64 130.07 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.517 HG12 HD11 ' A' ' 436' ' ' LEU . 37.3 mm -110.4 127.55 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.7 p -106.04 150.7 25.5 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.673 0.789 . . . . 0.0 108.999 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -165.87 135.96 3.47 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.583 0.753 . . . . 0.0 109.678 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 69.0 m -67.48 101.06 0.92 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.585 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -139.21 136.75 35.33 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 109.502 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.7 t70 62.71 31.64 16.53 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.97 1.308 . . . . 0.0 111.514 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 81.34 1.87 90.24 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.893 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.81 172.96 10.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.586 1.155 . . . . 0.0 109.308 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.8 t -87.75 102.24 14.47 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 164.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -85.94 133.08 33.96 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.439 ' HB3' HG22 ' A' ' 424' ' ' THR . 25.2 p -114.56 143.3 45.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.017 0.927 . . . . 0.0 110.445 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 413' ' ' LEU . 16.5 pt -128.46 168.44 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.046 0.938 . . . . 0.0 109.761 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -112.28 146.93 37.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.536 0.734 . . . . 0.0 110.766 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.7 mp -115.86 155.48 47.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.233 1.413 . . . . 0.0 108.355 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.17 128.66 14.11 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.79 1.66 . . . . 0.0 111.462 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.09 135.36 27.14 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.927 2.418 . . . . 0.0 111.617 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.16 160.78 4.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.285 0.564 . . . . 0.0 110.751 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.62 12.43 3.19 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.316 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 39.5 t -118.36 139.13 51.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.896 0.478 . . . . 0.0 109.97 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.25 45.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.462 1.105 . . . . 0.0 111.365 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 27.2 m -72.89 -22.4 60.76 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.03 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.41 -21.39 25.63 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.81 -60.73 2.36 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 121.701 0.762 . . . . 0.0 109.918 170.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 464' ' ' SER . 20.6 mt -69.69 -39.77 76.75 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.952 -174.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 0.0 OUTLIER -61.15 -30.8 70.61 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.879 0.872 . . . . 0.0 111.442 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -45.51 72.88 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.903 0.481 . . . . 0.0 110.492 -177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.564 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.51 -13.1 43.98 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.074 -0.488 . . . . 0.0 111.846 176.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 1.4 mm-40 -57.17 -56.98 14.71 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.725 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.39 -35.72 81.05 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.931 0.769 . . . . 0.0 111.147 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 38.8 t80 -60.31 -61.06 2.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.522 0.729 . . . . 0.0 110.818 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.85 -30.54 69.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.435 1.094 . . . . 0.0 111.81 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -66.04 -40.26 90.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.224 0.61 . . . . 0.0 110.582 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 49.9 m -67.91 -35.86 79.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.536 0.734 . . . . 0.0 110.486 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.567 HD13 HD21 ' A' ' 371' ' ' LEU . 50.3 mt -72.59 -12.91 61.25 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.542 0.737 . . . . 0.0 111.5 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 73.74 14.61 4.12 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.807 1.643 . . . . 0.0 111.61 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.523 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 15.3 p -93.88 139.59 30.71 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 123.379 0.672 . . . . 0.0 109.982 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -155.31 144.82 21.18 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 66.84 12.62 9.0 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 124.191 0.932 . . . . 0.0 110.342 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 34.8 tp -74.57 -17.94 60.65 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.866 0.866 . . . . 0.0 110.24 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.455 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.01 161.66 31.56 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.344 0.658 . . . . 0.0 110.775 177.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 80.8 p -167.81 129.06 1.45 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.698 0.799 . . . . 0.0 109.001 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 35.4 t . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.839 0.352 . . . . 0.0 111.432 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.439 ' SD ' ' HB3' ' A' ' 387' ' ' PRO . 20.1 ptp . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.883 0.373 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.5 t -76.74 172.49 13.0 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.8 p -136.68 137.02 39.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.392 0.677 . . . . 0.0 109.411 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 388' ' ' VAL . 17.2 m -138.25 165.9 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.024 0.93 . . . . 0.0 110.969 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 24.6 p -142.65 108.89 5.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 108.548 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -94.92 159.32 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.27 99.89 6.74 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.415 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 39.7 t -70.84 107.61 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 123.869 0.731 . . . . 0.0 110.313 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.55 89.6 5.05 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.368 1.067 . . . . 0.0 109.117 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.42 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.89 -3.6 42.54 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.509 178.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.95 -11.46 58.86 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.223 0.609 . . . . 0.0 110.414 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.56 -151.05 5.32 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 51.2 t-20 -77.52 139.26 39.56 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.41 -52.69 6.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.687 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.46 -76.22 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 114.738 -1.119 . . . . 0.0 114.32 -176.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.03 -10.06 13.83 Favored 'Cis proline' 0 C--N 1.371 1.759 0 CA-C-N 121.102 2.451 . . . . 0.0 114.095 -2.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 14.8 p-80 -61.29 -12.33 13.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.188 0.995 . . . . 0.0 113.029 175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.687 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.4 mt -98.69 143.07 29.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.152 0.981 . . . . 0.0 109.408 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 127.49 91.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 123.864 0.727 . . . . 0.0 110.068 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 29.7 Cg_endo -59.63 -41.25 57.83 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.992 2.461 . . . . 0.0 112.875 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -65.64 -45.2 83.93 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.398 0.436 . . . . 0.0 110.675 -175.273 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -66.88 -31.2 71.65 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.687 0.795 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 18.5 mm -66.63 -28.83 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.068 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 62.2 mm-40 -82.93 -23.04 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.961 -0.462 . . . . 0.0 110.906 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 70.9 mm-40 -74.6 -38.67 62.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.953 0.501 . . . . 0.0 111.716 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.1 pp -67.51 156.77 87.87 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.926 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.29 150.69 83.6 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.539 2.159 . . . . 0.0 113.122 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.55 -1.8 26.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.879 1.272 . . . . 0.0 111.442 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 39.7 p-80 -157.33 151.33 24.57 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 109.965 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -118.1 104.25 10.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 166.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 148.27 176.69 21.96 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.248 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -82.23 128.74 15.07 Favored 'Cis proline' 0 C--N 1.376 2.004 0 CA-C-N 118.751 1.276 . . . . 0.0 111.326 -2.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -153.49 -165.45 13.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.099 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.439 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 3.1 Cg_exo -70.97 146.31 52.4 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.951 2.434 . . . . 0.0 112.265 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.0 p -54.64 -45.32 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 124.28 1.032 . . . . 0.0 111.15 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -62.44 -49.74 74.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.064 1.346 . . . . 0.0 110.948 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 83.4 t -70.63 -48.9 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.508 -174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.12 -40.61 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.87 0.468 . . . . 0.0 111.897 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.7 pp -66.87 -41.84 86.6 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.421 ' N ' HD12 ' A' ' 392' ' ' LEU . 17.4 ptt180 -74.49 -25.4 59.35 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 123.32 0.388 . . . . 0.0 110.033 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 36.7 mmm-85 -64.09 -40.33 95.99 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.422 0.451 . . . . 0.0 110.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 359' ' ' VAL . 43.6 mm -63.55 -51.33 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.953 0.783 . . . . 0.0 109.735 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.79 -44.87 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.298 -174.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -79.58 -28.03 41.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.857 -0.592 . . . . 0.0 111.834 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -73.53 -31.88 63.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.274 0.488 . . . . 0.0 110.508 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.96 -56.12 19.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.085 0.554 . . . . 0.0 109.56 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.73 -30.13 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.729 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.06 -33.97 70.77 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.484 0.714 . . . . 0.0 111.566 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 379' ' ' LEU . 78.4 m -91.23 0.1 57.59 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.989 0.516 . . . . 0.0 111.637 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.93 138.84 54.95 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.4 mt -82.6 115.98 21.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.53 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 64.54 61.39 0.85 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.444 1.116 . . . . 0.0 109.286 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.0 m -51.8 -34.8 41.59 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.217 1.807 . . . . 0.0 112.806 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -54.93 -42.24 72.0 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.532 1.133 . . . . 0.0 112.315 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 49.6 m -80.53 -37.25 31.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 403' ' ' ALA . 90.8 t -65.37 -34.92 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.235 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.37 -16.64 60.36 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.832 0.853 . . . . 0.0 110.84 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -68.72 -13.55 66.18 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 116.257 -0.429 . . . . 0.0 114.14 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.88 -13.32 60.01 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.738 . . . . 0.0 111.444 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.614 HD22 ' HE1' ' A' ' 452' ' ' PHE . 1.0 OUTLIER -141.52 112.71 7.43 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.376 0.671 . . . . 0.0 110.267 -173.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 414' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 415' ' ' PRO . 47.0 mtpt -112.56 160.67 29.61 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 124.163 0.985 . . . . 0.0 109.637 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 414' ' ' LYS . 67.3 Cg_endo -67.75 155.52 69.62 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.288 1.992 . . . . 0.0 114.698 -170.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.87 124.34 26.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.062 1.345 . . . . 0.0 108.601 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.82 33.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.193 0.597 . . . . 0.0 112.212 -164.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -92.01 -10.62 38.56 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 111.42 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.65 41.33 64.96 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.53 -116.8 2.37 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 120.113 -0.27 . . . . 0.0 112.961 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.9 OUTLIER -77.4 168.73 19.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 110.592 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 81.2 t -132.92 125.29 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.631 0.772 . . . . 0.0 109.217 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 436' ' ' LEU . 37.6 mm -103.37 128.06 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.5 p -106.63 140.9 38.77 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.941 0.896 . . . . 0.0 109.809 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.05 141.8 24.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.037 0.935 . . . . 0.0 110.151 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.2 p -83.65 112.7 20.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -144.24 137.48 27.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.031 0.932 . . . . 0.0 109.428 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.17 18.32 11.38 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.494 1.117 . . . . 0.0 112.434 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.38 70.89 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 121.792 -0.567 . . . . 0.0 112.776 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -131.74 170.99 14.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.661 1.184 . . . . 0.0 109.71 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -92.09 126.08 37.03 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.8 126.9 53.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.728 0.811 . . . . 0.0 109.297 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.8 p -117.76 140.63 49.42 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 0.0 110.336 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.14 162.3 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.396 0.678 . . . . 0.0 109.947 172.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -99.27 146.69 25.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.816 0.847 . . . . 0.0 110.111 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 423' ' ' ILE . 8.5 mp -115.18 171.43 4.51 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.64 141.73 25.2 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 121.957 1.771 . . . . 0.0 111.735 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.32 128.47 8.91 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.148 1.898 . . . . 0.0 112.257 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.45 172.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.617 0.767 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -149.04 -0.93 0.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.008 0.523 . . . . 0.0 111.979 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -126.5 139.93 52.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.005 0.522 . . . . 0.0 110.751 -172.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.19 70.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.226 1.01 . . . . 0.0 111.517 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 t -63.49 -27.69 69.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.565 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -86.9 -27.87 23.13 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.734 0.414 . . . . 0.0 110.395 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.889 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.9 -66.94 0.31 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.974 0.91 . . . . 0.0 111.954 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 450' ' ' GLU . 0.9 OUTLIER -61.79 -43.75 98.23 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.179 178.181 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -31.59 58.47 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.364 1.066 . . . . 0.0 111.917 -175.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -62.65 -55.28 28.38 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.687 0.617 . . . . 0.0 110.046 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.76 -14.84 59.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.24 -178.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 446' ' ' LEU . 10.5 mm-40 -64.54 -45.92 85.1 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.292 0.496 . . . . 0.0 110.143 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.15 -39.59 65.55 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.169 0.588 . . . . 0.0 110.599 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.614 ' HE1' HD22 ' A' ' 413' ' ' LEU . 67.9 t80 -57.88 -59.14 5.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.657 0.783 . . . . 0.0 110.952 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.62 -27.16 69.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.118 0.967 . . . . 0.0 112.149 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -65.1 -41.53 94.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.03 0.532 . . . . 0.0 110.505 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 51.1 m -67.62 -21.84 65.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.708 0.803 . . . . 0.0 111.65 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 71.1 mt -100.05 -14.02 18.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.056 0.942 . . . . 0.0 112.963 -173.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 80.07 7.23 1.65 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.687 1.595 . . . . 0.0 112.19 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' CYS . . . . . . . . . . . . . 6.1 p -89.44 134.22 34.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.3 t70 -152.2 152.18 31.92 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 59.74 18.27 7.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.243 1.017 . . . . 0.0 111.259 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.23 -18.52 49.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.77 0.428 . . . . 0.0 110.966 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -163.74 172.5 14.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.23 0.612 . . . . 0.0 110.47 171.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 18.9 p -163.28 126.48 2.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.779 0.831 . . . . 0.0 108.839 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 29.2 t . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 122.66 0.384 . . . . 0.0 111.553 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.9 t -82.37 179.19 7.88 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.144 0.578 . . . . 0.0 110.864 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.5 p -137.89 134.69 35.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.18 0.992 . . . . 0.0 109.864 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.9 m -140.41 162.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.959 0.903 . . . . 0.0 110.771 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 20.4 p -137.45 115.57 11.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.431 1.092 . . . . 0.0 108.815 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 34.9 m -104.01 141.91 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.837 0.455 . . . . 0.0 109.801 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.48 98.24 7.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 67.5 t -70.68 99.59 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.463 1.102 . . . . 0.0 110.713 -173.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 33.6 t30 -94.47 97.11 9.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.62 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.4 -11.33 59.83 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.334 178.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -83.32 -15.74 48.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.546 0.738 . . . . 0.0 110.783 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -70.95 -88.32 0.11 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -141.13 152.0 44.37 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.0 -62.19 1.32 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.563 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -149.23 -91.75 0.09 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.609 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -85.5 10.48 53.13 Favored 'Cis proline' 0 C--N 1.371 1.763 0 CA-C-N 120.496 2.148 . . . . 0.0 114.832 11.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -74.16 -8.23 55.46 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 26.0 mt -107.89 136.06 48.24 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.415 1.086 . . . . 0.0 108.743 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.16 125.19 86.42 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.481 0.712 . . . . 0.0 110.318 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.529 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 35.0 Cg_endo -62.95 -31.03 77.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.717 2.278 . . . . 0.0 113.137 -172.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.32 -45.97 36.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.148 0.579 . . . . 0.0 110.119 -176.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -61.94 -34.59 76.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.356 1.062 . . . . 0.0 111.598 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 379' ' ' LEU . 24.2 mm -64.04 -29.93 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.777 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 76.9 mm-40 -83.18 -21.91 33.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.325 0.25 . . . . 0.0 110.859 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 82.9 mm-40 -79.58 -32.56 42.02 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.03 0.532 . . . . 0.0 112.148 -176.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -72.06 156.98 90.23 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.018 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.85 161.34 18.8 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.854 2.37 . . . . 0.0 114.33 -173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.36 -21.37 61.31 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.952 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.487 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 20.5 p-80 -167.05 154.04 8.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.086 0.955 . . . . 0.0 110.67 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -117.9 146.38 43.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.072 0.949 . . . . 0.0 108.969 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.18 -174.85 39.09 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.271 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.56 128.58 16.82 Favored 'Cis proline' 0 C--N 1.377 2.049 0 CA-C-N 119.187 1.493 . . . . 0.0 112.329 1.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.66 -154.69 7.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.201 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.31 137.2 25.44 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.655 2.237 . . . . 0.0 112.122 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.76 -42.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.606 1.562 . . . . 0.0 112.073 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.23 -55.5 27.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.395 1.478 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -70.13 -46.08 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.888 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.21 -36.63 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 122.566 0.346 . . . . 0.0 111.672 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.3 pp -73.89 -40.68 63.02 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.744 0.247 . . . . 0.0 111.02 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.5 ptt180 -67.98 -29.18 68.14 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 22.0 mmm-85 -65.37 -43.32 91.16 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 123.864 0.727 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 29.4 mm -65.26 -53.59 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.455 0.472 . . . . 0.0 109.838 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 400' ' ' VAL . 66.7 t -62.05 -44.81 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.027 0.829 . . . . 0.0 110.896 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.518 ' HA ' HG23 ' A' ' 423' ' ' ILE . 12.4 pt20 -67.5 -33.99 76.22 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.63 0.195 . . . . 0.0 110.838 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.1 84.67 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 122.879 0.472 . . . . 0.0 110.147 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 82.3 m -68.61 -51.35 43.3 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.591 0.756 . . . . 0.0 111.1 -175.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 406' ' ' THR . 21.0 t -62.06 -43.9 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.7 -33.35 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.002 0.521 . . . . 0.0 111.524 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 19.2 p -84.34 -10.07 57.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.696 0.398 . . . . 0.0 111.023 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.38 150.03 49.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 112.987 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.55 121.27 26.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.408 169.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 62.77 61.3 1.18 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 122.249 1.023 . . . . 0.0 109.148 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.522 HG23 HG12 ' A' ' 400' ' ' VAL . 52.2 m -54.63 -34.35 61.99 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.437 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -57.66 -37.23 73.02 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 113.175 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.8 m -84.42 -35.34 23.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.055 0.542 . . . . 0.0 110.281 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.531 HG21 ' HB1' ' A' ' 403' ' ' ALA . 88.6 t -64.58 -31.22 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.864 0.866 . . . . 0.0 110.837 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.56 -21.6 62.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.944 1.298 . . . . 0.0 110.436 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.59 76.07 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.198 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -77.38 -18.13 57.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.209 0.604 . . . . 0.0 111.689 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -133.26 125.56 29.59 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.501 0.721 . . . . 0.0 110.088 -175.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -103.45 159.03 30.59 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.931 0.892 . . . . 0.0 109.963 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.17 122.64 8.2 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.768 1.645 . . . . 0.0 112.64 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 4.3 m-20 -110.16 107.67 17.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.328 1.451 . . . . 0.0 107.342 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -83.83 67.62 9.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.095 0.95 . . . . 0.0 108.566 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -107.53 4.1 25.7 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.97 40.13 93.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.44 0.462 . . . . 0.0 113.053 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -106.61 -132.34 7.05 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 120.125 -0.264 . . . . 0.0 112.633 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.5 OUTLIER -73.21 172.78 10.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.972 0.909 . . . . 0.0 111.389 -175.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 131.22 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 109.32 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 397' ' ' GLN . 42.1 mm -111.77 123.73 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 433' ' ' SER . 17.0 p -106.51 144.95 32.45 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.831 0.852 . . . . 0.0 109.051 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -160.63 133.03 6.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.662 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.4 m -70.9 109.03 4.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.326 0.651 . . . . 0.0 111.91 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -131.21 126.85 36.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.684 1.194 . . . . 0.0 109.033 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.26 14.35 7.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.036 1.335 . . . . 0.0 112.355 169.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 7.2 62.5 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.721 -0.612 . . . . 0.0 113.015 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -120.6 166.08 14.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.256 1.022 . . . . 0.0 109.46 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.2 t -97.9 101.23 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -88.6 126.95 35.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 424' ' ' THR . 55.2 p -116.88 148.68 41.09 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.458 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 413' ' ' LEU . 46.4 pt -125.56 179.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.086 0.954 . . . . 0.0 109.215 173.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -115.66 153.21 31.71 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 86.1 mt -115.58 166.07 12.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.488 1.115 . . . . 0.0 108.933 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.92 135.07 12.26 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 121.814 1.676 . . . . 0.0 111.105 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.42 134.01 25.64 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.809 2.339 . . . . 0.0 112.494 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.29 173.64 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.787 0.835 . . . . 0.0 111.647 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -152.06 -4.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.43 0.692 . . . . 0.0 112.312 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.5 t -113.96 139.16 49.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.727 0.411 . . . . 0.0 109.999 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.12 67.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.541 0.736 . . . . 0.0 111.308 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 48.3 m -63.87 -32.94 74.62 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.441 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -83.21 -27.28 30.09 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.945 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.65 -62.27 1.7 Allowed 'General case' 0 C--N 1.366 1.3 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 449' ' ' LEU . 17.7 mt -66.31 -52.18 49.88 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.31 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -51.46 -36.14 42.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -59.06 -49.09 79.22 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.847 0.717 . . . . 0.0 109.964 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.58 -14.13 38.34 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.729 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 49.9 mt-10 -78.02 -36.57 48.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.348 0.976 . . . . 0.0 110.153 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.25 -42.28 96.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.088 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 58.8 t80 -72.42 -43.42 63.88 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.48 -174.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 20.7 p -70.84 -26.66 63.38 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.557 0.743 . . . . 0.0 109.963 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -65.74 -35.06 79.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.031 0.932 . . . . 0.0 110.271 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 17.2 m -75.94 -29.11 58.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.643 0.777 . . . . 0.0 110.598 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 371' ' ' LEU . 51.3 mt -80.27 -14.75 58.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.43 0.692 . . . . 0.0 110.951 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 75.69 9.74 3.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 0.0 112.07 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 11.8 p -91.5 138.42 31.59 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.34 0.656 . . . . 0.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -133.82 156.83 47.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 109.501 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 29.8 m-80 59.01 22.21 10.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.754 0.821 . . . . 0.0 111.634 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.95 -17.29 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.177 0.591 . . . . 0.0 110.255 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.05 172.55 17.96 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.982 0.913 . . . . 0.0 109.805 173.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 24.0 p -165.88 134.79 3.17 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.736 0.648 . . . . 0.0 109.882 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.123 0.487 . . . . 0.0 111.668 179.579 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.4 m -73.39 171.98 12.1 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.771 0.428 . . . . 0.0 110.87 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.3 p -133.6 137.99 45.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.169 0.588 . . . . 0.0 110.087 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.3 m -143.15 162.36 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.466 1.106 . . . . 0.0 109.819 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 46.9 t -135.27 107.94 7.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.56 0.744 . . . . 0.0 109.299 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 42.5 t -96.46 151.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.299 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.17 106.33 8.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.578 1.151 . . . . 0.0 108.669 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 379' ' ' LEU . 62.1 t -71.7 112.3 6.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.306 0.642 . . . . 0.0 110.31 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 51.5 t30 -93.51 81.22 4.34 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.31 -13.64 62.41 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.312 175.018 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -74.29 -23.04 59.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.481 0.713 . . . . 0.0 110.876 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.33 -140.8 2.1 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.094 0.246 . . . . 0.0 112.924 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 59.3 t-20 -74.62 143.55 44.3 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.92 -53.55 3.64 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -155.52 -70.88 0.01 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.447 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.21 5.12 58.47 Favored 'Cis proline' 0 C--N 1.373 1.842 0 CA-C-N 120.382 2.091 . . . . 0.0 114.702 2.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -76.35 -9.08 58.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 117.914 0.325 . . . . 0.0 111.275 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.557 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 25.4 mt -87.18 123.99 32.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.504 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 9.8 t70 -55.09 122.53 42.86 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 124.502 1.126 . . . . 0.0 110.374 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 37.1 Cg_endo -60.93 -31.11 91.16 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.015 2.477 . . . . 0.0 113.406 -172.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.95 -46.77 33.28 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.617 0.367 . . . . 0.0 110.489 -176.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ARG . . . . . 0.504 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 23.8 mtp180 -65.03 -30.92 71.93 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 110.719 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.7 mm -63.78 -28.78 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.123 0.969 . . . . 0.0 110.988 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.1 mm-40 -85.57 -25.37 26.76 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.492 0.317 . . . . 0.0 110.79 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 78.9 mm-40 -75.39 -31.68 60.54 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.756 0.422 . . . . 0.0 112.134 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.607 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.2 pp -71.2 155.28 93.26 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.167 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.05 158.09 40.84 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.451 2.101 . . . . 0.0 113.311 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.54 -3.58 25.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.697 1.199 . . . . 0.0 111.855 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 5.4 p80 -159.25 156.77 29.4 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.223 0.609 . . . . 0.0 110.513 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.417 ' HD2' HD13 ' A' ' 395' ' ' ILE . 50.2 m-85 -128.29 103.76 7.35 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 133.81 176.8 14.55 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.511 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.82 129.86 19.65 Favored 'Cis proline' 0 C--N 1.376 2.009 0 CA-C-N 120.008 1.904 . . . . 0.0 112.645 -4.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -154.24 -161.62 10.58 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.806 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -74.02 130.76 14.71 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.756 2.304 . . . . 0.0 111.176 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.2 p -38.01 -48.41 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.661 1.984 . . . . 0.0 113.63 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -72.97 -39.95 65.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.797 1.639 . . . . 0.0 112.134 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.33 -43.18 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.451 0.301 . . . . 0.0 110.718 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.35 -40.18 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.369 0.668 . . . . 0.0 111.892 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -67.95 -40.22 83.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.48 ' N ' HD12 ' A' ' 392' ' ' LEU . 5.5 ptt180 -70.69 -24.81 62.74 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.989 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -65.26 -42.05 93.65 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.816 0.846 . . . . 0.0 110.907 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.417 HD13 ' HD2' ' A' ' 383' ' ' PHE . 34.5 mm -64.81 -50.68 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 400' ' ' VAL . 99.2 t -59.27 -52.72 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.539 -1.209 . . . . 0.0 111.689 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.447 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.2 pt20 -65.54 -34.33 78.0 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.292 0.637 . . . . 0.0 110.793 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -69.12 -36.88 77.96 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 123.856 0.723 . . . . 0.0 110.586 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 89.2 m -68.56 -42.75 77.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.196 0.598 . . . . 0.0 111.462 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 396' ' ' VAL . 21.5 t -70.51 -41.66 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.774 0.43 . . . . 0.0 109.858 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.74 -40.93 96.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.922 0.889 . . . . 0.0 111.024 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.607 ' SG ' HD23 ' A' ' 379' ' ' LEU . 71.5 m -93.1 10.78 30.16 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.469 0.708 . . . . 0.0 111.975 -176.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.609 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -87.4 143.39 27.26 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.21 131.71 39.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 61.11 57.21 2.55 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 122.134 0.968 . . . . 0.0 109.741 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 32.1 m -50.37 -32.48 17.53 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.956 1.702 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -61.19 -34.65 75.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 112.949 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -81.8 -34.53 30.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.509 0.724 . . . . 0.0 109.953 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.609 HG21 ' HB1' ' A' ' 403' ' ' ALA . 45.7 t -71.4 -26.5 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.33 -23.2 61.89 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.064 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -80.82 -9.16 86.67 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.19 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 409' ' ' VAL . 31.2 m-85 -72.12 -21.89 61.41 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 117.787 0.793 . . . . 0.0 111.138 176.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.08 146.39 45.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.746 0.818 . . . . 0.0 110.624 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -116.75 155.75 48.65 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.071 0.948 . . . . 0.0 110.247 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.53 131.11 25.27 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.173 1.915 . . . . 0.0 112.065 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -102.57 167.77 9.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.725 1.21 . . . . 0.0 108.965 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -131.95 43.7 3.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.695 0.76 . . . . 0.0 111.96 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -104.8 2.49 30.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.482 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.25 32.01 75.43 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.229 0.331 . . . . 0.0 113.301 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.03 -117.04 1.5 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 113.711 0.244 . . . . 0.0 113.711 -172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 18.7 mm-40 -89.94 170.37 10.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.089 0.556 . . . . 0.0 111.457 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 434' ' ' ILE . 60.3 t -131.51 128.72 61.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 122.749 0.419 . . . . 0.0 109.96 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 433' ' ' SER . 43.4 mm -114.23 128.57 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.9 p -105.57 144.49 32.26 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.024 0.929 . . . . 0.0 109.862 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -157.05 127.67 6.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.05 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 60.4 p -72.49 124.63 25.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.243 0.617 . . . . 0.0 109.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -147.14 115.74 6.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.625 0.77 . . . . 0.0 109.918 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.3 t70 64.46 23.97 13.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.762 1.225 . . . . 0.0 111.504 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.63 -16.03 60.23 Favored Glycine 0 N--CA 1.471 0.97 0 O-C-N 121.89 -0.506 . . . . 0.0 113.138 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -97.88 168.69 10.15 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.592 0.757 . . . . 0.0 109.796 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.2 t -113.22 104.8 12.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -97.79 125.42 42.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.02 0.928 . . . . 0.0 110.378 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.5 p -118.19 138.78 52.08 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.748 0.819 . . . . 0.0 109.784 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 422' ' ' VAL . 23.8 pt -117.31 171.63 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.024 0.53 . . . . 0.0 109.863 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 77.8 mt-30 -102.62 150.45 23.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 170.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 80.1 mt -115.94 164.41 17.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.229 1.412 . . . . 0.0 108.278 169.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.82 139.03 32.73 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.898 1.732 . . . . 0.0 111.153 168.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.76 127.86 6.49 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.107 1.871 . . . . 0.0 110.994 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.67 164.35 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.09 0.471 . . . . 0.0 109.845 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -151.22 23.31 0.73 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.901 0.88 . . . . 0.0 110.163 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 388' ' ' VAL . 47.7 t -124.69 137.28 54.36 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.73 65.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.9 t -69.88 -21.27 63.34 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.033 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.4 -29.72 24.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.42 -67.51 0.27 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.995 0.918 . . . . 0.0 111.895 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 450' ' ' GLU . 0.1 OUTLIER -62.79 -45.06 94.42 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.651 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -59.48 -29.47 67.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.922 0.889 . . . . 0.0 112.399 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -61.84 -60.91 2.94 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.51 0.724 . . . . 0.0 109.609 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -76.97 -13.91 59.91 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 112.32 -177.008 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 446' ' ' LEU . 38.2 mt-10 -58.16 -41.66 84.29 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.883 0.765 . . . . 0.0 110.921 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -68.61 -44.57 74.0 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.398 0.437 . . . . 0.0 110.584 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.466 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 62.9 t80 -60.85 -52.62 64.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.622 0.769 . . . . 0.0 110.749 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.5 -34.29 76.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.699 1.2 . . . . 0.0 111.583 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -69.32 -32.98 72.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.842 0.457 . . . . 0.0 110.261 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.1 m -72.21 -28.44 63.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.52 0.728 . . . . 0.0 110.409 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 22.7 mt -80.9 -12.9 59.33 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.315 0.646 . . . . 0.0 111.292 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 76.27 5.39 3.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 126.562 1.945 . . . . 0.0 111.933 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.478 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.9 p -89.99 140.25 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.818 0.447 . . . . 0.0 110.102 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 23.3 t70 -148.6 151.92 35.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -174.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 9.6 p30 47.62 27.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.788 1.235 . . . . 0.0 112.539 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.41 -10.49 59.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.08 0.952 . . . . 0.0 109.443 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.85 158.01 35.97 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.629 0.772 . . . . 0.0 109.921 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 25.0 p -145.56 109.81 4.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.287 0.635 . . . . 0.0 109.937 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 16.5 t . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.306 0.643 . . . . 0.0 111.159 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.3 t -79.14 -172.91 3.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.686 0.794 . . . . 0.0 110.613 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.1 p -140.08 135.62 32.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 110.028 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 25.8 m -136.7 156.61 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 124.208 1.003 . . . . 0.0 110.88 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.547 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 26.3 p -119.54 107.15 12.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.521 0.728 . . . . 0.0 109.263 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 56.1 t -96.67 150.54 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -129.21 104.33 7.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.434 1.094 . . . . 0.0 108.564 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.467 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 64.8 t -74.28 105.17 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 110.31 -176.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 41.2 t30 -88.31 87.82 7.43 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -17.43 63.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.306 175.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -71.69 -17.99 62.2 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.592 . . . . 0.0 110.547 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -82.14 -167.63 40.12 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.832 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -68.03 129.28 39.45 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.964 0.506 . . . . 0.0 110.479 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.48 ' HB3' HG13 ' A' ' 376' ' ' ILE . 0.9 OUTLIER -75.95 -58.85 3.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.639 -173.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.42 -91.13 0.08 OUTLIER Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.341 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.5 19.86 33.93 Favored 'Cis proline' 0 C--N 1.37 1.702 0 CA-C-N 120.502 2.151 . . . . 0.0 114.31 11.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -77.15 -6.19 51.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.525 0.33 . . . . 0.0 111.359 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 456' ' ' LEU . 31.1 mt -111.28 142.91 42.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.397 1.079 . . . . 0.0 108.832 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.81 122.32 87.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.069 0.548 . . . . 0.0 110.159 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 26.1 Cg_endo -59.08 -28.21 87.19 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.283 2.655 . . . . 0.0 114.247 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.79 -48.08 23.15 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.384 0.427 . . . . 0.0 109.937 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -67.83 -28.78 67.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.559 0.744 . . . . 0.0 111.661 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.506 HD13 HD21 ' A' ' 379' ' ' LEU . 12.7 mm -60.35 -29.66 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.933 172.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 57.0 mm-40 -85.15 -25.38 27.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.612 0.365 . . . . 0.0 110.602 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 65.9 mm-40 -82.26 -24.06 34.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.016 0.527 . . . . 0.0 112.116 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.506 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -74.59 158.71 84.67 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.25 153.39 74.53 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.153 1.902 . . . . 0.0 112.718 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.99 -18.2 65.08 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.114 1.365 . . . . 0.0 112.386 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.467 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.6 p80 -161.97 160.14 27.39 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.197 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.513 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.3 m-85 -124.76 104.66 8.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 135.09 161.51 9.41 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.631 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -79.15 129.87 19.26 Favored 'Cis proline' 0 C--N 1.373 1.857 0 CA-C-N 120.147 1.973 . . . . 0.0 112.123 4.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.99 -176.04 34.64 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.667 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.46 133.91 33.98 Favored 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 112.838 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -38.27 -46.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 127.038 2.135 . . . . 0.0 113.621 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -76.81 -37.4 55.81 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.168 0.987 . . . . 0.0 111.684 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.0 t -74.41 -41.23 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 357' ' ' VAL . 74.2 t -61.36 -42.28 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.46 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.4 pp -70.42 -40.1 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.49 ' N ' HD12 ' A' ' 392' ' ' LEU . 16.2 ptm180 -68.52 -31.85 71.39 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 27.7 mmm-85 -72.35 -32.69 66.7 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.513 HD13 ' HD2' ' A' ' 383' ' ' PHE . 18.2 mm -65.4 -53.43 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 400' ' ' VAL . 93.9 t -55.76 -53.84 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 124.34 1.025 . . . . 0.0 110.749 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.36 -37.55 77.66 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' CYS . . . . . 0.617 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 83.3 m -71.75 -40.42 69.36 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.023 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 396' ' ' VAL . 74.8 t -68.56 -32.99 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.093 0.557 . . . . 0.0 110.42 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.77 -51.01 68.8 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.182 0.593 . . . . 0.0 109.973 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 29.6 p -79.36 -10.57 59.84 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.447 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -57.62 119.07 5.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.581 1.152 . . . . 0.0 113.459 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.24 116.94 7.1 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.852 167.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 63.58 68.73 0.58 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.026 0.917 . . . . 0.0 108.7 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.9 m -54.73 -40.93 69.78 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.466 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -50.86 -40.12 55.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.778 1.231 . . . . 0.0 113.878 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -84.98 -35.17 22.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.379 0.672 . . . . 0.0 110.207 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.5 t -66.15 -33.61 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.52 0.728 . . . . 0.0 111.063 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.45 -11.37 59.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.988 0.915 . . . . 0.0 110.083 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.75 -9.75 84.93 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.268 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.65 0.73 55.27 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.613 0.765 . . . . 0.0 111.597 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -142.7 133.74 25.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.274 0.63 . . . . 0.0 110.482 176.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -114.2 159.43 36.47 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 124.025 0.93 . . . . 0.0 109.764 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.45 143.07 30.55 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.029 1.819 . . . . 0.0 111.022 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -139.25 132.87 30.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -87.89 25.7 1.49 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -164.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -9.07 58.3 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.363 0.665 . . . . 0.0 110.871 171.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 67.28 31.91 78.43 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.556 0.535 . . . . 0.0 114.006 172.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.11 -121.07 1.2 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 123.598 0.234 . . . . 0.0 112.936 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.8 mp0 -82.26 172.71 12.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.842 0.857 . . . . 0.0 110.603 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 94.3 t -134.11 131.65 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.419 0.688 . . . . 0.0 109.837 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 433' ' ' SER . 46.5 mm -104.37 127.64 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 0.0 109.358 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.7 p -106.72 148.29 28.59 Favored 'General case' 0 C--O 1.241 0.635 0 O-C-N 123.906 0.754 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.01 170.97 20.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.849 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 52.3 m -103.2 115.87 31.39 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -142.87 125.46 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.359 0.663 . . . . 0.0 109.927 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 37.9 t70 67.08 16.45 10.29 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.916 1.286 . . . . 0.0 111.641 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 96.78 -15.41 62.72 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.95 -0.469 . . . . 0.0 112.937 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.77 171.21 8.92 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.174 0.99 . . . . 0.0 110.12 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.0 t -97.04 102.81 14.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -91.11 133.89 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 36.5 p -132.64 126.98 33.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 109.352 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.479 HD11 HD12 ' A' ' 413' ' ' LEU . 2.2 pp -117.07 163.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.838 0.855 . . . . 0.0 109.525 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -100.75 150.81 22.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.516 0.674 . . . . 0.0 111.206 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 421' ' ' GLU . 81.7 mt -114.59 160.75 31.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.296 1.438 . . . . 0.0 109.013 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.46 136.44 19.49 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 121.84 1.693 . . . . 0.0 111.519 164.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.81 144.53 31.09 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.92 2.414 . . . . 0.0 112.055 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.7 172.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.036 0.534 . . . . 0.0 110.846 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -154.91 4.19 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.367 0.667 . . . . 0.0 112.114 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.1 t -122.6 141.56 51.58 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.041 0.536 . . . . 0.0 110.212 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.77 -36.19 70.3 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.292 1.037 . . . . 0.0 112.499 -170.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 39.8 m -66.54 -22.15 66.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.313 0.645 . . . . 0.0 111.075 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.84 -22.52 25.76 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.725 0.41 . . . . 0.0 109.973 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.39 -66.24 0.42 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -29.38 68.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.587 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.3 -33.12 75.22 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.813 0.445 . . . . 0.0 110.864 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.66 -45.52 82.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.066 0.546 . . . . 0.0 110.749 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.35 -13.86 42.33 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.555 -179.524 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.6 -50.48 73.0 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.868 0.867 . . . . 0.0 111.375 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -67.41 -29.65 69.2 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.989 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.449 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 54.9 t80 -73.29 -42.63 62.19 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.216 0.606 . . . . 0.0 110.985 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.428 ' HA ' HD12 ' A' ' 456' ' ' LEU . 72.8 m -67.01 -26.83 66.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.918 0.887 . . . . 0.0 110.416 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -67.62 -38.8 84.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.19 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 18.7 m -67.51 -30.68 70.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.924 0.89 . . . . 0.0 111.132 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 371' ' ' LEU . 33.3 mt -82.28 -17.43 45.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 0.0 111.425 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 71.41 7.83 6.14 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.987 1.715 . . . . 0.0 111.758 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.426 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 24.7 p -75.82 135.77 40.22 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.103 0.478 . . . . 0.0 110.359 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 26.7 t70 -127.37 141.37 51.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.642 0.777 . . . . 0.0 110.605 -174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 8.0 p30 46.35 25.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.163 1.785 . . . . 0.0 113.286 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 52.9 tp -76.82 -15.61 59.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.339 1.055 . . . . 0.0 111.279 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -158.98 159.28 34.66 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.016 0.526 . . . . 0.0 110.184 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 61.7 p -160.63 129.71 4.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.247 0.619 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 21.6 t . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 123.243 0.617 . . . . 0.0 111.462 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.681 0.277 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -79.36 -179.04 6.56 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.162 0.585 . . . . 0.0 110.171 175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.1 p -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 0.0 110.972 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 3.1 m -137.76 157.47 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.567 1.147 . . . . 0.0 109.525 173.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 464' ' ' SER . 7.7 p -137.57 101.59 4.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.641 HG21 HD11 ' A' ' 395' ' ' ILE . 29.0 m -94.34 151.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.23 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 53.6 m-85 -110.05 100.49 9.42 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 23.2 t -70.65 88.38 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.8 0.688 . . . . 0.0 109.735 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -85.04 88.23 7.44 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.865 -174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -70.62 -12.45 61.57 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.731 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -76.26 -28.56 57.13 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.745 0.818 . . . . 0.0 111.134 173.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -61.22 -76.23 0.25 Allowed Glycine 0 C--N 1.353 1.523 0 O-C-N 123.429 0.456 . . . . 0.0 112.838 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.4 t30 -152.92 143.2 22.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.498 ' HA ' HG21 ' A' ' 376' ' ' ILE . 1.0 OUTLIER -86.06 -62.64 1.47 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.58 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.19 -94.81 0.17 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.271 0.982 . . . . 0.0 112.763 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -90.13 15.89 46.11 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.326 2.063 . . . . 0.0 113.804 10.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -82.69 -2.26 53.63 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 110.063 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.58 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 31.6 mt -109.83 142.91 40.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.126 1.37 . . . . 0.0 108.034 172.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' HE3' ' A' ' 374' ' ' LYS . 16.2 t70 -70.27 120.16 76.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.161 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.41 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 31.8 Cg_endo -60.71 -28.38 86.42 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.205 2.603 . . . . 0.0 114.192 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.06 -47.9 26.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.808 0.443 . . . . 0.0 110.706 -178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -67.49 -29.99 69.56 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.632 0.582 . . . . 0.0 111.146 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 379' ' ' LEU . 22.4 mm -62.01 -31.79 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.92 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.31 -24.68 42.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.211 0.604 . . . . 0.0 111.159 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.8 mm-40 -81.9 -34.76 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.033 0.533 . . . . 0.0 112.258 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 376' ' ' ILE . 2.4 pp -70.24 153.99 94.84 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.543 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -41.69 152.94 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 124.519 3.479 . . . . 0.0 116.052 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -86.41 -11.15 52.74 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.817 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -160.86 144.97 13.65 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.43 1.092 . . . . 0.0 110.013 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -120.61 128.9 53.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.98 179.57 33.0 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.958 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.79 137.42 46.15 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 120.341 2.07 . . . . 0.0 113.437 2.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 175.92 -166.05 37.03 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.768 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 17.9 Cg_endo -59.27 129.58 32.14 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.379 2.72 . . . . 0.0 113.369 -169.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.863 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.7 p -47.24 -44.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.796 1.638 . . . . 0.0 111.81 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.99 -45.3 93.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.081 1.352 . . . . 0.0 111.465 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -74.08 -51.72 22.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.74 -40.03 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.54 HD13 ' HD2' ' A' ' 448' ' ' PHE . 3.7 pp -68.14 -42.55 79.95 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.499 ' N ' HD12 ' A' ' 392' ' ' LEU . 14.0 ptt180 -74.91 -25.5 58.97 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 25.4 mmm180 -66.97 -34.37 77.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.911 0.884 . . . . 0.0 110.494 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.641 HD11 HG21 ' A' ' 359' ' ' VAL . 42.8 mm -64.58 -56.65 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 400' ' ' VAL . 58.5 t -60.81 -47.57 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 124.875 1.36 . . . . 0.0 111.817 -171.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLN . . . . . 0.494 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.3 pt20 -71.12 -34.98 71.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.826 0.45 . . . . 0.0 111.548 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.71 77.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.758 0.423 . . . . 0.0 109.925 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 371' ' ' LEU . 48.4 t -71.71 -43.29 66.18 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.161 0.984 . . . . 0.0 111.586 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 406' ' ' THR . 11.1 t -66.81 -45.87 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.93 -37.91 87.28 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.4 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' CYS . . . . . 0.469 ' SG ' HD23 ' A' ' 379' ' ' LEU . 93.1 m -83.24 -10.24 58.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.005 0.522 . . . . 0.0 111.773 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.583 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.61 141.88 55.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.2 122.6 23.04 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.801 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 409' ' ' VAL . 41.3 tt0 65.34 59.85 0.79 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.593 HG23 HG12 ' A' ' 400' ' ' VAL . 98.0 m -53.88 -31.06 48.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.899 1.68 . . . . 0.0 112.636 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -58.31 -39.83 80.43 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.676 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 64.9 m -82.13 -28.91 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.238 0.615 . . . . 0.0 110.431 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.583 HG21 ' HB1' ' A' ' 403' ' ' ALA . 60.0 t -72.03 -31.47 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.089 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -64.23 -21.87 66.74 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.636 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -69.45 -27.13 73.86 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.947 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.446 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 89.3 m-85 -75.7 -4.81 42.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.036 0.534 . . . . 0.0 112.313 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.05 136.42 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.189 0.595 . . . . 0.0 111.247 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -119.83 151.03 51.77 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.268 1.027 . . . . 0.0 111.013 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 435' ' ' GLN . 60.2 Cg_endo -69.69 156.57 63.16 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.651 2.234 . . . . 0.0 114.199 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.25 154.03 39.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.085 1.754 . . . . 0.0 109.119 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.12 30.52 4.78 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.199 0.523 . . . . 0.0 111.241 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -28.48 14.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 0.0 110.469 167.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.98 44.0 1.98 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.663 -0.244 . . . . 0.0 112.955 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.25 -132.22 5.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.7 OUTLIER -66.84 168.61 9.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.514 1.126 . . . . 0.0 111.454 -178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 422' ' ' VAL . . . . . 0.432 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 98.4 t -136.15 130.1 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 436' ' ' LEU . 29.1 mm -114.9 134.03 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.251 0.62 . . . . 0.0 109.368 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 22.4 p -105.96 139.93 39.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.75 0.82 . . . . 0.0 109.602 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.69 125.56 5.91 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.918 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.6 m -82.66 108.66 16.2 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 122.982 0.513 . . . . 0.0 110.752 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -131.92 143.0 49.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.209 1.004 . . . . 0.0 109.078 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 66.06 16.56 10.5 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.711 1.204 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.44 0.15 86.28 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.94 -172.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -107.92 159.04 16.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.197 0.999 . . . . 0.0 109.669 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.3 t -91.84 122.92 34.82 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -122.84 152.2 40.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.731 0.812 . . . . 0.0 109.72 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 62.2 p -143.69 144.4 31.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.015 0.526 . . . . 0.0 110.725 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.1 pt -125.86 -177.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.285 1.034 . . . . 0.0 109.059 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 74.3 mt-30 -115.27 148.49 39.11 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.103 0.561 . . . . 0.0 110.425 171.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 10.5 mp -116.56 147.48 39.83 Favored Pre-proline 0 N--CA 1.485 1.296 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.79 132.7 43.88 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.501 2.134 . . . . 0.0 112.61 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.77 129.8 20.57 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.805 2.337 . . . . 0.0 114.027 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.8 m -92.08 175.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.556 1.143 . . . . 0.0 110.602 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -155.12 11.04 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.8 t -126.9 141.35 51.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.23 0.468 . . . . 0.0 110.503 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.72 64.5 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.939 0.896 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.8 m -74.74 -28.16 60.66 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.263 0.625 . . . . 0.0 110.427 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 448' ' ' PHE . 3.8 t80 -84.24 -21.56 31.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.863 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.18 -63.18 1.21 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 124.428 1.091 . . . . 0.0 111.048 174.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.08 -41.08 71.12 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.272 -167.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 36.0 ttm180 -61.19 -33.82 74.07 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 124.68 1.237 . . . . 0.0 111.735 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 392' ' ' LEU . 4.3 t80 -68.74 -37.71 79.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 -173.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.39 -16.27 33.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.817 171.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 0.9 OUTLIER -64.4 -40.07 95.08 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.706 0.403 . . . . 0.0 110.522 -173.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.29 -45.95 90.97 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.556 0.742 . . . . 0.0 110.604 175.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.443 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 75.3 t80 -64.35 -53.51 47.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.751 -175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 82.6 m -63.35 -29.78 71.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.555 1.142 . . . . 0.0 111.823 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -69.72 -33.61 72.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.042 0.537 . . . . 0.0 110.797 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 42.7 m -71.0 -24.05 62.3 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.084 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.553 HD13 HD21 ' A' ' 371' ' ' LEU . 35.0 mt -100.18 -1.21 37.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.785 0.834 . . . . 0.0 111.048 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 71.71 7.33 5.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.115 1.766 . . . . 0.0 112.585 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.559 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 9.5 p -83.08 133.03 35.08 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 31.8 t70 -151.1 151.7 32.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.935 0.494 . . . . 0.0 109.779 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 59.59 14.97 4.27 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.585 0.754 . . . . 0.0 111.272 -170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.48 -18.26 45.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.616 0.767 . . . . 0.0 111.013 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -164.21 151.71 12.11 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.639 0.775 . . . . 0.0 109.751 174.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 68.0 m -158.07 133.67 8.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 108.433 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 12.8 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.468 0.651 . . . . 0.0 112.066 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.0 m -80.31 176.27 9.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.79 0.436 . . . . 0.0 110.232 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 76.2 p -133.9 138.63 45.66 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.617 0.767 . . . . 0.0 109.293 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 388' ' ' VAL . 22.1 m -139.07 163.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.527 0.731 . . . . 0.0 110.788 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 26.6 p -136.81 127.42 27.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.477 1.111 . . . . 0.0 108.068 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 28.9 m -112.91 161.71 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.104 0.561 . . . . 0.0 110.656 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -120.14 102.78 8.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.14 103.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.733 0.813 . . . . 0.0 110.899 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 53.7 t30 -96.16 85.54 4.03 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.881 0.848 . . . . 0.0 109.267 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.69 -23.97 65.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.473 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -73.45 -17.99 61.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.785 0.834 . . . . 0.0 111.471 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -67.8 -89.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.517 0 C-N-CA 123.101 0.381 . . . . 0.0 112.867 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 49.6 t-20 -141.72 148.31 38.82 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 0.5 OUTLIER -90.48 -64.64 1.1 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.265 1.026 . . . . 0.0 108.264 -173.045 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.22 -94.91 0.18 Allowed Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.358 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -88.52 18.04 38.01 Favored 'Cis proline' 0 C--N 1.373 1.866 0 CA-C-N 120.374 2.087 . . . . 0.0 114.293 9.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' HIS . . . . . 0.429 ' HB3' HG22 ' A' ' 409' ' ' VAL . 68.2 m80 -72.3 -18.42 61.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.201 0.6 . . . . 0.0 110.733 168.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.3 mt -104.74 140.01 38.7 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.939 1.295 . . . . 0.0 108.962 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.62 122.47 86.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.46 0.475 . . . . 0.0 110.385 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.3 Cg_endo -56.89 -34.0 96.12 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.659 2.906 . . . . 0.0 114.58 -173.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.44 -45.0 49.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.808 0.443 . . . . 0.0 110.702 -176.633 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.95 -29.78 68.92 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.706 0.629 . . . . 0.0 111.205 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 367' ' ' PHE . 21.6 mm -64.85 -30.67 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.977 0.911 . . . . 0.0 111.245 173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 75.5 mm-40 -79.95 -17.48 52.89 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 122.093 -0.379 . . . . 0.0 110.8 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.5 mm-40 -86.97 -5.8 58.97 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.757 0.423 . . . . 0.0 111.094 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 167.67 11.44 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.156 0.582 . . . . 0.0 111.542 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 158.22 58.05 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 121.761 1.64 . . . . 0.0 111.383 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.0 -18.08 59.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.545 0.738 . . . . 0.0 111.673 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -163.84 160.81 22.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 111.193 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -126.36 157.79 37.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.69 1.196 . . . . 0.0 108.878 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 81.95 -177.19 53.9 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.51 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 128.99 17.56 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.591 1.695 . . . . 0.0 112.302 -1.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.25 -172.91 30.28 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.42 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.36 129.95 35.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.219 2.613 . . . . 0.0 112.574 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.846 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.48 -46.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.656 1.983 . . . . 0.0 112.891 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.76 -36.95 81.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.908 1.283 . . . . 0.0 112.379 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 69.0 t -79.01 -47.19 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.195 -0.316 . . . . 0.0 110.646 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.46 -31.68 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 122.656 0.382 . . . . 0.0 111.715 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.0 pp -74.17 -41.13 61.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.111 0.164 . . . . 0.0 110.766 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.454 ' N ' HD12 ' A' ' 392' ' ' LEU . 6.2 ptt180 -69.49 -26.55 64.61 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -66.17 -31.78 72.83 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.806 0.842 . . . . 0.0 111.282 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 32.1 mm -74.71 -49.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 400' ' ' VAL . 94.5 t -59.62 -48.87 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 124.148 0.905 . . . . 0.0 111.424 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -71.8 -27.8 63.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.505 0.322 . . . . 0.0 111.29 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.85 90.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.82 -60.7 2.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 110.806 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 396' ' ' VAL . 43.1 t -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.039 0.936 . . . . 0.0 111.797 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.28 -46.67 66.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.723 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 71.9 m -80.08 3.22 21.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.137 0.575 . . . . 0.0 112.219 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -72.58 137.9 46.48 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.854 0.861 . . . . 0.0 112.411 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 404' ' ' LEU . 2.5 pp -84.86 132.57 34.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 57.82 61.72 2.31 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.371 1.082 . . . . 0.0 109.618 -172.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.1 m -57.27 -26.98 61.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.489 1.515 . . . . 0.0 112.614 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -60.46 -31.44 70.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.99 0.916 . . . . 0.0 112.438 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -75.41 -44.9 42.15 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.853 0.861 . . . . 0.0 109.576 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.535 HG21 ' HB1' ' A' ' 403' ' ' ALA . 97.9 t -68.78 -27.66 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-N 114.194 -1.367 . . . . 0.0 111.338 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.51 -30.05 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.361 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.11 -16.26 40.18 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -85.02 -17.35 37.8 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.393 0.677 . . . . 0.0 111.866 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.04 135.52 31.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.277 0.56 . . . . 0.0 112.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -113.4 168.68 7.42 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.609 0.764 . . . . 0.0 109.176 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.0 136.65 35.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 121.785 1.657 . . . . 0.0 112.742 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -141.7 99.51 3.56 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.012 1.725 . . . . 0.0 107.446 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -85.09 72.44 10.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.539 1.161 . . . . 0.0 108.814 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -97.39 -2.84 41.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.754 -1.567 . . . . 0.0 109.869 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 79.2 27.62 55.28 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -103.99 -120.79 4.82 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.507 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 14.6 mm-40 -84.88 178.91 7.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.116 0.567 . . . . 0.0 111.507 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.91 126.1 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 122.868 0.467 . . . . 0.0 110.426 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.24 143.05 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.423 1.089 . . . . 0.0 108.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 2.9 p -107.06 142.07 37.28 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.209 0.603 . . . . 0.0 109.824 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -132.16 115.95 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.279 1.031 . . . . 0.0 109.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 102.17 4.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.039 0.536 . . . . 0.0 110.275 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -123.34 120.62 33.58 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.289 1.036 . . . . 0.0 109.193 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.9 t70 57.23 50.13 12.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.212 1.405 . . . . 0.0 112.198 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 79.66 -3.91 66.93 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.372 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -118.56 171.71 7.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.085 0.954 . . . . 0.0 108.832 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.3 t -127.73 111.43 13.67 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.586 0.708 . . . . 0.0 109.955 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -94.57 127.0 40.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.573 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.0 p -95.35 138.78 32.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.071 0.949 . . . . 0.0 109.775 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.73 171.28 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.778 1.231 . . . . 0.0 109.263 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -115.38 143.77 44.78 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.235 0.541 . . . . 0.0 110.6 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 8.0 mp -113.88 155.8 44.72 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.072 1.349 . . . . 0.0 108.16 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.52 143.92 64.83 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.189 1.926 . . . . 0.0 111.762 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.34 155.22 25.04 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.295 1.997 . . . . 0.0 111.796 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.89 169.35 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 122.862 0.465 . . . . 0.0 109.864 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -147.47 8.36 0.9 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.108 0.563 . . . . 0.0 111.869 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 388' ' ' VAL . 46.3 t -115.9 138.67 50.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.631 0.372 . . . . 0.0 110.131 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -73.16 -26.54 61.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.031 0.932 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 31.4 m -72.03 -29.4 64.13 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.535 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.94 -21.09 29.75 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.846 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.43 -63.29 1.09 Allowed 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.098 0.873 . . . . 0.0 110.153 171.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 16.9 mt -65.1 -50.12 67.33 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 113.175 -1.829 . . . . 0.0 109.319 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -32.74 57.78 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 125.146 1.529 . . . . 0.0 112.706 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' PHE . . . . . 0.445 ' HE1' HD23 ' A' ' 436' ' ' LEU . 4.4 t80 -65.12 -49.19 70.9 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.651 0.381 . . . . 0.0 110.564 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.11 -15.83 35.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 0.8 OUTLIER -65.15 -46.64 80.05 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 109.699 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -37.84 85.14 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.033 0.833 . . . . 0.0 110.06 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 43.0 t80 -65.5 -50.66 64.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.57 0.748 . . . . 0.0 111.217 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.28 -28.54 67.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.089 0.956 . . . . 0.0 110.823 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.63 -34.16 75.26 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.993 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.9 m -75.05 -25.08 58.39 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.682 0.793 . . . . 0.0 110.962 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 371' ' ' LEU . 67.3 mt -82.91 -12.0 57.72 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.013 0.525 . . . . 0.0 110.977 173.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 74.67 8.14 4.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.782 1.633 . . . . 0.0 111.562 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.461 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 11.2 p -86.9 134.3 33.53 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.7 t70 -146.36 157.08 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.036 . . . . 0.0 108.379 -173.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 15.4 m-80 63.2 15.92 8.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.24 1.016 . . . . 0.0 111.109 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -83.34 -18.58 38.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.725 0.81 . . . . 0.0 111.366 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.78 166.15 26.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.365 0.666 . . . . 0.0 110.662 175.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 47.8 t -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.021 0.928 . . . . 0.0 108.769 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.466 ' HB2' HD21 ' A' ' 446' ' ' LEU . 39.9 t . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.425 0.69 . . . . 0.0 111.592 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 C--O 1.243 0.712 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 20.8 t -79.97 178.66 8.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.165 0.586 . . . . 0.0 110.241 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.0 p -131.9 134.17 45.39 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.772 0.829 . . . . 0.0 109.541 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.05 171.23 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.598 1.159 . . . . 0.0 109.565 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 52.6 t -146.85 105.97 3.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.659 0.784 . . . . 0.0 109.152 178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 395' ' ' ILE . 34.3 m -91.99 153.61 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.87 99.78 6.56 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' VAL . . . . . 0.401 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.2 t -63.96 98.85 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.537 1.148 . . . . 0.0 109.86 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -91.87 89.24 6.95 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.753 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -73.84 -9.26 58.47 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.166 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -74.25 -20.01 60.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.231 0.613 . . . . 0.0 109.804 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.29 -169.66 37.93 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.752 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -69.57 141.1 53.84 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.583 0.691 . . . . 0.0 110.497 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.58 -56.48 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.665 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.1 -83.84 0.06 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.494 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.17 1.42 23.95 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 120.53 2.165 . . . . 0.0 114.381 -0.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 16.3 p-80 -65.66 -16.11 63.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.966 0.906 . . . . 0.0 112.228 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.665 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 42.2 mt -95.46 136.55 35.69 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.855 0.862 . . . . 0.0 108.923 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.09 113.23 8.68 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 124.33 1.019 . . . . 0.0 110.119 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 34.7 Cg_endo -62.17 -16.89 53.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.182 2.588 . . . . 0.0 114.243 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -82.25 -49.18 10.37 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.104 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -62.48 -35.64 79.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.435 1.094 . . . . 0.0 111.95 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.55 -30.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.711 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 84.4 mm-40 -85.39 -19.27 31.64 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.977 -0.452 . . . . 0.0 111.236 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 66.8 mm-40 -81.64 -35.85 29.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.732 0.413 . . . . 0.0 111.277 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.1 pp -68.17 157.14 88.25 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.89 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.63 161.73 23.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.928 2.419 . . . . 0.0 114.078 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.8 -17.15 59.96 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.159 -173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.6 p80 -162.49 160.55 26.3 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.09 102.95 6.47 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 140.56 169.37 11.7 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.848 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.46 129.78 19.61 Favored 'Cis proline' 0 C--N 1.381 2.241 0 CA-C-N 119.512 1.656 . . . . 0.0 112.636 0.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.04 -165.55 15.71 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.306 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.28 141.65 16.29 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.834 2.356 . . . . 0.0 112.314 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.5 p -46.55 -45.05 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.993 1.717 . . . . 0.0 113.329 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -75.74 -35.29 60.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.098 0.959 . . . . 0.0 111.888 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 80.1 t -76.92 -46.15 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.44 -38.69 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.19 0.596 . . . . 0.0 112.116 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.3 -41.22 70.2 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 122.945 0.153 . . . . 0.0 111.204 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 12.0 ptp180 -67.57 -33.84 75.84 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 46.4 mmm-85 -63.07 -34.91 78.6 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.745 0.653 . . . . 0.0 111.711 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 359' ' ' VAL . 36.4 mm -68.09 -52.54 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 123.628 0.58 . . . . 0.0 109.797 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.19 -43.48 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.775 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.39 -21.97 59.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.84 0.456 . . . . 0.0 111.457 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -83.7 -16.73 43.86 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.359 0.664 . . . . 0.0 110.771 173.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.5 m -81.52 -61.88 1.81 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 122.876 0.471 . . . . 0.0 109.949 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.67 -50.65 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 0.0 111.071 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.22 -37.8 88.41 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.64 19.74 9.5 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.39 0.676 . . . . 0.0 111.522 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -85.13 150.65 24.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.334 0.654 . . . . 0.0 112.435 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 76.1 mt -66.45 114.12 5.21 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 162.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 61.96 73.43 0.47 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.284 0.99 . . . . 0.0 109.914 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.4 m -55.2 -41.18 71.66 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -54.59 -38.49 66.79 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 65.3 m -77.5 -38.57 48.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 403' ' ' ALA . 84.2 t -67.55 -26.65 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.367 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -75.03 -18.87 60.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.039 1.336 . . . . 0.0 110.147 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.08 -14.98 70.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 114.157 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -69.2 -37.46 78.1 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 117.871 0.836 . . . . 0.0 111.1 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.58 152.21 25.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.252 0.621 . . . . 0.0 109.818 175.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -117.19 157.54 46.68 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.844 0.858 . . . . 0.0 110.119 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.07 124.51 10.6 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 121.722 1.614 . . . . 0.0 111.54 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 49.7 m-20 -113.9 123.06 48.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.884 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -88.17 55.22 3.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.021 0.929 . . . . 0.0 110.007 -167.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.7 mpt_? -97.08 -32.24 12.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.09 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.22 33.09 8.32 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.127 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.78 -112.56 2.71 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.635 0.217 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.5 mp0 -79.08 165.26 23.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.854 0.862 . . . . 0.0 110.312 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.29 126.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.589 0.756 . . . . 0.0 109.155 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 436' ' ' LEU . 28.3 mm -106.26 122.96 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.238 0.615 . . . . 0.0 109.513 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 433' ' ' SER . 21.3 p -105.51 141.25 37.31 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.662 0.785 . . . . 0.0 109.816 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.56 130.82 6.04 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.497 -172.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 21.0 p -74.95 104.44 5.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.447 0.699 . . . . 0.0 109.882 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -114.61 107.34 15.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 0.0 109.359 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 36.1 t70 56.97 53.92 7.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.762 1.225 . . . . 0.0 111.502 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 86.18 -25.38 7.02 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.625 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.14 171.54 8.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.953 0.901 . . . . 0.0 109.569 -174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.1 t -115.63 104.17 11.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -110.73 160.54 16.62 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.862 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.406 ' HB3' HG22 ' A' ' 424' ' ' THR . 66.6 p -148.76 153.62 38.42 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.819 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.7 pt -123.08 166.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.624 0.77 . . . . 0.0 109.987 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 149.08 26.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.399 0.68 . . . . 0.0 109.813 172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.7 mp -115.86 159.48 38.9 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.941 1.296 . . . . 0.0 109.545 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.17 130.87 18.27 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.324 2.016 . . . . 0.0 111.765 164.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.07 151.83 56.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.909 2.406 . . . . 0.0 112.508 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.38 167.97 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.451 0.701 . . . . 0.0 110.733 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.78 2.68 0.94 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.987 0.515 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.4 m -119.15 140.08 50.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.958 0.503 . . . . 0.0 110.102 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.06 90.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.074 0.949 . . . . 0.0 112.373 -169.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.1 m -59.43 -28.51 67.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.608 0.763 . . . . 0.0 111.328 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -21.51 42.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.867 0.467 . . . . 0.0 110.147 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.8 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.26 -66.02 0.48 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 446' ' ' LEU . 0.2 OUTLIER -63.75 -43.87 95.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.797 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -33.58 70.28 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.531 0.732 . . . . 0.0 112.189 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.18 -51.55 67.36 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.55 0.531 . . . . 0.0 110.307 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -86.64 -15.3 40.14 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.667 -178.237 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 454' ' ' HIS . 1.7 tm-20 -61.77 -53.26 58.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.819 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -62.95 -40.91 99.1 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.975 0.797 . . . . 0.0 110.84 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.473 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 61.6 t80 -56.09 -64.31 0.9 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.558 1.143 . . . . 0.0 110.637 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 81.9 m -64.94 -27.17 68.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.728 1.211 . . . . 0.0 112.582 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 450' ' ' GLU . 51.2 t-80 -69.1 -41.63 77.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.644 0.777 . . . . 0.0 109.997 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.0 t -73.72 -7.95 54.09 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.416 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 92.0 mt -103.32 -6.41 22.02 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.71 0.804 . . . . 0.0 112.324 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 80.46 5.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.268 1.827 . . . . 0.0 112.682 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 453' ' ' CYS . 16.3 p -90.38 132.37 35.64 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -156.86 148.26 22.28 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 66.29 13.74 9.33 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.568 1.147 . . . . 0.0 110.736 -168.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.83 -20.31 35.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.129 0.571 . . . . 0.0 111.543 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.91 166.22 30.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.781 0.432 . . . . 0.0 110.506 175.012 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 37.2 p -162.79 121.69 2.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.704 0.802 . . . . 0.0 109.47 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 22.3 t . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 123.408 0.683 . . . . 0.0 111.816 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 p -146.16 136.1 23.48 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.999 0.92 . . . . 0.0 109.331 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -77.81 171.69 14.58 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.382 0.611 . . . . 0.0 110.71 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -75.23 -175.93 2.88 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.662 175.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 164.72 4.24 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.283 1.033 . . . . 0.0 111.964 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 -173.4 2.03 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.413 0.685 . . . . 0.0 111.337 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 23.8 p -140.65 144.45 35.72 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.031 0.932 . . . . 0.0 110.569 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 19.3 m -145.03 174.22 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 125.257 1.423 . . . . 0.0 110.339 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 466' ' ' PRO . 29.0 p -147.21 109.11 4.41 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.488 0.715 . . . . 0.0 109.82 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 33.8 m -98.21 149.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.192 0.597 . . . . 0.0 109.581 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 466' ' ' PRO . 9.1 m-85 -112.9 98.82 7.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 66.5 t -65.39 103.3 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 124.244 0.965 . . . . 0.0 110.706 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -98.63 99.87 11.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.669 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.19 -6.87 54.64 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.974 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -81.58 -21.83 38.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.392 0.677 . . . . 0.0 111.067 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.79 0.03 OUTLIER Glycine 0 C--N 1.353 1.516 0 O-C-N 123.35 0.406 . . . . 0.0 113.101 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 55.9 t-20 -131.91 150.75 52.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -91.38 -63.31 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -143.6 -93.49 0.18 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.317 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.06 18.98 31.82 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 120.469 2.135 . . . . 0.0 114.319 9.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.24 0.85 52.81 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.686 0.794 . . . . 0.0 110.783 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 456' ' ' LEU . 48.7 mt -116.21 145.93 42.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.65 1.18 . . . . 0.0 109.011 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.96 118.21 63.37 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 123.586 0.554 . . . . 0.0 109.675 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 36.1 Cg_endo -61.39 -29.82 86.16 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.779 2.319 . . . . 0.0 113.248 -173.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.498 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -72.78 -43.43 62.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.554 . . . . 0.0 110.581 -178.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -69.9 -30.27 67.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.153 0.581 . . . . 0.0 111.05 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.86 -31.11 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.492 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 77.7 mm-40 -82.81 -19.36 37.81 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 122.376 0.27 . . . . 0.0 111.324 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 83.3 mm-40 -80.1 -41.54 25.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.015 0.526 . . . . 0.0 112.061 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.499 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . 2.7 pp -65.18 163.94 27.2 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 123.828 0.851 . . . . 0.0 111.293 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 379' ' ' LEU . 74.0 Cg_endo -68.51 169.75 16.53 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 122.381 2.054 . . . . 0.0 114.565 -169.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.2 -20.91 54.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.832 1.253 . . . . 0.0 112.031 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.512 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 29.6 p80 -161.0 159.16 29.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.062 0.458 . . . . 0.0 111.224 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -125.11 102.04 7.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 141.14 167.51 11.13 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.454 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.65 129.89 19.63 Favored 'Cis proline' 0 C--N 1.381 2.249 0 CA-C-N 118.902 1.351 . . . . 0.0 112.498 -1.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.73 -178.83 37.67 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.192 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 42.3 Cg_endo -64.27 134.72 43.4 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.053 2.502 . . . . 0.0 114.434 -171.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -38.55 -48.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.337 2.255 . . . . 0.0 113.782 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -76.09 -33.7 59.51 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.63 1.172 . . . . 0.0 112.158 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.521 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 94.2 t -81.87 -35.39 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.513 0.325 . . . . 0.0 110.601 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.64 -42.67 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 122.174 0.19 . . . . 0.0 110.803 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.3 pp -67.0 -43.91 81.71 Favored 'General case' 0 C--N 1.359 0.988 0 O-C-N 123.189 0.306 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 397' ' ' GLN . 12.9 ptm180 -68.54 -33.9 74.92 Favored 'General case' 0 C--N 1.363 1.17 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -75.58 -20.18 58.78 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 32.4 mm -75.21 -52.58 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 167.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.6 t -58.5 -57.08 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.949 -172.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.4 pt20 -70.47 -23.83 62.76 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.797 0.439 . . . . 0.0 112.062 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.54 92.57 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 75.0 m -66.88 -47.66 71.16 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.946 0.779 . . . . 0.0 111.026 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 396' ' ' VAL . 12.3 t -65.35 -35.97 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.727 0.411 . . . . 0.0 110.344 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.51 -39.81 77.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.957 0.503 . . . . 0.0 110.222 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 75.0 m -78.01 -14.69 59.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.159 0.584 . . . . 0.0 111.894 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -60.36 130.82 48.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -167.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 81.4 mt -72.13 120.66 18.04 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 65.36 59.25 0.81 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.115 0.96 . . . . 0.0 109.199 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.3 m -54.58 -34.77 62.47 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.63 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.35 -38.71 43.65 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.764 1.226 . . . . 0.0 113.272 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.44 HG22 ' HE1' ' A' ' 412' ' ' TYR . 58.0 m -89.14 -40.51 12.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.334 0.654 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 403' ' ' ALA . 70.9 t -61.55 -30.24 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.006 0.922 . . . . 0.0 111.869 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.71 -15.44 60.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.353 1.061 . . . . 0.0 110.302 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -77.38 -25.49 63.36 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.699 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.44 ' HE1' HG22 ' A' ' 408' ' ' THR . 96.0 m-85 -76.47 2.92 12.37 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.41 0.684 . . . . 0.0 111.965 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 400' ' ' VAL . 0.4 OUTLIER -140.38 113.0 8.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.552 0.741 . . . . 0.0 109.815 165.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -76.7 159.15 79.79 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.911 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.65 123.29 9.68 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.127 1.218 . . . . 0.0 109.83 163.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -109.86 111.74 23.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -85.37 29.27 0.68 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.356 0.663 . . . . 0.0 112.035 -162.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -78.89 -25.49 43.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.358 0.663 . . . . 0.0 110.602 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.19 40.95 5.02 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.127 0.267 . . . . 0.0 113.359 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.24 -119.29 2.54 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.624 ' HB2' HD12 ' A' ' 436' ' ' LEU . 14.8 mm-40 -85.51 -178.63 6.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.58 . . . . 0.0 111.198 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.14 125.54 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.662 0.785 . . . . 0.0 109.067 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 41.6 mm -104.03 126.2 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.498 0.719 . . . . 0.0 109.085 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 24.5 p -105.95 149.74 26.33 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.768 0.827 . . . . 0.0 109.649 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -161.12 175.59 12.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.485 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 64.7 m -120.47 117.43 27.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.965 0.906 . . . . 0.0 109.708 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.64 112.68 12.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.977 0.911 . . . . 0.0 109.285 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.7 t70 71.05 23.2 4.26 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.441 1.497 . . . . 0.0 110.983 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 -12.67 69.37 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.722 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.97 164.73 15.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.695 0.798 . . . . 0.0 109.91 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.5 t -108.92 114.76 28.8 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -119.09 140.99 49.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.774 0.321 . . . . 0.0 110.227 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 55.7 p -125.12 149.28 48.02 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 110.327 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 26.8 pt -120.38 179.88 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 0.0 110.096 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -109.29 154.39 22.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.655 0.782 . . . . 0.0 109.81 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 421' ' ' GLU . 80.8 mt -115.61 167.91 9.27 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.381 1.073 . . . . 0.0 109.379 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.11 142.42 30.86 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.844 1.696 . . . . 0.0 111.877 165.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.08 138.55 18.31 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.559 2.172 . . . . 0.0 111.507 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.13 160.93 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.479 0.712 . . . . 0.0 110.605 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -142.56 -3.22 1.04 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.436 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -115.3 140.06 49.44 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.07 72.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.086 0.955 . . . . 0.0 111.643 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.7 m -63.4 -35.05 79.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.204 0.601 . . . . 0.0 111.227 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -23.22 59.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.709 0.404 . . . . 0.0 110.106 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.55 -59.0 5.46 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.3 -41.72 89.32 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.571 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -26.66 61.08 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.567 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -63.71 -55.4 23.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.801 0.441 . . . . 0.0 110.574 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.04 -14.99 58.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.138 -175.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -40.86 98.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 109.612 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -69.14 -43.08 75.09 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.162 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.48 -46.34 63.97 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.144 0.578 . . . . 0.0 111.509 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 71.3 m -63.68 -27.91 69.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.698 0.799 . . . . 0.0 111.108 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -66.93 -40.53 87.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.342 0.657 . . . . 0.0 111.175 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 72.6 p -75.36 -15.22 60.49 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.605 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 371' ' ' LEU . 47.5 mt -97.7 -6.34 33.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.536 0.734 . . . . 0.0 111.35 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 70.23 9.17 6.93 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.644 1.577 . . . . 0.0 112.129 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.519 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -87.62 133.57 33.79 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 20.9 t70 -155.37 151.69 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 65.99 18.09 10.96 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.653 0.781 . . . . 0.0 110.495 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.3 tp -83.81 -7.66 59.4 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.314 1.046 . . . . 0.0 110.251 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.86 163.12 32.26 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.584 1.153 . . . . 0.0 108.683 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 27.9 m -151.49 109.83 3.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 14.5 m -69.22 -15.26 63.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.286 1.035 . . . . 0.0 112.201 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.31 111.48 12.93 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.029 0.931 . . . . 0.0 109.382 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.553 ' HB3' ' SG ' ' A' ' 358' ' ' CYS . 90.8 Cg_endo -79.03 153.5 25.14 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.492 2.128 . . . . 0.0 113.21 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -81.7 1.56 33.72 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.459 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 CA--C 1.559 1.302 0 C-N-CA 124.792 1.237 . . . . 0.0 110.582 170.701 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -86.86 -36.47 18.44 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.564 0.746 . . . . 0.0 110.729 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.6 119.36 21.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.466 0.706 . . . . 0.0 110.681 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -89.8 6.47 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.304 0.641 . . . . 0.0 110.621 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -153.28 173.61 15.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.238 1.015 . . . . 0.0 110.567 -168.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.4 t -81.82 -179.39 7.37 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.819 0.847 . . . . 0.0 111.067 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.8 p -139.34 134.67 32.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.387 1.075 . . . . 0.0 109.6 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.52 159.52 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.558 0.743 . . . . 0.0 110.799 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 13.2 p -131.11 106.03 8.09 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.839 0.855 . . . . 0.0 109.602 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.427 HG11 HD23 ' A' ' 462' ' ' LEU . 46.2 t -93.56 158.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.378 1.071 . . . . 0.0 109.743 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.32 107.36 9.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 379' ' ' LEU . 46.6 t -77.53 105.92 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.152 0.581 . . . . 0.0 110.463 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 48.3 t30 -94.33 88.02 5.4 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.92 -14.12 62.85 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.559 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -83.97 -16.45 44.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.518 0.727 . . . . 0.0 111.136 174.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -71.6 -65.34 2.44 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 123.015 0.197 . . . . 0.0 112.626 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -154.93 165.54 36.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -109.22 -65.02 1.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.576 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -144.07 -95.2 0.2 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.774 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.9 22.09 29.43 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.54 2.17 . . . . 0.0 114.098 7.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -79.16 -8.21 58.82 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.753 0.421 . . . . 0.0 110.292 166.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.7 mt -110.85 142.61 42.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.99 1.316 . . . . 0.0 108.962 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.11 129.29 87.99 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.499 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.8 Cg_endo -59.78 -41.26 56.38 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.296 2.664 . . . . 0.0 113.549 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.499 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -69.92 -41.77 74.21 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.604 0.361 . . . . 0.0 110.725 -175.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -72.22 -28.48 63.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.207 0.603 . . . . 0.0 110.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.476 HD13 HD21 ' A' ' 379' ' ' LEU . 18.4 mm -65.42 -29.54 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.876 0.87 . . . . 0.0 110.52 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 81.8 mm-40 -80.04 -25.63 40.07 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.467 0.307 . . . . 0.0 110.92 174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 89.5 mm-40 -74.03 -34.56 64.15 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.102 0.561 . . . . 0.0 112.004 -176.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.532 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.3 pp -73.55 154.94 89.66 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.776 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.39 155.51 2.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 0.0 115.705 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.74 -7.59 59.64 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.228 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.4 147.06 7.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.735 0.814 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.66 126.97 50.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.967 0.907 . . . . 0.0 109.306 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 109.68 -173.91 17.35 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.973 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.79 127.47 14.41 Favored 'Cis proline' 0 C--N 1.381 2.247 0 CA-C-N 119.664 1.732 . . . . 0.0 112.33 -2.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.95 -174.13 25.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.0 138.72 58.28 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.567 2.178 . . . . 0.0 112.686 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -46.67 -40.82 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.363 1.865 . . . . 0.0 112.442 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.59 -51.82 65.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 0.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 91.7 t -71.54 -45.21 68.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.723 -174.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.4 -29.62 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.8 pp -75.76 -40.2 55.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.055 0.389 . . . . 0.0 110.442 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.409 ' N ' HD12 ' A' ' 392' ' ' LEU . 10.5 ptm180 -70.12 -33.33 71.71 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 16.2 mmm-85 -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.444 0.698 . . . . 0.0 111.503 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.423 HG21 ' HG ' ' A' ' 449' ' ' LEU . 35.6 mm -73.16 -55.12 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.0 t -66.13 -52.77 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.758 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 423' ' ' ILE . 7.9 pt20 -63.58 -23.86 67.56 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.208 0.603 . . . . 0.0 112.25 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.532 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -70.73 -49.52 46.0 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 77.8 m -63.18 -52.47 62.25 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.054 0.942 . . . . 0.0 112.688 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.462 HG12 HG23 ' A' ' 406' ' ' THR . 11.0 t -64.59 -41.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.353 0.661 . . . . 0.0 110.215 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -72.13 -31.92 66.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 379' ' ' LEU . 85.1 m -88.38 8.96 25.1 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.381 0.672 . . . . 0.0 111.819 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -82.32 161.14 22.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.3 119.79 26.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.601 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 59.49 72.6 0.52 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.192 0.997 . . . . 0.0 109.763 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 400' ' ' VAL . 93.7 m -62.25 -34.89 77.39 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.978 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -55.87 -37.37 68.7 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.1 m -76.53 -43.41 39.39 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.239 0.616 . . . . 0.0 109.546 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' A' ' 403' ' ' ALA . 74.7 t -66.01 -28.05 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.54 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.418 ' HD2' HG11 ' A' ' 400' ' ' VAL . 19.0 t80 -78.92 -17.65 55.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.476 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -74.94 -10.5 83.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.598 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -77.49 -10.15 59.31 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.517 0.727 . . . . 0.0 111.376 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -141.1 141.46 34.21 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.018 0.927 . . . . 0.0 109.561 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -115.89 159.55 38.68 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.215 0.606 . . . . 0.0 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.49 151.52 75.56 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.87 1.713 . . . . 0.0 111.766 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.92 122.32 17.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.136 1.374 . . . . 0.0 107.99 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -80.46 14.46 2.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.817 0.847 . . . . 0.0 112.425 -168.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.09 -45.76 92.1 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.379 1.072 . . . . 0.0 111.403 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 95.09 43.55 3.5 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.712 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -99.85 -109.91 3.11 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.811 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.4 mp0 -78.5 171.36 15.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.41 0.684 . . . . 0.0 110.915 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.3 135.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.812 0.845 . . . . 0.0 109.354 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 436' ' ' LEU . 36.0 mm -113.18 123.9 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.8 p -107.36 146.25 31.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.939 0.896 . . . . 0.0 109.646 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.83 159.89 14.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.869 0.868 . . . . 0.0 110.077 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.4 m -81.61 116.97 21.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.857 0.463 . . . . 0.0 110.456 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -143.12 120.69 11.76 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.163 0.985 . . . . 0.0 110.499 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.85 22.58 7.15 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.835 1.254 . . . . 0.0 113.264 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.8 58.07 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 113.895 0.318 . . . . 0.0 113.895 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.64 172.38 13.09 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.0 t -86.1 126.99 34.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -106.43 139.75 40.42 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.3 p -123.69 149.12 45.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.344 1.058 . . . . 0.0 109.861 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 413' ' ' LEU . 25.9 pt -124.8 176.35 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 0.0 110.247 173.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -112.94 144.07 43.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.996 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 423' ' ' ILE . 7.8 mp -114.35 160.71 31.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.858 1.263 . . . . 0.0 108.373 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.46 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 67.8 Cg_endo -75.48 134.97 17.65 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.083 1.855 . . . . 0.0 112.167 169.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.24 136.71 29.72 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 122.716 2.277 . . . . 0.0 112.918 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.75 174.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.424 1.09 . . . . 0.0 110.92 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -155.8 0.44 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.164 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 19.0 m -119.77 142.01 48.96 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.262 0.483 . . . . 0.0 110.511 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.62 80.6 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.019 0.928 . . . . 0.0 112.904 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.0 m -65.23 -26.64 68.2 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.447 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 1.8 t80 -85.19 -22.05 28.91 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.44 -60.41 3.33 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 121.544 0.688 . . . . 0.0 109.224 170.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.39 -36.49 74.13 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.518 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 448' ' ' PHE . 0.0 OUTLIER -63.86 -31.96 73.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.688 0.795 . . . . 0.0 111.569 177.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.491 ' HA ' HH11 ' A' ' 447' ' ' ARG . 2.5 t80 -67.19 -46.17 74.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.459 0.304 . . . . 0.0 111.358 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -86.83 -13.53 44.76 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.199 -0.313 . . . . 0.0 111.057 -178.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.62 -55.28 33.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.879 1.272 . . . . 0.0 111.864 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.09 -34.86 78.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.458 0.703 . . . . 0.0 111.277 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 40.8 t80 -65.87 -56.48 11.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.573 0.749 . . . . 0.0 110.635 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.3 m -60.9 -30.68 70.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.781 0.832 . . . . 0.0 110.979 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.84 -44.53 85.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.914 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 52.4 p -75.47 -21.16 58.32 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 79.9 mt -78.06 -11.11 59.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.99 0.516 . . . . 0.0 111.491 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 74.03 9.4 4.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.525 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 456' ' ' LEU . 22.6 p -95.05 133.37 38.92 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.39 0.676 . . . . 0.0 109.742 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -149.38 150.75 32.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 14.1 m-80 67.47 17.15 10.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.881 1.273 . . . . 0.0 109.884 -167.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.3 tp -78.99 -26.73 43.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.765 0.826 . . . . 0.0 110.263 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.427 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -163.24 150.4 12.77 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.959 0.504 . . . . 0.0 110.873 178.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 67.1 m -166.07 138.54 3.97 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.501 1.12 . . . . 0.0 108.987 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 30.2 t -72.71 -11.29 60.57 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.303 0.641 . . . . 0.0 110.77 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -73.73 141.51 79.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.384 1.073 . . . . 0.0 110.467 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.27 135.55 18.74 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.459 2.106 . . . . 0.0 111.011 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -82.65 -5.91 59.09 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.543 0.737 . . . . 0.0 111.204 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.606 1.162 . . . . 0.0 107.99 178.004 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.335 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 35.8 m -85.54 129.51 34.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -133.23 8.67 4.02 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.371 0.668 . . . . 0.0 110.113 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -85.15 -173.17 4.56 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.018 0.527 . . . . 0.0 110.984 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 172.51 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.983 0.913 . . . . 0.0 111.201 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.2 t -77.2 172.78 12.71 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -137.51 142.69 41.45 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.908 0.883 . . . . 0.0 110.193 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.64 166.02 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.468 1.107 . . . . 0.0 111.149 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.508 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 22.8 p -136.26 108.85 7.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.229 1.012 . . . . 0.0 109.631 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 25.0 t -93.99 149.76 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.535 0.734 . . . . 0.0 109.795 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -119.66 99.63 6.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.466 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -68.72 103.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.541 0.736 . . . . 0.0 110.018 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -94.9 94.58 8.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.857 0.863 . . . . 0.0 109.55 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.71 -11.57 59.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.764 177.005 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -76.61 -13.97 60.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.239 0.615 . . . . 0.0 110.339 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -83.69 -159.3 28.3 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 169.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 40.3 t30 -73.41 144.5 46.33 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.416 0.608 . . . . 0.0 110.516 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -61.15 1.79 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.565 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.07 -91.27 0.11 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.025 -0.875 . . . . 0.0 112.472 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -86.01 13.28 46.46 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.849 2.325 . . . . 0.0 113.906 7.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.99 -2.0 38.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.21 0.604 . . . . 0.0 111.351 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.565 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 30.3 mt -112.28 141.54 45.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.839 1.255 . . . . 0.0 108.321 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.491 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 16.3 t70 -70.74 117.93 60.28 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 110.009 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.48 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.4 Cg_endo -57.13 -34.61 98.06 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 123.597 2.864 . . . . 0.0 113.519 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -68.09 -51.42 46.61 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.577 0.548 . . . . 0.0 109.871 -177.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.491 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 19.7 mtp180 -62.31 -33.37 74.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.863 0.865 . . . . 0.0 111.398 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 379' ' ' LEU . 24.0 mm -61.64 -33.32 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.872 0.869 . . . . 0.0 111.04 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 73.9 mm-40 -80.55 -21.33 41.87 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.2 -0.313 . . . . 0.0 111.289 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 61.8 mm-40 -85.34 -37.22 20.18 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.726 0.41 . . . . 0.0 112.105 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.443 HD21 HD13 ' A' ' 376' ' ' ILE . 2.8 pp -64.84 156.01 80.92 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.828 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.13 154.32 28.74 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.848 2.365 . . . . 0.0 113.667 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.25 -14.0 60.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.818 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.466 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 9.7 p-80 -166.91 146.99 5.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.94 0.496 . . . . 0.0 111.552 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.92 104.43 10.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.744 1.218 . . . . 0.0 109.052 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 145.02 168.47 12.85 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.825 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.09 140.47 64.79 Favored 'Cis proline' 0 C--N 1.379 2.149 0 CA-C-N 119.713 1.757 . . . . 0.0 112.828 -1.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -164.4 -168.83 27.1 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.092 -0.838 . . . . 0.0 111.607 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.07 143.0 48.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 123.156 2.571 . . . . 0.0 111.949 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -52.85 -39.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.955 1.302 . . . . 0.0 111.638 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.427 ' HB3' HH21 ' A' ' 393' ' ' ARG . 14.3 m120 -68.89 -48.19 63.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 72.9 t -76.75 -44.31 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.5 -41.08 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.862 0.465 . . . . 0.0 111.487 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.82 -40.99 79.2 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 9.7 ptp180 -69.76 -25.78 63.99 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.135 0.272 . . . . 0.0 110.569 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 53.2 mmm-85 -70.8 -37.13 73.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.999 0.52 . . . . 0.0 111.258 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.79 -52.58 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.721 0.638 . . . . 0.0 109.489 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 400' ' ' VAL . 72.4 t -61.05 -47.74 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.998 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -65.01 -31.13 72.21 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.184 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.44 84.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.097 0.559 . . . . 0.0 110.231 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.34 -48.42 61.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.642 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 396' ' ' VAL . 36.4 t -62.9 -42.18 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.399 0.68 . . . . 0.0 110.468 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.88 -51.84 67.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 79.4 m -77.13 -8.0 56.76 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.726 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -65.5 123.05 18.63 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.908 0.883 . . . . 0.0 112.335 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.54 115.34 5.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 166.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 68.61 66.68 0.31 Allowed 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.543 1.164 . . . . 0.0 109.258 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 400' ' ' VAL . 84.6 m -55.43 -33.32 63.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.14 1.776 . . . . 0.0 112.428 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.91 1.284 . . . . 0.0 112.753 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.7 m -79.27 -34.29 42.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.898 0.879 . . . . 0.0 109.787 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -69.09 -30.36 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.51 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -69.24 -23.61 63.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.018 0.927 . . . . 0.0 110.196 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.04 71.07 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -79.98 -21.32 43.84 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.009 0.524 . . . . 0.0 112.163 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.26 115.08 20.46 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.688 0.756 . . . . 0.0 111.486 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.05 158.93 32.53 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.556 1.143 . . . . 0.0 110.045 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.21 126.84 10.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.244 1.963 . . . . 0.0 113.045 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.619 ' HB3' ' HE ' ' A' ' 418' ' ' ARG . 2.5 m-20 -123.77 104.96 9.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -86.09 58.77 5.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.768 0.827 . . . . 0.0 111.403 -164.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.619 ' HE ' ' HB3' ' A' ' 416' ' ' ASP . 0.9 OUTLIER -106.0 14.26 28.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.635 0.774 . . . . 0.0 111.073 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.58 26.19 72.85 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.33 -115.06 1.44 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.125 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.8 mp0 -86.1 170.39 12.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.112 0.565 . . . . 0.0 110.625 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.3 t -136.97 128.58 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 41.4 mm -116.48 138.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.4 p -106.51 142.7 35.74 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.817 0.847 . . . . 0.0 109.628 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.29 120.99 12.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.491 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.3 m -77.32 101.13 6.16 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -123.2 134.32 54.15 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.015 1.326 . . . . 0.0 108.213 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.3 t70 65.37 16.08 10.35 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.956 1.302 . . . . 0.0 110.29 -175.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 89.0 -13.35 63.39 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.936 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -96.85 153.65 17.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.483 0.713 . . . . 0.0 110.143 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -84.26 123.05 29.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -123.9 124.12 41.92 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 47.7 p -107.05 151.35 25.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.717 0.807 . . . . 0.0 111.057 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.02 -178.08 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.931 . . . . 0.0 110.217 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -118.06 150.64 38.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.811 0.844 . . . . 0.0 109.523 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.9 mp -116.56 160.26 37.02 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.726 1.21 . . . . 0.0 108.185 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.99 139.88 19.7 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.157 1.905 . . . . 0.0 110.818 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.52 145.48 37.71 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.507 2.138 . . . . 0.0 112.939 -173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.5 156.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.989 0.915 . . . . 0.0 110.332 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.44 9.4 2.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.215 0.606 . . . . 0.0 111.525 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 42.4 t -115.21 139.92 49.53 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.26 68.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.612 0.765 . . . . 0.0 112.187 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.4 m -69.87 -16.97 63.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.058 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.83 -27.79 23.3 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.26 -65.8 0.5 Allowed 'General case' 0 C--N 1.366 1.3 0 O-C-N 124.201 0.938 . . . . 0.0 109.914 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.77 -43.12 99.62 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.473 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -60.55 -36.39 78.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.58 0.752 . . . . 0.0 111.641 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -61.43 -52.68 63.54 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 123.579 0.549 . . . . 0.0 110.14 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -73.93 -19.14 60.78 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.938 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.68 -34.44 46.19 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.205 0.457 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -62.42 -35.77 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.997 171.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.401 ' CE2' HD11 ' A' ' 456' ' ' LEU . 75.5 t80 -76.85 -36.6 56.69 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.126 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 92.4 m -65.72 -26.98 68.0 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.208 0.603 . . . . 0.0 110.74 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.34 -39.36 93.73 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.818 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.3 m -70.38 -18.12 63.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.252 1.021 . . . . 0.0 111.813 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 371' ' ' LEU . 38.7 mt -98.35 -13.3 20.75 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.853 0.861 . . . . 0.0 111.612 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 70.41 8.61 6.68 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.32 1.448 . . . . 0.0 111.958 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.482 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 26.4 p -86.8 135.24 33.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 32.8 t70 -152.34 146.57 25.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 65.66 15.58 10.11 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.126 0.97 . . . . 0.0 110.067 -168.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 35.6 tp -79.77 -12.02 59.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.574 0.75 . . . . 0.0 110.519 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.04 164.75 36.41 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 108.829 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 72.3 m -158.62 108.9 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 13.6 m -79.9 -7.32 58.67 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.964 0.506 . . . . 0.0 110.34 173.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -81.93 105.96 5.4 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.09 173.82 12.93 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.376 2.051 . . . . 0.0 112.256 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -74.7 -19.08 60.4 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 110.336 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.501 0.72 . . . . 0.0 109.378 170.555 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 29.5 p -158.49 -179.36 8.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.983 0.913 . . . . 0.0 109.852 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -74.86 80.66 2.13 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.247 0.546 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.27 15.32 21.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.443 1.097 . . . . 0.0 108.975 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -159.56 177.63 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.242 1.817 . . . . 0.0 107.532 -178.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 43.3 t -79.21 171.75 14.76 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.4 p -138.86 134.41 33.27 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.572 0.749 . . . . 0.0 109.861 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.68 169.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.579 1.151 . . . . 0.0 110.218 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.5 106.86 4.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.635 0.774 . . . . 0.0 109.278 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.71 HG21 HD11 ' A' ' 395' ' ' ILE . 32.6 m -90.7 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.182 0.515 . . . . 0.0 110.133 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -118.34 100.63 7.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.55 105.92 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.031 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 30.8 t30 -87.34 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.499 ' HD3' ' HA ' ' A' ' 381' ' ' ASP . 6.7 mmmm -69.38 -31.02 69.14 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.094 -172.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.89 0.8 57.4 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.638 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.11 -80.9 0.23 Allowed Glycine 0 C--N 1.354 1.529 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -147.75 155.45 41.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.5 ' HA ' HG21 ' A' ' 376' ' ' ILE . 0.8 OUTLIER -97.54 -64.51 1.03 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.566 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.18 -91.4 0.1 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.367 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -86.88 12.12 53.11 Favored 'Cis proline' 0 C--N 1.374 1.879 0 CA-C-N 120.384 2.092 . . . . 0.0 114.325 11.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -76.64 -8.87 58.09 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.271 0.557 . . . . 0.0 110.335 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.566 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 45.6 mt -107.59 144.26 34.86 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -69.32 122.83 86.82 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.647 0.779 . . . . 0.0 110.302 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.519 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 57.0 Cg_endo -67.61 -21.16 46.16 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.969 2.446 . . . . 0.0 113.899 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -82.91 -45.47 14.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 4.5 mtt-85 -66.09 -32.49 73.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.913 . . . . 0.0 111.541 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 367' ' ' PHE . 22.2 mm -62.31 -27.85 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.187 172.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -83.84 -23.96 31.12 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.637 0.375 . . . . 0.0 110.667 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.6 mm-40 -77.6 -37.51 50.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.92 0.488 . . . . 0.0 112.103 -175.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.408 HD12 ' HE3' ' A' ' 363' ' ' LYS . 3.2 pp -63.7 153.34 83.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.086 171.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.9 169.36 10.45 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.609 2.206 . . . . 0.0 114.284 -172.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 363' ' ' LYS . 21.1 t70 -84.36 -3.34 58.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.419 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.17 151.78 18.04 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.255 0.622 . . . . 0.0 110.127 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -126.2 103.46 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 146.58 171.88 16.34 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.057 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -77.9 136.1 41.03 Favored 'Cis proline' 0 C--N 1.377 2.027 0 CA-C-N 118.65 1.225 . . . . 0.0 111.408 -1.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -160.92 -168.67 23.12 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.299 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.46 148.49 73.27 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.339 2.693 . . . . 0.0 112.383 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.4 p -55.32 -43.74 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.266 1.027 . . . . 0.0 111.634 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -72.01 -39.61 69.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.536 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 69.4 t -73.2 -48.93 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 119.559 -0.258 . . . . 0.0 110.847 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.8 t -58.74 -39.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.717 0.407 . . . . 0.0 111.775 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 421' ' ' GLU . 1.9 pp -68.67 -43.95 75.08 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.9 ptt180 -70.25 -27.99 64.88 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.155 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.3 mmt180 -63.78 -38.21 90.25 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.506 0.722 . . . . 0.0 110.91 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 359' ' ' VAL . 34.4 mm -66.17 -54.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.738 0.649 . . . . 0.0 109.279 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 400' ' ' VAL . 57.9 t -57.66 -63.63 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.427 1.08 . . . . 0.0 110.462 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -55.75 -36.27 67.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.7 0.8 . . . . 0.0 112.21 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.41 -44.86 81.8 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 122.746 0.418 . . . . 0.0 109.938 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 88.0 m -64.87 -38.84 92.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.575 0.75 . . . . 0.0 111.516 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 396' ' ' VAL . 11.8 t -69.5 -43.54 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.016 0.527 . . . . 0.0 110.275 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.55 -33.83 75.85 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.277 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 72.1 m -86.23 -4.83 59.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.509 0.724 . . . . 0.0 111.465 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -73.77 136.39 43.62 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.955 0.502 . . . . 0.0 111.429 -176.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 70.5 mt -83.43 129.5 34.99 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 164.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 66.48 54.0 0.92 Allowed 'General case' 0 CA--C 1.562 1.425 0 O-C-N 124.196 0.935 . . . . 0.0 108.874 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 89.8 m -55.03 -38.47 67.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.491 1.516 . . . . 0.0 111.961 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -57.5 -38.45 74.64 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.796 1.238 . . . . 0.0 113.762 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -83.84 -29.58 27.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.167 0.508 . . . . 0.0 110.148 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.4 t -65.79 -31.78 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.82 0.848 . . . . 0.0 110.369 171.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' PHE . . . . . 0.419 ' HA ' HD12 ' A' ' 413' ' ' LEU . 65.4 t80 -75.91 -15.63 60.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.382 1.073 . . . . 0.0 110.712 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.02 62.95 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 116.506 -0.315 . . . . 0.0 113.264 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -92.74 -1.46 56.8 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 110.821 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 423' ' ' ILE . 53.8 mt -121.66 100.16 6.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.027 0.931 . . . . 0.0 110.231 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -103.25 135.98 19.3 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 122.818 0.447 . . . . 0.0 110.12 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.74 162.35 42.39 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.555 2.837 . . . . 0.0 112.623 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.96 152.18 26.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -89.77 60.41 5.01 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.959 0.885 . . . . 0.0 109.185 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -109.87 -62.21 1.54 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.64 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.57 41.37 5.11 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.509 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.86 -72.63 1.14 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 19.2 mp0 -108.59 167.72 9.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.559 0.744 . . . . 0.0 109.267 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.46 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 83.5 t -138.79 127.86 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.109 0.964 . . . . 0.0 108.515 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 436' ' ' LEU . 36.6 mm -118.25 135.22 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 0.0 109.887 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 5.4 p -108.04 140.31 41.4 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.685 0.794 . . . . 0.0 109.563 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.02 118.51 10.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.429 1.092 . . . . 0.0 109.513 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.6 m -76.01 100.1 4.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.551 0.691 . . . . 0.0 109.47 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' PHE . . . . . 0.412 ' HB3' ' CD2' ' A' ' 432' ' ' HIS . 65.0 t80 -117.93 117.09 28.31 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.879 1.272 . . . . 0.0 108.815 -174.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 62.78 25.17 14.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.942 1.297 . . . . 0.0 111.89 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.76 61.23 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.174 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.86 160.28 14.62 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.853 0.827 . . . . 0.0 109.247 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 14.0 t -96.71 127.65 42.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 427' ' ' PHE . 26.3 m-70 -119.46 123.29 43.69 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.2 p -105.22 137.58 42.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.382 0.673 . . . . 0.0 110.06 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.9 pt -122.64 172.27 10.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 123.805 0.842 . . . . 0.0 109.445 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -123.17 140.61 52.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.55 0.69 . . . . 0.0 109.743 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 4.8 mp -114.47 156.78 44.11 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.025 1.33 . . . . 0.0 108.646 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.31 130.48 14.07 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.154 1.903 . . . . 0.0 112.429 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -60.27 144.22 99.5 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.275 2.65 . . . . 0.0 113.16 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 24.8 m -111.64 158.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.844 0.857 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -137.46 7.23 2.81 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.3 t -121.65 141.78 50.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.64 0.376 . . . . 0.0 110.125 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.1 72.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.245 1.018 . . . . 0.0 112.604 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.3 m -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.957 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.72 -23.8 36.51 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.49 -61.94 1.89 Allowed 'General case' 0 C--N 1.365 1.243 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.06 -48.11 66.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.458 -169.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -58.17 -34.21 70.07 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.884 0.74 . . . . 0.0 112.753 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.418 ' CE1' HD23 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -61.15 -43.93 98.11 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.938 0.774 . . . . 0.0 109.864 -176.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.06 -16.0 34.76 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.479 175.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.71 -42.17 82.38 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.408 1.004 . . . . 0.0 110.752 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -66.56 -37.7 85.52 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.838 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.427 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 63.3 t80 -67.0 -45.91 76.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.028 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 74.5 m -70.04 -25.96 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.132 0.973 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -66.58 -35.88 81.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.49 0.716 . . . . 0.0 109.926 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.4 m -71.13 -20.3 62.33 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.0 0.92 . . . . 0.0 111.538 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 371' ' ' LEU . 44.9 mt -99.76 -11.3 20.94 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.977 0.911 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 74.34 7.89 4.58 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 0.0 112.113 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 10.9 p -87.88 133.34 33.93 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.809 0.444 . . . . 0.0 110.232 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -149.53 149.61 30.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.545 0.738 . . . . 0.0 109.7 -175.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 23.4 m-80 67.42 15.85 9.93 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.7 1.2 . . . . 0.0 111.003 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.01 -21.91 53.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -152.78 163.81 39.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.313 0.645 . . . . 0.0 110.111 175.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.6 p -165.16 115.47 1.1 Allowed 'General case' 0 C--O 1.239 0.52 0 O-C-N 123.963 0.789 . . . . 0.0 109.402 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 10.1 t -85.19 0.3 52.25 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -78.73 110.08 12.98 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.36 158.93 44.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.09 1.86 . . . . 0.0 111.98 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.12 -23.96 67.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.822 0.849 . . . . 0.0 111.021 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.247 0.966 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.917 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 22.9 t -86.0 158.09 19.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 0.0 110.102 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -86.99 68.56 10.1 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.705 0.764 . . . . 0.0 109.916 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 24.8 ttt -145.22 132.8 20.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.173 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -75.57 172.27 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.886 0.874 . . . . 0.0 110.945 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.4 t -76.69 -179.7 5.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.347 0.659 . . . . 0.0 110.97 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.91 143.12 44.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.826 0.85 . . . . 0.0 110.314 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.36 169.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.677 1.191 . . . . 0.0 109.581 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.98 105.94 3.59 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.668 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.08 152.63 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.048 0.539 . . . . 0.0 109.962 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 76.2 m-85 -110.76 101.36 9.99 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.483 HG12 ' NZ ' ' A' ' 363' ' ' LYS . 58.1 t -70.62 92.84 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 124.15 0.98 . . . . 0.0 110.344 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -87.77 99.11 11.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.718 0.807 . . . . 0.0 108.969 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.483 ' NZ ' HG12 ' A' ' 361' ' ' VAL . 0.0 OUTLIER -80.65 -10.04 59.76 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.252 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -77.27 -14.36 59.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.681 0.392 . . . . 0.0 110.103 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.23 -166.93 29.97 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.362 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 2.5 t-20 -71.11 131.53 43.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.019 0.437 . . . . 0.0 110.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -78.04 -62.83 1.55 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.408 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.583 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -142.36 -94.96 0.22 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.824 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.86 9.67 56.82 Favored 'Cis proline' 0 C--N 1.373 1.847 0 CA-C-N 120.385 2.092 . . . . 0.0 114.96 10.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -73.8 -7.94 54.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.766 0.426 . . . . 0.0 111.33 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.583 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.9 mt -114.16 130.04 56.61 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.573 1.549 . . . . 0.0 107.557 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.13 125.32 89.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 123.583 0.552 . . . . 0.0 110.827 -176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 12.2 Cg_endo -53.78 -38.14 85.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.786 2.991 . . . . 0.0 114.377 -175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 374' ' ' LYS . 0.0 OUTLIER -75.82 -42.83 48.72 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.397 0.436 . . . . 0.0 110.209 -173.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -68.36 -30.42 69.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.555 0.742 . . . . 0.0 110.764 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.4 mm -63.84 -31.1 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.239 1.016 . . . . 0.0 111.198 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 64.5 mm-40 -74.98 -27.58 60.21 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 56.0 mm-40 -81.84 -3.38 53.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.384 0.674 . . . . 0.0 111.749 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 402' ' ' CYS . 18.6 mt -70.46 172.23 6.47 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.104 0.562 . . . . 0.0 110.187 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 379' ' ' LEU . 75.9 Cg_endo -73.34 163.65 37.26 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.114 1.209 . . . . 0.0 110.479 166.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.86 -23.22 60.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.199 0.6 . . . . 0.0 111.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 15.6 p-80 -158.76 147.04 18.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.617 0.367 . . . . 0.0 110.938 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.05 104.79 13.72 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 143.92 172.7 14.85 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.248 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.3 139.97 58.28 Favored 'Cis proline' 0 C--N 1.379 2.168 0 CA-C-N 119.134 1.467 . . . . 0.0 112.191 1.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.59 -170.23 27.13 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.473 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 390' ' ' VAL . 6.0 Cg_exo -69.98 145.72 56.71 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.312 2.675 . . . . 0.0 111.722 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.3 p -54.51 -39.4 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.501 1.12 . . . . 0.0 111.478 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.43 -47.01 74.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.613 1.165 . . . . 0.0 110.541 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 94.2 t -72.08 -51.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.84 -39.32 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.79 -42.34 73.9 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 421' ' ' GLU . 34.8 ptt180 -74.44 -24.76 59.11 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.885 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 15.2 mmt85 -63.75 -36.7 84.74 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.707 0.629 . . . . 0.0 110.515 174.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.668 HD11 HG21 ' A' ' 359' ' ' VAL . 48.5 mm -66.84 -54.25 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 109.694 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 400' ' ' VAL . 81.8 t -56.56 -50.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 124.336 1.022 . . . . 0.0 111.354 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -69.85 -34.16 73.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.95 0.5 . . . . 0.0 111.613 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.61 88.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -67.2 -55.23 14.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.035 0.834 . . . . 0.0 110.93 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 396' ' ' VAL . 61.1 t -57.5 -40.68 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.702 0.801 . . . . 0.0 111.446 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.54 -48.25 67.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 379' ' ' LEU . 74.0 m -73.61 -10.15 59.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.109 0.564 . . . . 0.0 111.908 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.63 148.36 50.56 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.071 0.949 . . . . 0.0 112.649 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.28 130.16 34.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 60.41 61.48 1.76 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.153 0.977 . . . . 0.0 109.33 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -50.78 -37.13 40.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 112.848 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -53.34 -41.12 65.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.914 1.286 . . . . 0.0 112.755 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 -41.94 20.48 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.632 0.773 . . . . 0.0 109.531 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 403' ' ' ALA . 76.7 t -60.35 -33.18 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.129 0.972 . . . . 0.0 111.767 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -81.82 -13.35 57.79 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.426 0.691 . . . . 0.0 110.903 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -78.94 -3.14 87.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.461 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.92 -5.21 58.15 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.279 0.632 . . . . 0.0 111.411 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -139.8 113.39 8.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.53 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.88 156.61 37.05 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.86 0.864 . . . . 0.0 110.886 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.71 129.38 17.55 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.26 1.973 . . . . 0.0 113.24 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.647 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 59.1 m-20 -122.28 111.77 17.33 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.749 174.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -88.94 45.6 1.31 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.865 0.84 . . . . 0.0 109.44 -171.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.647 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 12.2 mpt_? -78.58 -15.66 58.3 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 110.151 173.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 84.84 42.16 7.33 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.329 0.393 . . . . 0.0 113.399 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.88 -112.18 3.59 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 120.169 -0.24 . . . . 0.0 113.014 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 22.5 mp0 -79.53 167.24 21.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.309 0.644 . . . . 0.0 110.642 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.8 t -134.54 129.23 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 436' ' ' LEU . 41.1 mm -115.18 130.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 433' ' ' SER . 22.8 p -106.09 154.54 20.51 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 124.03 0.831 . . . . 0.0 109.403 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -154.91 158.66 39.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.963 0.905 . . . . 0.0 109.914 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 45.6 m -105.06 119.49 39.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.463 0.705 . . . . 0.0 109.435 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -132.29 109.99 10.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.406 0.682 . . . . 0.0 109.945 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.41 41.03 16.63 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.684 1.194 . . . . 0.0 111.114 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.6 -0.65 85.18 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.314 -0.857 . . . . 0.0 114.064 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -103.7 171.73 7.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 109.303 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -116.13 119.59 36.31 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -107.07 137.57 44.88 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.4 p -127.98 148.67 50.53 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 109.876 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 413' ' ' LEU . 36.0 pt -130.55 174.12 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.811 0.845 . . . . 0.0 110.054 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -113.87 149.88 34.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.5 mp -116.64 158.94 42.25 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.862 1.265 . . . . 0.0 108.664 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.452 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 71.2 Cg_endo -74.93 131.47 14.41 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 C-N-CA 122.362 2.041 . . . . 0.0 112.456 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.55 146.71 74.9 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.858 2.372 . . . . 0.0 113.422 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.35 161.25 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.89 0.876 . . . . 0.0 110.544 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -141.17 5.44 1.89 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.504 0.721 . . . . 0.0 111.767 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.7 m -124.26 140.49 52.91 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.52 0.6 . . . . 0.0 110.995 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.39 79.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.201 1.0 . . . . 0.0 112.542 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 m -69.1 -24.18 64.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.96 -22.16 25.75 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.14 -58.59 4.3 Favored 'General case' 0 C--N 1.365 1.271 0 CA-C-O 121.629 0.728 . . . . 0.0 109.239 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.79 -44.57 80.96 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.859 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -56.71 -38.65 72.61 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.443 1.089 . . . . 0.0 112.197 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.452 ' HZ ' ' HD2' ' A' ' 437' ' ' PRO . 4.3 t80 -65.63 -45.09 84.38 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.536 -171.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -85.82 -13.16 48.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.792 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.473 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 0.8 OUTLIER -63.82 -43.74 95.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.009 0.368 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.26 93.36 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.453 ' CE2' HD11 ' A' ' 456' ' ' LEU . 43.8 t80 -69.7 -45.43 68.27 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.448 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 29.4 p -72.59 -21.65 61.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.351 0.661 . . . . 0.0 110.073 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -70.58 -36.07 73.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.869 0.868 . . . . 0.0 109.844 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 -31.49 68.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.569 0.747 . . . . 0.0 110.99 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.453 HD11 ' CE2' ' A' ' 452' ' ' PHE . 45.5 mt -80.87 -17.62 50.07 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.171 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 72.06 8.91 6.01 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.714 1.606 . . . . 0.0 111.518 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.496 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 21.9 p -82.73 137.26 34.46 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.227 0.611 . . . . 0.0 109.947 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 29.5 t70 -151.52 148.89 28.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 109.563 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 64.01 14.42 8.45 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.214 1.005 . . . . 0.0 111.436 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.46 -20.74 43.07 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.405 0.682 . . . . 0.0 112.006 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.83 159.53 36.8 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.072 0.549 . . . . 0.0 110.624 176.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 35.5 p -165.88 121.78 1.31 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.916 0.486 . . . . 0.0 111.026 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 11.1 t -86.3 5.64 33.58 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.99 0.516 . . . . 0.0 111.273 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -102.7 103.43 32.55 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.912 0.885 . . . . 0.0 109.622 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.47 176.28 10.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.338 2.692 . . . . 0.0 112.836 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -56.45 -44.96 80.99 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.106 0.562 . . . . 0.0 110.766 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 123.701 0.801 . . . . 0.0 109.266 175.932 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.769 -0.132 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 44.3 m -65.47 -33.52 76.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.076 0.95 . . . . 0.0 111.956 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 48.9 m80 66.08 5.81 3.77 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.762 1.225 . . . . 0.0 113.416 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.5 ptm -89.61 -0.43 57.51 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.324 0.649 . . . . 0.0 111.137 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -125.58 172.26 9.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.512 1.125 . . . . 0.0 109.392 174.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.2 t -86.58 -177.66 6.21 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.627 0.771 . . . . 0.0 110.303 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.9 p -141.04 142.21 34.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.147 0.979 . . . . 0.0 109.913 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.06 147.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 123.908 0.883 . . . . 0.0 110.782 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.476 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 19.0 p -114.36 105.1 12.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.639 0.776 . . . . 0.0 108.972 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.472 HG11 HD23 ' A' ' 462' ' ' LEU . 48.4 t -98.34 154.44 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -130.18 107.5 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 36.6 t -78.01 106.48 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.476 0.71 . . . . 0.0 110.023 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 44.2 t30 -94.58 90.17 6.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.152 0.981 . . . . 0.0 109.257 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.18 -12.12 60.49 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.955 176.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 364' ' ' HIS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 82.3 t60 -73.35 -19.67 60.96 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.752 0.821 . . . . 0.0 111.034 169.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -72.47 -135.72 0.2 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.479 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 38.2 t30 -101.69 137.23 40.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.038 0.919 . . . . 0.0 109.295 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.02 -57.61 3.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -150.45 -87.98 0.07 OUTLIER Glycine 0 C--N 1.343 0.942 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.784 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.7 19.21 23.87 Favored 'Cis proline' 0 C--N 1.374 1.896 0 CA-C-N 120.705 2.252 . . . . 0.0 113.868 5.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.44 -7.27 46.33 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.627 0.771 . . . . 0.0 111.537 166.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.536 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.2 mt -116.84 140.05 49.89 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.2 1.0 . . . . 0.0 109.445 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.54 119.14 54.45 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.367 1.067 . . . . 0.0 110.619 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 24.5 Cg_endo -58.68 -24.64 71.83 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.478 2.785 . . . . 0.0 114.528 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -83.8 -44.64 14.15 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.746 0.419 . . . . 0.0 110.108 -176.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 32.7 mtt180 -67.23 -34.74 78.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.132 0.973 . . . . 0.0 111.723 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.48 -27.77 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.728 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 65.2 mm-40 -84.92 -27.76 26.37 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 122.058 -0.401 . . . . 0.0 110.469 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.9 mm-40 -71.96 -35.03 69.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.247 0.619 . . . . 0.0 112.253 -176.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.96 158.76 87.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.036 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.18 157.26 45.72 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.581 2.188 . . . . 0.0 113.042 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.25 0.27 29.31 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.504 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.496 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.1 p80 -166.4 149.97 7.31 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.442 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.7 m-85 -122.9 107.91 12.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 168.87 12.56 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.19 -0.783 . . . . 0.0 112.141 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 130.22 19.33 Favored 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 120.058 1.929 . . . . 0.0 113.609 -0.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.03 -165.41 14.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.99 140.62 38.45 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.533 2.155 . . . . 0.0 111.205 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.1 p -47.87 -42.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.697 1.199 . . . . 0.0 112.214 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.01 -55.27 27.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.048 1.339 . . . . 0.0 110.697 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 393' ' ' ARG . 58.0 t -67.9 -43.72 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.144 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.68 -47.49 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.728 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 117.861 0.3 . . . . 0.0 110.777 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.3 ptt180 -73.22 -32.78 64.97 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -65.55 -30.61 71.38 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.377 0.671 . . . . 0.0 111.289 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.543 HG21 ' HG ' ' A' ' 449' ' ' LEU . 20.7 mm -67.6 -59.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 80.7 t -61.44 -50.77 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.401 -171.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -65.32 -31.86 73.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.244 0.618 . . . . 0.0 111.785 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.23 94.71 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' CYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 452' ' ' PHE . 84.5 m -70.06 -41.64 73.89 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.184 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.522 HG22 ' CZ ' ' A' ' 452' ' ' PHE . 3.6 t -67.02 -42.6 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.18 -37.07 83.08 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 71.1 m -87.24 1.68 52.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 111.856 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.478 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.14 143.82 48.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 89.6 mt -82.27 125.11 30.58 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 67.74 53.17 0.7 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.502 1.121 . . . . 0.0 109.639 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.1 m -58.52 -27.24 64.32 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.068 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -56.35 -36.7 69.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.242 0.617 . . . . 0.0 111.669 177.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.2 m -88.95 -37.43 15.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 412' ' ' TYR . 98.3 t -64.05 -35.33 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.885 0.874 . . . . 0.0 111.722 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -72.27 -22.06 61.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.161 0.984 . . . . 0.0 110.28 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.81 -19.59 78.79 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.729 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.49 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 82.9 m-85 -75.68 -15.34 60.32 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.272 0.536 . . . . 0.0 111.726 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 104.46 6.5 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.685 0.755 . . . . 0.0 111.134 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 163.43 38.18 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.177 0.991 . . . . 0.0 110.181 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 167.54 26.73 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.284 1.989 . . . . 0.0 113.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 12.8 m-20 -145.3 130.37 18.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.941 1.296 . . . . 0.0 109.506 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -89.97 45.78 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.033 0.921 . . . . 0.0 109.708 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.676 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -93.15 -31.26 14.86 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.43 171.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.76 30.06 33.46 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.47 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.98 -122.54 1.55 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.401 ' HB2' HD22 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -69.54 166.67 18.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.368 0.667 . . . . 0.0 110.818 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 85.2 t -132.93 132.67 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 436' ' ' LEU . 28.1 mm -114.85 126.49 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.317 0.647 . . . . 0.0 109.883 175.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 9.2 p -107.64 151.0 26.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 110.716 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.91 140.56 12.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.221 1.008 . . . . 0.0 110.007 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 48.9 m -87.15 118.88 26.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.913 0.485 . . . . 0.0 110.443 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -140.36 134.5 30.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.747 0.819 . . . . 0.0 109.448 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.2 t70 64.51 25.99 13.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.702 1.201 . . . . 0.0 110.988 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.33 88.7 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.554 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -109.44 168.82 9.11 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.626 1.171 . . . . 0.0 110.331 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.8 t -100.12 135.05 42.14 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -132.1 133.63 44.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.179 0.592 . . . . 0.0 110.283 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 64.7 p -126.42 140.24 52.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.741 0.816 . . . . 0.0 110.524 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 20.2 pt -119.85 161.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.315 0.646 . . . . 0.0 109.857 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -103.32 147.41 27.11 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.103 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.54 HD11 HG12 ' A' ' 423' ' ' ILE . 7.6 mp -115.01 165.56 13.77 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.464 1.505 . . . . 0.0 108.809 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.31 142.0 23.59 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 121.92 1.747 . . . . 0.0 111.585 163.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.42 128.86 10.67 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.381 2.054 . . . . 0.0 112.87 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.07 172.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.556 0.742 . . . . 0.0 110.38 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -151.48 5.63 0.46 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.421 ' O ' HG21 ' A' ' 388' ' ' VAL . 45.7 t -125.23 141.14 52.27 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.341 0.519 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.47 -26.91 67.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.172 0.989 . . . . 0.0 111.919 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 33.2 t -70.34 -31.14 68.3 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.126 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -23.09 39.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.99 -62.05 1.91 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.242 0.544 . . . . 0.0 110.034 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.27 -35.67 68.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.812 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -62.75 -32.27 73.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.942 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.23 -56.4 11.45 Favored 'General case' 0 C--O 1.246 0.873 0 O-C-N 123.157 0.286 . . . . 0.0 110.608 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.543 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -73.67 -13.66 61.02 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.967 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.467 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 2.4 mm-40 -63.35 -47.06 83.72 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.351 0.66 . . . . 0.0 111.487 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -59.51 -43.86 93.28 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.615 0.766 . . . . 0.0 110.738 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 400' ' ' VAL . 44.6 t80 -69.98 -48.36 58.55 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.4 p -70.67 -21.32 62.61 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.574 0.749 . . . . 0.0 111.145 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -71.94 -37.55 69.99 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.634 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 77.0 p -76.58 -24.67 53.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.618 0.367 . . . . 0.0 110.582 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.502 HD11 ' CE2' ' A' ' 452' ' ' PHE . 72.6 mt -77.67 -17.94 57.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 111.313 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.26 7.59 6.15 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.817 1.647 . . . . 0.0 111.745 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.597 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 17.7 p -81.11 134.8 35.71 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.368 0.604 . . . . 0.0 110.419 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.479 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 6.5 p-10 -145.38 147.09 31.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.997 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 59.75 19.08 7.85 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.811 0.844 . . . . 0.0 110.907 -171.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 38.3 tp -81.02 -27.15 35.94 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.16 0.584 . . . . 0.0 111.228 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.472 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -164.41 150.08 10.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.023 0.529 . . . . 0.0 110.727 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 70.2 m -166.3 149.13 7.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.328 1.051 . . . . 0.0 109.197 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 70.9 m -88.06 47.03 1.44 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.871 0.843 . . . . 0.0 111.553 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.29 143.7 17.8 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.042 1.337 . . . . 0.0 107.626 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.94 166.8 21.53 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.197 1.931 . . . . 0.0 112.921 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -68.83 -32.06 71.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.537 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.033 0.933 . . . . 0.0 109.526 173.719 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 34.6 t -69.32 -34.51 74.76 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 109.889 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' HIS . . . . . 0.426 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 77.6 m-70 -92.22 156.78 17.07 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.766 0.827 . . . . 0.0 108.847 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -68.14 -21.19 64.93 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.046 0.538 . . . . 0.0 111.54 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 352' ' ' HIS . 1.3 pmm? -102.02 171.13 7.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.6 t -83.25 179.09 7.8 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.695 0.798 . . . . 0.0 110.647 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.2 p -139.74 136.83 34.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.575 1.15 . . . . 0.0 109.112 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.44 157.67 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.826 0.85 . . . . 0.0 110.834 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 385' ' ' PRO . 24.1 p -124.16 116.88 23.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.356 1.062 . . . . 0.0 109.188 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.6 t -113.16 151.24 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.096 0.558 . . . . 0.0 110.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -126.72 103.26 7.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.105 1.362 . . . . 0.0 108.065 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.04 110.77 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.628 0.771 . . . . 0.0 110.862 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -99.05 92.91 5.71 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.583 0.753 . . . . 0.0 110.12 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.42 -12.22 60.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.233 178.04 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -74.39 -19.59 60.37 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.774 0.83 . . . . 0.0 111.185 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.79 -111.11 0.03 OUTLIER Glycine 0 C--N 1.353 1.493 0 C-N-CA 122.985 0.326 . . . . 0.0 112.941 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 42.9 t30 -125.43 143.94 50.76 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.27 -62.28 1.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.03 -94.74 0.14 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.397 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -89.06 26.29 17.32 Favored 'Cis proline' 0 C--N 1.371 1.73 0 CA-C-N 120.116 1.958 . . . . 0.0 113.427 7.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.95 -10.25 59.49 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.214 0.606 . . . . 0.0 109.95 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.574 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 36.1 mt -114.74 140.86 48.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 125.454 1.501 . . . . 0.0 108.301 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.43 124.35 89.71 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.13 0.572 . . . . 0.0 110.414 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 30.5 Cg_endo -59.47 -32.97 97.21 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.244 2.63 . . . . 0.0 114.163 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.87 -42.55 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.468 0.307 . . . . 0.0 110.958 -176.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -70.96 -28.88 64.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 110.593 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 379' ' ' LEU . 20.7 mm -63.0 -30.48 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.825 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 68.0 mm-40 -81.67 -22.36 37.53 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.462 0.305 . . . . 0.0 111.043 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 81.8 mm-40 -81.93 -35.29 29.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.451 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.0 pp -66.48 153.81 92.28 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.911 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.72 161.33 21.71 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.675 2.25 . . . . 0.0 114.327 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.77 -8.92 58.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.678 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -161.95 153.16 18.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.937 0.495 . . . . 0.0 110.967 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 395' ' ' ILE . 52.6 m-85 -132.23 109.01 9.62 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.415 1.086 . . . . 0.0 108.078 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.27 -179.53 16.14 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 358' ' ' CYS . 59.7 Cg_endo -72.88 130.21 19.36 Favored 'Cis proline' 0 C--N 1.383 2.394 0 CA-C-N 119.889 1.845 . . . . 0.0 113.1 -4.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.71 -163.56 12.53 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.982 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -65.87 139.88 58.76 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.993 2.462 . . . . 0.0 111.926 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 445' ' ' ALA . 5.3 p -49.26 -41.35 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.352 1.061 . . . . 0.0 111.579 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.09 -52.18 63.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.942 1.297 . . . . 0.0 110.675 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 81.4 t -69.07 -50.87 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.941 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.49 -40.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 122.999 0.52 . . . . 0.0 112.203 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.99 -41.48 74.33 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 117.859 0.299 . . . . 0.0 110.624 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -73.27 -24.47 60.44 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.542 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 48.6 mmm-85 -68.44 -38.77 81.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.819 0.448 . . . . 0.0 111.073 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.57 HD13 ' HD2' ' A' ' 383' ' ' PHE . 8.4 mm -65.63 -53.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 91.3 t -61.78 -47.16 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.135 -174.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.421 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.6 pt20 -64.0 -30.03 71.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.582 0.353 . . . . 0.0 111.285 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -72.26 -40.97 67.25 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.256 0.622 . . . . 0.0 110.532 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.7 m -69.58 -46.47 66.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.341 0.657 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.8 t -65.7 -39.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.199 0.6 . . . . 0.0 110.084 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.34 -53.46 57.02 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.232 0.613 . . . . 0.0 110.581 173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.451 ' SG ' HD23 ' A' ' 379' ' ' LEU . 73.9 m -79.92 0.99 28.97 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.553 -172.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -71.73 135.32 46.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.71 118.36 17.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 160.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.16 60.01 0.66 Allowed 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.077 0.942 . . . . 0.0 109.431 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 96.9 m -51.41 -40.62 59.67 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.075 1.75 . . . . 0.0 112.416 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -50.44 -41.09 52.18 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.176 1.39 . . . . 0.0 114.04 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 98.4 m -78.96 -39.39 34.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.645 0.778 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.564 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -60.69 -41.57 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.71 -14.07 59.98 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.073 0.949 . . . . 0.0 110.774 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.45 -23.24 77.56 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.507 -0.315 . . . . 0.0 113.401 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -71.27 -24.77 62.23 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.072 0.549 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 434' ' ' ILE . 0.7 OUTLIER -119.43 112.72 19.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.026 0.931 . . . . 0.0 108.677 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -96.21 158.61 33.7 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.28 0.632 . . . . 0.0 110.738 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.69 144.9 45.27 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.168 1.912 . . . . 0.0 112.496 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.572 ' HB3' ' HG2' ' A' ' 418' ' ' ARG . 3.6 m-20 -150.13 136.1 18.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.977 1.311 . . . . 0.0 108.132 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.68 68.67 10.47 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.52 1.152 . . . . 0.0 108.33 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 416' ' ' ASP . 78.7 mmt-85 -106.93 -22.49 12.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.611 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.27 65.64 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.614 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -97.71 -127.22 5.65 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.958 -0.356 . . . . 0.0 112.387 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.0 OUTLIER -72.88 169.32 17.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.887 0.875 . . . . 0.0 110.841 -176.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 54.4 t -140.32 133.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.825 . . . . 0.0 109.102 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 47.8 mm -116.02 134.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 122.607 0.363 . . . . 0.0 110.219 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 433' ' ' SER . 18.0 p -107.25 143.09 35.98 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.93 15.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.527 0.731 . . . . 0.0 111.041 -169.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 430' ' ' GLU . 49.4 m -86.53 104.2 15.76 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.89 0.476 . . . . 0.0 110.312 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -116.23 106.57 13.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.29 1.036 . . . . 0.0 109.569 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.18 54.1 9.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.232 1.413 . . . . 0.0 111.56 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 83.2 -15.89 31.49 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.85 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 426' ' ' SER . 39.9 mt-10 -95.15 170.53 9.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.181 0.592 . . . . 0.0 111.37 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.9 t -111.46 102.02 10.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -94.92 142.26 27.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.397 0.679 . . . . 0.0 109.904 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 424' ' ' THR . 41.7 p -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.912 . . . . 0.0 109.771 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 413' ' ' LEU . 41.3 pt -123.99 -176.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.846 0.858 . . . . 0.0 111.047 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -127.28 143.31 51.26 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 121.462 0.648 . . . . 0.0 110.012 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.0 mp -111.0 159.2 33.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.901 1.68 . . . . 0.0 108.124 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.69 132.65 19.05 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.094 1.863 . . . . 0.0 111.706 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.19 129.7 19.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.279 1.986 . . . . 0.0 112.112 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.0 173.39 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.011 0.925 . . . . 0.0 110.87 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -153.46 -0.21 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.517 0.727 . . . . 0.0 111.243 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.6 m -118.21 138.29 52.43 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.07 -31.83 68.34 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.855 0.862 . . . . 0.0 111.281 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 22.0 m -59.57 -31.82 69.8 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.757 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -86.2 -22.79 26.76 Favored 'General case' 0 C--N 1.362 1.151 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -52.18 -66.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.598 0.759 . . . . 0.0 111.182 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.403 ' O ' HD22 ' A' ' 449' ' ' LEU . 0.4 OUTLIER -72.13 -34.62 68.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.68 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ARG . . . . . 0.465 ' NH1' ' HB2' ' A' ' 451' ' ' ASN . 0.0 OUTLIER -53.33 -36.33 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.285 0.634 . . . . 0.0 111.514 178.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -60.07 -56.48 21.07 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.139 0.899 . . . . 0.0 110.34 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.7 -13.92 58.59 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.706 -176.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.4 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 55.7 mt-10 -70.28 -46.63 63.95 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.673 0.669 . . . . 0.0 109.988 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.465 ' HB2' ' NH1' ' A' ' 447' ' ' ARG . 0.2 OUTLIER -67.52 -35.25 78.74 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 449' ' ' LEU . 36.9 t80 -68.6 -48.83 63.14 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.444 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.5 p -70.09 -22.88 62.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.068 0.547 . . . . 0.0 111.021 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -57.17 -46.4 82.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 93.7 p -73.07 -23.28 60.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.046 0.539 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.507 HD13 HD21 ' A' ' 371' ' ' LEU . 47.7 mt -83.7 -8.37 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.651 0.781 . . . . 0.0 111.077 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.82 9.16 7.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.35 1.46 . . . . 0.0 111.275 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.713 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.8 p -94.94 144.58 25.56 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.553 0.741 . . . . 0.0 110.044 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -163.04 164.21 25.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 65.53 14.58 9.57 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.159 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.08 -8.63 59.06 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.373 1.069 . . . . 0.0 111.533 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 169.22 22.66 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.347 0.659 . . . . 0.0 109.916 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 46.6 m -158.38 114.18 2.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.629 0.772 . . . . 0.0 109.79 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 26.5 t -73.23 -6.66 47.37 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.769 0.827 . . . . 0.0 111.237 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -105.76 149.68 38.25 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.323 1.049 . . . . 0.0 109.698 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.48 171.33 15.47 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.792 2.328 . . . . 0.0 112.645 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.78 -19.87 61.27 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.795 0.838 . . . . 0.0 111.358 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.252 1.19 0 C-N-CA 124.164 0.985 . . . . 0.0 108.367 172.839 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 46.7 t -151.24 163.79 38.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.975 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -159.06 123.33 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.288 1.035 . . . . 0.0 109.849 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.5 ptm -114.98 11.79 16.59 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.775 0.798 . . . . 0.0 109.548 165.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -148.8 167.66 25.04 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.414 1.485 . . . . 0.0 108.16 -177.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.9 m -72.99 178.05 4.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.027 0.531 . . . . 0.0 111.852 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.7 p -139.61 133.45 30.71 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.527 1.131 . . . . 0.0 109.131 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.57 157.49 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.285 1.034 . . . . 0.0 111.148 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.57 108.05 10.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.313 1.045 . . . . 0.0 108.72 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.59 120.95 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -88.54 97.94 11.37 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 379' ' ' LEU . 44.9 t -72.63 98.28 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.622 -171.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.477 ' HB2' ' HZ ' ' A' ' 467' ' ' PHE . 37.9 t30 -91.08 86.44 6.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.757 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -12.93 61.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.786 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.793 0.837 . . . . 0.0 110.299 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -76.9 -149.83 3.37 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.11 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 41.3 t30 -82.85 142.32 31.59 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.301 0.551 . . . . 0.0 110.132 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -85.42 -56.11 3.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.99 -88.95 0.07 OUTLIER Glycine 0 C--N 1.349 1.256 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.127 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.73 4.06 65.3 Favored 'Cis proline' 0 C--N 1.371 1.712 0 CA-C-N 120.879 2.34 . . . . 0.0 113.744 10.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -70.46 -13.01 61.95 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.953 0.901 . . . . 0.0 110.37 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.608 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 28.5 mt -99.1 143.96 28.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.0 109.116 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.31 121.82 84.45 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 123.99 0.806 . . . . 0.0 110.455 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.537 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 50.9 Cg_endo -64.35 -22.28 66.3 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.187 2.591 . . . . 0.0 114.646 -172.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.537 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -83.94 -43.63 15.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.121 0.418 . . . . 0.0 110.076 -176.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 57.9 mtt180 -67.22 -37.49 83.69 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.085 0.954 . . . . 0.0 111.923 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.453 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.7 mm -53.64 -28.85 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.433 0 C-N-CA 124.076 0.951 . . . . 0.0 112.347 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 71.0 mm-40 -83.59 -17.85 40.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.257 0.623 . . . . 0.0 111.737 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -80.33 -43.08 21.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.424 0.69 . . . . 0.0 111.728 -171.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 361' ' ' VAL . 0.4 OUTLIER -64.03 153.27 85.48 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.564 175.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -62.95 165.78 15.72 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.678 2.252 . . . . 0.0 113.233 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.66 -6.86 59.42 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.307 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.456 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.1 p80 -162.58 137.62 6.86 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.33 0.652 . . . . 0.0 110.605 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.97 103.81 14.47 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.38 -174.14 17.44 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.3 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 128.19 15.21 Favored 'Cis proline' 0 C--N 1.382 2.333 0 CA-C-N 119.291 1.545 . . . . 0.0 112.817 0.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.72 30.34 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.977 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.55 129.95 28.27 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.125 2.55 . . . . 0.0 113.279 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.1 p -45.42 -50.16 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.274 1.829 . . . . 0.0 112.688 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.455 ' OD1' HG13 ' A' ' 388' ' ' VAL . 2.4 m120 -57.64 -43.96 85.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.395 . . . . 0.0 112.009 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.494 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 93.7 t -76.41 -51.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.134 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.01 -42.27 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 123.386 0.674 . . . . 0.0 112.404 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 122.856 0.097 . . . . 0.0 110.984 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 392' ' ' LEU . 7.8 ptt180 -73.09 -25.54 60.92 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.141 0.276 . . . . 0.0 110.388 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 11.5 mmm180 -68.23 -35.21 77.6 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 122.846 0.458 . . . . 0.0 110.124 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 449' ' ' LEU . 25.9 mm -63.62 -47.67 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.875 0.734 . . . . 0.0 109.405 173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.504 ' HA ' ' CE2' ' A' ' 452' ' ' PHE . 38.9 t -63.96 -60.62 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.733 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.46 ' HA ' HG23 ' A' ' 423' ' ' ILE . 14.1 pt20 -60.86 -29.47 69.54 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.58 -59.63 2.72 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.25 -32.77 74.39 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.5 t -68.17 -47.51 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.92 -19.92 58.4 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.348 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 93.5 m -100.02 10.11 41.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.114 0.965 . . . . 0.0 110.352 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -86.07 151.29 23.82 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.47 122.78 27.95 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 162.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 66.65 57.67 0.67 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.48 1.112 . . . . 0.0 109.934 -174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 400' ' ' VAL . 89.6 m -54.12 -34.0 59.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.592 1.557 . . . . 0.0 112.415 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -55.64 -39.55 71.0 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.855 1.262 . . . . 0.0 113.466 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.3 m -81.47 -36.05 29.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 110.171 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 400' ' ' VAL . 67.7 t -62.44 -38.07 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.867 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -68.44 -19.31 64.57 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.95 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.81 -23.57 77.78 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.927 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -77.01 -10.73 59.56 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 117.276 0.538 . . . . 0.0 111.641 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 434' ' ' ILE . 0.3 OUTLIER -129.04 117.8 21.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.729 0.812 . . . . 0.0 109.614 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -95.18 157.91 35.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.789 0.836 . . . . 0.0 110.916 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.87 153.14 76.28 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.144 1.896 . . . . 0.0 111.434 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -151.15 136.54 17.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.689 0.28 . . . . 0.0 110.527 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.52 10.11 26.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.807 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.502 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 5.9 mpt_? -59.59 -35.0 73.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.527 1.131 . . . . 0.0 111.417 171.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 85.49 28.23 30.52 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.36 0.413 . . . . 0.0 113.378 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.93 -110.03 0.31 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 120.023 -0.321 . . . . 0.0 113.39 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.98 172.0 8.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.802 0.441 . . . . 0.0 110.348 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 75.8 t -132.08 130.2 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.9 mm -115.11 131.66 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.44 ' HB ' ' OG1' ' A' ' 431' ' ' THR . 19.2 p -108.86 137.64 46.46 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.417 1.087 . . . . 0.0 108.743 172.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -158.63 128.95 5.99 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.67 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.5 m -66.87 102.47 0.96 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.462 0.705 . . . . 0.0 112.149 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -135.68 136.2 40.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.936 1.294 . . . . 0.0 108.813 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.7 t70 66.63 16.35 10.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.391 1.076 . . . . 0.0 111.163 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.02 61.79 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 122.012 -0.43 . . . . 0.0 113.849 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -116.91 166.99 11.53 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 424' ' ' THR . 12.9 t -89.86 102.87 15.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.914 0.864 . . . . 0.0 109.248 175.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.73 131.41 40.82 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.046 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 34.8 p -111.01 131.46 55.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.328 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.636 HD11 HD12 ' A' ' 413' ' ' LEU . 16.4 pt -132.41 174.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 124.298 1.039 . . . . 0.0 109.762 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -113.11 147.88 36.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.273 0.629 . . . . 0.0 110.842 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.421 HD23 ' HE1' ' A' ' 448' ' ' PHE . 9.8 mp -115.48 166.6 11.69 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.156 1.382 . . . . 0.0 108.636 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.11 145.48 44.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 121.998 1.799 . . . . 0.0 111.939 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 418' ' ' ARG . 64.3 Cg_endo -83.54 159.95 14.62 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.453 2.102 . . . . 0.0 112.015 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.94 173.51 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.712 0.805 . . . . 0.0 109.695 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -150.43 18.26 0.83 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.807 0.443 . . . . 0.0 111.169 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.2 t -124.82 140.21 53.13 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.03 63.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.211 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.9 m -69.85 -25.01 63.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.104 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.7 -21.74 25.04 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.29 -65.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.7 0.8 . . . . 0.0 111.17 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 1.4 pp -62.68 -37.84 88.04 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.119 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.38 71.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.415 1.086 . . . . 0.0 112.019 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.421 ' HE1' HD23 ' A' ' 436' ' ' LEU . 31.1 t80 -71.74 -43.27 66.12 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.12 0.962 . . . . 0.0 108.562 -173.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 395' ' ' ILE . 3.9 pp -89.19 -14.3 36.36 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.418 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.1 tm-20 -69.21 -50.3 48.61 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.826 1.251 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.9 -38.01 77.91 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.728 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.504 ' CE2' ' HA ' ' A' ' 396' ' ' VAL . 34.8 t80 -66.84 -50.85 61.26 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.385 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 31.2 p -71.57 -22.0 61.8 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.408 0.683 . . . . 0.0 110.687 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -66.3 -39.92 89.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.087 0.955 . . . . 0.0 110.127 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.1 m -65.81 -29.74 70.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.803 0.841 . . . . 0.0 111.321 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 371' ' ' LEU . 41.0 mt -84.25 -13.5 52.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.008 0.923 . . . . 0.0 111.311 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 71.38 7.91 6.17 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.826 1.651 . . . . 0.0 111.668 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 21.1 p -83.27 133.64 34.98 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.4 p-10 -148.55 147.42 29.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.935 -173.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 59.86 21.85 10.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.583 0.753 . . . . 0.0 110.425 -168.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 18.3 tp -83.12 -15.76 49.45 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.449 0.7 . . . . 0.0 109.893 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.28 171.44 19.15 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.365 1.066 . . . . 0.0 108.757 174.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.0 m -165.79 115.54 1.01 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.1 t -64.74 -17.42 64.13 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.809 0.338 . . . . 0.0 111.398 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.85 151.26 38.26 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.274 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.12 168.53 23.86 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.565 2.176 . . . . 0.0 112.768 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' PHE . . . . . 0.477 ' HZ ' ' HB2' ' A' ' 362' ' ' ASN . 19.4 m-85 -74.13 -26.6 60.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.763 0.825 . . . . 0.0 110.301 178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.406 1.083 . . . . 0.0 108.243 169.263 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.964 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 m -80.97 175.92 10.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.785 0.834 . . . . 0.0 111.025 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -80.64 66.11 6.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.203 0.525 . . . . 0.0 109.82 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.1 ptm -75.0 -18.74 60.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.217 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -99.89 158.51 15.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 108.73 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 11.0 t -79.72 -177.9 6.12 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.845 0.458 . . . . 0.0 110.516 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 28.1 p -138.99 136.58 35.51 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.564 0.746 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.75 161.51 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.41 1.084 . . . . 0.0 110.851 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 30.5 p -132.76 132.36 42.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -117.34 154.58 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.119 0.568 . . . . 0.0 110.022 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 47.8 m-85 -111.78 100.32 8.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 379' ' ' LEU . 38.6 t -70.48 88.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 0.0 109.501 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -81.78 93.21 6.78 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.909 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -76.67 -5.22 47.02 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.114 178.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -84.31 -13.22 53.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.268 0.627 . . . . 0.0 111.006 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -73.3 -112.14 0.07 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -121.62 138.42 54.34 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.68 3.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.54 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -156.22 -86.98 0.06 OUTLIER Glycine 0 C--O 1.216 -0.974 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.485 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.04 12.9 44.41 Favored 'Cis proline' 0 C--N 1.368 1.582 0 CA-C-N 120.931 2.366 . . . . 0.0 114.084 8.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -72.75 -7.82 52.44 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.001 0.52 . . . . 0.0 111.478 172.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.1 mt -110.41 143.78 40.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.495 1.118 . . . . 0.0 109.227 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.15 118.92 60.52 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.631 0.772 . . . . 0.0 110.532 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 12.4 Cg_endo -52.84 -36.61 74.72 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.887 3.058 . . . . 0.0 114.337 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -80.28 -45.48 17.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -170.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -64.39 -36.06 82.91 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 111.58 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.418 HD13 HD21 ' A' ' 379' ' ' LEU . 17.6 mm -55.82 -31.96 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 124.392 1.058 . . . . 0.0 111.427 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 54.3 mm-40 -78.4 -35.92 46.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.7 0.4 . . . . 0.0 110.696 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 69.9 mm-40 -71.54 -33.84 69.5 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.524 0.73 . . . . 0.0 112.092 -171.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.418 HD21 HD13 ' A' ' 376' ' ' ILE . 2.5 pp -71.11 155.64 92.94 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.53 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.44 148.62 33.23 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.19 2.594 . . . . 0.0 113.903 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.27 -10.54 59.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.034 1.333 . . . . 0.0 111.825 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -164.52 145.5 8.05 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -114.57 159.44 20.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.79 1.236 . . . . 0.0 108.766 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.88 -179.68 51.0 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.111 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -79.87 128.82 16.75 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 119.441 1.621 . . . . 0.0 111.831 2.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.14 25.02 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 133.57 38.73 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 123.051 2.501 . . . . 0.0 113.629 -169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.2 p -47.3 -39.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.511 1.924 . . . . 0.0 111.985 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.29 -54.14 49.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.467 1.507 . . . . 0.0 111.014 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 393' ' ' ARG . 97.0 t -74.11 -47.64 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.121 -173.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.67 -38.54 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.15 -43.43 61.55 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 422' ' ' VAL . 39.6 ptt180 -72.1 -25.63 61.82 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.661 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.54 -36.15 82.96 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.81 0.694 . . . . 0.0 110.698 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 35.3 mm -66.66 -56.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 400' ' ' VAL . 95.5 t -57.57 -52.72 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 124.113 0.883 . . . . 0.0 111.045 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.8 pt20 -64.34 -35.89 82.35 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.7 0.4 . . . . 0.0 111.914 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -68.29 -36.44 79.37 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 123.381 0.426 . . . . 0.0 110.046 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 84.1 m -68.87 -49.82 55.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.025 0.53 . . . . 0.0 111.205 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.0 t -63.59 -48.23 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 122.921 0.488 . . . . 0.0 110.068 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.96 -36.4 77.86 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.59 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 72.6 m -83.99 -1.27 54.36 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.452 0.301 . . . . 0.0 111.286 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -71.33 137.47 48.5 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.37 117.15 8.96 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 166.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 64.46 66.26 0.61 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.135 0.969 . . . . 0.0 109.625 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 400' ' ' VAL . 78.0 m -54.75 -35.62 63.94 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.771 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -59.41 -35.36 73.85 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.56 1.144 . . . . 0.0 113.131 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 85.7 m -80.4 -37.89 31.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.69 0.796 . . . . 0.0 109.775 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 403' ' ' ALA . 40.3 t -69.43 -30.41 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.082 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -73.24 -20.01 60.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.444 1.098 . . . . 0.0 110.209 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -63.74 -15.05 57.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.584 -0.735 . . . . 0.0 114.692 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.07 3.03 55.88 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.598 0.699 . . . . 0.0 111.719 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -148.07 106.53 3.78 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.416 0.626 . . . . 0.0 110.476 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 160.8 31.0 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.133 0.973 . . . . 0.0 109.779 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.03 163.79 24.41 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.488 2.125 . . . . 0.0 113.655 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.08 163.18 23.65 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 0.0 108.857 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -130.26 35.95 4.03 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.235 0.614 . . . . 0.0 110.867 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.52 -39.75 4.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.868 170.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 100.65 42.59 2.47 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.23 -106.57 0.28 Allowed Glycine 0 C--N 1.343 0.947 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.736 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 5.2 mp0 -83.33 172.74 12.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.994 0.397 . . . . 0.0 110.266 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.467 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 90.0 t -138.96 131.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.887 0.875 . . . . 0.0 108.791 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 433' ' ' SER . 35.8 mm -117.81 133.53 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.152 0.581 . . . . 0.0 110.02 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.4 p -108.85 137.18 47.2 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.932 0.893 . . . . 0.0 109.931 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.09 134.71 11.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 13.6 p -77.2 115.89 17.37 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.203 0.601 . . . . 0.0 109.851 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -153.98 140.7 19.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 108.945 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 17.3 t70 63.01 16.9 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.728 1.211 . . . . 0.0 112.162 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.94 -18.44 57.18 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.11 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -109.23 166.38 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.5 t -89.69 104.72 17.26 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 167.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -95.53 129.07 42.83 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.312 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 57.8 p -118.07 132.88 56.32 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.586 0.755 . . . . 0.0 109.99 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 413' ' ' LEU . 30.7 pt -118.43 179.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.275 0.63 . . . . 0.0 109.843 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -111.36 151.73 28.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 82.4 mt -117.31 151.44 47.95 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.48 1.112 . . . . 0.0 108.557 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.26 131.22 35.42 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.392 2.062 . . . . 0.0 111.757 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.28 137.78 77.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.06 2.506 . . . . 0.0 114.533 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.2 m -109.82 167.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.917 0.887 . . . . 0.0 109.603 171.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.67 15.69 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.557 0.343 . . . . 0.0 111.254 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 26.0 t -123.48 141.43 52.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.804 0.442 . . . . 0.0 109.927 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.07 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.113 0.965 . . . . 0.0 112.322 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.5 m -70.3 -19.47 63.09 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.999 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.61 -60.98 2.54 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.65 -54.38 46.07 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.682 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -49.06 -40.66 32.34 Favored 'General case' 0 C--O 1.247 0.935 0 O-C-N 125.023 1.452 . . . . 0.0 112.281 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.18 -48.64 79.15 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.151 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -83.22 -17.1 43.92 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.133 178.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.59 -42.71 74.09 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 119.325 0.966 . . . . 0.0 110.047 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -62.42 -38.48 89.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.826 0.704 . . . . 0.0 110.629 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 456' ' ' LEU . 36.5 t80 -68.91 -49.8 54.98 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.033 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 89.5 m -67.39 -22.41 65.55 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.25 1.02 . . . . 0.0 111.514 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -65.97 -36.44 83.33 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.8 t -77.23 -28.58 53.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.876 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.531 HD13 HD21 ' A' ' 371' ' ' LEU . 64.9 mt -77.23 -16.75 58.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.256 0.623 . . . . 0.0 111.397 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 71.0 6.55 5.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.012 1.725 . . . . 0.0 111.471 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.574 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -78.0 132.34 37.77 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.496 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 34.5 t70 -147.35 142.34 27.0 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.065 -165.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 60.28 18.8 8.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.17 0.988 . . . . 0.0 110.276 -167.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 32.5 tp -80.81 -24.09 38.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 122.933 0.493 . . . . 0.0 111.019 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -155.58 160.35 40.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.668 0.387 . . . . 0.0 111.018 174.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 33.5 p -164.3 133.54 3.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.801 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 8.4 t -81.67 -2.2 49.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.069 0.548 . . . . 0.0 111.831 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -72.09 109.36 5.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.679 1.192 . . . . 0.0 110.17 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.68 174.58 4.0 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.809 2.339 . . . . 0.0 112.234 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -78.28 -21.83 49.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.108 0.563 . . . . 0.0 110.139 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.392 0 C-N-CA 123.821 0.848 . . . . 0.0 109.707 177.183 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 m -80.6 -35.3 34.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.264 0.626 . . . . 0.0 110.383 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -75.92 126.07 30.3 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.75 -165.5 0.45 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 123.696 0.622 . . . . 0.0 110.71 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -65.93 150.15 49.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.813 0.445 . . . . 0.0 110.448 171.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.1 t -72.48 -178.94 2.76 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.468 0.307 . . . . 0.0 110.178 168.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.29 138.3 43.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.23 0.612 . . . . 0.0 110.25 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.03 158.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.311 1.044 . . . . 0.0 110.485 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 21.0 p -134.36 107.5 7.65 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.65 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.627 HG21 HD11 ' A' ' 395' ' ' ILE . 34.4 m -94.77 154.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -117.63 99.95 7.3 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.452 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 48.6 t -69.9 98.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.743 0.817 . . . . 0.0 110.015 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.29 83.73 7.88 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.24 42.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.31 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -78.0 -21.26 51.09 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.467 0.707 . . . . 0.0 110.51 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.63 -148.08 6.28 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.885 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.5 t30 -74.46 140.37 44.56 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.283 0.564 . . . . 0.0 109.973 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -54.06 4.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.558 1.143 . . . . 0.0 108.253 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.699 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -155.22 -86.53 0.06 OUTLIER Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.75 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -88.61 15.99 44.42 Favored 'Cis proline' 0 C--N 1.365 1.422 0 CA-C-N 120.194 1.997 . . . . 0.0 114.022 8.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -70.75 -12.21 61.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.705 0.402 . . . . 0.0 110.847 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 22.5 mt -107.44 131.93 53.75 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 109.035 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.18 126.87 93.18 Favored Pre-proline 0 N--CA 1.481 1.099 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.498 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.1 Cg_endo -60.07 -41.49 51.92 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.349 2.699 . . . . 0.0 113.294 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -66.57 -39.7 88.61 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.879 0.471 . . . . 0.0 110.74 -175.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -74.11 -30.93 62.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.754 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 379' ' ' LEU . 10.0 mm -62.75 -24.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.047 0.939 . . . . 0.0 111.466 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 55.1 mm-40 -83.31 -17.05 43.84 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.675 0.39 . . . . 0.0 111.15 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -79.2 -30.46 43.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.162 0.585 . . . . 0.0 111.626 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 376' ' ' ILE . 0.3 OUTLIER -74.82 157.43 85.74 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 169.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.25 166.5 21.06 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.56 2.174 . . . . 0.0 112.972 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.39 1.49 21.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.13 0.972 . . . . 0.0 111.179 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.452 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.8 p80 -158.84 155.57 28.05 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.725 0.81 . . . . 0.0 110.34 173.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -125.07 113.29 17.55 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 167.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 114.53 176.75 18.97 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.357 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.65 128.98 16.81 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 119.71 1.755 . . . . 0.0 112.655 1.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.51 -164.29 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.051 -0.861 . . . . 0.0 111.594 -174.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.525 ' HB3' ' HG3' ' A' ' 354' ' ' MET . 7.8 Cg_exo -66.36 139.21 53.63 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.955 2.437 . . . . 0.0 112.072 -170.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.935 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.1 p -53.75 -45.71 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.133 0.973 . . . . 0.0 111.341 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.533 ' HB3' HH21 ' A' ' 393' ' ' ARG . 12.7 m120 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.277 . . . . 0.0 110.74 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 71.1 t -70.63 -57.67 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.632 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.75 -44.19 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.397 0.679 . . . . 0.0 112.457 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 449' ' ' LEU . 3.3 pp -69.36 -41.68 76.25 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-N 117.571 0.169 . . . . 0.0 110.564 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.533 HH21 ' HB3' ' A' ' 389' ' ' ASN . 11.4 ptp180 -70.48 -28.63 65.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 29.9 mmt180 -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 123.688 0.617 . . . . 0.0 110.989 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 359' ' ' VAL . 24.6 mm -65.62 -57.18 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.4 t -58.69 -49.31 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.737 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.56 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.3 pt20 -68.27 -37.36 80.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.631 0.372 . . . . 0.0 111.398 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -66.37 -35.35 80.11 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.395 0.435 . . . . 0.0 110.064 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 93.0 m -67.68 -53.33 28.62 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.597 0.561 . . . . 0.0 110.978 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 396' ' ' VAL . 20.3 t -61.26 -47.27 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 122.748 0.419 . . . . 0.0 110.527 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.98 -46.8 76.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 89.3 m -73.61 -5.68 41.89 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.895 0.478 . . . . 0.0 112.264 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.67 143.78 55.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.414 0.625 . . . . 0.0 112.635 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.94 126.79 30.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.959 163.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 56.5 2.72 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-O 122.085 0.945 . . . . 0.0 109.694 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 92.2 m -53.75 -32.16 51.23 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.037 1.335 . . . . 0.0 111.77 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -57.48 -32.23 66.78 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.815 1.246 . . . . 0.0 112.666 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 80.7 m -89.3 -42.73 11.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.716 0.806 . . . . 0.0 110.48 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.7 t -60.66 -32.91 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.832 0.853 . . . . 0.0 111.66 -177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -72.48 -26.83 61.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.771 1.228 . . . . 0.0 110.557 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.29 -15.36 72.44 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.966 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -79.73 -2.66 44.03 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.492 0.646 . . . . 0.0 111.845 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -145.81 105.26 3.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.489 0.661 . . . . 0.0 110.148 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -83.9 157.42 63.41 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.146 0.978 . . . . 0.0 110.375 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.91 163.39 37.66 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.007 1.805 . . . . 0.0 112.873 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.15 137.5 29.12 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.464 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -96.34 38.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.265 0.626 . . . . 0.0 111.423 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -95.01 -16.98 22.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.402 0.681 . . . . 0.0 110.638 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 74.97 39.42 38.15 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.29 -122.63 3.91 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.153 -0.248 . . . . 0.0 113.09 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.4 OUTLIER -70.07 162.63 27.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.788 0.835 . . . . 0.0 110.642 -177.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.1 128.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.56 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.6 mm -111.4 121.92 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.452 0.701 . . . . 0.0 110.215 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.2 p -107.51 142.9 36.67 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.442 1.097 . . . . 0.0 110.221 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -163.41 136.33 5.45 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.891 0.744 . . . . 0.0 110.986 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 67.4 m -74.88 119.6 19.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.48 0.712 . . . . 0.0 111.875 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -148.51 137.7 21.81 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.468 1.107 . . . . 0.0 109.73 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 58.83 33.47 23.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.945 1.298 . . . . 0.0 112.117 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.04 87.15 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.386 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.82 171.68 13.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.06 0.944 . . . . 0.0 109.572 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -94.77 130.18 41.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -119.37 142.45 48.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.651 0.781 . . . . 0.0 109.716 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 42.2 p -129.08 143.07 50.74 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 110.483 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 413' ' ' LEU . 26.8 pt -119.61 173.65 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.216 0.606 . . . . 0.0 109.42 171.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -113.8 151.72 31.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.351 0.661 . . . . 0.0 110.342 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 78.9 mt -116.56 168.49 8.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.287 1.435 . . . . 0.0 108.962 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.24 136.77 20.36 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.601 1.534 . . . . 0.0 111.256 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -73.07 133.04 19.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.469 2.112 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.5 m -99.99 174.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.977 0.911 . . . . 0.0 110.997 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.32 12.11 0.41 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.959 0.504 . . . . 0.0 110.966 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.6 t -119.21 138.32 53.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.722 0.409 . . . . 0.0 110.635 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.89 -29.21 62.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.978 0.911 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 18.6 m -71.87 -22.25 61.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.187 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.6 -32.98 20.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.935 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.38 -63.73 0.97 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.708 1.203 . . . . 0.0 111.478 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.25 -47.77 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.994 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -32.34 64.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.122 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' A' ' 436' ' ' LEU . 28.1 t80 -62.98 -56.6 15.67 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 122.884 0.474 . . . . 0.0 110.121 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -78.54 -14.97 59.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.556 -178.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.556 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 50.0 mt-10 -72.74 -40.3 66.19 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.586 0.63 . . . . 0.0 109.853 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.73 -32.3 72.82 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.511 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.516 ' CE2' HD11 ' A' ' 456' ' ' LEU . 48.4 t80 -81.02 -42.14 21.59 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.405 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 21.7 p -68.28 -23.85 64.8 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.199 0.599 . . . . 0.0 110.411 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -62.17 -32.81 73.47 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.07 1.348 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -78.34 -32.86 49.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.539 0.736 . . . . 0.0 110.794 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.519 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 39.0 mt -83.8 -10.29 58.18 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.641 0.776 . . . . 0.0 112.204 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 71.26 7.29 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.741 1.616 . . . . 0.0 111.373 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.699 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -84.67 135.42 34.17 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 122.894 0.478 . . . . 0.0 110.04 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 28.1 t70 -147.12 158.66 44.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.602 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.2 p30 48.64 26.11 1.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.643 1.177 . . . . 0.0 112.654 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.55 -15.66 30.24 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.905 1.282 . . . . 0.0 110.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.406 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.74 164.56 33.75 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.354 0.661 . . . . 0.0 110.273 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 42.0 p -168.06 129.0 1.37 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 108.459 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.2 t -67.85 -20.64 65.16 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.103 0.561 . . . . 0.0 111.72 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 146.95 34.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.984 0.914 . . . . 0.0 109.096 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.44 174.88 11.81 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.301 2.0 . . . . 0.0 111.621 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -75.27 -8.94 57.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.919 0.488 . . . . 0.0 112.184 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 CA--C 1.556 1.211 0 C-N-CA 123.569 0.748 . . . . 0.0 109.394 175.73 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 52.6 p -67.36 -39.93 85.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.197 0.599 . . . . 0.0 111.048 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -80.71 1.87 28.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.671 0.788 . . . . 0.0 112.641 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 43.0 ttm -80.0 -41.54 25.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.596 0.758 . . . . 0.0 110.834 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.66 -175.51 5.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.263 0.625 . . . . 0.0 111.071 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.7 t -90.34 178.2 6.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.396 1.078 . . . . 0.0 110.841 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.2 p -136.39 135.32 38.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.729 1.212 . . . . 0.0 109.624 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.96 167.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.922 0.889 . . . . 0.0 110.738 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.44 121.24 18.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.068 0.947 . . . . 0.0 108.809 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 395' ' ' ILE . 35.5 m -105.19 146.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 170.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -111.94 98.46 7.38 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.519 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 42.4 t -68.66 101.53 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 124.323 1.014 . . . . 0.0 109.897 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.426 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 51.2 t30 -92.21 90.39 7.28 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.156 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.05 -5.69 49.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.761 176.031 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 364' ' ' HIS . . . . . 0.426 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 66.5 t60 -76.87 -19.36 57.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.673 0.789 . . . . 0.0 110.174 167.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -74.0 -125.74 0.12 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.677 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -106.8 156.05 19.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.496 0.648 . . . . 0.0 109.374 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.14 -64.41 1.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.593 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.94 -87.9 0.07 OUTLIER Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.275 -173.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -85.91 17.2 33.85 Favored 'Cis proline' 0 C--N 1.374 1.907 0 CA-C-N 120.51 2.155 . . . . 0.0 113.998 4.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -70.81 -22.69 62.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.117 0.567 . . . . 0.0 110.284 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.593 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.7 mt -96.34 136.74 36.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.33 1.052 . . . . 0.0 109.56 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 375' ' ' ARG . 12.8 t70 -65.35 126.16 90.89 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.827 0.851 . . . . 0.0 110.653 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 60.5 Cg_endo -68.0 -19.49 45.71 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.814 2.343 . . . . 0.0 113.872 -170.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -84.74 -47.41 10.45 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 38.4 mtt180 -62.32 -35.53 79.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 0.0 112.064 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.9 mm -58.47 -29.64 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.505 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.6 mm-40 -85.76 -19.12 31.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.568 0.347 . . . . 0.0 110.996 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 79.3 mm-40 -87.4 -29.11 21.73 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.345 0.658 . . . . 0.0 112.556 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.454 HD13 HG11 ' A' ' 361' ' ' VAL . 2.7 pp -69.84 159.61 83.36 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.741 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.2 152.13 74.15 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.512 2.142 . . . . 0.0 113.279 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.34 -4.07 37.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.41 1.084 . . . . 0.0 111.808 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 38.7 p-80 -161.55 148.76 14.61 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.339 0.656 . . . . 0.0 110.815 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -116.85 104.17 11.04 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 133.03 -173.92 20.79 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.376 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.99 128.36 14.48 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.097 -5.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -152.27 -162.3 10.78 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.21 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -68.69 139.39 44.03 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.067 2.511 . . . . 0.0 112.072 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -50.51 -39.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.46 1.104 . . . . 0.0 111.754 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.61 -48.28 67.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.65 -47.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.23 -43.58 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.23 0.612 . . . . 0.0 111.98 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 449' ' ' LEU . 2.7 pp -68.21 -44.29 76.11 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 120.68 0.276 . . . . 0.0 110.563 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.5 HH11 ' HA ' ' A' ' 421' ' ' GLU . 29.4 ptt180 -74.56 -24.51 58.93 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.54 -38.63 91.7 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.921 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 359' ' ' VAL . 27.6 mm -65.42 -55.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 68.2 t -61.66 -47.02 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.706 -172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.98 -32.14 71.5 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.645 0.378 . . . . 0.0 110.88 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.551 0.532 . . . . 0.0 110.068 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.37 -56.17 12.36 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.152 0.908 . . . . 0.0 110.949 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 3.0 t -62.55 -37.38 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.75 -43.73 95.56 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.593 0.757 . . . . 0.0 111.19 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 19.9 p -83.44 -8.03 59.45 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.166 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.622 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.04 134.02 45.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 53.2 mt -75.76 124.6 27.56 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.655 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 64.55 68.49 0.53 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.624 1.17 . . . . 0.0 109.319 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 55.3 m -61.18 -37.83 84.33 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.533 -173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -51.06 -43.13 60.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.864 0.866 . . . . 0.0 113.035 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.3 m -74.71 -38.64 62.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.472 0.654 . . . . 0.0 109.874 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.622 HG21 ' HB1' ' A' ' 403' ' ' ALA . 78.0 t -68.94 -31.4 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.638 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.06 -10.28 59.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.334 1.054 . . . . 0.0 110.034 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.67 -7.74 83.89 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.908 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -83.34 -9.72 58.9 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 117.621 0.711 . . . . 0.0 111.869 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.98 142.74 49.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.636 0.775 . . . . 0.0 109.713 174.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -117.06 149.71 44.74 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.443 0.697 . . . . 0.0 111.091 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.67 128.07 16.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.832 2.355 . . . . 0.0 112.603 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.06 169.64 8.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.843 1.257 . . . . 0.0 108.801 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -118.99 22.58 11.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.71 . . . . 0.0 112.391 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 438' ' ' PRO . 0.5 OUTLIER -100.9 -25.12 14.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.085 0.554 . . . . 0.0 111.623 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.2 45.89 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.191 1.237 . . . . 0.0 116.191 162.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -85.69 -85.0 1.03 Allowed Glycine 0 C--O 1.239 0.436 0 CA-C-N 116.779 0.29 . . . . 0.0 112.694 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 3.1 mp0 -85.17 162.79 19.08 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.84 0.456 . . . . 0.0 110.346 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 67.5 t -136.08 124.21 36.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.063 0.945 . . . . 0.0 108.633 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.561 HG12 HD11 ' A' ' 436' ' ' LEU . 32.3 mm -104.39 122.82 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.2 p -106.76 145.75 31.69 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.257 1.023 . . . . 0.0 109.498 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.37 142.85 4.9 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.539 0.736 . . . . 0.0 110.879 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 103.38 6.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 110.024 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -114.92 124.64 52.22 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.706 0.802 . . . . 0.0 109.098 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 32.0 t70 61.19 28.59 18.19 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-O 122.245 1.022 . . . . 0.0 111.124 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.87 -17.8 58.22 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.863 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.29 162.01 15.45 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 117.441 0.621 . . . . 0.0 110.651 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.1 t -81.98 121.88 27.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -126.42 149.96 48.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.54 0.736 . . . . 0.0 109.871 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.0 p -140.29 146.08 38.08 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.354 0.662 . . . . 0.0 110.252 -173.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 29.0 pt -120.11 178.84 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.558 0.743 . . . . 0.0 110.361 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -118.51 147.88 43.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.578 0.751 . . . . 0.0 109.863 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.0 mp -116.26 156.04 47.61 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.863 1.265 . . . . 0.0 108.188 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.16 131.06 21.25 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 121.877 1.718 . . . . 0.0 111.061 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 418' ' ' ARG . 41.6 Cg_endo -66.33 128.79 20.04 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.954 2.436 . . . . 0.0 113.167 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.08 168.8 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.249 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -153.22 0.07 0.25 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.386 0.674 . . . . 0.0 110.772 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.6 t -120.61 142.63 49.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.274 0.63 . . . . 0.0 109.997 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.16 67.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.835 0.854 . . . . 0.0 112.462 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.4 m -70.39 -28.2 64.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.444 0.698 . . . . 0.0 111.321 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -24.03 29.87 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.16 -59.68 3.22 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 123.907 0.754 . . . . 0.0 109.668 171.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.89 -51.03 62.22 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -48.76 -41.94 33.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.319 1.047 . . . . 0.0 112.878 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -41.11 99.11 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.955 0.784 . . . . 0.0 110.951 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.44 -18.92 28.83 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.318 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.29 -42.38 59.65 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.861 0.755 . . . . 0.0 110.416 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.63 -40.8 92.95 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.444 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 456' ' ' LEU . 67.7 t80 -65.57 -47.11 76.91 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.257 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 86.7 m -66.66 -31.43 72.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 110.771 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.59 -32.4 71.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.249 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 45.9 m -67.28 -33.81 76.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.136 0.574 . . . . 0.0 110.511 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.56 HD13 HD21 ' A' ' 371' ' ' LEU . 56.7 mt -84.31 -8.93 58.86 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.635 0.774 . . . . 0.0 111.702 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 79.02 5.23 2.3 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.502 1.921 . . . . 0.0 111.779 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.455 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 7.4 p -87.4 146.44 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.059 0.544 . . . . 0.0 110.896 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -162.64 154.45 18.32 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 32.3 m-80 64.54 18.84 11.58 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.268 1.027 . . . . 0.0 111.115 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 23.7 tp -83.32 -9.42 59.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.574 0.749 . . . . 0.0 110.606 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.423 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.6 171.85 19.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.935 0.894 . . . . 0.0 109.908 176.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 29.1 p -162.16 126.22 3.17 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.473 0.709 . . . . 0.0 109.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 21.5 t -72.27 -6.32 42.21 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.83 146.91 52.12 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.499 1.12 . . . . 0.0 109.381 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.52 163.21 38.94 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.394 2.063 . . . . 0.0 112.568 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -77.27 -16.6 58.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 0.0 111.542 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.667 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 76.0 p -161.68 156.44 23.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.39 0.676 . . . . 0.0 111.058 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -125.61 -172.41 2.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.654 1.182 . . . . 0.0 109.459 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 50.3 tpp -74.7 130.37 39.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.586 0.354 . . . . 0.0 110.593 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.39 164.75 13.1 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.011 0.924 . . . . 0.0 110.509 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.7 m -75.27 -177.39 3.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.596 0.358 . . . . 0.0 111.801 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.0 p -141.6 134.37 28.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.119 0.968 . . . . 0.0 109.622 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 388' ' ' VAL . 13.0 m -137.29 171.4 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.344 1.058 . . . . 0.0 110.509 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 25.9 p -145.83 108.12 4.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.383 0.673 . . . . 0.0 109.751 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.647 HG21 HD11 ' A' ' 395' ' ' ILE . 30.8 m -98.34 143.91 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -109.89 100.69 9.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.493 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 78.0 t -73.42 102.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.411 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 36.3 t30 -97.11 96.13 8.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.828 0.851 . . . . 0.0 109.624 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.13 -5.93 53.18 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.023 177.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -85.8 -8.93 57.8 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.524 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.61 -137.04 2.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.455 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 45.4 t30 -92.13 142.78 27.13 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 117.817 0.808 . . . . 0.0 109.369 174.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 376' ' ' ILE . 1.8 m-85 -84.03 -56.23 3.79 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -147.38 -74.48 0.02 OUTLIER Glycine 0 C--N 1.349 1.268 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.912 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.8 -15.26 17.65 Favored 'Cis proline' 0 C--N 1.371 1.729 0 CA-C-N 121.118 2.459 . . . . 0.0 115.308 4.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -73.09 0.94 10.1 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.907 0.776 . . . . 0.0 113.079 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.581 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 12.7 mt -91.39 127.86 37.0 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.01 118.38 17.35 Favored Pre-proline 0 N--CA 1.478 0.974 0 O-C-N 124.165 0.916 . . . . 0.0 110.763 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 58.7 Cg_endo -65.61 -19.36 60.17 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.92 2.413 . . . . 0.0 113.664 -169.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 3.1 mppt? -84.5 -42.7 15.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.86 0.362 . . . . 0.0 110.04 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 24.1 mtt-85 -68.01 -33.08 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.216 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 367' ' ' PHE . 24.6 mm -60.68 -27.02 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.159 171.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 69.7 mm-40 -84.47 -22.3 30.33 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 174.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 85.7 mm-40 -79.73 -30.19 40.79 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.318 0.647 . . . . 0.0 112.367 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 376' ' ' ILE . 3.1 pp -73.2 154.6 90.39 Favored Pre-proline 0 N--CA 1.482 1.137 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.29 164.78 24.36 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.233 1.955 . . . . 0.0 114.773 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.27 -18.28 61.82 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.461 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.493 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 47.5 p-80 -166.32 149.93 7.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.54 0.736 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -116.49 101.94 9.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 144.68 165.85 11.28 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.444 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.23 130.36 20.59 Favored 'Cis proline' 0 C--N 1.379 2.171 0 CA-C-N 118.984 1.392 . . . . 0.0 112.237 -3.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.67 -173.22 24.06 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.875 -0.958 . . . . 0.0 111.074 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.44 143.11 34.22 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.933 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.3 p -45.47 -50.95 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 112.775 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.49 -34.58 72.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.617 1.167 . . . . 0.0 111.817 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 99.4 t -76.57 -47.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.17 -38.82 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 122.883 0.473 . . . . 0.0 111.658 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -70.77 -41.61 71.5 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.146 0.179 . . . . 0.0 111.428 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.487 ' N ' HD12 ' A' ' 392' ' ' LEU . 28.8 ptt180 -71.9 -30.74 65.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -68.84 -29.39 67.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.614 0.765 . . . . 0.0 111.51 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.647 HD11 HG21 ' A' ' 359' ' ' VAL . 35.4 mm -69.6 -54.85 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 98.3 t -58.76 -50.07 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 O-C-N 124.193 0.933 . . . . 0.0 111.572 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.7 pt20 -68.44 -31.35 70.61 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.929 0.491 . . . . 0.0 111.91 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.22 83.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.01 -32.45 72.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.45 0.7 . . . . 0.0 112.629 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.7 t -80.24 -52.38 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.55 -38.98 89.43 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.734 0.414 . . . . 0.0 111.055 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 50.5 m -89.28 12.94 14.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.297 0.639 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -89.51 144.91 25.66 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.212 0.605 . . . . 0.0 111.732 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.87 122.23 18.2 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.839 166.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.32 62.28 0.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.445 1.09 . . . . 0.0 109.192 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 400' ' ' VAL . 89.5 m -55.96 -41.13 74.25 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.64 1.576 . . . . 0.0 111.483 -173.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -54.2 -34.67 61.11 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.116 1.366 . . . . 0.0 114.497 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.2 m -79.14 -39.4 33.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.469 0.652 . . . . 0.0 109.653 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 403' ' ' ALA . 59.8 t -67.11 -26.17 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.013 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.3 -17.54 63.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.314 1.446 . . . . 0.0 110.146 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -81.9 -8.21 86.97 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.4 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.16 -2.31 55.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.213 0.605 . . . . 0.0 111.3 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 434' ' ' ILE . 1.5 pt? -149.31 139.17 21.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.611 0.764 . . . . 0.0 110.052 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -105.87 152.7 40.29 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.101 0.961 . . . . 0.0 111.474 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.03 151.68 62.01 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.046 166.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -148.24 107.78 3.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -91.06 44.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.019 0.914 . . . . 0.0 110.979 -167.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.63 5.94 50.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.407 169.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.81 66.2 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.51 0.506 . . . . 0.0 113.178 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.52 -126.86 2.38 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.737 0.316 . . . . 0.0 112.727 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.461 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.5 mp0 -85.12 174.56 9.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.415 0.686 . . . . 0.0 110.755 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.64 135.31 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.34 0.656 . . . . 0.0 109.432 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 397' ' ' GLN . 31.2 mm -109.74 124.19 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.897 0.879 . . . . 0.0 108.998 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.8 p -106.87 133.83 50.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.224 0.61 . . . . 0.0 109.613 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.47 134.04 10.86 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.605 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 62.7 m -77.03 104.64 7.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 122.951 0.5 . . . . 0.0 111.023 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -111.05 110.63 21.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.985 0.914 . . . . 0.0 110.598 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 39.0 t70 58.09 57.6 3.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.745 1.218 . . . . 0.0 111.76 169.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 78.32 -6.94 49.2 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.131 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.98 170.84 7.83 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.708 0.754 . . . . 0.0 110.309 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 5.1 t -114.22 109.39 18.32 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -120.66 168.75 11.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.608 0.763 . . . . 0.0 110.686 -173.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 51.0 p -147.94 154.86 40.9 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.331 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 413' ' ' LEU . 25.5 pt -122.49 -179.75 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.957 0.903 . . . . 0.0 109.173 172.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -116.17 153.32 32.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.404 0.681 . . . . 0.0 110.211 170.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 421' ' ' GLU . 85.0 mt -114.96 164.68 15.96 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 0.0 109.374 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.34 134.47 17.3 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.814 1.676 . . . . 0.0 111.008 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.43 128.02 14.84 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.002 1.801 . . . . 0.0 112.248 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.51 172.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 0.0 110.369 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.18 -12.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.421 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.9 m -108.78 138.89 44.38 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.4 0.545 . . . . 0.0 111.044 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.81 -30.37 68.91 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.265 1.026 . . . . 0.0 111.622 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.6 m -62.85 -33.53 75.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.837 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -82.56 -25.32 33.43 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.933 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.2 -65.97 0.48 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.865 0.866 . . . . 0.0 111.473 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 3.1 pp -65.98 -37.43 85.93 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.609 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.65 71.69 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.263 1.025 . . . . 0.0 111.686 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -62.73 -49.71 73.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.529 0.732 . . . . 0.0 110.245 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -89.05 -14.5 36.25 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.519 -175.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.0 OUTLIER -59.69 -48.86 79.98 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.047 0.939 . . . . 0.0 110.807 -176.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.92 -32.89 71.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.075 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 60.4 t80 -68.23 -52.83 29.74 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.136 0.575 . . . . 0.0 110.87 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.08 -28.01 69.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.824 1.249 . . . . 0.0 111.31 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.72 -36.53 80.77 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.624 0.769 . . . . 0.0 110.273 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.1 m -71.41 -28.13 63.79 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.723 0.809 . . . . 0.0 110.923 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 23.9 mt -82.91 -17.81 42.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.128 0.571 . . . . 0.0 111.157 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 73.8 6.82 4.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 111.777 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 22.4 p -79.22 131.53 36.21 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.9 t70 -151.68 145.43 25.05 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.358 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 18.1 m-80 62.72 20.67 12.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 -167.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -86.27 -19.95 29.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.51 0.724 . . . . 0.0 110.476 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.09 169.55 24.23 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.537 0.735 . . . . 0.0 110.059 173.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.9 p -157.22 109.43 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 37.9 t -71.7 -17.84 62.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.518 0.727 . . . . 0.0 111.626 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -85.97 111.16 36.1 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.62 151.74 64.37 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.159 1.906 . . . . 0.0 112.928 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -67.18 -27.09 66.98 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.837 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.96 0.904 . . . . 0.0 108.936 177.572 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 CA-C-O 120.041 -0.311 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 48.4 p -72.57 78.97 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.463 1.105 . . . . 0.0 111.286 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -81.96 77.96 8.72 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -73.45 -21.81 60.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.929 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -118.02 170.23 9.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 108.755 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.2 p -86.47 -173.58 4.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.941 0.496 . . . . 0.0 110.899 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -139.62 142.44 37.04 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.611 0.764 . . . . 0.0 110.667 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.416 HG23 HG11 ' A' ' 391' ' ' VAL . 12.4 m -143.22 152.7 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.459 1.103 . . . . 0.0 110.584 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.479 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 42.2 t -121.07 105.72 10.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 0.0 109.102 171.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.1 t -94.95 149.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.66 0.784 . . . . 0.0 109.734 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.5 103.46 9.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.572 1.149 . . . . 0.0 108.585 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.419 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -75.78 106.53 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.033 0.533 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -91.64 87.93 6.53 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.439 0.696 . . . . 0.0 109.271 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -15.61 61.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.257 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -73.98 -19.22 60.72 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.397 0.679 . . . . 0.0 110.833 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -80.52 -153.95 9.66 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.201 0.429 . . . . 0.0 112.89 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 52.5 t30 -72.69 141.5 48.23 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.828 0.347 . . . . 0.0 110.169 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 371' ' ' LEU . 2.0 m-85 -97.32 -64.63 1.02 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -138.32 -100.89 0.53 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.029 -0.873 . . . . 0.0 112.259 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -88.75 15.94 44.84 Favored 'Cis proline' 0 C--N 1.373 1.862 0 CA-C-N 120.312 2.056 . . . . 0.0 114.238 12.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -83.58 -1.79 54.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.641 0.777 . . . . 0.0 111.196 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 456' ' ' LEU . 42.4 mt -114.78 146.79 40.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.361 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.19 122.37 86.1 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.611 0.764 . . . . 0.0 110.701 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.465 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 37.6 Cg_endo -61.34 -23.76 77.47 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.229 2.619 . . . . 0.0 114.871 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -84.7 -48.2 9.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.149 0.432 . . . . 0.0 110.457 -176.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 64.7 mtt180 -68.5 -34.68 76.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.077 0.951 . . . . 0.0 111.949 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.427 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.8 mm -52.55 -31.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.909 0.883 . . . . 0.0 111.884 170.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -80.28 -28.2 38.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.115 0.566 . . . . 0.0 111.385 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -78.45 -31.33 47.93 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.623 0.769 . . . . 0.0 112.346 -169.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' A' ' 398' ' ' ALA . 0.8 OUTLIER -71.54 154.0 93.45 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.106 172.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.2 165.44 8.9 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.977 2.451 . . . . 0.0 114.812 -171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.91 -13.62 60.93 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.522 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.2 p80 -159.7 150.47 19.27 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.2 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -119.46 104.22 10.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 178.09 15.17 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.963 -0.91 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.67 136.53 36.72 Favored 'Cis proline' 0 C--N 1.386 2.54 0 CA-C-N 119.875 1.838 . . . . 0.0 113.23 -2.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -170.46 -172.89 37.28 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.03 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 58.5 Cg_endo -68.26 138.78 44.04 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.841 2.361 . . . . 0.0 112.366 -174.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 445' ' ' ALA . 11.4 p -51.05 -43.02 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.333 1.453 . . . . 0.0 111.724 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -50.77 -59.33 4.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 111.035 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.523 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 57.6 t -71.74 -42.37 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.867 -172.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 357' ' ' VAL . 97.1 t -63.27 -45.26 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.844 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.66 -40.65 84.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 390' ' ' VAL . 10.9 ptm180 -72.71 -30.05 63.89 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -72.23 -23.06 61.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.086 0.554 . . . . 0.0 111.929 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.564 HG21 ' HG ' ' A' ' 449' ' ' LEU . 22.0 mm -73.42 -55.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.9 t -62.29 -55.79 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.587 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.0 pt20 -64.07 -29.63 70.75 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.795 0.438 . . . . 0.0 111.9 -176.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -64.09 -48.9 74.38 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.24 -47.86 78.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.856 0.723 . . . . 0.0 112.318 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 396' ' ' VAL . 10.2 t -65.13 -48.12 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.958 0.409 . . . . 0.0 110.154 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.95 -33.55 74.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.686 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 73.5 m -93.01 17.22 11.11 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.429 0.692 . . . . 0.0 110.958 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.596 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -91.13 155.46 18.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.611 0.719 . . . . 0.0 112.318 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.47 121.94 26.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.689 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 57.32 61.91 2.36 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.333 1.02 . . . . 0.0 109.712 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 400' ' ' VAL . 97.1 m -48.67 -35.81 14.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.094 1.758 . . . . 0.0 112.742 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -56.93 -39.51 74.62 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.492 1.117 . . . . 0.0 113.036 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 92.9 m -79.6 -40.48 29.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.816 0.847 . . . . 0.0 109.772 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.596 HG21 ' HB1' ' A' ' 403' ' ' ALA . 94.5 t -61.08 -33.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.429 1.092 . . . . 0.0 111.46 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.12 -10.54 59.49 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.368 1.067 . . . . 0.0 110.908 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -82.38 -6.94 88.24 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.574 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.14 10.1 28.32 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.414 0.685 . . . . 0.0 111.464 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -152.14 141.05 21.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.295 1.038 . . . . 0.0 108.964 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -117.15 154.99 50.1 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 123.688 0.795 . . . . 0.0 111.53 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.09 157.8 56.73 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.692 2.261 . . . . 0.0 112.037 167.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.405 ' OD1' ' HD2' ' A' ' 418' ' ' ARG . 5.3 t0 -155.15 139.23 16.47 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -90.12 27.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.405 ' HD2' ' OD1' ' A' ' 416' ' ' ASP . 0.0 OUTLIER -84.44 -33.42 23.67 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 111.024 175.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.77 41.82 8.63 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.723 0.249 . . . . 0.0 113.723 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -94.18 -110.25 2.19 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.761 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 23.5 mp0 -74.28 162.74 28.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.446 ' HB ' ' NH2' ' A' ' 393' ' ' ARG . 90.1 t -135.64 130.07 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.517 HG12 HD11 ' A' ' 436' ' ' LEU . 37.3 mm -110.4 127.55 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.7 p -106.04 150.7 25.5 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.673 0.789 . . . . 0.0 108.999 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -165.87 135.96 3.47 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.583 0.753 . . . . 0.0 109.678 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 69.0 m -67.48 101.06 0.92 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.585 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -139.21 136.75 35.33 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 109.502 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.7 t70 62.71 31.64 16.53 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.97 1.308 . . . . 0.0 111.514 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 81.34 1.87 90.24 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.893 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.81 172.96 10.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.586 1.155 . . . . 0.0 109.308 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.8 t -87.75 102.24 14.47 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 164.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -85.94 133.08 33.96 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.439 ' HB3' HG22 ' A' ' 424' ' ' THR . 25.2 p -114.56 143.3 45.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.017 0.927 . . . . 0.0 110.445 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 413' ' ' LEU . 16.5 pt -128.46 168.44 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.046 0.938 . . . . 0.0 109.761 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -112.28 146.93 37.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.536 0.734 . . . . 0.0 110.766 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.7 mp -115.86 155.48 47.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.233 1.413 . . . . 0.0 108.355 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.17 128.66 14.11 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.79 1.66 . . . . 0.0 111.462 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.09 135.36 27.14 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.927 2.418 . . . . 0.0 111.617 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.16 160.78 4.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.285 0.564 . . . . 0.0 110.751 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.62 12.43 3.19 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.316 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 39.5 t -118.36 139.13 51.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.896 0.478 . . . . 0.0 109.97 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.25 45.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.462 1.105 . . . . 0.0 111.365 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 27.2 m -72.89 -22.4 60.76 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.03 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.41 -21.39 25.63 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.81 -60.73 2.36 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 121.701 0.762 . . . . 0.0 109.918 170.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 464' ' ' SER . 20.6 mt -69.69 -39.77 76.75 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.952 -174.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 0.0 OUTLIER -61.15 -30.8 70.61 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.879 0.872 . . . . 0.0 111.442 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -45.51 72.88 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.903 0.481 . . . . 0.0 110.492 -177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.564 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.51 -13.1 43.98 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.074 -0.488 . . . . 0.0 111.846 176.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 1.4 mm-40 -57.17 -56.98 14.71 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.725 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.39 -35.72 81.05 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.931 0.769 . . . . 0.0 111.147 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 38.8 t80 -60.31 -61.06 2.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.522 0.729 . . . . 0.0 110.818 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.85 -30.54 69.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.435 1.094 . . . . 0.0 111.81 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -66.04 -40.26 90.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.224 0.61 . . . . 0.0 110.582 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 49.9 m -67.91 -35.86 79.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.536 0.734 . . . . 0.0 110.486 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.567 HD13 HD21 ' A' ' 371' ' ' LEU . 50.3 mt -72.59 -12.91 61.25 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.542 0.737 . . . . 0.0 111.5 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 73.74 14.61 4.12 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.807 1.643 . . . . 0.0 111.61 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.523 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 15.3 p -93.88 139.59 30.71 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 123.379 0.672 . . . . 0.0 109.982 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -155.31 144.82 21.18 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 66.84 12.62 9.0 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 124.191 0.932 . . . . 0.0 110.342 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 34.8 tp -74.57 -17.94 60.65 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.866 0.866 . . . . 0.0 110.24 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.455 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.01 161.66 31.56 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.344 0.658 . . . . 0.0 110.775 177.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 80.8 p -167.81 129.06 1.45 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.698 0.799 . . . . 0.0 109.001 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 35.4 t -66.47 -25.72 66.85 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.839 0.352 . . . . 0.0 111.432 177.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -93.57 133.31 28.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.1 174.48 9.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.826 2.35 . . . . 0.0 111.653 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -71.28 -11.46 60.93 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.873 0.469 . . . . 0.0 111.775 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.505 1.122 . . . . 0.0 108.27 168.983 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.924 0 CA-C-O 120.358 -0.135 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.9 m -73.33 -10.01 59.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.812 0.845 . . . . 0.0 112.868 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.29 156.27 20.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.775 0.83 . . . . 0.0 110.117 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.95 133.43 43.04 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.391 0.676 . . . . 0.0 110.078 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.439 ' SD ' ' HB3' ' A' ' 387' ' ' PRO . 20.1 ptp -70.94 170.64 12.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.587 0.755 . . . . 0.0 110.442 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.5 t -76.74 172.49 13.0 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.8 p -136.68 137.02 39.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.392 0.677 . . . . 0.0 109.411 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 388' ' ' VAL . 17.2 m -138.25 165.9 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.024 0.93 . . . . 0.0 110.969 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 24.6 p -142.65 108.89 5.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 108.548 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -94.92 159.32 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.27 99.89 6.74 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.415 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 39.7 t -70.84 107.61 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 123.869 0.731 . . . . 0.0 110.313 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.55 89.6 5.05 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.368 1.067 . . . . 0.0 109.117 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.42 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.89 -3.6 42.54 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.509 178.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.95 -11.46 58.86 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.223 0.609 . . . . 0.0 110.414 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.56 -151.05 5.32 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 51.2 t-20 -77.52 139.26 39.56 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.41 -52.69 6.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.687 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.46 -76.22 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 114.738 -1.119 . . . . 0.0 114.32 -176.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.03 -10.06 13.83 Favored 'Cis proline' 0 C--N 1.371 1.759 0 CA-C-N 121.102 2.451 . . . . 0.0 114.095 -2.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 14.8 p-80 -61.29 -12.33 13.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.188 0.995 . . . . 0.0 113.029 175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.687 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.4 mt -98.69 143.07 29.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.152 0.981 . . . . 0.0 109.408 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 127.49 91.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 123.864 0.727 . . . . 0.0 110.068 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 29.7 Cg_endo -59.63 -41.25 57.83 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.992 2.461 . . . . 0.0 112.875 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -65.64 -45.2 83.93 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.398 0.436 . . . . 0.0 110.675 -175.273 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -66.88 -31.2 71.65 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.687 0.795 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 18.5 mm -66.63 -28.83 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.068 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 62.2 mm-40 -82.93 -23.04 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.961 -0.462 . . . . 0.0 110.906 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 70.9 mm-40 -74.6 -38.67 62.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.953 0.501 . . . . 0.0 111.716 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.1 pp -67.51 156.77 87.87 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.926 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.29 150.69 83.6 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.539 2.159 . . . . 0.0 113.122 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.55 -1.8 26.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.879 1.272 . . . . 0.0 111.442 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 39.7 p-80 -157.33 151.33 24.57 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 109.965 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -118.1 104.25 10.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 166.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 148.27 176.69 21.96 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.248 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -82.23 128.74 15.07 Favored 'Cis proline' 0 C--N 1.376 2.004 0 CA-C-N 118.751 1.276 . . . . 0.0 111.326 -2.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -153.49 -165.45 13.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.099 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.439 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 3.1 Cg_exo -70.97 146.31 52.4 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.951 2.434 . . . . 0.0 112.265 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.0 p -54.64 -45.32 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 124.28 1.032 . . . . 0.0 111.15 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -62.44 -49.74 74.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.064 1.346 . . . . 0.0 110.948 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 83.4 t -70.63 -48.9 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.508 -174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.12 -40.61 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.87 0.468 . . . . 0.0 111.897 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.7 pp -66.87 -41.84 86.6 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.421 ' N ' HD12 ' A' ' 392' ' ' LEU . 17.4 ptt180 -74.49 -25.4 59.35 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 123.32 0.388 . . . . 0.0 110.033 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 36.7 mmm-85 -64.09 -40.33 95.99 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.422 0.451 . . . . 0.0 110.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 359' ' ' VAL . 43.6 mm -63.55 -51.33 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.953 0.783 . . . . 0.0 109.735 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.79 -44.87 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.298 -174.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -79.58 -28.03 41.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.857 -0.592 . . . . 0.0 111.834 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -73.53 -31.88 63.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.274 0.488 . . . . 0.0 110.508 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.96 -56.12 19.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.085 0.554 . . . . 0.0 109.56 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.73 -30.13 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.729 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.06 -33.97 70.77 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.484 0.714 . . . . 0.0 111.566 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 379' ' ' LEU . 78.4 m -91.23 0.1 57.59 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.989 0.516 . . . . 0.0 111.637 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.93 138.84 54.95 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.4 mt -82.6 115.98 21.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.53 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 64.54 61.39 0.85 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.444 1.116 . . . . 0.0 109.286 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.0 m -51.8 -34.8 41.59 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.217 1.807 . . . . 0.0 112.806 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -54.93 -42.24 72.0 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.532 1.133 . . . . 0.0 112.315 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 49.6 m -80.53 -37.25 31.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 403' ' ' ALA . 90.8 t -65.37 -34.92 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.235 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.37 -16.64 60.36 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.832 0.853 . . . . 0.0 110.84 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -68.72 -13.55 66.18 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 116.257 -0.429 . . . . 0.0 114.14 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.88 -13.32 60.01 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.738 . . . . 0.0 111.444 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.614 HD22 ' HE1' ' A' ' 452' ' ' PHE . 1.0 OUTLIER -141.52 112.71 7.43 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.376 0.671 . . . . 0.0 110.267 -173.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 415' ' ' PRO . 47.0 mtpt -112.56 160.67 29.61 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 124.163 0.985 . . . . 0.0 109.637 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 414' ' ' LYS . 67.3 Cg_endo -67.75 155.52 69.62 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.288 1.992 . . . . 0.0 114.698 -170.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.87 124.34 26.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.062 1.345 . . . . 0.0 108.601 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.82 33.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.193 0.597 . . . . 0.0 112.212 -164.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -92.01 -10.62 38.56 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 111.42 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.65 41.33 64.96 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.53 -116.8 2.37 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 120.113 -0.27 . . . . 0.0 112.961 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.9 OUTLIER -77.4 168.73 19.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 110.592 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 81.2 t -132.92 125.29 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.631 0.772 . . . . 0.0 109.217 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 436' ' ' LEU . 37.6 mm -103.37 128.06 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.5 p -106.63 140.9 38.77 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.941 0.896 . . . . 0.0 109.809 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.05 141.8 24.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.037 0.935 . . . . 0.0 110.151 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.2 p -83.65 112.7 20.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -144.24 137.48 27.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.031 0.932 . . . . 0.0 109.428 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.17 18.32 11.38 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.494 1.117 . . . . 0.0 112.434 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.38 70.89 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 121.792 -0.567 . . . . 0.0 112.776 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -131.74 170.99 14.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.661 1.184 . . . . 0.0 109.71 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -92.09 126.08 37.03 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.8 126.9 53.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.728 0.811 . . . . 0.0 109.297 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.8 p -117.76 140.63 49.42 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 0.0 110.336 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.14 162.3 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.396 0.678 . . . . 0.0 109.947 172.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -99.27 146.69 25.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.816 0.847 . . . . 0.0 110.111 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 423' ' ' ILE . 8.5 mp -115.18 171.43 4.51 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.64 141.73 25.2 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 121.957 1.771 . . . . 0.0 111.735 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.32 128.47 8.91 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.148 1.898 . . . . 0.0 112.257 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.45 172.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.617 0.767 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -149.04 -0.93 0.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.008 0.523 . . . . 0.0 111.979 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -126.5 139.93 52.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.005 0.522 . . . . 0.0 110.751 -172.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.19 70.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.226 1.01 . . . . 0.0 111.517 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 t -63.49 -27.69 69.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.565 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -86.9 -27.87 23.13 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.734 0.414 . . . . 0.0 110.395 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.889 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.9 -66.94 0.31 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.974 0.91 . . . . 0.0 111.954 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 450' ' ' GLU . 0.9 OUTLIER -61.79 -43.75 98.23 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.179 178.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -31.59 58.47 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.364 1.066 . . . . 0.0 111.917 -175.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -62.65 -55.28 28.38 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.687 0.617 . . . . 0.0 110.046 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.76 -14.84 59.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.24 -178.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 446' ' ' LEU . 10.5 mm-40 -64.54 -45.92 85.1 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.292 0.496 . . . . 0.0 110.143 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.15 -39.59 65.55 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.169 0.588 . . . . 0.0 110.599 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.614 ' HE1' HD22 ' A' ' 413' ' ' LEU . 67.9 t80 -57.88 -59.14 5.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.657 0.783 . . . . 0.0 110.952 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.62 -27.16 69.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.118 0.967 . . . . 0.0 112.149 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -65.1 -41.53 94.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.03 0.532 . . . . 0.0 110.505 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 51.1 m -67.62 -21.84 65.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.708 0.803 . . . . 0.0 111.65 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 71.1 mt -100.05 -14.02 18.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.056 0.942 . . . . 0.0 112.963 -173.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 80.07 7.23 1.65 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.687 1.595 . . . . 0.0 112.19 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' CYS . . . . . . . . . . . . . 6.1 p -89.44 134.22 34.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.3 t70 -152.2 152.18 31.92 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 59.74 18.27 7.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.243 1.017 . . . . 0.0 111.259 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.23 -18.52 49.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.77 0.428 . . . . 0.0 110.966 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -163.74 172.5 14.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.23 0.612 . . . . 0.0 110.47 171.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 18.9 p -163.28 126.48 2.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.779 0.831 . . . . 0.0 108.839 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 29.2 t -70.27 -17.17 63.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.66 0.384 . . . . 0.0 111.553 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 15.0 pm0 -94.65 146.84 32.16 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.831 0.852 . . . . 0.0 109.386 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.66 171.25 14.7 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.661 2.24 . . . . 0.0 112.104 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -75.95 -31.6 59.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.949 0.5 . . . . 0.0 111.202 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.547 0.864 0 C-N-CA 123.752 0.821 . . . . 0.0 109.081 174.661 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 CA-C-O 120.26 -0.189 . . . . 0.0 112.775 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 43.7 m -67.37 -35.91 80.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.788 0.835 . . . . 0.0 110.317 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -119.09 129.12 54.9 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 24.3 ptp -99.12 10.01 42.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.869 0.868 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -149.71 168.93 22.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.007 0.923 . . . . 0.0 109.949 -171.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.9 t -82.37 179.19 7.88 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.144 0.578 . . . . 0.0 110.864 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.5 p -137.89 134.69 35.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.18 0.992 . . . . 0.0 109.864 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.9 m -140.41 162.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.959 0.903 . . . . 0.0 110.771 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 20.4 p -137.45 115.57 11.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.431 1.092 . . . . 0.0 108.815 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 34.9 m -104.01 141.91 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.837 0.455 . . . . 0.0 109.801 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.48 98.24 7.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 67.5 t -70.68 99.59 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.463 1.102 . . . . 0.0 110.713 -173.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.505 ' HB2' ' HZ ' ' A' ' 467' ' ' PHE . 33.6 t30 -94.47 97.11 9.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.62 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.4 -11.33 59.83 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.334 178.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -83.32 -15.74 48.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.546 0.738 . . . . 0.0 110.783 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -70.95 -88.32 0.11 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -141.13 152.0 44.37 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.0 -62.19 1.32 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.563 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -149.23 -91.75 0.09 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.609 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -85.5 10.48 53.13 Favored 'Cis proline' 0 C--N 1.371 1.763 0 CA-C-N 120.496 2.148 . . . . 0.0 114.832 11.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -74.16 -8.23 55.46 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 26.0 mt -107.89 136.06 48.24 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.415 1.086 . . . . 0.0 108.743 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.16 125.19 86.42 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.481 0.712 . . . . 0.0 110.318 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.529 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 35.0 Cg_endo -62.95 -31.03 77.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.717 2.278 . . . . 0.0 113.137 -172.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.32 -45.97 36.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.148 0.579 . . . . 0.0 110.119 -176.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -61.94 -34.59 76.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.356 1.062 . . . . 0.0 111.598 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 379' ' ' LEU . 24.2 mm -64.04 -29.93 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.777 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 76.9 mm-40 -83.18 -21.91 33.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.325 0.25 . . . . 0.0 110.859 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 82.9 mm-40 -79.58 -32.56 42.02 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.03 0.532 . . . . 0.0 112.148 -176.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -72.06 156.98 90.23 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.018 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.85 161.34 18.8 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.854 2.37 . . . . 0.0 114.33 -173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.36 -21.37 61.31 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.952 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.487 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 20.5 p-80 -167.05 154.04 8.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.086 0.955 . . . . 0.0 110.67 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -117.9 146.38 43.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.072 0.949 . . . . 0.0 108.969 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.18 -174.85 39.09 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.271 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.56 128.58 16.82 Favored 'Cis proline' 0 C--N 1.377 2.049 0 CA-C-N 119.187 1.493 . . . . 0.0 112.329 1.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.66 -154.69 7.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.201 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.31 137.2 25.44 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.655 2.237 . . . . 0.0 112.122 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.76 -42.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.606 1.562 . . . . 0.0 112.073 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.23 -55.5 27.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.395 1.478 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -70.13 -46.08 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.888 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.21 -36.63 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 122.566 0.346 . . . . 0.0 111.672 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.3 pp -73.89 -40.68 63.02 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.744 0.247 . . . . 0.0 111.02 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.5 ptt180 -67.98 -29.18 68.14 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 22.0 mmm-85 -65.37 -43.32 91.16 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 123.864 0.727 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 29.4 mm -65.26 -53.59 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.455 0.472 . . . . 0.0 109.838 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 400' ' ' VAL . 66.7 t -62.05 -44.81 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.027 0.829 . . . . 0.0 110.896 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.518 ' HA ' HG23 ' A' ' 423' ' ' ILE . 12.4 pt20 -67.5 -33.99 76.22 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.63 0.195 . . . . 0.0 110.838 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.1 84.67 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 122.879 0.472 . . . . 0.0 110.147 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 82.3 m -68.61 -51.35 43.3 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.591 0.756 . . . . 0.0 111.1 -175.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 406' ' ' THR . 21.0 t -62.06 -43.9 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.7 -33.35 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.002 0.521 . . . . 0.0 111.524 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 19.2 p -84.34 -10.07 57.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.696 0.398 . . . . 0.0 111.023 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.38 150.03 49.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 112.987 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.55 121.27 26.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.408 169.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 62.77 61.3 1.18 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 122.249 1.023 . . . . 0.0 109.148 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.522 HG23 HG12 ' A' ' 400' ' ' VAL . 52.2 m -54.63 -34.35 61.99 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.437 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -57.66 -37.23 73.02 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 113.175 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.8 m -84.42 -35.34 23.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.055 0.542 . . . . 0.0 110.281 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.531 HG21 ' HB1' ' A' ' 403' ' ' ALA . 88.6 t -64.58 -31.22 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.864 0.866 . . . . 0.0 110.837 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.56 -21.6 62.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.944 1.298 . . . . 0.0 110.436 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.59 76.07 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.198 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -77.38 -18.13 57.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.209 0.604 . . . . 0.0 111.689 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -133.26 125.56 29.59 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.501 0.721 . . . . 0.0 110.088 -175.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -103.45 159.03 30.59 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.931 0.892 . . . . 0.0 109.963 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.17 122.64 8.2 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.768 1.645 . . . . 0.0 112.64 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 4.3 m-20 -110.16 107.67 17.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.328 1.451 . . . . 0.0 107.342 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -83.83 67.62 9.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.095 0.95 . . . . 0.0 108.566 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -107.53 4.1 25.7 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.97 40.13 93.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.44 0.462 . . . . 0.0 113.053 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -106.61 -132.34 7.05 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 120.125 -0.264 . . . . 0.0 112.633 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.5 OUTLIER -73.21 172.78 10.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.972 0.909 . . . . 0.0 111.389 -175.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 131.22 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 109.32 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 397' ' ' GLN . 42.1 mm -111.77 123.73 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 433' ' ' SER . 17.0 p -106.51 144.95 32.45 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.831 0.852 . . . . 0.0 109.051 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -160.63 133.03 6.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.662 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.4 m -70.9 109.03 4.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.326 0.651 . . . . 0.0 111.91 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -131.21 126.85 36.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.684 1.194 . . . . 0.0 109.033 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.26 14.35 7.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.036 1.335 . . . . 0.0 112.355 169.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 7.2 62.5 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.721 -0.612 . . . . 0.0 113.015 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -120.6 166.08 14.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.256 1.022 . . . . 0.0 109.46 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.2 t -97.9 101.23 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -88.6 126.95 35.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 424' ' ' THR . 55.2 p -116.88 148.68 41.09 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.458 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 413' ' ' LEU . 46.4 pt -125.56 179.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.086 0.954 . . . . 0.0 109.215 173.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -115.66 153.21 31.71 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 86.1 mt -115.58 166.07 12.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.488 1.115 . . . . 0.0 108.933 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.92 135.07 12.26 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 121.814 1.676 . . . . 0.0 111.105 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.42 134.01 25.64 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.809 2.339 . . . . 0.0 112.494 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.29 173.64 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.787 0.835 . . . . 0.0 111.647 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -152.06 -4.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.43 0.692 . . . . 0.0 112.312 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.5 t -113.96 139.16 49.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.727 0.411 . . . . 0.0 109.999 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.12 67.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.541 0.736 . . . . 0.0 111.308 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 48.3 m -63.87 -32.94 74.62 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.441 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -83.21 -27.28 30.09 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.945 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.65 -62.27 1.7 Allowed 'General case' 0 C--N 1.366 1.3 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 449' ' ' LEU . 17.7 mt -66.31 -52.18 49.88 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.31 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -51.46 -36.14 42.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -59.06 -49.09 79.22 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.847 0.717 . . . . 0.0 109.964 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.58 -14.13 38.34 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.729 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 49.9 mt-10 -78.02 -36.57 48.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.348 0.976 . . . . 0.0 110.153 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.25 -42.28 96.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.088 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 58.8 t80 -72.42 -43.42 63.88 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.48 -174.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 20.7 p -70.84 -26.66 63.38 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.557 0.743 . . . . 0.0 109.963 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -65.74 -35.06 79.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.031 0.932 . . . . 0.0 110.271 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 17.2 m -75.94 -29.11 58.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.643 0.777 . . . . 0.0 110.598 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 371' ' ' LEU . 51.3 mt -80.27 -14.75 58.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.43 0.692 . . . . 0.0 110.951 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 75.69 9.74 3.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 0.0 112.07 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 11.8 p -91.5 138.42 31.59 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.34 0.656 . . . . 0.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -133.82 156.83 47.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 109.501 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 29.8 m-80 59.01 22.21 10.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.754 0.821 . . . . 0.0 111.634 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.95 -17.29 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.177 0.591 . . . . 0.0 110.255 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.05 172.55 17.96 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.982 0.913 . . . . 0.0 109.805 173.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 24.0 p -165.88 134.79 3.17 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.736 0.648 . . . . 0.0 109.882 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 23.1 t -68.31 -22.51 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.123 0.487 . . . . 0.0 111.668 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -118.47 147.59 42.24 Favored Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 124.501 1.12 . . . . 0.0 109.076 -174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.97 174.37 6.92 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.641 2.227 . . . . 0.0 112.292 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 362' ' ' ASN . 26.8 m-85 -78.9 -24.08 44.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.166 0.586 . . . . 0.0 110.103 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.557 1.222 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.024 171.769 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.404 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 31.3 t -112.06 137.08 50.59 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.714 0.806 . . . . 0.0 109.837 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -88.93 -25.49 22.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.103 0.561 . . . . 0.0 110.553 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.1 ttt -85.44 130.54 34.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -75.17 164.4 26.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.999 0.92 . . . . 0.0 109.77 171.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.4 m -73.39 171.98 12.1 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.771 0.428 . . . . 0.0 110.87 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.3 p -133.6 137.99 45.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.169 0.588 . . . . 0.0 110.087 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.3 m -143.15 162.36 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.466 1.106 . . . . 0.0 109.819 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 46.9 t -135.27 107.94 7.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.56 0.744 . . . . 0.0 109.299 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 42.5 t -96.46 151.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.299 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.17 106.33 8.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.578 1.151 . . . . 0.0 108.669 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 379' ' ' LEU . 62.1 t -71.7 112.3 6.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.306 0.642 . . . . 0.0 110.31 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 51.5 t30 -93.51 81.22 4.34 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.31 -13.64 62.41 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.312 175.018 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -74.29 -23.04 59.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.481 0.713 . . . . 0.0 110.876 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.33 -140.8 2.1 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.094 0.246 . . . . 0.0 112.924 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 59.3 t-20 -74.62 143.55 44.3 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.92 -53.55 3.64 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -155.52 -70.88 0.01 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.447 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.21 5.12 58.47 Favored 'Cis proline' 0 C--N 1.373 1.842 0 CA-C-N 120.382 2.091 . . . . 0.0 114.702 2.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -76.35 -9.08 58.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 117.914 0.325 . . . . 0.0 111.275 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.557 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 25.4 mt -87.18 123.99 32.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.504 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 9.8 t70 -55.09 122.53 42.86 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 124.502 1.126 . . . . 0.0 110.374 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 37.1 Cg_endo -60.93 -31.11 91.16 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.015 2.477 . . . . 0.0 113.406 -172.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.95 -46.77 33.28 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.617 0.367 . . . . 0.0 110.489 -176.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ARG . . . . . 0.504 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 23.8 mtp180 -65.03 -30.92 71.93 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 110.719 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.7 mm -63.78 -28.78 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.123 0.969 . . . . 0.0 110.988 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.1 mm-40 -85.57 -25.37 26.76 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.492 0.317 . . . . 0.0 110.79 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 78.9 mm-40 -75.39 -31.68 60.54 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.756 0.422 . . . . 0.0 112.134 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.607 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.2 pp -71.2 155.28 93.26 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.167 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.05 158.09 40.84 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.451 2.101 . . . . 0.0 113.311 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.54 -3.58 25.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.697 1.199 . . . . 0.0 111.855 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 5.4 p80 -159.25 156.77 29.4 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.223 0.609 . . . . 0.0 110.513 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.417 ' HD2' HD13 ' A' ' 395' ' ' ILE . 50.2 m-85 -128.29 103.76 7.35 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 133.81 176.8 14.55 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.511 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.82 129.86 19.65 Favored 'Cis proline' 0 C--N 1.376 2.009 0 CA-C-N 120.008 1.904 . . . . 0.0 112.645 -4.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -154.24 -161.62 10.58 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.806 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -74.02 130.76 14.71 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.756 2.304 . . . . 0.0 111.176 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.2 p -38.01 -48.41 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.661 1.984 . . . . 0.0 113.63 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -72.97 -39.95 65.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.797 1.639 . . . . 0.0 112.134 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.33 -43.18 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.451 0.301 . . . . 0.0 110.718 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.35 -40.18 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.369 0.668 . . . . 0.0 111.892 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -67.95 -40.22 83.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.48 ' N ' HD12 ' A' ' 392' ' ' LEU . 5.5 ptt180 -70.69 -24.81 62.74 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.989 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -65.26 -42.05 93.65 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.816 0.846 . . . . 0.0 110.907 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.417 HD13 ' HD2' ' A' ' 383' ' ' PHE . 34.5 mm -64.81 -50.68 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 400' ' ' VAL . 99.2 t -59.27 -52.72 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.539 -1.209 . . . . 0.0 111.689 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.447 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.2 pt20 -65.54 -34.33 78.0 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.292 0.637 . . . . 0.0 110.793 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -69.12 -36.88 77.96 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 123.856 0.723 . . . . 0.0 110.586 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 89.2 m -68.56 -42.75 77.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.196 0.598 . . . . 0.0 111.462 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 396' ' ' VAL . 21.5 t -70.51 -41.66 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.774 0.43 . . . . 0.0 109.858 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.74 -40.93 96.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.922 0.889 . . . . 0.0 111.024 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.607 ' SG ' HD23 ' A' ' 379' ' ' LEU . 71.5 m -93.1 10.78 30.16 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.469 0.708 . . . . 0.0 111.975 -176.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.609 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -87.4 143.39 27.26 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.21 131.71 39.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 61.11 57.21 2.55 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 122.134 0.968 . . . . 0.0 109.741 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 32.1 m -50.37 -32.48 17.53 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.956 1.702 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -61.19 -34.65 75.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 112.949 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -81.8 -34.53 30.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.509 0.724 . . . . 0.0 109.953 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.609 HG21 ' HB1' ' A' ' 403' ' ' ALA . 45.7 t -71.4 -26.5 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.33 -23.2 61.89 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.064 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -80.82 -9.16 86.67 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.19 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 409' ' ' VAL . 31.2 m-85 -72.12 -21.89 61.41 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 117.787 0.793 . . . . 0.0 111.138 176.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.08 146.39 45.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.746 0.818 . . . . 0.0 110.624 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -116.75 155.75 48.65 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.071 0.948 . . . . 0.0 110.247 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.53 131.11 25.27 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.173 1.915 . . . . 0.0 112.065 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -102.57 167.77 9.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.725 1.21 . . . . 0.0 108.965 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -131.95 43.7 3.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.695 0.76 . . . . 0.0 111.96 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -104.8 2.49 30.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.482 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.25 32.01 75.43 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.229 0.331 . . . . 0.0 113.301 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.03 -117.04 1.5 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 113.711 0.244 . . . . 0.0 113.711 -172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 18.7 mm-40 -89.94 170.37 10.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.089 0.556 . . . . 0.0 111.457 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 434' ' ' ILE . 60.3 t -131.51 128.72 61.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 122.749 0.419 . . . . 0.0 109.96 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 433' ' ' SER . 43.4 mm -114.23 128.57 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.9 p -105.57 144.49 32.26 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.024 0.929 . . . . 0.0 109.862 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -157.05 127.67 6.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.05 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 60.4 p -72.49 124.63 25.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.243 0.617 . . . . 0.0 109.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -147.14 115.74 6.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.625 0.77 . . . . 0.0 109.918 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.3 t70 64.46 23.97 13.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.762 1.225 . . . . 0.0 111.504 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.63 -16.03 60.23 Favored Glycine 0 N--CA 1.471 0.97 0 O-C-N 121.89 -0.506 . . . . 0.0 113.138 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -97.88 168.69 10.15 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.592 0.757 . . . . 0.0 109.796 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.2 t -113.22 104.8 12.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -97.79 125.42 42.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.02 0.928 . . . . 0.0 110.378 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.5 p -118.19 138.78 52.08 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.748 0.819 . . . . 0.0 109.784 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 422' ' ' VAL . 23.8 pt -117.31 171.63 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.024 0.53 . . . . 0.0 109.863 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 77.8 mt-30 -102.62 150.45 23.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 170.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 80.1 mt -115.94 164.41 17.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.229 1.412 . . . . 0.0 108.278 169.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.82 139.03 32.73 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.898 1.732 . . . . 0.0 111.153 168.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.76 127.86 6.49 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.107 1.871 . . . . 0.0 110.994 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.67 164.35 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.09 0.471 . . . . 0.0 109.845 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -151.22 23.31 0.73 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.901 0.88 . . . . 0.0 110.163 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 388' ' ' VAL . 47.7 t -124.69 137.28 54.36 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.73 65.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.9 t -69.88 -21.27 63.34 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.033 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.4 -29.72 24.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.42 -67.51 0.27 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.995 0.918 . . . . 0.0 111.895 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 450' ' ' GLU . 0.1 OUTLIER -62.79 -45.06 94.42 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.651 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -59.48 -29.47 67.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.922 0.889 . . . . 0.0 112.399 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -61.84 -60.91 2.94 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.51 0.724 . . . . 0.0 109.609 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -76.97 -13.91 59.91 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 112.32 -177.008 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 446' ' ' LEU . 38.2 mt-10 -58.16 -41.66 84.29 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.883 0.765 . . . . 0.0 110.921 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -68.61 -44.57 74.0 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.398 0.437 . . . . 0.0 110.584 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.466 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 62.9 t80 -60.85 -52.62 64.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.622 0.769 . . . . 0.0 110.749 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.5 -34.29 76.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.699 1.2 . . . . 0.0 111.583 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -69.32 -32.98 72.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.842 0.457 . . . . 0.0 110.261 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.1 m -72.21 -28.44 63.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.52 0.728 . . . . 0.0 110.409 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 22.7 mt -80.9 -12.9 59.33 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.315 0.646 . . . . 0.0 111.292 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 76.27 5.39 3.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 126.562 1.945 . . . . 0.0 111.933 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.478 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.9 p -89.99 140.25 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.818 0.447 . . . . 0.0 110.102 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 23.3 t70 -148.6 151.92 35.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -174.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 9.6 p30 47.62 27.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.788 1.235 . . . . 0.0 112.539 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.41 -10.49 59.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.08 0.952 . . . . 0.0 109.443 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.85 158.01 35.97 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.629 0.772 . . . . 0.0 109.921 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 25.0 p -145.56 109.81 4.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.287 0.635 . . . . 0.0 109.937 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 16.5 t -76.72 -5.51 48.34 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.306 0.643 . . . . 0.0 111.159 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -114.37 120.07 38.87 Favored Pre-proline 0 C--N 1.351 0.648 0 C-N-CA 123.629 0.771 . . . . 0.0 109.415 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.16 176.78 9.49 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.451 2.767 . . . . 0.0 112.024 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -63.23 -34.99 78.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.386 0.674 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 123.885 0.874 . . . . 0.0 109.03 175.199 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 49.8 m -148.61 156.73 42.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.73 0.812 . . . . 0.0 110.346 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -79.0 81.5 5.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.154 0.582 . . . . 0.0 109.805 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.3 ptp -72.81 -16.14 61.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.98 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -137.96 163.46 31.47 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.008 1.323 . . . . 0.0 109.503 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.3 t -79.14 -172.91 3.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.686 0.794 . . . . 0.0 110.613 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.1 p -140.08 135.62 32.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 110.028 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 25.8 m -136.7 156.61 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 124.208 1.003 . . . . 0.0 110.88 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.547 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 26.3 p -119.54 107.15 12.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.521 0.728 . . . . 0.0 109.263 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 56.1 t -96.67 150.54 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -129.21 104.33 7.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.434 1.094 . . . . 0.0 108.564 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.467 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 64.8 t -74.28 105.17 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 110.31 -176.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 41.2 t30 -88.31 87.82 7.43 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -17.43 63.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.306 175.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -71.69 -17.99 62.2 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.592 . . . . 0.0 110.547 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -82.14 -167.63 40.12 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.832 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -68.03 129.28 39.45 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.964 0.506 . . . . 0.0 110.479 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.48 ' HB3' HG13 ' A' ' 376' ' ' ILE . 0.9 OUTLIER -75.95 -58.85 3.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.639 -173.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.42 -91.13 0.08 OUTLIER Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.341 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.5 19.86 33.93 Favored 'Cis proline' 0 C--N 1.37 1.702 0 CA-C-N 120.502 2.151 . . . . 0.0 114.31 11.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -77.15 -6.19 51.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.525 0.33 . . . . 0.0 111.359 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 456' ' ' LEU . 31.1 mt -111.28 142.91 42.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.397 1.079 . . . . 0.0 108.832 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.81 122.32 87.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.069 0.548 . . . . 0.0 110.159 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 26.1 Cg_endo -59.08 -28.21 87.19 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.283 2.655 . . . . 0.0 114.247 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.79 -48.08 23.15 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.384 0.427 . . . . 0.0 109.937 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -67.83 -28.78 67.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.559 0.744 . . . . 0.0 111.661 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.506 HD13 HD21 ' A' ' 379' ' ' LEU . 12.7 mm -60.35 -29.66 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.933 172.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 57.0 mm-40 -85.15 -25.38 27.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.612 0.365 . . . . 0.0 110.602 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 65.9 mm-40 -82.26 -24.06 34.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.016 0.527 . . . . 0.0 112.116 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.506 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -74.59 158.71 84.67 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.25 153.39 74.53 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.153 1.902 . . . . 0.0 112.718 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.99 -18.2 65.08 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.114 1.365 . . . . 0.0 112.386 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.467 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.6 p80 -161.97 160.14 27.39 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.197 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.513 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.3 m-85 -124.76 104.66 8.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 135.09 161.51 9.41 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.631 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -79.15 129.87 19.26 Favored 'Cis proline' 0 C--N 1.373 1.857 0 CA-C-N 120.147 1.973 . . . . 0.0 112.123 4.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.99 -176.04 34.64 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.667 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.46 133.91 33.98 Favored 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 112.838 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -38.27 -46.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 127.038 2.135 . . . . 0.0 113.621 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -76.81 -37.4 55.81 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.168 0.987 . . . . 0.0 111.684 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.0 t -74.41 -41.23 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 357' ' ' VAL . 74.2 t -61.36 -42.28 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.46 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.4 pp -70.42 -40.1 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.49 ' N ' HD12 ' A' ' 392' ' ' LEU . 16.2 ptm180 -68.52 -31.85 71.39 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 27.7 mmm-85 -72.35 -32.69 66.7 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.513 HD13 ' HD2' ' A' ' 383' ' ' PHE . 18.2 mm -65.4 -53.43 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 400' ' ' VAL . 93.9 t -55.76 -53.84 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 124.34 1.025 . . . . 0.0 110.749 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.36 -37.55 77.66 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' CYS . . . . . 0.617 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 83.3 m -71.75 -40.42 69.36 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.023 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 396' ' ' VAL . 74.8 t -68.56 -32.99 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.093 0.557 . . . . 0.0 110.42 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.77 -51.01 68.8 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.182 0.593 . . . . 0.0 109.973 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 29.6 p -79.36 -10.57 59.84 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.447 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -57.62 119.07 5.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.581 1.152 . . . . 0.0 113.459 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.24 116.94 7.1 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.852 167.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 63.58 68.73 0.58 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.026 0.917 . . . . 0.0 108.7 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.9 m -54.73 -40.93 69.78 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.466 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -50.86 -40.12 55.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.778 1.231 . . . . 0.0 113.878 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -84.98 -35.17 22.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.379 0.672 . . . . 0.0 110.207 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.5 t -66.15 -33.61 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.52 0.728 . . . . 0.0 111.063 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.45 -11.37 59.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.988 0.915 . . . . 0.0 110.083 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.75 -9.75 84.93 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.268 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.65 0.73 55.27 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.613 0.765 . . . . 0.0 111.597 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -142.7 133.74 25.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.274 0.63 . . . . 0.0 110.482 176.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -114.2 159.43 36.47 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 124.025 0.93 . . . . 0.0 109.764 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.45 143.07 30.55 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.029 1.819 . . . . 0.0 111.022 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -139.25 132.87 30.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -87.89 25.7 1.49 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -164.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -9.07 58.3 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.363 0.665 . . . . 0.0 110.871 171.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 67.28 31.91 78.43 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.556 0.535 . . . . 0.0 114.006 172.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.11 -121.07 1.2 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 123.598 0.234 . . . . 0.0 112.936 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.8 mp0 -82.26 172.71 12.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.842 0.857 . . . . 0.0 110.603 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 94.3 t -134.11 131.65 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.419 0.688 . . . . 0.0 109.837 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 433' ' ' SER . 46.5 mm -104.37 127.64 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 0.0 109.358 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.7 p -106.72 148.29 28.59 Favored 'General case' 0 C--O 1.241 0.635 0 O-C-N 123.906 0.754 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.01 170.97 20.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.849 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 52.3 m -103.2 115.87 31.39 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -142.87 125.46 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.359 0.663 . . . . 0.0 109.927 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 37.9 t70 67.08 16.45 10.29 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.916 1.286 . . . . 0.0 111.641 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 96.78 -15.41 62.72 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.95 -0.469 . . . . 0.0 112.937 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.77 171.21 8.92 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.174 0.99 . . . . 0.0 110.12 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.0 t -97.04 102.81 14.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -91.11 133.89 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 36.5 p -132.64 126.98 33.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 109.352 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.479 HD11 HD12 ' A' ' 413' ' ' LEU . 2.2 pp -117.07 163.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.838 0.855 . . . . 0.0 109.525 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -100.75 150.81 22.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.516 0.674 . . . . 0.0 111.206 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 421' ' ' GLU . 81.7 mt -114.59 160.75 31.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.296 1.438 . . . . 0.0 109.013 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.46 136.44 19.49 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 121.84 1.693 . . . . 0.0 111.519 164.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.81 144.53 31.09 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.92 2.414 . . . . 0.0 112.055 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.7 172.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.036 0.534 . . . . 0.0 110.846 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -154.91 4.19 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.367 0.667 . . . . 0.0 112.114 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.1 t -122.6 141.56 51.58 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.041 0.536 . . . . 0.0 110.212 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.77 -36.19 70.3 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.292 1.037 . . . . 0.0 112.499 -170.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 39.8 m -66.54 -22.15 66.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.313 0.645 . . . . 0.0 111.075 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.84 -22.52 25.76 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.725 0.41 . . . . 0.0 109.973 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.39 -66.24 0.42 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -29.38 68.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.587 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.3 -33.12 75.22 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.813 0.445 . . . . 0.0 110.864 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.66 -45.52 82.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.066 0.546 . . . . 0.0 110.749 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.35 -13.86 42.33 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.555 -179.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.6 -50.48 73.0 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.868 0.867 . . . . 0.0 111.375 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -67.41 -29.65 69.2 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.989 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.449 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 54.9 t80 -73.29 -42.63 62.19 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.216 0.606 . . . . 0.0 110.985 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.428 ' HA ' HD12 ' A' ' 456' ' ' LEU . 72.8 m -67.01 -26.83 66.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.918 0.887 . . . . 0.0 110.416 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -67.62 -38.8 84.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.19 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 18.7 m -67.51 -30.68 70.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.924 0.89 . . . . 0.0 111.132 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 371' ' ' LEU . 33.3 mt -82.28 -17.43 45.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 0.0 111.425 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 71.41 7.83 6.14 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.987 1.715 . . . . 0.0 111.758 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.426 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 24.7 p -75.82 135.77 40.22 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.103 0.478 . . . . 0.0 110.359 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 26.7 t70 -127.37 141.37 51.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.642 0.777 . . . . 0.0 110.605 -174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 8.0 p30 46.35 25.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.163 1.785 . . . . 0.0 113.286 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 52.9 tp -76.82 -15.61 59.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.339 1.055 . . . . 0.0 111.279 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -158.98 159.28 34.66 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.016 0.526 . . . . 0.0 110.184 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 61.7 p -160.63 129.71 4.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.247 0.619 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 21.6 t -80.55 4.29 18.93 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.243 0.617 . . . . 0.0 111.462 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.47 117.71 68.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.087 0.955 . . . . 0.0 109.209 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.14 174.83 11.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.084 2.523 . . . . 0.0 112.881 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -65.65 -30.91 71.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.157 0.583 . . . . 0.0 110.99 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.557 1.231 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.093 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.87 -0.092 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 60.2 p -87.85 157.38 19.01 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.742 0.817 . . . . 0.0 110.16 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 35.7 t60 62.32 28.46 16.94 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.031 0.933 . . . . 0.0 109.26 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 21.3 ttt -70.15 149.48 47.51 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -97.63 172.55 7.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.404 0.682 . . . . 0.0 110.583 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -79.36 -179.04 6.56 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.162 0.585 . . . . 0.0 110.171 175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.1 p -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 0.0 110.972 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 3.1 m -137.76 157.47 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.567 1.147 . . . . 0.0 109.525 173.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 464' ' ' SER . 7.7 p -137.57 101.59 4.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.641 HG21 HD11 ' A' ' 395' ' ' ILE . 29.0 m -94.34 151.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.23 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 53.6 m-85 -110.05 100.49 9.42 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 23.2 t -70.65 88.38 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.8 0.688 . . . . 0.0 109.735 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -85.04 88.23 7.44 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.865 -174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -70.62 -12.45 61.57 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.731 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -76.26 -28.56 57.13 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.745 0.818 . . . . 0.0 111.134 173.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -61.22 -76.23 0.25 Allowed Glycine 0 C--N 1.353 1.523 0 O-C-N 123.429 0.456 . . . . 0.0 112.838 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.4 t30 -152.92 143.2 22.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.498 ' HA ' HG21 ' A' ' 376' ' ' ILE . 1.0 OUTLIER -86.06 -62.64 1.47 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.58 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.19 -94.81 0.17 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.271 0.982 . . . . 0.0 112.763 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -90.13 15.89 46.11 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.326 2.063 . . . . 0.0 113.804 10.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -82.69 -2.26 53.63 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 110.063 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.58 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 31.6 mt -109.83 142.91 40.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.126 1.37 . . . . 0.0 108.034 172.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' HE3' ' A' ' 374' ' ' LYS . 16.2 t70 -70.27 120.16 76.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.161 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.41 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 31.8 Cg_endo -60.71 -28.38 86.42 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.205 2.603 . . . . 0.0 114.192 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.06 -47.9 26.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.808 0.443 . . . . 0.0 110.706 -178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -67.49 -29.99 69.56 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.632 0.582 . . . . 0.0 111.146 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 379' ' ' LEU . 22.4 mm -62.01 -31.79 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.92 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.31 -24.68 42.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.211 0.604 . . . . 0.0 111.159 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.8 mm-40 -81.9 -34.76 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.033 0.533 . . . . 0.0 112.258 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 376' ' ' ILE . 2.4 pp -70.24 153.99 94.84 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.543 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -41.69 152.94 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 124.519 3.479 . . . . 0.0 116.052 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -86.41 -11.15 52.74 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.817 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -160.86 144.97 13.65 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.43 1.092 . . . . 0.0 110.013 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -120.61 128.9 53.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.98 179.57 33.0 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.958 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.79 137.42 46.15 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 120.341 2.07 . . . . 0.0 113.437 2.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 175.92 -166.05 37.03 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.768 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 17.9 Cg_endo -59.27 129.58 32.14 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.379 2.72 . . . . 0.0 113.369 -169.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.863 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.7 p -47.24 -44.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.796 1.638 . . . . 0.0 111.81 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.99 -45.3 93.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.081 1.352 . . . . 0.0 111.465 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -74.08 -51.72 22.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.74 -40.03 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.54 HD13 ' HD2' ' A' ' 448' ' ' PHE . 3.7 pp -68.14 -42.55 79.95 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.499 ' N ' HD12 ' A' ' 392' ' ' LEU . 14.0 ptt180 -74.91 -25.5 58.97 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 25.4 mmm180 -66.97 -34.37 77.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.911 0.884 . . . . 0.0 110.494 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.641 HD11 HG21 ' A' ' 359' ' ' VAL . 42.8 mm -64.58 -56.65 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 400' ' ' VAL . 58.5 t -60.81 -47.57 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 124.875 1.36 . . . . 0.0 111.817 -171.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLN . . . . . 0.494 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.3 pt20 -71.12 -34.98 71.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.826 0.45 . . . . 0.0 111.548 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.71 77.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.758 0.423 . . . . 0.0 109.925 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 371' ' ' LEU . 48.4 t -71.71 -43.29 66.18 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.161 0.984 . . . . 0.0 111.586 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 406' ' ' THR . 11.1 t -66.81 -45.87 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.93 -37.91 87.28 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.4 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' CYS . . . . . 0.469 ' SG ' HD23 ' A' ' 379' ' ' LEU . 93.1 m -83.24 -10.24 58.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.005 0.522 . . . . 0.0 111.773 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.583 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.61 141.88 55.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.2 122.6 23.04 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.801 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 409' ' ' VAL . 41.3 tt0 65.34 59.85 0.79 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.593 HG23 HG12 ' A' ' 400' ' ' VAL . 98.0 m -53.88 -31.06 48.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.899 1.68 . . . . 0.0 112.636 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -58.31 -39.83 80.43 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.676 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 64.9 m -82.13 -28.91 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.238 0.615 . . . . 0.0 110.431 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.583 HG21 ' HB1' ' A' ' 403' ' ' ALA . 60.0 t -72.03 -31.47 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.089 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -64.23 -21.87 66.74 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.636 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -69.45 -27.13 73.86 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.947 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.446 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 89.3 m-85 -75.7 -4.81 42.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.036 0.534 . . . . 0.0 112.313 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.05 136.42 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.189 0.595 . . . . 0.0 111.247 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -119.83 151.03 51.77 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.268 1.027 . . . . 0.0 111.013 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 435' ' ' GLN . 60.2 Cg_endo -69.69 156.57 63.16 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.651 2.234 . . . . 0.0 114.199 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.25 154.03 39.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.085 1.754 . . . . 0.0 109.119 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.12 30.52 4.78 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.199 0.523 . . . . 0.0 111.241 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -28.48 14.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 0.0 110.469 167.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.98 44.0 1.98 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.663 -0.244 . . . . 0.0 112.955 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.25 -132.22 5.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.7 OUTLIER -66.84 168.61 9.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.514 1.126 . . . . 0.0 111.454 -178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 422' ' ' VAL . . . . . 0.432 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 98.4 t -136.15 130.1 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 436' ' ' LEU . 29.1 mm -114.9 134.03 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.251 0.62 . . . . 0.0 109.368 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 22.4 p -105.96 139.93 39.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.75 0.82 . . . . 0.0 109.602 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.69 125.56 5.91 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.918 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.6 m -82.66 108.66 16.2 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 122.982 0.513 . . . . 0.0 110.752 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -131.92 143.0 49.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.209 1.004 . . . . 0.0 109.078 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 66.06 16.56 10.5 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.711 1.204 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.44 0.15 86.28 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.94 -172.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -107.92 159.04 16.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.197 0.999 . . . . 0.0 109.669 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.3 t -91.84 122.92 34.82 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -122.84 152.2 40.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.731 0.812 . . . . 0.0 109.72 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 62.2 p -143.69 144.4 31.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.015 0.526 . . . . 0.0 110.725 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.1 pt -125.86 -177.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.285 1.034 . . . . 0.0 109.059 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 74.3 mt-30 -115.27 148.49 39.11 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.103 0.561 . . . . 0.0 110.425 171.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 10.5 mp -116.56 147.48 39.83 Favored Pre-proline 0 N--CA 1.485 1.296 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.79 132.7 43.88 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.501 2.134 . . . . 0.0 112.61 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.77 129.8 20.57 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.805 2.337 . . . . 0.0 114.027 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.8 m -92.08 175.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.556 1.143 . . . . 0.0 110.602 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -155.12 11.04 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.8 t -126.9 141.35 51.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.23 0.468 . . . . 0.0 110.503 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.72 64.5 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.939 0.896 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.8 m -74.74 -28.16 60.66 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.263 0.625 . . . . 0.0 110.427 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 448' ' ' PHE . 3.8 t80 -84.24 -21.56 31.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.863 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.18 -63.18 1.21 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 124.428 1.091 . . . . 0.0 111.048 174.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.08 -41.08 71.12 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.272 -167.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 36.0 ttm180 -61.19 -33.82 74.07 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 124.68 1.237 . . . . 0.0 111.735 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 392' ' ' LEU . 4.3 t80 -68.74 -37.71 79.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 -173.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.39 -16.27 33.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.817 171.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 0.9 OUTLIER -64.4 -40.07 95.08 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.706 0.403 . . . . 0.0 110.522 -173.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.29 -45.95 90.97 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.556 0.742 . . . . 0.0 110.604 175.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.443 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 75.3 t80 -64.35 -53.51 47.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.751 -175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 82.6 m -63.35 -29.78 71.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.555 1.142 . . . . 0.0 111.823 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -69.72 -33.61 72.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.042 0.537 . . . . 0.0 110.797 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 42.7 m -71.0 -24.05 62.3 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.084 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.553 HD13 HD21 ' A' ' 371' ' ' LEU . 35.0 mt -100.18 -1.21 37.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.785 0.834 . . . . 0.0 111.048 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 71.71 7.33 5.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.115 1.766 . . . . 0.0 112.585 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.559 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 9.5 p -83.08 133.03 35.08 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 31.8 t70 -151.1 151.7 32.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.935 0.494 . . . . 0.0 109.779 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 59.59 14.97 4.27 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.585 0.754 . . . . 0.0 111.272 -170.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.48 -18.26 45.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.616 0.767 . . . . 0.0 111.013 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -164.21 151.71 12.11 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.639 0.775 . . . . 0.0 109.751 174.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 68.0 m -158.07 133.67 8.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 108.433 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 12.8 t -83.08 19.14 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.468 0.651 . . . . 0.0 112.066 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -147.75 154.11 43.68 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.719 1.608 . . . . 0.0 108.032 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.27 149.33 90.43 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.039 1.826 . . . . 0.0 111.586 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.74 -11.57 60.44 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.656 0.782 . . . . 0.0 111.506 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.015 1.326 . . . . 0.0 108.609 174.547 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 33.5 t -78.08 167.59 21.2 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 111.111 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -149.09 -33.99 0.2 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -52.84 61.99 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.454 0.702 . . . . 0.0 111.789 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -169.82 173.22 6.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.658 0.783 . . . . 0.0 110.11 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.0 m -80.31 176.27 9.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.79 0.436 . . . . 0.0 110.232 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 76.2 p -133.9 138.63 45.66 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.617 0.767 . . . . 0.0 109.293 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 388' ' ' VAL . 22.1 m -139.07 163.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.527 0.731 . . . . 0.0 110.788 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 26.6 p -136.81 127.42 27.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.477 1.111 . . . . 0.0 108.068 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 28.9 m -112.91 161.71 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.104 0.561 . . . . 0.0 110.656 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -120.14 102.78 8.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.14 103.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.733 0.813 . . . . 0.0 110.899 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 53.7 t30 -96.16 85.54 4.03 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.881 0.848 . . . . 0.0 109.267 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.69 -23.97 65.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.473 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -73.45 -17.99 61.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.785 0.834 . . . . 0.0 111.471 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -67.8 -89.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.517 0 C-N-CA 123.101 0.381 . . . . 0.0 112.867 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 49.6 t-20 -141.72 148.31 38.82 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 0.5 OUTLIER -90.48 -64.64 1.1 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.265 1.026 . . . . 0.0 108.264 -173.045 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.22 -94.91 0.18 Allowed Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.358 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -88.52 18.04 38.01 Favored 'Cis proline' 0 C--N 1.373 1.866 0 CA-C-N 120.374 2.087 . . . . 0.0 114.293 9.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' HIS . . . . . 0.429 ' HB3' HG22 ' A' ' 409' ' ' VAL . 68.2 m80 -72.3 -18.42 61.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.201 0.6 . . . . 0.0 110.733 168.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.3 mt -104.74 140.01 38.7 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.939 1.295 . . . . 0.0 108.962 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.62 122.47 86.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.46 0.475 . . . . 0.0 110.385 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.3 Cg_endo -56.89 -34.0 96.12 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.659 2.906 . . . . 0.0 114.58 -173.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.44 -45.0 49.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.808 0.443 . . . . 0.0 110.702 -176.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.95 -29.78 68.92 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.706 0.629 . . . . 0.0 111.205 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 367' ' ' PHE . 21.6 mm -64.85 -30.67 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.977 0.911 . . . . 0.0 111.245 173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 75.5 mm-40 -79.95 -17.48 52.89 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 122.093 -0.379 . . . . 0.0 110.8 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.5 mm-40 -86.97 -5.8 58.97 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.757 0.423 . . . . 0.0 111.094 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 167.67 11.44 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.156 0.582 . . . . 0.0 111.542 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 158.22 58.05 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 121.761 1.64 . . . . 0.0 111.383 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.0 -18.08 59.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.545 0.738 . . . . 0.0 111.673 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -163.84 160.81 22.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 111.193 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -126.36 157.79 37.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.69 1.196 . . . . 0.0 108.878 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 81.95 -177.19 53.9 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.51 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 128.99 17.56 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.591 1.695 . . . . 0.0 112.302 -1.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.25 -172.91 30.28 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.42 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.36 129.95 35.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.219 2.613 . . . . 0.0 112.574 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.846 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.48 -46.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.656 1.983 . . . . 0.0 112.891 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.76 -36.95 81.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.908 1.283 . . . . 0.0 112.379 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 69.0 t -79.01 -47.19 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.195 -0.316 . . . . 0.0 110.646 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.46 -31.68 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 122.656 0.382 . . . . 0.0 111.715 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.0 pp -74.17 -41.13 61.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.111 0.164 . . . . 0.0 110.766 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.454 ' N ' HD12 ' A' ' 392' ' ' LEU . 6.2 ptt180 -69.49 -26.55 64.61 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -66.17 -31.78 72.83 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.806 0.842 . . . . 0.0 111.282 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 32.1 mm -74.71 -49.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 400' ' ' VAL . 94.5 t -59.62 -48.87 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 124.148 0.905 . . . . 0.0 111.424 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -71.8 -27.8 63.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.505 0.322 . . . . 0.0 111.29 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.85 90.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.82 -60.7 2.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 110.806 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 396' ' ' VAL . 43.1 t -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.039 0.936 . . . . 0.0 111.797 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.28 -46.67 66.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.723 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 71.9 m -80.08 3.22 21.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.137 0.575 . . . . 0.0 112.219 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -72.58 137.9 46.48 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.854 0.861 . . . . 0.0 112.411 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 404' ' ' LEU . 2.5 pp -84.86 132.57 34.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 57.82 61.72 2.31 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.371 1.082 . . . . 0.0 109.618 -172.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.1 m -57.27 -26.98 61.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.489 1.515 . . . . 0.0 112.614 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -60.46 -31.44 70.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.99 0.916 . . . . 0.0 112.438 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -75.41 -44.9 42.15 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.853 0.861 . . . . 0.0 109.576 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.535 HG21 ' HB1' ' A' ' 403' ' ' ALA . 97.9 t -68.78 -27.66 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-N 114.194 -1.367 . . . . 0.0 111.338 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.51 -30.05 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.361 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.11 -16.26 40.18 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -85.02 -17.35 37.8 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.393 0.677 . . . . 0.0 111.866 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.04 135.52 31.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.277 0.56 . . . . 0.0 112.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -113.4 168.68 7.42 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.609 0.764 . . . . 0.0 109.176 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.0 136.65 35.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 121.785 1.657 . . . . 0.0 112.742 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -141.7 99.51 3.56 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.012 1.725 . . . . 0.0 107.446 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -85.09 72.44 10.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.539 1.161 . . . . 0.0 108.814 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -97.39 -2.84 41.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.754 -1.567 . . . . 0.0 109.869 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 79.2 27.62 55.28 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -103.99 -120.79 4.82 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.507 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 14.6 mm-40 -84.88 178.91 7.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.116 0.567 . . . . 0.0 111.507 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.91 126.1 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 122.868 0.467 . . . . 0.0 110.426 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.24 143.05 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.423 1.089 . . . . 0.0 108.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 2.9 p -107.06 142.07 37.28 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.209 0.603 . . . . 0.0 109.824 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -132.16 115.95 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.279 1.031 . . . . 0.0 109.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 102.17 4.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.039 0.536 . . . . 0.0 110.275 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -123.34 120.62 33.58 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.289 1.036 . . . . 0.0 109.193 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.9 t70 57.23 50.13 12.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.212 1.405 . . . . 0.0 112.198 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 79.66 -3.91 66.93 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.372 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -118.56 171.71 7.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.085 0.954 . . . . 0.0 108.832 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.3 t -127.73 111.43 13.67 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.586 0.708 . . . . 0.0 109.955 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -94.57 127.0 40.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.573 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.0 p -95.35 138.78 32.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.071 0.949 . . . . 0.0 109.775 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.73 171.28 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.778 1.231 . . . . 0.0 109.263 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -115.38 143.77 44.78 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.235 0.541 . . . . 0.0 110.6 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 8.0 mp -113.88 155.8 44.72 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.072 1.349 . . . . 0.0 108.16 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.52 143.92 64.83 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.189 1.926 . . . . 0.0 111.762 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.34 155.22 25.04 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.295 1.997 . . . . 0.0 111.796 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.89 169.35 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 122.862 0.465 . . . . 0.0 109.864 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -147.47 8.36 0.9 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.108 0.563 . . . . 0.0 111.869 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 388' ' ' VAL . 46.3 t -115.9 138.67 50.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.631 0.372 . . . . 0.0 110.131 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -73.16 -26.54 61.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.031 0.932 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 31.4 m -72.03 -29.4 64.13 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.535 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.94 -21.09 29.75 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.846 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.43 -63.29 1.09 Allowed 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.098 0.873 . . . . 0.0 110.153 171.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 16.9 mt -65.1 -50.12 67.33 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 113.175 -1.829 . . . . 0.0 109.319 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -32.74 57.78 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 125.146 1.529 . . . . 0.0 112.706 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' PHE . . . . . 0.445 ' HE1' HD23 ' A' ' 436' ' ' LEU . 4.4 t80 -65.12 -49.19 70.9 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.651 0.381 . . . . 0.0 110.564 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.11 -15.83 35.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 0.8 OUTLIER -65.15 -46.64 80.05 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 109.699 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -37.84 85.14 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.033 0.833 . . . . 0.0 110.06 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 43.0 t80 -65.5 -50.66 64.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.57 0.748 . . . . 0.0 111.217 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.28 -28.54 67.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.089 0.956 . . . . 0.0 110.823 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.63 -34.16 75.26 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.993 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.9 m -75.05 -25.08 58.39 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.682 0.793 . . . . 0.0 110.962 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 371' ' ' LEU . 67.3 mt -82.91 -12.0 57.72 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.013 0.525 . . . . 0.0 110.977 173.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 74.67 8.14 4.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.782 1.633 . . . . 0.0 111.562 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.461 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 11.2 p -86.9 134.3 33.53 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.7 t70 -146.36 157.08 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.036 . . . . 0.0 108.379 -173.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 15.4 m-80 63.2 15.92 8.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.24 1.016 . . . . 0.0 111.109 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -83.34 -18.58 38.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.725 0.81 . . . . 0.0 111.366 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.78 166.15 26.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.365 0.666 . . . . 0.0 110.662 175.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 47.8 t -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.021 0.928 . . . . 0.0 108.769 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.466 ' HB2' HD21 ' A' ' 446' ' ' LEU . 39.9 t -69.53 -24.02 63.68 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.425 0.69 . . . . 0.0 111.592 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -102.67 148.77 36.01 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 109.776 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.12 143.42 90.21 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.649 2.233 . . . . 0.0 112.155 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.56 -19.66 62.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.768 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.95 0.9 . . . . 0.0 109.549 177.147 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 48.9 m -69.35 120.95 15.95 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 111.114 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -76.7 80.9 3.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.073 0.549 . . . . 0.0 109.526 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.6 ptm -90.58 -33.62 15.81 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -101.76 152.41 20.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.657 0.783 . . . . 0.0 108.891 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 20.8 t -79.97 178.66 8.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.165 0.586 . . . . 0.0 110.241 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.0 p -131.9 134.17 45.39 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.772 0.829 . . . . 0.0 109.541 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.05 171.23 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.598 1.159 . . . . 0.0 109.565 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 52.6 t -146.85 105.97 3.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.659 0.784 . . . . 0.0 109.152 178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 395' ' ' ILE . 34.3 m -91.99 153.61 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.87 99.78 6.56 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' VAL . . . . . 0.401 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.2 t -63.96 98.85 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.537 1.148 . . . . 0.0 109.86 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -91.87 89.24 6.95 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.753 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -73.84 -9.26 58.47 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.166 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -74.25 -20.01 60.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.231 0.613 . . . . 0.0 109.804 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.29 -169.66 37.93 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.752 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -69.57 141.1 53.84 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.583 0.691 . . . . 0.0 110.497 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.58 -56.48 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.665 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.1 -83.84 0.06 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.494 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.17 1.42 23.95 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 120.53 2.165 . . . . 0.0 114.381 -0.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 16.3 p-80 -65.66 -16.11 63.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.966 0.906 . . . . 0.0 112.228 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.665 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 42.2 mt -95.46 136.55 35.69 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.855 0.862 . . . . 0.0 108.923 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.09 113.23 8.68 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 124.33 1.019 . . . . 0.0 110.119 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 34.7 Cg_endo -62.17 -16.89 53.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.182 2.588 . . . . 0.0 114.243 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -82.25 -49.18 10.37 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.104 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -62.48 -35.64 79.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.435 1.094 . . . . 0.0 111.95 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.55 -30.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.711 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 84.4 mm-40 -85.39 -19.27 31.64 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.977 -0.452 . . . . 0.0 111.236 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 66.8 mm-40 -81.64 -35.85 29.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.732 0.413 . . . . 0.0 111.277 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.1 pp -68.17 157.14 88.25 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.89 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.63 161.73 23.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.928 2.419 . . . . 0.0 114.078 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.8 -17.15 59.96 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.159 -173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.6 p80 -162.49 160.55 26.3 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.09 102.95 6.47 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 140.56 169.37 11.7 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.848 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.46 129.78 19.61 Favored 'Cis proline' 0 C--N 1.381 2.241 0 CA-C-N 119.512 1.656 . . . . 0.0 112.636 0.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.04 -165.55 15.71 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.306 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.28 141.65 16.29 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.834 2.356 . . . . 0.0 112.314 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.5 p -46.55 -45.05 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.993 1.717 . . . . 0.0 113.329 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -75.74 -35.29 60.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.098 0.959 . . . . 0.0 111.888 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 80.1 t -76.92 -46.15 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.44 -38.69 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.19 0.596 . . . . 0.0 112.116 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.3 -41.22 70.2 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 122.945 0.153 . . . . 0.0 111.204 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 12.0 ptp180 -67.57 -33.84 75.84 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 46.4 mmm-85 -63.07 -34.91 78.6 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.745 0.653 . . . . 0.0 111.711 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 359' ' ' VAL . 36.4 mm -68.09 -52.54 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 123.628 0.58 . . . . 0.0 109.797 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.19 -43.48 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.775 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.39 -21.97 59.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.84 0.456 . . . . 0.0 111.457 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -83.7 -16.73 43.86 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.359 0.664 . . . . 0.0 110.771 173.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.5 m -81.52 -61.88 1.81 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 122.876 0.471 . . . . 0.0 109.949 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.67 -50.65 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 0.0 111.071 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.22 -37.8 88.41 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.64 19.74 9.5 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.39 0.676 . . . . 0.0 111.522 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -85.13 150.65 24.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.334 0.654 . . . . 0.0 112.435 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 76.1 mt -66.45 114.12 5.21 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 162.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 61.96 73.43 0.47 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.284 0.99 . . . . 0.0 109.914 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.4 m -55.2 -41.18 71.66 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -54.59 -38.49 66.79 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 65.3 m -77.5 -38.57 48.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 403' ' ' ALA . 84.2 t -67.55 -26.65 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.367 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -75.03 -18.87 60.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.039 1.336 . . . . 0.0 110.147 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.08 -14.98 70.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 114.157 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -69.2 -37.46 78.1 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 117.871 0.836 . . . . 0.0 111.1 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.58 152.21 25.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.252 0.621 . . . . 0.0 109.818 175.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -117.19 157.54 46.68 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.844 0.858 . . . . 0.0 110.119 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.07 124.51 10.6 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 121.722 1.614 . . . . 0.0 111.54 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 49.7 m-20 -113.9 123.06 48.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.884 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -88.17 55.22 3.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.021 0.929 . . . . 0.0 110.007 -167.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.7 mpt_? -97.08 -32.24 12.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.09 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.22 33.09 8.32 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.127 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.78 -112.56 2.71 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.635 0.217 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.5 mp0 -79.08 165.26 23.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.854 0.862 . . . . 0.0 110.312 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.29 126.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.589 0.756 . . . . 0.0 109.155 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 436' ' ' LEU . 28.3 mm -106.26 122.96 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.238 0.615 . . . . 0.0 109.513 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 433' ' ' SER . 21.3 p -105.51 141.25 37.31 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.662 0.785 . . . . 0.0 109.816 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.56 130.82 6.04 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.497 -172.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 21.0 p -74.95 104.44 5.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.447 0.699 . . . . 0.0 109.882 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -114.61 107.34 15.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 0.0 109.359 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 36.1 t70 56.97 53.92 7.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.762 1.225 . . . . 0.0 111.502 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 86.18 -25.38 7.02 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.625 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.14 171.54 8.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.953 0.901 . . . . 0.0 109.569 -174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.1 t -115.63 104.17 11.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -110.73 160.54 16.62 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.862 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.406 ' HB3' HG22 ' A' ' 424' ' ' THR . 66.6 p -148.76 153.62 38.42 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.819 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.7 pt -123.08 166.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.624 0.77 . . . . 0.0 109.987 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 149.08 26.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.399 0.68 . . . . 0.0 109.813 172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.7 mp -115.86 159.48 38.9 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.941 1.296 . . . . 0.0 109.545 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.17 130.87 18.27 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.324 2.016 . . . . 0.0 111.765 164.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.07 151.83 56.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.909 2.406 . . . . 0.0 112.508 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.38 167.97 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.451 0.701 . . . . 0.0 110.733 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.78 2.68 0.94 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.987 0.515 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.4 m -119.15 140.08 50.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.958 0.503 . . . . 0.0 110.102 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.06 90.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.074 0.949 . . . . 0.0 112.373 -169.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.1 m -59.43 -28.51 67.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.608 0.763 . . . . 0.0 111.328 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -21.51 42.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.867 0.467 . . . . 0.0 110.147 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.8 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.26 -66.02 0.48 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 446' ' ' LEU . 0.2 OUTLIER -63.75 -43.87 95.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.797 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -33.58 70.28 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.531 0.732 . . . . 0.0 112.189 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.18 -51.55 67.36 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.55 0.531 . . . . 0.0 110.307 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -86.64 -15.3 40.14 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.667 -178.237 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 454' ' ' HIS . 1.7 tm-20 -61.77 -53.26 58.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.819 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -62.95 -40.91 99.1 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.975 0.797 . . . . 0.0 110.84 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.473 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 61.6 t80 -56.09 -64.31 0.9 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.558 1.143 . . . . 0.0 110.637 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 81.9 m -64.94 -27.17 68.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.728 1.211 . . . . 0.0 112.582 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 450' ' ' GLU . 51.2 t-80 -69.1 -41.63 77.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.644 0.777 . . . . 0.0 109.997 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.0 t -73.72 -7.95 54.09 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.416 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 92.0 mt -103.32 -6.41 22.02 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.71 0.804 . . . . 0.0 112.324 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 80.46 5.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.268 1.827 . . . . 0.0 112.682 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 453' ' ' CYS . 16.3 p -90.38 132.37 35.64 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -156.86 148.26 22.28 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 66.29 13.74 9.33 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.568 1.147 . . . . 0.0 110.736 -168.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.83 -20.31 35.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.129 0.571 . . . . 0.0 111.543 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.91 166.22 30.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.781 0.432 . . . . 0.0 110.506 175.012 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 37.2 p -162.79 121.69 2.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.704 0.802 . . . . 0.0 109.47 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 22.3 t -80.03 3.91 18.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.408 0.683 . . . . 0.0 111.816 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.6 116.42 59.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.376 1.07 . . . . 0.0 108.191 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.91 174.74 11.8 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.833 2.355 . . . . 0.0 112.752 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -78.0 -32.83 51.39 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.262 0.625 . . . . 0.0 110.561 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 123.489 0.716 . . . . 0.0 109.707 174.864 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 -173.4 2.03 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.413 0.685 . . . . 0.0 111.337 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 23.8 p -140.65 144.45 35.72 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.031 0.932 . . . . 0.0 110.569 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 19.3 m -145.03 174.22 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 125.257 1.423 . . . . 0.0 110.339 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 29.0 p -147.21 109.11 4.41 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.488 0.715 . . . . 0.0 109.82 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 33.8 m -98.21 149.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.192 0.597 . . . . 0.0 109.581 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -112.9 98.82 7.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 66.5 t -65.39 103.3 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 124.244 0.965 . . . . 0.0 110.706 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -98.63 99.87 11.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.669 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.19 -6.87 54.64 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.974 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -81.58 -21.83 38.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.392 0.677 . . . . 0.0 111.067 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.79 0.03 OUTLIER Glycine 0 C--N 1.353 1.516 0 O-C-N 123.35 0.406 . . . . 0.0 113.101 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 55.9 t-20 -131.91 150.75 52.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -91.38 -63.31 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -143.6 -93.49 0.18 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.317 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.06 18.98 31.82 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 120.469 2.135 . . . . 0.0 114.319 9.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.24 0.85 52.81 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.686 0.794 . . . . 0.0 110.783 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 456' ' ' LEU . 48.7 mt -116.21 145.93 42.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.65 1.18 . . . . 0.0 109.011 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.96 118.21 63.37 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 123.586 0.554 . . . . 0.0 109.675 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 36.1 Cg_endo -61.39 -29.82 86.16 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.779 2.319 . . . . 0.0 113.248 -173.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.498 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -72.78 -43.43 62.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.554 . . . . 0.0 110.581 -178.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -69.9 -30.27 67.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.153 0.581 . . . . 0.0 111.05 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.86 -31.11 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.492 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 77.7 mm-40 -82.81 -19.36 37.81 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 122.376 0.27 . . . . 0.0 111.324 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 83.3 mm-40 -80.1 -41.54 25.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.015 0.526 . . . . 0.0 112.061 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.499 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . 2.7 pp -65.18 163.94 27.2 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 123.828 0.851 . . . . 0.0 111.293 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 379' ' ' LEU . 74.0 Cg_endo -68.51 169.75 16.53 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 122.381 2.054 . . . . 0.0 114.565 -169.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.2 -20.91 54.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.832 1.253 . . . . 0.0 112.031 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.512 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 29.6 p80 -161.0 159.16 29.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.062 0.458 . . . . 0.0 111.224 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -125.11 102.04 7.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 141.14 167.51 11.13 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.454 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.65 129.89 19.63 Favored 'Cis proline' 0 C--N 1.381 2.249 0 CA-C-N 118.902 1.351 . . . . 0.0 112.498 -1.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.73 -178.83 37.67 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.192 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 42.3 Cg_endo -64.27 134.72 43.4 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.053 2.502 . . . . 0.0 114.434 -171.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -38.55 -48.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.337 2.255 . . . . 0.0 113.782 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -76.09 -33.7 59.51 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.63 1.172 . . . . 0.0 112.158 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.521 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 94.2 t -81.87 -35.39 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.513 0.325 . . . . 0.0 110.601 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.64 -42.67 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 122.174 0.19 . . . . 0.0 110.803 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.3 pp -67.0 -43.91 81.71 Favored 'General case' 0 C--N 1.359 0.988 0 O-C-N 123.189 0.306 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 397' ' ' GLN . 12.9 ptm180 -68.54 -33.9 74.92 Favored 'General case' 0 C--N 1.363 1.17 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -75.58 -20.18 58.78 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 32.4 mm -75.21 -52.58 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 167.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.6 t -58.5 -57.08 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.949 -172.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.4 pt20 -70.47 -23.83 62.76 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.797 0.439 . . . . 0.0 112.062 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.54 92.57 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 75.0 m -66.88 -47.66 71.16 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.946 0.779 . . . . 0.0 111.026 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 396' ' ' VAL . 12.3 t -65.35 -35.97 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.727 0.411 . . . . 0.0 110.344 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.51 -39.81 77.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.957 0.503 . . . . 0.0 110.222 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 75.0 m -78.01 -14.69 59.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.159 0.584 . . . . 0.0 111.894 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -60.36 130.82 48.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -167.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 81.4 mt -72.13 120.66 18.04 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 65.36 59.25 0.81 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.115 0.96 . . . . 0.0 109.199 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.3 m -54.58 -34.77 62.47 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.63 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.35 -38.71 43.65 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.764 1.226 . . . . 0.0 113.272 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.44 HG22 ' HE1' ' A' ' 412' ' ' TYR . 58.0 m -89.14 -40.51 12.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.334 0.654 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 403' ' ' ALA . 70.9 t -61.55 -30.24 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.006 0.922 . . . . 0.0 111.869 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.71 -15.44 60.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.353 1.061 . . . . 0.0 110.302 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -77.38 -25.49 63.36 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.699 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.44 ' HE1' HG22 ' A' ' 408' ' ' THR . 96.0 m-85 -76.47 2.92 12.37 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.41 0.684 . . . . 0.0 111.965 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 400' ' ' VAL . 0.4 OUTLIER -140.38 113.0 8.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.552 0.741 . . . . 0.0 109.815 165.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -76.7 159.15 79.79 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.911 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.65 123.29 9.68 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.127 1.218 . . . . 0.0 109.83 163.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -109.86 111.74 23.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -85.37 29.27 0.68 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.356 0.663 . . . . 0.0 112.035 -162.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -78.89 -25.49 43.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.358 0.663 . . . . 0.0 110.602 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.19 40.95 5.02 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.127 0.267 . . . . 0.0 113.359 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.24 -119.29 2.54 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.624 ' HB2' HD12 ' A' ' 436' ' ' LEU . 14.8 mm-40 -85.51 -178.63 6.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.58 . . . . 0.0 111.198 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.14 125.54 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.662 0.785 . . . . 0.0 109.067 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 41.6 mm -104.03 126.2 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.498 0.719 . . . . 0.0 109.085 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 24.5 p -105.95 149.74 26.33 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.768 0.827 . . . . 0.0 109.649 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -161.12 175.59 12.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.485 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 64.7 m -120.47 117.43 27.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.965 0.906 . . . . 0.0 109.708 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.64 112.68 12.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.977 0.911 . . . . 0.0 109.285 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.7 t70 71.05 23.2 4.26 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.441 1.497 . . . . 0.0 110.983 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 -12.67 69.37 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.722 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.97 164.73 15.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.695 0.798 . . . . 0.0 109.91 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.5 t -108.92 114.76 28.8 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -119.09 140.99 49.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.774 0.321 . . . . 0.0 110.227 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 55.7 p -125.12 149.28 48.02 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 110.327 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 26.8 pt -120.38 179.88 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 0.0 110.096 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.29 154.39 22.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.655 0.782 . . . . 0.0 109.81 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 421' ' ' GLU . 80.8 mt -115.61 167.91 9.27 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.381 1.073 . . . . 0.0 109.379 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.11 142.42 30.86 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.844 1.696 . . . . 0.0 111.877 165.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.08 138.55 18.31 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.559 2.172 . . . . 0.0 111.507 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.13 160.93 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.479 0.712 . . . . 0.0 110.605 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -142.56 -3.22 1.04 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.436 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -115.3 140.06 49.44 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.07 72.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.086 0.955 . . . . 0.0 111.643 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.7 m -63.4 -35.05 79.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.204 0.601 . . . . 0.0 111.227 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -23.22 59.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.709 0.404 . . . . 0.0 110.106 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.55 -59.0 5.46 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.3 -41.72 89.32 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.571 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -26.66 61.08 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.567 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -63.71 -55.4 23.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.801 0.441 . . . . 0.0 110.574 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.04 -14.99 58.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.138 -175.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -40.86 98.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 109.612 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -69.14 -43.08 75.09 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.162 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.48 -46.34 63.97 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.144 0.578 . . . . 0.0 111.509 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 71.3 m -63.68 -27.91 69.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.698 0.799 . . . . 0.0 111.108 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -66.93 -40.53 87.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.342 0.657 . . . . 0.0 111.175 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 72.6 p -75.36 -15.22 60.49 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.605 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 371' ' ' LEU . 47.5 mt -97.7 -6.34 33.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.536 0.734 . . . . 0.0 111.35 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 70.23 9.17 6.93 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.644 1.577 . . . . 0.0 112.129 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.519 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -87.62 133.57 33.79 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 20.9 t70 -155.37 151.69 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 65.99 18.09 10.96 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.653 0.781 . . . . 0.0 110.495 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.3 tp -83.81 -7.66 59.4 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.314 1.046 . . . . 0.0 110.251 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.86 163.12 32.26 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.584 1.153 . . . . 0.0 108.683 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 27.9 m -151.49 109.83 3.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 124.286 1.035 . . . . 0.0 112.201 -176.783 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 120.487 0.184 . . . . 0.0 110.567 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.4 t -81.82 -179.39 7.37 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.819 0.847 . . . . 0.0 111.067 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.8 p -139.34 134.67 32.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.387 1.075 . . . . 0.0 109.6 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.52 159.52 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.558 0.743 . . . . 0.0 110.799 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 13.2 p -131.11 106.03 8.09 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.839 0.855 . . . . 0.0 109.602 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.427 HG11 HD23 ' A' ' 462' ' ' LEU . 46.2 t -93.56 158.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.378 1.071 . . . . 0.0 109.743 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.32 107.36 9.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 379' ' ' LEU . 46.6 t -77.53 105.92 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.152 0.581 . . . . 0.0 110.463 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 48.3 t30 -94.33 88.02 5.4 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.92 -14.12 62.85 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.559 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -83.97 -16.45 44.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.518 0.727 . . . . 0.0 111.136 174.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -71.6 -65.34 2.44 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 123.015 0.197 . . . . 0.0 112.626 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -154.93 165.54 36.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -109.22 -65.02 1.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.576 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -144.07 -95.2 0.2 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.774 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.9 22.09 29.43 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.54 2.17 . . . . 0.0 114.098 7.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -79.16 -8.21 58.82 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.753 0.421 . . . . 0.0 110.292 166.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.7 mt -110.85 142.61 42.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.99 1.316 . . . . 0.0 108.962 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.11 129.29 87.99 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.499 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.8 Cg_endo -59.78 -41.26 56.38 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.296 2.664 . . . . 0.0 113.549 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.499 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -69.92 -41.77 74.21 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.604 0.361 . . . . 0.0 110.725 -175.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -72.22 -28.48 63.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.207 0.603 . . . . 0.0 110.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.476 HD13 HD21 ' A' ' 379' ' ' LEU . 18.4 mm -65.42 -29.54 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.876 0.87 . . . . 0.0 110.52 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 81.8 mm-40 -80.04 -25.63 40.07 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.467 0.307 . . . . 0.0 110.92 174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 89.5 mm-40 -74.03 -34.56 64.15 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.102 0.561 . . . . 0.0 112.004 -176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.532 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.3 pp -73.55 154.94 89.66 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.776 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.39 155.51 2.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 0.0 115.705 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.74 -7.59 59.64 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.228 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.4 147.06 7.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.735 0.814 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.66 126.97 50.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.967 0.907 . . . . 0.0 109.306 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 109.68 -173.91 17.35 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.973 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.79 127.47 14.41 Favored 'Cis proline' 0 C--N 1.381 2.247 0 CA-C-N 119.664 1.732 . . . . 0.0 112.33 -2.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.95 -174.13 25.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.0 138.72 58.28 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.567 2.178 . . . . 0.0 112.686 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -46.67 -40.82 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.363 1.865 . . . . 0.0 112.442 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.59 -51.82 65.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 0.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 91.7 t -71.54 -45.21 68.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.723 -174.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.4 -29.62 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.8 pp -75.76 -40.2 55.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.055 0.389 . . . . 0.0 110.442 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.409 ' N ' HD12 ' A' ' 392' ' ' LEU . 10.5 ptm180 -70.12 -33.33 71.71 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 16.2 mmm-85 -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.444 0.698 . . . . 0.0 111.503 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.423 HG21 ' HG ' ' A' ' 449' ' ' LEU . 35.6 mm -73.16 -55.12 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.0 t -66.13 -52.77 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.758 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 423' ' ' ILE . 7.9 pt20 -63.58 -23.86 67.56 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.208 0.603 . . . . 0.0 112.25 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.532 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -70.73 -49.52 46.0 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 77.8 m -63.18 -52.47 62.25 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.054 0.942 . . . . 0.0 112.688 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.462 HG12 HG23 ' A' ' 406' ' ' THR . 11.0 t -64.59 -41.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.353 0.661 . . . . 0.0 110.215 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -72.13 -31.92 66.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 379' ' ' LEU . 85.1 m -88.38 8.96 25.1 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.381 0.672 . . . . 0.0 111.819 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -82.32 161.14 22.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.3 119.79 26.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.601 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 59.49 72.6 0.52 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.192 0.997 . . . . 0.0 109.763 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 400' ' ' VAL . 93.7 m -62.25 -34.89 77.39 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.978 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -55.87 -37.37 68.7 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.1 m -76.53 -43.41 39.39 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.239 0.616 . . . . 0.0 109.546 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' A' ' 403' ' ' ALA . 74.7 t -66.01 -28.05 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.54 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.418 ' HD2' HG11 ' A' ' 400' ' ' VAL . 19.0 t80 -78.92 -17.65 55.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.476 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -74.94 -10.5 83.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.598 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -77.49 -10.15 59.31 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.517 0.727 . . . . 0.0 111.376 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -141.1 141.46 34.21 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.018 0.927 . . . . 0.0 109.561 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -115.89 159.55 38.68 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.215 0.606 . . . . 0.0 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.49 151.52 75.56 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.87 1.713 . . . . 0.0 111.766 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.92 122.32 17.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.136 1.374 . . . . 0.0 107.99 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -80.46 14.46 2.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.817 0.847 . . . . 0.0 112.425 -168.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.09 -45.76 92.1 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.379 1.072 . . . . 0.0 111.403 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 95.09 43.55 3.5 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.712 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -99.85 -109.91 3.11 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.811 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.4 mp0 -78.5 171.36 15.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.41 0.684 . . . . 0.0 110.915 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.3 135.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.812 0.845 . . . . 0.0 109.354 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 436' ' ' LEU . 36.0 mm -113.18 123.9 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.8 p -107.36 146.25 31.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.939 0.896 . . . . 0.0 109.646 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.83 159.89 14.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.869 0.868 . . . . 0.0 110.077 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.4 m -81.61 116.97 21.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.857 0.463 . . . . 0.0 110.456 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -143.12 120.69 11.76 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.163 0.985 . . . . 0.0 110.499 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.85 22.58 7.15 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.835 1.254 . . . . 0.0 113.264 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.8 58.07 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 113.895 0.318 . . . . 0.0 113.895 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.64 172.38 13.09 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.0 t -86.1 126.99 34.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -106.43 139.75 40.42 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.3 p -123.69 149.12 45.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.344 1.058 . . . . 0.0 109.861 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 413' ' ' LEU . 25.9 pt -124.8 176.35 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 0.0 110.247 173.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -112.94 144.07 43.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.996 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 423' ' ' ILE . 7.8 mp -114.35 160.71 31.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.858 1.263 . . . . 0.0 108.373 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.46 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 67.8 Cg_endo -75.48 134.97 17.65 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.083 1.855 . . . . 0.0 112.167 169.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.24 136.71 29.72 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 122.716 2.277 . . . . 0.0 112.918 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.75 174.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.424 1.09 . . . . 0.0 110.92 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.8 0.44 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.164 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 19.0 m -119.77 142.01 48.96 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.262 0.483 . . . . 0.0 110.511 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.62 80.6 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.019 0.928 . . . . 0.0 112.904 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.0 m -65.23 -26.64 68.2 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.447 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 1.8 t80 -85.19 -22.05 28.91 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.44 -60.41 3.33 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 121.544 0.688 . . . . 0.0 109.224 170.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.39 -36.49 74.13 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.518 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 448' ' ' PHE . 0.0 OUTLIER -63.86 -31.96 73.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.688 0.795 . . . . 0.0 111.569 177.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.491 ' HA ' HH11 ' A' ' 447' ' ' ARG . 2.5 t80 -67.19 -46.17 74.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.459 0.304 . . . . 0.0 111.358 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -86.83 -13.53 44.76 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.199 -0.313 . . . . 0.0 111.057 -178.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.62 -55.28 33.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.879 1.272 . . . . 0.0 111.864 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.09 -34.86 78.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.458 0.703 . . . . 0.0 111.277 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 40.8 t80 -65.87 -56.48 11.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.573 0.749 . . . . 0.0 110.635 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.3 m -60.9 -30.68 70.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.781 0.832 . . . . 0.0 110.979 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.84 -44.53 85.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.914 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 52.4 p -75.47 -21.16 58.32 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 79.9 mt -78.06 -11.11 59.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.99 0.516 . . . . 0.0 111.491 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 74.03 9.4 4.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.525 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 456' ' ' LEU . 22.6 p -95.05 133.37 38.92 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.39 0.676 . . . . 0.0 109.742 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -149.38 150.75 32.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 14.1 m-80 67.47 17.15 10.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.881 1.273 . . . . 0.0 109.884 -167.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.3 tp -78.99 -26.73 43.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.765 0.826 . . . . 0.0 110.263 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.427 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -163.24 150.4 12.77 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.959 0.504 . . . . 0.0 110.873 178.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 67.1 m -166.07 138.54 3.97 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.501 1.12 . . . . 0.0 108.987 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.483 1.208 0 C-N-CA 123.303 0.641 . . . . 0.0 110.77 170.309 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 121.015 0.436 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.2 t -77.2 172.78 12.71 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -137.51 142.69 41.45 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.908 0.883 . . . . 0.0 110.193 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.64 166.02 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.468 1.107 . . . . 0.0 111.149 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.508 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 22.8 p -136.26 108.85 7.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.229 1.012 . . . . 0.0 109.631 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 25.0 t -93.99 149.76 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.535 0.734 . . . . 0.0 109.795 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -119.66 99.63 6.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.466 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -68.72 103.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.541 0.736 . . . . 0.0 110.018 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -94.9 94.58 8.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.857 0.863 . . . . 0.0 109.55 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.71 -11.57 59.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.764 177.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -76.61 -13.97 60.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.239 0.615 . . . . 0.0 110.339 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -83.69 -159.3 28.3 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 169.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 40.3 t30 -73.41 144.5 46.33 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.416 0.608 . . . . 0.0 110.516 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -61.15 1.79 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.565 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.07 -91.27 0.11 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.025 -0.875 . . . . 0.0 112.472 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -86.01 13.28 46.46 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.849 2.325 . . . . 0.0 113.906 7.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.99 -2.0 38.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.21 0.604 . . . . 0.0 111.351 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.565 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 30.3 mt -112.28 141.54 45.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.839 1.255 . . . . 0.0 108.321 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.491 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 16.3 t70 -70.74 117.93 60.28 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 110.009 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.48 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.4 Cg_endo -57.13 -34.61 98.06 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 123.597 2.864 . . . . 0.0 113.519 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -68.09 -51.42 46.61 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.577 0.548 . . . . 0.0 109.871 -177.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.491 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 19.7 mtp180 -62.31 -33.37 74.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.863 0.865 . . . . 0.0 111.398 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 379' ' ' LEU . 24.0 mm -61.64 -33.32 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.872 0.869 . . . . 0.0 111.04 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 73.9 mm-40 -80.55 -21.33 41.87 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.2 -0.313 . . . . 0.0 111.289 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 61.8 mm-40 -85.34 -37.22 20.18 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.726 0.41 . . . . 0.0 112.105 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.443 HD21 HD13 ' A' ' 376' ' ' ILE . 2.8 pp -64.84 156.01 80.92 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.828 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.13 154.32 28.74 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.848 2.365 . . . . 0.0 113.667 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.25 -14.0 60.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.818 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.466 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 9.7 p-80 -166.91 146.99 5.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.94 0.496 . . . . 0.0 111.552 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.92 104.43 10.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.744 1.218 . . . . 0.0 109.052 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 145.02 168.47 12.85 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.825 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.09 140.47 64.79 Favored 'Cis proline' 0 C--N 1.379 2.149 0 CA-C-N 119.713 1.757 . . . . 0.0 112.828 -1.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -164.4 -168.83 27.1 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.092 -0.838 . . . . 0.0 111.607 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.07 143.0 48.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 123.156 2.571 . . . . 0.0 111.949 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -52.85 -39.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.955 1.302 . . . . 0.0 111.638 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.427 ' HB3' HH21 ' A' ' 393' ' ' ARG . 14.3 m120 -68.89 -48.19 63.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 72.9 t -76.75 -44.31 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.5 -41.08 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.862 0.465 . . . . 0.0 111.487 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.82 -40.99 79.2 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 9.7 ptp180 -69.76 -25.78 63.99 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.135 0.272 . . . . 0.0 110.569 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 53.2 mmm-85 -70.8 -37.13 73.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.999 0.52 . . . . 0.0 111.258 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.79 -52.58 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.721 0.638 . . . . 0.0 109.489 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 400' ' ' VAL . 72.4 t -61.05 -47.74 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.998 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -65.01 -31.13 72.21 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.184 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.44 84.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.097 0.559 . . . . 0.0 110.231 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.34 -48.42 61.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.642 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 396' ' ' VAL . 36.4 t -62.9 -42.18 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.399 0.68 . . . . 0.0 110.468 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.88 -51.84 67.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 79.4 m -77.13 -8.0 56.76 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.726 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -65.5 123.05 18.63 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.908 0.883 . . . . 0.0 112.335 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.54 115.34 5.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 166.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 68.61 66.68 0.31 Allowed 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.543 1.164 . . . . 0.0 109.258 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 400' ' ' VAL . 84.6 m -55.43 -33.32 63.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.14 1.776 . . . . 0.0 112.428 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.91 1.284 . . . . 0.0 112.753 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.7 m -79.27 -34.29 42.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.898 0.879 . . . . 0.0 109.787 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -69.09 -30.36 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.51 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -69.24 -23.61 63.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.018 0.927 . . . . 0.0 110.196 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.04 71.07 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -79.98 -21.32 43.84 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.009 0.524 . . . . 0.0 112.163 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.26 115.08 20.46 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.688 0.756 . . . . 0.0 111.486 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.05 158.93 32.53 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.556 1.143 . . . . 0.0 110.045 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.21 126.84 10.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.244 1.963 . . . . 0.0 113.045 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.619 ' HB3' ' HE ' ' A' ' 418' ' ' ARG . 2.5 m-20 -123.77 104.96 9.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.09 58.77 5.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.768 0.827 . . . . 0.0 111.403 -164.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.619 ' HE ' ' HB3' ' A' ' 416' ' ' ASP . 0.9 OUTLIER -106.0 14.26 28.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.635 0.774 . . . . 0.0 111.073 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.58 26.19 72.85 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.33 -115.06 1.44 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.125 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.8 mp0 -86.1 170.39 12.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.112 0.565 . . . . 0.0 110.625 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.3 t -136.97 128.58 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 41.4 mm -116.48 138.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.4 p -106.51 142.7 35.74 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.817 0.847 . . . . 0.0 109.628 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.29 120.99 12.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.491 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.3 m -77.32 101.13 6.16 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -123.2 134.32 54.15 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.015 1.326 . . . . 0.0 108.213 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.3 t70 65.37 16.08 10.35 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.956 1.302 . . . . 0.0 110.29 -175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 89.0 -13.35 63.39 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.936 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -96.85 153.65 17.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.483 0.713 . . . . 0.0 110.143 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -84.26 123.05 29.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -123.9 124.12 41.92 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 47.7 p -107.05 151.35 25.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.717 0.807 . . . . 0.0 111.057 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.02 -178.08 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.931 . . . . 0.0 110.217 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -118.06 150.64 38.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.811 0.844 . . . . 0.0 109.523 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.9 mp -116.56 160.26 37.02 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.726 1.21 . . . . 0.0 108.185 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.99 139.88 19.7 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.157 1.905 . . . . 0.0 110.818 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.52 145.48 37.71 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.507 2.138 . . . . 0.0 112.939 -173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.5 156.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.989 0.915 . . . . 0.0 110.332 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.44 9.4 2.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.215 0.606 . . . . 0.0 111.525 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 42.4 t -115.21 139.92 49.53 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.26 68.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.612 0.765 . . . . 0.0 112.187 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.4 m -69.87 -16.97 63.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.058 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.83 -27.79 23.3 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.26 -65.8 0.5 Allowed 'General case' 0 C--N 1.366 1.3 0 O-C-N 124.201 0.938 . . . . 0.0 109.914 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.77 -43.12 99.62 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.473 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -60.55 -36.39 78.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.58 0.752 . . . . 0.0 111.641 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -61.43 -52.68 63.54 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 123.579 0.549 . . . . 0.0 110.14 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -73.93 -19.14 60.78 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.938 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.68 -34.44 46.19 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.205 0.457 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -62.42 -35.77 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.997 171.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.401 ' CE2' HD11 ' A' ' 456' ' ' LEU . 75.5 t80 -76.85 -36.6 56.69 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.126 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 92.4 m -65.72 -26.98 68.0 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.208 0.603 . . . . 0.0 110.74 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.34 -39.36 93.73 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.818 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.3 m -70.38 -18.12 63.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.252 1.021 . . . . 0.0 111.813 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 371' ' ' LEU . 38.7 mt -98.35 -13.3 20.75 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.853 0.861 . . . . 0.0 111.612 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 70.41 8.61 6.68 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.32 1.448 . . . . 0.0 111.958 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.482 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 26.4 p -86.8 135.24 33.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 32.8 t70 -152.34 146.57 25.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 65.66 15.58 10.11 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.126 0.97 . . . . 0.0 110.067 -168.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 35.6 tp -79.77 -12.02 59.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.574 0.75 . . . . 0.0 110.519 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.04 164.75 36.41 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 108.829 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 72.3 m -158.62 108.9 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 13.6 m . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 122.964 0.506 . . . . 0.0 110.34 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 43.3 t -79.21 171.75 14.76 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.4 p -138.86 134.41 33.27 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.572 0.749 . . . . 0.0 109.861 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.68 169.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.579 1.151 . . . . 0.0 110.218 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.5 106.86 4.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.635 0.774 . . . . 0.0 109.278 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.71 HG21 HD11 ' A' ' 395' ' ' ILE . 32.6 m -90.7 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.182 0.515 . . . . 0.0 110.133 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -118.34 100.63 7.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.55 105.92 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.031 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 30.8 t30 -87.34 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.499 ' HD3' ' HA ' ' A' ' 381' ' ' ASP . 6.7 mmmm -69.38 -31.02 69.14 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.094 -172.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.89 0.8 57.4 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.638 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.11 -80.9 0.23 Allowed Glycine 0 C--N 1.354 1.529 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -147.75 155.45 41.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.5 ' HA ' HG21 ' A' ' 376' ' ' ILE . 0.8 OUTLIER -97.54 -64.51 1.03 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.566 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.18 -91.4 0.1 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.367 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -86.88 12.12 53.11 Favored 'Cis proline' 0 C--N 1.374 1.879 0 CA-C-N 120.384 2.092 . . . . 0.0 114.325 11.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -76.64 -8.87 58.09 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.271 0.557 . . . . 0.0 110.335 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.566 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 45.6 mt -107.59 144.26 34.86 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -69.32 122.83 86.82 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.647 0.779 . . . . 0.0 110.302 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.519 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 57.0 Cg_endo -67.61 -21.16 46.16 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.969 2.446 . . . . 0.0 113.899 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -82.91 -45.47 14.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 4.5 mtt-85 -66.09 -32.49 73.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.913 . . . . 0.0 111.541 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 367' ' ' PHE . 22.2 mm -62.31 -27.85 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.187 172.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -83.84 -23.96 31.12 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.637 0.375 . . . . 0.0 110.667 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.6 mm-40 -77.6 -37.51 50.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.92 0.488 . . . . 0.0 112.103 -175.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.408 HD12 ' HE3' ' A' ' 363' ' ' LYS . 3.2 pp -63.7 153.34 83.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.086 171.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.9 169.36 10.45 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.609 2.206 . . . . 0.0 114.284 -172.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 363' ' ' LYS . 21.1 t70 -84.36 -3.34 58.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.419 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.17 151.78 18.04 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.255 0.622 . . . . 0.0 110.127 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -126.2 103.46 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 146.58 171.88 16.34 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.057 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -77.9 136.1 41.03 Favored 'Cis proline' 0 C--N 1.377 2.027 0 CA-C-N 118.65 1.225 . . . . 0.0 111.408 -1.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -160.92 -168.67 23.12 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.299 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.46 148.49 73.27 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.339 2.693 . . . . 0.0 112.383 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.4 p -55.32 -43.74 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.266 1.027 . . . . 0.0 111.634 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -72.01 -39.61 69.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.536 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 69.4 t -73.2 -48.93 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 119.559 -0.258 . . . . 0.0 110.847 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.8 t -58.74 -39.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.717 0.407 . . . . 0.0 111.775 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 421' ' ' GLU . 1.9 pp -68.67 -43.95 75.08 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.9 ptt180 -70.25 -27.99 64.88 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.155 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.3 mmt180 -63.78 -38.21 90.25 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.506 0.722 . . . . 0.0 110.91 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 359' ' ' VAL . 34.4 mm -66.17 -54.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.738 0.649 . . . . 0.0 109.279 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 400' ' ' VAL . 57.9 t -57.66 -63.63 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.427 1.08 . . . . 0.0 110.462 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -55.75 -36.27 67.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.7 0.8 . . . . 0.0 112.21 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.41 -44.86 81.8 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 122.746 0.418 . . . . 0.0 109.938 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 88.0 m -64.87 -38.84 92.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.575 0.75 . . . . 0.0 111.516 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 396' ' ' VAL . 11.8 t -69.5 -43.54 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.016 0.527 . . . . 0.0 110.275 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.55 -33.83 75.85 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.277 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 72.1 m -86.23 -4.83 59.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.509 0.724 . . . . 0.0 111.465 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -73.77 136.39 43.62 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.955 0.502 . . . . 0.0 111.429 -176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 70.5 mt -83.43 129.5 34.99 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 164.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 66.48 54.0 0.92 Allowed 'General case' 0 CA--C 1.562 1.425 0 O-C-N 124.196 0.935 . . . . 0.0 108.874 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 89.8 m -55.03 -38.47 67.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.491 1.516 . . . . 0.0 111.961 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -57.5 -38.45 74.64 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.796 1.238 . . . . 0.0 113.762 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -83.84 -29.58 27.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.167 0.508 . . . . 0.0 110.148 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.4 t -65.79 -31.78 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.82 0.848 . . . . 0.0 110.369 171.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . 0.419 ' HA ' HD12 ' A' ' 413' ' ' LEU . 65.4 t80 -75.91 -15.63 60.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.382 1.073 . . . . 0.0 110.712 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.02 62.95 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 116.506 -0.315 . . . . 0.0 113.264 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -92.74 -1.46 56.8 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 110.821 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 423' ' ' ILE . 53.8 mt -121.66 100.16 6.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.027 0.931 . . . . 0.0 110.231 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -103.25 135.98 19.3 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 122.818 0.447 . . . . 0.0 110.12 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.74 162.35 42.39 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.555 2.837 . . . . 0.0 112.623 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.96 152.18 26.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -89.77 60.41 5.01 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.959 0.885 . . . . 0.0 109.185 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -109.87 -62.21 1.54 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.64 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.57 41.37 5.11 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.509 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.86 -72.63 1.14 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 19.2 mp0 -108.59 167.72 9.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.559 0.744 . . . . 0.0 109.267 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.46 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 83.5 t -138.79 127.86 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.109 0.964 . . . . 0.0 108.515 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 436' ' ' LEU . 36.6 mm -118.25 135.22 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 0.0 109.887 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 5.4 p -108.04 140.31 41.4 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.685 0.794 . . . . 0.0 109.563 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.02 118.51 10.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.429 1.092 . . . . 0.0 109.513 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.6 m -76.01 100.1 4.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.551 0.691 . . . . 0.0 109.47 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . 0.412 ' HB3' ' CD2' ' A' ' 432' ' ' HIS . 65.0 t80 -117.93 117.09 28.31 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.879 1.272 . . . . 0.0 108.815 -174.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 62.78 25.17 14.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.942 1.297 . . . . 0.0 111.89 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.76 61.23 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.174 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.86 160.28 14.62 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.853 0.827 . . . . 0.0 109.247 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 14.0 t -96.71 127.65 42.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 427' ' ' PHE . 26.3 m-70 -119.46 123.29 43.69 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.2 p -105.22 137.58 42.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.382 0.673 . . . . 0.0 110.06 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.9 pt -122.64 172.27 10.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 123.805 0.842 . . . . 0.0 109.445 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -123.17 140.61 52.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.55 0.69 . . . . 0.0 109.743 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 4.8 mp -114.47 156.78 44.11 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.025 1.33 . . . . 0.0 108.646 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.31 130.48 14.07 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.154 1.903 . . . . 0.0 112.429 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -60.27 144.22 99.5 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.275 2.65 . . . . 0.0 113.16 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 24.8 m -111.64 158.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.844 0.857 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -137.46 7.23 2.81 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.3 t -121.65 141.78 50.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.64 0.376 . . . . 0.0 110.125 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.1 72.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.245 1.018 . . . . 0.0 112.604 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.3 m -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.957 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.72 -23.8 36.51 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.49 -61.94 1.89 Allowed 'General case' 0 C--N 1.365 1.243 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.06 -48.11 66.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.458 -169.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -58.17 -34.21 70.07 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.884 0.74 . . . . 0.0 112.753 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.418 ' CE1' HD23 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -61.15 -43.93 98.11 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.938 0.774 . . . . 0.0 109.864 -176.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.06 -16.0 34.76 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.479 175.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.71 -42.17 82.38 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.408 1.004 . . . . 0.0 110.752 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -66.56 -37.7 85.52 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.838 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.427 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 63.3 t80 -67.0 -45.91 76.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.028 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 74.5 m -70.04 -25.96 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.132 0.973 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -66.58 -35.88 81.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.49 0.716 . . . . 0.0 109.926 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.4 m -71.13 -20.3 62.33 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.0 0.92 . . . . 0.0 111.538 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 371' ' ' LEU . 44.9 mt -99.76 -11.3 20.94 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.977 0.911 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 74.34 7.89 4.58 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 0.0 112.113 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 10.9 p -87.88 133.34 33.93 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.809 0.444 . . . . 0.0 110.232 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -149.53 149.61 30.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.545 0.738 . . . . 0.0 109.7 -175.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 23.4 m-80 67.42 15.85 9.93 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.7 1.2 . . . . 0.0 111.003 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.01 -21.91 53.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -152.78 163.81 39.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.313 0.645 . . . . 0.0 110.111 175.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.6 p -165.16 115.47 1.1 Allowed 'General case' 0 C--O 1.239 0.52 0 O-C-N 123.963 0.789 . . . . 0.0 109.402 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 10.1 t . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.802 0.334 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.4 t -76.69 -179.7 5.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.347 0.659 . . . . 0.0 110.97 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.91 143.12 44.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.826 0.85 . . . . 0.0 110.314 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.36 169.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.677 1.191 . . . . 0.0 109.581 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.98 105.94 3.59 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.668 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.08 152.63 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.048 0.539 . . . . 0.0 109.962 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 76.2 m-85 -110.76 101.36 9.99 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.483 HG12 ' NZ ' ' A' ' 363' ' ' LYS . 58.1 t -70.62 92.84 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 124.15 0.98 . . . . 0.0 110.344 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -87.77 99.11 11.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.718 0.807 . . . . 0.0 108.969 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.483 ' NZ ' HG12 ' A' ' 361' ' ' VAL . 0.0 OUTLIER -80.65 -10.04 59.76 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.252 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -77.27 -14.36 59.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.681 0.392 . . . . 0.0 110.103 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.23 -166.93 29.97 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.362 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 45.4 t30 -71.11 131.53 43.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.019 0.437 . . . . 0.0 110.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -78.04 -62.83 1.55 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.408 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.583 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -142.36 -94.96 0.22 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.824 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.86 9.67 56.82 Favored 'Cis proline' 0 C--N 1.373 1.847 0 CA-C-N 120.385 2.092 . . . . 0.0 114.96 10.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -73.8 -7.94 54.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.766 0.426 . . . . 0.0 111.33 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.583 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.9 mt -114.16 130.04 56.61 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.573 1.549 . . . . 0.0 107.557 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.13 125.32 89.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 123.583 0.552 . . . . 0.0 110.827 -176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 12.2 Cg_endo -53.78 -38.14 85.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.786 2.991 . . . . 0.0 114.377 -175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 374' ' ' LYS . 0.0 OUTLIER -75.82 -42.83 48.72 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.397 0.436 . . . . 0.0 110.209 -173.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -68.36 -30.42 69.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.555 0.742 . . . . 0.0 110.764 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.4 mm -63.84 -31.1 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.239 1.016 . . . . 0.0 111.198 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 64.5 mm-40 -74.98 -27.58 60.21 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 56.0 mm-40 -81.84 -3.38 53.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.384 0.674 . . . . 0.0 111.749 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 402' ' ' CYS . 18.6 mt -70.46 172.23 6.47 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.104 0.562 . . . . 0.0 110.187 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 379' ' ' LEU . 75.9 Cg_endo -73.34 163.65 37.26 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.114 1.209 . . . . 0.0 110.479 166.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.86 -23.22 60.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.199 0.6 . . . . 0.0 111.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 15.6 p-80 -158.76 147.04 18.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.617 0.367 . . . . 0.0 110.938 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.05 104.79 13.72 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 143.92 172.7 14.85 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.248 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.3 139.97 58.28 Favored 'Cis proline' 0 C--N 1.379 2.168 0 CA-C-N 119.134 1.467 . . . . 0.0 112.191 1.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.59 -170.23 27.13 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.473 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 390' ' ' VAL . 6.0 Cg_exo -69.98 145.72 56.71 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.312 2.675 . . . . 0.0 111.722 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.3 p -54.51 -39.4 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.501 1.12 . . . . 0.0 111.478 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.43 -47.01 74.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.613 1.165 . . . . 0.0 110.541 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 94.2 t -72.08 -51.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.84 -39.32 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.79 -42.34 73.9 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 421' ' ' GLU . 34.8 ptt180 -74.44 -24.76 59.11 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.885 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 15.2 mmt85 -63.75 -36.7 84.74 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.707 0.629 . . . . 0.0 110.515 174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.668 HD11 HG21 ' A' ' 359' ' ' VAL . 48.5 mm -66.84 -54.25 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 109.694 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 400' ' ' VAL . 81.8 t -56.56 -50.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 124.336 1.022 . . . . 0.0 111.354 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.85 -34.16 73.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.95 0.5 . . . . 0.0 111.613 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.61 88.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -67.2 -55.23 14.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.035 0.834 . . . . 0.0 110.93 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 396' ' ' VAL . 61.1 t -57.5 -40.68 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.702 0.801 . . . . 0.0 111.446 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.54 -48.25 67.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 379' ' ' LEU . 74.0 m -73.61 -10.15 59.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.109 0.564 . . . . 0.0 111.908 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.63 148.36 50.56 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.071 0.949 . . . . 0.0 112.649 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.28 130.16 34.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 60.41 61.48 1.76 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.153 0.977 . . . . 0.0 109.33 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -50.78 -37.13 40.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 112.848 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -53.34 -41.12 65.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.914 1.286 . . . . 0.0 112.755 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 -41.94 20.48 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.632 0.773 . . . . 0.0 109.531 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 403' ' ' ALA . 76.7 t -60.35 -33.18 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.129 0.972 . . . . 0.0 111.767 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -81.82 -13.35 57.79 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.426 0.691 . . . . 0.0 110.903 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -78.94 -3.14 87.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.461 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.92 -5.21 58.15 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.279 0.632 . . . . 0.0 111.411 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -139.8 113.39 8.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.53 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.88 156.61 37.05 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.86 0.864 . . . . 0.0 110.886 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.71 129.38 17.55 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.26 1.973 . . . . 0.0 113.24 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.647 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 59.1 m-20 -122.28 111.77 17.33 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.749 174.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -88.94 45.6 1.31 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.865 0.84 . . . . 0.0 109.44 -171.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.647 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 12.2 mpt_? -78.58 -15.66 58.3 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 110.151 173.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 84.84 42.16 7.33 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.329 0.393 . . . . 0.0 113.399 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.88 -112.18 3.59 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 120.169 -0.24 . . . . 0.0 113.014 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 22.5 mp0 -79.53 167.24 21.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.309 0.644 . . . . 0.0 110.642 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.8 t -134.54 129.23 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 436' ' ' LEU . 41.1 mm -115.18 130.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 433' ' ' SER . 22.8 p -106.09 154.54 20.51 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 124.03 0.831 . . . . 0.0 109.403 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -154.91 158.66 39.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.963 0.905 . . . . 0.0 109.914 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 45.6 m -105.06 119.49 39.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.463 0.705 . . . . 0.0 109.435 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -132.29 109.99 10.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.406 0.682 . . . . 0.0 109.945 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.41 41.03 16.63 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.684 1.194 . . . . 0.0 111.114 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.6 -0.65 85.18 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.314 -0.857 . . . . 0.0 114.064 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -103.7 171.73 7.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 109.303 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -116.13 119.59 36.31 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -107.07 137.57 44.88 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.4 p -127.98 148.67 50.53 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 109.876 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 413' ' ' LEU . 36.0 pt -130.55 174.12 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.811 0.845 . . . . 0.0 110.054 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -113.87 149.88 34.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.5 mp -116.64 158.94 42.25 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.862 1.265 . . . . 0.0 108.664 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.452 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 71.2 Cg_endo -74.93 131.47 14.41 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 C-N-CA 122.362 2.041 . . . . 0.0 112.456 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.55 146.71 74.9 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.858 2.372 . . . . 0.0 113.422 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.35 161.25 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.89 0.876 . . . . 0.0 110.544 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -141.17 5.44 1.89 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.504 0.721 . . . . 0.0 111.767 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.7 m -124.26 140.49 52.91 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.52 0.6 . . . . 0.0 110.995 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.39 79.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.201 1.0 . . . . 0.0 112.542 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 m -69.1 -24.18 64.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.96 -22.16 25.75 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.14 -58.59 4.3 Favored 'General case' 0 C--N 1.365 1.271 0 CA-C-O 121.629 0.728 . . . . 0.0 109.239 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.79 -44.57 80.96 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.859 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -56.71 -38.65 72.61 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.443 1.089 . . . . 0.0 112.197 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.452 ' HZ ' ' HD2' ' A' ' 437' ' ' PRO . 4.3 t80 -65.63 -45.09 84.38 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.536 -171.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -85.82 -13.16 48.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.792 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.473 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 0.8 OUTLIER -63.82 -43.74 95.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.009 0.368 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.26 93.36 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.453 ' CE2' HD11 ' A' ' 456' ' ' LEU . 43.8 t80 -69.7 -45.43 68.27 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.448 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 29.4 p -72.59 -21.65 61.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.351 0.661 . . . . 0.0 110.073 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -70.58 -36.07 73.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.869 0.868 . . . . 0.0 109.844 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 -31.49 68.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.569 0.747 . . . . 0.0 110.99 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.453 HD11 ' CE2' ' A' ' 452' ' ' PHE . 45.5 mt -80.87 -17.62 50.07 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.171 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 72.06 8.91 6.01 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.714 1.606 . . . . 0.0 111.518 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.496 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 21.9 p -82.73 137.26 34.46 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.227 0.611 . . . . 0.0 109.947 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 29.5 t70 -151.52 148.89 28.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 109.563 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 64.01 14.42 8.45 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.214 1.005 . . . . 0.0 111.436 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.46 -20.74 43.07 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.405 0.682 . . . . 0.0 112.006 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.83 159.53 36.8 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.072 0.549 . . . . 0.0 110.624 176.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 35.5 p -165.88 121.78 1.31 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.916 0.486 . . . . 0.0 111.026 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 122.99 0.516 . . . . 0.0 111.273 175.812 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.2 t -86.58 -177.66 6.21 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.627 0.771 . . . . 0.0 110.303 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.9 p -141.04 142.21 34.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.147 0.979 . . . . 0.0 109.913 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.06 147.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 123.908 0.883 . . . . 0.0 110.782 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.476 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 19.0 p -114.36 105.1 12.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.639 0.776 . . . . 0.0 108.972 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.472 HG11 HD23 ' A' ' 462' ' ' LEU . 48.4 t -98.34 154.44 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -130.18 107.5 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 36.6 t -78.01 106.48 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.476 0.71 . . . . 0.0 110.023 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 44.2 t30 -94.58 90.17 6.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.152 0.981 . . . . 0.0 109.257 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.18 -12.12 60.49 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.955 176.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 82.3 t60 -73.35 -19.67 60.96 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.752 0.821 . . . . 0.0 111.034 169.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -72.47 -135.72 0.2 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.479 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 38.2 t30 -101.69 137.23 40.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.038 0.919 . . . . 0.0 109.295 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.02 -57.61 3.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -150.45 -87.98 0.07 OUTLIER Glycine 0 C--N 1.343 0.942 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.784 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.7 19.21 23.87 Favored 'Cis proline' 0 C--N 1.374 1.896 0 CA-C-N 120.705 2.252 . . . . 0.0 113.868 5.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.44 -7.27 46.33 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.627 0.771 . . . . 0.0 111.537 166.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.536 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.2 mt -116.84 140.05 49.89 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.2 1.0 . . . . 0.0 109.445 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.54 119.14 54.45 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.367 1.067 . . . . 0.0 110.619 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 24.5 Cg_endo -58.68 -24.64 71.83 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.478 2.785 . . . . 0.0 114.528 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -83.8 -44.64 14.15 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.746 0.419 . . . . 0.0 110.108 -176.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 32.7 mtt180 -67.23 -34.74 78.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.132 0.973 . . . . 0.0 111.723 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.48 -27.77 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.728 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 65.2 mm-40 -84.92 -27.76 26.37 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 122.058 -0.401 . . . . 0.0 110.469 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.9 mm-40 -71.96 -35.03 69.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.247 0.619 . . . . 0.0 112.253 -176.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.96 158.76 87.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.036 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.18 157.26 45.72 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.581 2.188 . . . . 0.0 113.042 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.25 0.27 29.31 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.504 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.496 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.1 p80 -166.4 149.97 7.31 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.442 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.7 m-85 -122.9 107.91 12.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 168.87 12.56 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.19 -0.783 . . . . 0.0 112.141 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 130.22 19.33 Favored 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 120.058 1.929 . . . . 0.0 113.609 -0.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.03 -165.41 14.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.99 140.62 38.45 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.533 2.155 . . . . 0.0 111.205 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.1 p -47.87 -42.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.697 1.199 . . . . 0.0 112.214 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.01 -55.27 27.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.048 1.339 . . . . 0.0 110.697 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 393' ' ' ARG . 58.0 t -67.9 -43.72 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.144 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.68 -47.49 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.728 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 117.861 0.3 . . . . 0.0 110.777 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.3 ptt180 -73.22 -32.78 64.97 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -65.55 -30.61 71.38 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.377 0.671 . . . . 0.0 111.289 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.543 HG21 ' HG ' ' A' ' 449' ' ' LEU . 20.7 mm -67.6 -59.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 80.7 t -61.44 -50.77 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.401 -171.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -65.32 -31.86 73.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.244 0.618 . . . . 0.0 111.785 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.23 94.71 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 452' ' ' PHE . 84.5 m -70.06 -41.64 73.89 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.184 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.522 HG22 ' CZ ' ' A' ' 452' ' ' PHE . 3.6 t -67.02 -42.6 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.18 -37.07 83.08 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 71.1 m -87.24 1.68 52.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 111.856 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.478 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.14 143.82 48.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 89.6 mt -82.27 125.11 30.58 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 67.74 53.17 0.7 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.502 1.121 . . . . 0.0 109.639 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.1 m -58.52 -27.24 64.32 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.068 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -56.35 -36.7 69.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.242 0.617 . . . . 0.0 111.669 177.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.2 m -88.95 -37.43 15.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 412' ' ' TYR . 98.3 t -64.05 -35.33 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.885 0.874 . . . . 0.0 111.722 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -72.27 -22.06 61.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.161 0.984 . . . . 0.0 110.28 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.81 -19.59 78.79 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.729 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.49 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 82.9 m-85 -75.68 -15.34 60.32 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.272 0.536 . . . . 0.0 111.726 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 104.46 6.5 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.685 0.755 . . . . 0.0 111.134 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 163.43 38.18 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.177 0.991 . . . . 0.0 110.181 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 167.54 26.73 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.284 1.989 . . . . 0.0 113.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 12.8 m-20 -145.3 130.37 18.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.941 1.296 . . . . 0.0 109.506 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -89.97 45.78 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.033 0.921 . . . . 0.0 109.708 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.676 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -93.15 -31.26 14.86 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.43 171.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.76 30.06 33.46 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.47 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.98 -122.54 1.55 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.401 ' HB2' HD22 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -69.54 166.67 18.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.368 0.667 . . . . 0.0 110.818 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 85.2 t -132.93 132.67 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 436' ' ' LEU . 28.1 mm -114.85 126.49 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.317 0.647 . . . . 0.0 109.883 175.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 9.2 p -107.64 151.0 26.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 110.716 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.91 140.56 12.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.221 1.008 . . . . 0.0 110.007 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 48.9 m -87.15 118.88 26.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.913 0.485 . . . . 0.0 110.443 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -140.36 134.5 30.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.747 0.819 . . . . 0.0 109.448 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.2 t70 64.51 25.99 13.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.702 1.201 . . . . 0.0 110.988 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.33 88.7 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.554 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -109.44 168.82 9.11 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.626 1.171 . . . . 0.0 110.331 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.8 t -100.12 135.05 42.14 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -132.1 133.63 44.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.179 0.592 . . . . 0.0 110.283 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 64.7 p -126.42 140.24 52.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.741 0.816 . . . . 0.0 110.524 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 20.2 pt -119.85 161.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.315 0.646 . . . . 0.0 109.857 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -103.32 147.41 27.11 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.103 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.54 HD11 HG12 ' A' ' 423' ' ' ILE . 7.6 mp -115.01 165.56 13.77 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.464 1.505 . . . . 0.0 108.809 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.31 142.0 23.59 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 121.92 1.747 . . . . 0.0 111.585 163.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.42 128.86 10.67 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.381 2.054 . . . . 0.0 112.87 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.07 172.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.556 0.742 . . . . 0.0 110.38 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -151.48 5.63 0.46 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . 0.421 ' O ' HG21 ' A' ' 388' ' ' VAL . 45.7 t -125.23 141.14 52.27 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.341 0.519 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.47 -26.91 67.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.172 0.989 . . . . 0.0 111.919 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 33.2 t -70.34 -31.14 68.3 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.126 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -23.09 39.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.99 -62.05 1.91 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.242 0.544 . . . . 0.0 110.034 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.27 -35.67 68.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.812 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -62.75 -32.27 73.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.942 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.23 -56.4 11.45 Favored 'General case' 0 C--O 1.246 0.873 0 O-C-N 123.157 0.286 . . . . 0.0 110.608 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.543 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -73.67 -13.66 61.02 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.967 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.467 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 2.4 mm-40 -63.35 -47.06 83.72 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.351 0.66 . . . . 0.0 111.487 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -59.51 -43.86 93.28 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.615 0.766 . . . . 0.0 110.738 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 400' ' ' VAL . 44.6 t80 -69.98 -48.36 58.55 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.4 p -70.67 -21.32 62.61 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.574 0.749 . . . . 0.0 111.145 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -71.94 -37.55 69.99 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.634 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 77.0 p -76.58 -24.67 53.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.618 0.367 . . . . 0.0 110.582 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.502 HD11 ' CE2' ' A' ' 452' ' ' PHE . 72.6 mt -77.67 -17.94 57.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 111.313 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.26 7.59 6.15 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.817 1.647 . . . . 0.0 111.745 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.597 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 17.7 p -81.11 134.8 35.71 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.368 0.604 . . . . 0.0 110.419 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.479 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 6.5 p-10 -145.38 147.09 31.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.997 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 59.75 19.08 7.85 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.811 0.844 . . . . 0.0 110.907 -171.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 38.3 tp -81.02 -27.15 35.94 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.16 0.584 . . . . 0.0 111.228 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.472 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -164.41 150.08 10.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.023 0.529 . . . . 0.0 110.727 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 70.2 m -166.3 149.13 7.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.328 1.051 . . . . 0.0 109.197 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 121.871 0.843 . . . . 0.0 111.553 176.513 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 120.903 0.382 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.6 t -83.25 179.09 7.8 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.695 0.798 . . . . 0.0 110.647 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.2 p -139.74 136.83 34.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.575 1.15 . . . . 0.0 109.112 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.44 157.67 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.826 0.85 . . . . 0.0 110.834 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 385' ' ' PRO . 24.1 p -124.16 116.88 23.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.356 1.062 . . . . 0.0 109.188 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.6 t -113.16 151.24 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.096 0.558 . . . . 0.0 110.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -126.72 103.26 7.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.105 1.362 . . . . 0.0 108.065 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.04 110.77 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.628 0.771 . . . . 0.0 110.862 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -99.05 92.91 5.71 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.583 0.753 . . . . 0.0 110.12 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.42 -12.22 60.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.233 178.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -74.39 -19.59 60.37 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.774 0.83 . . . . 0.0 111.185 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.79 -111.11 0.03 OUTLIER Glycine 0 C--N 1.353 1.493 0 C-N-CA 122.985 0.326 . . . . 0.0 112.941 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 42.9 t30 -125.43 143.94 50.76 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.27 -62.28 1.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.03 -94.74 0.14 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.397 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -89.06 26.29 17.32 Favored 'Cis proline' 0 C--N 1.371 1.73 0 CA-C-N 120.116 1.958 . . . . 0.0 113.427 7.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.95 -10.25 59.49 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.214 0.606 . . . . 0.0 109.95 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.574 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 36.1 mt -114.74 140.86 48.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 125.454 1.501 . . . . 0.0 108.301 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.43 124.35 89.71 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.13 0.572 . . . . 0.0 110.414 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 30.5 Cg_endo -59.47 -32.97 97.21 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.244 2.63 . . . . 0.0 114.163 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.87 -42.55 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.468 0.307 . . . . 0.0 110.958 -176.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -70.96 -28.88 64.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 110.593 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 379' ' ' LEU . 20.7 mm -63.0 -30.48 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.825 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 68.0 mm-40 -81.67 -22.36 37.53 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.462 0.305 . . . . 0.0 111.043 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 81.8 mm-40 -81.93 -35.29 29.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.451 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.0 pp -66.48 153.81 92.28 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.911 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.72 161.33 21.71 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.675 2.25 . . . . 0.0 114.327 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.77 -8.92 58.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.678 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -161.95 153.16 18.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.937 0.495 . . . . 0.0 110.967 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 395' ' ' ILE . 52.6 m-85 -132.23 109.01 9.62 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.415 1.086 . . . . 0.0 108.078 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.27 -179.53 16.14 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 358' ' ' CYS . 59.7 Cg_endo -72.88 130.21 19.36 Favored 'Cis proline' 0 C--N 1.383 2.394 0 CA-C-N 119.889 1.845 . . . . 0.0 113.1 -4.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.71 -163.56 12.53 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.982 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -65.87 139.88 58.76 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.993 2.462 . . . . 0.0 111.926 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 445' ' ' ALA . 5.3 p -49.26 -41.35 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.352 1.061 . . . . 0.0 111.579 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.09 -52.18 63.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.942 1.297 . . . . 0.0 110.675 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 81.4 t -69.07 -50.87 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.941 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.49 -40.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 122.999 0.52 . . . . 0.0 112.203 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.99 -41.48 74.33 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 117.859 0.299 . . . . 0.0 110.624 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -73.27 -24.47 60.44 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.542 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 48.6 mmm-85 -68.44 -38.77 81.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.819 0.448 . . . . 0.0 111.073 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.57 HD13 ' HD2' ' A' ' 383' ' ' PHE . 8.4 mm -65.63 -53.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 91.3 t -61.78 -47.16 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.135 -174.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.421 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.6 pt20 -64.0 -30.03 71.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.582 0.353 . . . . 0.0 111.285 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -72.26 -40.97 67.25 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.256 0.622 . . . . 0.0 110.532 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.7 m -69.58 -46.47 66.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.341 0.657 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.8 t -65.7 -39.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.199 0.6 . . . . 0.0 110.084 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.34 -53.46 57.02 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.232 0.613 . . . . 0.0 110.581 173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.451 ' SG ' HD23 ' A' ' 379' ' ' LEU . 73.9 m -79.92 0.99 28.97 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.553 -172.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -71.73 135.32 46.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.71 118.36 17.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 160.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.16 60.01 0.66 Allowed 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.077 0.942 . . . . 0.0 109.431 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 96.9 m -51.41 -40.62 59.67 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.075 1.75 . . . . 0.0 112.416 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -50.44 -41.09 52.18 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.176 1.39 . . . . 0.0 114.04 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 98.4 m -78.96 -39.39 34.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.645 0.778 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.564 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -60.69 -41.57 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.71 -14.07 59.98 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.073 0.949 . . . . 0.0 110.774 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.45 -23.24 77.56 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.507 -0.315 . . . . 0.0 113.401 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -71.27 -24.77 62.23 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.072 0.549 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 434' ' ' ILE . 0.7 OUTLIER -119.43 112.72 19.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.026 0.931 . . . . 0.0 108.677 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -96.21 158.61 33.7 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.28 0.632 . . . . 0.0 110.738 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.69 144.9 45.27 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.168 1.912 . . . . 0.0 112.496 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.572 ' HB3' ' HG2' ' A' ' 418' ' ' ARG . 3.6 m-20 -150.13 136.1 18.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.977 1.311 . . . . 0.0 108.132 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.68 68.67 10.47 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.52 1.152 . . . . 0.0 108.33 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 416' ' ' ASP . 78.7 mmt-85 -106.93 -22.49 12.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.611 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.27 65.64 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.614 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -97.71 -127.22 5.65 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.958 -0.356 . . . . 0.0 112.387 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.0 OUTLIER -72.88 169.32 17.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.887 0.875 . . . . 0.0 110.841 -176.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 54.4 t -140.32 133.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.825 . . . . 0.0 109.102 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 47.8 mm -116.02 134.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 122.607 0.363 . . . . 0.0 110.219 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 433' ' ' SER . 18.0 p -107.25 143.09 35.98 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.93 15.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.527 0.731 . . . . 0.0 111.041 -169.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 430' ' ' GLU . 49.4 m -86.53 104.2 15.76 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.89 0.476 . . . . 0.0 110.312 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -116.23 106.57 13.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.29 1.036 . . . . 0.0 109.569 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.18 54.1 9.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.232 1.413 . . . . 0.0 111.56 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 83.2 -15.89 31.49 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.85 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 426' ' ' SER . 39.9 mt-10 -95.15 170.53 9.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.181 0.592 . . . . 0.0 111.37 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.9 t -111.46 102.02 10.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -94.92 142.26 27.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.397 0.679 . . . . 0.0 109.904 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 424' ' ' THR . 41.7 p -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.912 . . . . 0.0 109.771 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 413' ' ' LEU . 41.3 pt -123.99 -176.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.846 0.858 . . . . 0.0 111.047 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.28 143.31 51.26 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 121.462 0.648 . . . . 0.0 110.012 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.0 mp -111.0 159.2 33.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.901 1.68 . . . . 0.0 108.124 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.69 132.65 19.05 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.094 1.863 . . . . 0.0 111.706 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.19 129.7 19.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.279 1.986 . . . . 0.0 112.112 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.0 173.39 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.011 0.925 . . . . 0.0 110.87 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -153.46 -0.21 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.517 0.727 . . . . 0.0 111.243 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.6 m -118.21 138.29 52.43 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.07 -31.83 68.34 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.855 0.862 . . . . 0.0 111.281 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 22.0 m -59.57 -31.82 69.8 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.757 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -86.2 -22.79 26.76 Favored 'General case' 0 C--N 1.362 1.151 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -52.18 -66.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.598 0.759 . . . . 0.0 111.182 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.403 ' O ' HD22 ' A' ' 449' ' ' LEU . 0.4 OUTLIER -72.13 -34.62 68.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.68 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . 0.465 ' NH1' ' HB2' ' A' ' 451' ' ' ASN . 0.0 OUTLIER -53.33 -36.33 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.285 0.634 . . . . 0.0 111.514 178.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -60.07 -56.48 21.07 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.139 0.899 . . . . 0.0 110.34 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.7 -13.92 58.59 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.706 -176.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.4 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 55.7 mt-10 -70.28 -46.63 63.95 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.673 0.669 . . . . 0.0 109.988 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.465 ' HB2' ' NH1' ' A' ' 447' ' ' ARG . 0.2 OUTLIER -67.52 -35.25 78.74 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 449' ' ' LEU . 36.9 t80 -68.6 -48.83 63.14 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.444 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.5 p -70.09 -22.88 62.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.068 0.547 . . . . 0.0 111.021 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -57.17 -46.4 82.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 93.7 p -73.07 -23.28 60.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.046 0.539 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.507 HD13 HD21 ' A' ' 371' ' ' LEU . 47.7 mt -83.7 -8.37 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.651 0.781 . . . . 0.0 111.077 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.82 9.16 7.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.35 1.46 . . . . 0.0 111.275 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.713 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.8 p -94.94 144.58 25.56 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.553 0.741 . . . . 0.0 110.044 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -163.04 164.21 25.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 65.53 14.58 9.57 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.159 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.08 -8.63 59.06 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.373 1.069 . . . . 0.0 111.533 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 169.22 22.66 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.347 0.659 . . . . 0.0 109.916 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 46.6 m -158.38 114.18 2.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.629 0.772 . . . . 0.0 109.79 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 26.5 t . . . . . 0 CA--C 1.554 1.109 0 C-N-CA 123.769 0.827 . . . . 0.0 111.237 175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.78 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.9 m -72.99 178.05 4.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.027 0.531 . . . . 0.0 111.852 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.7 p -139.61 133.45 30.71 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.527 1.131 . . . . 0.0 109.131 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.57 157.49 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.285 1.034 . . . . 0.0 111.148 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.57 108.05 10.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.313 1.045 . . . . 0.0 108.72 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.59 120.95 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -88.54 97.94 11.37 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 379' ' ' LEU . 44.9 t -72.63 98.28 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.622 -171.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -91.08 86.44 6.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.757 -175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -12.93 61.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.786 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.793 0.837 . . . . 0.0 110.299 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -76.9 -149.83 3.37 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.11 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 41.3 t30 -82.85 142.32 31.59 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.301 0.551 . . . . 0.0 110.132 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -85.42 -56.11 3.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.99 -88.95 0.07 OUTLIER Glycine 0 C--N 1.349 1.256 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.127 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.73 4.06 65.3 Favored 'Cis proline' 0 C--N 1.371 1.712 0 CA-C-N 120.879 2.34 . . . . 0.0 113.744 10.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -70.46 -13.01 61.95 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.953 0.901 . . . . 0.0 110.37 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.608 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 28.5 mt -99.1 143.96 28.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.0 109.116 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.31 121.82 84.45 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 123.99 0.806 . . . . 0.0 110.455 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.537 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 50.9 Cg_endo -64.35 -22.28 66.3 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.187 2.591 . . . . 0.0 114.646 -172.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.537 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -83.94 -43.63 15.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.121 0.418 . . . . 0.0 110.076 -176.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 57.9 mtt180 -67.22 -37.49 83.69 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.085 0.954 . . . . 0.0 111.923 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.453 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.7 mm -53.64 -28.85 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.433 0 C-N-CA 124.076 0.951 . . . . 0.0 112.347 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 71.0 mm-40 -83.59 -17.85 40.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.257 0.623 . . . . 0.0 111.737 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -80.33 -43.08 21.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.424 0.69 . . . . 0.0 111.728 -171.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 361' ' ' VAL . 0.4 OUTLIER -64.03 153.27 85.48 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.564 175.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -62.95 165.78 15.72 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.678 2.252 . . . . 0.0 113.233 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.66 -6.86 59.42 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.307 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.456 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.1 p80 -162.58 137.62 6.86 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.33 0.652 . . . . 0.0 110.605 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.97 103.81 14.47 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.38 -174.14 17.44 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.3 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 128.19 15.21 Favored 'Cis proline' 0 C--N 1.382 2.333 0 CA-C-N 119.291 1.545 . . . . 0.0 112.817 0.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.72 30.34 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.977 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.55 129.95 28.27 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.125 2.55 . . . . 0.0 113.279 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.1 p -45.42 -50.16 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.274 1.829 . . . . 0.0 112.688 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.455 ' OD1' HG13 ' A' ' 388' ' ' VAL . 2.4 m120 -57.64 -43.96 85.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.395 . . . . 0.0 112.009 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.494 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 93.7 t -76.41 -51.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.134 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.01 -42.27 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 123.386 0.674 . . . . 0.0 112.404 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 122.856 0.097 . . . . 0.0 110.984 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 392' ' ' LEU . 7.8 ptt180 -73.09 -25.54 60.92 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.141 0.276 . . . . 0.0 110.388 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 11.5 mmm180 -68.23 -35.21 77.6 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 122.846 0.458 . . . . 0.0 110.124 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 449' ' ' LEU . 25.9 mm -63.62 -47.67 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.875 0.734 . . . . 0.0 109.405 173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.504 ' HA ' ' CE2' ' A' ' 452' ' ' PHE . 38.9 t -63.96 -60.62 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.733 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.46 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.5 pt20 -60.86 -29.47 69.54 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.58 -59.63 2.72 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.25 -32.77 74.39 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.5 t -68.17 -47.51 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.92 -19.92 58.4 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.348 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 93.5 m -100.02 10.11 41.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.114 0.965 . . . . 0.0 110.352 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -86.07 151.29 23.82 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.47 122.78 27.95 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 162.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 66.65 57.67 0.67 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.48 1.112 . . . . 0.0 109.934 -174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 400' ' ' VAL . 89.6 m -54.12 -34.0 59.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.592 1.557 . . . . 0.0 112.415 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -55.64 -39.55 71.0 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.855 1.262 . . . . 0.0 113.466 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.3 m -81.47 -36.05 29.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 110.171 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 400' ' ' VAL . 67.7 t -62.44 -38.07 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.867 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -68.44 -19.31 64.57 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.95 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.81 -23.57 77.78 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.927 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -77.01 -10.73 59.56 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 117.276 0.538 . . . . 0.0 111.641 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 434' ' ' ILE . 0.3 OUTLIER -129.04 117.8 21.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.729 0.812 . . . . 0.0 109.614 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -95.18 157.91 35.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.789 0.836 . . . . 0.0 110.916 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.87 153.14 76.28 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.144 1.896 . . . . 0.0 111.434 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -151.15 136.54 17.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.689 0.28 . . . . 0.0 110.527 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.52 10.11 26.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.807 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.502 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 5.9 mpt_? -59.59 -35.0 73.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.527 1.131 . . . . 0.0 111.417 171.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 85.49 28.23 30.52 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.36 0.413 . . . . 0.0 113.378 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.93 -110.03 0.31 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 120.023 -0.321 . . . . 0.0 113.39 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.98 172.0 8.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.802 0.441 . . . . 0.0 110.348 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 75.8 t -132.08 130.2 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.9 mm -115.11 131.66 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.44 ' HB ' ' OG1' ' A' ' 431' ' ' THR . 19.2 p -108.86 137.64 46.46 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.417 1.087 . . . . 0.0 108.743 172.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -158.63 128.95 5.99 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.67 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.5 m -66.87 102.47 0.96 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.462 0.705 . . . . 0.0 112.149 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -135.68 136.2 40.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.936 1.294 . . . . 0.0 108.813 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.7 t70 66.63 16.35 10.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.391 1.076 . . . . 0.0 111.163 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.02 61.79 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 122.012 -0.43 . . . . 0.0 113.849 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -116.91 166.99 11.53 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 424' ' ' THR . 12.9 t -89.86 102.87 15.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.914 0.864 . . . . 0.0 109.248 175.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.73 131.41 40.82 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.046 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 34.8 p -111.01 131.46 55.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.328 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.636 HD11 HD12 ' A' ' 413' ' ' LEU . 16.4 pt -132.41 174.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 124.298 1.039 . . . . 0.0 109.762 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.443 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 21.0 mt-30 -113.11 147.88 36.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.273 0.629 . . . . 0.0 110.842 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.421 HD23 ' HE1' ' A' ' 448' ' ' PHE . 9.8 mp -115.48 166.6 11.69 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.156 1.382 . . . . 0.0 108.636 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.11 145.48 44.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 121.998 1.799 . . . . 0.0 111.939 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 418' ' ' ARG . 64.3 Cg_endo -83.54 159.95 14.62 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.453 2.102 . . . . 0.0 112.015 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.94 173.51 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.712 0.805 . . . . 0.0 109.695 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -150.43 18.26 0.83 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.807 0.443 . . . . 0.0 111.169 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.2 t -124.82 140.21 53.13 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.03 63.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.211 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.9 m -69.85 -25.01 63.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.104 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.7 -21.74 25.04 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.29 -65.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.7 0.8 . . . . 0.0 111.17 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 1.4 pp -62.68 -37.84 88.04 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.119 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.38 71.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.415 1.086 . . . . 0.0 112.019 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.421 ' HE1' HD23 ' A' ' 436' ' ' LEU . 31.1 t80 -71.74 -43.27 66.12 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.12 0.962 . . . . 0.0 108.562 -173.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 395' ' ' ILE . 3.9 pp -89.19 -14.3 36.36 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.418 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.1 tm-20 -69.21 -50.3 48.61 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.826 1.251 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.9 -38.01 77.91 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.728 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.504 ' CE2' ' HA ' ' A' ' 396' ' ' VAL . 34.8 t80 -66.84 -50.85 61.26 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.385 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 31.2 p -71.57 -22.0 61.8 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.408 0.683 . . . . 0.0 110.687 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -66.3 -39.92 89.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.087 0.955 . . . . 0.0 110.127 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.1 m -65.81 -29.74 70.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.803 0.841 . . . . 0.0 111.321 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 371' ' ' LEU . 41.0 mt -84.25 -13.5 52.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.008 0.923 . . . . 0.0 111.311 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 71.38 7.91 6.17 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.826 1.651 . . . . 0.0 111.668 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 21.1 p -83.27 133.64 34.98 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.4 p-10 -148.55 147.42 29.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.935 -173.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 59.86 21.85 10.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.583 0.753 . . . . 0.0 110.425 -168.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 18.3 tp -83.12 -15.76 49.45 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.449 0.7 . . . . 0.0 109.893 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.28 171.44 19.15 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.365 1.066 . . . . 0.0 108.757 174.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.0 m -165.79 115.54 1.01 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.1 t . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.809 0.338 . . . . 0.0 111.398 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 11.0 t -79.72 -177.9 6.12 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.845 0.458 . . . . 0.0 110.516 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 28.1 p -138.99 136.58 35.51 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.564 0.746 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.75 161.51 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.41 1.084 . . . . 0.0 110.851 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 30.5 p -132.76 132.36 42.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -117.34 154.58 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.119 0.568 . . . . 0.0 110.022 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 47.8 m-85 -111.78 100.32 8.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 379' ' ' LEU . 38.6 t -70.48 88.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 0.0 109.501 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -81.78 93.21 6.78 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.909 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -76.67 -5.22 47.02 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.114 178.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -84.31 -13.22 53.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.268 0.627 . . . . 0.0 111.006 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -73.3 -112.14 0.07 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -121.62 138.42 54.34 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.68 3.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.54 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -156.22 -86.98 0.06 OUTLIER Glycine 0 C--O 1.216 -0.974 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.485 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.04 12.9 44.41 Favored 'Cis proline' 0 C--N 1.368 1.582 0 CA-C-N 120.931 2.366 . . . . 0.0 114.084 8.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -72.75 -7.82 52.44 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.001 0.52 . . . . 0.0 111.478 172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.1 mt -110.41 143.78 40.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.495 1.118 . . . . 0.0 109.227 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.15 118.92 60.52 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.631 0.772 . . . . 0.0 110.532 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 12.4 Cg_endo -52.84 -36.61 74.72 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.887 3.058 . . . . 0.0 114.337 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -80.28 -45.48 17.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -170.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -64.39 -36.06 82.91 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 111.58 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.418 HD13 HD21 ' A' ' 379' ' ' LEU . 17.6 mm -55.82 -31.96 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 124.392 1.058 . . . . 0.0 111.427 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 54.3 mm-40 -78.4 -35.92 46.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.7 0.4 . . . . 0.0 110.696 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 69.9 mm-40 -71.54 -33.84 69.5 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.524 0.73 . . . . 0.0 112.092 -171.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.418 HD21 HD13 ' A' ' 376' ' ' ILE . 2.5 pp -71.11 155.64 92.94 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.53 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.44 148.62 33.23 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.19 2.594 . . . . 0.0 113.903 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.27 -10.54 59.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.034 1.333 . . . . 0.0 111.825 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -164.52 145.5 8.05 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -114.57 159.44 20.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.79 1.236 . . . . 0.0 108.766 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.88 -179.68 51.0 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.111 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -79.87 128.82 16.75 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 119.441 1.621 . . . . 0.0 111.831 2.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.14 25.02 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 133.57 38.73 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 123.051 2.501 . . . . 0.0 113.629 -169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.2 p -47.3 -39.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.511 1.924 . . . . 0.0 111.985 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.29 -54.14 49.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.467 1.507 . . . . 0.0 111.014 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 393' ' ' ARG . 97.0 t -74.11 -47.64 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.121 -173.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.67 -38.54 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.15 -43.43 61.55 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 422' ' ' VAL . 39.6 ptt180 -72.1 -25.63 61.82 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.661 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.54 -36.15 82.96 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.81 0.694 . . . . 0.0 110.698 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 35.3 mm -66.66 -56.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 400' ' ' VAL . 95.5 t -57.57 -52.72 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 124.113 0.883 . . . . 0.0 111.045 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.8 pt20 -64.34 -35.89 82.35 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.7 0.4 . . . . 0.0 111.914 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -68.29 -36.44 79.37 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 123.381 0.426 . . . . 0.0 110.046 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 84.1 m -68.87 -49.82 55.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.025 0.53 . . . . 0.0 111.205 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.0 t -63.59 -48.23 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 122.921 0.488 . . . . 0.0 110.068 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.96 -36.4 77.86 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.59 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 72.6 m -83.99 -1.27 54.36 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.452 0.301 . . . . 0.0 111.286 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -71.33 137.47 48.5 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.37 117.15 8.96 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 166.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 64.46 66.26 0.61 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.135 0.969 . . . . 0.0 109.625 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 400' ' ' VAL . 78.0 m -54.75 -35.62 63.94 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.771 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -59.41 -35.36 73.85 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.56 1.144 . . . . 0.0 113.131 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 85.7 m -80.4 -37.89 31.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.69 0.796 . . . . 0.0 109.775 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 403' ' ' ALA . 40.3 t -69.43 -30.41 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.082 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -73.24 -20.01 60.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.444 1.098 . . . . 0.0 110.209 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -63.74 -15.05 57.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.584 -0.735 . . . . 0.0 114.692 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.07 3.03 55.88 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.598 0.699 . . . . 0.0 111.719 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -148.07 106.53 3.78 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.416 0.626 . . . . 0.0 110.476 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 160.8 31.0 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.133 0.973 . . . . 0.0 109.779 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.03 163.79 24.41 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.488 2.125 . . . . 0.0 113.655 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.08 163.18 23.65 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 0.0 108.857 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -130.26 35.95 4.03 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.235 0.614 . . . . 0.0 110.867 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.52 -39.75 4.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.868 170.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 100.65 42.59 2.47 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.23 -106.57 0.28 Allowed Glycine 0 C--N 1.343 0.947 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.736 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 5.2 mp0 -83.33 172.74 12.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.994 0.397 . . . . 0.0 110.266 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.467 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 90.0 t -138.96 131.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.887 0.875 . . . . 0.0 108.791 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 433' ' ' SER . 35.8 mm -117.81 133.53 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.152 0.581 . . . . 0.0 110.02 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.4 p -108.85 137.18 47.2 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.932 0.893 . . . . 0.0 109.931 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.09 134.71 11.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 13.6 p -77.2 115.89 17.37 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.203 0.601 . . . . 0.0 109.851 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -153.98 140.7 19.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 108.945 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . 0.421 ' HB3' ' HE1' ' A' ' 432' ' ' HIS . 17.3 t70 63.01 16.9 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.728 1.211 . . . . 0.0 112.162 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.94 -18.44 57.18 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.11 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -109.23 166.38 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.5 t -89.69 104.72 17.26 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 167.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . 0.421 ' HE1' ' HB3' ' A' ' 428' ' ' ASP . 51.0 m80 -95.53 129.07 42.83 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.312 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 57.8 p -118.07 132.88 56.32 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.586 0.755 . . . . 0.0 109.99 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 413' ' ' LEU . 30.7 pt -118.43 179.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.275 0.63 . . . . 0.0 109.843 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -111.36 151.73 28.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 82.4 mt -117.31 151.44 47.95 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.48 1.112 . . . . 0.0 108.557 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.26 131.22 35.42 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.392 2.062 . . . . 0.0 111.757 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.28 137.78 77.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.06 2.506 . . . . 0.0 114.533 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.2 m -109.82 167.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.917 0.887 . . . . 0.0 109.603 171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.67 15.69 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.557 0.343 . . . . 0.0 111.254 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 26.0 t -123.48 141.43 52.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.804 0.442 . . . . 0.0 109.927 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.07 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.113 0.965 . . . . 0.0 112.322 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.5 m -70.3 -19.47 63.09 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.999 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.61 -60.98 2.54 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.65 -54.38 46.07 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.682 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -49.06 -40.66 32.34 Favored 'General case' 0 C--O 1.247 0.935 0 O-C-N 125.023 1.452 . . . . 0.0 112.281 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.18 -48.64 79.15 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.151 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -83.22 -17.1 43.92 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.133 178.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.59 -42.71 74.09 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 119.325 0.966 . . . . 0.0 110.047 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -62.42 -38.48 89.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.826 0.704 . . . . 0.0 110.629 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 456' ' ' LEU . 36.5 t80 -68.91 -49.8 54.98 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.033 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 89.5 m -67.39 -22.41 65.55 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.25 1.02 . . . . 0.0 111.514 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -65.97 -36.44 83.33 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.8 t -77.23 -28.58 53.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.876 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.531 HD13 HD21 ' A' ' 371' ' ' LEU . 64.9 mt -77.23 -16.75 58.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.256 0.623 . . . . 0.0 111.397 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 71.0 6.55 5.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.012 1.725 . . . . 0.0 111.471 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.574 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -78.0 132.34 37.77 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.496 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 34.5 t70 -147.35 142.34 27.0 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.065 -165.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 60.28 18.8 8.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.17 0.988 . . . . 0.0 110.276 -167.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 32.5 tp -80.81 -24.09 38.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 122.933 0.493 . . . . 0.0 111.019 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -155.58 160.35 40.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.668 0.387 . . . . 0.0 111.018 174.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 33.5 p -164.3 133.54 3.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.801 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 123.069 0.548 . . . . 0.0 111.831 -177.256 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 387' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 120.803 0.335 . . . . 0.0 110.448 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.1 t -72.48 -178.94 2.76 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.468 0.307 . . . . 0.0 110.178 168.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.29 138.3 43.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.23 0.612 . . . . 0.0 110.25 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.03 158.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.311 1.044 . . . . 0.0 110.485 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 21.0 p -134.36 107.5 7.65 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.65 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.627 HG21 HD11 ' A' ' 395' ' ' ILE . 34.4 m -94.77 154.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -117.63 99.95 7.3 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.452 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 48.6 t -69.9 98.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.743 0.817 . . . . 0.0 110.015 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.29 83.73 7.88 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.24 42.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.31 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -78.0 -21.26 51.09 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.467 0.707 . . . . 0.0 110.51 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.63 -148.08 6.28 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.885 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.5 t30 -74.46 140.37 44.56 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.283 0.564 . . . . 0.0 109.973 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -54.06 4.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.558 1.143 . . . . 0.0 108.253 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.699 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -155.22 -86.53 0.06 OUTLIER Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.75 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -88.61 15.99 44.42 Favored 'Cis proline' 0 C--N 1.365 1.422 0 CA-C-N 120.194 1.997 . . . . 0.0 114.022 8.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -70.75 -12.21 61.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.705 0.402 . . . . 0.0 110.847 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 22.5 mt -107.44 131.93 53.75 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 109.035 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.18 126.87 93.18 Favored Pre-proline 0 N--CA 1.481 1.099 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.498 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.1 Cg_endo -60.07 -41.49 51.92 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.349 2.699 . . . . 0.0 113.294 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -66.57 -39.7 88.61 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.879 0.471 . . . . 0.0 110.74 -175.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -74.11 -30.93 62.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.754 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 379' ' ' LEU . 10.0 mm -62.75 -24.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.047 0.939 . . . . 0.0 111.466 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 55.1 mm-40 -83.31 -17.05 43.84 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.675 0.39 . . . . 0.0 111.15 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -79.2 -30.46 43.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.162 0.585 . . . . 0.0 111.626 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 376' ' ' ILE . 0.3 OUTLIER -74.82 157.43 85.74 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 169.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.25 166.5 21.06 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.56 2.174 . . . . 0.0 112.972 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.39 1.49 21.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.13 0.972 . . . . 0.0 111.179 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.452 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.8 p80 -158.84 155.57 28.05 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.725 0.81 . . . . 0.0 110.34 173.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -125.07 113.29 17.55 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 167.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 114.53 176.75 18.97 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.357 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.65 128.98 16.81 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 119.71 1.755 . . . . 0.0 112.655 1.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.51 -164.29 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.051 -0.861 . . . . 0.0 111.594 -174.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.525 ' HB3' ' HG3' ' A' ' 354' ' ' MET . 7.8 Cg_exo -66.36 139.21 53.63 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.955 2.437 . . . . 0.0 112.072 -170.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.935 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.1 p -53.75 -45.71 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.133 0.973 . . . . 0.0 111.341 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.533 ' HB3' HH21 ' A' ' 393' ' ' ARG . 12.7 m120 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.277 . . . . 0.0 110.74 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 71.1 t -70.63 -57.67 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.632 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.75 -44.19 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.397 0.679 . . . . 0.0 112.457 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 449' ' ' LEU . 3.3 pp -69.36 -41.68 76.25 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-N 117.571 0.169 . . . . 0.0 110.564 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.533 HH21 ' HB3' ' A' ' 389' ' ' ASN . 11.4 ptp180 -70.48 -28.63 65.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 29.9 mmt180 -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 123.688 0.617 . . . . 0.0 110.989 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 359' ' ' VAL . 24.6 mm -65.62 -57.18 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.4 t -58.69 -49.31 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.737 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.56 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.3 pt20 -68.27 -37.36 80.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.631 0.372 . . . . 0.0 111.398 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -66.37 -35.35 80.11 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.395 0.435 . . . . 0.0 110.064 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 93.0 m -67.68 -53.33 28.62 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.597 0.561 . . . . 0.0 110.978 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 396' ' ' VAL . 20.3 t -61.26 -47.27 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 122.748 0.419 . . . . 0.0 110.527 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.98 -46.8 76.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 89.3 m -73.61 -5.68 41.89 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.895 0.478 . . . . 0.0 112.264 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.67 143.78 55.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.414 0.625 . . . . 0.0 112.635 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.94 126.79 30.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.959 163.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 56.5 2.72 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-O 122.085 0.945 . . . . 0.0 109.694 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 92.2 m -53.75 -32.16 51.23 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.037 1.335 . . . . 0.0 111.77 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -57.48 -32.23 66.78 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.815 1.246 . . . . 0.0 112.666 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 80.7 m -89.3 -42.73 11.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.716 0.806 . . . . 0.0 110.48 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.7 t -60.66 -32.91 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.832 0.853 . . . . 0.0 111.66 -177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -72.48 -26.83 61.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.771 1.228 . . . . 0.0 110.557 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.29 -15.36 72.44 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.966 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -79.73 -2.66 44.03 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.492 0.646 . . . . 0.0 111.845 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -145.81 105.26 3.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.489 0.661 . . . . 0.0 110.148 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -83.9 157.42 63.41 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.146 0.978 . . . . 0.0 110.375 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.91 163.39 37.66 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.007 1.805 . . . . 0.0 112.873 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.15 137.5 29.12 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.464 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -96.34 38.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.265 0.626 . . . . 0.0 111.423 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -95.01 -16.98 22.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.402 0.681 . . . . 0.0 110.638 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 74.97 39.42 38.15 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.29 -122.63 3.91 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.153 -0.248 . . . . 0.0 113.09 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.4 OUTLIER -70.07 162.63 27.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.788 0.835 . . . . 0.0 110.642 -177.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.1 128.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.56 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.6 mm -111.4 121.92 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.452 0.701 . . . . 0.0 110.215 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.2 p -107.51 142.9 36.67 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.442 1.097 . . . . 0.0 110.221 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -163.41 136.33 5.45 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.891 0.744 . . . . 0.0 110.986 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 67.4 m -74.88 119.6 19.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.48 0.712 . . . . 0.0 111.875 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -148.51 137.7 21.81 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.468 1.107 . . . . 0.0 109.73 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 58.83 33.47 23.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.945 1.298 . . . . 0.0 112.117 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.04 87.15 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.386 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.82 171.68 13.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.06 0.944 . . . . 0.0 109.572 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -94.77 130.18 41.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -119.37 142.45 48.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.651 0.781 . . . . 0.0 109.716 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 42.2 p -129.08 143.07 50.74 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 110.483 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 413' ' ' LEU . 26.8 pt -119.61 173.65 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.216 0.606 . . . . 0.0 109.42 171.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.411 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 28.5 mt-30 -113.8 151.72 31.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.351 0.661 . . . . 0.0 110.342 171.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 78.9 mt -116.56 168.49 8.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.287 1.435 . . . . 0.0 108.962 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.24 136.77 20.36 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.601 1.534 . . . . 0.0 111.256 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -73.07 133.04 19.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.469 2.112 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.5 m -99.99 174.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.977 0.911 . . . . 0.0 110.997 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.32 12.11 0.41 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.959 0.504 . . . . 0.0 110.966 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.6 t -119.21 138.32 53.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.722 0.409 . . . . 0.0 110.635 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.89 -29.21 62.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.978 0.911 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 18.6 m -71.87 -22.25 61.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.187 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.6 -32.98 20.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.935 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.38 -63.73 0.97 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.708 1.203 . . . . 0.0 111.478 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.25 -47.77 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.994 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -32.34 64.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.122 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' A' ' 436' ' ' LEU . 28.1 t80 -62.98 -56.6 15.67 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 122.884 0.474 . . . . 0.0 110.121 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -78.54 -14.97 59.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.556 -178.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.556 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 50.0 mt-10 -72.74 -40.3 66.19 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.586 0.63 . . . . 0.0 109.853 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.73 -32.3 72.82 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.511 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.516 ' CE2' HD11 ' A' ' 456' ' ' LEU . 48.4 t80 -81.02 -42.14 21.59 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.405 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 21.7 p -68.28 -23.85 64.8 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.199 0.599 . . . . 0.0 110.411 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -62.17 -32.81 73.47 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.07 1.348 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -78.34 -32.86 49.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.539 0.736 . . . . 0.0 110.794 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.519 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 39.0 mt -83.8 -10.29 58.18 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.641 0.776 . . . . 0.0 112.204 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 71.26 7.29 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.741 1.616 . . . . 0.0 111.373 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.699 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -84.67 135.42 34.17 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 122.894 0.478 . . . . 0.0 110.04 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 28.1 t70 -147.12 158.66 44.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.602 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.2 p30 48.64 26.11 1.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.643 1.177 . . . . 0.0 112.654 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.55 -15.66 30.24 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.905 1.282 . . . . 0.0 110.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.406 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.74 164.56 33.75 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.354 0.661 . . . . 0.0 110.273 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 42.0 p -168.06 129.0 1.37 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 108.459 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.2 t . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.103 0.561 . . . . 0.0 111.72 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.772 0.32 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.7 t -90.34 178.2 6.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.396 1.078 . . . . 0.0 110.841 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.2 p -136.39 135.32 38.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.729 1.212 . . . . 0.0 109.624 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.96 167.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.922 0.889 . . . . 0.0 110.738 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.44 121.24 18.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.068 0.947 . . . . 0.0 108.809 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 395' ' ' ILE . 35.5 m -105.19 146.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 170.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -111.94 98.46 7.38 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.519 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 42.4 t -68.66 101.53 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 124.323 1.014 . . . . 0.0 109.897 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.426 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 51.2 t30 -92.21 90.39 7.28 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.156 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.05 -5.69 49.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.761 176.031 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . 0.426 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 66.5 t60 -76.87 -19.36 57.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.673 0.789 . . . . 0.0 110.174 167.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -74.0 -125.74 0.12 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.677 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -106.8 156.05 19.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.496 0.648 . . . . 0.0 109.374 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.14 -64.41 1.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.593 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.94 -87.9 0.07 OUTLIER Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.275 -173.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . 0.434 ' HD2' HE21 ' A' ' 457' ' ' GLN . 36.6 Cg_endo -85.91 17.2 33.85 Favored 'Cis proline' 0 C--N 1.374 1.907 0 CA-C-N 120.51 2.155 . . . . 0.0 113.998 4.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -70.81 -22.69 62.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.117 0.567 . . . . 0.0 110.284 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.593 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.7 mt -96.34 136.74 36.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.33 1.052 . . . . 0.0 109.56 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 375' ' ' ARG . 12.8 t70 -65.35 126.16 90.89 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.827 0.851 . . . . 0.0 110.653 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 60.5 Cg_endo -68.0 -19.49 45.71 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.814 2.343 . . . . 0.0 113.872 -170.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -84.74 -47.41 10.45 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 38.4 mtt180 -62.32 -35.53 79.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 0.0 112.064 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.9 mm -58.47 -29.64 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.505 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.6 mm-40 -85.76 -19.12 31.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.568 0.347 . . . . 0.0 110.996 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 79.3 mm-40 -87.4 -29.11 21.73 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.345 0.658 . . . . 0.0 112.556 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.454 HD13 HG11 ' A' ' 361' ' ' VAL . 2.7 pp -69.84 159.61 83.36 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.741 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.2 152.13 74.15 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.512 2.142 . . . . 0.0 113.279 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.34 -4.07 37.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.41 1.084 . . . . 0.0 111.808 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 38.7 p-80 -161.55 148.76 14.61 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.339 0.656 . . . . 0.0 110.815 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -116.85 104.17 11.04 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 133.03 -173.92 20.79 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.376 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.99 128.36 14.48 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.097 -5.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -152.27 -162.3 10.78 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.21 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -68.69 139.39 44.03 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.067 2.511 . . . . 0.0 112.072 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -50.51 -39.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.46 1.104 . . . . 0.0 111.754 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.61 -48.28 67.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.65 -47.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.23 -43.58 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.23 0.612 . . . . 0.0 111.98 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 449' ' ' LEU . 2.7 pp -68.21 -44.29 76.11 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 120.68 0.276 . . . . 0.0 110.563 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.5 HH11 ' HA ' ' A' ' 421' ' ' GLU . 29.4 ptt180 -74.56 -24.51 58.93 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.54 -38.63 91.7 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.921 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 359' ' ' VAL . 27.6 mm -65.42 -55.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 68.2 t -61.66 -47.02 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.706 -172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.98 -32.14 71.5 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.645 0.378 . . . . 0.0 110.88 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.551 0.532 . . . . 0.0 110.068 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.37 -56.17 12.36 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.152 0.908 . . . . 0.0 110.949 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 3.0 t -62.55 -37.38 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.75 -43.73 95.56 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.593 0.757 . . . . 0.0 111.19 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 19.9 p -83.44 -8.03 59.45 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.166 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.622 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.04 134.02 45.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 53.2 mt -75.76 124.6 27.56 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.655 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 64.55 68.49 0.53 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.624 1.17 . . . . 0.0 109.319 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 55.3 m -61.18 -37.83 84.33 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.533 -173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -51.06 -43.13 60.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.864 0.866 . . . . 0.0 113.035 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.3 m -74.71 -38.64 62.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.472 0.654 . . . . 0.0 109.874 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.622 HG21 ' HB1' ' A' ' 403' ' ' ALA . 78.0 t -68.94 -31.4 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.638 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.06 -10.28 59.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.334 1.054 . . . . 0.0 110.034 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.67 -7.74 83.89 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.908 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -83.34 -9.72 58.9 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 117.621 0.711 . . . . 0.0 111.869 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.98 142.74 49.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.636 0.775 . . . . 0.0 109.713 174.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -117.06 149.71 44.74 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.443 0.697 . . . . 0.0 111.091 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.67 128.07 16.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.832 2.355 . . . . 0.0 112.603 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.06 169.64 8.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.843 1.257 . . . . 0.0 108.801 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -118.99 22.58 11.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.71 . . . . 0.0 112.391 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 438' ' ' PRO . 0.5 OUTLIER -100.9 -25.12 14.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.085 0.554 . . . . 0.0 111.623 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.2 45.89 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.191 1.237 . . . . 0.0 116.191 162.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -85.69 -85.0 1.03 Allowed Glycine 0 C--O 1.239 0.436 0 CA-C-N 116.779 0.29 . . . . 0.0 112.694 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 3.1 mp0 -85.17 162.79 19.08 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.84 0.456 . . . . 0.0 110.346 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 67.5 t -136.08 124.21 36.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.063 0.945 . . . . 0.0 108.633 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.561 HG12 HD11 ' A' ' 436' ' ' LEU . 32.3 mm -104.39 122.82 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.2 p -106.76 145.75 31.69 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.257 1.023 . . . . 0.0 109.498 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.37 142.85 4.9 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.539 0.736 . . . . 0.0 110.879 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 103.38 6.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 110.024 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -114.92 124.64 52.22 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.706 0.802 . . . . 0.0 109.098 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 32.0 t70 61.19 28.59 18.19 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-O 122.245 1.022 . . . . 0.0 111.124 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.87 -17.8 58.22 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.863 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.29 162.01 15.45 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 117.441 0.621 . . . . 0.0 110.651 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.1 t -81.98 121.88 27.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -126.42 149.96 48.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.54 0.736 . . . . 0.0 109.871 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.0 p -140.29 146.08 38.08 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.354 0.662 . . . . 0.0 110.252 -173.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 29.0 pt -120.11 178.84 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.558 0.743 . . . . 0.0 110.361 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -118.51 147.88 43.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.578 0.751 . . . . 0.0 109.863 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.0 mp -116.26 156.04 47.61 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.863 1.265 . . . . 0.0 108.188 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.16 131.06 21.25 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 121.877 1.718 . . . . 0.0 111.061 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 418' ' ' ARG . 41.6 Cg_endo -66.33 128.79 20.04 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.954 2.436 . . . . 0.0 113.167 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.08 168.8 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.249 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -153.22 0.07 0.25 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.386 0.674 . . . . 0.0 110.772 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.6 t -120.61 142.63 49.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.274 0.63 . . . . 0.0 109.997 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.16 67.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.835 0.854 . . . . 0.0 112.462 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.4 m -70.39 -28.2 64.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.444 0.698 . . . . 0.0 111.321 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -24.03 29.87 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.16 -59.68 3.22 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 123.907 0.754 . . . . 0.0 109.668 171.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.89 -51.03 62.22 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -48.76 -41.94 33.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.319 1.047 . . . . 0.0 112.878 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -41.11 99.11 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.955 0.784 . . . . 0.0 110.951 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.44 -18.92 28.83 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.318 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.29 -42.38 59.65 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.861 0.755 . . . . 0.0 110.416 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.63 -40.8 92.95 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.444 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 456' ' ' LEU . 67.7 t80 -65.57 -47.11 76.91 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.257 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 86.7 m -66.66 -31.43 72.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 110.771 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.59 -32.4 71.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.249 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 45.9 m -67.28 -33.81 76.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.136 0.574 . . . . 0.0 110.511 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.56 HD13 HD21 ' A' ' 371' ' ' LEU . 56.7 mt -84.31 -8.93 58.86 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.635 0.774 . . . . 0.0 111.702 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . 0.434 HE21 ' HD2' ' A' ' 369' ' ' PRO . 17.4 mt-30 79.02 5.23 2.3 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.502 1.921 . . . . 0.0 111.779 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.455 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 7.4 p -87.4 146.44 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.059 0.544 . . . . 0.0 110.896 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -162.64 154.45 18.32 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 32.3 m-80 64.54 18.84 11.58 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.268 1.027 . . . . 0.0 111.115 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 23.7 tp -83.32 -9.42 59.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.574 0.749 . . . . 0.0 110.606 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.423 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.6 171.85 19.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.935 0.894 . . . . 0.0 109.908 176.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 29.1 p -162.16 126.22 3.17 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.473 0.709 . . . . 0.0 109.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.629 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.554 1.105 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.7 m -75.27 -177.39 3.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.596 0.358 . . . . 0.0 111.801 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.0 p -141.6 134.37 28.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.119 0.968 . . . . 0.0 109.622 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 388' ' ' VAL . 13.0 m -137.29 171.4 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.344 1.058 . . . . 0.0 110.509 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 25.9 p -145.83 108.12 4.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.383 0.673 . . . . 0.0 109.751 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.647 HG21 HD11 ' A' ' 395' ' ' ILE . 30.8 m -98.34 143.91 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -109.89 100.69 9.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.493 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 78.0 t -73.42 102.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.411 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 36.3 t30 -97.11 96.13 8.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.828 0.851 . . . . 0.0 109.624 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.13 -5.93 53.18 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.023 177.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -85.8 -8.93 57.8 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.524 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.61 -137.04 2.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.455 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 45.4 t30 -92.13 142.78 27.13 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 117.817 0.808 . . . . 0.0 109.369 174.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 376' ' ' ILE . 1.8 m-85 -84.03 -56.23 3.79 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -147.38 -74.48 0.02 OUTLIER Glycine 0 C--N 1.349 1.268 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.912 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.8 -15.26 17.65 Favored 'Cis proline' 0 C--N 1.371 1.729 0 CA-C-N 121.118 2.459 . . . . 0.0 115.308 4.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -73.09 0.94 10.1 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.907 0.776 . . . . 0.0 113.079 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.581 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 12.7 mt -91.39 127.86 37.0 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.01 118.38 17.35 Favored Pre-proline 0 N--CA 1.478 0.974 0 O-C-N 124.165 0.916 . . . . 0.0 110.763 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 58.7 Cg_endo -65.61 -19.36 60.17 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.92 2.413 . . . . 0.0 113.664 -169.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 3.1 mppt? -84.5 -42.7 15.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.86 0.362 . . . . 0.0 110.04 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 24.1 mtt-85 -68.01 -33.08 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.216 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 367' ' ' PHE . 24.6 mm -60.68 -27.02 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.159 171.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 69.7 mm-40 -84.47 -22.3 30.33 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 174.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 85.7 mm-40 -79.73 -30.19 40.79 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.318 0.647 . . . . 0.0 112.367 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 376' ' ' ILE . 3.1 pp -73.2 154.6 90.39 Favored Pre-proline 0 N--CA 1.482 1.137 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.29 164.78 24.36 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.233 1.955 . . . . 0.0 114.773 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.27 -18.28 61.82 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.461 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.493 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 47.5 p-80 -166.32 149.93 7.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.54 0.736 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -116.49 101.94 9.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 144.68 165.85 11.28 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.444 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.23 130.36 20.59 Favored 'Cis proline' 0 C--N 1.379 2.171 0 CA-C-N 118.984 1.392 . . . . 0.0 112.237 -3.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.67 -173.22 24.06 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.875 -0.958 . . . . 0.0 111.074 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.44 143.11 34.22 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.933 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.3 p -45.47 -50.95 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 112.775 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.49 -34.58 72.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.617 1.167 . . . . 0.0 111.817 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 99.4 t -76.57 -47.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.17 -38.82 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 122.883 0.473 . . . . 0.0 111.658 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -70.77 -41.61 71.5 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.146 0.179 . . . . 0.0 111.428 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.487 ' N ' HD12 ' A' ' 392' ' ' LEU . 28.8 ptt180 -71.9 -30.74 65.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -68.84 -29.39 67.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.614 0.765 . . . . 0.0 111.51 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.647 HD11 HG21 ' A' ' 359' ' ' VAL . 35.4 mm -69.6 -54.85 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 98.3 t -58.76 -50.07 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 O-C-N 124.193 0.933 . . . . 0.0 111.572 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.7 pt20 -68.44 -31.35 70.61 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.929 0.491 . . . . 0.0 111.91 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.22 83.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.01 -32.45 72.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.45 0.7 . . . . 0.0 112.629 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.7 t -80.24 -52.38 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.55 -38.98 89.43 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.734 0.414 . . . . 0.0 111.055 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 50.5 m -89.28 12.94 14.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.297 0.639 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -89.51 144.91 25.66 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.212 0.605 . . . . 0.0 111.732 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.87 122.23 18.2 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.839 166.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.32 62.28 0.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.445 1.09 . . . . 0.0 109.192 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 400' ' ' VAL . 89.5 m -55.96 -41.13 74.25 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.64 1.576 . . . . 0.0 111.483 -173.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -54.2 -34.67 61.11 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.116 1.366 . . . . 0.0 114.497 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.2 m -79.14 -39.4 33.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.469 0.652 . . . . 0.0 109.653 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 403' ' ' ALA . 59.8 t -67.11 -26.17 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.013 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.3 -17.54 63.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.314 1.446 . . . . 0.0 110.146 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -81.9 -8.21 86.97 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.4 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.16 -2.31 55.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.213 0.605 . . . . 0.0 111.3 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 434' ' ' ILE . 1.5 pt? -149.31 139.17 21.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.611 0.764 . . . . 0.0 110.052 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -105.87 152.7 40.29 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.101 0.961 . . . . 0.0 111.474 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.03 151.68 62.01 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.046 166.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -148.24 107.78 3.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -91.06 44.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.019 0.914 . . . . 0.0 110.979 -167.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.63 5.94 50.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.407 169.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.81 66.2 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.51 0.506 . . . . 0.0 113.178 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.52 -126.86 2.38 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.737 0.316 . . . . 0.0 112.727 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.461 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.5 mp0 -85.12 174.56 9.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.415 0.686 . . . . 0.0 110.755 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.64 135.31 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.34 0.656 . . . . 0.0 109.432 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 397' ' ' GLN . 31.2 mm -109.74 124.19 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.897 0.879 . . . . 0.0 108.998 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.8 p -106.87 133.83 50.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.224 0.61 . . . . 0.0 109.613 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.47 134.04 10.86 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.605 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 62.7 m -77.03 104.64 7.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 122.951 0.5 . . . . 0.0 111.023 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -111.05 110.63 21.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.985 0.914 . . . . 0.0 110.598 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 39.0 t70 58.09 57.6 3.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.745 1.218 . . . . 0.0 111.76 169.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 78.32 -6.94 49.2 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.131 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.98 170.84 7.83 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.708 0.754 . . . . 0.0 110.309 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 5.1 t -114.22 109.39 18.32 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -120.66 168.75 11.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.608 0.763 . . . . 0.0 110.686 -173.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 51.0 p -147.94 154.86 40.9 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.331 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 413' ' ' LEU . 25.5 pt -122.49 -179.75 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.957 0.903 . . . . 0.0 109.173 172.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -116.17 153.32 32.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.404 0.681 . . . . 0.0 110.211 170.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 421' ' ' GLU . 85.0 mt -114.96 164.68 15.96 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 0.0 109.374 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.34 134.47 17.3 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.814 1.676 . . . . 0.0 111.008 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.43 128.02 14.84 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.002 1.801 . . . . 0.0 112.248 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.51 172.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 0.0 110.369 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.18 -12.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.421 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.9 m -108.78 138.89 44.38 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.4 0.545 . . . . 0.0 111.044 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.81 -30.37 68.91 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.265 1.026 . . . . 0.0 111.622 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.6 m -62.85 -33.53 75.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.837 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -82.56 -25.32 33.43 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.933 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.2 -65.97 0.48 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.865 0.866 . . . . 0.0 111.473 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 3.1 pp -65.98 -37.43 85.93 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.609 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.65 71.69 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.263 1.025 . . . . 0.0 111.686 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -62.73 -49.71 73.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.529 0.732 . . . . 0.0 110.245 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -89.05 -14.5 36.25 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.519 -175.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.0 OUTLIER -59.69 -48.86 79.98 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.047 0.939 . . . . 0.0 110.807 -176.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.92 -32.89 71.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.075 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 60.4 t80 -68.23 -52.83 29.74 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.136 0.575 . . . . 0.0 110.87 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.08 -28.01 69.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.824 1.249 . . . . 0.0 111.31 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.72 -36.53 80.77 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.624 0.769 . . . . 0.0 110.273 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.1 m -71.41 -28.13 63.79 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.723 0.809 . . . . 0.0 110.923 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 23.9 mt -82.91 -17.81 42.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.128 0.571 . . . . 0.0 111.157 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 73.8 6.82 4.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 111.777 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 22.4 p -79.22 131.53 36.21 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.9 t70 -151.68 145.43 25.05 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.358 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 18.1 m-80 62.72 20.67 12.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 -167.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -86.27 -19.95 29.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.51 0.724 . . . . 0.0 110.476 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.09 169.55 24.23 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.537 0.735 . . . . 0.0 110.059 173.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.9 p -157.22 109.43 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 123.518 0.727 . . . . 0.0 111.626 -177.523 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.55 0.973 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.2 p -86.47 -173.58 4.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.941 0.496 . . . . 0.0 110.899 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -139.62 142.44 37.04 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.611 0.764 . . . . 0.0 110.667 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.416 HG23 HG11 ' A' ' 391' ' ' VAL . 12.4 m -143.22 152.7 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.459 1.103 . . . . 0.0 110.584 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.479 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 42.2 t -121.07 105.72 10.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 0.0 109.102 171.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.1 t -94.95 149.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.66 0.784 . . . . 0.0 109.734 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.5 103.46 9.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.572 1.149 . . . . 0.0 108.585 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.419 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -75.78 106.53 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.033 0.533 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -91.64 87.93 6.53 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.439 0.696 . . . . 0.0 109.271 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -15.61 61.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.257 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -73.98 -19.22 60.72 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.397 0.679 . . . . 0.0 110.833 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -80.52 -153.95 9.66 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.201 0.429 . . . . 0.0 112.89 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 52.5 t30 -72.69 141.5 48.23 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.828 0.347 . . . . 0.0 110.169 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 371' ' ' LEU . 2.0 m-85 -97.32 -64.63 1.02 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -138.32 -100.89 0.53 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.029 -0.873 . . . . 0.0 112.259 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -88.75 15.94 44.84 Favored 'Cis proline' 0 C--N 1.373 1.862 0 CA-C-N 120.312 2.056 . . . . 0.0 114.238 12.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -83.58 -1.79 54.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.641 0.777 . . . . 0.0 111.196 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 456' ' ' LEU . 42.4 mt -114.78 146.79 40.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.361 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.19 122.37 86.1 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.611 0.764 . . . . 0.0 110.701 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.465 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 37.6 Cg_endo -61.34 -23.76 77.47 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.229 2.619 . . . . 0.0 114.871 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -84.7 -48.2 9.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.149 0.432 . . . . 0.0 110.457 -176.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 64.7 mtt180 -68.5 -34.68 76.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.077 0.951 . . . . 0.0 111.949 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.427 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.8 mm -52.55 -31.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.909 0.883 . . . . 0.0 111.884 170.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -80.28 -28.2 38.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.115 0.566 . . . . 0.0 111.385 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -78.45 -31.33 47.93 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.623 0.769 . . . . 0.0 112.346 -169.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' A' ' 398' ' ' ALA . 0.8 OUTLIER -71.54 154.0 93.45 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.106 172.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.2 165.44 8.9 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.977 2.451 . . . . 0.0 114.812 -171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.91 -13.62 60.93 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.522 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.2 p80 -159.7 150.47 19.27 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.2 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -119.46 104.22 10.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 178.09 15.17 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.963 -0.91 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.67 136.53 36.72 Favored 'Cis proline' 0 C--N 1.386 2.54 0 CA-C-N 119.875 1.838 . . . . 0.0 113.23 -2.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -170.46 -172.89 37.28 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.03 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 58.5 Cg_endo -68.26 138.78 44.04 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.841 2.361 . . . . 0.0 112.366 -174.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 445' ' ' ALA . 11.4 p -51.05 -43.02 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.333 1.453 . . . . 0.0 111.724 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -50.77 -59.33 4.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 111.035 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.523 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 57.6 t -71.74 -42.37 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.867 -172.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 357' ' ' VAL . 97.1 t -63.27 -45.26 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.844 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.66 -40.65 84.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 390' ' ' VAL . 10.9 ptm180 -72.71 -30.05 63.89 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -72.23 -23.06 61.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.086 0.554 . . . . 0.0 111.929 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.564 HG21 ' HG ' ' A' ' 449' ' ' LEU . 22.0 mm -73.42 -55.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.9 t -62.29 -55.79 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.587 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.0 pt20 -64.07 -29.63 70.75 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.795 0.438 . . . . 0.0 111.9 -176.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -64.09 -48.9 74.38 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.24 -47.86 78.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.856 0.723 . . . . 0.0 112.318 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 396' ' ' VAL . 10.2 t -65.13 -48.12 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.958 0.409 . . . . 0.0 110.154 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.95 -33.55 74.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.686 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 73.5 m -93.01 17.22 11.11 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.429 0.692 . . . . 0.0 110.958 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.596 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -91.13 155.46 18.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.611 0.719 . . . . 0.0 112.318 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.47 121.94 26.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.689 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 57.32 61.91 2.36 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.333 1.02 . . . . 0.0 109.712 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 400' ' ' VAL . 97.1 m -48.67 -35.81 14.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.094 1.758 . . . . 0.0 112.742 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -56.93 -39.51 74.62 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.492 1.117 . . . . 0.0 113.036 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 92.9 m -79.6 -40.48 29.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.816 0.847 . . . . 0.0 109.772 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.596 HG21 ' HB1' ' A' ' 403' ' ' ALA . 94.5 t -61.08 -33.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.429 1.092 . . . . 0.0 111.46 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.12 -10.54 59.49 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.368 1.067 . . . . 0.0 110.908 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -82.38 -6.94 88.24 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.574 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.14 10.1 28.32 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.414 0.685 . . . . 0.0 111.464 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -152.14 141.05 21.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.295 1.038 . . . . 0.0 108.964 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -117.15 154.99 50.1 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 123.688 0.795 . . . . 0.0 111.53 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.09 157.8 56.73 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.692 2.261 . . . . 0.0 112.037 167.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.405 ' OD1' ' HD2' ' A' ' 418' ' ' ARG . 5.3 t0 -155.15 139.23 16.47 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -90.12 27.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.405 ' HD2' ' OD1' ' A' ' 416' ' ' ASP . 0.0 OUTLIER -84.44 -33.42 23.67 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 111.024 175.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.77 41.82 8.63 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.723 0.249 . . . . 0.0 113.723 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -94.18 -110.25 2.19 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.761 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 23.5 mp0 -74.28 162.74 28.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.446 ' HB ' ' NH2' ' A' ' 393' ' ' ARG . 90.1 t -135.64 130.07 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.517 HG12 HD11 ' A' ' 436' ' ' LEU . 37.3 mm -110.4 127.55 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.7 p -106.04 150.7 25.5 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.673 0.789 . . . . 0.0 108.999 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -165.87 135.96 3.47 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.583 0.753 . . . . 0.0 109.678 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 69.0 m -67.48 101.06 0.92 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.585 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -139.21 136.75 35.33 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 109.502 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.7 t70 62.71 31.64 16.53 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.97 1.308 . . . . 0.0 111.514 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 81.34 1.87 90.24 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.893 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.81 172.96 10.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.586 1.155 . . . . 0.0 109.308 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.8 t -87.75 102.24 14.47 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 164.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -85.94 133.08 33.96 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.439 ' HB3' HG22 ' A' ' 424' ' ' THR . 25.2 p -114.56 143.3 45.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.017 0.927 . . . . 0.0 110.445 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 413' ' ' LEU . 16.5 pt -128.46 168.44 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.046 0.938 . . . . 0.0 109.761 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -112.28 146.93 37.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.536 0.734 . . . . 0.0 110.766 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.7 mp -115.86 155.48 47.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.233 1.413 . . . . 0.0 108.355 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.17 128.66 14.11 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.79 1.66 . . . . 0.0 111.462 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.09 135.36 27.14 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.927 2.418 . . . . 0.0 111.617 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.16 160.78 4.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.285 0.564 . . . . 0.0 110.751 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.62 12.43 3.19 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.316 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 39.5 t -118.36 139.13 51.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.896 0.478 . . . . 0.0 109.97 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.25 45.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.462 1.105 . . . . 0.0 111.365 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 27.2 m -72.89 -22.4 60.76 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.03 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.41 -21.39 25.63 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.81 -60.73 2.36 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 121.701 0.762 . . . . 0.0 109.918 170.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 464' ' ' SER . 20.6 mt -69.69 -39.77 76.75 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.952 -174.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 0.0 OUTLIER -61.15 -30.8 70.61 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.879 0.872 . . . . 0.0 111.442 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -45.51 72.88 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.903 0.481 . . . . 0.0 110.492 -177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.564 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.51 -13.1 43.98 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.074 -0.488 . . . . 0.0 111.846 176.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 1.4 mm-40 -57.17 -56.98 14.71 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.725 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.39 -35.72 81.05 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.931 0.769 . . . . 0.0 111.147 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 38.8 t80 -60.31 -61.06 2.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.522 0.729 . . . . 0.0 110.818 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.85 -30.54 69.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.435 1.094 . . . . 0.0 111.81 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -66.04 -40.26 90.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.224 0.61 . . . . 0.0 110.582 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 49.9 m -67.91 -35.86 79.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.536 0.734 . . . . 0.0 110.486 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.567 HD13 HD21 ' A' ' 371' ' ' LEU . 50.3 mt -72.59 -12.91 61.25 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.542 0.737 . . . . 0.0 111.5 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 73.74 14.61 4.12 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.807 1.643 . . . . 0.0 111.61 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.523 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 15.3 p -93.88 139.59 30.71 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 123.379 0.672 . . . . 0.0 109.982 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -155.31 144.82 21.18 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 3.2 t30 66.84 12.62 9.0 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 124.191 0.932 . . . . 0.0 110.342 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 34.8 tp -74.57 -17.94 60.65 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.866 0.866 . . . . 0.0 110.24 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.455 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.01 161.66 31.56 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.344 0.658 . . . . 0.0 110.775 177.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 80.8 p -167.81 129.06 1.45 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.698 0.799 . . . . 0.0 109.001 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 35.4 t . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.839 0.352 . . . . 0.0 111.432 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.439 ' SD ' ' HB3' ' A' ' 387' ' ' PRO . 20.1 ptp . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 120.883 0.373 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.5 t -76.74 172.49 13.0 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.8 p -136.68 137.02 39.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.392 0.677 . . . . 0.0 109.411 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 388' ' ' VAL . 17.2 m -138.25 165.9 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.024 0.93 . . . . 0.0 110.969 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 24.6 p -142.65 108.89 5.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 108.548 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -94.92 159.32 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.27 99.89 6.74 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.415 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 39.7 t -70.84 107.61 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 123.869 0.731 . . . . 0.0 110.313 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.55 89.6 5.05 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.368 1.067 . . . . 0.0 109.117 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.42 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.89 -3.6 42.54 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.509 178.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.95 -11.46 58.86 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.223 0.609 . . . . 0.0 110.414 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.56 -151.05 5.32 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 51.2 t-20 -77.52 139.26 39.56 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.41 -52.69 6.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.687 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.46 -76.22 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 114.738 -1.119 . . . . 0.0 114.32 -176.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.03 -10.06 13.83 Favored 'Cis proline' 0 C--N 1.371 1.759 0 CA-C-N 121.102 2.451 . . . . 0.0 114.095 -2.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 14.8 p-80 -61.29 -12.33 13.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.188 0.995 . . . . 0.0 113.029 175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.687 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.4 mt -98.69 143.07 29.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.152 0.981 . . . . 0.0 109.408 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 127.49 91.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 123.864 0.727 . . . . 0.0 110.068 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 29.7 Cg_endo -59.63 -41.25 57.83 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.992 2.461 . . . . 0.0 112.875 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -65.64 -45.2 83.93 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.398 0.436 . . . . 0.0 110.675 -175.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -66.88 -31.2 71.65 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.687 0.795 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 18.5 mm -66.63 -28.83 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.068 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 62.2 mm-40 -82.93 -23.04 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.961 -0.462 . . . . 0.0 110.906 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 70.9 mm-40 -74.6 -38.67 62.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.953 0.501 . . . . 0.0 111.716 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.1 pp -67.51 156.77 87.87 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.926 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.29 150.69 83.6 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.539 2.159 . . . . 0.0 113.122 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.55 -1.8 26.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.879 1.272 . . . . 0.0 111.442 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 39.7 p-80 -157.33 151.33 24.57 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 109.965 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -118.1 104.25 10.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 166.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 148.27 176.69 21.96 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.248 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -82.23 128.74 15.07 Favored 'Cis proline' 0 C--N 1.376 2.004 0 CA-C-N 118.751 1.276 . . . . 0.0 111.326 -2.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -153.49 -165.45 13.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.099 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.439 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 3.1 Cg_exo -70.97 146.31 52.4 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.951 2.434 . . . . 0.0 112.265 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.0 p -54.64 -45.32 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 124.28 1.032 . . . . 0.0 111.15 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -62.44 -49.74 74.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.064 1.346 . . . . 0.0 110.948 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 83.4 t -70.63 -48.9 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.508 -174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.12 -40.61 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.87 0.468 . . . . 0.0 111.897 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.7 pp -66.87 -41.84 86.6 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.421 ' N ' HD12 ' A' ' 392' ' ' LEU . 17.4 ptt180 -74.49 -25.4 59.35 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 123.32 0.388 . . . . 0.0 110.033 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 36.7 mmm-85 -64.09 -40.33 95.99 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.422 0.451 . . . . 0.0 110.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 359' ' ' VAL . 43.6 mm -63.55 -51.33 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.953 0.783 . . . . 0.0 109.735 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.79 -44.87 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.298 -174.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.58 -28.03 41.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.857 -0.592 . . . . 0.0 111.834 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -73.53 -31.88 63.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.274 0.488 . . . . 0.0 110.508 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.96 -56.12 19.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.085 0.554 . . . . 0.0 109.56 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.73 -30.13 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.729 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.06 -33.97 70.77 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.484 0.714 . . . . 0.0 111.566 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 379' ' ' LEU . 78.4 m -91.23 0.1 57.59 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.989 0.516 . . . . 0.0 111.637 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.93 138.84 54.95 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.4 mt -82.6 115.98 21.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.53 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 64.54 61.39 0.85 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.444 1.116 . . . . 0.0 109.286 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.0 m -51.8 -34.8 41.59 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.217 1.807 . . . . 0.0 112.806 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -54.93 -42.24 72.0 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.532 1.133 . . . . 0.0 112.315 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 49.6 m -80.53 -37.25 31.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 403' ' ' ALA . 90.8 t -65.37 -34.92 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.235 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.37 -16.64 60.36 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.832 0.853 . . . . 0.0 110.84 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -68.72 -13.55 66.18 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 116.257 -0.429 . . . . 0.0 114.14 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.88 -13.32 60.01 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.738 . . . . 0.0 111.444 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.614 HD22 ' HE1' ' A' ' 452' ' ' PHE . 1.0 OUTLIER -141.52 112.71 7.43 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.376 0.671 . . . . 0.0 110.267 -173.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 415' ' ' PRO . 47.0 mtpt -112.56 160.67 29.61 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 124.163 0.985 . . . . 0.0 109.637 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 414' ' ' LYS . 67.3 Cg_endo -67.75 155.52 69.62 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.288 1.992 . . . . 0.0 114.698 -170.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.87 124.34 26.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.062 1.345 . . . . 0.0 108.601 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.82 33.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.193 0.597 . . . . 0.0 112.212 -164.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -92.01 -10.62 38.56 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 111.42 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.65 41.33 64.96 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.53 -116.8 2.37 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 120.113 -0.27 . . . . 0.0 112.961 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.9 OUTLIER -77.4 168.73 19.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 110.592 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 81.2 t -132.92 125.29 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.631 0.772 . . . . 0.0 109.217 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 436' ' ' LEU . 37.6 mm -103.37 128.06 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.5 p -106.63 140.9 38.77 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.941 0.896 . . . . 0.0 109.809 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.05 141.8 24.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.037 0.935 . . . . 0.0 110.151 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.2 p -83.65 112.7 20.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -144.24 137.48 27.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.031 0.932 . . . . 0.0 109.428 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.17 18.32 11.38 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.494 1.117 . . . . 0.0 112.434 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.38 70.89 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 121.792 -0.567 . . . . 0.0 112.776 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -131.74 170.99 14.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.661 1.184 . . . . 0.0 109.71 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -92.09 126.08 37.03 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.8 126.9 53.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.728 0.811 . . . . 0.0 109.297 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.8 p -117.76 140.63 49.42 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 0.0 110.336 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.14 162.3 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.396 0.678 . . . . 0.0 109.947 172.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -99.27 146.69 25.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.816 0.847 . . . . 0.0 110.111 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 423' ' ' ILE . 8.5 mp -115.18 171.43 4.51 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.64 141.73 25.2 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 121.957 1.771 . . . . 0.0 111.735 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.32 128.47 8.91 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.148 1.898 . . . . 0.0 112.257 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.45 172.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.617 0.767 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -149.04 -0.93 0.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.008 0.523 . . . . 0.0 111.979 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -126.5 139.93 52.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.005 0.522 . . . . 0.0 110.751 -172.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.19 70.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.226 1.01 . . . . 0.0 111.517 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 t -63.49 -27.69 69.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.565 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -86.9 -27.87 23.13 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.734 0.414 . . . . 0.0 110.395 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.889 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.9 -66.94 0.31 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.974 0.91 . . . . 0.0 111.954 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 450' ' ' GLU . 0.9 OUTLIER -61.79 -43.75 98.23 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.179 178.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -31.59 58.47 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.364 1.066 . . . . 0.0 111.917 -175.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -62.65 -55.28 28.38 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.687 0.617 . . . . 0.0 110.046 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.76 -14.84 59.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.24 -178.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 446' ' ' LEU . 10.5 mm-40 -64.54 -45.92 85.1 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.292 0.496 . . . . 0.0 110.143 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.15 -39.59 65.55 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.169 0.588 . . . . 0.0 110.599 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.614 ' HE1' HD22 ' A' ' 413' ' ' LEU . 67.9 t80 -57.88 -59.14 5.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.657 0.783 . . . . 0.0 110.952 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.62 -27.16 69.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.118 0.967 . . . . 0.0 112.149 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -65.1 -41.53 94.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.03 0.532 . . . . 0.0 110.505 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 51.1 m -67.62 -21.84 65.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.708 0.803 . . . . 0.0 111.65 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 71.1 mt -100.05 -14.02 18.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.056 0.942 . . . . 0.0 112.963 -173.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.07 7.23 1.65 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.687 1.595 . . . . 0.0 112.19 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . . . . . . . . . 6.1 p -89.44 134.22 34.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.3 t70 -152.2 152.18 31.92 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 59.74 18.27 7.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.243 1.017 . . . . 0.0 111.259 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.23 -18.52 49.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.77 0.428 . . . . 0.0 110.966 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -163.74 172.5 14.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.23 0.612 . . . . 0.0 110.47 171.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 18.9 p -163.28 126.48 2.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.779 0.831 . . . . 0.0 108.839 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 29.2 t . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 122.66 0.384 . . . . 0.0 111.553 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.9 t -82.37 179.19 7.88 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.144 0.578 . . . . 0.0 110.864 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.5 p -137.89 134.69 35.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.18 0.992 . . . . 0.0 109.864 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.9 m -140.41 162.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.959 0.903 . . . . 0.0 110.771 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 20.4 p -137.45 115.57 11.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.431 1.092 . . . . 0.0 108.815 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 34.9 m -104.01 141.91 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.837 0.455 . . . . 0.0 109.801 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.48 98.24 7.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 67.5 t -70.68 99.59 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.463 1.102 . . . . 0.0 110.713 -173.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 33.6 t30 -94.47 97.11 9.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.62 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.4 -11.33 59.83 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.334 178.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -83.32 -15.74 48.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.546 0.738 . . . . 0.0 110.783 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -70.95 -88.32 0.11 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -141.13 152.0 44.37 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.0 -62.19 1.32 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.563 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -149.23 -91.75 0.09 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.609 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . 0.425 ' HD2' HE21 ' A' ' 457' ' ' GLN . 29.6 Cg_endo -85.5 10.48 53.13 Favored 'Cis proline' 0 C--N 1.371 1.763 0 CA-C-N 120.496 2.148 . . . . 0.0 114.832 11.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -74.16 -8.23 55.46 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 26.0 mt -107.89 136.06 48.24 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.415 1.086 . . . . 0.0 108.743 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.16 125.19 86.42 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.481 0.712 . . . . 0.0 110.318 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.529 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 35.0 Cg_endo -62.95 -31.03 77.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.717 2.278 . . . . 0.0 113.137 -172.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.32 -45.97 36.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.148 0.579 . . . . 0.0 110.119 -176.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -61.94 -34.59 76.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.356 1.062 . . . . 0.0 111.598 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 379' ' ' LEU . 24.2 mm -64.04 -29.93 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.777 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 76.9 mm-40 -83.18 -21.91 33.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.325 0.25 . . . . 0.0 110.859 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 82.9 mm-40 -79.58 -32.56 42.02 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.03 0.532 . . . . 0.0 112.148 -176.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -72.06 156.98 90.23 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.018 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.85 161.34 18.8 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.854 2.37 . . . . 0.0 114.33 -173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.36 -21.37 61.31 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.952 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.487 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 20.5 p-80 -167.05 154.04 8.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.086 0.955 . . . . 0.0 110.67 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -117.9 146.38 43.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.072 0.949 . . . . 0.0 108.969 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.18 -174.85 39.09 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.271 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.56 128.58 16.82 Favored 'Cis proline' 0 C--N 1.377 2.049 0 CA-C-N 119.187 1.493 . . . . 0.0 112.329 1.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.66 -154.69 7.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.201 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.31 137.2 25.44 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.655 2.237 . . . . 0.0 112.122 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.76 -42.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.606 1.562 . . . . 0.0 112.073 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.23 -55.5 27.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.395 1.478 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -70.13 -46.08 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.888 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.21 -36.63 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 122.566 0.346 . . . . 0.0 111.672 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.3 pp -73.89 -40.68 63.02 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.744 0.247 . . . . 0.0 111.02 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.5 ptt180 -67.98 -29.18 68.14 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 22.0 mmm-85 -65.37 -43.32 91.16 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 123.864 0.727 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 29.4 mm -65.26 -53.59 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.455 0.472 . . . . 0.0 109.838 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 400' ' ' VAL . 66.7 t -62.05 -44.81 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.027 0.829 . . . . 0.0 110.896 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.518 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.6 pt20 -67.5 -33.99 76.22 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.63 0.195 . . . . 0.0 110.838 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.1 84.67 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 122.879 0.472 . . . . 0.0 110.147 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 82.3 m -68.61 -51.35 43.3 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.591 0.756 . . . . 0.0 111.1 -175.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 406' ' ' THR . 21.0 t -62.06 -43.9 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.7 -33.35 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.002 0.521 . . . . 0.0 111.524 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 19.2 p -84.34 -10.07 57.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.696 0.398 . . . . 0.0 111.023 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.38 150.03 49.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 112.987 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.55 121.27 26.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.408 169.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 62.77 61.3 1.18 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 122.249 1.023 . . . . 0.0 109.148 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.522 HG23 HG12 ' A' ' 400' ' ' VAL . 52.2 m -54.63 -34.35 61.99 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.437 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -57.66 -37.23 73.02 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 113.175 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.8 m -84.42 -35.34 23.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.055 0.542 . . . . 0.0 110.281 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.531 HG21 ' HB1' ' A' ' 403' ' ' ALA . 88.6 t -64.58 -31.22 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.864 0.866 . . . . 0.0 110.837 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.56 -21.6 62.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.944 1.298 . . . . 0.0 110.436 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.59 76.07 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.198 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -77.38 -18.13 57.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.209 0.604 . . . . 0.0 111.689 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -133.26 125.56 29.59 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.501 0.721 . . . . 0.0 110.088 -175.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -103.45 159.03 30.59 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.931 0.892 . . . . 0.0 109.963 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.17 122.64 8.2 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.768 1.645 . . . . 0.0 112.64 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 4.3 m-20 -110.16 107.67 17.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.328 1.451 . . . . 0.0 107.342 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -83.83 67.62 9.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.095 0.95 . . . . 0.0 108.566 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -107.53 4.1 25.7 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.97 40.13 93.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.44 0.462 . . . . 0.0 113.053 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -106.61 -132.34 7.05 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 120.125 -0.264 . . . . 0.0 112.633 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.5 OUTLIER -73.21 172.78 10.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.972 0.909 . . . . 0.0 111.389 -175.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 131.22 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 109.32 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 397' ' ' GLN . 42.1 mm -111.77 123.73 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 433' ' ' SER . 17.0 p -106.51 144.95 32.45 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.831 0.852 . . . . 0.0 109.051 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -160.63 133.03 6.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.662 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.4 m -70.9 109.03 4.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.326 0.651 . . . . 0.0 111.91 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -131.21 126.85 36.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.684 1.194 . . . . 0.0 109.033 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.26 14.35 7.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.036 1.335 . . . . 0.0 112.355 169.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 7.2 62.5 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.721 -0.612 . . . . 0.0 113.015 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -120.6 166.08 14.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.256 1.022 . . . . 0.0 109.46 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.2 t -97.9 101.23 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -88.6 126.95 35.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 424' ' ' THR . 55.2 p -116.88 148.68 41.09 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.458 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 413' ' ' LEU . 46.4 pt -125.56 179.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.086 0.954 . . . . 0.0 109.215 173.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -115.66 153.21 31.71 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 86.1 mt -115.58 166.07 12.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.488 1.115 . . . . 0.0 108.933 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.92 135.07 12.26 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 121.814 1.676 . . . . 0.0 111.105 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.42 134.01 25.64 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.809 2.339 . . . . 0.0 112.494 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.29 173.64 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.787 0.835 . . . . 0.0 111.647 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -152.06 -4.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.43 0.692 . . . . 0.0 112.312 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.5 t -113.96 139.16 49.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.727 0.411 . . . . 0.0 109.999 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.12 67.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.541 0.736 . . . . 0.0 111.308 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 48.3 m -63.87 -32.94 74.62 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.441 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -83.21 -27.28 30.09 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.945 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.65 -62.27 1.7 Allowed 'General case' 0 C--N 1.366 1.3 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 449' ' ' LEU . 17.7 mt -66.31 -52.18 49.88 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.31 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -51.46 -36.14 42.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -59.06 -49.09 79.22 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.847 0.717 . . . . 0.0 109.964 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.58 -14.13 38.34 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.729 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 49.9 mt-10 -78.02 -36.57 48.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.348 0.976 . . . . 0.0 110.153 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.25 -42.28 96.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.088 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 58.8 t80 -72.42 -43.42 63.88 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.48 -174.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 20.7 p -70.84 -26.66 63.38 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.557 0.743 . . . . 0.0 109.963 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -65.74 -35.06 79.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.031 0.932 . . . . 0.0 110.271 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 17.2 m -75.94 -29.11 58.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.643 0.777 . . . . 0.0 110.598 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 371' ' ' LEU . 51.3 mt -80.27 -14.75 58.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.43 0.692 . . . . 0.0 110.951 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . 0.425 HE21 ' HD2' ' A' ' 369' ' ' PRO . 17.6 mt-30 75.69 9.74 3.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 0.0 112.07 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 11.8 p -91.5 138.42 31.59 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.34 0.656 . . . . 0.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -133.82 156.83 47.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 109.501 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 29.8 m-80 59.01 22.21 10.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.754 0.821 . . . . 0.0 111.634 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.95 -17.29 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.177 0.591 . . . . 0.0 110.255 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.05 172.55 17.96 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.982 0.913 . . . . 0.0 109.805 173.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 24.0 p -165.88 134.79 3.17 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.736 0.648 . . . . 0.0 109.882 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.123 0.487 . . . . 0.0 111.668 179.579 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.4 m -73.39 171.98 12.1 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.771 0.428 . . . . 0.0 110.87 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.3 p -133.6 137.99 45.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.169 0.588 . . . . 0.0 110.087 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.3 m -143.15 162.36 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.466 1.106 . . . . 0.0 109.819 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 46.9 t -135.27 107.94 7.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.56 0.744 . . . . 0.0 109.299 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 42.5 t -96.46 151.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.299 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.17 106.33 8.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.578 1.151 . . . . 0.0 108.669 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 379' ' ' LEU . 62.1 t -71.7 112.3 6.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.306 0.642 . . . . 0.0 110.31 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 51.5 t30 -93.51 81.22 4.34 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.31 -13.64 62.41 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.312 175.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -74.29 -23.04 59.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.481 0.713 . . . . 0.0 110.876 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.33 -140.8 2.1 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.094 0.246 . . . . 0.0 112.924 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 59.3 t-20 -74.62 143.55 44.3 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.92 -53.55 3.64 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -155.52 -70.88 0.01 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.447 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.21 5.12 58.47 Favored 'Cis proline' 0 C--N 1.373 1.842 0 CA-C-N 120.382 2.091 . . . . 0.0 114.702 2.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -76.35 -9.08 58.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 117.914 0.325 . . . . 0.0 111.275 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.557 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 25.4 mt -87.18 123.99 32.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.504 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 9.8 t70 -55.09 122.53 42.86 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 124.502 1.126 . . . . 0.0 110.374 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 37.1 Cg_endo -60.93 -31.11 91.16 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.015 2.477 . . . . 0.0 113.406 -172.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.95 -46.77 33.28 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.617 0.367 . . . . 0.0 110.489 -176.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . 0.504 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 23.8 mtp180 -65.03 -30.92 71.93 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 110.719 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.7 mm -63.78 -28.78 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.123 0.969 . . . . 0.0 110.988 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.1 mm-40 -85.57 -25.37 26.76 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.492 0.317 . . . . 0.0 110.79 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 78.9 mm-40 -75.39 -31.68 60.54 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.756 0.422 . . . . 0.0 112.134 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.607 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.2 pp -71.2 155.28 93.26 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.167 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.05 158.09 40.84 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.451 2.101 . . . . 0.0 113.311 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.54 -3.58 25.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.697 1.199 . . . . 0.0 111.855 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 5.4 p80 -159.25 156.77 29.4 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.223 0.609 . . . . 0.0 110.513 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.417 ' HD2' HD13 ' A' ' 395' ' ' ILE . 50.2 m-85 -128.29 103.76 7.35 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 133.81 176.8 14.55 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.511 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.82 129.86 19.65 Favored 'Cis proline' 0 C--N 1.376 2.009 0 CA-C-N 120.008 1.904 . . . . 0.0 112.645 -4.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -154.24 -161.62 10.58 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.806 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -74.02 130.76 14.71 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.756 2.304 . . . . 0.0 111.176 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.2 p -38.01 -48.41 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.661 1.984 . . . . 0.0 113.63 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -72.97 -39.95 65.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.797 1.639 . . . . 0.0 112.134 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.33 -43.18 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.451 0.301 . . . . 0.0 110.718 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.35 -40.18 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.369 0.668 . . . . 0.0 111.892 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -67.95 -40.22 83.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.48 ' N ' HD12 ' A' ' 392' ' ' LEU . 5.5 ptt180 -70.69 -24.81 62.74 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.989 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -65.26 -42.05 93.65 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.816 0.846 . . . . 0.0 110.907 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.417 HD13 ' HD2' ' A' ' 383' ' ' PHE . 34.5 mm -64.81 -50.68 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 400' ' ' VAL . 99.2 t -59.27 -52.72 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.539 -1.209 . . . . 0.0 111.689 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.447 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.2 pt20 -65.54 -34.33 78.0 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.292 0.637 . . . . 0.0 110.793 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -69.12 -36.88 77.96 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 123.856 0.723 . . . . 0.0 110.586 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 89.2 m -68.56 -42.75 77.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.196 0.598 . . . . 0.0 111.462 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 396' ' ' VAL . 21.5 t -70.51 -41.66 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.774 0.43 . . . . 0.0 109.858 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.74 -40.93 96.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.922 0.889 . . . . 0.0 111.024 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.607 ' SG ' HD23 ' A' ' 379' ' ' LEU . 71.5 m -93.1 10.78 30.16 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.469 0.708 . . . . 0.0 111.975 -176.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.609 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -87.4 143.39 27.26 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.21 131.71 39.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 61.11 57.21 2.55 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 122.134 0.968 . . . . 0.0 109.741 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 32.1 m -50.37 -32.48 17.53 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.956 1.702 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -61.19 -34.65 75.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 112.949 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -81.8 -34.53 30.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.509 0.724 . . . . 0.0 109.953 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.609 HG21 ' HB1' ' A' ' 403' ' ' ALA . 45.7 t -71.4 -26.5 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.33 -23.2 61.89 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.064 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -80.82 -9.16 86.67 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.19 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 409' ' ' VAL . 31.2 m-85 -72.12 -21.89 61.41 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 117.787 0.793 . . . . 0.0 111.138 176.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.08 146.39 45.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.746 0.818 . . . . 0.0 110.624 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -116.75 155.75 48.65 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.071 0.948 . . . . 0.0 110.247 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.53 131.11 25.27 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.173 1.915 . . . . 0.0 112.065 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -102.57 167.77 9.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.725 1.21 . . . . 0.0 108.965 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -131.95 43.7 3.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.695 0.76 . . . . 0.0 111.96 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -104.8 2.49 30.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.482 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.25 32.01 75.43 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.229 0.331 . . . . 0.0 113.301 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.03 -117.04 1.5 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 113.711 0.244 . . . . 0.0 113.711 -172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 18.7 mm-40 -89.94 170.37 10.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.089 0.556 . . . . 0.0 111.457 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 434' ' ' ILE . 60.3 t -131.51 128.72 61.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 122.749 0.419 . . . . 0.0 109.96 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 433' ' ' SER . 43.4 mm -114.23 128.57 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.9 p -105.57 144.49 32.26 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.024 0.929 . . . . 0.0 109.862 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -157.05 127.67 6.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.05 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 60.4 p -72.49 124.63 25.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.243 0.617 . . . . 0.0 109.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -147.14 115.74 6.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.625 0.77 . . . . 0.0 109.918 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.3 t70 64.46 23.97 13.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.762 1.225 . . . . 0.0 111.504 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.63 -16.03 60.23 Favored Glycine 0 N--CA 1.471 0.97 0 O-C-N 121.89 -0.506 . . . . 0.0 113.138 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -97.88 168.69 10.15 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.592 0.757 . . . . 0.0 109.796 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.2 t -113.22 104.8 12.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -97.79 125.42 42.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.02 0.928 . . . . 0.0 110.378 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.5 p -118.19 138.78 52.08 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.748 0.819 . . . . 0.0 109.784 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 422' ' ' VAL . 23.8 pt -117.31 171.63 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.024 0.53 . . . . 0.0 109.863 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 27.7 mt-30 -102.62 150.45 23.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 170.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 80.1 mt -115.94 164.41 17.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.229 1.412 . . . . 0.0 108.278 169.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.82 139.03 32.73 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.898 1.732 . . . . 0.0 111.153 168.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.76 127.86 6.49 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.107 1.871 . . . . 0.0 110.994 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.67 164.35 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.09 0.471 . . . . 0.0 109.845 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -151.22 23.31 0.73 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.901 0.88 . . . . 0.0 110.163 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 388' ' ' VAL . 47.7 t -124.69 137.28 54.36 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.73 65.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.9 t -69.88 -21.27 63.34 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.033 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.4 -29.72 24.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.42 -67.51 0.27 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.995 0.918 . . . . 0.0 111.895 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 450' ' ' GLU . 0.1 OUTLIER -62.79 -45.06 94.42 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.651 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -59.48 -29.47 67.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.922 0.889 . . . . 0.0 112.399 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -61.84 -60.91 2.94 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.51 0.724 . . . . 0.0 109.609 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -76.97 -13.91 59.91 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 112.32 -177.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 446' ' ' LEU . 38.2 mt-10 -58.16 -41.66 84.29 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.883 0.765 . . . . 0.0 110.921 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -68.61 -44.57 74.0 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.398 0.437 . . . . 0.0 110.584 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.466 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 62.9 t80 -60.85 -52.62 64.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.622 0.769 . . . . 0.0 110.749 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.5 -34.29 76.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.699 1.2 . . . . 0.0 111.583 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -69.32 -32.98 72.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.842 0.457 . . . . 0.0 110.261 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.1 m -72.21 -28.44 63.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.52 0.728 . . . . 0.0 110.409 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 22.7 mt -80.9 -12.9 59.33 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.315 0.646 . . . . 0.0 111.292 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 76.27 5.39 3.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 126.562 1.945 . . . . 0.0 111.933 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.478 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.9 p -89.99 140.25 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.818 0.447 . . . . 0.0 110.102 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 23.3 t70 -148.6 151.92 35.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -174.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 9.6 p30 47.62 27.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.788 1.235 . . . . 0.0 112.539 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.41 -10.49 59.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.08 0.952 . . . . 0.0 109.443 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.85 158.01 35.97 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.629 0.772 . . . . 0.0 109.921 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 25.0 p -145.56 109.81 4.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.287 0.635 . . . . 0.0 109.937 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 16.5 t . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.306 0.643 . . . . 0.0 111.159 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.941 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.3 t -79.14 -172.91 3.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.686 0.794 . . . . 0.0 110.613 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.1 p -140.08 135.62 32.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 110.028 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 25.8 m -136.7 156.61 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 124.208 1.003 . . . . 0.0 110.88 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.547 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 26.3 p -119.54 107.15 12.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.521 0.728 . . . . 0.0 109.263 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 56.1 t -96.67 150.54 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -129.21 104.33 7.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.434 1.094 . . . . 0.0 108.564 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.467 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 64.8 t -74.28 105.17 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 110.31 -176.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 41.2 t30 -88.31 87.82 7.43 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -17.43 63.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.306 175.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -71.69 -17.99 62.2 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.592 . . . . 0.0 110.547 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -82.14 -167.63 40.12 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.832 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -68.03 129.28 39.45 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.964 0.506 . . . . 0.0 110.479 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.48 ' HB3' HG13 ' A' ' 376' ' ' ILE . 0.9 OUTLIER -75.95 -58.85 3.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.639 -173.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.42 -91.13 0.08 OUTLIER Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.341 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.5 19.86 33.93 Favored 'Cis proline' 0 C--N 1.37 1.702 0 CA-C-N 120.502 2.151 . . . . 0.0 114.31 11.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -77.15 -6.19 51.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.525 0.33 . . . . 0.0 111.359 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 456' ' ' LEU . 31.1 mt -111.28 142.91 42.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.397 1.079 . . . . 0.0 108.832 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.81 122.32 87.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.069 0.548 . . . . 0.0 110.159 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 26.1 Cg_endo -59.08 -28.21 87.19 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.283 2.655 . . . . 0.0 114.247 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.79 -48.08 23.15 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.384 0.427 . . . . 0.0 109.937 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -67.83 -28.78 67.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.559 0.744 . . . . 0.0 111.661 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.506 HD13 HD21 ' A' ' 379' ' ' LEU . 12.7 mm -60.35 -29.66 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.933 172.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 57.0 mm-40 -85.15 -25.38 27.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.612 0.365 . . . . 0.0 110.602 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 65.9 mm-40 -82.26 -24.06 34.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.016 0.527 . . . . 0.0 112.116 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.506 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -74.59 158.71 84.67 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.25 153.39 74.53 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.153 1.902 . . . . 0.0 112.718 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.99 -18.2 65.08 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.114 1.365 . . . . 0.0 112.386 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.467 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.6 p80 -161.97 160.14 27.39 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.197 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.513 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.3 m-85 -124.76 104.66 8.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 135.09 161.51 9.41 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.631 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -79.15 129.87 19.26 Favored 'Cis proline' 0 C--N 1.373 1.857 0 CA-C-N 120.147 1.973 . . . . 0.0 112.123 4.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.99 -176.04 34.64 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.667 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.46 133.91 33.98 Favored 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 112.838 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -38.27 -46.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 127.038 2.135 . . . . 0.0 113.621 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -76.81 -37.4 55.81 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.168 0.987 . . . . 0.0 111.684 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.0 t -74.41 -41.23 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 357' ' ' VAL . 74.2 t -61.36 -42.28 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.46 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.4 pp -70.42 -40.1 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.49 ' N ' HD12 ' A' ' 392' ' ' LEU . 16.2 ptm180 -68.52 -31.85 71.39 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 27.7 mmm-85 -72.35 -32.69 66.7 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.513 HD13 ' HD2' ' A' ' 383' ' ' PHE . 18.2 mm -65.4 -53.43 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 400' ' ' VAL . 93.9 t -55.76 -53.84 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 124.34 1.025 . . . . 0.0 110.749 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.36 -37.55 77.66 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . 0.617 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 83.3 m -71.75 -40.42 69.36 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.023 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 396' ' ' VAL . 74.8 t -68.56 -32.99 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.093 0.557 . . . . 0.0 110.42 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.77 -51.01 68.8 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.182 0.593 . . . . 0.0 109.973 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 29.6 p -79.36 -10.57 59.84 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.447 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -57.62 119.07 5.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.581 1.152 . . . . 0.0 113.459 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.24 116.94 7.1 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.852 167.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 63.58 68.73 0.58 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.026 0.917 . . . . 0.0 108.7 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.9 m -54.73 -40.93 69.78 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.466 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -50.86 -40.12 55.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.778 1.231 . . . . 0.0 113.878 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -84.98 -35.17 22.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.379 0.672 . . . . 0.0 110.207 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.5 t -66.15 -33.61 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.52 0.728 . . . . 0.0 111.063 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.45 -11.37 59.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.988 0.915 . . . . 0.0 110.083 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.75 -9.75 84.93 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.268 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.65 0.73 55.27 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.613 0.765 . . . . 0.0 111.597 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -142.7 133.74 25.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.274 0.63 . . . . 0.0 110.482 176.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -114.2 159.43 36.47 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 124.025 0.93 . . . . 0.0 109.764 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.45 143.07 30.55 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.029 1.819 . . . . 0.0 111.022 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -139.25 132.87 30.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -87.89 25.7 1.49 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -164.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -9.07 58.3 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.363 0.665 . . . . 0.0 110.871 171.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 67.28 31.91 78.43 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.556 0.535 . . . . 0.0 114.006 172.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.11 -121.07 1.2 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 123.598 0.234 . . . . 0.0 112.936 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.8 mp0 -82.26 172.71 12.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.842 0.857 . . . . 0.0 110.603 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 94.3 t -134.11 131.65 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.419 0.688 . . . . 0.0 109.837 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 433' ' ' SER . 46.5 mm -104.37 127.64 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 0.0 109.358 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.7 p -106.72 148.29 28.59 Favored 'General case' 0 C--O 1.241 0.635 0 O-C-N 123.906 0.754 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.01 170.97 20.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.849 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 52.3 m -103.2 115.87 31.39 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -142.87 125.46 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.359 0.663 . . . . 0.0 109.927 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 37.9 t70 67.08 16.45 10.29 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.916 1.286 . . . . 0.0 111.641 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 96.78 -15.41 62.72 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.95 -0.469 . . . . 0.0 112.937 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.77 171.21 8.92 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.174 0.99 . . . . 0.0 110.12 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.0 t -97.04 102.81 14.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -91.11 133.89 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 36.5 p -132.64 126.98 33.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 109.352 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.479 HD11 HD12 ' A' ' 413' ' ' LEU . 2.2 pp -117.07 163.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.838 0.855 . . . . 0.0 109.525 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.75 150.81 22.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.516 0.674 . . . . 0.0 111.206 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 421' ' ' GLU . 81.7 mt -114.59 160.75 31.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.296 1.438 . . . . 0.0 109.013 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.46 136.44 19.49 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 121.84 1.693 . . . . 0.0 111.519 164.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.81 144.53 31.09 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.92 2.414 . . . . 0.0 112.055 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.7 172.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.036 0.534 . . . . 0.0 110.846 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -154.91 4.19 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.367 0.667 . . . . 0.0 112.114 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.1 t -122.6 141.56 51.58 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.041 0.536 . . . . 0.0 110.212 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.77 -36.19 70.3 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.292 1.037 . . . . 0.0 112.499 -170.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 39.8 m -66.54 -22.15 66.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.313 0.645 . . . . 0.0 111.075 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.84 -22.52 25.76 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.725 0.41 . . . . 0.0 109.973 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.39 -66.24 0.42 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -29.38 68.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.587 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.3 -33.12 75.22 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.813 0.445 . . . . 0.0 110.864 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.66 -45.52 82.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.066 0.546 . . . . 0.0 110.749 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.35 -13.86 42.33 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.555 -179.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.6 -50.48 73.0 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.868 0.867 . . . . 0.0 111.375 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -67.41 -29.65 69.2 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.989 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.449 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 54.9 t80 -73.29 -42.63 62.19 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.216 0.606 . . . . 0.0 110.985 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.428 ' HA ' HD12 ' A' ' 456' ' ' LEU . 72.8 m -67.01 -26.83 66.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.918 0.887 . . . . 0.0 110.416 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -67.62 -38.8 84.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.19 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 18.7 m -67.51 -30.68 70.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.924 0.89 . . . . 0.0 111.132 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 371' ' ' LEU . 33.3 mt -82.28 -17.43 45.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 0.0 111.425 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 71.41 7.83 6.14 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.987 1.715 . . . . 0.0 111.758 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.426 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 24.7 p -75.82 135.77 40.22 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.103 0.478 . . . . 0.0 110.359 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 26.7 t70 -127.37 141.37 51.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.642 0.777 . . . . 0.0 110.605 -174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 8.0 p30 46.35 25.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.163 1.785 . . . . 0.0 113.286 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 52.9 tp -76.82 -15.61 59.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.339 1.055 . . . . 0.0 111.279 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -158.98 159.28 34.66 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.016 0.526 . . . . 0.0 110.184 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 61.7 p -160.63 129.71 4.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.247 0.619 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 21.6 t . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 123.243 0.617 . . . . 0.0 111.462 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 120.681 0.277 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -79.36 -179.04 6.56 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.162 0.585 . . . . 0.0 110.171 175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.1 p -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 0.0 110.972 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 3.1 m -137.76 157.47 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.567 1.147 . . . . 0.0 109.525 173.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 464' ' ' SER . 7.7 p -137.57 101.59 4.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.641 HG21 HD11 ' A' ' 395' ' ' ILE . 29.0 m -94.34 151.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.23 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 53.6 m-85 -110.05 100.49 9.42 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 23.2 t -70.65 88.38 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.8 0.688 . . . . 0.0 109.735 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -85.04 88.23 7.44 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.865 -174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -70.62 -12.45 61.57 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.731 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -76.26 -28.56 57.13 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.745 0.818 . . . . 0.0 111.134 173.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -61.22 -76.23 0.25 Allowed Glycine 0 C--N 1.353 1.523 0 O-C-N 123.429 0.456 . . . . 0.0 112.838 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.4 t30 -152.92 143.2 22.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.498 ' HA ' HG21 ' A' ' 376' ' ' ILE . 1.0 OUTLIER -86.06 -62.64 1.47 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.58 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.19 -94.81 0.17 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.271 0.982 . . . . 0.0 112.763 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -90.13 15.89 46.11 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.326 2.063 . . . . 0.0 113.804 10.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -82.69 -2.26 53.63 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 110.063 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.58 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 31.6 mt -109.83 142.91 40.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.126 1.37 . . . . 0.0 108.034 172.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' HE3' ' A' ' 374' ' ' LYS . 16.2 t70 -70.27 120.16 76.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.161 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.41 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 31.8 Cg_endo -60.71 -28.38 86.42 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.205 2.603 . . . . 0.0 114.192 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.06 -47.9 26.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.808 0.443 . . . . 0.0 110.706 -178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -67.49 -29.99 69.56 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.632 0.582 . . . . 0.0 111.146 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 379' ' ' LEU . 22.4 mm -62.01 -31.79 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.92 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.31 -24.68 42.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.211 0.604 . . . . 0.0 111.159 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.8 mm-40 -81.9 -34.76 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.033 0.533 . . . . 0.0 112.258 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 376' ' ' ILE . 2.4 pp -70.24 153.99 94.84 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.543 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -41.69 152.94 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 124.519 3.479 . . . . 0.0 116.052 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -86.41 -11.15 52.74 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.817 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -160.86 144.97 13.65 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.43 1.092 . . . . 0.0 110.013 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -120.61 128.9 53.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.98 179.57 33.0 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.958 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.79 137.42 46.15 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 120.341 2.07 . . . . 0.0 113.437 2.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 175.92 -166.05 37.03 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.768 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 17.9 Cg_endo -59.27 129.58 32.14 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.379 2.72 . . . . 0.0 113.369 -169.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.863 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.7 p -47.24 -44.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.796 1.638 . . . . 0.0 111.81 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.99 -45.3 93.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.081 1.352 . . . . 0.0 111.465 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -74.08 -51.72 22.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.74 -40.03 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.54 HD13 ' HD2' ' A' ' 448' ' ' PHE . 3.7 pp -68.14 -42.55 79.95 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.499 ' N ' HD12 ' A' ' 392' ' ' LEU . 14.0 ptt180 -74.91 -25.5 58.97 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 25.4 mmm180 -66.97 -34.37 77.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.911 0.884 . . . . 0.0 110.494 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.641 HD11 HG21 ' A' ' 359' ' ' VAL . 42.8 mm -64.58 -56.65 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 400' ' ' VAL . 58.5 t -60.81 -47.57 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 124.875 1.36 . . . . 0.0 111.817 -171.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . 0.494 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.3 pt20 -71.12 -34.98 71.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.826 0.45 . . . . 0.0 111.548 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.71 77.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.758 0.423 . . . . 0.0 109.925 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 371' ' ' LEU . 48.4 t -71.71 -43.29 66.18 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.161 0.984 . . . . 0.0 111.586 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 406' ' ' THR . 11.1 t -66.81 -45.87 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.93 -37.91 87.28 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.4 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . 0.469 ' SG ' HD23 ' A' ' 379' ' ' LEU . 93.1 m -83.24 -10.24 58.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.005 0.522 . . . . 0.0 111.773 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.583 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.61 141.88 55.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.2 122.6 23.04 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.801 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 409' ' ' VAL . 41.3 tt0 65.34 59.85 0.79 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.593 HG23 HG12 ' A' ' 400' ' ' VAL . 98.0 m -53.88 -31.06 48.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.899 1.68 . . . . 0.0 112.636 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -58.31 -39.83 80.43 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.676 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 64.9 m -82.13 -28.91 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.238 0.615 . . . . 0.0 110.431 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.583 HG21 ' HB1' ' A' ' 403' ' ' ALA . 60.0 t -72.03 -31.47 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.089 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -64.23 -21.87 66.74 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.636 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -69.45 -27.13 73.86 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.947 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.446 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 89.3 m-85 -75.7 -4.81 42.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.036 0.534 . . . . 0.0 112.313 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.05 136.42 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.189 0.595 . . . . 0.0 111.247 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -119.83 151.03 51.77 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.268 1.027 . . . . 0.0 111.013 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 435' ' ' GLN . 60.2 Cg_endo -69.69 156.57 63.16 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.651 2.234 . . . . 0.0 114.199 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.25 154.03 39.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.085 1.754 . . . . 0.0 109.119 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.12 30.52 4.78 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.199 0.523 . . . . 0.0 111.241 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -28.48 14.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 0.0 110.469 167.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.98 44.0 1.98 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.663 -0.244 . . . . 0.0 112.955 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.25 -132.22 5.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.7 OUTLIER -66.84 168.61 9.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.514 1.126 . . . . 0.0 111.454 -178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . 0.432 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 98.4 t -136.15 130.1 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 436' ' ' LEU . 29.1 mm -114.9 134.03 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.251 0.62 . . . . 0.0 109.368 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 22.4 p -105.96 139.93 39.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.75 0.82 . . . . 0.0 109.602 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.69 125.56 5.91 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.918 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.6 m -82.66 108.66 16.2 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 122.982 0.513 . . . . 0.0 110.752 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -131.92 143.0 49.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.209 1.004 . . . . 0.0 109.078 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 66.06 16.56 10.5 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.711 1.204 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.44 0.15 86.28 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.94 -172.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -107.92 159.04 16.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.197 0.999 . . . . 0.0 109.669 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.3 t -91.84 122.92 34.82 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -122.84 152.2 40.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.731 0.812 . . . . 0.0 109.72 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 62.2 p -143.69 144.4 31.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.015 0.526 . . . . 0.0 110.725 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.1 pt -125.86 -177.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.285 1.034 . . . . 0.0 109.059 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 26.4 mt-30 -115.27 148.49 39.11 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.103 0.561 . . . . 0.0 110.425 171.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 10.5 mp -116.56 147.48 39.83 Favored Pre-proline 0 N--CA 1.485 1.296 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.79 132.7 43.88 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.501 2.134 . . . . 0.0 112.61 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.77 129.8 20.57 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.805 2.337 . . . . 0.0 114.027 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.8 m -92.08 175.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.556 1.143 . . . . 0.0 110.602 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -155.12 11.04 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.8 t -126.9 141.35 51.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.23 0.468 . . . . 0.0 110.503 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.72 64.5 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.939 0.896 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.8 m -74.74 -28.16 60.66 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.263 0.625 . . . . 0.0 110.427 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 448' ' ' PHE . 3.8 t80 -84.24 -21.56 31.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.863 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.18 -63.18 1.21 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 124.428 1.091 . . . . 0.0 111.048 174.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.08 -41.08 71.12 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.272 -167.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 36.0 ttm180 -61.19 -33.82 74.07 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 124.68 1.237 . . . . 0.0 111.735 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 392' ' ' LEU . 4.3 t80 -68.74 -37.71 79.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 -173.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.39 -16.27 33.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.817 171.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 0.9 OUTLIER -64.4 -40.07 95.08 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.706 0.403 . . . . 0.0 110.522 -173.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.29 -45.95 90.97 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.556 0.742 . . . . 0.0 110.604 175.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.443 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 75.3 t80 -64.35 -53.51 47.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.751 -175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 82.6 m -63.35 -29.78 71.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.555 1.142 . . . . 0.0 111.823 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -69.72 -33.61 72.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.042 0.537 . . . . 0.0 110.797 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 42.7 m -71.0 -24.05 62.3 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.084 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.553 HD13 HD21 ' A' ' 371' ' ' LEU . 35.0 mt -100.18 -1.21 37.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.785 0.834 . . . . 0.0 111.048 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 71.71 7.33 5.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.115 1.766 . . . . 0.0 112.585 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.559 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 9.5 p -83.08 133.03 35.08 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 31.8 t70 -151.1 151.7 32.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.935 0.494 . . . . 0.0 109.779 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 59.59 14.97 4.27 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.585 0.754 . . . . 0.0 111.272 -170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.48 -18.26 45.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.616 0.767 . . . . 0.0 111.013 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -164.21 151.71 12.11 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.639 0.775 . . . . 0.0 109.751 174.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 68.0 m -158.07 133.67 8.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 108.433 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 12.8 t . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.468 0.651 . . . . 0.0 112.066 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.0 m -80.31 176.27 9.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.79 0.436 . . . . 0.0 110.232 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 76.2 p -133.9 138.63 45.66 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.617 0.767 . . . . 0.0 109.293 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 388' ' ' VAL . 22.1 m -139.07 163.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.527 0.731 . . . . 0.0 110.788 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 26.6 p -136.81 127.42 27.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.477 1.111 . . . . 0.0 108.068 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 28.9 m -112.91 161.71 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.104 0.561 . . . . 0.0 110.656 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -120.14 102.78 8.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.14 103.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.733 0.813 . . . . 0.0 110.899 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 53.7 t30 -96.16 85.54 4.03 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.881 0.848 . . . . 0.0 109.267 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.69 -23.97 65.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.473 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -73.45 -17.99 61.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.785 0.834 . . . . 0.0 111.471 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -67.8 -89.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.517 0 C-N-CA 123.101 0.381 . . . . 0.0 112.867 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 49.6 t-20 -141.72 148.31 38.82 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 0.5 OUTLIER -90.48 -64.64 1.1 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.265 1.026 . . . . 0.0 108.264 -173.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.22 -94.91 0.18 Allowed Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.358 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . 0.455 ' HD2' HE21 ' A' ' 457' ' ' GLN . 25.4 Cg_endo -88.52 18.04 38.01 Favored 'Cis proline' 0 C--N 1.373 1.866 0 CA-C-N 120.374 2.087 . . . . 0.0 114.293 9.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . 0.429 ' HB3' HG22 ' A' ' 409' ' ' VAL . 76.8 m-70 -72.3 -18.42 61.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.201 0.6 . . . . 0.0 110.733 168.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.3 mt -104.74 140.01 38.7 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.939 1.295 . . . . 0.0 108.962 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.62 122.47 86.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.46 0.475 . . . . 0.0 110.385 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.3 Cg_endo -56.89 -34.0 96.12 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.659 2.906 . . . . 0.0 114.58 -173.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.44 -45.0 49.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.808 0.443 . . . . 0.0 110.702 -176.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.95 -29.78 68.92 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.706 0.629 . . . . 0.0 111.205 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 367' ' ' PHE . 21.6 mm -64.85 -30.67 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.977 0.911 . . . . 0.0 111.245 173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 75.5 mm-40 -79.95 -17.48 52.89 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 122.093 -0.379 . . . . 0.0 110.8 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.5 mm-40 -86.97 -5.8 58.97 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.757 0.423 . . . . 0.0 111.094 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 167.67 11.44 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.156 0.582 . . . . 0.0 111.542 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 158.22 58.05 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 121.761 1.64 . . . . 0.0 111.383 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.0 -18.08 59.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.545 0.738 . . . . 0.0 111.673 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -163.84 160.81 22.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 111.193 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -126.36 157.79 37.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.69 1.196 . . . . 0.0 108.878 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 81.95 -177.19 53.9 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.51 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 128.99 17.56 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.591 1.695 . . . . 0.0 112.302 -1.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.25 -172.91 30.28 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.42 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.36 129.95 35.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.219 2.613 . . . . 0.0 112.574 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.846 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.48 -46.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.656 1.983 . . . . 0.0 112.891 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.76 -36.95 81.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.908 1.283 . . . . 0.0 112.379 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 69.0 t -79.01 -47.19 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.195 -0.316 . . . . 0.0 110.646 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.46 -31.68 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 122.656 0.382 . . . . 0.0 111.715 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.0 pp -74.17 -41.13 61.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.111 0.164 . . . . 0.0 110.766 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.454 ' N ' HD12 ' A' ' 392' ' ' LEU . 6.2 ptt180 -69.49 -26.55 64.61 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -66.17 -31.78 72.83 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.806 0.842 . . . . 0.0 111.282 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 32.1 mm -74.71 -49.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 400' ' ' VAL . 94.5 t -59.62 -48.87 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 124.148 0.905 . . . . 0.0 111.424 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.8 -27.8 63.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.505 0.322 . . . . 0.0 111.29 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.85 90.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.82 -60.7 2.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 110.806 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 396' ' ' VAL . 43.1 t -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.039 0.936 . . . . 0.0 111.797 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.28 -46.67 66.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.723 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 71.9 m -80.08 3.22 21.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.137 0.575 . . . . 0.0 112.219 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -72.58 137.9 46.48 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.854 0.861 . . . . 0.0 112.411 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 404' ' ' LEU . 2.5 pp -84.86 132.57 34.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 57.82 61.72 2.31 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.371 1.082 . . . . 0.0 109.618 -172.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.1 m -57.27 -26.98 61.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.489 1.515 . . . . 0.0 112.614 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -60.46 -31.44 70.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.99 0.916 . . . . 0.0 112.438 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -75.41 -44.9 42.15 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.853 0.861 . . . . 0.0 109.576 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.535 HG21 ' HB1' ' A' ' 403' ' ' ALA . 97.9 t -68.78 -27.66 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-N 114.194 -1.367 . . . . 0.0 111.338 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.51 -30.05 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.361 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.11 -16.26 40.18 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -85.02 -17.35 37.8 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.393 0.677 . . . . 0.0 111.866 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.04 135.52 31.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.277 0.56 . . . . 0.0 112.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -113.4 168.68 7.42 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.609 0.764 . . . . 0.0 109.176 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.0 136.65 35.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 121.785 1.657 . . . . 0.0 112.742 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -141.7 99.51 3.56 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.012 1.725 . . . . 0.0 107.446 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -85.09 72.44 10.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.539 1.161 . . . . 0.0 108.814 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -97.39 -2.84 41.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.754 -1.567 . . . . 0.0 109.869 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 79.2 27.62 55.28 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -103.99 -120.79 4.82 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.507 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 14.6 mm-40 -84.88 178.91 7.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.116 0.567 . . . . 0.0 111.507 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.91 126.1 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 122.868 0.467 . . . . 0.0 110.426 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.24 143.05 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.423 1.089 . . . . 0.0 108.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 2.9 p -107.06 142.07 37.28 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.209 0.603 . . . . 0.0 109.824 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -132.16 115.95 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.279 1.031 . . . . 0.0 109.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 102.17 4.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.039 0.536 . . . . 0.0 110.275 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -123.34 120.62 33.58 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.289 1.036 . . . . 0.0 109.193 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.9 t70 57.23 50.13 12.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.212 1.405 . . . . 0.0 112.198 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 79.66 -3.91 66.93 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.372 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -118.56 171.71 7.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.085 0.954 . . . . 0.0 108.832 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.3 t -127.73 111.43 13.67 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.586 0.708 . . . . 0.0 109.955 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -94.57 127.0 40.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.573 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.0 p -95.35 138.78 32.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.071 0.949 . . . . 0.0 109.775 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.73 171.28 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.778 1.231 . . . . 0.0 109.263 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -115.38 143.77 44.78 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.235 0.541 . . . . 0.0 110.6 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 8.0 mp -113.88 155.8 44.72 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.072 1.349 . . . . 0.0 108.16 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.52 143.92 64.83 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.189 1.926 . . . . 0.0 111.762 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.34 155.22 25.04 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.295 1.997 . . . . 0.0 111.796 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.89 169.35 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 122.862 0.465 . . . . 0.0 109.864 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -147.47 8.36 0.9 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.108 0.563 . . . . 0.0 111.869 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 388' ' ' VAL . 46.3 t -115.9 138.67 50.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.631 0.372 . . . . 0.0 110.131 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -73.16 -26.54 61.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.031 0.932 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 31.4 m -72.03 -29.4 64.13 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.535 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.94 -21.09 29.75 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.846 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.43 -63.29 1.09 Allowed 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.098 0.873 . . . . 0.0 110.153 171.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 16.9 mt -65.1 -50.12 67.33 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 113.175 -1.829 . . . . 0.0 109.319 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -32.74 57.78 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 125.146 1.529 . . . . 0.0 112.706 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . 0.445 ' HE1' HD23 ' A' ' 436' ' ' LEU . 4.4 t80 -65.12 -49.19 70.9 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.651 0.381 . . . . 0.0 110.564 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.11 -15.83 35.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 0.8 OUTLIER -65.15 -46.64 80.05 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 109.699 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -37.84 85.14 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.033 0.833 . . . . 0.0 110.06 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 43.0 t80 -65.5 -50.66 64.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.57 0.748 . . . . 0.0 111.217 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.28 -28.54 67.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.089 0.956 . . . . 0.0 110.823 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.63 -34.16 75.26 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.993 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.9 m -75.05 -25.08 58.39 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.682 0.793 . . . . 0.0 110.962 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 371' ' ' LEU . 67.3 mt -82.91 -12.0 57.72 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.013 0.525 . . . . 0.0 110.977 173.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . 0.455 HE21 ' HD2' ' A' ' 369' ' ' PRO . 17.0 mt-30 74.67 8.14 4.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.782 1.633 . . . . 0.0 111.562 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.461 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 11.2 p -86.9 134.3 33.53 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.7 t70 -146.36 157.08 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.036 . . . . 0.0 108.379 -173.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 15.4 m-80 63.2 15.92 8.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.24 1.016 . . . . 0.0 111.109 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -83.34 -18.58 38.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.725 0.81 . . . . 0.0 111.366 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.78 166.15 26.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.365 0.666 . . . . 0.0 110.662 175.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 47.8 t -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.021 0.928 . . . . 0.0 108.769 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.466 ' HB2' HD21 ' A' ' 446' ' ' LEU . 39.9 t . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.425 0.69 . . . . 0.0 111.592 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 C--O 1.243 0.712 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 20.8 t -79.97 178.66 8.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.165 0.586 . . . . 0.0 110.241 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.0 p -131.9 134.17 45.39 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.772 0.829 . . . . 0.0 109.541 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.05 171.23 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.598 1.159 . . . . 0.0 109.565 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 52.6 t -146.85 105.97 3.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.659 0.784 . . . . 0.0 109.152 178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 395' ' ' ILE . 34.3 m -91.99 153.61 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.87 99.78 6.56 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' VAL . . . . . 0.401 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.2 t -63.96 98.85 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.537 1.148 . . . . 0.0 109.86 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -91.87 89.24 6.95 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.753 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -73.84 -9.26 58.47 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.166 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -74.25 -20.01 60.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.231 0.613 . . . . 0.0 109.804 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.29 -169.66 37.93 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.752 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -69.57 141.1 53.84 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.583 0.691 . . . . 0.0 110.497 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.58 -56.48 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.665 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.1 -83.84 0.06 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.494 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.17 1.42 23.95 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 120.53 2.165 . . . . 0.0 114.381 -0.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 16.3 p-80 -65.66 -16.11 63.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.966 0.906 . . . . 0.0 112.228 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.665 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 42.2 mt -95.46 136.55 35.69 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.855 0.862 . . . . 0.0 108.923 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.09 113.23 8.68 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 124.33 1.019 . . . . 0.0 110.119 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 34.7 Cg_endo -62.17 -16.89 53.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.182 2.588 . . . . 0.0 114.243 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -82.25 -49.18 10.37 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -62.48 -35.64 79.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.435 1.094 . . . . 0.0 111.95 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.55 -30.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.711 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 84.4 mm-40 -85.39 -19.27 31.64 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.977 -0.452 . . . . 0.0 111.236 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 66.8 mm-40 -81.64 -35.85 29.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.732 0.413 . . . . 0.0 111.277 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.1 pp -68.17 157.14 88.25 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.89 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.63 161.73 23.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.928 2.419 . . . . 0.0 114.078 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.8 -17.15 59.96 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.159 -173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.6 p80 -162.49 160.55 26.3 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.09 102.95 6.47 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 140.56 169.37 11.7 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.848 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.46 129.78 19.61 Favored 'Cis proline' 0 C--N 1.381 2.241 0 CA-C-N 119.512 1.656 . . . . 0.0 112.636 0.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.04 -165.55 15.71 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.306 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.28 141.65 16.29 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.834 2.356 . . . . 0.0 112.314 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.5 p -46.55 -45.05 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.993 1.717 . . . . 0.0 113.329 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -75.74 -35.29 60.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.098 0.959 . . . . 0.0 111.888 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 80.1 t -76.92 -46.15 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.44 -38.69 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.19 0.596 . . . . 0.0 112.116 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.3 -41.22 70.2 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 122.945 0.153 . . . . 0.0 111.204 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 12.0 ptp180 -67.57 -33.84 75.84 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 46.4 mmm-85 -63.07 -34.91 78.6 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.745 0.653 . . . . 0.0 111.711 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 359' ' ' VAL . 36.4 mm -68.09 -52.54 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 123.628 0.58 . . . . 0.0 109.797 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.19 -43.48 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.775 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.39 -21.97 59.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.84 0.456 . . . . 0.0 111.457 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -83.7 -16.73 43.86 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.359 0.664 . . . . 0.0 110.771 173.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.5 m -81.52 -61.88 1.81 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 122.876 0.471 . . . . 0.0 109.949 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.67 -50.65 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 0.0 111.071 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.22 -37.8 88.41 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.64 19.74 9.5 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.39 0.676 . . . . 0.0 111.522 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -85.13 150.65 24.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.334 0.654 . . . . 0.0 112.435 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 76.1 mt -66.45 114.12 5.21 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 162.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 61.96 73.43 0.47 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.284 0.99 . . . . 0.0 109.914 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.4 m -55.2 -41.18 71.66 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -54.59 -38.49 66.79 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 65.3 m -77.5 -38.57 48.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 403' ' ' ALA . 84.2 t -67.55 -26.65 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.367 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -75.03 -18.87 60.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.039 1.336 . . . . 0.0 110.147 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.08 -14.98 70.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 114.157 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -69.2 -37.46 78.1 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 117.871 0.836 . . . . 0.0 111.1 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.58 152.21 25.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.252 0.621 . . . . 0.0 109.818 175.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -117.19 157.54 46.68 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.844 0.858 . . . . 0.0 110.119 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.07 124.51 10.6 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 121.722 1.614 . . . . 0.0 111.54 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 49.7 m-20 -113.9 123.06 48.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.884 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -88.17 55.22 3.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.021 0.929 . . . . 0.0 110.007 -167.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.7 mpt_? -97.08 -32.24 12.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.09 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.22 33.09 8.32 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.127 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.78 -112.56 2.71 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.635 0.217 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.5 mp0 -79.08 165.26 23.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.854 0.862 . . . . 0.0 110.312 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.29 126.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.589 0.756 . . . . 0.0 109.155 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 436' ' ' LEU . 28.3 mm -106.26 122.96 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.238 0.615 . . . . 0.0 109.513 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 433' ' ' SER . 21.3 p -105.51 141.25 37.31 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.662 0.785 . . . . 0.0 109.816 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.56 130.82 6.04 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.497 -172.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 21.0 p -74.95 104.44 5.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.447 0.699 . . . . 0.0 109.882 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -114.61 107.34 15.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 0.0 109.359 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 36.1 t70 56.97 53.92 7.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.762 1.225 . . . . 0.0 111.502 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 86.18 -25.38 7.02 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.625 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.14 171.54 8.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.953 0.901 . . . . 0.0 109.569 -174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.1 t -115.63 104.17 11.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -110.73 160.54 16.62 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.862 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.406 ' HB3' HG22 ' A' ' 424' ' ' THR . 66.6 p -148.76 153.62 38.42 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.819 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.7 pt -123.08 166.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.624 0.77 . . . . 0.0 109.987 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.86 149.08 26.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.399 0.68 . . . . 0.0 109.813 172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.7 mp -115.86 159.48 38.9 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.941 1.296 . . . . 0.0 109.545 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.17 130.87 18.27 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.324 2.016 . . . . 0.0 111.765 164.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.07 151.83 56.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.909 2.406 . . . . 0.0 112.508 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.38 167.97 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.451 0.701 . . . . 0.0 110.733 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.78 2.68 0.94 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.987 0.515 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.4 m -119.15 140.08 50.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.958 0.503 . . . . 0.0 110.102 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.06 90.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.074 0.949 . . . . 0.0 112.373 -169.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.1 m -59.43 -28.51 67.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.608 0.763 . . . . 0.0 111.328 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -21.51 42.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.867 0.467 . . . . 0.0 110.147 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.8 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.26 -66.02 0.48 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 446' ' ' LEU . 0.2 OUTLIER -63.75 -43.87 95.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.797 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -33.58 70.28 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.531 0.732 . . . . 0.0 112.189 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.18 -51.55 67.36 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.55 0.531 . . . . 0.0 110.307 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -86.64 -15.3 40.14 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.667 -178.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 454' ' ' HIS . 1.7 tm-20 -61.77 -53.26 58.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.819 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -62.95 -40.91 99.1 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.975 0.797 . . . . 0.0 110.84 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.473 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 61.6 t80 -56.09 -64.31 0.9 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.558 1.143 . . . . 0.0 110.637 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 81.9 m -64.94 -27.17 68.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.728 1.211 . . . . 0.0 112.582 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 450' ' ' GLU . 51.2 t-80 -69.1 -41.63 77.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.644 0.777 . . . . 0.0 109.997 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.0 t -73.72 -7.95 54.09 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.416 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 92.0 mt -103.32 -6.41 22.02 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.71 0.804 . . . . 0.0 112.324 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 80.46 5.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.268 1.827 . . . . 0.0 112.682 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 453' ' ' CYS . 16.3 p -90.38 132.37 35.64 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -156.86 148.26 22.28 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 66.29 13.74 9.33 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.568 1.147 . . . . 0.0 110.736 -168.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.83 -20.31 35.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.129 0.571 . . . . 0.0 111.543 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.91 166.22 30.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.781 0.432 . . . . 0.0 110.506 175.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 37.2 p -162.79 121.69 2.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.704 0.802 . . . . 0.0 109.47 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 22.3 t . . . . . 0 N--CA 1.485 1.311 0 C-N-CA 123.408 0.683 . . . . 0.0 111.816 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 p -146.16 136.1 23.48 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.999 0.92 . . . . 0.0 109.331 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -77.81 171.69 14.58 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.382 0.611 . . . . 0.0 110.71 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -75.23 -175.93 2.88 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.662 175.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 164.72 4.24 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 124.283 1.033 . . . . 0.0 111.964 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.8 t -75.29 -173.4 2.03 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.413 0.685 . . . . 0.0 111.337 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 23.8 p -140.65 144.45 35.72 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.031 0.932 . . . . 0.0 110.569 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 19.3 m -145.03 174.22 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 125.257 1.423 . . . . 0.0 110.339 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 466' ' ' PRO . 29.0 p -147.21 109.11 4.41 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.488 0.715 . . . . 0.0 109.82 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 33.8 m -98.21 149.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.192 0.597 . . . . 0.0 109.581 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.471 ' CE1' ' HA ' ' A' ' 466' ' ' PRO . 9.1 m-85 -112.9 98.82 7.43 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.512 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 66.5 t -65.39 103.3 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 124.244 0.965 . . . . 0.0 110.706 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -98.63 99.87 11.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.669 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.463 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.19 -6.87 54.64 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.974 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -81.58 -21.83 38.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.392 0.677 . . . . 0.0 111.067 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -66.61 -96.79 0.03 OUTLIER Glycine 0 C--N 1.353 1.516 0 O-C-N 123.35 0.406 . . . . 0.0 113.101 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 55.9 t-20 -131.91 150.75 52.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 172.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.426 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -91.38 -63.31 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -143.6 -93.49 0.18 Allowed Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.317 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.06 18.98 31.82 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 120.469 2.135 . . . . 0.0 114.319 9.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.24 0.85 52.81 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.686 0.794 . . . . 0.0 110.783 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 456' ' ' LEU . 48.7 mt -116.21 145.93 42.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.65 1.18 . . . . 0.0 109.011 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.96 118.21 63.37 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 123.586 0.554 . . . . 0.0 109.675 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 36.1 Cg_endo -61.39 -29.82 86.16 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.779 2.319 . . . . 0.0 113.248 -173.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.498 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -72.78 -43.43 62.81 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.554 . . . . 0.0 110.581 -178.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -69.9 -30.27 67.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.153 0.581 . . . . 0.0 111.05 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.86 -31.11 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.492 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 77.7 mm-40 -82.81 -19.36 37.81 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 122.376 0.27 . . . . 0.0 111.324 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 83.3 mm-40 -80.1 -41.54 25.33 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.015 0.526 . . . . 0.0 112.061 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.499 ' HB2' ' HD2' ' A' ' 380' ' ' PRO . 2.7 pp -65.18 163.94 27.2 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 123.828 0.851 . . . . 0.0 111.293 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 379' ' ' LEU . 74.0 Cg_endo -68.51 169.75 16.53 Favored 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 122.381 2.054 . . . . 0.0 114.565 -169.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.2 -20.91 54.71 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.832 1.253 . . . . 0.0 112.031 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.512 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 29.6 p80 -161.0 159.16 29.08 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.062 0.458 . . . . 0.0 111.224 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -125.11 102.04 7.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 166.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 141.14 167.51 11.13 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.454 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.65 129.89 19.63 Favored 'Cis proline' 0 C--N 1.381 2.249 0 CA-C-N 118.902 1.351 . . . . 0.0 112.498 -1.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.73 -178.83 37.67 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.192 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 42.3 Cg_endo -64.27 134.72 43.4 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 123.053 2.502 . . . . 0.0 114.434 -171.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.86 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -38.55 -48.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 127.337 2.255 . . . . 0.0 113.782 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -76.09 -33.7 59.51 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.63 1.172 . . . . 0.0 112.158 -172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.521 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 94.2 t -81.87 -35.39 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 122.513 0.325 . . . . 0.0 110.601 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.64 -42.67 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 122.174 0.19 . . . . 0.0 110.803 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.3 pp -67.0 -43.91 81.71 Favored 'General case' 0 C--N 1.359 0.988 0 O-C-N 123.189 0.306 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 397' ' ' GLN . 12.9 ptm180 -68.54 -33.9 74.92 Favored 'General case' 0 C--N 1.363 1.17 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -75.58 -20.18 58.78 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 32.4 mm -75.21 -52.58 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 167.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.6 t -58.5 -57.08 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.949 -172.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.4 pt20 -70.47 -23.83 62.76 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.797 0.439 . . . . 0.0 112.062 -177.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.54 92.57 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 171.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 75.0 m -66.88 -47.66 71.16 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.946 0.779 . . . . 0.0 111.026 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 396' ' ' VAL . 12.3 t -65.35 -35.97 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 122.727 0.411 . . . . 0.0 110.344 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -69.51 -39.81 77.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.957 0.503 . . . . 0.0 110.222 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 75.0 m -78.01 -14.69 59.42 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.159 0.584 . . . . 0.0 111.894 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -60.36 130.82 48.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -167.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 81.4 mt -72.13 120.66 18.04 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 162.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 65.36 59.25 0.81 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.115 0.96 . . . . 0.0 109.199 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.3 m -54.58 -34.77 62.47 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.63 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.35 -38.71 43.65 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.764 1.226 . . . . 0.0 113.272 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.44 HG22 ' HE1' ' A' ' 412' ' ' TYR . 58.0 m -89.14 -40.51 12.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.334 0.654 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.49 HG21 ' HB1' ' A' ' 403' ' ' ALA . 70.9 t -61.55 -30.24 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 124.006 0.922 . . . . 0.0 111.869 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -75.71 -15.44 60.29 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.353 1.061 . . . . 0.0 110.302 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -77.38 -25.49 63.36 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.699 171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.44 ' HE1' HG22 ' A' ' 408' ' ' THR . 96.0 m-85 -76.47 2.92 12.37 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.41 0.684 . . . . 0.0 111.965 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 400' ' ' VAL . 0.4 OUTLIER -140.38 113.0 8.03 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.552 0.741 . . . . 0.0 109.815 165.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -76.7 159.15 79.79 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.911 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.65 123.29 9.68 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.127 1.218 . . . . 0.0 109.83 163.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -109.86 111.74 23.34 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -85.37 29.27 0.68 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.356 0.663 . . . . 0.0 112.035 -162.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -78.89 -25.49 43.86 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.358 0.663 . . . . 0.0 110.602 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 92.19 40.95 5.02 Favored Glycine 0 C--N 1.349 1.286 0 O-C-N 123.127 0.267 . . . . 0.0 113.359 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.24 -119.29 2.54 Favored Glycine 0 C--N 1.337 0.626 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.624 ' HB2' HD12 ' A' ' 436' ' ' LEU . 14.8 mm-40 -85.51 -178.63 6.73 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.149 0.58 . . . . 0.0 111.198 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.14 125.54 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.662 0.785 . . . . 0.0 109.067 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 41.6 mm -104.03 126.2 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.498 0.719 . . . . 0.0 109.085 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 24.5 p -105.95 149.74 26.33 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.768 0.827 . . . . 0.0 109.649 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -161.12 175.59 12.22 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.485 -173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 64.7 m -120.47 117.43 27.66 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.965 0.906 . . . . 0.0 109.708 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -132.64 112.68 12.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.977 0.911 . . . . 0.0 109.285 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.7 t70 71.05 23.2 4.26 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.441 1.497 . . . . 0.0 110.983 173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 -12.67 69.37 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.722 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.97 164.73 15.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.695 0.798 . . . . 0.0 109.91 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.5 t -108.92 114.76 28.8 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -119.09 140.99 49.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.774 0.321 . . . . 0.0 110.227 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 55.7 p -125.12 149.28 48.02 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.043 0.937 . . . . 0.0 110.327 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 26.8 pt -120.38 179.88 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.389 0.676 . . . . 0.0 110.096 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.29 154.39 22.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.655 0.782 . . . . 0.0 109.81 169.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 421' ' ' GLU . 80.8 mt -115.61 167.91 9.27 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.381 1.073 . . . . 0.0 109.379 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.11 142.42 30.86 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 121.844 1.696 . . . . 0.0 111.877 165.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.08 138.55 18.31 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.559 2.172 . . . . 0.0 111.507 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.0 m -117.13 160.93 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.479 0.712 . . . . 0.0 110.605 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -142.56 -3.22 1.04 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.436 -178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -115.3 140.06 49.44 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.07 72.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.086 0.955 . . . . 0.0 111.643 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 49.7 m -63.4 -35.05 79.14 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.204 0.601 . . . . 0.0 111.227 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -23.22 59.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.709 0.404 . . . . 0.0 110.106 -175.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.86 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.55 -59.0 5.46 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 170.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.3 -41.72 89.32 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.571 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.39 -26.66 61.08 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.076 -1.42 . . . . 0.0 111.567 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -63.71 -55.4 23.6 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.801 0.441 . . . . 0.0 110.574 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.04 -14.99 58.12 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.138 -175.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.49 -40.86 98.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 109.612 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -69.14 -43.08 75.09 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.162 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -70.48 -46.34 63.97 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.144 0.578 . . . . 0.0 111.509 -175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 71.3 m -63.68 -27.91 69.54 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.698 0.799 . . . . 0.0 111.108 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -66.93 -40.53 87.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.342 0.657 . . . . 0.0 111.175 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 72.6 p -75.36 -15.22 60.49 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.605 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 371' ' ' LEU . 47.5 mt -97.7 -6.34 33.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.536 0.734 . . . . 0.0 111.35 174.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 70.23 9.17 6.93 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.644 1.577 . . . . 0.0 112.129 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.519 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -87.62 133.57 33.79 Favored 'General case' 0 C--N 1.348 0.537 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 20.9 t70 -155.37 151.69 28.18 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 65.99 18.09 10.96 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.653 0.781 . . . . 0.0 110.495 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.3 tp -83.81 -7.66 59.4 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.314 1.046 . . . . 0.0 110.251 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.412 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.86 163.12 32.26 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.584 1.153 . . . . 0.0 108.683 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 27.9 m -151.49 109.83 3.77 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 14.5 m -69.22 -15.26 63.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.286 1.035 . . . . 0.0 112.201 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -74.31 111.48 12.93 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.029 0.931 . . . . 0.0 109.382 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.553 ' HB3' ' SG ' ' A' ' 358' ' ' CYS . 90.8 Cg_endo -79.03 153.5 25.14 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.492 2.128 . . . . 0.0 113.21 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -81.7 1.56 33.72 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.459 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 CA--C 1.559 1.302 0 C-N-CA 124.792 1.237 . . . . 0.0 110.582 170.701 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -86.86 -36.47 18.44 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.564 0.746 . . . . 0.0 110.729 175.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -77.6 119.36 21.05 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.466 0.706 . . . . 0.0 110.681 -175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -89.8 6.47 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.304 0.641 . . . . 0.0 110.621 171.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -153.28 173.61 15.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.238 1.015 . . . . 0.0 110.567 -168.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.4 t -81.82 -179.39 7.37 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.819 0.847 . . . . 0.0 111.067 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 31.8 p -139.34 134.67 32.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.387 1.075 . . . . 0.0 109.6 174.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.9 m -134.52 159.52 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.558 0.743 . . . . 0.0 110.799 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 13.2 p -131.11 106.03 8.09 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.839 0.855 . . . . 0.0 109.602 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.427 HG11 HD23 ' A' ' 462' ' ' LEU . 46.2 t -93.56 158.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.378 1.071 . . . . 0.0 109.743 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -127.32 107.36 9.92 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.402 HG11 ' CD1' ' A' ' 379' ' ' LEU . 46.6 t -77.53 105.92 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 123.152 0.581 . . . . 0.0 110.463 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 48.3 t30 -94.33 88.02 5.4 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.449 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.92 -14.12 62.85 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.559 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -83.97 -16.45 44.03 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.518 0.727 . . . . 0.0 111.136 174.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -71.6 -65.34 2.44 Favored Glycine 0 C--N 1.355 1.597 0 O-C-N 123.015 0.197 . . . . 0.0 112.626 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -154.93 165.54 36.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 1.2 m-85 -109.22 -65.02 1.18 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.576 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -144.07 -95.2 0.2 Allowed Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.774 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.9 22.09 29.43 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.54 2.17 . . . . 0.0 114.098 7.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -79.16 -8.21 58.82 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.753 0.421 . . . . 0.0 110.292 166.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 31.7 mt -110.85 142.61 42.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.99 1.316 . . . . 0.0 108.962 176.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -72.11 129.29 87.99 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.516 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.499 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.8 Cg_endo -59.78 -41.26 56.38 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.296 2.664 . . . . 0.0 113.549 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.499 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -69.92 -41.77 74.21 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.604 0.361 . . . . 0.0 110.725 -175.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -72.22 -28.48 63.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.207 0.603 . . . . 0.0 110.926 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.476 HD13 HD21 ' A' ' 379' ' ' LEU . 18.4 mm -65.42 -29.54 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.876 0.87 . . . . 0.0 110.52 170.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 81.8 mm-40 -80.04 -25.63 40.07 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 122.467 0.307 . . . . 0.0 110.92 174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 89.5 mm-40 -74.03 -34.56 64.15 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.102 0.561 . . . . 0.0 112.004 -176.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.532 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.3 pp -73.55 154.94 89.66 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.629 -0.7 . . . . 0.0 109.776 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.39 155.51 2.1 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 124.012 3.141 . . . . 0.0 115.705 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.74 -7.59 59.64 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.228 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.4 147.06 7.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.735 0.814 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -121.66 126.97 50.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.967 0.907 . . . . 0.0 109.306 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 109.68 -173.91 17.35 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.973 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.79 127.47 14.41 Favored 'Cis proline' 0 C--N 1.381 2.247 0 CA-C-N 119.664 1.732 . . . . 0.0 112.33 -2.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.95 -174.13 25.39 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.789 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.0 138.72 58.28 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.567 2.178 . . . . 0.0 112.686 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -46.67 -40.82 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.363 1.865 . . . . 0.0 112.442 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -62.59 -51.82 65.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.786 1.234 . . . . 0.0 110.851 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 91.7 t -71.54 -45.21 68.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.723 -174.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.4 -29.62 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.8 pp -75.76 -40.2 55.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 118.055 0.389 . . . . 0.0 110.442 178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.409 ' N ' HD12 ' A' ' 392' ' ' LEU . 10.5 ptm180 -70.12 -33.33 71.71 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 16.2 mmm-85 -56.21 -31.14 63.21 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.444 0.698 . . . . 0.0 111.503 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.423 HG21 ' HG ' ' A' ' 449' ' ' LEU . 35.6 mm -73.16 -55.12 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 400' ' ' VAL . 61.0 t -66.13 -52.77 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.758 -171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 423' ' ' ILE . 7.9 pt20 -63.58 -23.86 67.56 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 123.208 0.603 . . . . 0.0 112.25 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.532 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -70.73 -49.52 46.0 Favored 'General case' 0 C--O 1.216 -0.688 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 171.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 77.8 m -63.18 -52.47 62.25 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.054 0.942 . . . . 0.0 112.688 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.462 HG12 HG23 ' A' ' 406' ' ' THR . 11.0 t -64.59 -41.68 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.353 0.661 . . . . 0.0 110.215 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -72.13 -31.92 66.46 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.786 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.445 ' SG ' HD23 ' A' ' 379' ' ' LEU . 85.1 m -88.38 8.96 25.1 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.381 0.672 . . . . 0.0 111.819 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -82.32 161.14 22.7 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.3 119.79 26.96 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 113.658 -1.61 . . . . 0.0 108.601 166.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 59.49 72.6 0.52 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.192 0.997 . . . . 0.0 109.763 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 400' ' ' VAL . 93.7 m -62.25 -34.89 77.39 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.978 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -55.87 -37.37 68.7 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.1 m -76.53 -43.41 39.39 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.239 0.616 . . . . 0.0 109.546 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' A' ' 403' ' ' ALA . 74.7 t -66.01 -28.05 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.54 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.418 ' HD2' HG11 ' A' ' 400' ' ' VAL . 19.0 t80 -78.92 -17.65 55.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.976 0.911 . . . . 0.0 109.476 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -74.94 -10.5 83.89 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 116.024 -0.535 . . . . 0.0 113.598 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -77.49 -10.15 59.31 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.517 0.727 . . . . 0.0 111.376 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -141.1 141.46 34.21 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.018 0.927 . . . . 0.0 109.561 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -115.89 159.55 38.68 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.215 0.606 . . . . 0.0 110.345 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.49 151.52 75.56 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 121.87 1.713 . . . . 0.0 111.766 169.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -138.92 122.32 17.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.136 1.374 . . . . 0.0 107.99 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -80.46 14.46 2.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.817 0.847 . . . . 0.0 112.425 -168.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.09 -45.76 92.1 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.379 1.072 . . . . 0.0 111.403 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 95.09 43.55 3.5 Favored Glycine 0 C--N 1.351 1.414 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.712 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -99.85 -109.91 3.11 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.811 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.4 mp0 -78.5 171.36 15.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.41 0.684 . . . . 0.0 110.915 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.3 135.16 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.812 0.845 . . . . 0.0 109.354 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.591 HG12 HD11 ' A' ' 436' ' ' LEU . 36.0 mm -113.18 123.9 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 170.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.538 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.8 p -107.36 146.25 31.85 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.939 0.896 . . . . 0.0 109.646 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.83 159.89 14.05 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.869 0.868 . . . . 0.0 110.077 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.4 m -81.61 116.97 21.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.857 0.463 . . . . 0.0 110.456 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -143.12 120.69 11.76 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.163 0.985 . . . . 0.0 110.499 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.85 22.58 7.15 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.835 1.254 . . . . 0.0 113.264 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.8 58.07 Favored Glycine 0 N--CA 1.479 1.518 0 N-CA-C 113.895 0.318 . . . . 0.0 113.895 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.64 172.38 13.09 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.0 t -86.1 126.99 34.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 167.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -106.43 139.75 40.42 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.538 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.3 p -123.69 149.12 45.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.344 1.058 . . . . 0.0 109.861 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 413' ' ' LEU . 25.9 pt -124.8 176.35 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.53 0.732 . . . . 0.0 110.247 173.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -112.94 144.07 43.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.996 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 423' ' ' ILE . 7.8 mp -114.35 160.71 31.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.858 1.263 . . . . 0.0 108.373 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.46 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 67.8 Cg_endo -75.48 134.97 17.65 Favored 'Trans proline' 0 CA--C 1.565 2.053 0 C-N-CA 122.083 1.855 . . . . 0.0 112.167 169.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.24 136.71 29.72 Favored 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 122.716 2.277 . . . . 0.0 112.918 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.75 174.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.424 1.09 . . . . 0.0 110.92 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.8 0.44 0.15 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.164 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 19.0 m -119.77 142.01 48.96 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 118.262 0.483 . . . . 0.0 110.511 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.62 80.6 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.019 0.928 . . . . 0.0 112.904 -173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.0 m -65.23 -26.64 68.2 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.447 174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 447' ' ' ARG . 1.8 t80 -85.19 -22.05 28.91 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.832 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.44 -60.41 3.33 Favored 'General case' 0 C--N 1.364 1.199 0 CA-C-O 121.544 0.688 . . . . 0.0 109.224 170.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 21.3 mt -70.39 -36.49 74.13 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.518 -173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 448' ' ' PHE . 0.0 OUTLIER -63.86 -31.96 73.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.688 0.795 . . . . 0.0 111.569 177.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.491 ' HA ' HH11 ' A' ' 447' ' ' ARG . 2.5 t80 -67.19 -46.17 74.73 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.459 0.304 . . . . 0.0 111.358 -172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.483 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -86.83 -13.53 44.76 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.199 -0.313 . . . . 0.0 111.057 -178.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.62 -55.28 33.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.879 1.272 . . . . 0.0 111.864 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -63.09 -34.86 78.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.458 0.703 . . . . 0.0 111.277 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 40.8 t80 -65.87 -56.48 11.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.573 0.749 . . . . 0.0 110.635 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.3 m -60.9 -30.68 70.32 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.781 0.832 . . . . 0.0 110.979 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.84 -44.53 85.25 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.914 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 52.4 p -75.47 -21.16 58.32 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.209 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 79.9 mt -78.06 -11.11 59.88 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.99 0.516 . . . . 0.0 111.491 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 74.03 9.4 4.66 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.693 1.597 . . . . 0.0 111.525 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 456' ' ' LEU . 22.6 p -95.05 133.37 38.92 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 123.39 0.676 . . . . 0.0 109.742 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -149.38 150.75 32.94 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.434 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 14.1 m-80 67.47 17.15 10.05 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.881 1.273 . . . . 0.0 109.884 -167.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.3 tp -78.99 -26.73 43.35 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.765 0.826 . . . . 0.0 110.263 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.427 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -163.24 150.4 12.77 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.959 0.504 . . . . 0.0 110.873 178.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 67.1 m -166.07 138.54 3.97 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.501 1.12 . . . . 0.0 108.987 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 30.2 t -72.71 -11.29 60.57 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.303 0.641 . . . . 0.0 110.77 170.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -73.73 141.51 79.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.384 1.073 . . . . 0.0 110.467 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.27 135.55 18.74 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.459 2.106 . . . . 0.0 111.011 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -82.65 -5.91 59.09 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.543 0.737 . . . . 0.0 111.204 -178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.606 1.162 . . . . 0.0 107.99 178.004 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.335 0 CA-C-O 120.029 -0.317 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 35.8 m -85.54 129.51 34.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.458 0.703 . . . . 0.0 111.227 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -133.23 8.67 4.02 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.371 0.668 . . . . 0.0 110.113 175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -85.15 -173.17 4.56 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.018 0.527 . . . . 0.0 110.984 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 172.51 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.983 0.913 . . . . 0.0 111.201 171.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.2 t -77.2 172.78 12.71 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -137.51 142.69 41.45 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.908 0.883 . . . . 0.0 110.193 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -143.64 166.02 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 124.468 1.107 . . . . 0.0 111.149 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.508 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 22.8 p -136.26 108.85 7.44 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.229 1.012 . . . . 0.0 109.631 175.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 25.0 t -93.99 149.76 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.535 0.734 . . . . 0.0 109.795 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -119.66 99.63 6.77 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.466 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -68.72 103.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.541 0.736 . . . . 0.0 110.018 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -94.9 94.58 8.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.857 0.863 . . . . 0.0 109.55 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.71 -11.57 59.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.764 177.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -76.61 -13.97 60.02 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.239 0.615 . . . . 0.0 110.339 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -83.69 -159.3 28.3 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 169.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 40.3 t30 -73.41 144.5 46.33 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 117.416 0.608 . . . . 0.0 110.516 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.29 -61.15 1.79 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.565 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.07 -91.27 0.11 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.025 -0.875 . . . . 0.0 112.472 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -86.01 13.28 46.46 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.849 2.325 . . . . 0.0 113.906 7.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.99 -2.0 38.12 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.21 0.604 . . . . 0.0 111.351 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.565 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 30.3 mt -112.28 141.54 45.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.839 1.255 . . . . 0.0 108.321 177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.491 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 16.3 t70 -70.74 117.93 60.28 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.19 0.596 . . . . 0.0 110.009 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.48 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.4 Cg_endo -57.13 -34.61 98.06 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 123.597 2.864 . . . . 0.0 113.519 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -68.09 -51.42 46.61 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 123.577 0.548 . . . . 0.0 109.871 -177.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.491 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 19.7 mtp180 -62.31 -33.37 74.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.863 0.865 . . . . 0.0 111.398 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.443 HD13 HD21 ' A' ' 379' ' ' LEU . 24.0 mm -61.64 -33.32 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.872 0.869 . . . . 0.0 111.04 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 73.9 mm-40 -80.55 -21.33 41.87 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 122.2 -0.313 . . . . 0.0 111.289 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 61.8 mm-40 -85.34 -37.22 20.18 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.726 0.41 . . . . 0.0 112.105 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.443 HD21 HD13 ' A' ' 376' ' ' ILE . 2.8 pp -64.84 156.01 80.92 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.828 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.13 154.32 28.74 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.848 2.365 . . . . 0.0 113.667 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.25 -14.0 60.14 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.818 -175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.466 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 9.7 p-80 -166.91 146.99 5.6 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.94 0.496 . . . . 0.0 111.552 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.92 104.43 10.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.744 1.218 . . . . 0.0 109.052 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.508 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 145.02 168.47 12.85 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.825 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.09 140.47 64.79 Favored 'Cis proline' 0 C--N 1.379 2.149 0 CA-C-N 119.713 1.757 . . . . 0.0 112.828 -1.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -164.4 -168.83 27.1 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 119.092 -0.838 . . . . 0.0 111.607 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.07 143.0 48.0 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 123.156 2.571 . . . . 0.0 111.949 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -52.85 -39.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 124.955 1.302 . . . . 0.0 111.638 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.427 ' HB3' HH21 ' A' ' 393' ' ' ARG . 14.3 m120 -68.89 -48.19 63.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 72.9 t -76.75 -44.31 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -171.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.5 -41.08 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 C-N-CA 122.862 0.465 . . . . 0.0 111.487 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.82 -40.99 79.2 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 9.7 ptp180 -69.76 -25.78 63.99 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 123.135 0.272 . . . . 0.0 110.569 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 53.2 mmm-85 -70.8 -37.13 73.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.999 0.52 . . . . 0.0 111.258 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.79 -52.58 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.721 0.638 . . . . 0.0 109.489 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 400' ' ' VAL . 72.4 t -61.05 -47.74 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.998 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -65.01 -31.13 72.21 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.533 0.333 . . . . 0.0 111.184 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.44 84.11 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.097 0.559 . . . . 0.0 110.231 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 81.1 m -69.34 -48.42 61.43 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.642 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 396' ' ' VAL . 36.4 t -62.9 -42.18 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.399 0.68 . . . . 0.0 110.468 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -59.88 -51.84 67.97 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 79.4 m -77.13 -8.0 56.76 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.726 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -65.5 123.05 18.63 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.908 0.883 . . . . 0.0 112.335 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.54 115.34 5.08 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 166.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 68.61 66.68 0.31 Allowed 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.543 1.164 . . . . 0.0 109.258 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 400' ' ' VAL . 84.6 m -55.43 -33.32 63.46 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.14 1.776 . . . . 0.0 112.428 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -58.39 -39.8 80.62 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.91 1.284 . . . . 0.0 112.753 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.7 m -79.27 -34.29 42.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.898 0.879 . . . . 0.0 109.787 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -69.09 -30.36 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.51 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -69.24 -23.61 63.89 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.018 0.927 . . . . 0.0 110.196 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.93 -26.04 71.07 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -79.98 -21.32 43.84 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.009 0.524 . . . . 0.0 112.163 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.26 115.08 20.46 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.688 0.756 . . . . 0.0 111.486 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.05 158.93 32.53 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.556 1.143 . . . . 0.0 110.045 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.21 126.84 10.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.244 1.963 . . . . 0.0 113.045 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.619 ' HB3' ' HE ' ' A' ' 418' ' ' ARG . 2.5 m-20 -123.77 104.96 9.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.09 58.77 5.24 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.768 0.827 . . . . 0.0 111.403 -164.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.619 ' HE ' ' HB3' ' A' ' 416' ' ' ASP . 0.9 OUTLIER -106.0 14.26 28.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.635 0.774 . . . . 0.0 111.073 179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.58 26.19 72.85 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.33 -115.06 1.44 Allowed Glycine 0 C--N 1.337 0.628 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.125 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.8 mp0 -86.1 170.39 12.25 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.112 0.565 . . . . 0.0 110.625 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.3 t -136.97 128.58 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 41.4 mm -116.48 138.46 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 21.4 p -106.51 142.7 35.74 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.817 0.847 . . . . 0.0 109.628 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.29 120.99 12.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.491 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.3 m -77.32 101.13 6.16 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -123.2 134.32 54.15 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.015 1.326 . . . . 0.0 108.213 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 18.3 t70 65.37 16.08 10.35 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.956 1.302 . . . . 0.0 110.29 -175.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 89.0 -13.35 63.39 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.936 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -96.85 153.65 17.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.483 0.713 . . . . 0.0 110.143 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -84.26 123.05 29.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -123.9 124.12 41.92 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 47.7 p -107.05 151.35 25.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.717 0.807 . . . . 0.0 111.057 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.02 -178.08 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.029 0.931 . . . . 0.0 110.217 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -118.06 150.64 38.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.811 0.844 . . . . 0.0 109.523 171.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.9 mp -116.56 160.26 37.02 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.726 1.21 . . . . 0.0 108.185 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.99 139.88 19.7 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.157 1.905 . . . . 0.0 110.818 168.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.52 145.48 37.71 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.507 2.138 . . . . 0.0 112.939 -173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.4 m -110.5 156.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.989 0.915 . . . . 0.0 110.332 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -140.44 9.4 2.25 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.215 0.606 . . . . 0.0 111.525 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 42.4 t -115.21 139.92 49.53 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.28 -38.26 68.82 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.612 0.765 . . . . 0.0 112.187 -172.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 46.4 m -69.87 -16.97 63.34 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.058 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.83 -27.79 23.3 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.888 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.26 -65.8 0.5 Allowed 'General case' 0 C--N 1.366 1.3 0 O-C-N 124.201 0.938 . . . . 0.0 109.914 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.77 -43.12 99.62 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.473 -173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -60.55 -36.39 78.33 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.58 0.752 . . . . 0.0 111.641 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -61.43 -52.68 63.54 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 123.579 0.549 . . . . 0.0 110.14 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -73.93 -19.14 60.78 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 118.694 -0.67 . . . . 0.0 111.938 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -78.68 -34.44 46.19 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.205 0.457 . . . . 0.0 110.625 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -62.42 -35.77 80.27 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.997 171.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.401 ' CE2' HD11 ' A' ' 456' ' ' LEU . 75.5 t80 -76.85 -36.6 56.69 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.126 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 92.4 m -65.72 -26.98 68.0 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.208 0.603 . . . . 0.0 110.74 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -64.34 -39.36 93.73 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.818 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 21.3 m -70.38 -18.12 63.04 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.252 1.021 . . . . 0.0 111.813 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.523 HD13 HD11 ' A' ' 371' ' ' LEU . 38.7 mt -98.35 -13.3 20.75 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.853 0.861 . . . . 0.0 111.612 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 70.41 8.61 6.68 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.32 1.448 . . . . 0.0 111.958 -172.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.482 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 26.4 p -86.8 135.24 33.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.407 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 32.8 t70 -152.34 146.57 25.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 65.66 15.58 10.11 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.126 0.97 . . . . 0.0 110.067 -168.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 35.6 tp -79.77 -12.02 59.8 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.574 0.75 . . . . 0.0 110.519 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.04 164.75 36.41 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.826 0.85 . . . . 0.0 108.829 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 72.3 m -158.62 108.9 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 13.6 m -79.9 -7.32 58.67 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.964 0.506 . . . . 0.0 110.34 173.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -81.93 105.96 5.4 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.09 173.82 12.93 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.376 2.051 . . . . 0.0 112.256 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -74.7 -19.08 60.4 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.929 0.492 . . . . 0.0 110.336 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.251 1.151 0 C-N-CA 123.501 0.72 . . . . 0.0 109.378 170.555 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 112.398 -0.281 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 29.5 p -158.49 -179.36 8.02 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.983 0.913 . . . . 0.0 109.852 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -74.86 80.66 2.13 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.247 0.546 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.0 ptp -111.27 15.32 21.49 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.443 1.097 . . . . 0.0 108.975 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -159.56 177.63 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.242 1.817 . . . . 0.0 107.532 -178.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 43.3 t -79.21 171.75 14.76 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 17.4 p -138.86 134.41 33.27 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.572 0.749 . . . . 0.0 109.861 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.68 169.73 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 124.579 1.151 . . . . 0.0 110.218 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 27.4 p -145.5 106.86 4.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.635 0.774 . . . . 0.0 109.278 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.71 HG21 HD11 ' A' ' 395' ' ' ILE . 32.6 m -90.7 153.06 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.182 0.515 . . . . 0.0 110.133 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -118.34 100.63 7.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.55 105.92 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.031 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 30.8 t30 -87.34 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.499 ' HD3' ' HA ' ' A' ' 381' ' ' ASP . 6.7 mmmm -69.38 -31.02 69.14 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.094 -172.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -90.89 0.8 57.4 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.638 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.11 -80.9 0.23 Allowed Glycine 0 C--N 1.354 1.529 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -147.75 155.45 41.71 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.5 ' HA ' HG21 ' A' ' 376' ' ' ILE . 0.8 OUTLIER -97.54 -64.51 1.03 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 177.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.566 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.18 -91.4 0.1 OUTLIER Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.367 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -86.88 12.12 53.11 Favored 'Cis proline' 0 C--N 1.374 1.879 0 CA-C-N 120.384 2.092 . . . . 0.0 114.325 11.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -76.64 -8.87 58.09 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.271 0.557 . . . . 0.0 110.335 175.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.566 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 45.6 mt -107.59 144.26 34.86 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -69.32 122.83 86.82 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.647 0.779 . . . . 0.0 110.302 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.519 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 57.0 Cg_endo -67.61 -21.16 46.16 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.969 2.446 . . . . 0.0 113.899 -171.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -82.91 -45.47 14.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 4.5 mtt-85 -66.09 -32.49 73.98 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.913 . . . . 0.0 111.541 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 367' ' ' PHE . 22.2 mm -62.31 -27.85 43.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.187 172.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -83.84 -23.96 31.12 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.637 0.375 . . . . 0.0 110.667 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.6 mm-40 -77.6 -37.51 50.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.92 0.488 . . . . 0.0 112.103 -175.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.408 HD12 ' HE3' ' A' ' 363' ' ' LYS . 3.2 pp -63.7 153.34 83.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.086 171.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.9 169.36 10.45 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.609 2.206 . . . . 0.0 114.284 -172.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 363' ' ' LYS . 21.1 t70 -84.36 -3.34 58.23 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.57 -1.196 . . . . 0.0 111.419 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -161.17 151.78 18.04 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.255 0.622 . . . . 0.0 110.127 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -126.2 103.46 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 165.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 146.58 171.88 16.34 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.625 -0.542 . . . . 0.0 113.057 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -77.9 136.1 41.03 Favored 'Cis proline' 0 C--N 1.377 2.027 0 CA-C-N 118.65 1.225 . . . . 0.0 111.408 -1.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -160.92 -168.67 23.12 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.241 -0.755 . . . . 0.0 112.299 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -68.46 148.49 73.27 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 123.339 2.693 . . . . 0.0 112.383 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.4 p -55.32 -43.74 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 124.266 1.027 . . . . 0.0 111.634 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -72.01 -39.61 69.09 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.536 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 69.4 t -73.2 -48.93 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 119.559 -0.258 . . . . 0.0 110.847 -178.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.8 t -58.74 -39.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.717 0.407 . . . . 0.0 111.775 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 421' ' ' GLU . 1.9 pp -68.67 -43.95 75.08 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.9 ptt180 -70.25 -27.99 64.88 Favored 'General case' 0 C--N 1.359 1.002 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.155 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 32.3 mmt180 -63.78 -38.21 90.25 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 123.506 0.722 . . . . 0.0 110.91 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 359' ' ' VAL . 34.4 mm -66.17 -54.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.738 0.649 . . . . 0.0 109.279 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 400' ' ' VAL . 57.9 t -57.66 -63.63 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 124.427 1.08 . . . . 0.0 110.462 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -55.75 -36.27 67.1 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.7 0.8 . . . . 0.0 112.21 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.41 -44.86 81.8 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 122.746 0.418 . . . . 0.0 109.938 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 88.0 m -64.87 -38.84 92.33 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.575 0.75 . . . . 0.0 111.516 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 396' ' ' VAL . 11.8 t -69.5 -43.54 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.016 0.527 . . . . 0.0 110.275 -178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.55 -33.83 75.85 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.277 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 72.1 m -86.23 -4.83 59.25 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.509 0.724 . . . . 0.0 111.465 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -73.77 136.39 43.62 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.955 0.502 . . . . 0.0 111.429 -176.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 70.5 mt -83.43 129.5 34.99 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 164.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 66.48 54.0 0.92 Allowed 'General case' 0 CA--C 1.562 1.425 0 O-C-N 124.196 0.935 . . . . 0.0 108.874 -171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 89.8 m -55.03 -38.47 67.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.491 1.516 . . . . 0.0 111.961 -177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -57.5 -38.45 74.64 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.796 1.238 . . . . 0.0 113.762 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 28.5 m -83.84 -29.58 27.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.167 0.508 . . . . 0.0 110.148 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.573 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.4 t -65.79 -31.78 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.82 0.848 . . . . 0.0 110.369 171.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . 0.419 ' HA ' HD12 ' A' ' 413' ' ' LEU . 65.4 t80 -75.91 -15.63 60.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.382 1.073 . . . . 0.0 110.712 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -64.52 -18.02 62.95 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 116.506 -0.315 . . . . 0.0 113.264 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -92.74 -1.46 56.8 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.816 0.847 . . . . 0.0 110.821 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 423' ' ' ILE . 53.8 mt -121.66 100.16 6.86 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.027 0.931 . . . . 0.0 110.231 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -103.25 135.98 19.3 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 122.818 0.447 . . . . 0.0 110.12 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.74 162.35 42.39 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.555 2.837 . . . . 0.0 112.623 174.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -156.96 152.18 26.34 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -89.77 60.41 5.01 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.959 0.885 . . . . 0.0 109.185 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -109.87 -62.21 1.54 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.64 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.57 41.37 5.11 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.509 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.86 -72.63 1.14 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 19.2 mp0 -108.59 167.72 9.85 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.559 0.744 . . . . 0.0 109.267 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.46 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 83.5 t -138.79 127.86 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.109 0.964 . . . . 0.0 108.515 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.508 HG12 HD11 ' A' ' 436' ' ' LEU . 36.6 mm -118.25 135.22 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.342 0.657 . . . . 0.0 109.887 176.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 5.4 p -108.04 140.31 41.4 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.685 0.794 . . . . 0.0 109.563 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -142.02 118.51 10.92 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.429 1.092 . . . . 0.0 109.513 -173.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.6 m -76.01 100.1 4.79 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.551 0.691 . . . . 0.0 109.47 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . 0.412 ' HB3' ' CD2' ' A' ' 432' ' ' HIS . 65.0 t80 -117.93 117.09 28.31 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.879 1.272 . . . . 0.0 108.815 -174.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 62.78 25.17 14.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.942 1.297 . . . . 0.0 111.89 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.76 61.23 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-O 119.624 -0.542 . . . . 0.0 114.174 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -101.86 160.28 14.62 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.853 0.827 . . . . 0.0 109.247 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 14.0 t -96.71 127.65 42.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . 0.412 ' CD2' ' HB3' ' A' ' 427' ' ' PHE . 26.3 m-70 -119.46 123.29 43.69 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 66.2 p -105.22 137.58 42.78 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.382 0.673 . . . . 0.0 110.06 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 35.9 pt -122.64 172.27 10.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 123.805 0.842 . . . . 0.0 109.445 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -123.17 140.61 52.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.55 0.69 . . . . 0.0 109.743 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 4.8 mp -114.47 156.78 44.11 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.025 1.33 . . . . 0.0 108.646 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.31 130.48 14.07 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.154 1.903 . . . . 0.0 112.429 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -60.27 144.22 99.5 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.275 2.65 . . . . 0.0 113.16 -173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 24.8 m -111.64 158.54 12.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.844 0.857 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -137.46 7.23 2.81 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.3 t -121.65 141.78 50.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.64 0.376 . . . . 0.0 110.125 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.45 -32.1 72.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.245 1.018 . . . . 0.0 112.604 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.3 m -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.957 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.72 -23.8 36.51 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.815 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.49 -61.94 1.89 Allowed 'General case' 0 C--N 1.365 1.243 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 24.3 mt -68.06 -48.11 66.49 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 113.158 -1.837 . . . . 0.0 110.458 -169.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -58.17 -34.21 70.07 Favored 'General case' 0 C--O 1.245 0.824 0 O-C-N 123.884 0.74 . . . . 0.0 112.753 -176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.418 ' CE1' HD23 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -61.15 -43.93 98.11 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 123.938 0.774 . . . . 0.0 109.864 -176.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.06 -16.0 34.76 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.479 175.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -67.71 -42.17 82.38 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.408 1.004 . . . . 0.0 110.752 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -66.56 -37.7 85.52 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.838 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.427 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 63.3 t80 -67.0 -45.91 76.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.028 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 74.5 m -70.04 -25.96 63.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.132 0.973 . . . . 0.0 110.787 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -66.58 -35.88 81.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.49 0.716 . . . . 0.0 109.926 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 20.4 m -71.13 -20.3 62.33 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.0 0.92 . . . . 0.0 111.538 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 371' ' ' LEU . 44.9 mt -99.76 -11.3 20.94 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.977 0.911 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 74.34 7.89 4.58 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.09 1.756 . . . . 0.0 112.113 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.522 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 10.9 p -87.88 133.34 33.93 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.809 0.444 . . . . 0.0 110.232 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -149.53 149.61 30.99 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.545 0.738 . . . . 0.0 109.7 -175.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 23.4 m-80 67.42 15.85 9.93 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.7 1.2 . . . . 0.0 111.003 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 24.8 tp -77.01 -21.91 53.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.182 0.593 . . . . 0.0 110.809 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.617 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -152.78 163.81 39.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.313 0.645 . . . . 0.0 110.111 175.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.6 p -165.16 115.47 1.1 Allowed 'General case' 0 C--O 1.239 0.52 0 O-C-N 123.963 0.789 . . . . 0.0 109.402 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 10.1 t -85.19 0.3 52.25 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -78.73 110.08 12.98 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.36 158.93 44.18 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.09 1.86 . . . . 0.0 111.98 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -64.12 -23.96 67.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.822 0.849 . . . . 0.0 111.021 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.247 0.966 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 22.9 t -86.0 158.09 19.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.266 0.626 . . . . 0.0 110.102 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -86.99 68.56 10.1 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.705 0.764 . . . . 0.0 109.916 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 24.8 ttt -145.22 132.8 20.87 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.173 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -75.57 172.27 12.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.886 0.874 . . . . 0.0 110.945 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.4 t -76.69 -179.7 5.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.347 0.659 . . . . 0.0 110.97 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.91 143.12 44.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.826 0.85 . . . . 0.0 110.314 177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.36 169.79 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.677 1.191 . . . . 0.0 109.581 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.98 105.94 3.59 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.668 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.08 152.63 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.048 0.539 . . . . 0.0 109.962 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 76.2 m-85 -110.76 101.36 9.99 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.483 HG12 ' NZ ' ' A' ' 363' ' ' LYS . 58.1 t -70.62 92.84 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 124.15 0.98 . . . . 0.0 110.344 -177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -87.77 99.11 11.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.718 0.807 . . . . 0.0 108.969 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.483 ' NZ ' HG12 ' A' ' 361' ' ' VAL . 0.0 OUTLIER -80.65 -10.04 59.76 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.252 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -77.27 -14.36 59.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.681 0.392 . . . . 0.0 110.103 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.23 -166.93 29.97 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.362 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 45.4 t30 -71.11 131.53 43.73 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.019 0.437 . . . . 0.0 110.155 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -78.04 -62.83 1.55 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.408 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.583 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -142.36 -94.96 0.22 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.824 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -85.86 9.67 56.82 Favored 'Cis proline' 0 C--N 1.373 1.847 0 CA-C-N 120.385 2.092 . . . . 0.0 114.96 10.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -73.8 -7.94 54.13 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.766 0.426 . . . . 0.0 111.33 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.583 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.9 mt -114.16 130.04 56.61 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.573 1.549 . . . . 0.0 107.557 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.13 125.32 89.93 Favored Pre-proline 0 CA--C 1.548 0.899 0 O-C-N 123.583 0.552 . . . . 0.0 110.827 -176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 12.2 Cg_endo -53.78 -38.14 85.04 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.786 2.991 . . . . 0.0 114.377 -175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.499 ' H ' ' HD3' ' A' ' 374' ' ' LYS . 0.0 OUTLIER -75.82 -42.83 48.72 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.397 0.436 . . . . 0.0 110.209 -173.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -68.36 -30.42 69.37 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.555 0.742 . . . . 0.0 110.764 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 15.4 mm -63.84 -31.1 51.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.239 1.016 . . . . 0.0 111.198 172.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 64.5 mm-40 -74.98 -27.58 60.21 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 56.0 mm-40 -81.84 -3.38 53.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.384 0.674 . . . . 0.0 111.749 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.482 HD21 ' SG ' ' A' ' 402' ' ' CYS . 18.6 mt -70.46 172.23 6.47 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.104 0.562 . . . . 0.0 110.187 174.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 379' ' ' LEU . 75.9 Cg_endo -73.34 163.65 37.26 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.114 1.209 . . . . 0.0 110.479 166.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -72.86 -23.22 60.72 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.199 0.6 . . . . 0.0 111.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 15.6 p-80 -158.76 147.04 18.25 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 122.617 0.367 . . . . 0.0 110.938 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.05 104.79 13.72 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 170.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 143.92 172.7 14.85 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-O 119.337 -0.702 . . . . 0.0 113.248 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.3 139.97 58.28 Favored 'Cis proline' 0 C--N 1.379 2.168 0 CA-C-N 119.134 1.467 . . . . 0.0 112.191 1.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.59 -170.23 27.13 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.473 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 390' ' ' VAL . 6.0 Cg_exo -69.98 145.72 56.71 Favored 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.312 2.675 . . . . 0.0 111.722 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.812 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.3 p -54.51 -39.4 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.501 1.12 . . . . 0.0 111.478 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -66.43 -47.01 74.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.613 1.165 . . . . 0.0 110.541 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 94.2 t -72.08 -51.18 32.15 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.238 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.84 -39.32 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.79 -42.34 73.9 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 421' ' ' GLU . 34.8 ptt180 -74.44 -24.76 59.11 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.885 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 15.2 mmt85 -63.75 -36.7 84.74 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.707 0.629 . . . . 0.0 110.515 174.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.668 HD11 HG21 ' A' ' 359' ' ' VAL . 48.5 mm -66.84 -54.25 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.64 0.588 . . . . 0.0 109.694 175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 400' ' ' VAL . 81.8 t -56.56 -50.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 124.336 1.022 . . . . 0.0 111.354 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -69.85 -34.16 73.25 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.95 0.5 . . . . 0.0 111.613 -177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.61 88.2 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -67.2 -55.23 14.96 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 124.035 0.834 . . . . 0.0 110.93 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 396' ' ' VAL . 61.1 t -57.5 -40.68 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 123.702 0.801 . . . . 0.0 111.446 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.54 -48.25 67.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 379' ' ' LEU . 74.0 m -73.61 -10.15 59.4 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.109 0.564 . . . . 0.0 111.908 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.63 148.36 50.56 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.071 0.949 . . . . 0.0 112.649 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 2.1 mp -87.28 130.16 34.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 60.41 61.48 1.76 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 122.153 0.977 . . . . 0.0 109.33 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 88.7 m -50.78 -37.13 40.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.755 1.622 . . . . 0.0 112.848 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -53.34 -41.12 65.43 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.914 1.286 . . . . 0.0 112.755 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.2 m -81.76 -41.94 20.48 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.632 0.773 . . . . 0.0 109.531 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 403' ' ' ALA . 76.7 t -60.35 -33.18 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.129 0.972 . . . . 0.0 111.767 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -81.82 -13.35 57.79 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.426 0.691 . . . . 0.0 110.903 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -78.94 -3.14 87.77 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.461 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.92 -5.21 58.15 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.279 0.632 . . . . 0.0 111.411 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.488 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -139.8 113.39 8.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.709 0.804 . . . . 0.0 109.53 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.88 156.61 37.05 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.86 0.864 . . . . 0.0 110.886 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.71 129.38 17.55 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.26 1.973 . . . . 0.0 113.24 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.647 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 59.1 m-20 -122.28 111.77 17.33 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.749 174.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -88.94 45.6 1.31 Allowed 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.865 0.84 . . . . 0.0 109.44 -171.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.647 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 12.2 mpt_? -78.58 -15.66 58.3 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 110.151 173.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 84.84 42.16 7.33 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 123.329 0.393 . . . . 0.0 113.399 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -107.88 -112.18 3.59 Favored Glycine 0 C--N 1.344 0.983 0 CA-C-O 120.169 -0.24 . . . . 0.0 113.014 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 22.5 mp0 -79.53 167.24 21.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.309 0.644 . . . . 0.0 110.642 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 98.8 t -134.54 129.23 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 436' ' ' LEU . 41.1 mm -115.18 130.78 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 433' ' ' SER . 22.8 p -106.09 154.54 20.51 Favored 'General case' 0 C--O 1.241 0.638 0 O-C-N 124.03 0.831 . . . . 0.0 109.403 175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -154.91 158.66 39.62 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.963 0.905 . . . . 0.0 109.914 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 45.6 m -105.06 119.49 39.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.463 0.705 . . . . 0.0 109.435 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -132.29 109.99 10.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.406 0.682 . . . . 0.0 109.945 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.41 41.03 16.63 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.684 1.194 . . . . 0.0 111.114 172.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.6 -0.65 85.18 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.314 -0.857 . . . . 0.0 114.064 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -103.7 171.73 7.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 109.303 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.1 t -116.13 119.59 36.31 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -107.07 137.57 44.88 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.449 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.4 p -127.98 148.67 50.53 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 109.876 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.488 HD11 HD12 ' A' ' 413' ' ' LEU . 36.0 pt -130.55 174.12 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.811 0.845 . . . . 0.0 110.054 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -113.87 149.88 34.43 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.5 mp -116.64 158.94 42.25 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.862 1.265 . . . . 0.0 108.664 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.452 ' HD2' ' HZ ' ' A' ' 448' ' ' PHE . 71.2 Cg_endo -74.93 131.47 14.41 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 C-N-CA 122.362 2.041 . . . . 0.0 112.456 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -67.55 146.71 74.9 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.858 2.372 . . . . 0.0 113.422 -171.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.35 161.25 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.89 0.876 . . . . 0.0 110.544 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -141.17 5.44 1.89 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.504 0.721 . . . . 0.0 111.767 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 56.7 m -124.26 140.49 52.91 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 118.52 0.6 . . . . 0.0 110.995 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -67.17 -35.39 79.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.201 1.0 . . . . 0.0 112.542 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 m -69.1 -24.18 64.09 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.96 -22.16 25.75 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.812 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.14 -58.59 4.3 Favored 'General case' 0 C--N 1.365 1.271 0 CA-C-O 121.629 0.728 . . . . 0.0 109.239 170.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 35.9 mt -66.79 -44.57 80.96 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.859 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -56.71 -38.65 72.61 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.443 1.089 . . . . 0.0 112.197 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.452 ' HZ ' ' HD2' ' A' ' 437' ' ' PRO . 4.3 t80 -65.63 -45.09 84.38 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.536 -171.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -85.82 -13.16 48.94 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.792 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.473 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 0.8 OUTLIER -63.82 -43.74 95.35 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.009 0.368 . . . . 0.0 110.497 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -39.26 93.36 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.453 ' CE2' HD11 ' A' ' 456' ' ' LEU . 43.8 t80 -69.7 -45.43 68.27 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.448 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 29.4 p -72.59 -21.65 61.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.351 0.661 . . . . 0.0 110.073 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -70.58 -36.07 73.38 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.869 0.868 . . . . 0.0 109.844 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 26.5 m -70.85 -31.49 68.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.569 0.747 . . . . 0.0 110.99 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.453 HD11 ' CE2' ' A' ' 452' ' ' PHE . 45.5 mt -80.87 -17.62 50.07 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.343 0.657 . . . . 0.0 111.171 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 72.06 8.91 6.01 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.714 1.606 . . . . 0.0 111.518 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.496 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 21.9 p -82.73 137.26 34.46 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.227 0.611 . . . . 0.0 109.947 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 29.5 t70 -151.52 148.89 28.58 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 109.563 -170.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 64.01 14.42 8.45 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.214 1.005 . . . . 0.0 111.436 -171.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.46 -20.74 43.07 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.405 0.682 . . . . 0.0 112.006 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.685 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.83 159.53 36.8 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.072 0.549 . . . . 0.0 110.624 176.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 35.5 p -165.88 121.78 1.31 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.916 0.486 . . . . 0.0 111.026 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 11.1 t -86.3 5.64 33.58 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.99 0.516 . . . . 0.0 111.273 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -102.7 103.43 32.55 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.912 0.885 . . . . 0.0 109.622 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.47 176.28 10.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.338 2.692 . . . . 0.0 112.836 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -56.45 -44.96 80.99 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.106 0.562 . . . . 0.0 110.766 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 123.701 0.801 . . . . 0.0 109.266 175.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.769 -0.132 . . . . 0.0 112.769 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 44.3 m -65.47 -33.52 76.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.076 0.95 . . . . 0.0 111.956 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 48.9 m80 66.08 5.81 3.77 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.762 1.225 . . . . 0.0 113.416 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.5 ptm -89.61 -0.43 57.51 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.324 0.649 . . . . 0.0 111.137 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -125.58 172.26 9.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.512 1.125 . . . . 0.0 109.392 174.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 24.2 t -86.58 -177.66 6.21 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.627 0.771 . . . . 0.0 110.303 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 30.9 p -141.04 142.21 34.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.147 0.979 . . . . 0.0 109.913 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.06 147.42 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 123.908 0.883 . . . . 0.0 110.782 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.476 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 19.0 p -114.36 105.1 12.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.639 0.776 . . . . 0.0 108.972 170.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.472 HG11 HD23 ' A' ' 462' ' ' LEU . 48.4 t -98.34 154.44 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -130.18 107.5 9.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.655 1.182 . . . . 0.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.496 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 36.6 t -78.01 106.48 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.476 0.71 . . . . 0.0 110.023 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 44.2 t30 -94.58 90.17 6.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.152 0.981 . . . . 0.0 109.257 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.44 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.18 -12.12 60.49 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.955 176.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . 0.402 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 82.3 t60 -73.35 -19.67 60.96 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.752 0.821 . . . . 0.0 111.034 169.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -72.47 -135.72 0.2 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.479 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 38.2 t30 -101.69 137.23 40.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 118.038 0.919 . . . . 0.0 109.295 175.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.02 -57.61 3.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -150.45 -87.98 0.07 OUTLIER Glycine 0 C--N 1.343 0.942 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.784 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -84.7 19.21 23.87 Favored 'Cis proline' 0 C--N 1.374 1.896 0 CA-C-N 120.705 2.252 . . . . 0.0 113.868 5.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -71.44 -7.27 46.33 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.627 0.771 . . . . 0.0 111.537 166.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.536 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.2 mt -116.84 140.05 49.89 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.2 1.0 . . . . 0.0 109.445 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.54 119.14 54.45 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.367 1.067 . . . . 0.0 110.619 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 24.5 Cg_endo -58.68 -24.64 71.83 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.478 2.785 . . . . 0.0 114.528 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -83.8 -44.64 14.15 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.746 0.419 . . . . 0.0 110.108 -176.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 32.7 mtt180 -67.23 -34.74 78.11 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.132 0.973 . . . . 0.0 111.723 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.48 -27.77 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.728 171.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 65.2 mm-40 -84.92 -27.76 26.37 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 122.058 -0.401 . . . . 0.0 110.469 175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 75.9 mm-40 -71.96 -35.03 69.44 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.247 0.619 . . . . 0.0 112.253 -176.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.96 158.76 87.44 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.036 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.18 157.26 45.72 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.581 2.188 . . . . 0.0 113.042 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.25 0.27 29.31 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.504 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.496 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.1 p80 -166.4 149.97 7.31 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 123.207 0.603 . . . . 0.0 111.19 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.442 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.7 m-85 -122.9 107.91 12.38 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 168.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 168.87 12.56 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.19 -0.783 . . . . 0.0 112.141 -177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 130.22 19.33 Favored 'Cis proline' 0 C--N 1.376 1.992 0 CA-C-N 120.058 1.929 . . . . 0.0 113.609 -0.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.03 -165.41 14.48 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.99 140.62 38.45 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.533 2.155 . . . . 0.0 111.205 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.1 p -47.87 -42.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.697 1.199 . . . . 0.0 112.214 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -63.01 -55.27 27.16 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.048 1.339 . . . . 0.0 110.697 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 393' ' ' ARG . 58.0 t -67.9 -43.72 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.144 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.68 -47.49 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-O 119.334 -0.365 . . . . 0.0 111.728 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 117.861 0.3 . . . . 0.0 110.777 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.3 ptt180 -73.22 -32.78 64.97 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -65.55 -30.61 71.38 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.377 0.671 . . . . 0.0 111.289 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.543 HG21 ' HG ' ' A' ' 449' ' ' LEU . 20.7 mm -67.6 -59.01 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 80.7 t -61.44 -50.77 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.401 -171.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -65.32 -31.86 73.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.244 0.618 . . . . 0.0 111.785 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.23 94.71 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . 0.46 ' HB2' ' HE2' ' A' ' 452' ' ' PHE . 84.5 m -70.06 -41.64 73.89 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.184 -178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.522 HG22 ' CZ ' ' A' ' 452' ' ' PHE . 3.6 t -67.02 -42.6 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.18 -37.07 83.08 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 71.1 m -87.24 1.68 52.4 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.095 0.558 . . . . 0.0 111.856 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.478 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.14 143.82 48.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 89.6 mt -82.27 125.11 30.58 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 164.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 67.74 53.17 0.7 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.502 1.121 . . . . 0.0 109.639 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 85.1 m -58.52 -27.24 64.32 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.068 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -56.35 -36.7 69.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.242 0.617 . . . . 0.0 111.669 177.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.2 m -88.95 -37.43 15.24 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.452 0.701 . . . . 0.0 110.879 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.49 ' HA ' ' HD2' ' A' ' 412' ' ' TYR . 98.3 t -64.05 -35.33 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.885 0.874 . . . . 0.0 111.722 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -72.27 -22.06 61.27 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.161 0.984 . . . . 0.0 110.28 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.81 -19.59 78.79 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.729 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.49 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 82.9 m-85 -75.68 -15.34 60.32 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.272 0.536 . . . . 0.0 111.726 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.17 104.46 6.5 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.685 0.755 . . . . 0.0 111.134 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 163.43 38.18 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.177 0.991 . . . . 0.0 110.181 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 167.54 26.73 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.284 1.989 . . . . 0.0 113.865 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 12.8 m-20 -145.3 130.37 18.39 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.941 1.296 . . . . 0.0 109.506 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -89.97 45.78 1.3 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 122.033 0.921 . . . . 0.0 109.708 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.676 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -93.15 -31.26 14.86 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.43 171.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.76 30.06 33.46 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.47 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.98 -122.54 1.55 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 112.215 -0.354 . . . . 0.0 112.215 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.401 ' HB2' HD22 ' A' ' 436' ' ' LEU . 1.0 OUTLIER -69.54 166.67 18.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.368 0.667 . . . . 0.0 110.818 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 85.2 t -132.93 132.67 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 436' ' ' LEU . 28.1 mm -114.85 126.49 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.317 0.647 . . . . 0.0 109.883 175.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 9.2 p -107.64 151.0 26.23 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.91 0.884 . . . . 0.0 110.716 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.91 140.56 12.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.221 1.008 . . . . 0.0 110.007 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 48.9 m -87.15 118.88 26.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 122.913 0.485 . . . . 0.0 110.443 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -140.36 134.5 30.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.747 0.819 . . . . 0.0 109.448 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 16.2 t70 64.51 25.99 13.33 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.702 1.201 . . . . 0.0 110.988 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.06 2.33 88.7 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.554 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -109.44 168.82 9.11 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.626 1.171 . . . . 0.0 110.331 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.8 t -100.12 135.05 42.14 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 171.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -132.1 133.63 44.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.179 0.592 . . . . 0.0 110.283 -177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 64.7 p -126.42 140.24 52.64 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.741 0.816 . . . . 0.0 110.524 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 20.2 pt -119.85 161.7 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.315 0.646 . . . . 0.0 109.857 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -103.32 147.41 27.11 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.103 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.54 HD11 HG12 ' A' ' 423' ' ' ILE . 7.6 mp -115.01 165.56 13.77 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 125.464 1.505 . . . . 0.0 108.809 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.31 142.0 23.59 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 121.92 1.747 . . . . 0.0 111.585 163.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.42 128.86 10.67 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.381 2.054 . . . . 0.0 112.87 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.07 172.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.556 0.742 . . . . 0.0 110.38 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -151.48 5.63 0.46 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.421 ' O ' HG21 ' A' ' 388' ' ' VAL . 45.7 t -125.23 141.14 52.27 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.341 0.519 . . . . 0.0 110.53 -175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -66.47 -26.91 67.42 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.172 0.989 . . . . 0.0 111.919 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 33.2 t -70.34 -31.14 68.3 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.126 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.89 -23.09 39.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.829 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.99 -62.05 1.91 Allowed 'General case' 0 C--N 1.356 0.874 0 CA-C-O 121.242 0.544 . . . . 0.0 110.034 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.27 -35.67 68.81 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.812 -172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -62.75 -32.27 73.37 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.942 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -66.23 -56.4 11.45 Favored 'General case' 0 C--O 1.246 0.873 0 O-C-N 123.157 0.286 . . . . 0.0 110.608 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.543 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -73.67 -13.66 61.02 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.967 -179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.467 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 2.4 mm-40 -63.35 -47.06 83.72 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.351 0.66 . . . . 0.0 111.487 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -59.51 -43.86 93.28 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.615 0.766 . . . . 0.0 110.738 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.522 ' CZ ' HG22 ' A' ' 400' ' ' VAL . 44.6 t80 -69.98 -48.36 58.55 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.415 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.4 p -70.67 -21.32 62.61 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.574 0.749 . . . . 0.0 111.145 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -71.94 -37.55 69.99 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.634 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 77.0 p -76.58 -24.67 53.5 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.618 0.367 . . . . 0.0 110.582 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.502 HD11 ' CE2' ' A' ' 452' ' ' PHE . 72.6 mt -77.67 -17.94 57.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 111.313 172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 71.26 7.59 6.15 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.817 1.647 . . . . 0.0 111.745 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.597 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 17.7 p -81.11 134.8 35.71 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.368 0.604 . . . . 0.0 110.419 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.479 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 6.5 p-10 -145.38 147.09 31.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.997 -173.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 59.75 19.08 7.85 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.811 0.844 . . . . 0.0 110.907 -171.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 38.3 tp -81.02 -27.15 35.94 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 123.16 0.584 . . . . 0.0 111.228 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.472 HD23 HG11 ' A' ' 359' ' ' VAL . 0.0 OUTLIER -164.41 150.08 10.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.023 0.529 . . . . 0.0 110.727 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 70.2 m -166.3 149.13 7.07 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.328 1.051 . . . . 0.0 109.197 -176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 70.9 m -88.06 47.03 1.44 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.871 0.843 . . . . 0.0 111.553 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.29 143.7 17.8 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.042 1.337 . . . . 0.0 107.626 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.94 166.8 21.53 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.197 1.931 . . . . 0.0 112.921 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -68.83 -32.06 71.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.537 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.033 0.933 . . . . 0.0 109.526 173.719 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 34.6 t -69.32 -34.51 74.76 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.562 0.745 . . . . 0.0 109.889 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . 0.426 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 77.6 m-70 -92.22 156.78 17.07 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.766 0.827 . . . . 0.0 108.847 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -68.14 -21.19 64.93 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.046 0.538 . . . . 0.0 111.54 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.426 ' SD ' ' HB3' ' A' ' 352' ' ' HIS . 1.3 pmm? -102.02 171.13 7.69 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.217 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.6 t -83.25 179.09 7.8 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.695 0.798 . . . . 0.0 110.647 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 13.2 p -139.74 136.83 34.57 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.575 1.15 . . . . 0.0 109.112 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.44 157.67 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 123.826 0.85 . . . . 0.0 110.834 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 385' ' ' PRO . 24.1 p -124.16 116.88 23.45 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.356 1.062 . . . . 0.0 109.188 176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.6 t -113.16 151.24 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.096 0.558 . . . . 0.0 110.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -126.72 103.26 7.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.105 1.362 . . . . 0.0 108.065 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 48.4 t -70.04 110.77 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.628 0.771 . . . . 0.0 110.862 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -99.05 92.91 5.71 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.583 0.753 . . . . 0.0 110.12 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.461 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -74.42 -12.22 60.45 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.233 178.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -74.39 -19.59 60.37 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.774 0.83 . . . . 0.0 111.185 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -69.79 -111.11 0.03 OUTLIER Glycine 0 C--N 1.353 1.493 0 C-N-CA 122.985 0.326 . . . . 0.0 112.941 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 42.9 t30 -125.43 143.94 50.76 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 175.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.27 -62.28 1.54 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.713 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -148.03 -94.74 0.14 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 114.656 -1.157 . . . . 0.0 111.397 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -89.06 26.29 17.32 Favored 'Cis proline' 0 C--N 1.371 1.73 0 CA-C-N 120.116 1.958 . . . . 0.0 113.427 7.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.95 -10.25 59.49 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.214 0.606 . . . . 0.0 109.95 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.574 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 36.1 mt -114.74 140.86 48.54 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 125.454 1.501 . . . . 0.0 108.301 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.43 124.35 89.71 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.13 0.572 . . . . 0.0 110.414 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.49 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 30.5 Cg_endo -59.47 -32.97 97.21 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 123.244 2.63 . . . . 0.0 114.163 -173.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.87 -42.55 57.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.468 0.307 . . . . 0.0 110.958 -176.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -70.96 -28.88 64.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 110.593 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.449 HD13 HD21 ' A' ' 379' ' ' LEU . 20.7 mm -63.0 -30.48 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.825 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 68.0 mm-40 -81.67 -22.36 37.53 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.462 0.305 . . . . 0.0 111.043 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 81.8 mm-40 -81.93 -35.29 29.28 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.451 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.0 pp -66.48 153.81 92.28 Favored Pre-proline 0 N--CA 1.488 1.454 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.911 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -60.72 161.33 21.71 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.675 2.25 . . . . 0.0 114.327 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.77 -8.92 58.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.471 -1.241 . . . . 0.0 111.678 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -161.95 153.16 18.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.937 0.495 . . . . 0.0 110.967 -175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 395' ' ' ILE . 52.6 m-85 -132.23 109.01 9.62 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.415 1.086 . . . . 0.0 108.078 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.27 -179.53 16.14 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.208 -0.773 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 358' ' ' CYS . 59.7 Cg_endo -72.88 130.21 19.36 Favored 'Cis proline' 0 C--N 1.383 2.394 0 CA-C-N 119.889 1.845 . . . . 0.0 113.1 -4.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -156.71 -163.56 12.53 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.982 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -65.87 139.88 58.76 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.993 2.462 . . . . 0.0 111.926 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 445' ' ' ALA . 5.3 p -49.26 -41.35 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 124.352 1.061 . . . . 0.0 111.579 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.09 -52.18 63.69 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.942 1.297 . . . . 0.0 110.675 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 81.4 t -69.07 -50.87 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.941 -173.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.2 t -56.49 -40.75 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 122.999 0.52 . . . . 0.0 112.203 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.99 -41.48 74.33 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 117.859 0.299 . . . . 0.0 110.624 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -73.27 -24.47 60.44 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.542 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 48.6 mmm-85 -68.44 -38.77 81.45 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.819 0.448 . . . . 0.0 111.073 176.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.57 HD13 ' HD2' ' A' ' 383' ' ' PHE . 8.4 mm -65.63 -53.45 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 91.3 t -61.78 -47.16 94.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.135 -174.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.421 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.6 pt20 -64.0 -30.03 71.14 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 122.582 0.353 . . . . 0.0 111.285 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -72.26 -40.97 67.25 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.256 0.622 . . . . 0.0 110.532 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.7 m -69.58 -46.47 66.29 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.341 0.657 . . . . 0.0 111.256 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.8 t -65.7 -39.31 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.199 0.6 . . . . 0.0 110.084 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.34 -53.46 57.02 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.232 0.613 . . . . 0.0 110.581 173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.451 ' SG ' HD23 ' A' ' 379' ' ' LEU . 73.9 m -79.92 0.99 28.97 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.553 -172.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -71.73 135.32 46.73 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -172.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.71 118.36 17.59 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 160.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.16 60.01 0.66 Allowed 'General case' 0 CA--C 1.557 1.222 0 CA-C-O 122.077 0.942 . . . . 0.0 109.431 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 96.9 m -51.41 -40.62 59.67 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.075 1.75 . . . . 0.0 112.416 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -50.44 -41.09 52.18 Favored 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.176 1.39 . . . . 0.0 114.04 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 98.4 m -78.96 -39.39 34.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.645 0.778 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.564 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.2 t -60.69 -41.57 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.71 -14.07 59.98 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.073 0.949 . . . . 0.0 110.774 -176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -73.45 -23.24 77.56 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.507 -0.315 . . . . 0.0 113.401 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -71.27 -24.77 62.23 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.072 0.549 . . . . 0.0 111.564 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 434' ' ' ILE . 0.7 OUTLIER -119.43 112.72 19.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.026 0.931 . . . . 0.0 108.677 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -96.21 158.61 33.7 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.28 0.632 . . . . 0.0 110.738 -175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.69 144.9 45.27 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.168 1.912 . . . . 0.0 112.496 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.572 ' HB3' ' HG2' ' A' ' 418' ' ' ARG . 3.6 m-20 -150.13 136.1 18.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.977 1.311 . . . . 0.0 108.132 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -85.68 68.67 10.47 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 122.52 1.152 . . . . 0.0 108.33 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 416' ' ' ASP . 78.7 mmt-85 -106.93 -22.49 12.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 113.742 -1.572 . . . . 0.0 110.611 -174.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.27 65.64 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.614 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -97.71 -127.22 5.65 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 119.958 -0.356 . . . . 0.0 112.387 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.0 OUTLIER -72.88 169.32 17.09 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.887 0.875 . . . . 0.0 110.841 -176.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 54.4 t -140.32 133.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.761 0.825 . . . . 0.0 109.102 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.44 HG12 HD11 ' A' ' 436' ' ' LEU . 47.8 mm -116.02 134.18 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 122.607 0.363 . . . . 0.0 110.219 172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.402 HG22 ' HB3' ' A' ' 433' ' ' SER . 18.0 p -107.25 143.09 35.98 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.226 1.01 . . . . 0.0 109.678 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.19 137.93 15.26 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.527 0.731 . . . . 0.0 111.041 -169.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 430' ' ' GLU . 49.4 m -86.53 104.2 15.76 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 122.89 0.476 . . . . 0.0 110.312 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -116.23 106.57 13.83 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.29 1.036 . . . . 0.0 109.569 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 24.5 t70 55.18 54.1 9.23 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.232 1.413 . . . . 0.0 111.56 175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 83.2 -15.89 31.49 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.15 -0.932 . . . . 0.0 113.85 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 426' ' ' SER . 39.9 mt-10 -95.15 170.53 9.33 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.181 0.592 . . . . 0.0 111.37 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.9 t -111.46 102.02 10.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -94.92 142.26 27.68 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.397 0.679 . . . . 0.0 109.904 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 424' ' ' THR . 41.7 p -140.09 138.94 35.72 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.981 0.912 . . . . 0.0 109.771 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.52 HD11 HD12 ' A' ' 413' ' ' LEU . 41.3 pt -123.99 -176.66 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.846 0.858 . . . . 0.0 111.047 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -127.28 143.31 51.26 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-O 121.462 0.648 . . . . 0.0 110.012 172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.0 mp -111.0 159.2 33.47 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 125.901 1.68 . . . . 0.0 108.124 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -72.69 132.65 19.05 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.094 1.863 . . . . 0.0 111.706 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.19 129.7 19.87 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.279 1.986 . . . . 0.0 112.112 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.0 173.39 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 124.011 0.925 . . . . 0.0 110.87 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -153.46 -0.21 0.24 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.517 0.727 . . . . 0.0 111.243 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.6 m -118.21 138.29 52.43 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -174.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.07 -31.83 68.34 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.855 0.862 . . . . 0.0 111.281 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 22.0 m -59.57 -31.82 69.8 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.757 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -86.2 -22.79 26.76 Favored 'General case' 0 C--N 1.362 1.151 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.899 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -52.18 -66.88 0.31 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.598 0.759 . . . . 0.0 111.182 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.403 ' O ' HD22 ' A' ' 449' ' ' LEU . 0.4 OUTLIER -72.13 -34.62 68.71 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.68 -178.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . 0.465 ' NH1' ' HB2' ' A' ' 451' ' ' ASN . 0.0 OUTLIER -53.33 -36.33 61.17 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.285 0.634 . . . . 0.0 111.514 178.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -60.07 -56.48 21.07 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.139 0.899 . . . . 0.0 110.34 -177.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -80.7 -13.92 58.59 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.706 -176.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.4 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 55.7 mt-10 -70.28 -46.63 63.95 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 118.673 0.669 . . . . 0.0 109.988 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.465 ' HB2' ' NH1' ' A' ' 447' ' ' ARG . 0.2 OUTLIER -67.52 -35.25 78.74 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.493 178.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 449' ' ' LEU . 36.9 t80 -68.6 -48.83 63.14 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.444 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 30.5 p -70.09 -22.88 62.99 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.068 0.547 . . . . 0.0 111.021 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -57.17 -46.4 82.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.795 0.838 . . . . 0.0 110.822 174.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 93.7 p -73.07 -23.28 60.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.046 0.539 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.507 HD13 HD21 ' A' ' 371' ' ' LEU . 47.7 mt -83.7 -8.37 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.651 0.781 . . . . 0.0 111.077 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.82 9.16 7.05 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.35 1.46 . . . . 0.0 111.275 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.713 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.8 p -94.94 144.58 25.56 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.553 0.741 . . . . 0.0 110.044 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -163.04 164.21 25.64 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 65.53 14.58 9.57 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.374 1.07 . . . . 0.0 110.159 -172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 20.2 tp -84.08 -8.63 59.06 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 124.373 1.069 . . . . 0.0 111.533 -175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.2 169.22 22.66 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.347 0.659 . . . . 0.0 109.916 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 46.6 m -158.38 114.18 2.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.629 0.772 . . . . 0.0 109.79 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 26.5 t -73.23 -6.66 47.37 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.769 0.827 . . . . 0.0 111.237 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -105.76 149.68 38.25 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.323 1.049 . . . . 0.0 109.698 173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.48 171.33 15.47 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.792 2.328 . . . . 0.0 112.645 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -72.78 -19.87 61.27 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.795 0.838 . . . . 0.0 111.358 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.252 1.19 0 C-N-CA 124.164 0.985 . . . . 0.0 108.367 172.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 46.7 t -151.24 163.79 38.07 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.014 0.525 . . . . 0.0 110.975 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -159.06 123.33 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.288 1.035 . . . . 0.0 109.849 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.5 ptm -114.98 11.79 16.59 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.775 0.798 . . . . 0.0 109.548 165.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -148.8 167.66 25.04 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 125.414 1.485 . . . . 0.0 108.16 -177.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 57.9 m -72.99 178.05 4.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.027 0.531 . . . . 0.0 111.852 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 15.7 p -139.61 133.45 30.71 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.527 1.131 . . . . 0.0 109.131 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.57 157.49 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.285 1.034 . . . . 0.0 111.148 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.57 108.05 10.78 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.313 1.045 . . . . 0.0 108.72 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 395' ' ' ILE . 30.4 m -92.59 120.95 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -88.54 97.94 11.37 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 379' ' ' LEU . 44.9 t -72.63 98.28 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.622 -171.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.477 ' HB2' ' HZ ' ' A' ' 467' ' ' PHE . 37.9 t30 -91.08 86.44 6.22 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.757 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -12.93 61.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.786 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.793 0.837 . . . . 0.0 110.299 169.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -76.9 -149.83 3.37 Favored Glycine 0 C--N 1.349 1.289 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.11 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.404 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 41.3 t30 -82.85 142.32 31.59 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.301 0.551 . . . . 0.0 110.132 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -85.42 -56.11 3.68 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.608 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.99 -88.95 0.07 OUTLIER Glycine 0 C--N 1.349 1.256 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.127 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.73 4.06 65.3 Favored 'Cis proline' 0 C--N 1.371 1.712 0 CA-C-N 120.879 2.34 . . . . 0.0 113.744 10.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -70.46 -13.01 61.95 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.953 0.901 . . . . 0.0 110.37 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.608 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 28.5 mt -99.1 143.96 28.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.558 1.143 . . . . 0.0 109.116 174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -70.31 121.82 84.45 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 123.99 0.806 . . . . 0.0 110.455 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.537 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 50.9 Cg_endo -64.35 -22.28 66.3 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.187 2.591 . . . . 0.0 114.646 -172.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.537 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -83.94 -43.63 15.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.121 0.418 . . . . 0.0 110.076 -176.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 57.9 mtt180 -67.22 -37.49 83.69 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.085 0.954 . . . . 0.0 111.923 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.453 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.7 mm -53.64 -28.85 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.433 0 C-N-CA 124.076 0.951 . . . . 0.0 112.347 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 71.0 mm-40 -83.59 -17.85 40.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.257 0.623 . . . . 0.0 111.737 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -80.33 -43.08 21.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.424 0.69 . . . . 0.0 111.728 -171.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 361' ' ' VAL . 0.4 OUTLIER -64.03 153.27 85.48 Favored Pre-proline 0 N--CA 1.483 1.213 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.564 175.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -62.95 165.78 15.72 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.678 2.252 . . . . 0.0 113.233 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -81.66 -6.86 59.42 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.307 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.456 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.1 p80 -162.58 137.62 6.86 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.33 0.652 . . . . 0.0 110.605 171.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.97 103.81 14.47 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 170.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 125.38 -174.14 17.44 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.3 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.55 128.19 15.21 Favored 'Cis proline' 0 C--N 1.382 2.333 0 CA-C-N 119.291 1.545 . . . . 0.0 112.817 0.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -163.75 -171.72 30.34 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.977 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.55 129.95 28.27 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.125 2.55 . . . . 0.0 113.279 -169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.1 p -45.42 -50.16 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.274 1.829 . . . . 0.0 112.688 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.455 ' OD1' HG13 ' A' ' 388' ' ' VAL . 2.4 m120 -57.64 -43.96 85.26 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.189 1.395 . . . . 0.0 112.009 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.494 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 93.7 t -76.41 -51.33 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.134 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.01 -42.27 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 123.386 0.674 . . . . 0.0 112.404 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -69.04 -40.54 78.52 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 122.856 0.097 . . . . 0.0 110.984 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 392' ' ' LEU . 7.8 ptt180 -73.09 -25.54 60.92 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.141 0.276 . . . . 0.0 110.388 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 11.5 mmm180 -68.23 -35.21 77.6 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 122.846 0.458 . . . . 0.0 110.124 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.64 HG13 HD22 ' A' ' 449' ' ' LEU . 25.9 mm -63.62 -47.67 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 123.875 0.734 . . . . 0.0 109.405 173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.504 ' HA ' ' CE2' ' A' ' 452' ' ' PHE . 38.9 t -63.96 -60.62 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.733 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.46 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.5 pt20 -60.86 -29.47 69.54 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.58 -59.63 2.72 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 72.6 m -66.25 -32.77 74.39 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 396' ' ' VAL . 38.5 t -68.17 -47.51 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.92 -19.92 58.4 Favored 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.348 -175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 93.5 m -100.02 10.11 41.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.114 0.965 . . . . 0.0 110.352 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -86.07 151.29 23.82 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.47 122.78 27.95 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 162.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 66.65 57.67 0.67 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 124.48 1.112 . . . . 0.0 109.934 -174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 400' ' ' VAL . 89.6 m -54.12 -34.0 59.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.592 1.557 . . . . 0.0 112.415 178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -55.64 -39.55 71.0 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.855 1.262 . . . . 0.0 113.466 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 86.3 m -81.47 -36.05 29.81 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.228 0.611 . . . . 0.0 110.171 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.441 HG11 ' HA ' ' A' ' 400' ' ' VAL . 67.7 t -62.44 -38.07 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.867 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -68.44 -19.31 64.57 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.95 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.81 -23.57 77.78 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.927 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -77.01 -10.73 59.56 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 117.276 0.538 . . . . 0.0 111.641 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 434' ' ' ILE . 0.3 OUTLIER -129.04 117.8 21.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.729 0.812 . . . . 0.0 109.614 178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -95.18 157.91 35.66 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.789 0.836 . . . . 0.0 110.916 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.87 153.14 76.28 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.144 1.896 . . . . 0.0 111.434 165.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -151.15 136.54 17.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.689 0.28 . . . . 0.0 110.527 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.52 10.11 26.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.807 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.502 ' HB3' ' HD3' ' A' ' 438' ' ' PRO . 5.9 mpt_? -59.59 -35.0 73.46 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.527 1.131 . . . . 0.0 111.417 171.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 85.49 28.23 30.52 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.36 0.413 . . . . 0.0 113.378 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.93 -110.03 0.31 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 120.023 -0.321 . . . . 0.0 113.39 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.98 172.0 8.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.802 0.441 . . . . 0.0 110.348 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 75.8 t -132.08 130.2 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.9 mm -115.11 131.66 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.44 ' HB ' ' OG1' ' A' ' 431' ' ' THR . 19.2 p -108.86 137.64 46.46 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.417 1.087 . . . . 0.0 108.743 172.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -158.63 128.95 5.99 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.67 -169.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.5 m -66.87 102.47 0.96 Allowed 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.462 0.705 . . . . 0.0 112.149 -174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -135.68 136.2 40.71 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.936 1.294 . . . . 0.0 108.813 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.7 t70 66.63 16.35 10.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.391 1.076 . . . . 0.0 111.163 176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.02 61.79 Favored Glycine 0 C--N 1.353 1.499 0 O-C-N 122.012 -0.43 . . . . 0.0 113.849 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -116.91 166.99 11.53 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 424' ' ' THR . 12.9 t -89.86 102.87 15.57 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.914 0.864 . . . . 0.0 109.248 175.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -74.73 131.41 40.82 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.046 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 34.8 p -111.01 131.46 55.04 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.328 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.636 HD11 HD12 ' A' ' 413' ' ' LEU . 16.4 pt -132.41 174.02 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 124.298 1.039 . . . . 0.0 109.762 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.443 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 21.0 mt-30 -113.11 147.88 36.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.273 0.629 . . . . 0.0 110.842 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.421 HD23 ' HE1' ' A' ' 448' ' ' PHE . 9.8 mp -115.48 166.6 11.69 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.156 1.382 . . . . 0.0 108.636 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.11 145.48 44.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 C-N-CA 121.998 1.799 . . . . 0.0 111.939 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 418' ' ' ARG . 64.3 Cg_endo -83.54 159.95 14.62 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.453 2.102 . . . . 0.0 112.015 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.94 173.51 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.712 0.805 . . . . 0.0 109.695 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -150.43 18.26 0.83 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.807 0.443 . . . . 0.0 111.169 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.2 t -124.82 140.21 53.13 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.03 63.12 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.211 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.9 m -69.85 -25.01 63.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.104 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.7 -21.74 25.04 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -53.29 -65.85 0.49 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.7 0.8 . . . . 0.0 111.17 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 1.4 pp -62.68 -37.84 88.04 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 113.342 -1.754 . . . . 0.0 110.119 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -30.38 71.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.415 1.086 . . . . 0.0 112.019 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.421 ' HE1' HD23 ' A' ' 436' ' ' LEU . 31.1 t80 -71.74 -43.27 66.12 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.12 0.962 . . . . 0.0 108.562 -173.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.64 HD22 HG13 ' A' ' 395' ' ' ILE . 3.9 pp -89.19 -14.3 36.36 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.418 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.1 tm-20 -69.21 -50.3 48.61 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.826 1.251 . . . . 0.0 110.421 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -58.9 -38.01 77.91 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.728 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.504 ' CE2' ' HA ' ' A' ' 396' ' ' VAL . 34.8 t80 -66.84 -50.85 61.26 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.385 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.524 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 31.2 p -71.57 -22.0 61.8 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.408 0.683 . . . . 0.0 110.687 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -66.3 -39.92 89.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.087 0.955 . . . . 0.0 110.127 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.1 m -65.81 -29.74 70.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.803 0.841 . . . . 0.0 111.321 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 371' ' ' LEU . 41.0 mt -84.25 -13.5 52.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.008 0.923 . . . . 0.0 111.311 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 71.38 7.91 6.17 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.826 1.651 . . . . 0.0 111.668 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 21.1 p -83.27 133.64 34.98 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.4 p-10 -148.55 147.42 29.02 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.935 -173.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 59.86 21.85 10.79 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.583 0.753 . . . . 0.0 110.425 -168.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 18.3 tp -83.12 -15.76 49.45 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.449 0.7 . . . . 0.0 109.893 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -160.28 171.44 19.15 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.365 1.066 . . . . 0.0 108.757 174.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 40.0 m -165.79 115.54 1.01 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.1 t -64.74 -17.42 64.13 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.809 0.338 . . . . 0.0 111.398 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -95.85 151.26 38.26 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.274 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.12 168.53 23.86 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.565 2.176 . . . . 0.0 112.768 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . 0.477 ' HZ ' ' HB2' ' A' ' 362' ' ' ASN . 19.4 m-85 -74.13 -26.6 60.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.763 0.825 . . . . 0.0 110.301 178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.251 1.171 0 C-N-CA 124.406 1.083 . . . . 0.0 108.243 169.263 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.964 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 m -80.97 175.92 10.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.785 0.834 . . . . 0.0 111.025 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -80.64 66.11 6.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.203 0.525 . . . . 0.0 109.82 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.1 ptm -75.0 -18.74 60.32 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.261 0.553 . . . . 0.0 110.217 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -99.89 158.51 15.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.197 0.999 . . . . 0.0 108.73 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 11.0 t -79.72 -177.9 6.12 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.845 0.458 . . . . 0.0 110.516 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 28.1 p -138.99 136.58 35.51 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.564 0.746 . . . . 0.0 110.491 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.75 161.51 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.41 1.084 . . . . 0.0 110.851 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 30.5 p -132.76 132.36 42.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.624 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -117.34 154.58 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.119 0.568 . . . . 0.0 110.022 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 47.8 m-85 -111.78 100.32 8.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.403 HG11 ' CD1' ' A' ' 379' ' ' LEU . 38.6 t -70.48 88.19 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 0.0 109.501 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -81.78 93.21 6.78 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.909 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -76.67 -5.22 47.02 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.114 178.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -84.31 -13.22 53.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.268 0.627 . . . . 0.0 111.006 173.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -73.3 -112.14 0.07 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -121.62 138.42 54.34 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.68 3.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.54 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -156.22 -86.98 0.06 OUTLIER Glycine 0 C--O 1.216 -0.974 0 CA-C-O 118.88 -0.955 . . . . 0.0 111.485 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.04 12.9 44.41 Favored 'Cis proline' 0 C--N 1.368 1.582 0 CA-C-N 120.931 2.366 . . . . 0.0 114.084 8.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -72.75 -7.82 52.44 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.001 0.52 . . . . 0.0 111.478 172.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.1 mt -110.41 143.78 40.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.495 1.118 . . . . 0.0 109.227 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -67.15 118.92 60.52 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.631 0.772 . . . . 0.0 110.532 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 12.4 Cg_endo -52.84 -36.61 74.72 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.887 3.058 . . . . 0.0 114.337 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -80.28 -45.48 17.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -170.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -64.39 -36.06 82.91 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.159 0.984 . . . . 0.0 111.58 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.418 HD13 HD21 ' A' ' 379' ' ' LEU . 17.6 mm -55.82 -31.96 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 124.392 1.058 . . . . 0.0 111.427 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 54.3 mm-40 -78.4 -35.92 46.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.7 0.4 . . . . 0.0 110.696 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 69.9 mm-40 -71.54 -33.84 69.5 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.524 0.73 . . . . 0.0 112.092 -171.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.418 HD21 HD13 ' A' ' 376' ' ' ILE . 2.5 pp -71.11 155.64 92.94 Favored Pre-proline 0 N--CA 1.482 1.141 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.53 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.44 148.62 33.23 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.19 2.594 . . . . 0.0 113.903 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.27 -10.54 59.69 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.034 1.333 . . . . 0.0 111.825 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -164.52 145.5 8.05 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.211 0.604 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -114.57 159.44 20.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.79 1.236 . . . . 0.0 108.766 172.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 77.88 -179.68 51.0 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.111 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -79.87 128.82 16.75 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 119.441 1.621 . . . . 0.0 111.831 2.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.14 25.02 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 133.57 38.73 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 123.051 2.501 . . . . 0.0 113.629 -169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.2 p -47.3 -39.4 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 126.511 1.924 . . . . 0.0 111.985 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -60.29 -54.14 49.26 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.467 1.507 . . . . 0.0 111.014 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 393' ' ' ARG . 97.0 t -74.11 -47.64 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.121 -173.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.67 -38.54 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.15 -43.43 61.55 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 422' ' ' VAL . 39.6 ptt180 -72.1 -25.63 61.82 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.661 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -65.54 -36.15 82.96 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.81 0.694 . . . . 0.0 110.698 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.624 HD11 HG21 ' A' ' 359' ' ' VAL . 35.3 mm -66.66 -56.75 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 400' ' ' VAL . 95.5 t -57.57 -52.72 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 O-C-N 124.113 0.883 . . . . 0.0 111.045 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.8 pt20 -64.34 -35.89 82.35 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 122.7 0.4 . . . . 0.0 111.914 -176.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -68.29 -36.44 79.37 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 123.381 0.426 . . . . 0.0 110.046 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 84.1 m -68.87 -49.82 55.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.025 0.53 . . . . 0.0 111.205 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.0 t -63.59 -48.23 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 122.921 0.488 . . . . 0.0 110.068 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.96 -36.4 77.86 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.59 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 72.6 m -83.99 -1.27 54.36 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.452 0.301 . . . . 0.0 111.286 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -71.33 137.47 48.5 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 82.7 mt -67.37 117.15 8.96 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 166.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 64.46 66.26 0.61 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.135 0.969 . . . . 0.0 109.625 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.529 HG23 HG12 ' A' ' 400' ' ' VAL . 78.0 m -54.75 -35.62 63.94 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.709 -1.587 . . . . 0.0 112.771 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.8 ptmt -59.41 -35.36 73.85 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.56 1.144 . . . . 0.0 113.131 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 85.7 m -80.4 -37.89 31.32 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.69 0.796 . . . . 0.0 109.775 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.477 HG21 ' HB1' ' A' ' 403' ' ' ALA . 40.3 t -69.43 -30.41 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.082 177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -73.24 -20.01 60.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.444 1.098 . . . . 0.0 110.209 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -63.74 -15.05 57.19 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.584 -0.735 . . . . 0.0 114.692 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.07 3.03 55.88 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.598 0.699 . . . . 0.0 111.719 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.49 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -148.07 106.53 3.78 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.416 0.626 . . . . 0.0 110.476 -178.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.41 160.8 31.0 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 124.133 0.973 . . . . 0.0 109.779 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.03 163.79 24.41 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.488 2.125 . . . . 0.0 113.655 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -126.08 163.18 23.65 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.772 1.629 . . . . 0.0 108.857 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -130.26 35.95 4.03 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.235 0.614 . . . . 0.0 110.867 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.52 -39.75 4.0 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.868 170.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 100.65 42.59 2.47 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 114.153 0.421 . . . . 0.0 114.153 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -80.23 -106.57 0.28 Allowed Glycine 0 C--N 1.343 0.947 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.736 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 5.2 mp0 -83.33 172.74 12.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 116.994 0.397 . . . . 0.0 110.266 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.467 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 90.0 t -138.96 131.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.887 0.875 . . . . 0.0 108.791 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 433' ' ' SER . 35.8 mm -117.81 133.53 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.152 0.581 . . . . 0.0 110.02 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.4 p -108.85 137.18 47.2 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.932 0.893 . . . . 0.0 109.931 174.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.09 134.71 11.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.073 -174.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 13.6 p -77.2 115.89 17.37 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.203 0.601 . . . . 0.0 109.851 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -153.98 140.7 19.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.494 1.118 . . . . 0.0 108.945 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . 0.421 ' HB3' ' HE1' ' A' ' 432' ' ' HIS . 17.3 t70 63.01 16.9 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.728 1.211 . . . . 0.0 112.162 173.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.94 -18.44 57.18 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.11 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -109.23 166.38 10.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.607 0.763 . . . . 0.0 110.861 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.5 t -89.69 104.72 17.26 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 167.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . 0.421 ' HE1' ' HB3' ' A' ' 428' ' ' ASP . 51.0 m80 -95.53 129.07 42.83 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.312 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 57.8 p -118.07 132.88 56.32 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.586 0.755 . . . . 0.0 109.99 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.49 HD11 HD12 ' A' ' 413' ' ' LEU . 30.7 pt -118.43 179.52 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.275 0.63 . . . . 0.0 109.843 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -111.36 151.73 28.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.55 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 82.4 mt -117.31 151.44 47.95 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.48 1.112 . . . . 0.0 108.557 172.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -61.26 131.22 35.42 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.392 2.062 . . . . 0.0 111.757 175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.28 137.78 77.01 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.06 2.506 . . . . 0.0 114.533 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.2 m -109.82 167.09 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.917 0.887 . . . . 0.0 109.603 171.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -155.67 15.69 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.557 0.343 . . . . 0.0 111.254 172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 26.0 t -123.48 141.43 52.0 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.804 0.442 . . . . 0.0 109.927 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.07 78.91 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.113 0.965 . . . . 0.0 112.322 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 50.5 m -70.3 -19.47 63.09 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.999 175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -85.85 -22.0 27.78 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.847 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.61 -60.98 2.54 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 22.2 mt -60.65 -54.38 46.07 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.682 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -49.06 -40.66 32.34 Favored 'General case' 0 C--O 1.247 0.935 0 O-C-N 125.023 1.452 . . . . 0.0 112.281 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.18 -48.64 79.15 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.151 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -83.22 -17.1 43.92 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 118.19 -0.91 . . . . 0.0 112.133 178.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.59 -42.71 74.09 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 119.325 0.966 . . . . 0.0 110.047 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -62.42 -38.48 89.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 123.826 0.704 . . . . 0.0 110.629 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.477 ' CE2' HD11 ' A' ' 456' ' ' LEU . 36.5 t80 -68.91 -49.8 54.98 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.033 178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 89.5 m -67.39 -22.41 65.55 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.25 1.02 . . . . 0.0 111.514 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -65.97 -36.44 83.33 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 22.8 t -77.23 -28.58 53.77 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.876 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.531 HD13 HD21 ' A' ' 371' ' ' LEU . 64.9 mt -77.23 -16.75 58.91 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.256 0.623 . . . . 0.0 111.397 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 71.0 6.55 5.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.012 1.725 . . . . 0.0 111.471 -176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.574 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -78.0 132.34 37.77 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.496 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 34.5 t70 -147.35 142.34 27.0 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.065 -165.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 60.28 18.8 8.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.17 0.988 . . . . 0.0 110.276 -167.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 32.5 tp -80.81 -24.09 38.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 122.933 0.493 . . . . 0.0 111.019 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.565 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -155.58 160.35 40.41 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.668 0.387 . . . . 0.0 111.018 174.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 33.5 p -164.3 133.54 3.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.801 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 8.4 t -81.67 -2.2 49.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.069 0.548 . . . . 0.0 111.831 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -72.09 109.36 5.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.679 1.192 . . . . 0.0 110.17 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -88.68 174.58 4.0 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.809 2.339 . . . . 0.0 112.234 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -78.28 -21.83 49.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.108 0.563 . . . . 0.0 110.139 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.392 0 C-N-CA 123.821 0.848 . . . . 0.0 109.707 177.183 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 40.7 m -80.6 -35.3 34.31 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.264 0.626 . . . . 0.0 110.383 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -75.92 126.07 30.3 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 168.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -75.75 -165.5 0.45 Allowed 'General case' 0 CA--C 1.549 0.928 0 O-C-N 123.696 0.622 . . . . 0.0 110.71 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 387' ' ' PRO . 0.0 OUTLIER -65.93 150.15 49.08 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.813 0.445 . . . . 0.0 110.448 171.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 23.1 t -72.48 -178.94 2.76 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 122.468 0.307 . . . . 0.0 110.178 168.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 20.6 p -135.29 138.3 43.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.23 0.612 . . . . 0.0 110.25 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.03 158.02 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.311 1.044 . . . . 0.0 110.485 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 21.0 p -134.36 107.5 7.65 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.65 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.627 HG21 HD11 ' A' ' 395' ' ' ILE . 34.4 m -94.77 154.3 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 170.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -117.63 99.95 7.3 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.452 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 48.6 t -69.9 98.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.743 0.817 . . . . 0.0 110.015 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.29 83.73 7.88 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.24 42.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.31 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -78.0 -21.26 51.09 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.467 0.707 . . . . 0.0 110.51 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.63 -148.08 6.28 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.885 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.5 t30 -74.46 140.37 44.56 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.283 0.564 . . . . 0.0 109.973 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.48 -54.06 4.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.558 1.143 . . . . 0.0 108.253 -178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.699 ' HA2' ' HB3' ' A' ' 458' ' ' CYS . . . -155.22 -86.53 0.06 OUTLIER Glycine 0 C--O 1.219 -0.84 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.75 -175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -88.61 15.99 44.42 Favored 'Cis proline' 0 C--N 1.365 1.422 0 CA-C-N 120.194 1.997 . . . . 0.0 114.022 8.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -70.75 -12.21 61.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.705 0.402 . . . . 0.0 110.847 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 22.5 mt -107.44 131.93 53.75 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.675 1.19 . . . . 0.0 109.035 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -67.18 126.87 93.18 Favored Pre-proline 0 N--CA 1.481 1.099 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.498 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.524 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 30.1 Cg_endo -60.07 -41.49 51.92 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.349 2.699 . . . . 0.0 113.294 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.524 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -66.57 -39.7 88.61 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.879 0.471 . . . . 0.0 110.74 -175.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -74.11 -30.93 62.57 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.754 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 379' ' ' LEU . 10.0 mm -62.75 -24.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 C-N-CA 124.047 0.939 . . . . 0.0 111.466 173.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 55.1 mm-40 -83.31 -17.05 43.84 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.675 0.39 . . . . 0.0 111.15 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -79.2 -30.46 43.39 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.162 0.585 . . . . 0.0 111.626 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 376' ' ' ILE . 0.3 OUTLIER -74.82 157.43 85.74 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 169.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.25 166.5 21.06 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.56 2.174 . . . . 0.0 112.972 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.39 1.49 21.87 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.13 0.972 . . . . 0.0 111.179 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.452 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 33.8 p80 -158.84 155.57 28.05 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 123.725 0.81 . . . . 0.0 110.34 173.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -125.07 113.29 17.55 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 167.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 114.53 176.75 18.97 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.457 -0.635 . . . . 0.0 112.357 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.65 128.98 16.81 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 119.71 1.755 . . . . 0.0 112.655 1.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -169.51 -164.29 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.051 -0.861 . . . . 0.0 111.594 -174.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.525 ' HB3' ' HG3' ' A' ' 354' ' ' MET . 7.8 Cg_exo -66.36 139.21 53.63 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.955 2.437 . . . . 0.0 112.072 -170.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.935 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.1 p -53.75 -45.71 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.133 0.973 . . . . 0.0 111.341 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.533 ' HB3' HH21 ' A' ' 393' ' ' ARG . 12.7 m120 -63.65 -45.48 89.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.894 1.277 . . . . 0.0 110.74 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 71.1 t -70.63 -57.67 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.632 -176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 84.2 t -50.75 -44.19 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 123.397 0.679 . . . . 0.0 112.457 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 449' ' ' LEU . 3.3 pp -69.36 -41.68 76.25 Favored 'General case' 0 C--N 1.363 1.174 0 CA-C-N 117.571 0.169 . . . . 0.0 110.564 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.533 HH21 ' HB3' ' A' ' 389' ' ' ASN . 11.4 ptp180 -70.48 -28.63 65.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 29.9 mmt180 -70.53 -34.09 71.89 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 123.688 0.617 . . . . 0.0 110.989 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.627 HD11 HG21 ' A' ' 359' ' ' VAL . 24.6 mm -65.62 -57.18 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 173.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.4 t -58.69 -49.31 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.737 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.56 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.3 pt20 -68.27 -37.36 80.64 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.631 0.372 . . . . 0.0 111.398 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.464 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -66.37 -35.35 80.11 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.395 0.435 . . . . 0.0 110.064 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 93.0 m -67.68 -53.33 28.62 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 123.597 0.561 . . . . 0.0 110.978 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 396' ' ' VAL . 20.3 t -61.26 -47.27 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 122.748 0.419 . . . . 0.0 110.527 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.98 -46.8 76.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 89.3 m -73.61 -5.68 41.89 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.895 0.478 . . . . 0.0 112.264 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.67 143.78 55.81 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.414 0.625 . . . . 0.0 112.635 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.94 126.79 30.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.444 -1.253 . . . . 0.0 107.959 163.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 61.16 56.5 2.72 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-O 122.085 0.945 . . . . 0.0 109.694 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 92.2 m -53.75 -32.16 51.23 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.037 1.335 . . . . 0.0 111.77 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -57.48 -32.23 66.78 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.815 1.246 . . . . 0.0 112.666 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 80.7 m -89.3 -42.73 11.42 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.716 0.806 . . . . 0.0 110.48 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.505 HG21 ' HB1' ' A' ' 403' ' ' ALA . 69.7 t -60.66 -32.91 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.832 0.853 . . . . 0.0 111.66 -177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -72.48 -26.83 61.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.771 1.228 . . . . 0.0 110.557 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -70.29 -15.36 72.44 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.966 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -79.73 -2.66 44.03 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.492 0.646 . . . . 0.0 111.845 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 434' ' ' ILE . 1.0 OUTLIER -145.81 105.26 3.95 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.489 0.661 . . . . 0.0 110.148 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -83.9 157.42 63.41 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.146 0.978 . . . . 0.0 110.375 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.91 163.39 37.66 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.007 1.805 . . . . 0.0 112.873 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -143.15 137.5 29.12 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.464 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -96.34 38.65 1.19 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.265 0.626 . . . . 0.0 111.423 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -95.01 -16.98 22.32 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.402 0.681 . . . . 0.0 110.638 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 435' ' ' GLN . . . 74.97 39.42 38.15 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 113.974 0.35 . . . . 0.0 113.974 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.29 -122.63 3.91 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-O 120.153 -0.248 . . . . 0.0 113.09 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.4 OUTLIER -70.07 162.63 27.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.788 0.835 . . . . 0.0 110.642 -177.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 61.1 t -130.1 128.24 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.56 HG23 ' HA ' ' A' ' 397' ' ' GLN . 36.6 mm -111.4 121.92 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.452 0.701 . . . . 0.0 110.215 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.2 p -107.51 142.9 36.67 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.442 1.097 . . . . 0.0 110.221 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -163.41 136.33 5.45 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.891 0.744 . . . . 0.0 110.986 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 67.4 m -74.88 119.6 19.27 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.48 0.712 . . . . 0.0 111.875 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -148.51 137.7 21.81 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.468 1.107 . . . . 0.0 109.73 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 58.83 33.47 23.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.945 1.298 . . . . 0.0 112.117 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.04 87.15 Favored Glycine 0 N--CA 1.469 0.888 0 CA-C-N 115.752 -0.658 . . . . 0.0 114.386 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -132.82 171.68 13.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.06 0.944 . . . . 0.0 109.572 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -94.77 130.18 41.42 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -119.37 142.45 48.15 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.651 0.781 . . . . 0.0 109.716 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 42.2 p -129.08 143.07 50.74 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 110.483 -175.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 413' ' ' LEU . 26.8 pt -119.61 173.65 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.216 0.606 . . . . 0.0 109.42 171.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.411 ' NE2' ' HA2' ' A' ' 419' ' ' GLY . 28.5 mt-30 -113.8 151.72 31.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.351 0.661 . . . . 0.0 110.342 171.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 78.9 mt -116.56 168.49 8.65 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.287 1.435 . . . . 0.0 108.962 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.24 136.77 20.36 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 121.601 1.534 . . . . 0.0 111.256 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -73.07 133.04 19.02 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.469 2.112 . . . . 0.0 112.166 -177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.5 m -99.99 174.1 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.977 0.911 . . . . 0.0 110.997 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.32 12.11 0.41 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.959 0.504 . . . . 0.0 110.966 173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.6 t -119.21 138.32 53.04 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.722 0.409 . . . . 0.0 110.635 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -72.89 -29.21 62.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.978 0.911 . . . . 0.0 111.081 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 18.6 m -71.87 -22.25 61.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.187 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -86.6 -32.98 20.33 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.935 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.38 -63.73 0.97 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.708 1.203 . . . . 0.0 111.478 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.25 -47.77 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 113.403 -1.726 . . . . 0.0 108.994 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -32.34 64.36 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 112.122 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' A' ' 436' ' ' LEU . 28.1 t80 -62.98 -56.6 15.67 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 122.884 0.474 . . . . 0.0 110.121 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -78.54 -14.97 59.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.556 -178.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.556 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 50.0 mt-10 -72.74 -40.3 66.19 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 118.586 0.63 . . . . 0.0 109.853 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -67.73 -32.3 72.82 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.511 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.516 ' CE2' HD11 ' A' ' 456' ' ' LEU . 48.4 t80 -81.02 -42.14 21.59 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.405 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 21.7 p -68.28 -23.85 64.8 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.199 0.599 . . . . 0.0 110.411 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -62.17 -32.81 73.47 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.07 1.348 . . . . 0.0 111.034 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 24.0 m -78.34 -32.86 49.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.539 0.736 . . . . 0.0 110.794 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.519 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 39.0 mt -83.8 -10.29 58.18 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.641 0.776 . . . . 0.0 112.204 -176.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 71.26 7.29 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.741 1.616 . . . . 0.0 111.373 -176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.699 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 14.8 p -84.67 135.42 34.17 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 122.894 0.478 . . . . 0.0 110.04 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 28.1 t70 -147.12 158.66 44.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.602 -175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 8.2 p30 48.64 26.11 1.14 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.643 1.177 . . . . 0.0 112.654 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.55 -15.66 30.24 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 124.905 1.282 . . . . 0.0 110.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.406 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.74 164.56 33.75 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.354 0.661 . . . . 0.0 110.273 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 42.0 p -168.06 129.0 1.37 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.146 0.978 . . . . 0.0 108.459 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 23.2 t -67.85 -20.64 65.16 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.103 0.561 . . . . 0.0 111.72 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 146.95 34.65 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.984 0.914 . . . . 0.0 109.096 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.44 174.88 11.81 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.301 2.0 . . . . 0.0 111.621 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -75.27 -8.94 57.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.919 0.488 . . . . 0.0 112.184 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 CA--C 1.556 1.211 0 C-N-CA 123.569 0.748 . . . . 0.0 109.394 175.73 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 52.6 p -67.36 -39.93 85.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.197 0.599 . . . . 0.0 111.048 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -80.71 1.87 28.38 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.671 0.788 . . . . 0.0 112.641 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 43.0 ttm -80.0 -41.54 25.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.596 0.758 . . . . 0.0 110.834 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.66 -175.51 5.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.263 0.625 . . . . 0.0 111.071 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.7 t -90.34 178.2 6.2 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.396 1.078 . . . . 0.0 110.841 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.2 p -136.39 135.32 38.67 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.729 1.212 . . . . 0.0 109.624 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.96 167.37 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 123.922 0.889 . . . . 0.0 110.738 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.8 t -136.44 121.24 18.59 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.068 0.947 . . . . 0.0 108.809 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 395' ' ' ILE . 35.5 m -105.19 146.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 170.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -111.94 98.46 7.38 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.519 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 42.4 t -68.66 101.53 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 124.323 1.014 . . . . 0.0 109.897 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.426 ' OD1' ' HB3' ' A' ' 364' ' ' HIS . 51.2 t30 -92.21 90.39 7.28 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.156 -173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.05 -5.69 49.82 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.761 176.031 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . 0.426 ' HB3' ' OD1' ' A' ' 362' ' ' ASN . 66.5 t60 -76.87 -19.36 57.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.673 0.789 . . . . 0.0 110.174 167.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -74.0 -125.74 0.12 Allowed Glycine 0 C--N 1.353 1.503 0 CA-C-O 120.01 -0.328 . . . . 0.0 112.677 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -106.8 156.05 19.07 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.496 0.648 . . . . 0.0 109.374 177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.14 -64.41 1.07 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.593 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.94 -87.9 0.07 OUTLIER Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.275 -173.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . 0.434 ' HD2' HE21 ' A' ' 457' ' ' GLN . 36.6 Cg_endo -85.91 17.2 33.85 Favored 'Cis proline' 0 C--N 1.374 1.907 0 CA-C-N 120.51 2.155 . . . . 0.0 113.998 4.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -70.81 -22.69 62.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.117 0.567 . . . . 0.0 110.284 169.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.593 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 26.7 mt -96.34 136.74 36.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.33 1.052 . . . . 0.0 109.56 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 375' ' ' ARG . 12.8 t70 -65.35 126.16 90.89 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.827 0.851 . . . . 0.0 110.653 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 60.5 Cg_endo -68.0 -19.49 45.71 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.814 2.343 . . . . 0.0 113.872 -170.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -84.74 -47.41 10.45 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -178.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 38.4 mtt180 -62.32 -35.53 79.36 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.501 1.12 . . . . 0.0 112.064 -179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 22.9 mm -58.47 -29.64 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.505 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.6 mm-40 -85.76 -19.12 31.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.568 0.347 . . . . 0.0 110.996 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 79.3 mm-40 -87.4 -29.11 21.73 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.345 0.658 . . . . 0.0 112.556 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.454 HD13 HG11 ' A' ' 361' ' ' VAL . 2.7 pp -69.84 159.61 83.36 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.453 -0.784 . . . . 0.0 109.741 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.2 152.13 74.15 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.512 2.142 . . . . 0.0 113.279 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.34 -4.07 37.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.41 1.084 . . . . 0.0 111.808 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.519 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 38.7 p-80 -161.55 148.76 14.61 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.339 0.656 . . . . 0.0 110.815 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -116.85 104.17 11.04 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 133.03 -173.92 20.79 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 119.82 -0.433 . . . . 0.0 113.376 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.99 128.36 14.48 Favored 'Cis proline' 0 C--N 1.377 2.078 0 C-N-CA 123.881 -1.3 . . . . 0.0 113.097 -5.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -152.27 -162.3 10.78 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.21 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -68.69 139.39 44.03 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 123.067 2.511 . . . . 0.0 112.072 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.843 HG23 ' HB2' ' A' ' 445' ' ' ALA . 6.8 p -50.51 -39.65 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 124.46 1.104 . . . . 0.0 111.754 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -67.61 -48.28 67.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.543 1.137 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 53.2 t -74.65 -47.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.983 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 97.4 t -54.23 -43.58 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.23 0.612 . . . . 0.0 111.98 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 449' ' ' LEU . 2.7 pp -68.21 -44.29 76.11 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 120.68 0.276 . . . . 0.0 110.563 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.5 HH11 ' HA ' ' A' ' 421' ' ' GLU . 29.4 ptt180 -74.56 -24.51 58.93 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.493 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.54 -38.63 91.7 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.266 0.626 . . . . 0.0 110.921 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.679 HD11 HG21 ' A' ' 359' ' ' VAL . 27.6 mm -65.42 -55.51 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 400' ' ' VAL . 68.2 t -61.66 -47.02 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.706 -172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -68.98 -32.14 71.5 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.645 0.378 . . . . 0.0 110.88 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -66.46 -36.72 83.48 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 123.551 0.532 . . . . 0.0 110.068 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.6 m -66.37 -56.17 12.36 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.152 0.908 . . . . 0.0 110.949 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 396' ' ' VAL . 3.0 t -62.55 -37.38 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.75 -43.73 95.56 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.593 0.757 . . . . 0.0 111.19 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 19.9 p -83.44 -8.03 59.45 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.166 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.622 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -72.04 134.02 45.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 53.2 mt -75.76 124.6 27.56 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.655 169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 64.55 68.49 0.53 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.624 1.17 . . . . 0.0 109.319 -171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.483 HG23 HG12 ' A' ' 400' ' ' VAL . 55.3 m -61.18 -37.83 84.33 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 113.91 -1.495 . . . . 0.0 112.533 -173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' A' ' 407' ' ' LYS . 0.0 OUTLIER -51.06 -43.13 60.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.864 0.866 . . . . 0.0 113.035 178.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 90.3 m -74.71 -38.64 62.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.472 0.654 . . . . 0.0 109.874 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.622 HG21 ' HB1' ' A' ' 403' ' ' ALA . 78.0 t -68.94 -31.4 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.638 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.06 -10.28 59.54 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.334 1.054 . . . . 0.0 110.034 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.67 -7.74 83.89 Favored Glycine 0 C--N 1.352 1.465 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.908 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -83.34 -9.72 58.9 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 117.621 0.711 . . . . 0.0 111.869 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.98 142.74 49.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.636 0.775 . . . . 0.0 109.713 174.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -117.06 149.71 44.74 Favored Pre-proline 0 N--CA 1.482 1.165 0 C-N-CA 123.443 0.697 . . . . 0.0 111.091 -174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.67 128.07 16.47 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.832 2.355 . . . . 0.0 112.603 174.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.06 169.64 8.55 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.843 1.257 . . . . 0.0 108.801 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -118.99 22.58 11.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.71 . . . . 0.0 112.391 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.403 ' HB3' ' HD2' ' A' ' 438' ' ' PRO . 0.5 OUTLIER -100.9 -25.12 14.2 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.085 0.554 . . . . 0.0 111.623 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.2 45.89 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.191 1.237 . . . . 0.0 116.191 162.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -85.69 -85.0 1.03 Allowed Glycine 0 C--O 1.239 0.436 0 CA-C-N 116.779 0.29 . . . . 0.0 112.694 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 3.1 mp0 -85.17 162.79 19.08 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.84 0.456 . . . . 0.0 110.346 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 67.5 t -136.08 124.21 36.18 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 C-N-CA 124.063 0.945 . . . . 0.0 108.633 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.561 HG12 HD11 ' A' ' 436' ' ' LEU . 32.3 mm -104.39 122.82 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.2 p -106.76 145.75 31.69 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.257 1.023 . . . . 0.0 109.498 178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -166.37 142.85 4.9 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.539 0.736 . . . . 0.0 110.879 -173.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.0 m -77.09 103.38 6.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.754 0.822 . . . . 0.0 110.024 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -114.92 124.64 52.22 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.706 0.802 . . . . 0.0 109.098 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 32.0 t70 61.19 28.59 18.19 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-O 122.245 1.022 . . . . 0.0 111.124 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 97.87 -17.8 58.22 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.863 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -111.29 162.01 15.45 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 117.441 0.621 . . . . 0.0 110.651 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.1 t -81.98 121.88 27.08 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -126.42 149.96 48.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.54 0.736 . . . . 0.0 109.871 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 424' ' ' THR . 54.0 p -140.29 146.08 38.08 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.354 0.662 . . . . 0.0 110.252 -173.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 29.0 pt -120.11 178.84 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.558 0.743 . . . . 0.0 110.361 175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -118.51 147.88 43.19 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.578 0.751 . . . . 0.0 109.863 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.0 mp -116.26 156.04 47.61 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 124.863 1.265 . . . . 0.0 108.188 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.16 131.06 21.25 Favored 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 121.877 1.718 . . . . 0.0 111.061 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 418' ' ' ARG . 41.6 Cg_endo -66.33 128.79 20.04 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.954 2.436 . . . . 0.0 113.167 -175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.08 168.8 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.249 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -153.22 0.07 0.25 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.386 0.674 . . . . 0.0 110.772 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 46.6 t -120.61 142.63 49.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.274 0.63 . . . . 0.0 109.997 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.16 67.96 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.835 0.854 . . . . 0.0 112.462 -172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 24.4 m -70.39 -28.2 64.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.444 0.698 . . . . 0.0 111.321 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.37 -24.03 29.87 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.843 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.16 -59.68 3.22 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 123.907 0.754 . . . . 0.0 109.668 171.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 16.3 mt -65.89 -51.03 62.22 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.041 -171.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -48.76 -41.94 33.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.319 1.047 . . . . 0.0 112.878 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -41.11 99.11 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.955 0.784 . . . . 0.0 110.951 -171.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.503 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.44 -18.92 28.83 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 118.681 -0.676 . . . . 0.0 112.318 175.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.29 -42.38 59.65 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.861 0.755 . . . . 0.0 110.416 -175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -65.63 -40.8 92.95 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.444 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 456' ' ' LEU . 67.7 t80 -65.57 -47.11 76.91 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.257 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 86.7 m -66.66 -31.43 72.1 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.369 0.668 . . . . 0.0 110.771 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 45.6 t60 -69.59 -32.4 71.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.249 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 45.9 m -67.28 -33.81 76.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.136 0.574 . . . . 0.0 110.511 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.56 HD13 HD21 ' A' ' 371' ' ' LEU . 56.7 mt -84.31 -8.93 58.86 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.635 0.774 . . . . 0.0 111.702 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . 0.434 HE21 ' HD2' ' A' ' 369' ' ' PRO . 17.4 mt-30 79.02 5.23 2.3 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.502 1.921 . . . . 0.0 111.779 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.455 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 7.4 p -87.4 146.44 25.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.059 0.544 . . . . 0.0 110.896 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -162.64 154.45 18.32 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 32.3 m-80 64.54 18.84 11.58 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.268 1.027 . . . . 0.0 111.115 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 23.7 tp -83.32 -9.42 59.09 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.574 0.749 . . . . 0.0 110.606 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.423 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -157.6 171.85 19.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.935 0.894 . . . . 0.0 109.908 176.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 29.1 p -162.16 126.22 3.17 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.473 0.709 . . . . 0.0 109.843 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 21.5 t -72.27 -6.32 42.21 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -138.83 146.91 52.12 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.499 1.12 . . . . 0.0 109.381 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.52 163.21 38.94 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.394 2.063 . . . . 0.0 112.568 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -77.27 -16.6 58.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 0.0 111.542 -174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.254 1.323 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 172.667 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 76.0 p -161.68 156.44 23.04 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.39 0.676 . . . . 0.0 111.058 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -125.61 -172.41 2.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.654 1.182 . . . . 0.0 109.459 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 50.3 tpp -74.7 130.37 39.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.586 0.354 . . . . 0.0 110.593 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.39 164.75 13.1 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.011 0.924 . . . . 0.0 110.509 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 75.7 m -75.27 -177.39 3.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.596 0.358 . . . . 0.0 111.801 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.0 p -141.6 134.37 28.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.119 0.968 . . . . 0.0 109.622 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 388' ' ' VAL . 13.0 m -137.29 171.4 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.344 1.058 . . . . 0.0 110.509 -177.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 25.9 p -145.83 108.12 4.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.383 0.673 . . . . 0.0 109.751 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.647 HG21 HD11 ' A' ' 395' ' ' ILE . 30.8 m -98.34 143.91 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -109.89 100.69 9.62 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.493 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 78.0 t -73.42 102.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.411 -174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 36.3 t30 -97.11 96.13 8.24 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.828 0.851 . . . . 0.0 109.624 -175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.437 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -78.13 -5.93 53.18 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.023 177.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -85.8 -8.93 57.8 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.365 0.666 . . . . 0.0 110.524 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -81.61 -137.04 2.23 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 171.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.455 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 45.4 t30 -92.13 142.78 27.13 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 117.817 0.808 . . . . 0.0 109.369 174.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.458 ' HB3' HG13 ' A' ' 376' ' ' ILE . 1.8 m-85 -84.03 -56.23 3.79 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.581 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -147.38 -74.48 0.02 OUTLIER Glycine 0 C--N 1.349 1.268 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.912 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -72.8 -15.26 17.65 Favored 'Cis proline' 0 C--N 1.371 1.729 0 CA-C-N 121.118 2.459 . . . . 0.0 115.308 4.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -73.09 0.94 10.1 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 118.907 0.776 . . . . 0.0 113.079 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.581 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 12.7 mt -91.39 127.86 37.0 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 171.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -55.01 118.38 17.35 Favored Pre-proline 0 N--CA 1.478 0.974 0 O-C-N 124.165 0.916 . . . . 0.0 110.763 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 58.7 Cg_endo -65.61 -19.36 60.17 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.92 2.413 . . . . 0.0 113.664 -169.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 3.1 mppt? -84.5 -42.7 15.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.86 0.362 . . . . 0.0 110.04 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 24.1 mtt-85 -68.01 -33.08 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.216 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 367' ' ' PHE . 24.6 mm -60.68 -27.02 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.406 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.159 171.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 69.7 mm-40 -84.47 -22.3 30.33 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.974 -0.454 . . . . 0.0 110.886 174.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 85.7 mm-40 -79.73 -30.19 40.79 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.318 0.647 . . . . 0.0 112.367 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 376' ' ' ILE . 3.1 pp -73.2 154.6 90.39 Favored Pre-proline 0 N--CA 1.482 1.137 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.29 164.78 24.36 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.233 1.955 . . . . 0.0 114.773 -170.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -72.27 -18.28 61.82 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.461 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.493 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 47.5 p-80 -166.32 149.93 7.41 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.54 0.736 . . . . 0.0 110.224 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -116.49 101.94 9.06 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 168.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 144.68 165.85 11.28 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 119.483 -0.621 . . . . 0.0 113.444 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.23 130.36 20.59 Favored 'Cis proline' 0 C--N 1.379 2.171 0 CA-C-N 118.984 1.392 . . . . 0.0 112.237 -3.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -155.67 -173.22 24.06 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 118.875 -0.958 . . . . 0.0 111.074 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -73.44 143.11 34.22 Favored 'Trans proline' 0 C--N 1.368 1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.933 HG23 ' HB2' ' A' ' 445' ' ' ALA . 3.3 p -45.47 -50.95 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.689 1.596 . . . . 0.0 112.775 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -70.49 -34.58 72.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.617 1.167 . . . . 0.0 111.817 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 99.4 t -76.57 -47.45 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.878 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 94.6 t -59.17 -38.82 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 122.883 0.473 . . . . 0.0 111.658 -177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -70.77 -41.61 71.5 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.146 0.179 . . . . 0.0 111.428 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.487 ' N ' HD12 ' A' ' 392' ' ' LEU . 28.8 ptt180 -71.9 -30.74 65.7 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -68.84 -29.39 67.7 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.614 0.765 . . . . 0.0 111.51 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.647 HD11 HG21 ' A' ' 359' ' ' VAL . 35.4 mm -69.6 -54.85 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 400' ' ' VAL . 98.3 t -58.76 -50.07 80.57 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 O-C-N 124.193 0.933 . . . . 0.0 111.572 -172.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.469 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.7 pt20 -68.44 -31.35 70.61 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 122.929 0.491 . . . . 0.0 111.91 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.48 -42.22 83.3 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.01 -32.45 72.0 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.45 0.7 . . . . 0.0 112.629 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 396' ' ' VAL . 17.7 t -80.24 -52.38 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -61.55 -38.98 89.43 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.734 0.414 . . . . 0.0 111.055 -176.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 50.5 m -89.28 12.94 14.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.297 0.639 . . . . 0.0 111.342 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -89.51 144.91 25.66 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.212 0.605 . . . . 0.0 111.732 177.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 83.4 mt -68.87 122.23 18.2 Favored 'General case' 0 C--O 1.242 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.839 166.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 66.32 62.28 0.57 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.445 1.09 . . . . 0.0 109.192 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 400' ' ' VAL . 89.5 m -55.96 -41.13 74.25 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.64 1.576 . . . . 0.0 111.483 -173.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -54.2 -34.67 61.11 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.116 1.366 . . . . 0.0 114.497 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.2 m -79.14 -39.4 33.63 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.469 0.652 . . . . 0.0 109.653 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.523 HG21 ' HB1' ' A' ' 403' ' ' ALA . 59.8 t -67.11 -26.17 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.013 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -70.3 -17.54 63.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.314 1.446 . . . . 0.0 110.146 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -81.9 -8.21 86.97 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.4 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -83.16 -2.31 55.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.213 0.605 . . . . 0.0 111.3 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.506 HD12 HD11 ' A' ' 434' ' ' ILE . 1.5 pt? -149.31 139.17 21.93 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.611 0.764 . . . . 0.0 110.052 -174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -105.87 152.7 40.29 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.101 0.961 . . . . 0.0 111.474 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.03 151.68 62.01 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 122.698 2.265 . . . . 0.0 111.046 166.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -148.24 107.78 3.96 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -91.06 44.94 1.22 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.019 0.914 . . . . 0.0 110.979 -167.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.63 5.94 50.35 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.407 169.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.81 66.2 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.51 0.506 . . . . 0.0 113.178 171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.52 -126.86 2.38 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 123.737 0.316 . . . . 0.0 112.727 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.461 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.5 mp0 -85.12 174.56 9.59 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.415 0.686 . . . . 0.0 110.755 -175.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.1 t -130.64 135.31 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.34 0.656 . . . . 0.0 109.432 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 397' ' ' GLN . 31.2 mm -109.74 124.19 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.897 0.879 . . . . 0.0 108.998 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.8 p -106.87 133.83 50.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.224 0.61 . . . . 0.0 109.613 175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.47 134.04 10.86 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.605 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 62.7 m -77.03 104.64 7.64 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 122.951 0.5 . . . . 0.0 111.023 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -111.05 110.63 21.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.985 0.914 . . . . 0.0 110.598 -173.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 39.0 t70 58.09 57.6 3.96 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.745 1.218 . . . . 0.0 111.76 169.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 78.32 -6.94 49.2 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 114.131 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -110.98 170.84 7.83 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 117.708 0.754 . . . . 0.0 110.309 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 5.1 t -114.22 109.39 18.32 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -120.66 168.75 11.06 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.608 0.763 . . . . 0.0 110.686 -173.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 51.0 p -147.94 154.86 40.9 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.331 -175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.506 HD11 HD12 ' A' ' 413' ' ' LEU . 25.5 pt -122.49 -179.75 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.957 0.903 . . . . 0.0 109.173 172.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -116.17 153.32 32.04 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.404 0.681 . . . . 0.0 110.211 170.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 421' ' ' GLU . 85.0 mt -114.96 164.68 15.96 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 0.0 109.374 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.34 134.47 17.3 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.814 1.676 . . . . 0.0 111.008 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.43 128.02 14.84 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.002 1.801 . . . . 0.0 112.248 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 10.7 m -99.51 172.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.642 0.777 . . . . 0.0 110.369 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.18 -12.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.421 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 64.9 m -108.78 138.89 44.38 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.4 0.545 . . . . 0.0 111.044 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.81 -30.37 68.91 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.265 1.026 . . . . 0.0 111.622 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.6 m -62.85 -33.53 75.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.837 173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -82.56 -25.32 33.43 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.858 -175.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.933 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.2 -65.97 0.48 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.865 0.866 . . . . 0.0 111.473 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 3.1 pp -65.98 -37.43 85.93 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.609 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.38 -30.65 71.69 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.263 1.025 . . . . 0.0 111.686 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -62.73 -49.71 73.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.529 0.732 . . . . 0.0 110.245 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.576 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -89.05 -14.5 36.25 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.519 -175.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 1.0 OUTLIER -59.69 -48.86 79.98 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.047 0.939 . . . . 0.0 110.807 -176.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -69.92 -32.89 71.41 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.075 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.441 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 60.4 t80 -68.23 -52.83 29.74 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.136 0.575 . . . . 0.0 110.87 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.08 -28.01 69.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.824 1.249 . . . . 0.0 111.31 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -67.72 -36.53 80.77 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.624 0.769 . . . . 0.0 110.273 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 23.1 m -71.41 -28.13 63.79 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.723 0.809 . . . . 0.0 110.923 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 23.9 mt -82.91 -17.81 42.4 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.128 0.571 . . . . 0.0 111.157 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 73.8 6.82 4.94 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.263 1.825 . . . . 0.0 111.777 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 22.4 p -79.22 131.53 36.21 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.9 t70 -151.68 145.43 25.05 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.358 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 18.1 m-80 62.72 20.67 12.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 -167.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -86.27 -19.95 29.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.51 0.724 . . . . 0.0 110.476 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.09 169.55 24.23 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 123.537 0.735 . . . . 0.0 110.059 173.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 21.9 p -157.22 109.43 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 37.9 t -71.7 -17.84 62.2 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.518 0.727 . . . . 0.0 111.626 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -85.97 111.16 36.1 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.62 151.74 64.37 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.159 1.906 . . . . 0.0 112.928 -176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -67.18 -27.09 66.98 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.837 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.251 1.139 0 C-N-CA 123.96 0.904 . . . . 0.0 108.936 177.572 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 CA-C-O 120.041 -0.311 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 48.4 p -72.57 78.97 1.06 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.463 1.105 . . . . 0.0 111.286 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -81.96 77.96 8.72 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -73.45 -21.81 60.36 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.929 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -118.02 170.23 9.01 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.388 1.075 . . . . 0.0 108.755 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 79.2 p -86.47 -173.58 4.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.941 0.496 . . . . 0.0 110.899 173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 40.3 p -139.62 142.44 37.04 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.611 0.764 . . . . 0.0 110.667 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.416 HG23 HG11 ' A' ' 391' ' ' VAL . 12.4 m -143.22 152.7 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.459 1.103 . . . . 0.0 110.584 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.479 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 42.2 t -121.07 105.72 10.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 0.0 109.102 171.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 58.1 t -94.95 149.69 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.66 0.784 . . . . 0.0 109.734 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -118.5 103.46 9.76 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.572 1.149 . . . . 0.0 108.585 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.419 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.5 t -75.78 106.53 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.033 0.533 . . . . 0.0 110.749 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -91.64 87.93 6.53 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.439 0.696 . . . . 0.0 109.271 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -15.61 61.76 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.257 176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -73.98 -19.22 60.72 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.397 0.679 . . . . 0.0 110.833 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -80.52 -153.95 9.66 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.201 0.429 . . . . 0.0 112.89 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 458' ' ' CYS . 52.5 t30 -72.69 141.5 48.23 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 120.828 0.347 . . . . 0.0 110.169 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.424 ' O ' HD12 ' A' ' 371' ' ' LEU . 2.0 m-85 -97.32 -64.63 1.02 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -138.32 -100.89 0.53 Allowed Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.029 -0.873 . . . . 0.0 112.259 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -88.75 15.94 44.84 Favored 'Cis proline' 0 C--N 1.373 1.862 0 CA-C-N 120.312 2.056 . . . . 0.0 114.238 12.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -83.58 -1.79 54.62 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.641 0.777 . . . . 0.0 111.196 172.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.567 HD21 HD13 ' A' ' 456' ' ' LEU . 42.4 mt -114.78 146.79 40.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.361 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -77.19 122.37 86.1 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.611 0.764 . . . . 0.0 110.701 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.465 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 37.6 Cg_endo -61.34 -23.76 77.47 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.229 2.619 . . . . 0.0 114.871 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -84.7 -48.2 9.7 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.149 0.432 . . . . 0.0 110.457 -176.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 402' ' ' CYS . 64.7 mtt180 -68.5 -34.68 76.33 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.077 0.951 . . . . 0.0 111.949 -175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.427 ' HA ' HD21 ' A' ' 379' ' ' LEU . 15.8 mm -52.55 -31.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.909 0.883 . . . . 0.0 111.884 170.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -80.28 -28.2 38.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.115 0.566 . . . . 0.0 111.385 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -78.45 -31.33 47.93 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.623 0.769 . . . . 0.0 112.346 -169.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.453 HD22 ' HB1' ' A' ' 398' ' ' ALA . 0.8 OUTLIER -71.54 154.0 93.45 Favored Pre-proline 0 N--CA 1.482 1.155 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.106 172.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.2 165.44 8.9 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.977 2.451 . . . . 0.0 114.812 -171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.91 -13.62 60.93 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 114.178 -1.373 . . . . 0.0 111.522 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.2 p80 -159.7 150.47 19.27 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.331 0.652 . . . . 0.0 110.2 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -119.46 104.22 10.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 168.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 127.7 178.09 15.17 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.963 -0.91 . . . . 0.0 112.941 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.67 136.53 36.72 Favored 'Cis proline' 0 C--N 1.386 2.54 0 CA-C-N 119.875 1.838 . . . . 0.0 113.23 -2.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -170.46 -172.89 37.28 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.03 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 58.5 Cg_endo -68.26 138.78 44.04 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 122.841 2.361 . . . . 0.0 112.366 -174.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 445' ' ' ALA . 11.4 p -51.05 -43.02 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.333 1.453 . . . . 0.0 111.724 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -50.77 -59.33 4.2 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 111.035 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.523 ' HB ' ' HG2' ' A' ' 387' ' ' PRO . 57.6 t -71.74 -42.37 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.867 -172.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 357' ' ' VAL . 97.1 t -63.27 -45.26 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.844 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 2.4 pp -67.66 -40.65 84.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -177.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 390' ' ' VAL . 10.9 ptm180 -72.71 -30.05 63.89 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -72.23 -23.06 61.17 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.086 0.554 . . . . 0.0 111.929 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.564 HG21 ' HG ' ' A' ' 449' ' ' LEU . 22.0 mm -73.42 -55.0 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 171.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 400' ' ' VAL . 85.9 t -62.29 -55.79 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.587 -172.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 393' ' ' ARG . 3.0 pt20 -64.07 -29.63 70.75 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.795 0.438 . . . . 0.0 111.9 -176.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.453 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -64.09 -48.9 74.38 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 74.7 m -64.24 -47.86 78.03 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.856 0.723 . . . . 0.0 112.318 -177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 396' ' ' VAL . 10.2 t -65.13 -48.12 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 120.958 0.409 . . . . 0.0 110.154 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.95 -33.55 74.89 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.686 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 375' ' ' ARG . 73.5 m -93.01 17.22 11.11 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.429 0.692 . . . . 0.0 110.958 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.596 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -91.13 155.46 18.61 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 121.611 0.719 . . . . 0.0 112.318 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 85.0 mt -80.47 121.94 26.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.689 170.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 57.32 61.91 2.36 Favored 'General case' 0 CA--C 1.552 1.02 0 O-C-N 124.333 1.02 . . . . 0.0 109.712 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 400' ' ' VAL . 97.1 m -48.67 -35.81 14.67 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.094 1.758 . . . . 0.0 112.742 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -56.93 -39.51 74.62 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.492 1.117 . . . . 0.0 113.036 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 92.9 m -79.6 -40.48 29.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.816 0.847 . . . . 0.0 109.772 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.596 HG21 ' HB1' ' A' ' 403' ' ' ALA . 94.5 t -61.08 -33.53 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.429 1.092 . . . . 0.0 111.46 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.12 -10.54 59.49 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.368 1.067 . . . . 0.0 110.908 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -82.38 -6.94 88.24 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.574 173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.14 10.1 28.32 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.414 0.685 . . . . 0.0 111.464 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.624 HD12 HD11 ' A' ' 434' ' ' ILE . 1.1 pt? -152.14 141.05 21.1 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.295 1.038 . . . . 0.0 108.964 175.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -117.15 154.99 50.1 Favored Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 123.688 0.795 . . . . 0.0 111.53 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.09 157.8 56.73 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.692 2.261 . . . . 0.0 112.037 167.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.405 ' OD1' ' HD2' ' A' ' 418' ' ' ARG . 5.3 t0 -155.15 139.23 16.47 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -90.12 27.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.405 ' HD2' ' OD1' ' A' ' 416' ' ' ASP . 0.0 OUTLIER -84.44 -33.42 23.67 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.176 0.591 . . . . 0.0 111.024 175.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 82.77 41.82 8.63 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 113.723 0.249 . . . . 0.0 113.723 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -94.18 -110.25 2.19 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 120.144 -0.253 . . . . 0.0 112.761 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 23.5 mp0 -74.28 162.74 28.6 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.446 ' HB ' ' NH2' ' A' ' 393' ' ' ARG . 90.1 t -135.64 130.07 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.517 HG12 HD11 ' A' ' 436' ' ' LEU . 37.3 mm -110.4 127.55 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 433' ' ' SER . 23.7 p -106.04 150.7 25.5 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.673 0.789 . . . . 0.0 108.999 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -165.87 135.96 3.47 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.583 0.753 . . . . 0.0 109.678 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 69.0 m -67.48 101.06 0.92 Allowed 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.585 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -139.21 136.75 35.33 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.924 1.289 . . . . 0.0 109.502 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 15.7 t70 62.71 31.64 16.53 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.97 1.308 . . . . 0.0 111.514 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 81.34 1.87 90.24 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-N 115.771 -0.65 . . . . 0.0 113.893 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.81 172.96 10.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.586 1.155 . . . . 0.0 109.308 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 4.8 t -87.75 102.24 14.47 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 164.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -85.94 133.08 33.96 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.439 ' HB3' HG22 ' A' ' 424' ' ' THR . 25.2 p -114.56 143.3 45.2 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.017 0.927 . . . . 0.0 110.445 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.624 HD11 HD12 ' A' ' 413' ' ' LEU . 16.5 pt -128.46 168.44 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.046 0.938 . . . . 0.0 109.761 173.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -112.28 146.93 37.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.536 0.734 . . . . 0.0 110.766 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 6.7 mp -115.86 155.48 47.69 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.233 1.413 . . . . 0.0 108.355 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.17 128.66 14.11 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 121.79 1.66 . . . . 0.0 111.462 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.09 135.36 27.14 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.927 2.418 . . . . 0.0 111.617 -171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.9 m -104.16 160.78 4.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.285 0.564 . . . . 0.0 110.751 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -136.62 12.43 3.19 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.316 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 39.5 t -118.36 139.13 51.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.896 0.478 . . . . 0.0 109.97 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -78.73 -29.25 45.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.462 1.105 . . . . 0.0 111.365 -174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 27.2 m -72.89 -22.4 60.76 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.03 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -87.41 -21.39 25.63 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.81 -60.73 2.36 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 121.701 0.762 . . . . 0.0 109.918 170.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 464' ' ' SER . 20.6 mt -69.69 -39.77 76.75 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 112.734 -2.03 . . . . 0.0 109.952 -174.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 0.0 OUTLIER -61.15 -30.8 70.61 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.879 0.872 . . . . 0.0 111.442 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -45.51 72.88 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.903 0.481 . . . . 0.0 110.492 -177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.564 ' HG ' HG21 ' A' ' 395' ' ' ILE . 0.0 OUTLIER -87.51 -13.1 43.98 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.074 -0.488 . . . . 0.0 111.846 176.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 1.4 mm-40 -57.17 -56.98 14.71 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.525 0.73 . . . . 0.0 110.725 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -66.39 -35.72 81.05 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.931 0.769 . . . . 0.0 111.147 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 38.8 t80 -60.31 -61.06 2.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.522 0.729 . . . . 0.0 110.818 178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.85 -30.54 69.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.435 1.094 . . . . 0.0 111.81 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -66.04 -40.26 90.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.224 0.61 . . . . 0.0 110.582 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 49.9 m -67.91 -35.86 79.19 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.536 0.734 . . . . 0.0 110.486 176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.567 HD13 HD21 ' A' ' 371' ' ' LEU . 50.3 mt -72.59 -12.91 61.25 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.542 0.737 . . . . 0.0 111.5 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 73.74 14.61 4.12 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.807 1.643 . . . . 0.0 111.61 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.523 ' HA ' ' ND2' ' A' ' 366' ' ' ASN . 15.3 p -93.88 139.59 30.71 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 123.379 0.672 . . . . 0.0 109.982 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -155.31 144.82 21.18 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 3.2 t30 66.84 12.62 9.0 Favored 'General case' 0 CA--C 1.567 1.605 0 O-C-N 124.191 0.932 . . . . 0.0 110.342 -174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 34.8 tp -74.57 -17.94 60.65 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.866 0.866 . . . . 0.0 110.24 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.455 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.01 161.66 31.56 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.344 0.658 . . . . 0.0 110.775 177.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 80.8 p -167.81 129.06 1.45 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.698 0.799 . . . . 0.0 109.001 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 35.4 t -66.47 -25.72 66.85 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 120.839 0.352 . . . . 0.0 111.432 177.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -93.57 133.31 28.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.1 174.48 9.74 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.826 2.35 . . . . 0.0 111.653 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -71.28 -11.46 60.93 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.873 0.469 . . . . 0.0 111.775 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.505 1.122 . . . . 0.0 108.27 168.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.924 0 CA-C-O 120.358 -0.135 . . . . 0.0 112.779 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.9 m -73.33 -10.01 59.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.812 0.845 . . . . 0.0 112.868 -175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.29 156.27 20.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.775 0.83 . . . . 0.0 110.117 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.4 ttt -73.95 133.43 43.04 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.391 0.676 . . . . 0.0 110.078 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.439 ' SD ' ' HB3' ' A' ' 387' ' ' PRO . 20.1 ptp -70.94 170.64 12.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.587 0.755 . . . . 0.0 110.442 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 27.5 t -76.74 172.49 13.0 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.8 p -136.68 137.02 39.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.392 0.677 . . . . 0.0 109.411 177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 388' ' ' VAL . 17.2 m -138.25 165.9 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.024 0.93 . . . . 0.0 110.969 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 24.6 p -142.65 108.89 5.25 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 108.548 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 395' ' ' ILE . 26.3 m -94.92 159.32 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -121.27 99.89 6.74 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.415 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 39.7 t -70.84 107.61 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 123.869 0.731 . . . . 0.0 110.313 -174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -96.55 89.6 5.05 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.368 1.067 . . . . 0.0 109.117 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.42 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.89 -3.6 42.54 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.509 178.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -81.95 -11.46 58.86 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.223 0.609 . . . . 0.0 110.414 169.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -78.56 -151.05 5.32 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.509 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 51.2 t-20 -77.52 139.26 39.56 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.41 -52.69 6.3 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.687 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -148.46 -76.22 0.02 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 114.738 -1.119 . . . . 0.0 114.32 -176.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.03 -10.06 13.83 Favored 'Cis proline' 0 C--N 1.371 1.759 0 CA-C-N 121.102 2.451 . . . . 0.0 114.095 -2.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . 0.631 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 14.8 p-80 -61.29 -12.33 13.12 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.188 0.995 . . . . 0.0 113.029 175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.687 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 40.4 mt -98.69 143.07 29.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.152 0.981 . . . . 0.0 109.408 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 127.49 91.62 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 123.864 0.727 . . . . 0.0 110.068 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 29.7 Cg_endo -59.63 -41.25 57.83 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.992 2.461 . . . . 0.0 112.875 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -65.64 -45.2 83.93 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 123.398 0.436 . . . . 0.0 110.675 -175.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -66.88 -31.2 71.65 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.687 0.795 . . . . 0.0 110.981 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 18.5 mm -66.63 -28.83 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.068 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 62.2 mm-40 -82.93 -23.04 33.67 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.961 -0.462 . . . . 0.0 110.906 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 70.9 mm-40 -74.6 -38.67 62.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.953 0.501 . . . . 0.0 111.716 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.63 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.1 pp -67.51 156.77 87.87 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.926 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.29 150.69 83.6 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.539 2.159 . . . . 0.0 113.122 -175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.55 -1.8 26.05 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.879 1.272 . . . . 0.0 111.442 -178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 39.7 p-80 -157.33 151.33 24.57 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.596 0.758 . . . . 0.0 109.965 171.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -118.1 104.25 10.66 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 166.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 148.27 176.69 21.96 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.616 -0.546 . . . . 0.0 113.248 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -82.23 128.74 15.07 Favored 'Cis proline' 0 C--N 1.376 2.004 0 CA-C-N 118.751 1.276 . . . . 0.0 111.326 -2.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -153.49 -165.45 13.59 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-O 119.281 -0.733 . . . . 0.0 112.099 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.439 ' HB3' ' SD ' ' A' ' 354' ' ' MET . 3.1 Cg_exo -70.97 146.31 52.4 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.951 2.434 . . . . 0.0 112.265 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.0 p -54.64 -45.32 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 124.28 1.032 . . . . 0.0 111.15 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -62.44 -49.74 74.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.064 1.346 . . . . 0.0 110.948 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 83.4 t -70.63 -48.9 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.508 -174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 98.1 t -60.12 -40.61 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 122.87 0.468 . . . . 0.0 111.897 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.7 pp -66.87 -41.84 86.6 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.421 ' N ' HD12 ' A' ' 392' ' ' LEU . 17.4 ptt180 -74.49 -25.4 59.35 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 123.32 0.388 . . . . 0.0 110.033 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 36.7 mmm-85 -64.09 -40.33 95.99 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 123.422 0.451 . . . . 0.0 110.88 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 359' ' ' VAL . 43.6 mm -63.55 -51.33 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 123.953 0.783 . . . . 0.0 109.735 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.79 -44.87 94.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.298 -174.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.58 -28.03 41.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.857 -0.592 . . . . 0.0 111.834 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -73.53 -31.88 63.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.274 0.488 . . . . 0.0 110.508 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.96 -56.12 19.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.085 0.554 . . . . 0.0 109.56 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.73 -30.13 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.729 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.06 -33.97 70.77 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.484 0.714 . . . . 0.0 111.566 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 379' ' ' LEU . 78.4 m -91.23 0.1 57.59 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.989 0.516 . . . . 0.0 111.637 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.549 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.93 138.84 54.95 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -171.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 69.4 mt -82.6 115.98 21.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.53 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 64.54 61.39 0.85 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.444 1.116 . . . . 0.0 109.286 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 91.0 m -51.8 -34.8 41.59 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.217 1.807 . . . . 0.0 112.806 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -54.93 -42.24 72.0 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.532 1.133 . . . . 0.0 112.315 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 49.6 m -80.53 -37.25 31.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.525 0.73 . . . . 0.0 110.362 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.549 HG21 ' HB1' ' A' ' 403' ' ' ALA . 90.8 t -65.37 -34.92 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.235 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.37 -16.64 60.36 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.832 0.853 . . . . 0.0 110.84 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -68.72 -13.55 66.18 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 116.257 -0.429 . . . . 0.0 114.14 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -76.88 -13.32 60.01 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.738 . . . . 0.0 111.444 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.614 HD22 ' HE1' ' A' ' 452' ' ' PHE . 1.0 OUTLIER -141.52 112.71 7.43 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.376 0.671 . . . . 0.0 110.267 -173.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 415' ' ' PRO . 47.0 mtpt -112.56 160.67 29.61 Favored Pre-proline 0 N--CA 1.485 1.279 0 C-N-CA 124.163 0.985 . . . . 0.0 109.637 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 414' ' ' LYS . 67.3 Cg_endo -67.75 155.52 69.62 Favored 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.288 1.992 . . . . 0.0 114.698 -170.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.87 124.34 26.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.062 1.345 . . . . 0.0 108.601 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.82 33.21 0.65 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.193 0.597 . . . . 0.0 112.212 -164.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -92.01 -10.62 38.56 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 111.42 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 70.65 41.33 64.96 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 114.316 0.486 . . . . 0.0 114.316 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.53 -116.8 2.37 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 120.113 -0.27 . . . . 0.0 112.961 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.9 OUTLIER -77.4 168.73 19.54 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.58 0.752 . . . . 0.0 110.592 -178.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 81.2 t -132.92 125.29 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.631 0.772 . . . . 0.0 109.217 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 436' ' ' LEU . 37.6 mm -103.37 128.06 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 13.5 p -106.63 140.9 38.77 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.941 0.896 . . . . 0.0 109.809 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -149.05 141.8 24.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.037 0.935 . . . . 0.0 110.151 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.2 p -83.65 112.7 20.27 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -144.24 137.48 27.34 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.031 0.932 . . . . 0.0 109.428 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 33.0 t70 65.17 18.32 11.38 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.494 1.117 . . . . 0.0 112.434 174.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.61 18.38 70.89 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 121.792 -0.567 . . . . 0.0 112.776 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -131.74 170.99 14.05 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.661 1.184 . . . . 0.0 109.71 -176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.2 t -92.09 126.08 37.03 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.8 126.9 53.76 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.728 0.811 . . . . 0.0 109.297 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.8 p -117.76 140.63 49.42 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.944 0.898 . . . . 0.0 110.336 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.14 162.3 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.396 0.678 . . . . 0.0 109.947 172.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -99.27 146.69 25.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.816 0.847 . . . . 0.0 110.111 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 423' ' ' ILE . 8.5 mp -115.18 171.43 4.51 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.64 141.73 25.2 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 121.957 1.771 . . . . 0.0 111.735 164.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.32 128.47 8.91 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.148 1.898 . . . . 0.0 112.257 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.45 172.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.617 0.767 . . . . 0.0 110.71 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -149.04 -0.93 0.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.008 0.523 . . . . 0.0 111.979 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 t -126.5 139.93 52.85 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.005 0.522 . . . . 0.0 110.751 -172.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -68.45 -31.19 70.32 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.226 1.01 . . . . 0.0 111.517 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 23.2 t -63.49 -27.69 69.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.565 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -86.9 -27.87 23.13 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 122.734 0.414 . . . . 0.0 110.395 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.889 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -48.9 -66.94 0.31 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.974 0.91 . . . . 0.0 111.954 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 450' ' ' GLU . 0.9 OUTLIER -61.79 -43.75 98.23 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.179 178.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -31.59 58.47 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.364 1.066 . . . . 0.0 111.917 -175.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -62.65 -55.28 28.38 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.687 0.617 . . . . 0.0 110.046 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -78.76 -14.84 59.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.24 -178.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 446' ' ' LEU . 10.5 mm-40 -64.54 -45.92 85.1 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 118.292 0.496 . . . . 0.0 110.143 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -73.15 -39.59 65.55 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.169 0.588 . . . . 0.0 110.599 177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.614 ' HE1' HD22 ' A' ' 413' ' ' LEU . 67.9 t80 -57.88 -59.14 5.7 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.657 0.783 . . . . 0.0 110.952 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 84.9 m -63.62 -27.16 69.04 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.118 0.967 . . . . 0.0 112.149 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -65.1 -41.53 94.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.03 0.532 . . . . 0.0 110.505 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 51.1 m -67.62 -21.84 65.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.708 0.803 . . . . 0.0 111.65 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 71.1 mt -100.05 -14.02 18.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.056 0.942 . . . . 0.0 112.963 -173.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 80.07 7.23 1.65 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.687 1.595 . . . . 0.0 112.19 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . . . . . . . . . 6.1 p -89.44 134.22 34.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 8.3 t70 -152.2 152.18 31.92 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 59.74 18.27 7.1 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.243 1.017 . . . . 0.0 111.259 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.23 -18.52 49.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.77 0.428 . . . . 0.0 110.966 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.624 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -163.74 172.5 14.08 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.23 0.612 . . . . 0.0 110.47 171.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 18.9 p -163.28 126.48 2.72 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.779 0.831 . . . . 0.0 108.839 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 29.2 t -70.27 -17.17 63.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.66 0.384 . . . . 0.0 111.553 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . 0.447 HE21 ' N ' ' A' ' 465' ' ' GLN . 0.0 OUTLIER -94.65 146.84 32.16 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.831 0.852 . . . . 0.0 109.386 178.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.66 171.25 14.7 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.661 2.24 . . . . 0.0 112.104 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -75.95 -31.6 59.15 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.949 0.5 . . . . 0.0 111.202 -177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.547 0.864 0 C-N-CA 123.752 0.821 . . . . 0.0 109.081 174.661 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.775 0 CA-C-O 120.26 -0.189 . . . . 0.0 112.775 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 43.7 m -67.37 -35.91 80.29 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.788 0.835 . . . . 0.0 110.317 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -119.09 129.12 54.9 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 167.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 24.3 ptp -99.12 10.01 42.31 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.869 0.868 . . . . 0.0 110.13 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -149.71 168.93 22.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.007 0.923 . . . . 0.0 109.949 -171.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 22.9 t -82.37 179.19 7.88 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.144 0.578 . . . . 0.0 110.864 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 21.5 p -137.89 134.69 35.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.18 0.992 . . . . 0.0 109.864 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.9 m -140.41 162.17 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.959 0.903 . . . . 0.0 110.771 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 20.4 p -137.45 115.57 11.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.431 1.092 . . . . 0.0 108.815 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 34.9 m -104.01 141.91 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 122.837 0.455 . . . . 0.0 109.801 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.48 98.24 7.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.487 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 67.5 t -70.68 99.59 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 O-C-N 124.463 1.102 . . . . 0.0 110.713 -173.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.505 ' HB2' ' HZ ' ' A' ' 467' ' ' PHE . 33.6 t30 -94.47 97.11 9.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.895 0.878 . . . . 0.0 109.62 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -77.4 -11.33 59.83 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.334 178.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -83.32 -15.74 48.89 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.546 0.738 . . . . 0.0 110.783 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -70.95 -88.32 0.11 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -141.13 152.0 44.37 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.0 -62.19 1.32 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.563 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -149.23 -91.75 0.09 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.609 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . 0.425 ' HD2' HE21 ' A' ' 457' ' ' GLN . 29.6 Cg_endo -85.5 10.48 53.13 Favored 'Cis proline' 0 C--N 1.371 1.763 0 CA-C-N 120.496 2.148 . . . . 0.0 114.832 11.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -74.16 -8.23 55.46 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 26.0 mt -107.89 136.06 48.24 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.415 1.086 . . . . 0.0 108.743 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.16 125.19 86.42 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.481 0.712 . . . . 0.0 110.318 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.529 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 35.0 Cg_endo -62.95 -31.03 77.3 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.717 2.278 . . . . 0.0 113.137 -172.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.32 -45.97 36.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.148 0.579 . . . . 0.0 110.119 -176.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -61.94 -34.59 76.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.356 1.062 . . . . 0.0 111.598 177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 379' ' ' LEU . 24.2 mm -64.04 -29.93 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.777 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 76.9 mm-40 -83.18 -21.91 33.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 122.325 0.25 . . . . 0.0 110.859 174.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 82.9 mm-40 -79.58 -32.56 42.02 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.03 0.532 . . . . 0.0 112.148 -176.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.446 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -72.06 156.98 90.23 Favored Pre-proline 0 CA--C 1.557 1.24 0 CA-C-O 118.71 -0.662 . . . . 0.0 110.018 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.85 161.34 18.8 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.854 2.37 . . . . 0.0 114.33 -173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.36 -21.37 61.31 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.77 -1.559 . . . . 0.0 111.952 -174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.487 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 20.5 p-80 -167.05 154.04 8.72 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.086 0.955 . . . . 0.0 110.67 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -117.9 146.38 43.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.072 0.949 . . . . 0.0 108.969 172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 91.18 -174.85 39.09 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.271 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.56 128.58 16.82 Favored 'Cis proline' 0 C--N 1.377 2.049 0 CA-C-N 119.187 1.493 . . . . 0.0 112.329 1.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.66 -154.69 7.29 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 118.76 -1.022 . . . . 0.0 111.201 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.31 137.2 25.44 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.655 2.237 . . . . 0.0 112.122 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.945 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.76 -42.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 125.606 1.562 . . . . 0.0 112.073 174.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -62.23 -55.5 27.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.395 1.478 . . . . 0.0 111.282 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -70.13 -46.08 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.888 -172.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.21 -36.63 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 122.566 0.346 . . . . 0.0 111.672 -176.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 393' ' ' ARG . 3.3 pp -73.89 -40.68 63.02 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.744 0.247 . . . . 0.0 111.02 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 24.5 ptt180 -67.98 -29.18 68.14 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -175.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 22.0 mmm-85 -65.37 -43.32 91.16 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 123.864 0.727 . . . . 0.0 111.477 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 29.4 mm -65.26 -53.59 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 123.455 0.472 . . . . 0.0 109.838 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 400' ' ' VAL . 66.7 t -62.05 -44.81 99.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 O-C-N 124.027 0.829 . . . . 0.0 110.896 -174.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.518 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.6 pt20 -67.5 -33.99 76.22 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.63 0.195 . . . . 0.0 110.838 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.1 84.67 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 122.879 0.472 . . . . 0.0 110.147 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . 0.462 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 82.3 m -68.61 -51.35 43.3 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 123.591 0.756 . . . . 0.0 111.1 -175.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.522 HG12 HG23 ' A' ' 406' ' ' THR . 21.0 t -62.06 -43.9 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.7 -33.35 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.002 0.521 . . . . 0.0 111.524 -177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.462 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 19.2 p -84.34 -10.07 57.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.696 0.398 . . . . 0.0 111.023 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -67.38 150.03 49.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.658 0.783 . . . . 0.0 112.987 -174.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 55.8 mt -82.55 121.27 26.58 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.408 169.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 62.77 61.3 1.18 Allowed 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 122.249 1.023 . . . . 0.0 109.148 -171.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.522 HG23 HG12 ' A' ' 400' ' ' VAL . 52.2 m -54.63 -34.35 61.99 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.657 -1.61 . . . . 0.0 112.437 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -57.66 -37.23 73.02 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 113.175 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 89.8 m -84.42 -35.34 23.15 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.055 0.542 . . . . 0.0 110.281 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.531 HG21 ' HB1' ' A' ' 403' ' ' ALA . 88.6 t -64.58 -31.22 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.864 0.866 . . . . 0.0 110.837 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -70.56 -21.6 62.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.944 1.298 . . . . 0.0 110.436 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.59 76.07 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.794 -0.639 . . . . 0.0 114.198 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -77.38 -18.13 57.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.209 0.604 . . . . 0.0 111.689 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -133.26 125.56 29.59 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.501 0.721 . . . . 0.0 110.088 -175.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -103.45 159.03 30.59 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.931 0.892 . . . . 0.0 109.963 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.17 122.64 8.2 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.768 1.645 . . . . 0.0 112.64 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 4.3 m-20 -110.16 107.67 17.56 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.328 1.451 . . . . 0.0 107.342 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -83.83 67.62 9.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.095 0.95 . . . . 0.0 108.566 -175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.596 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.5 mpt_? -107.53 4.1 25.7 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.873 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 66.97 40.13 93.36 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.44 0.462 . . . . 0.0 113.053 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -106.61 -132.34 7.05 Favored Glycine 0 C--N 1.343 0.933 0 CA-C-O 120.125 -0.264 . . . . 0.0 112.633 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.5 OUTLIER -73.21 172.78 10.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.972 0.909 . . . . 0.0 111.389 -175.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 131.22 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.352 0.661 . . . . 0.0 109.32 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.518 HG23 ' HA ' ' A' ' 397' ' ' GLN . 42.1 mm -111.77 123.73 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 433' ' ' SER . 17.0 p -106.51 144.95 32.45 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.831 0.852 . . . . 0.0 109.051 173.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -160.63 133.03 6.17 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.662 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 68.4 m -70.9 109.03 4.8 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.326 0.651 . . . . 0.0 111.91 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -131.21 126.85 36.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.684 1.194 . . . . 0.0 109.033 175.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.26 14.35 7.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.036 1.335 . . . . 0.0 112.355 169.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 93.16 7.2 62.5 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.721 -0.612 . . . . 0.0 113.015 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -120.6 166.08 14.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.256 1.022 . . . . 0.0 109.46 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 7.2 t -97.9 101.23 12.66 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -88.6 126.95 35.53 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.462 ' HB3' HG22 ' A' ' 424' ' ' THR . 55.2 p -116.88 148.68 41.09 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.458 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.433 HD11 HD12 ' A' ' 413' ' ' LEU . 46.4 pt -125.56 179.48 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 124.086 0.954 . . . . 0.0 109.215 173.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -115.66 153.21 31.71 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 86.1 mt -115.58 166.07 12.98 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.488 1.115 . . . . 0.0 108.933 174.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.92 135.07 12.26 Favored 'Trans proline' 0 CA--C 1.563 1.933 0 C-N-CA 121.814 1.676 . . . . 0.0 111.105 166.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.42 134.01 25.64 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 122.809 2.339 . . . . 0.0 112.494 -173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.7 m -97.29 173.64 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.787 0.835 . . . . 0.0 111.647 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -152.06 -4.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.43 0.692 . . . . 0.0 112.312 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.5 t -113.96 139.16 49.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.727 0.411 . . . . 0.0 109.999 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.12 67.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.541 0.736 . . . . 0.0 111.308 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 48.3 m -63.87 -32.94 74.62 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.441 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -83.21 -27.28 30.09 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.945 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -50.65 -62.27 1.7 Allowed 'General case' 0 C--N 1.366 1.3 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 449' ' ' LEU . 17.7 mt -66.31 -52.18 49.88 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 113.371 -1.74 . . . . 0.0 109.31 -173.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -51.46 -36.14 42.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.96 0.904 . . . . 0.0 112.69 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -59.06 -49.09 79.22 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 123.847 0.717 . . . . 0.0 109.964 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.58 -14.13 38.34 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 118.129 -0.939 . . . . 0.0 112.729 177.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' A' ' 453' ' ' CYS . 49.9 mt-10 -78.02 -36.57 48.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.348 0.976 . . . . 0.0 110.153 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.25 -42.28 96.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.088 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.437 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 58.8 t80 -72.42 -43.42 63.88 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.48 -174.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 458' ' ' CYS . 20.7 p -70.84 -26.66 63.38 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.557 0.743 . . . . 0.0 109.963 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 47.7 t60 -65.74 -35.06 79.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.031 0.932 . . . . 0.0 110.271 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 17.2 m -75.94 -29.11 58.21 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.643 0.777 . . . . 0.0 110.598 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.489 HD13 HD11 ' A' ' 371' ' ' LEU . 51.3 mt -80.27 -14.75 58.15 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.43 0.692 . . . . 0.0 110.951 175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . 0.425 HE21 ' HD2' ' A' ' 369' ' ' PRO . 17.6 mt-30 75.69 9.74 3.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.889 1.676 . . . . 0.0 112.07 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 453' ' ' CYS . 11.8 p -91.5 138.42 31.59 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 123.34 0.656 . . . . 0.0 110.505 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -133.82 156.83 47.34 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.051 0.94 . . . . 0.0 109.501 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 29.8 m-80 59.01 22.21 10.18 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.754 0.821 . . . . 0.0 111.634 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 25.4 tp -79.95 -17.29 53.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.177 0.591 . . . . 0.0 110.255 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.576 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.05 172.55 17.96 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.982 0.913 . . . . 0.0 109.805 173.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 24.0 p -165.88 134.79 3.17 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.736 0.648 . . . . 0.0 109.882 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . . . . . . . . . 23.1 t -68.31 -22.51 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.123 0.487 . . . . 0.0 111.668 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -118.47 147.59 42.24 Favored Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 124.501 1.12 . . . . 0.0 109.076 -174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.97 174.37 6.92 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.641 2.227 . . . . 0.0 112.292 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 362' ' ' ASN . 26.8 m-85 -78.9 -24.08 44.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.166 0.586 . . . . 0.0 110.103 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 25.6 p . . . . . 0 CA--C 1.557 1.222 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.024 171.769 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.404 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 31.3 t -112.06 137.08 50.59 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.714 0.806 . . . . 0.0 109.837 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -88.93 -25.49 22.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.103 0.561 . . . . 0.0 110.553 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 26.1 ttt -85.44 130.54 34.56 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -75.17 164.4 26.53 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.999 0.92 . . . . 0.0 109.77 171.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 38.4 m -73.39 171.98 12.1 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.771 0.428 . . . . 0.0 110.87 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.3 p -133.6 137.99 45.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.169 0.588 . . . . 0.0 110.087 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 388' ' ' VAL . 15.3 m -143.15 162.36 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.466 1.106 . . . . 0.0 109.819 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.427 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 46.9 t -135.27 107.94 7.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.56 0.744 . . . . 0.0 109.299 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 42.5 t -96.46 151.66 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.299 177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -128.17 106.33 8.98 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.578 1.151 . . . . 0.0 108.669 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.457 HG11 ' CD1' ' A' ' 379' ' ' LEU . 62.1 t -71.7 112.3 6.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.306 0.642 . . . . 0.0 110.31 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 51.5 t30 -93.51 81.22 4.34 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.415 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -68.31 -13.64 62.41 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.312 175.018 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -74.29 -23.04 59.04 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.481 0.713 . . . . 0.0 110.876 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.33 -140.8 2.1 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.094 0.246 . . . . 0.0 112.924 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 59.3 t-20 -74.62 143.55 44.3 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.92 -53.55 3.64 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -155.52 -70.88 0.01 OUTLIER Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.447 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -84.21 5.12 58.47 Favored 'Cis proline' 0 C--N 1.373 1.842 0 CA-C-N 120.382 2.091 . . . . 0.0 114.702 2.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -76.35 -9.08 58.37 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 117.914 0.325 . . . . 0.0 111.275 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.557 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 25.4 mt -87.18 123.99 32.8 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.504 ' HB3' ' HD3' ' A' ' 375' ' ' ARG . 9.8 t70 -55.09 122.53 42.86 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 124.502 1.126 . . . . 0.0 110.374 -177.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 37.1 Cg_endo -60.93 -31.11 91.16 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 123.015 2.477 . . . . 0.0 113.406 -172.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.95 -46.77 33.28 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.617 0.367 . . . . 0.0 110.489 -176.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . 0.504 ' HD3' ' HB3' ' A' ' 372' ' ' ASP . 23.8 mtp180 -65.03 -30.92 71.93 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 110.719 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 20.7 mm -63.78 -28.78 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 C-N-CA 124.123 0.969 . . . . 0.0 110.988 173.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 58.1 mm-40 -85.57 -25.37 26.76 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.492 0.317 . . . . 0.0 110.79 176.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 78.9 mm-40 -75.39 -31.68 60.54 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.756 0.422 . . . . 0.0 112.134 -174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.607 HD23 ' SG ' ' A' ' 402' ' ' CYS . 3.2 pp -71.2 155.28 93.26 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-O 118.56 -0.734 . . . . 0.0 109.167 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -62.05 158.09 40.84 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.451 2.101 . . . . 0.0 113.311 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.54 -3.58 25.4 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.697 1.199 . . . . 0.0 111.855 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.415 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 5.4 p80 -159.25 156.77 29.4 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.223 0.609 . . . . 0.0 110.513 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.417 ' HD2' HD13 ' A' ' 395' ' ' ILE . 50.2 m-85 -128.29 103.76 7.35 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 133.81 176.8 14.55 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.112 -0.827 . . . . 0.0 112.511 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.82 129.86 19.65 Favored 'Cis proline' 0 C--N 1.376 2.009 0 CA-C-N 120.008 1.904 . . . . 0.0 112.645 -4.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -154.24 -161.62 10.58 Favored Glycine 0 C--O 1.239 0.437 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.806 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -74.02 130.76 14.71 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.756 2.304 . . . . 0.0 111.176 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.2 p -38.01 -48.41 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 126.661 1.984 . . . . 0.0 113.63 -178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -72.97 -39.95 65.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.797 1.639 . . . . 0.0 112.134 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.33 -43.18 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.451 0.301 . . . . 0.0 110.718 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.35 -40.18 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.369 0.668 . . . . 0.0 111.892 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.2 pp -67.95 -40.22 83.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.48 ' N ' HD12 ' A' ' 392' ' ' LEU . 5.5 ptt180 -70.69 -24.81 62.74 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.989 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -65.26 -42.05 93.65 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 123.816 0.846 . . . . 0.0 110.907 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.417 HD13 ' HD2' ' A' ' 383' ' ' PHE . 34.5 mm -64.81 -50.68 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 400' ' ' VAL . 99.2 t -59.27 -52.72 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 114.539 -1.209 . . . . 0.0 111.689 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.447 ' HA ' HG23 ' A' ' 423' ' ' ILE . 3.2 pt20 -65.54 -34.33 78.0 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.292 0.637 . . . . 0.0 110.793 -176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.541 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -69.12 -36.88 77.96 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 123.856 0.723 . . . . 0.0 110.586 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 89.2 m -68.56 -42.75 77.91 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.196 0.598 . . . . 0.0 111.462 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 396' ' ' VAL . 21.5 t -70.51 -41.66 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.774 0.43 . . . . 0.0 109.858 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.74 -40.93 96.83 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.922 0.889 . . . . 0.0 111.024 178.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.607 ' SG ' HD23 ' A' ' 379' ' ' LEU . 71.5 m -93.1 10.78 30.16 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.469 0.708 . . . . 0.0 111.975 -176.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.609 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -87.4 143.39 27.26 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 78.0 mt -76.21 131.71 39.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 164.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 61.11 57.21 2.55 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-O 122.134 0.968 . . . . 0.0 109.741 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 32.1 m -50.37 -32.48 17.53 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.956 1.702 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -61.19 -34.65 75.42 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.761 1.224 . . . . 0.0 112.949 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -81.8 -34.53 30.24 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.509 0.724 . . . . 0.0 109.953 176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.609 HG21 ' HB1' ' A' ' 403' ' ' ALA . 45.7 t -71.4 -26.5 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -71.33 -23.2 61.89 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.064 172.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -80.82 -9.16 86.67 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.19 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 409' ' ' VAL . 31.2 m-85 -72.12 -21.89 61.41 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 117.787 0.793 . . . . 0.0 111.138 176.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.08 146.39 45.08 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.746 0.818 . . . . 0.0 110.624 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -116.75 155.75 48.65 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 124.071 0.948 . . . . 0.0 110.247 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.53 131.11 25.27 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.173 1.915 . . . . 0.0 112.065 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -102.57 167.77 9.71 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.725 1.21 . . . . 0.0 108.965 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -131.95 43.7 3.0 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.695 0.76 . . . . 0.0 111.96 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 54.0 mmt-85 -104.8 2.49 30.18 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.482 169.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 68.25 32.01 75.43 Favored Glycine 0 C--N 1.352 1.451 0 O-C-N 123.229 0.331 . . . . 0.0 113.301 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -89.03 -117.04 1.5 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 113.711 0.244 . . . . 0.0 113.711 -172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 18.7 mm-40 -89.94 170.37 10.43 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.089 0.556 . . . . 0.0 111.457 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 434' ' ' ILE . 60.3 t -131.51 128.72 61.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 122.749 0.419 . . . . 0.0 109.96 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 433' ' ' SER . 43.4 mm -114.23 128.57 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 18.9 p -105.57 144.49 32.26 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.024 0.929 . . . . 0.0 109.862 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -157.05 127.67 6.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.05 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 60.4 p -72.49 124.63 25.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.243 0.617 . . . . 0.0 109.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -147.14 115.74 6.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.625 0.77 . . . . 0.0 109.918 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 26.3 t70 64.46 23.97 13.05 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.762 1.225 . . . . 0.0 111.504 169.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 98.63 -16.03 60.23 Favored Glycine 0 N--CA 1.471 0.97 0 O-C-N 121.89 -0.506 . . . . 0.0 113.138 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -97.88 168.69 10.15 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.592 0.757 . . . . 0.0 109.796 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.2 t -113.22 104.8 12.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -97.79 125.42 42.62 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.02 0.928 . . . . 0.0 110.378 -176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 61.5 p -118.19 138.78 52.08 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.748 0.819 . . . . 0.0 109.784 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 422' ' ' VAL . 23.8 pt -117.31 171.63 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.024 0.53 . . . . 0.0 109.863 175.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 27.7 mt-30 -102.62 150.45 23.41 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 170.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.669 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 80.1 mt -115.94 164.41 17.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.229 1.412 . . . . 0.0 108.278 169.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.82 139.03 32.73 Favored 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 121.898 1.732 . . . . 0.0 111.153 168.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.76 127.86 6.49 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.107 1.871 . . . . 0.0 110.994 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.67 164.35 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.09 0.471 . . . . 0.0 109.845 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -151.22 23.31 0.73 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.901 0.88 . . . . 0.0 110.163 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 388' ' ' VAL . 47.7 t -124.69 137.28 54.36 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 169.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -70.36 -28.73 65.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.004 0.922 . . . . 0.0 110.948 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.9 t -69.88 -21.27 63.34 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.033 176.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.4 -29.72 24.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.42 -67.51 0.27 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.995 0.918 . . . . 0.0 111.895 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 450' ' ' GLU . 0.1 OUTLIER -62.79 -45.06 94.42 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.651 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -59.48 -29.47 67.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.922 0.889 . . . . 0.0 112.399 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -61.84 -60.91 2.94 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.51 0.724 . . . . 0.0 109.609 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.551 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -76.97 -13.91 59.91 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 112.32 -177.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 446' ' ' LEU . 38.2 mt-10 -58.16 -41.66 84.29 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.883 0.765 . . . . 0.0 110.921 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -68.61 -44.57 74.0 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 123.398 0.437 . . . . 0.0 110.584 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.466 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 62.9 t80 -60.85 -52.62 64.28 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.622 0.769 . . . . 0.0 110.749 -177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.5 -34.29 76.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.699 1.2 . . . . 0.0 111.583 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -69.32 -32.98 72.46 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.842 0.457 . . . . 0.0 110.261 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.1 m -72.21 -28.44 63.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.52 0.728 . . . . 0.0 110.409 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 452' ' ' PHE . 22.7 mt -80.9 -12.9 59.33 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.315 0.646 . . . . 0.0 111.292 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 76.27 5.39 3.67 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 126.562 1.945 . . . . 0.0 111.933 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.478 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 25.9 p -89.99 140.25 29.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.818 0.447 . . . . 0.0 110.102 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 23.3 t70 -148.6 151.92 35.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -174.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 9.6 p30 47.62 27.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.788 1.235 . . . . 0.0 112.539 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 40.4 tp -82.41 -10.49 59.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.08 0.952 . . . . 0.0 109.443 172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.529 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -156.85 158.01 35.97 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.629 0.772 . . . . 0.0 109.921 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 25.0 p -145.56 109.81 4.94 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.287 0.635 . . . . 0.0 109.937 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 16.5 t -76.72 -5.51 48.34 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.306 0.643 . . . . 0.0 111.159 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -114.37 120.07 38.87 Favored Pre-proline 0 C--N 1.351 0.648 0 C-N-CA 123.629 0.771 . . . . 0.0 109.415 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.16 176.78 9.49 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 123.451 2.767 . . . . 0.0 112.024 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -63.23 -34.99 78.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.386 0.674 . . . . 0.0 110.75 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 CA--C 1.557 1.213 0 C-N-CA 123.885 0.874 . . . . 0.0 109.03 175.199 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.945 -0.462 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 49.8 m -148.61 156.73 42.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.73 0.812 . . . . 0.0 110.346 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -79.0 81.5 5.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.154 0.582 . . . . 0.0 109.805 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 25.3 ptp -72.81 -16.14 61.62 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.98 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.412 ' N ' ' SD ' ' A' ' 354' ' ' MET . 0.0 OUTLIER -137.96 163.46 31.47 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.008 1.323 . . . . 0.0 109.503 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 33.3 t -79.14 -172.91 3.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.686 0.794 . . . . 0.0 110.613 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 25.1 p -140.08 135.62 32.77 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 110.028 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 25.8 m -136.7 156.61 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 124.208 1.003 . . . . 0.0 110.88 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.547 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 26.3 p -119.54 107.15 12.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.521 0.728 . . . . 0.0 109.263 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 464' ' ' SER . 56.1 t -96.67 150.54 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -129.21 104.33 7.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.434 1.094 . . . . 0.0 108.564 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.467 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 64.8 t -74.28 105.17 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.379 1.072 . . . . 0.0 110.31 -176.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 41.2 t30 -88.31 87.82 7.43 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -17.43 63.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.306 175.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -71.69 -17.99 62.2 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.592 . . . . 0.0 110.547 171.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -82.14 -167.63 40.12 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.832 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.459 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 34.8 t30 -68.03 129.28 39.45 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.964 0.506 . . . . 0.0 110.479 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.48 ' HB3' HG13 ' A' ' 376' ' ' ILE . 0.9 OUTLIER -75.95 -58.85 3.04 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.639 -173.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.486 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -150.42 -91.13 0.08 OUTLIER Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.341 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.5 19.86 33.93 Favored 'Cis proline' 0 C--N 1.37 1.702 0 CA-C-N 120.502 2.151 . . . . 0.0 114.31 11.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -77.15 -6.19 51.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.525 0.33 . . . . 0.0 111.359 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.586 HD11 HD13 ' A' ' 456' ' ' LEU . 31.1 mt -111.28 142.91 42.89 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.397 1.079 . . . . 0.0 108.832 175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.81 122.32 87.22 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.069 0.548 . . . . 0.0 110.159 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 26.1 Cg_endo -59.08 -28.21 87.19 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 123.283 2.655 . . . . 0.0 114.247 -174.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.79 -48.08 23.15 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.384 0.427 . . . . 0.0 109.937 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 22.4 mtp180 -67.83 -28.78 67.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.559 0.744 . . . . 0.0 111.661 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.506 HD13 HD21 ' A' ' 379' ' ' LEU . 12.7 mm -60.35 -29.66 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.933 172.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 57.0 mm-40 -85.15 -25.38 27.48 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.612 0.365 . . . . 0.0 110.602 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 65.9 mm-40 -82.26 -24.06 34.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.016 0.527 . . . . 0.0 112.116 -173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.506 HD21 HD13 ' A' ' 376' ' ' ILE . 3.0 pp -74.59 158.71 84.67 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.25 153.39 74.53 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.153 1.902 . . . . 0.0 112.718 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.99 -18.2 65.08 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.114 1.365 . . . . 0.0 112.386 -175.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.467 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 7.6 p80 -161.97 160.14 27.39 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.058 0.456 . . . . 0.0 111.197 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.513 ' HD2' HD13 ' A' ' 395' ' ' ILE . 57.3 m-85 -124.76 104.66 8.77 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 170.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 135.09 161.51 9.41 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.631 -175.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -79.15 129.87 19.26 Favored 'Cis proline' 0 C--N 1.373 1.857 0 CA-C-N 120.147 1.973 . . . . 0.0 112.123 4.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.99 -176.04 34.64 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 119.257 -0.746 . . . . 0.0 111.667 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.46 133.91 33.98 Favored 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 112.838 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.7 p -38.27 -46.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 127.038 2.135 . . . . 0.0 113.621 -177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -76.81 -37.4 55.81 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.168 0.987 . . . . 0.0 111.684 -171.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.0 t -74.41 -41.23 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.42 HG11 HG23 ' A' ' 357' ' ' VAL . 74.2 t -61.36 -42.28 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.46 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.4 pp -70.42 -40.1 74.03 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.49 ' N ' HD12 ' A' ' 392' ' ' LEU . 16.2 ptm180 -68.52 -31.85 71.39 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 27.7 mmm-85 -72.35 -32.69 66.7 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.513 HD13 ' HD2' ' A' ' 383' ' ' PHE . 18.2 mm -65.4 -53.43 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 400' ' ' VAL . 93.9 t -55.76 -53.84 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 124.34 1.025 . . . . 0.0 110.749 -177.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -69.36 -37.55 77.66 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . 0.617 ' HA ' ' SG ' ' A' ' 402' ' ' CYS . 83.3 m -71.75 -40.42 69.36 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.023 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 396' ' ' VAL . 74.8 t -68.56 -32.99 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.093 0.557 . . . . 0.0 110.42 178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.77 -51.01 68.8 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.182 0.593 . . . . 0.0 109.973 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 399' ' ' CYS . 29.6 p -79.36 -10.57 59.84 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.447 -174.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -57.62 119.07 5.95 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.581 1.152 . . . . 0.0 113.459 -175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.24 116.94 7.1 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.852 167.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 63.58 68.73 0.58 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.026 0.917 . . . . 0.0 108.7 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.9 m -54.73 -40.93 69.78 Favored 'General case' 0 C--O 1.21 -1.007 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.466 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -50.86 -40.12 55.45 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.778 1.231 . . . . 0.0 113.878 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -84.98 -35.17 22.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.379 0.672 . . . . 0.0 110.207 -176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' A' ' 403' ' ' ALA . 55.5 t -66.15 -33.61 64.71 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 123.52 0.728 . . . . 0.0 111.063 173.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -78.45 -11.37 59.95 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.988 0.915 . . . . 0.0 110.083 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -75.75 -9.75 84.93 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.268 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -87.65 0.73 55.27 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.613 0.765 . . . . 0.0 111.597 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . 0.479 HD12 HD11 ' A' ' 434' ' ' ILE . 0.9 OUTLIER -142.7 133.74 25.78 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.274 0.63 . . . . 0.0 110.482 176.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -114.2 159.43 36.47 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 124.025 0.93 . . . . 0.0 109.764 -177.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.45 143.07 30.55 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.029 1.819 . . . . 0.0 111.022 171.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -139.25 132.87 30.47 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -87.89 25.7 1.49 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -164.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -9.07 58.3 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.363 0.665 . . . . 0.0 110.871 171.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 67.28 31.91 78.43 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.556 0.535 . . . . 0.0 114.006 172.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -86.11 -121.07 1.2 Allowed Glycine 0 C--N 1.339 0.718 0 O-C-N 123.598 0.234 . . . . 0.0 112.936 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' A' ' 436' ' ' LEU . 3.8 mp0 -82.26 172.71 12.82 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.842 0.857 . . . . 0.0 110.603 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 94.3 t -134.11 131.65 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.419 0.688 . . . . 0.0 109.837 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 433' ' ' SER . 46.5 mm -104.37 127.64 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 0.0 109.358 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 20.7 p -106.72 148.29 28.59 Favored 'General case' 0 C--O 1.241 0.635 0 O-C-N 123.906 0.754 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -155.01 170.97 20.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.849 -173.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 52.3 m -103.2 115.87 31.39 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -142.87 125.46 15.82 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.359 0.663 . . . . 0.0 109.927 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 37.9 t70 67.08 16.45 10.29 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.916 1.286 . . . . 0.0 111.641 174.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 96.78 -15.41 62.72 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.95 -0.469 . . . . 0.0 112.937 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -94.77 171.21 8.92 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.174 0.99 . . . . 0.0 110.12 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.0 t -97.04 102.81 14.66 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -91.11 133.89 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 36.5 p -132.64 126.98 33.9 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.183 0.993 . . . . 0.0 109.352 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.479 HD11 HD12 ' A' ' 413' ' ' LEU . 2.2 pp -117.07 163.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.838 0.855 . . . . 0.0 109.525 -178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.75 150.81 22.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.516 0.674 . . . . 0.0 111.206 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 421' ' ' GLU . 81.7 mt -114.59 160.75 31.97 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 125.296 1.438 . . . . 0.0 109.013 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.46 136.44 19.49 Favored 'Trans proline' 0 CA--C 1.562 1.903 0 C-N-CA 121.84 1.693 . . . . 0.0 111.519 164.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.81 144.53 31.09 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.92 2.414 . . . . 0.0 112.055 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 8.4 m -114.7 172.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.036 0.534 . . . . 0.0 110.846 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -154.91 4.19 0.22 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.367 0.667 . . . . 0.0 112.114 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.1 t -122.6 141.56 51.58 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.041 0.536 . . . . 0.0 110.212 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -71.77 -36.19 70.3 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.292 1.037 . . . . 0.0 112.499 -170.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 39.8 m -66.54 -22.15 66.16 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.313 0.645 . . . . 0.0 111.075 175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.84 -22.52 25.76 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.725 0.41 . . . . 0.0 109.973 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.39 -66.24 0.42 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 121.479 0.657 . . . . 0.0 110.509 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -29.38 68.18 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.587 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.3 -33.12 75.22 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.813 0.445 . . . . 0.0 110.864 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -65.66 -45.52 82.62 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.066 0.546 . . . . 0.0 110.749 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.528 HD13 ' H ' ' A' ' 449' ' ' LEU . 0.0 OUTLIER -87.35 -13.86 42.33 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.555 -179.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.6 -50.48 73.0 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.868 0.867 . . . . 0.0 111.375 -175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -67.41 -29.65 69.2 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.989 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.449 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 54.9 t80 -73.29 -42.63 62.19 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.216 0.606 . . . . 0.0 110.985 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.428 ' HA ' HD12 ' A' ' 456' ' ' LEU . 72.8 m -67.01 -26.83 66.97 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.918 0.887 . . . . 0.0 110.416 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 -67.62 -38.8 84.43 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.19 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 18.7 m -67.51 -30.68 70.43 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.924 0.89 . . . . 0.0 111.132 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 371' ' ' LEU . 33.3 mt -82.28 -17.43 45.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 0.0 111.425 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 71.41 7.83 6.14 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.987 1.715 . . . . 0.0 111.758 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.426 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 24.7 p -75.82 135.77 40.22 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.103 0.478 . . . . 0.0 110.359 -174.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.459 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 26.7 t70 -127.37 141.37 51.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.642 0.777 . . . . 0.0 110.605 -174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 8.0 p30 46.35 25.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.163 1.785 . . . . 0.0 113.286 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 52.9 tp -76.82 -15.61 59.67 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.339 1.055 . . . . 0.0 111.279 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.4 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -158.98 159.28 34.66 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.016 0.526 . . . . 0.0 110.184 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 61.7 p -160.63 129.71 4.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.247 0.619 . . . . 0.0 109.58 178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 21.6 t -80.55 4.29 18.93 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.243 0.617 . . . . 0.0 111.462 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -79.47 117.71 68.57 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 124.087 0.955 . . . . 0.0 109.209 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -74.14 174.83 11.78 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.084 2.523 . . . . 0.0 112.881 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -65.65 -30.91 71.67 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.157 0.583 . . . . 0.0 110.99 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.557 1.231 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 170.093 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.87 -0.092 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 60.2 p -87.85 157.38 19.01 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.742 0.817 . . . . 0.0 110.16 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 35.7 t60 62.32 28.46 16.94 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.031 0.933 . . . . 0.0 109.26 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 21.3 ttt -70.15 149.48 47.51 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.171 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -97.63 172.55 7.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.404 0.682 . . . . 0.0 110.583 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 18.2 t -79.36 -179.04 6.56 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.162 0.585 . . . . 0.0 110.171 175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 32.1 p -133.78 141.73 47.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.35 0.66 . . . . 0.0 110.972 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 388' ' ' VAL . 3.1 m -137.76 157.47 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.567 1.147 . . . . 0.0 109.525 173.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 464' ' ' SER . 7.7 p -137.57 101.59 4.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.641 HG21 HD11 ' A' ' 395' ' ' ILE . 29.0 m -94.34 151.58 3.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.169 0.509 . . . . 0.0 110.23 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 462' ' ' LEU . 53.6 m-85 -110.05 100.49 9.42 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 23.2 t -70.65 88.38 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.607 0 O-C-N 123.8 0.688 . . . . 0.0 109.735 -178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -85.04 88.23 7.44 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.865 -174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -70.62 -12.45 61.57 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.731 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -76.26 -28.56 57.13 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.745 0.818 . . . . 0.0 111.134 173.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -61.22 -76.23 0.25 Allowed Glycine 0 C--N 1.353 1.523 0 O-C-N 123.429 0.456 . . . . 0.0 112.838 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 459' ' ' ASP . 40.4 t30 -152.92 143.2 22.48 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.498 ' HA ' HG21 ' A' ' 376' ' ' ILE . 1.0 OUTLIER -86.06 -62.64 1.47 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.58 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -146.19 -94.81 0.17 Allowed Glycine 0 C--N 1.346 1.094 0 O-C-N 124.271 0.982 . . . . 0.0 112.763 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -90.13 15.89 46.11 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 120.326 2.063 . . . . 0.0 113.804 10.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -82.69 -2.26 53.63 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 110.063 172.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.58 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 31.6 mt -109.83 142.91 40.44 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.126 1.37 . . . . 0.0 108.034 172.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' HE3' ' A' ' 374' ' ' LYS . 16.2 t70 -70.27 120.16 76.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.161 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.41 ' HG2' ' HD3' ' A' ' 374' ' ' LYS . 31.8 Cg_endo -60.71 -28.38 86.42 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.205 2.603 . . . . 0.0 114.192 -172.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -75.06 -47.9 26.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.808 0.443 . . . . 0.0 110.706 -178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -67.49 -29.99 69.56 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.632 0.582 . . . . 0.0 111.146 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.533 HD13 HD21 ' A' ' 379' ' ' LEU . 22.4 mm -62.01 -31.79 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.92 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -79.31 -24.68 42.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.211 0.604 . . . . 0.0 111.159 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.8 mm-40 -81.9 -34.76 29.8 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.033 0.533 . . . . 0.0 112.258 -174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 376' ' ' ILE . 2.4 pp -70.24 153.99 94.84 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.543 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -41.69 152.94 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 124.519 3.479 . . . . 0.0 116.052 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -86.41 -11.15 52.74 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.817 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -160.86 144.97 13.65 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.43 1.092 . . . . 0.0 110.013 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -120.61 128.9 53.46 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 97.98 179.57 33.0 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.958 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.79 137.42 46.15 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 120.341 2.07 . . . . 0.0 113.437 2.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 175.92 -166.05 37.03 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.768 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . 0.401 ' HG2' ' HB ' ' A' ' 390' ' ' VAL . 17.9 Cg_endo -59.27 129.58 32.14 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.379 2.72 . . . . 0.0 113.369 -169.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.863 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.7 p -47.24 -44.46 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.796 1.638 . . . . 0.0 111.81 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -62.99 -45.3 93.07 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.081 1.352 . . . . 0.0 111.465 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 97.7 t -74.08 -51.72 22.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.298 -176.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.74 -40.03 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.54 HD13 ' HD2' ' A' ' 448' ' ' PHE . 3.7 pp -68.14 -42.55 79.95 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.499 ' N ' HD12 ' A' ' 392' ' ' LEU . 14.0 ptt180 -74.91 -25.5 58.97 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -173.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 25.4 mmm180 -66.97 -34.37 77.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.911 0.884 . . . . 0.0 110.494 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.641 HD11 HG21 ' A' ' 359' ' ' VAL . 42.8 mm -64.58 -56.65 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 172.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 400' ' ' VAL . 58.5 t -60.81 -47.57 92.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 O-C-N 124.875 1.36 . . . . 0.0 111.817 -171.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . 0.494 ' HA ' HG23 ' A' ' 423' ' ' ILE . 2.3 pt20 -71.12 -34.98 71.57 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.826 0.45 . . . . 0.0 111.548 -175.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.99 -34.71 77.05 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.758 0.423 . . . . 0.0 109.925 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . 0.517 ' SG ' HD11 ' A' ' 371' ' ' LEU . 48.4 t -71.71 -43.29 66.18 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.161 0.984 . . . . 0.0 111.586 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 406' ' ' THR . 11.1 t -66.81 -45.87 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -65.93 -37.91 87.28 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.4 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . 0.469 ' SG ' HD23 ' A' ' 379' ' ' LEU . 93.1 m -83.24 -10.24 58.67 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.005 0.522 . . . . 0.0 111.773 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.583 ' HB1' HG21 ' A' ' 409' ' ' VAL . . . -68.61 141.88 55.3 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 92.3 mt -74.2 122.6 23.04 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.801 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 409' ' ' VAL . 41.3 tt0 65.34 59.85 0.79 Allowed 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.593 HG23 HG12 ' A' ' 400' ' ' VAL . 98.0 m -53.88 -31.06 48.54 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.899 1.68 . . . . 0.0 112.636 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -58.31 -39.83 80.43 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.738 1.215 . . . . 0.0 112.676 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 64.9 m -82.13 -28.91 31.93 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.238 0.615 . . . . 0.0 110.431 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.583 HG21 ' HB1' ' A' ' 403' ' ' ALA . 60.0 t -72.03 -31.47 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.089 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -64.23 -21.87 66.74 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.636 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -69.45 -27.13 73.86 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 113.947 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.446 ' HD2' ' HA ' ' A' ' 409' ' ' VAL . 89.3 m-85 -75.7 -4.81 42.39 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.036 0.534 . . . . 0.0 112.313 -176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.05 136.42 33.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.189 0.595 . . . . 0.0 111.247 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -119.83 151.03 51.77 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.268 1.027 . . . . 0.0 111.013 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 435' ' ' GLN . 60.2 Cg_endo -69.69 156.57 63.16 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.651 2.234 . . . . 0.0 114.199 -176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -123.25 154.03 39.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.085 1.754 . . . . 0.0 109.119 -176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -130.12 30.52 4.78 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 121.199 0.523 . . . . 0.0 111.241 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.64 -28.48 14.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.116 0.566 . . . . 0.0 110.469 167.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 101.98 44.0 1.98 Allowed Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.663 -0.244 . . . . 0.0 112.955 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -92.25 -132.22 5.76 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 0.7 OUTLIER -66.84 168.61 9.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.514 1.126 . . . . 0.0 111.454 -178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . 0.432 ' H ' ' HD2' ' A' ' 393' ' ' ARG . 98.4 t -136.15 130.1 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.577 HG12 HD13 ' A' ' 436' ' ' LEU . 29.1 mm -114.9 134.03 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.251 0.62 . . . . 0.0 109.368 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 22.4 p -105.96 139.93 39.75 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.75 0.82 . . . . 0.0 109.602 176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -156.69 125.56 5.91 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.918 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 49.6 m -82.66 108.66 16.2 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 122.982 0.513 . . . . 0.0 110.752 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -131.92 143.0 49.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.209 1.004 . . . . 0.0 109.078 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 31.1 t70 66.06 16.56 10.5 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.711 1.204 . . . . 0.0 110.686 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 80.44 0.15 86.28 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.94 -172.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -107.92 159.04 16.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.197 0.999 . . . . 0.0 109.669 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 10.3 t -91.84 122.92 34.82 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -122.84 152.2 40.95 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.731 0.812 . . . . 0.0 109.72 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 423' ' ' ILE . 62.2 p -143.69 144.4 31.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.015 0.526 . . . . 0.0 110.725 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.1 pt -125.86 -177.82 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.285 1.034 . . . . 0.0 109.059 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 421' ' ' GLU . 26.4 mt-30 -115.27 148.49 39.11 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.103 0.561 . . . . 0.0 110.425 171.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 10.5 mp -116.56 147.48 39.83 Favored Pre-proline 0 N--CA 1.485 1.296 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 171.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.79 132.7 43.88 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.501 2.134 . . . . 0.0 112.61 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.77 129.8 20.57 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.805 2.337 . . . . 0.0 114.027 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.8 m -92.08 175.35 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.556 1.143 . . . . 0.0 110.602 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -155.12 11.04 0.34 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.8 t -126.9 141.35 51.83 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 118.23 0.468 . . . . 0.0 110.503 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -69.68 -26.72 64.5 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.939 0.896 . . . . 0.0 111.714 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 19.8 m -74.74 -28.16 60.66 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.263 0.625 . . . . 0.0 110.427 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 448' ' ' PHE . 3.8 t80 -84.24 -21.56 31.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.863 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -51.18 -63.18 1.21 Allowed 'General case' 0 C--N 1.36 1.051 0 C-N-CA 124.428 1.091 . . . . 0.0 111.048 174.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.08 -41.08 71.12 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 112.795 -2.002 . . . . 0.0 110.272 -167.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 450' ' ' GLU . 36.0 ttm180 -61.19 -33.82 74.07 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 124.68 1.237 . . . . 0.0 111.735 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 392' ' ' LEU . 4.3 t80 -68.74 -37.71 79.61 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.581 -173.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.39 -16.27 33.35 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 119.052 -0.499 . . . . 0.0 111.817 171.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 447' ' ' ARG . 0.9 OUTLIER -64.4 -40.07 95.08 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.706 0.403 . . . . 0.0 110.522 -173.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -62.29 -45.95 90.97 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.556 0.742 . . . . 0.0 110.604 175.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.443 ' HZ ' HG22 ' A' ' 400' ' ' VAL . 75.3 t80 -64.35 -53.51 47.61 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.751 -175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 82.6 m -63.35 -29.78 71.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.555 1.142 . . . . 0.0 111.823 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -69.72 -33.61 72.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.042 0.537 . . . . 0.0 110.797 178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 42.7 m -71.0 -24.05 62.3 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.084 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.553 HD13 HD21 ' A' ' 371' ' ' LEU . 35.0 mt -100.18 -1.21 37.16 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.785 0.834 . . . . 0.0 111.048 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 71.71 7.33 5.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.115 1.766 . . . . 0.0 112.585 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.559 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 9.5 p -83.08 133.03 35.08 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 366' ' ' ASN . 31.8 t70 -151.1 151.7 32.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.935 0.494 . . . . 0.0 109.779 -167.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 59.59 14.97 4.27 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.585 0.754 . . . . 0.0 111.272 -170.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.48 -18.26 45.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.616 0.767 . . . . 0.0 111.013 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.709 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -164.21 151.71 12.11 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.639 0.775 . . . . 0.0 109.751 174.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 68.0 m -158.07 133.67 8.98 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 108.433 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 12.8 t -83.08 19.14 1.48 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.468 0.651 . . . . 0.0 112.066 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -147.75 154.11 43.68 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 125.719 1.608 . . . . 0.0 108.032 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.27 149.33 90.43 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.039 1.826 . . . . 0.0 111.586 174.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.74 -11.57 60.44 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.656 0.782 . . . . 0.0 111.506 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.015 1.326 . . . . 0.0 108.609 174.547 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 33.5 t -78.08 167.59 21.2 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.618 0.767 . . . . 0.0 111.111 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -149.09 -33.99 0.2 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -52.84 61.99 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.454 0.702 . . . . 0.0 111.789 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -169.82 173.22 6.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.658 0.783 . . . . 0.0 110.11 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 63.0 m -80.31 176.27 9.91 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.79 0.436 . . . . 0.0 110.232 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 76.2 p -133.9 138.63 45.66 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.617 0.767 . . . . 0.0 109.293 176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 388' ' ' VAL . 22.1 m -139.07 163.52 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.527 0.731 . . . . 0.0 110.788 177.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 26.6 p -136.81 127.42 27.0 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.477 1.111 . . . . 0.0 108.068 172.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 395' ' ' ILE . 28.9 m -112.91 161.71 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.104 0.561 . . . . 0.0 110.656 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -120.14 102.78 8.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . . . . . . . . . 99.7 t -68.14 103.93 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.733 0.813 . . . . 0.0 110.899 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 460' ' ' ASN . 53.7 t30 -96.16 85.54 4.03 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.881 0.848 . . . . 0.0 109.267 177.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -60.69 -23.97 65.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.473 174.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -73.45 -17.99 61.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.785 0.834 . . . . 0.0 111.471 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -67.8 -89.44 0.06 OUTLIER Glycine 0 C--N 1.353 1.517 0 C-N-CA 123.101 0.381 . . . . 0.0 112.867 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.493 ' HB3' ' H ' ' A' ' 459' ' ' ASP . 49.6 t-20 -141.72 148.31 38.82 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 371' ' ' LEU . 0.5 OUTLIER -90.48 -64.64 1.1 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.265 1.026 . . . . 0.0 108.264 -173.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.59 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.22 -94.91 0.18 Allowed Glycine 0 C--N 1.349 1.289 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.358 -177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . 0.455 ' HD2' HE21 ' A' ' 457' ' ' GLN . 25.4 Cg_endo -88.52 18.04 38.01 Favored 'Cis proline' 0 C--N 1.373 1.866 0 CA-C-N 120.374 2.087 . . . . 0.0 114.293 9.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . 0.429 ' HB3' HG22 ' A' ' 409' ' ' VAL . 76.8 m-70 -72.3 -18.42 61.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.201 0.6 . . . . 0.0 110.733 168.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 403' ' ' ALA . 29.3 mt -104.74 140.01 38.7 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 124.939 1.295 . . . . 0.0 108.962 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -70.62 122.47 86.74 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.46 0.475 . . . . 0.0 110.385 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 19.3 Cg_endo -56.89 -34.0 96.12 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.659 2.906 . . . . 0.0 114.58 -173.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -74.44 -45.0 49.24 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.808 0.443 . . . . 0.0 110.702 -176.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.95 -29.78 68.92 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 123.706 0.629 . . . . 0.0 111.205 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 367' ' ' PHE . 21.6 mm -64.85 -30.67 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.977 0.911 . . . . 0.0 111.245 173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 75.5 mm-40 -79.95 -17.48 52.89 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 122.093 -0.379 . . . . 0.0 110.8 175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 67.5 mm-40 -86.97 -5.8 58.97 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.757 0.423 . . . . 0.0 111.094 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 42.3 mt -66.1 167.67 11.44 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.156 0.582 . . . . 0.0 111.542 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 158.22 58.05 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 121.761 1.64 . . . . 0.0 111.383 165.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.0 -18.08 59.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.545 0.738 . . . . 0.0 111.673 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -163.84 160.81 22.71 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.221 0.608 . . . . 0.0 111.193 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -126.36 157.79 37.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.69 1.196 . . . . 0.0 108.878 172.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 81.95 -177.19 53.9 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.51 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 128.99 17.56 Favored 'Cis proline' 0 C--N 1.376 1.984 0 CA-C-N 119.591 1.695 . . . . 0.0 112.302 -1.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -162.25 -172.91 30.28 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.42 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.36 129.95 35.22 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.219 2.613 . . . . 0.0 112.574 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.846 HG23 ' HB2' ' A' ' 445' ' ' ALA . 4.6 p -42.48 -46.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.656 1.983 . . . . 0.0 112.891 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.76 -36.95 81.45 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.908 1.283 . . . . 0.0 112.379 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 69.0 t -79.01 -47.19 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.195 -0.316 . . . . 0.0 110.646 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.46 -31.68 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 122.656 0.382 . . . . 0.0 111.715 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 393' ' ' ARG . 4.0 pp -74.17 -41.13 61.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.111 0.164 . . . . 0.0 110.766 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.454 ' N ' HD12 ' A' ' 392' ' ' LEU . 6.2 ptt180 -69.49 -26.55 64.61 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -66.17 -31.78 72.83 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.806 0.842 . . . . 0.0 111.282 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.639 HD11 HG21 ' A' ' 359' ' ' VAL . 32.1 mm -74.71 -49.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 400' ' ' VAL . 94.5 t -59.62 -48.87 85.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 O-C-N 124.148 0.905 . . . . 0.0 111.424 -176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -71.8 -27.8 63.18 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.505 0.322 . . . . 0.0 111.29 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.85 90.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.3 m -66.82 -60.7 2.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 110.806 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 396' ' ' VAL . 43.1 t -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.039 0.936 . . . . 0.0 111.797 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.28 -46.67 66.66 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.723 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 71.9 m -80.08 3.22 21.04 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.137 0.575 . . . . 0.0 112.219 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -72.58 137.9 46.48 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.854 0.861 . . . . 0.0 112.411 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 404' ' ' LEU . 2.5 pp -84.86 132.57 34.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 57.82 61.72 2.31 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.371 1.082 . . . . 0.0 109.618 -172.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 86.1 m -57.27 -26.98 61.69 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.489 1.515 . . . . 0.0 112.614 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -60.46 -31.44 70.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.99 0.916 . . . . 0.0 112.438 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 95.1 m -75.41 -44.9 42.15 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.853 0.861 . . . . 0.0 109.576 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.535 HG21 ' HB1' ' A' ' 403' ' ' ALA . 97.9 t -68.78 -27.66 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-N 114.194 -1.367 . . . . 0.0 111.338 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -76.51 -30.05 57.04 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.361 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -60.11 -16.26 40.18 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -85.02 -17.35 37.8 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.393 0.677 . . . . 0.0 111.866 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.04 135.52 31.13 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.277 0.56 . . . . 0.0 112.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -113.4 168.68 7.42 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 123.609 0.764 . . . . 0.0 109.176 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.0 136.65 35.57 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 121.785 1.657 . . . . 0.0 112.742 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -141.7 99.51 3.56 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 126.012 1.725 . . . . 0.0 107.446 177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -85.09 72.44 10.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.539 1.161 . . . . 0.0 108.814 -169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -97.39 -2.84 41.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 113.754 -1.567 . . . . 0.0 109.869 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 79.2 27.62 55.28 Favored Glycine 0 C--N 1.356 1.675 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -103.99 -120.79 4.82 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.507 -177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 14.6 mm-40 -84.88 178.91 7.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.116 0.567 . . . . 0.0 111.507 -173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.2 p -152.91 126.1 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 122.868 0.467 . . . . 0.0 110.426 -175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.24 143.05 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.423 1.089 . . . . 0.0 108.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . . . . . . . . . 2.9 p -107.06 142.07 37.28 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.209 0.603 . . . . 0.0 109.824 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -132.16 115.95 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.279 1.031 . . . . 0.0 109.168 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 102.17 4.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.039 0.536 . . . . 0.0 110.275 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -123.34 120.62 33.58 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.289 1.036 . . . . 0.0 109.193 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 20.9 t70 57.23 50.13 12.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.212 1.405 . . . . 0.0 112.198 170.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 79.66 -3.91 66.93 Favored Glycine 0 N--CA 1.474 1.181 0 CA-C-N 115.274 -0.875 . . . . 0.0 114.372 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -118.56 171.71 7.99 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.085 0.954 . . . . 0.0 108.832 178.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 8.3 t -127.73 111.43 13.67 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.586 0.708 . . . . 0.0 109.955 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -94.57 127.0 40.22 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.573 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.0 p -95.35 138.78 32.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.071 0.949 . . . . 0.0 109.775 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.73 171.28 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.778 1.231 . . . . 0.0 109.263 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -115.38 143.77 44.78 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.235 0.541 . . . . 0.0 110.6 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 8.0 mp -113.88 155.8 44.72 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 125.072 1.349 . . . . 0.0 108.16 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.52 143.92 64.83 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.189 1.926 . . . . 0.0 111.762 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.34 155.22 25.04 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.295 1.997 . . . . 0.0 111.796 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 6.2 m -123.89 169.35 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 122.862 0.465 . . . . 0.0 109.864 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -147.47 8.36 0.9 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.108 0.563 . . . . 0.0 111.869 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 388' ' ' VAL . 46.3 t -115.9 138.67 50.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.631 0.372 . . . . 0.0 110.131 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -73.16 -26.54 61.23 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.031 0.932 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 31.4 m -72.03 -29.4 64.13 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.535 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.94 -21.09 29.75 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -173.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.846 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -47.43 -63.29 1.09 Allowed 'General case' 0 C--N 1.366 1.286 0 O-C-N 124.098 0.873 . . . . 0.0 110.153 171.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 450' ' ' GLU . 16.9 mt -65.1 -50.12 67.33 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 113.175 -1.829 . . . . 0.0 109.319 -174.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -32.74 57.78 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 125.146 1.529 . . . . 0.0 112.706 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . 0.445 ' HE1' HD23 ' A' ' 436' ' ' LEU . 4.4 t80 -65.12 -49.19 70.9 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.651 0.381 . . . . 0.0 110.564 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -88.11 -15.83 35.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 -176.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 446' ' ' LEU . 0.8 OUTLIER -65.15 -46.64 80.05 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 109.699 -175.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -37.84 85.14 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.033 0.833 . . . . 0.0 110.06 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.401 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 43.0 t80 -65.5 -50.66 64.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.57 0.748 . . . . 0.0 111.217 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.28 -28.54 67.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.089 0.956 . . . . 0.0 110.823 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.63 -34.16 75.26 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.993 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 30.9 m -75.05 -25.08 58.39 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.682 0.793 . . . . 0.0 110.962 174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 371' ' ' LEU . 67.3 mt -82.91 -12.0 57.72 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.013 0.525 . . . . 0.0 110.977 173.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . 0.455 HE21 ' HD2' ' A' ' 369' ' ' PRO . 17.0 mt-30 74.67 8.14 4.35 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.782 1.633 . . . . 0.0 111.562 -178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.461 ' HB3' ' HA2' ' A' ' 368' ' ' GLY . 11.2 p -86.9 134.3 33.53 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . 0.493 ' H ' ' HB3' ' A' ' 366' ' ' ASN . 38.7 t70 -146.36 157.08 43.74 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.291 1.036 . . . . 0.0 108.379 -173.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 362' ' ' ASN . 15.4 m-80 63.2 15.92 8.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.24 1.016 . . . . 0.0 111.109 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 27.7 tp -83.34 -18.58 38.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.725 0.81 . . . . 0.0 111.366 -174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.639 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -161.78 166.15 26.92 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.365 0.666 . . . . 0.0 110.662 175.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 47.8 t -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.021 0.928 . . . . 0.0 108.769 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.466 ' HB2' HD21 ' A' ' 446' ' ' LEU . 39.9 t -69.53 -24.02 63.68 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.425 0.69 . . . . 0.0 111.592 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -102.67 148.77 36.01 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 123.695 0.798 . . . . 0.0 109.776 -172.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.12 143.42 90.21 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.649 2.233 . . . . 0.0 112.155 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.56 -19.66 62.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.768 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.95 0.9 . . . . 0.0 109.549 177.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 48.9 m -69.35 120.95 15.95 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 123.308 0.643 . . . . 0.0 111.114 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -76.7 80.9 3.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.073 0.549 . . . . 0.0 109.526 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 23.6 ptm -90.58 -33.62 15.81 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -101.76 152.41 20.9 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.657 0.783 . . . . 0.0 108.891 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' SER . . . . . . . . . . . . . 20.8 t -79.97 178.66 8.06 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.165 0.586 . . . . 0.0 110.241 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.0 p -131.9 134.17 45.39 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.772 0.829 . . . . 0.0 109.541 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 17.1 m -140.05 171.23 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.598 1.159 . . . . 0.0 109.565 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 384' ' ' GLY . 52.6 t -146.85 105.97 3.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.659 0.784 . . . . 0.0 109.152 178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' VAL . . . . . 0.643 HG21 HD11 ' A' ' 395' ' ' ILE . 34.3 m -91.99 153.61 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -122.87 99.78 6.56 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' VAL . . . . . 0.401 ' H ' ' HA ' ' A' ' 382' ' ' HIS . 45.2 t -63.96 98.85 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.537 1.148 . . . . 0.0 109.86 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -91.87 89.24 6.95 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.753 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 363' ' ' LYS . 0.0 OUTLIER -73.84 -9.26 58.47 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.166 176.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -74.25 -20.01 60.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.231 0.613 . . . . 0.0 109.804 168.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -79.29 -169.66 37.93 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.752 167.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -69.57 141.1 53.84 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 117.583 0.691 . . . . 0.0 110.497 -177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -83.58 -56.48 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.665 ' HA3' ' H ' ' A' ' 371' ' ' LEU . . . -145.1 -83.84 0.06 OUTLIER Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.494 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.17 1.42 23.95 Favored 'Cis proline' 0 N--CA 1.5 1.879 0 CA-C-N 120.53 2.165 . . . . 0.0 114.381 -0.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' A' ' 456' ' ' LEU . 16.3 p-80 -65.66 -16.11 63.42 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.966 0.906 . . . . 0.0 112.228 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.665 ' H ' ' HA3' ' A' ' 368' ' ' GLY . 42.2 mt -95.46 136.55 35.69 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.855 0.862 . . . . 0.0 108.923 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.09 113.23 8.68 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 124.33 1.019 . . . . 0.0 110.119 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 377' ' ' GLN . 34.7 Cg_endo -62.17 -16.89 53.58 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.182 2.588 . . . . 0.0 114.243 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 378' ' ' GLN . 0.0 OUTLIER -82.25 -49.18 10.37 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.104 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -62.48 -35.64 79.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.435 1.094 . . . . 0.0 111.95 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.55 -30.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.711 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 373' ' ' PRO . 84.4 mm-40 -85.39 -19.27 31.64 Favored 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.977 -0.452 . . . . 0.0 111.236 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 374' ' ' LYS . 66.8 mm-40 -81.64 -35.85 29.53 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.732 0.413 . . . . 0.0 111.277 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 398' ' ' ALA . 3.1 pp -68.17 157.14 88.25 Favored Pre-proline 0 N--CA 1.486 1.371 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.89 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.63 161.73 23.67 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.928 2.419 . . . . 0.0 114.078 -174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.8 -17.15 59.96 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.372 -1.286 . . . . 0.0 112.159 -173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 361' ' ' VAL . 17.6 p80 -162.49 160.55 26.3 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.044 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -130.09 102.95 6.47 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 358' ' ' CYS . . . 140.56 169.37 11.7 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.119 -0.823 . . . . 0.0 112.848 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.46 129.78 19.61 Favored 'Cis proline' 0 C--N 1.381 2.241 0 CA-C-N 119.512 1.656 . . . . 0.0 112.636 0.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -158.04 -165.55 15.71 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.306 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.28 141.65 16.29 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.834 2.356 . . . . 0.0 112.314 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 445' ' ' ALA . 7.5 p -46.55 -45.05 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.993 1.717 . . . . 0.0 113.329 -177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -75.74 -35.29 60.24 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.098 0.959 . . . . 0.0 111.888 -175.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 394' ' ' ARG . 80.1 t -76.92 -46.15 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.44 -38.69 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 C-N-CA 123.19 0.596 . . . . 0.0 112.116 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.3 -41.22 70.2 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 122.945 0.153 . . . . 0.0 111.204 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 12.0 ptp180 -67.57 -33.84 75.84 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 390' ' ' VAL . 46.4 mmm-85 -63.07 -34.91 78.6 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.745 0.653 . . . . 0.0 111.711 -178.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 359' ' ' VAL . 36.4 mm -68.09 -52.54 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 123.628 0.58 . . . . 0.0 109.797 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.19 -43.48 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.775 -172.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -74.39 -21.97 59.4 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.84 0.456 . . . . 0.0 111.457 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 379' ' ' LEU . . . -83.7 -16.73 43.86 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.359 0.664 . . . . 0.0 110.771 173.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' CYS . . . . . . . . . . . . . 71.5 m -81.52 -61.88 1.81 Allowed 'General case' 0 C--N 1.347 0.485 0 C-N-CA 122.876 0.471 . . . . 0.0 109.949 173.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.67 -50.65 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 0.0 111.071 -170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.22 -37.8 88.41 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.322 -177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' CYS . . . . . . . . . . . . . 73.9 m -94.64 19.74 9.5 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.39 0.676 . . . . 0.0 111.522 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 371' ' ' LEU . . . -85.13 150.65 24.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.334 0.654 . . . . 0.0 112.435 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 76.1 mt -66.45 114.12 5.21 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 162.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 61.96 73.43 0.47 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.284 0.99 . . . . 0.0 109.914 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.4 m -55.2 -41.18 71.66 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 125.302 1.441 . . . . 0.0 112.046 -177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -54.59 -38.49 66.79 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 65.3 m -77.5 -38.57 48.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.963 0.505 . . . . 0.0 109.767 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 403' ' ' ALA . 84.2 t -67.55 -26.65 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.367 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -75.03 -18.87 60.26 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.039 1.336 . . . . 0.0 110.147 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -84.08 -14.98 70.78 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 114.157 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -69.2 -37.46 78.1 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 117.871 0.836 . . . . 0.0 111.1 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.58 152.21 25.07 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.252 0.621 . . . . 0.0 109.818 175.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -117.19 157.54 46.68 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.844 0.858 . . . . 0.0 110.119 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.07 124.51 10.6 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 121.722 1.614 . . . . 0.0 111.54 169.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.404 ' HB3' ' HD3' ' A' ' 418' ' ' ARG . 49.7 m-20 -113.9 123.06 48.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.252 1.421 . . . . 0.0 108.884 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -88.17 55.22 3.35 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.021 0.929 . . . . 0.0 110.007 -167.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 416' ' ' ASP . 11.7 mpt_? -97.08 -32.24 12.08 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.09 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 91.22 33.09 8.32 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.387 -0.369 . . . . 0.0 113.127 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -95.78 -112.56 2.71 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 116.635 0.217 . . . . 0.0 112.683 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 436' ' ' LEU . 1.5 mp0 -79.08 165.26 23.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.854 0.862 . . . . 0.0 110.312 -177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 93.2 t -133.29 126.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.589 0.756 . . . . 0.0 109.155 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 436' ' ' LEU . 28.3 mm -106.26 122.96 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.238 0.615 . . . . 0.0 109.513 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 433' ' ' SER . 21.3 p -105.51 141.25 37.31 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.662 0.785 . . . . 0.0 109.816 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -159.56 130.82 6.04 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.497 -172.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 21.0 p -74.95 104.44 5.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.447 0.699 . . . . 0.0 109.882 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -114.61 107.34 15.36 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 0.0 109.359 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ASP . . . . . . . . . . . . . 36.1 t70 56.97 53.92 7.55 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.762 1.225 . . . . 0.0 111.502 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 86.18 -25.38 7.02 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.625 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.14 171.54 8.54 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.953 0.901 . . . . 0.0 109.569 -174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 6.1 t -115.63 104.17 11.44 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -110.73 160.54 16.62 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.862 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.406 ' HB3' HG22 ' A' ' 424' ' ' THR . 66.6 p -148.76 153.62 38.42 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.819 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 18.7 pt -123.08 166.27 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 123.624 0.77 . . . . 0.0 109.987 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.86 149.08 26.86 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.399 0.68 . . . . 0.0 109.813 172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LEU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 421' ' ' GLU . 7.7 mp -115.86 159.48 38.9 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 124.941 1.296 . . . . 0.0 109.545 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.17 130.87 18.27 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.324 2.016 . . . . 0.0 111.765 164.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.07 151.83 56.15 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.909 2.406 . . . . 0.0 112.508 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.38 167.97 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 123.451 0.701 . . . . 0.0 110.733 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.78 2.68 0.94 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.987 0.515 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.4 m -119.15 140.08 50.74 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.958 0.503 . . . . 0.0 110.102 -174.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.06 90.58 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.074 0.949 . . . . 0.0 112.373 -169.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' SER . . . . . . . . . . . . . 25.1 m -59.43 -28.51 67.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.608 0.763 . . . . 0.0 111.328 175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -21.51 42.37 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.867 0.467 . . . . 0.0 110.147 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.8 ' HB2' HG23 ' A' ' 388' ' ' VAL . . . -55.26 -66.02 0.48 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 446' ' ' LEU . 0.2 OUTLIER -63.75 -43.87 95.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.797 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -33.58 70.28 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.531 0.732 . . . . 0.0 112.189 -177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -62.18 -51.55 67.36 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.55 0.531 . . . . 0.0 110.307 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 462' ' ' LEU . 0.0 OUTLIER -86.64 -15.3 40.14 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.667 -178.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 454' ' ' HIS . 1.7 tm-20 -61.77 -53.26 58.43 Favored 'General case' 0 C--N 1.35 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.819 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -62.95 -40.91 99.1 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.975 0.797 . . . . 0.0 110.84 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.473 ' O ' ' HG ' ' A' ' 456' ' ' LEU . 61.6 t80 -56.09 -64.31 0.9 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.558 1.143 . . . . 0.0 110.637 176.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 458' ' ' CYS . 81.9 m -64.94 -27.17 68.66 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.728 1.211 . . . . 0.0 112.582 -176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 450' ' ' GLU . 51.2 t-80 -69.1 -41.63 77.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.644 0.777 . . . . 0.0 109.997 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' SER . . . . . . . . . . . . . 38.0 t -73.72 -7.95 54.09 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.416 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 370' ' ' HIS . 92.0 mt -103.32 -6.41 22.02 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.71 0.804 . . . . 0.0 112.324 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 80.46 5.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.268 1.827 . . . . 0.0 112.682 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 453' ' ' CYS . 16.3 p -90.38 132.37 35.64 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -156.86 148.26 22.28 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 66.29 13.74 9.33 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.568 1.147 . . . . 0.0 110.736 -168.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 29.1 tp -82.83 -20.31 35.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.129 0.571 . . . . 0.0 111.543 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' LEU . . . . . 0.717 HD21 HD21 ' A' ' 449' ' ' LEU . 0.0 OUTLIER -159.91 166.22 30.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.781 0.432 . . . . 0.0 110.506 175.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' SER . . . . . . . . . . . . . 37.2 p -162.79 121.69 2.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.704 0.802 . . . . 0.0 109.47 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 359' ' ' VAL . 22.3 t -80.03 3.91 18.72 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.408 0.683 . . . . 0.0 111.816 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.6 116.42 59.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.376 1.07 . . . . 0.0 108.191 176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.91 174.74 11.8 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.833 2.355 . . . . 0.0 112.752 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -78.0 -32.83 51.39 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.262 0.625 . . . . 0.0 110.561 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 123.489 0.716 . . . . 0.0 109.707 174.864 . . . . . . . . 0 0 . 1 stop_ save_